>ELAGILAN_00001 Cytochrome c biogenesis ATP-binding export protein CcmA
MLECENLSCTRNNKVLFKNLSFKAELKSKILITGPNGSGKTSLIRSLSGLLPPVSGNIRH
CGKDIYDDPKSYISSMVYIGHKNACKDSLTVAQNVEFWAGIRNTRELIVAAICCLQLQPV
LNIRYGELSAGWKRRVALARLLISNANVWLIDEPFCNLDSATCELVLNLISIRSEQNGIV
IITGHSSTEQLCDFTTIDIRNFNRLLV
>ELAGILAN_00002 hypothetical protein
MPLTQIILYSVTLLAVAAVFLFLRKIYKNRIRKIILPRKVFKEEWEEDRKFNELYQKNKQ
KELMKQQETLREKQKDVQVYKEDPEIVDIAKPVGKWTKMVMMGNGLMQRFAQLIHREGGQ
KGFWELFVKAQASTQGKHKGKGR
>ELAGILAN_00003 Aspartate--tRNA ligase
MNCYKTHTCNELRKNDVEKEVTLSGWLYRKRDHGNLIFVDLRDFYGITQLVFNNDKDFFD
EISNLKLESVITVTGIVEARTEDTVNSSISTGEIEVIVNNLRVESEVEFHFDEEIAKEER
SILASITGEQEYPENMRFKYRFLDLRREKVRNNIILRSQIIAELRKLMIERGFLEIQTPI
LTASSPEGARDYLVPSRLNPGKFYALPQAPQIFKQLLMVSGFDKYFQIAPCFRDEDARAD
RSPGEFYQLDLEMSFVTQEDIFQIIESTLYRVFAKFSRKSVDKDFPRITYKEAMLKYGSD
KPDLRNPLLISDVTEIFRDSGFNIFKSNIERGMVVRAIPAPKTAEEPRSFFDKKIEHAQK
EFGAKGLGYITFDKDGTAKGPIAKFLDENRLNHIREATNIEPGDSVFFASDKENEAANIA
GKVRTLLGSELSLIDDNIFKFCWIIDFPYFVYDDKSKKIDFFHNPFSMPHGGLKDLEDKN
PLDILAYQYDLVCNGIELSSGAIRNNKLDIMYKAFAIAGYSRGEVDTRFGALVRAFRFGV
PPHGGIAPGVDRIVMLLADEPNIREVICFPMNQQGEDVLMGAPSKVEDKHLRELSLKVIE
>ELAGILAN_00004 Proline/betaine transporter
MNNIQKAILSGMICNMIVWYELTLFGVLTDTIINVFFPSEDHYLSTLKFLGVFAIGFAFR
PIGAVIFGYMGDKYGRRKTLLTSVILISISSTIMGIIPGYKEIGLLSPVLLVFCRIVQGI
TAGGETSINTAFTIEHSKDKKNLGFLGSMKPFSGALGTLLCITMIFICKRVTGENYEIWG
WKLLFYFCFFLGTIGFLTRYILKESLAYKTNKYANNLAHSPLLELVRNYKRPLIISINLG
IAQNAIVYAAIMFYNISIKELVILSISVKDLMRIVIQVVFAASAVLFAILSDKVGRKRVM
IPVLIMLSLIGTCVLPLLSSVNHYVVIITYLLITIPVGASFGIYGSVICELFPTKVRCTG
VSLANNISAGIFGGLSPYICMWLIEKTETKLAAGIYLTACALISLISVLQIKAKDRKVDW
>ELAGILAN_00005 Ribosomal large subunit pseudouridine synthase C
MLQSIKTILIEDDNVRLDRYIRRIFPDLKQSVIEKSLRKGLIKVDDCKAKSSDRVNSGQT
ITLKHLNYIENANSDRKYNEKLVNLLRENILYEDEYILAINKPAGVIVQGGVKVKISMSD
LLDQIREGETFKIVHRLDRDTSGVIIFARNANVARYLMEEFKGRRVKKTYLALTSGIPSK
DSGTIDYPLVKKYVSGQEKVVVDENSPQNATTHFSIIAKSKHNVAYLKLQPITGRTHQLR
AHLAHINCPILGDGKYGGKKAFIDGIANKIHLHSHSLSLKLPNNKEITITAPITKHIEKS
IEALFFD
>ELAGILAN_00006 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKAENFTKEQIIGFYRKMLLIRRFEEKAGQLYGMGLIGGFCHLSIGQEAVAVGTQAASKL
GDAFITSYRDHGLMLACDSDPNVVMAELTGKETGCSKGKGGSMHVFDVEKKFFGGHGIVG
AQVPIGTGIAFANKYKKKDNVVFTYFGDGAANQGQVYESFNMASLWELPVVYIIENNEYA
MGTSVQRSTLVTELYKRGESFGIPGKQVDGMDFFSVYEATSEAAEHTRSGKGPILLEMKT
YRYRGHSMSDPATYRLKEEVEDMKQNHDPISTLKKYMTDNKMASEEECKIIDKEIRDLVK
KSEDFAKNSKEPSVDELYTDVYKFVS
>ELAGILAN_00007 hypothetical protein
MNYYHWLEAFHVISVIMWMAGMLYLPRLYVYHATVKPGSENDSLLQTMEKRLLRYIINPA
MLFSLGLGITLMVIREAYREGWFHVKAFAILLMLIIHMLLAKYRKNFAMGSNKKSHIYFR
VLNEAVTVLIIVIVIMVVVKPF
>ELAGILAN_00008 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MKGLYIKTYGCQMNVYDSVLMENVIKPLGFNVVSDAGKADLVILNTCHIREKAAEKLYSE
LGKIHSLRKEMTIVVAGCVAQAEGEEVFRRAPFVDIVVGPQSIATLPELIVKASRSKGHV
INTDFPEVAKFDKLPDECYGNSQGSSAFLAIQEGCDKFCTFCVVPYTRGAEYSRPVNEIF
REALKLVANGANEINLLGQNVNAYHGECEGEVWDLGKLISHIAKIEKLERIRYTTSHPRD
MHESLYLAHAEEPKLMPFVHLPVQSGSNKILHAMNRKHTAEEYLEIIDRFRKLKPEIEFS
SDFIVGFPGETEKDFEETMKLVEKVRYAQAYSFKYSPRPGTPGAERKDQVPEEVKTERLL
RLQKLISKQQLEFNQSMVGKTIPVLFSDKKGKHQNQIIGKSPYMQSVCIDDSEDKYRDKI
VNVKVLEARQSSLLGCAFH
>ELAGILAN_00009 Dipeptide and tripeptide permease A
MDQKTDKFPQFLKMLCFVEMWERFSYYGMRALLVLFLTSHLGFTDERAFTIYSLFAATGY
AIPILGGFLADKLMGFRNMVLLGGIVMIAGHACMSLVKFEPGLLYLGLSLIAIGTGMFKG
NVTNLLSSCYGKDDPERSRGFTLFYVGVNIGAILASISCGYVAHLFGWHYGFGLAGIGMS
IGLIFFLKFQNLLGDSGLSPYPELMNKRILGIKIFGIVLIGSFLSSSIIAKMLIHSEFFT
NMLIFIGITALGIFIYIISKLSAEQRRKLVALSILVVFFLCFFALEMQLGSLVNLFTERN
VINNVLGITIPASVSQAINPLSIIIFGFLFGTYMKFKQKYATSMFTLGLLTMAMCFFTLY
IGCLNSNIEGKVEYLYLIIAISFMGLGELCIAPLVQEQATTLAPKNLRGVVMGIVMLSLA
FSNLAGVAISKFMSVPSVNGKINYLESLEIYKEGFLKVGIFNLMLVIVFLFFFNFIHKVV
TNSSCTKN
>ELAGILAN_00010 Isoleucine--tRNA ligase
MKSKHYPDTVSNPDFSSLEKEIIKFWQENKVFEQSVEERSKDNCFVFYDGPPFANGLPHY
GHLLTGFIKDAFARYQTMLQKRVERRFGWDCHGLPAEMGAEKELGISGRTEIEKFGIEKF
NNHCRTSVMKFSSEWEKYVNRQARWVDFHNDYKTMDKSFMESVMWAFKQLYDKGLVYESV
RVVPYSWACETPLSNFETRLDNAYREKTSKAVTVAFELLENPQQFKNIEQKCKLLAWTTT
PWTLPSNLALAIGKDIKYCAVSVHSLAAREAGIQEGNKCLHAEVTSNQPNEIYIFAESYL
EKFISHSEQNNIPYENCNIKLKANDLAGLSYKPLFDYFKDTKNAFRVFIADYVTGEDGTG
VVHTAPGFGEEDFYLCQSHDIPVICPIDNSGKFTAEVSDLAGVHVFDANDTVIKKLKGQG
SWFKTEQYIHNYPHCWRTDTPLIYRTMPSWYVAVTKFKSRMVELNKRVNWIPNHIRDGQF
GKWLEGAHDWPISRNRFWGTPIPVWKSDDARYPRVDVYGSIEELERDFNVKIDDLHRPFI
DTLTRPNPDDPTGKSVMRRVPDVFDCWFESGSMPFAQIHYPFENKEGFESADFITEYIAQ
TRGWFYTLFVLSTALFDREPFKNCICHGVVLDVKGQKLSKRLNNYADPMEVFDRYGSDAL
RFLMLSGSIVCGGNLLLDKEGNSIRDVLKNVIKPIWNSYHFFTMYANADGIKAEVCKDYQ
STIDRYMISKCFEAVEGIQASMNNYNSQEACKILMNFFEVLNNWYIRRSRERFWKSDLDQ
DKTDAYNVLYTVFYYILRAAAPLLPLITENIWQGLKYEETSVHLANFPQLEKFDSQLIAK
MDLVREICNSALSIRNTFNIRIRQPLGSMIIYHQSSCSFLEGEPFSVIPEFSPVIQVADT
GIQCAADSNEYQEMIKDEVNVKKLELVNRLEDIASLELKLSFPLLGKRIPDKIKKLVQYV
KEGKWKQVENEQVFLGNESENYIIEKGEYELLLKANSGYSAVFDNNKGVVILNTELNDEL
ILEGLARDVVRLIQETRKQADFHISDRIRVIIKTEDEKIKEAINTWFEYIKEQTLALSLD
INTEIGTNFYSKEYQDLSVSIER
>ELAGILAN_00011 hypothetical protein
MNKAVADDYEEVVNNSGGLGKAESVVTLEEEEEFFDAMEAVSNVEEGNNLGLATSEEEEE
FFDAVEEQEPLANFNVPLSIFHYKDYNSDFFTSWYNISSEIFKEINRTCPEKKILNLALS
VLMLPYIAFTALGLVVCSRFQANSKTQDSVGEDKTKKSETGVPKRLAYGVLAAIAIFVNM
AVLVALVVPATIALATFYLLNRDLSHSLVTALKISMGRYSNKHQNIEVSFHEKEVTGPNI
AWDMEIEFPPQFKRLLRDLYENENNKWFDVTRNSEHSIVLKLSTNINLKNGLKPLRNEIK
DVLATSIQEFAKTMEELIKLEKKEITYDKLKELLNEFKSKEVDSIGPNLTSHLIQSAYQV
AFIQAIKFQRDRRGEDFSLEDEIKNSLVRQELESLRGIGQTRCNDIYKKLKEIHENSSLT
NDTLKRGLEDLFKFEYDDQEIERRLIKSVMKKVQGKLSQSDIPDKEKQSLRKQLEDLEKK
VKVPSDKEASAKINDFIEKMYLEIKKYKVQRLLREQKKGVLRLCKKLRKYGESGLAEIIE
AFRVQDEGHLEKSTLEQTLKDQNKRLQAEQNNREKGHPGTRSIEVLLKRNEEILKALKQL
ELGKKELLINEETKNDYKEELTSREKIKFAVIEDDLLKVFKLETFDEKEIKKLLERAELE
YCLAEKRIKYPVIKTKDNIKHFSQNLLSPLIDNLTKNIINNIPGNSEGCIQKVKNWSKVM
FGAIKIGASNAYKETTERKALNVAHNTYKEGETFLQCFQSNYEGIGAFLGNLFSDDGVTF
KNDVWPKIEEHLHGMWDRFFKDIEFNIENKLDEVSVTQQRQETMIVTQR
>ELAGILAN_00012 Phenylalanine--tRNA ligase beta subunit
MKFTLSWLLEYLETNASLEEITDKLTHIGLEVEDVIDNTKLAGFIVAEVLEVIQHPNADK
LKLCKVDDGSKILQIVCGANNVREGMKTVLASLGSTLPESDFTIKPTKIRGVLSEGMLCS
ASELALVQEESEGIIELSDDYKVGDKFFNCDPVIDINVTPNRGDCLGIYGIARDLAATGI
GTLKTLSIPQLTSFINSPIDVEVTDGESFISGIYIANVKNQESPKWLKDRLESIGMRSIS
AIVDITNYIMISFSRPMHAYDAKKIEGELTVRKANDGEKFAGLNGKEYLLNKDISVIAGD
KNIHGIAGIIGGKCSECTLETTDIFLESAWFDPISITKSSRQLGISTDASYRFARSVDPG
FTFDGLNLAAKMILDLCGGETSSVVSAGSLDSVDTKVSFDYQDVNKFGSVSVSPDEVLDI
LTKLGFSIDKKTEGNWNVQVPSWRPDVTIPADLIEEVTRIYGYDKIKEEPLPNNVEEVDS
TYDNLRILMTNRGFHEVLTWSFMSESTAEKFGYSNKLFIIDNPFNNNFNIMRPSIMPNLL
QVTADNIAHGISDLAIFEIGPIYDGEARSKHVLSGIRTGNNLPRNHYNTDRKVDVFDAKA
DCIAALEFFNVNCDNLTIEKAEKEHYHPGKSGTLSFKNKVAGYFGELHPNILDLFDIKQK
VVGFEVILENIENLPVSRKKFIDYKYQSVKRDFAFIVNKDVEVGNIINVIKKSSELITEV
LIFDVYHGNNIEPNKMSIALSVTFCSPIHTLTEKEIQKESSAIVNLVCENTGGTLRTYR
>ELAGILAN_00013 hypothetical protein
MNEIDFINTNHPLNLEQEFGNGYIESVDCFLDEDTRDYYIGLNNAIIHFFFDGNIDEDAW
DYESLKFFLEIDLKGDIEKILSLRKKI
>ELAGILAN_00014 ATP synthase subunit a
MALNPLEQFKVYTVIELPRLFGYDVSFTNSSLFMMISVILVILFLLFGIKKGAVIPGYLQ
AAVEYVYDFVISIIENNTGSKGLQHIPLIFTVFIFILSCNLVGVLPYSFTVTSHVIVTFA
LSMVVFIYITIVGFKERGVEFLRILLPKGTPSWLAPIIIIIKLFAYLVRPVSLSIRLAAN
MIAGHTIIKVIAGFIVNMNIFFTPAPFLFIIALIGFEVFVAILQAYIFTILTCVYLSDAV
K
>ELAGILAN_00015 ATP synthase subunit c
MDLVALKFIAIGLAVFGMLGAGLGIANIFSAMLNGIARNPESEGKMKSYVYIGAAMVEIM
GLLAFVLAMLLIFAA
>ELAGILAN_00016 ATP synthase subunit b'
MPQLDVSTFFSQVFWFLIFFSSLFFVVSCLFLPKLDKIISTRSKEVLGSFNSSVHLLRLT
EEQIAKYNAALNQARIQAKKIIDDALAQVEEMRANVKNILEEEDKKMSKLIEEKVAEFKS
EYTDQLKQMATSIALIYYTKLTNSEIEEEFIADLVSKEF
>ELAGILAN_00017 ATP synthase subunit b
MSTSLIIGLAFLVGFVLSYKLLKKVIKNALNNKRNKSKFSSEETEKFRKDMLEYYKKSSE
KYKKLDAEVNEMMNEALDKANSIIKHNRQQLDQTLDDNAHSNLKKVTDQVEKALGDLQAN
TASIAADAVKKIMHERKDDKRSSEVISSFSRDLNKKLH
>ELAGILAN_00018 hypothetical protein
MPILQADNVEKIKFDSSLCKEQEKLFYYKFNIIPWQKLNNTTFFMVEDTSRDINRWVEAH
YGIDYVLIKVDSEQILNLLNSHFGISEFASNYLYYKNPNFSAKSIKLSSIFFASFFIVTS
ILTLTEKYTYFALMLIFIIGCSSYLFKFIATIFNLCETSNQKVDYSKLNEEDFPIYTILL
PAFKESAVIEQLIESIESLDYPKSKLDVKLQVESDDQETLAAIEKYTLPQYFEVIKVPHS
LPRTKAKSCNYAMSFARGKYAVIYDADDKPDPLQLKKALIEFNKGDDKLACVQAKLNYYN
CDCNFLTKSFSLEYMNWFQYLLPGFQKMNMPMPLGGSSNHFSVKILRKMFFWDAYSVTED
ADLGLRLAQMGYKTRMIDSETLEESPIAVFAWIKQRARWIKGYMQTYIVHLKNIKSLYKH
TGFKGILLLNLFVGSAAFLFFTTPFLLLSLILTKVLNELFLYYFVVVYVTNLILLVIAVK
QQKMPFYFYIVSIFFPVYSLLHSVAAFLALWEFILYPERWNKTQHGLWKQNL
>ELAGILAN_00019 Heme A synthase
MEQNSAWFMEAKPVAIWLFLCSVMVILMVGIGGFTRLSKAGLSITEWKPITGTLPPLSEQ
DWLQEKLKYEATPEYKALNYGISMEEFRAIYLIEYIHRLVARLTGLVFVLPFIYFILRRK
ISKKVVIKLFVALLFGALQAFAGWYMVKSGLVAKPHVSHYRLALHLLLALVIFALLSYQF
FDYQIRPQQTKLKVSGNTIYYARMILVLIVIQIIFGAFVAGLNAGLIYNTFPLMDGQIVP
EDLFFLQPIWLNIFENRATVQFIHRALALLILTLVVILTVKNASIKPVYIMLLSVVIQII
LGVITLLLHIPIAIAIAHQVFSFILFGSSLYFLCYLRKQTTSPICTFFPS
>ELAGILAN_00020 Acetyl-/propionyl-coenzyme A carboxylase alpha chain
MTEKKYSKILIANRGEIACRIIRTAHKMGISCVCIYSDADVNSVHVRQADESRYIGPSPS
CLSYLNIEKICEVAVETGAEAVHPGYGFLAENPDFPRALQKHNIDFIGPSAETIEVTANK
ITAKEAAKKAGVNVVPGYMGKISDAAHAAQVAEEIGFPVMLKAASGGGGKGMRIVNSKKE
IELAFTSATNEAEKSFKDGSIFIEKYIELPRHIEIQIIADKYGNIVCLGERECSIQRNNQ
KIIEETPSPFISEEVRQKMYVQCVSLAKQVGYFSAGTVEFVVDKDQNFYFLEVNTRLQVE
HPVTEFITGIDIVEEMIRTSCGEKLRFNQDDIKLTGSAIESRICAEDPSKKFFPSSGRIK
YYDKPGENDYVRIDDGVAAGSEISMFYDSMIAKVITYGKDRVEAISRMQKALSECYIEGV
TNNIEFLESIFHHPNFIAAKLHTRFIPDHYPSGFHGDFVTEEYIKIFIFTALYVHLENEE
RYHHKAVNETSQVSFQCVTLESSKKEGAPVSATRMAGDRARDLFIVNINDNEYSVNAKYQ
DNILITVYNHNKYSVIGKWKSSYRLLYITINDDTNIALKIERQGSKYFIRHAGMKAECCI
LKPHVAELSKLMLNNETEGISADAVKSPISGLLVKLHVNVGDQVEIGQPLFVVEAMKMEN
IICAEAAMVIKNIPVQEGKNVQIGDVVCFLK
>ELAGILAN_00021 hypothetical protein
MYELVDIAKLLSDNEANINWHYTGPFDKTKQRIRGDNLLHLAAKTGKVDKFLSIFKKSVE
SNVHLLEYNKDHENPFHIAAEVGILPSVVKGIFKHLESEKTNPNCDPKKLENVKNYVKEA
LCNRCALDQSKKTPLDWVSKTVKKEIKEIAGIKDSFICNQKFRLCLYIVGAIACIAALCL
SLYFLFLVSQSLALASMAGIISGGAAYLSGKVFSEIHDLHDVSTPVETFSNEDLARI
>ELAGILAN_00022 Glutamate--tRNA ligase 1
MLDVVTRFAPSPTGFLHIGGARTALFNWLYAKHHGGRVLLRIEDTDRKRSTKEAIDAIIE
GLRWLGVSYDGEIVYQSKRIERHKEVANLLVEKGRAYHCYCPEDEVAEKKIKAREEGKIY
KHKCTTKPPSCHPSSRHWDPEENMWSRAGMTSGVRSVIRFKVPDSQEIVIDDKIYGQIKV
NSNQLDDIVILRSDNTPTYIFAVVIDDHDAGITDIIRGSDHLTNTFKHLLIYQALDFDIP
RFAHVPLIHGEDGNKLSKRHGATSVCDYEKMGILPKAMRNYLLRLGWSHGNDEIISDEQA
IEWFNLESIGRSPARLDFKKLEHLNNHYISNMSNEDILTLMLRENTLTDKKKGYLLQGLT
ELKKRANYLTELLDLAKFYIQDPPLDLSEEAEQIVKSNLDIIKLLASFLSEIGDENWNKG
FLSSQIKECAKLHDMKISDVYHSLRAPITGVMDAPGIIDIMVILGKDECIRRLQAI
>ELAGILAN_00023 hypothetical protein
MLGNDNTSYSLISAVREGRLERARELINSFGLSYSQAWSEGYVLLRDAIENKHTAVTKLL
LTNGSKVNSKNKRPSNTPLHFAAINGDIEIVKMLLDRGANIDAKNQYGRTPLHNAIENKK
MEITELLLNRGANINVRSNDGITPLHIAAEREYLQIVEHLLKYGAYVNCVCTSTWKKGYA
PLHFAVEKGSKEVITLLLSRGANVDVKGEDSITPLHIAAKKGYMHIAEDLLNHGACTHSF
TLKEGYTPLHFASELGNEEAVKLFLNKGADINASTNSNLTPLHIATKTGRKTVVKLLLQH
GAKVDNQDKDGKTTLHLAVEKGYLMIVEDVLKYCPDINHQSNRSSLKIAVHGYGEEYKKI
VEALLEYGLIVNLEDANNPKLLHAAVEKGYLKIVEDLLKYGADVNTLHNSTSKEGFTPLH
SAAKNKQEEVAKLLISYGADINAQDKTGKTPIFYATENADLKITKLLLTNRANVKDNPEL
LNIAVKKECIEIVEALLQHDTDINASDKYGRTALHFTALSESEGFFGFLTNEDPDINIKG
EIAKLLLSKGANINAQTKNGITTLHAAAQKGYTKVVEALLEYNADVNSTVKSDITPLHLS
AQQGNEVRGCPETSKRL
>ELAGILAN_00024 hypothetical protein
MHVPKQQTSFYQEDKQFLSRSYTSKEEFIREYKKLYRRKAKAEELYLLVLTELEEAISDG
NVDSLKKLSNFIDYISDAEDQVTLRDYYDNANNPVKSTNLVILACKHNKVKILEYLLGNN
SKILSNLSVGIRETTILPDDEDETCHNAFYYAIRSGNVELLDTLINKWPGNYFAVHFREL
DEILSRSYEELKLKNVFLSEEIEIFVENKLINLRFFSSASGQDQNVKSYLNNIRERIELV
LQNISLLKAEYSNTEKVDEKFLFIAKFIAQNIHILKRQLKSTYNRLPWEEMEFCLISFVS
SHIKRQEMNLFYNATLNKSKILNHLENFAKKLKEEKDIIEGVDIGKFADLPKLKRERVVA
EIVRNYPQFGELYSDYQQIRDIHSLEKISDYIKLALSADPKQREGQLIITRVLQVIGEYL
KNPLESPKLSSTTSELLLLSLPRNTREVIIDLRNSLSHAYSLSKRTEIEENTDVSFFIGV
QNDTKRIDNVITDILYNNKIKIVIMLLKKITSSENLDEIKEVAGIFSNVELDEMITESFK
VMEHYKLEKLIKELSNNITEKTNYEKELFNKIDNIINFAKTKSKNIRTDYVTAFISLKSL
DVGLNDNKIDHNVIRGIKFFANKTLENIPSQIESHNLKEIAELSMKISHSVRSRIQDDNL
DKVNRLTCEIFYIAELGTGDLKWIEELRNKLNEKGSFIPIHKQRKAYNITEEKYNNQLEL
KLSELKSILRNNALSGKLTEKLPSYKRNKELQAVVEMLVLDIMSILGRSEKHLENNLLFL
DDNTPLLTGKCLRNHLAHDNTLVDVLLSDPSIAVILNAKKLISENVIKSKKKIGKSVRDD
PSKLKDKYDQNLITITNQEKMFAALEEGNLEDLKSYLKKGADINARSINSWTTLHFAAKG
PSLEIIKFVLNQNLDVNVKDINGQSPLHIAAAYGRKNIVEFFIGKTGVYVDDLDNSGKTS
LHIAAKNGHKDAVEILLKNNANTNTKDIAGFSPLHYAIKNNHIDVAKIMLEKEANVDINE
TMGGFTSLHIAAESGYLGLVNFLLKNEANVNARNDKEGIPLHTAALNGHLEVVNALILKG
ADVNSRVIDGCTPLHYAIENGHEKIANILLKHGANVNVVDKTYNNTPLHYAAKDGHEKIV
KALLTNKANASIATVEGITPLHFAVQSGHLKIVVALLEHGVNIRAKDKNNATPLHYAAES
GHKAVAELLIKNGVEINDKANNNLTPLHVAALKGHKDIIELLIRNKAEVRAQGIKVSTPL
HAAAMNGSKDIIDLLIKNKAEVDARTNDGMTPLHVAALSGHKDAIAFLIKSKAEVNTSAN
YGLTPLHAAIVGGHKDIVNLLIKNKAKVNTEGIAGSTPLHVAVEGGHKEIVGILVANRAS
VNVKSNNLTPLLSAIKHNHKEIVEVLVENGASVNAEGGEPLSLAVLAGYRDIVEILLKNK
AHIDIKGPEDATLLHLAAKRGHKGIVNALIERGANVDAMTINSITPLYLAAQEGHEEVAE
VLIANKANVNFVNVEGTPLHIAAGHGHVNVVEVLLSNGAKVNVKDNKSRTPLELAVAHGH
LQVVKMLLQYKKVDMNAKGNDDWTILHIASQESNLEMVKCLVDEGSNINAKNASGSKPIH
IAAREGYKDTVEFFLSKGLSINELGTANQTLLHYAAMKGRLEVVKYLIAQGADVNAKDTN
GLTPMHIAANFGYKDVIEVLLKNGAVYNAVDKLCRRPLEMTNDKDVINLLASTEKLFEAV
KRNSSSEVENYIKAGAFVNAKNADSVTPLYYAAWKGYDGVVNILLQNKANPNVVGNKGFT
PLHYAAKFSHLKVVKALLSNGAVYNAVSDSGKTPSDFTVDKSITSLFKLVSESFKKVKDG
NAQVINDLNKIKDIDTVKAVMSARNRENKTLVVAAVHSNFSKVEQLKQISQSDVSAQIDT
ALVLLNQGNYQKALSIFRSAFERRKEILGTDNPGTLDIQTYIAKVLYKQGIYQEALNMLE
EIFQKQKEMLGSNDKDTLSTRSTIALVLHRQGKDEEAFNIYQEVYQRQKEILGSNHSDTL
NTQFHMALVLDKQGKYEEALNINRAVFEKRKETLGTHDLATVSAKNNIAMVLANQGKYEE
SLKIYKEVFEKKKIILGINHADTLRTLHNIAGVLFNQNKYHEALKAFQEVLNIQKKALQQ
NHPEALNTQYNIANVLFAQGKWISALKVYRESFDQRKAVFGPSHPSVLDILKKIEMINFR
FKLEGSEASEVLQHLQKDINIAASKGDIRTVQRLLKDGADANDKDIDGRTPLHYAVSNGH
IDIVNILLTNGANVSQVTNKGNTPLHTATSKCYKEIVEVLLQHISRDKLNDFVNAKTTSS
GTTSLHVAAKGGSLEVVKSLLKHGAIYNIENKEGKIPIDLSKDQKVTNLLKLIEELFGDA
KKGNVEIISKLKAVKPDEFIAVTNARNNQGNTLLQVAIANKHKNIATKLLKMLKEPDQNL
QDVNIESGVKSLKL
>ELAGILAN_00025 hypothetical protein
MLNNNINKELEKAVYERNLEKVKALLSAGANANLRVERNRDTLLHTTSSVEITKELLLGG
AEVNSRNMYSETPLHSAITLGKELELVRELLKHGADVNATNRKGNTALNHAVKKSGKNLG
VVKELLEYGADINIRNRERRLYDNCSTSLDNAVSDLACTKLLIKFTLVRNFNKDYGKIID
LSPYKGCSNYSKLSSYLDDCVCEILQMKTDEIKDSLPLYEFVTNNFNIHVLYNNQLSVRL
AKIDYSIRYPIYNDIILDKVKPFLERADLLNKLSKIQFYTKLDVADQDAKEKKIILDHDS
TYNITEYLYNDNLLNFIVAFDDSNKRTFQSLSPLNNLVEPGTRLYETSISNDTKRARLE
>ELAGILAN_00026 hypothetical protein
MFTNRISNNLDQLQFFVEFLNENYETQKHLSLTPLHLAAGNGQLDLVNTLLGEGLDINSE
IKYDGFTPLYFAIAKNRLEMVNFLIAHGADVNHRAILGFTPLSFASQQGYLDIVNTLIAN
GADLSTKTDKLNTPLHLAAENGHLDIVNVFIEKGLDVNAVNNDRARPLHSAVQNGNLEVV
KALISQGSNINAGSSGIGNHKVDANITPLHLGTQTGRLDIVKVLLEAGANVNAKTDDKIT
PLHLASQNGFLELVDILLKAKSNVNAKDYENLTPLHLAAERNHFGVVKSLLLVKGIDVNA
KGHDNSTALHIGSQNGHLEVVKLLIEKKANVNAKKNEGFTPLHLAIQQSHFEVSDFLIKN
GANINTVDDQNWTPLHNAAYNGFSLKIVESLIAKGANINAKMDDGRRALHLAAEHNHLEI
MNFLIENGADINALDNRSWTPLHCAAYDGSLEVAKSLLDKGADINAKTVKSTTPLHFAVD
HDHLEVVELLLEKEADINALDHTNWTPLHFAAEKGYDQIATVLLKHGADVNVKENQNTGT
ALHLAAQYGHPKVVKTLIINGADVNAKMDKNATPLHLGAQIGNLDIVRSLLMSGAYFNAR
AEGGRYVLPLHFAERRGNPEVIKLLKLVEKLFKAIEDNNYLGIESFIRDGAIIDSKNVDG
RTPLHYAVNNGHIKVVNILLANGADATKVTNKGNTPLHTAASKGHKEIIEALLQRVSHNK
LSDFINAKTIVKGTASLHVATENSFFEAVKSLLKHGAIYNIKNKEGKIPLDLSRDQNITN
LLKLVEELFENAKNGNVEIISKLKAIKPDERVAVTNARNDQDKSLVQVAVINKHSNLASR
LLEILKSPDQSLQDVSVENRVKSLKL
>ELAGILAN_00027 hypothetical protein
MTKYILSVDGGGIRGIIPAIILAEIESRTKKPISQIFDLMAGTSTGGIVVAGLCESNKLQ
YSANDLVELYQEYGAYIFQASLWRKSIASWLSGSQYSYKNMEFILNKYFGESTMADVASN
LLLTSYDIHNSCEFFFKSWKEENIKLKDALRATTAAPTYFTPKRLKISQTERVLIDGGVF
ANNPAACAYASGKRLFPNDEIILLSIGTGGTNRSIKYANSRRFGKIGWIKPLLNVMFASG
LDCVDYQLEQVIDDKYIRIQSQLKVASTEMDNITLKNIKFLQQEASKMIEDNQKVIDKFC
KQNPKL
>ELAGILAN_00028 hypothetical protein
MTNTGKIPVAVIATMVIQTIALIWWLAKLDLRVHMHDKFIEQNQRTTEIIYRLEERVKNL
AEEVNELEQRQK
>ELAGILAN_00029 hypothetical protein
MKSSLFWKLLTSSIIPIICVIVLYQHFSTDQLSKDVPIKSKASGNDLETLSTAAEKCNLD
TVRSLIKNVVDINATHHFGATSLHYATSGGCLEVVKFLIEEGIDVNTTDAFSWTALHYAA
RKGHLEIAKFLLKNGANPSAKNKDKKTPLDLAVEELNNNKEDIYEEIINLLSNYQLFP
>ELAGILAN_00030 hypothetical protein
MTPDFSISVEGISITELVKSRLVSMHITDEAGVISDTAVIHLDDRDSLFEIPRTGAKLNI
LLGYKETGIVPMGDYIVNEITLQGPPQSLKIKSHAADLKESLKEQVFNEWHQITLNDLVK
KIADKHGYQAKIAAEFVNIMISHIDQTAESDMHFLTRLAQIYGAIAKPAGGYLLFVSKGK
AKSVTGKTLSTVTLTPRDITNWKVKFNERNQYGSVIAYWYDYEKAETITEKVGDQEPSYI
LRDIYASSDLAQSAASAKLNQLMSNAATLNVTMPGNPELFAEAKINLSGFRKGVYGKWII
NRAEHVIDNLGYRTIVTGIIDSWKVN
>ELAGILAN_00031 hypothetical protein
MYYKTKENDMLDLICWNYYGFSSGAVEIVLRANPGLAEYELLPAGLIIKLPVIQKETQKQ
VVKLWD
>ELAGILAN_00032 hypothetical protein
MLSLGPYRFSLIEQGFTRRSEYRWPALERIGEKPLLQSIGPGEDIVELAGVIYSGGLKQI
NNMRNSSKPLLLIDGQGNILGHFVIVKIEETQKYFFPNGEPRKIEFHLSLKHYDNVLSDG
SLNNPVDNIQLDDDVLQN
>ELAGILAN_00033 hypothetical protein
MKAISIVIGATLQSSFNSTIAGSTKQLSRIGSTIKQLESSSKSVSKFKELSRDALLARRS
WDELEIKTKSLAKQIKNTEAPSKKLQNEFTRSKAAALKAKTAYLQKRSALHLLRTEFSKS
GRDIKSLIGDQVKLGSSIEKLKNSYTALNSVMQKRKGVLAQRANFRAQIMDTVALGLTLA
APLKAAISFESAMADVKKVVKFEDTDVNGLTKLGETLKEMSRTIPLSAAELAQITASGGQ
LGIKAKDLTTFTDTVAKMATAFDMSAEEAGDAIAKLSNIYQIEIGEMKGIGDAINHISDN
TAAKAKDIVPALNRIGGTARQFGLTAVEAGALASSFISLGKTPEKAGTAINAMLSKLQTA
SKQGGNFQKSFQQLKINAKEFEKAIGKNAQGTLLKFLETVAKLDKQERSSVLFDLFGLEY
QDDIALLTGSLDEYRKSLRLINEEYHGSMQREFENRANTTANNLQLLKNSIAEVGMNLGY
VLLPPLNFTVNLLRSATTQVALYAKEYPVLTTVIMSTTTALISIKIAAISLGYAWTFVKG
SLFALLSTWRMFGSVITLVKIGLYSTSAVFPAIIAGFKALTIAVMSNPMGLIIGGIAVAA
TLIITKWQAVKNFFVTIWESVKIVWKSFSDWVGKFWNNITQPFRTISNLWNKRNESKLEV
KSVNNVISDSLKYPIAAHSKAIENKTQNNHFSINIHSTPGQDTRSIADEVMERIREQFSG
ALYDIN
>ELAGILAN_00034 hypothetical protein
MQKIKLTEPIKIDGILVSEITLRRPKVRDRLAVERMSNNDAEKEVALIANLASISREAVE
ELDLADYSKIQEALQGFLSQQKS
>ELAGILAN_00035 hypothetical protein
MLPKILKNFNVFVDGRGYAGKIDEITLPKLTIKTEEYRAGGMDIPINIDMGMEKLEAELT
FAEYDSELFRLFGLINNNAVSLTLRGGLQGSSDTESVVINLRGLFKELDFGSWKPAEKAM
LKCTVAANYYKLTIDGKELIEIDAENTIRKIDGVDQMTSMRTALGI
>ELAGILAN_00036 Putative prophage major tail sheath protein
MAEEFLHGVNVIEVTSGAKTVRTAKSSVIGVIGTAPEADEQKFPLNSPVLIAGSLKEAAK
LGKSGTLPSAINGIFSQIGATVVVIRVEESETIQNIIGGVDKETGEYQGIEAFLSSESIV
HVLPRILIAPQFTHQLPEDGKNPAVAALVPIAEKLRSIIVADGPNTNDEEAIKWRKSVGS
SRVYVVDPWVKVFIEGKEEILPPSSFVAGLIAKVDSEQGFWHSPSNKEINGIIGTSRPID
FTLGNTNCRANHLNENEVTTIIHQNGYRLWGNRTCSNDAKWTFLSVRRTADLINDSLLRA
HLWAVDRNITKTYIDDVIEGVNSYLANLKAQGAIISGKCYATPELNTPANIASGKVSFDF
EFTPPYPAEQITFRSHLVSGTIL
>ELAGILAN_00037 hypothetical protein
MPIYIRFEHNKQVETTTLKSKPAGNDWYEAPENFEWQKSYCLTEGGEIAQRTKEDIQKEL
LDNAKLCAFDNIRTHFNNFTSRFSGHSHQKAKSYEIQAKTAENILTTQESIDEKDAAIIE
PLARVRGISVVEMAKIIEEKAEKAVKAIIKCEELEDLAKRKIEEAKSEEELEDLLNNFKQ
KMQRNG
>ELAGILAN_00038 hypothetical protein
MKEAIYQRIKDLAVSSTADQLAYLAKSLELIADKKAISNVVQMTEVKGIIDALQKRLKDL
VANSTPDQLAYLAKALESIVDKSAVSEIVQMTDGKLKELLDSAKKHLSDINSNKTNSISS
ITAVKTESVNEINKLRDNSLNTLKASSDSHISLLDTRKNANIAAINSISNSHKDGLKGLV
EDFRAVNNVPSGSSIIREIETRDNQLKTSLINEVKTRDEQLKASLINEIRKRNMAEPGSL
PFLFGVLGRKNNYFGHGTFTTELGKWSSDITKTDYMLQLLAGSHTYNTDYVSFYRPRQLS
FIEGSKGTFIYGELCTKSFSGSYDEIYYYPYAALGVVFVKNTTNVNINKTIEFIGSSYSS
TEYGGAGLFVGTPDNTNSNKSSISKIVWKNVYQYTSSDSKLAGSGNVEIPAGKTVAILLY
TSSYLCSRTQVSQGMLASNYVYNYGQFIQWGIYNIRSNFLTTGLEVDVERTLRAWQCPGL
DATHKIWN
>ELAGILAN_00039 hypothetical protein
MPNDKTSREYPLPHPENIAVEDVVRIRKAIEKIDEDMSKGENKHNQLKSNFERFRFETFL
NFWE
>ELAGILAN_00040 hypothetical protein
MEKRANNQGKLKGKVKVPANIPAGTKLVQFYGDKGSYGEATYTGKKTITIEERRRVIAAR
RVDPLAQTFTLNESRHIGGLELWFINKGKKRVVVQIRETAVGMPSQTVIAESYIEPKDIK
IDGTATRITWSPVFCHAGEEYAIVLLTDDPGTAVKIAELGKYDAVNSRWVTSQPYQVGVL
LSSSNASTWTPHQNLDLTFRLLAAKFSEVSHVVDLGKVTVNNVSDLIVLTNVEKVAFDTN
VEFILTDEEGKENFLSDNLPLALRERLSGELTVKANLKGSKEKSPVLYPGLQLVMGNIGE
KGDYVTKSITAGTNTKITITYDALIPGTADVKAYVQKNVDWQLVNLTSGKPIGENWVERT
HVLTNFNANETRIKLVLSGTVVYRPKVKNLRIVIT
>ELAGILAN_00041 hypothetical protein
MNLLVSGQPLNDFPISEIKKVDITVQKTITVTHGSYSGAVDPIPDSAILELIQAKQGNVI
YENSIDYKLNAGNVDWSLPGKEPAPGSSYQITYRCRTHVSPEDISEEGCKVKGAVDNSLV
LIDYTWKMPRFDLITIDSKGVVRRIKGIAHPWRPSMPKAPSGQLLLCYIHQTWKKGEGVK
IVNNAIHAVPMNELEAMKKRINDLYALVAQERLRSDANSREPTTKKGVFVDPFFDDDMRD
QGISQFAAIVNRELVLPIDVEVADIEKGGERYLLPYELEPVLEQLLQTKGEKINPYQAFD
PVPAQITLNKNIDHWTEVKTNWKSPVTRVFNAKETTELLSSTSYETEFMREAVQNFEIEG
FEPDEKLKEIKFDGISIIPMA
>ELAGILAN_00042 hypothetical protein
MADNLSLELIKCLINQPGLDVNVRGLNGKTPLHCAIEFDELSMVDLLLTKKNINPFVEDN
EGKTSLDYAKEGKKAEILQALINNKYGSEQDSLLHLAAMIGEVNAVRYLIRKDTVLLVNK
KVIKILQIA
>ELAGILAN_00043 hypothetical protein
MGPFGQNSGFGGPDLGPSLALDIFQMLTTYEIIAEKCLSSAKKGEKKVRITQAEWAREKG
FSRQYVCSLVKKGIVELEDGLIDREQANEAVAAIRDPSQPLRRKERGETLSTILLKTRIK
NETERGKLLEAKVKAEIGKFVSIEEEKTEAFNVARVVRNNLLNIPNRVSALLASLSDTEK
IHMVLTEEITNSLQELSNTKFQI
>ELAGILAN_00044 hypothetical protein
MLTLDLGKQTGWTILNDGIVQSGSKSFHVSRFSGGGMQFLNFRNWLNSLKYKFPGIEVVY
FEEVRRHLGTDAAHIYGGFLAHLSAWCEESNIPYQGVSVKTIKRFITGKGNASKADVIEA
VQKKGFCPTDDNEADSLALMFYVMNFSKDFNTLEIS
>ELAGILAN_00045 hypothetical protein
MFRRFLNKHLQERVNYKKFSKIEDFLDVIFSNLVYICTRQLKDLVNKLAVKEFSC
>ELAGILAN_00046 hypothetical protein
MLLCRTGAKINNTDAIFNLLIFCYFFLRIILMQFKIIQFRFLEPILNGFQRMGSSGFLKL
Y
>ELAGILAN_00047 hypothetical protein
MKLQNYHIVIKNVKYQAYRLKLAKCFINEAHEDLEQELFCEIWPCLDQYDEDKSSFNTFV
ARLTENKAINLLKKQRCAKRDINNYISTDVTELLESEITKRIDVDYMISVLPKEWQNICE
QLKFFNLHEVAKMNNVSRTTLNNIIKKIRAKLSSIYYAGKKKN
>ELAGILAN_00048 hypothetical protein
MVLKILNNNERLQTISTVKMVIFGPYGIGKTSLLKTIDEPTLCLDFEAGLLAVQDWKGDS
TEIRTWNEARDIACLIGGPNPALKSDQAYSQRHYEHVSSKYKDFSSEFSKYRCIFVDSIT
VASRLCLLWAKMQPEAFSERSGKQDMRVAYGLLAQEMMAWLNQFQHIRDKDIIIVGTLGQ
YLDDCNRPVWLPQCEGTKTASEIPGIVDEVISMVGIKKDDGTEKRSFVCHTLNPWGYPAK
DRSGRLSMVEEPHLGKLLTKIKSKF
>ELAGILAN_00049 hypothetical protein
MLEDLLTDFNTVKPQSRLIPKCTIVKVKMTIKPGGYENWFTKSYATGSIYLNAEFIVTEG
PYAKRKIFQVIGIKSGKASVEGDTWGESGRSMLRSILESARNIHAHDTSEKAVIARKINS
IADFNGLEFTAKVGIEADSRYGDRNRITAVVTPEQNNSIESDWVPF
>ELAGILAN_00050 hypothetical protein
MKYDEEKLWSAVVTRGIQDAVGKNPKLREEAINWLNSKSFETVCELANLNFTRMKNMYGS
FMSKKQEKIKALLIDNIKECVSYLLPNGEFYRDKTYIGNLNGNTITVKIVGKEAGDWRNF
TEGTGGDIIDLWILIKGDIYSARKWLNKKSKSGEKKGGKREEKIFSVKQYLSDQSPIPED
IIAPRILTPGGLLVIGGTPKVGKSYFLLSLLAHLAAGVSFLKMKSARPLKIIYLQNEMEY
NYIRERIQQIITNQRLPNLAEENLIVTTKMRLTLNDEGIERIKEIIGEKFKTIDLIVLDS
LDYENMFSGLQSRVEKLRSIINPMAGIIITRHTRKVSTATLAKSPFQALIGANALRSFYT
SGMVMFQPSKRANVLQVVYELRNGKSIPAKFISRVNGRWQNSKIIATA
>ELAGILAN_00051 hypothetical protein
MVELKTQLLQNIRSCLFHLLPRGTFRGDKFYVGDVQGNKGKSTVIELTGERAGLWKDFAT
GEGGDIIDLWATVHGKNAKIEFPEVMASISEWLGLKKQNNIRNLEQYLTCSWNYYDENNQ
LIVIVYRYDPPLEKKQFKPFDVKRQKFKEPEIRPLYNIPGILKSDKVILVEGEKCAEALI
EKGITATTAMFGANAPIDRTDWTPLRGKHVIIWPDNDEAGNKYAKNVEKKLLELGVASLA
MLKIPPNKPKSWDAADCLLEGINIEEFIEKNSRKIIIKPPLDIFSWSVERFVGPVPKQRF
LVEGLFPLGVTSILAAMGDTGKGMLLLDLALKVAGSVDQVCGFGQLVTEHGSVVVFSAED
DTNEIHRRLERLDPKCERLKYKDRLFIVPLPNIGGSFTILKNVRGKVVEISPEFESVVKQ
LSKVKDLKLIIFDPLASFIHADLNADPAVGDYLMCLLSDLACSTGASIITAHHMRKLKGE
KPISTVEQARDAIRGTSALVNGVRCSFAFWPVEDMTKPMIFRSIGKIPRQNALFYGAVVK
ANGLADRTIRTYLRNEETGLLEDITEQLKAQNISDKDLKIYLTDSIARAASSGHPFTHTG
SAGIHKQRHRLPEVFHSMGRDRLERIVQELLQAKQIVKGMANGSKEDKWLDVKTGPFARG
VGKFTHGAENF
>ELAGILAN_00052 hypothetical protein
MVLKSFHEQIADLLSLNNSWINPSQNHIKAARYLFDLGLIKMQERCYIVCSREEDHLDWP
NVIDPSCSNEIFIDPDFDEACDDAICENCSRHILPNTYKKQRFHLLSIYLNTERIIDWFE
IKLNDSRLMWEKVEKGVYYICNQGRIVNLIILDFCTDAIFLTIDKLRVHPTVLITLKKDI
PNLLLSLYVVPMVKLFCQLKTLTEIFQEAAKRGVPEVVENTSLQVLPASYISLKRIEPII
PTKLLELQVVKGMVYVNSIEVINKKAASCLNIFRILFRQFLHDCEKELPPEKHTLLNINQ
LEKLLGLNLEADLEQQIRKPLNKMQRTIKSILAEKLGLSIERDDVIQTLGWQRSSHGYRI
NPFTLTIKK
>ELAGILAN_00053 hypothetical protein
MNVYPSNEFWESDLEVPVNLLLERFQDSNVRQSWLDSLSGKQLSIIFQHCFKNHLNGQLF
QDGNYDDRSTQQKRKILTSYSDSLFDYYLISYFDRTKLEATVSEVARFALTEKLMRSYLV
KNNTKYDKRSLLFLLFHINCELLKSVYHFDKVQKRGFVSFALQKSPRQINTSFKEFMSQE
AVEQILKFENQLQGFFHHQDRIYMFVRRGSDMDLLLNSNKVVHGHKPEWMILDFSIDGTK
VNLCAKNTNKAVEIANSIVSGYFNCECTFVNIQDKNFPLQVYKFLQACIDGSDPDICIFE
LNFKSDYFKNSNTYLTLSVKPYDPIAPELHILKPAIGNILQSIQSAKVMFQNKKVTFSFK
ISGEVYYSEHPLNKKEREDLKKHMEQSYGLKILSRANC
>ELAGILAN_00054 hypothetical protein
MVTVSLYARVSSRQQAQENTIESQIVELERRISSDGHELLDEHRFVDNGYSGSNLERPGL
ESLRDRVAEGKIDKIYIHSPDRLSRKFSYQMILLEEFKKAGSEIVFLNHKFDDNPDSHLF
LQIQGAIAEYERAKIMERNRRGKLHAAKAGCISVMGRAPYGYRYIAKHVGEGSAQFEVDE
EEANIVRKIFSRVGQERASIGEVVHELNKIPIITRTGKRYWKRSTIWNMLKNPAYIGQAA
YGKTRTCSKPQVKKSKKGTCGKLKSGRFNSDKENWTYIPVPKIINENLFDSVQTQLAENR
QRARVRQRRETYLLQGLMVCQRCQYTYCGTNHVHKKSTYYYYRCSGTNSSKFNGNKICDN
KSIRTDVLDTVVWEEVKSILKEPDRIANEYQRRLSENKKPLHNQTREKQESKLRLSIKKF
IDSYAKGFISQEEFEPRITTMKQHLKEIEEEKEKVLDQKKLQQELSLVTDSLKNFSSSVE
SKLDQVDWQTKQNIIRMLIHQIEINHNHLYIVFRIKSLANFDQNRHNRIMQCCTSSQYCW
IAR
>ELAGILAN_00055 Competence protein ComM
MPDKTVAESKERIRAALNSINLLLPPKRITVNLSPADLLKEGSHYDLAIAIGLLVVMNVI
PVEKVQSYIIMGELALDSRVIPVSGVLPTAINAKKDNKGVICPRGNGVEAVWVKNVSILA
IEKLTDIIRHFKGEQLIQPVIFNYSDAPKEKRLVPDMKDIKGQVVAKRAAEIAAAGGHNM
LLVGPPGTGKSMLAKRFIGLLPDLTEQEMIDVNIISSITKTGNEIFKVTRPFREPHHSCS
MPAMIGGGKNAKPGEITMAHNGVLFLDELPEFPRLVLDSLRQPLEDRKVTVARANAHITY
PANFQLIAAMNPCRCGYLGDASRSCNKAPKCGTDYKNKISGPLLDRIDICIEMPNVSILS
PEISVEGESTKIIRERVIAARKVQTERYSELNIRCNSEVSGEAFNKFTEPDQAGLELLKY
VLKENYISNRGYTRVLKVARTIADLAKSEEVKRAHIAEALNYRIKVY
>ELAGILAN_00056 hypothetical protein
MALTNYEYGKGDGIFYAIPQGYIQAEKYWGIPGAASGAGQYAMHNKGRTALFPLAVASVV
FTAMHMKAGFVSAAEASGFLAKTASYFVGTNQAIAASLPGFIGTGVAGQIVAGAIMAIAA
VAAVYGTYQVASKLKDVAVEALKGKGQEV
>ELAGILAN_00057 Cell division protein FtsZ
MSIDLSLPELPILHPRITVVGVGGAGGNAVNNMIQSNLQGVNFVVANTDAQALEKSLCDK
KIQLGINLTKGLGAGALPDVGKGAAEESIDEIMEHIKDSHMLFITAGMGGGTGTGAAPVI
AKAAREARAAVKDRAPKEKKILTVGVVTKPFGFEGVRRMRIAELGLEELQKYVDTLIVIP
NQNLFRIANEKTTFSDAFKLADNVLHIGIRGVTDLMVMPGLINLDFADIETVMSEMGKAM
IGTGEAEGEDRAISAAEAAISNPLLDNVSMKGAQGILINITGGGDMTLFEVDAAANRVRE
EVDENANIIFGATFDQAMEGRVRVSVLATGIDGRNNKSETSPISQSEDSEKEKFKWPYSQ
SESTQDKTLETKPAEQVSEGAKWGSNIYDIPAYLRRKK
>ELAGILAN_00058 hypothetical protein
MQFWLLKSEPSEYSWQKMEKEQVVEWDGVRNYQAQNYMKIMKASDLAFFYHTGKEKAILG
IVEVFKEYYHVNDPKFGLVNVKFLKPLNNQVTLNNIKQNPLLKNMTILKQPRLSIAPVSE
IEWNEIIRMSDV
>ELAGILAN_00059 hypothetical protein
MMSSQHTTHSCMNICLEGSALNVIADFASNTKVSFQCLTLESSLNATTLKPLCFNIRLAT
FIFTNLMSNQNSWIPVPRHWDDILLVYNIRTVVYMTQGSITLLFWIPVSAICMTPLLMCH
SC
>ELAGILAN_00060 Endoribonuclease YbeY
MLEVNILDKKWCSIIENPKNFVLGVINASLKELKIDHYKPNISIALADDDLLHQLNLKFR
EMDKPTNVLSFPYEQLSNECDLGDIAISIDTIKRESHEYYIPILAHIAHMLVHGLLHLLG
YDHQKKDEEIIMKNLEREILASLGYNMCAI
>ELAGILAN_00061 Succinate dehydrogenase iron-sulfur subunit
MVQFSLPKNSKINQKGKIYPIPARAKNIRRFQIYRWSADDEKNPRIDTFFIDMDSCGPMV
LDALIKIKDEIDSTLTFRRSCREGICGSCAMNIDGTNTLACTRSIHDIKGDVKIYPLPHM
YVIKDLVSDLSQFYEQYKSIKPWLQADKPALPNKEYSQSSEDRKKLDGLSDCILCACCST
GCPSYWWNSDKFLGPAILLQAYRWIADSRDNKTGERLDVLNDPFKLYRCHAIMNCTKTCP
KGLNPARAIAKVKQLMVEREGV
>ELAGILAN_00062 hypothetical protein
MFFLYEVVLILILILFFLSYSKLKISNKIKNLQHQNVIINNLIDTVNDGFYIWDAKKRIE
KFSPNLLILLNTVFYSFNEFVNFFEQSESLIKNFVEAKEINKSFTLDLKSKDSEVYCICY
GRSIIDDSNNVIGVLLWIRNVSDCKIKANGLELENSKLTQEVESYKNVFNSLPFPILRYN
KSRKVEFYNLFYDKYVDGSKKFAITGSAHSTKPGRHVITYKNEPKVFDFVKIPIQGSGSI
VMYGKDVSDAEKLYTELNSDLATQKNLLERLPVAIVIYSKNQKLKFYNNAFIKTFQFDPK
FLASYPTYHEVMLYLFESKKLLEKEDFQTISNQRHELFKKLFESYDDTMHFTNGKAFRVL
TIPYASEGLLFSYEECKR
>ELAGILAN_00063 hypothetical protein
MQDKKIYYSSLIVQNLKDYILYTANLSEWEVHDEFDNIIFTINGTRESLFNFVFCGDQCT
ELSIQKTLDYLRTRDIEATWVINSHMKIRDILEKCEIKHVSTPKKALLNMKNYFLPADVI
PNLRLNAVNGSNLLEQLDLHTSKIFYHGVGIVSTFFRGLSNYDDKNSRLRFFLVTLNNEI
IGTCGLYVQDSVAGFYSDGVLPIYRNRGIGTQMVLERIKIAKQLECKYIVAHCMKSSVNL
YKRLGFQMLGNLYLYTSSA
>ELAGILAN_00064 Phosphatidylglycerophosphatase A
MKFLYKLISTWWLSGTVKKMPGTVGSLASFPLVPVILSNKILGAAIISFLFLIGLWSTGN
YIKHYKTSCDPKEVVIDEVVGQLLTILLVSILLSQEMNCSSLLLCFFSFRFFDIIKTWPI
NLIDKNTKGPLGIMLDDVIAAILACVLIGAFYCLLLVYAG
>ELAGILAN_00065 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MAISILGAGAWGTAIAISLGSKKDVILWTRNETTFESINGKRESDKLPGCRISDNVSVKL
AIEDTINASVTILAVPTQSLRKVCQQLHNCNLKKDVAIILACKGIEKSTLKLPSEIVNEI
LPNNPIAIFSGPSFAVEVARKLPYSMVLACQNNTLGSKLVSELQQENVKLEFSNDIIGVQ
ICAALKNVFAIACGIVLGSKLGFNAHAALITKSMSEIKALYSAKIGDGSVDINTLLGPAC
LGDLIMTCTSLNSRNLSFGFKIGNSDNGFNVQQILSEGKSVIEGFSTAESIFNLAGKLKI
KMPICEAVYRLLYESASIEDTISVLIS
>ELAGILAN_00066 Cell cycle response regulator CtrA
MRILLIEDDQVSAKTVVNALTSDGHFCDVVTSAQDYNNNMVSSNGDYYDLVILDIHLPGD
IDGYDILLRLRSAKIKVPVLILSCISAVNHKAKGLGYGADDYLTKPFHKSELLARIKAIV
RRTKGHPESVIKIGNININFDHRIVEVKGKTVHLTNKEYSMIELLALRKGTVLTKEMFLN
HLYNGLDEPSDNKIVDVFMCKLRKKLESANDGKSHIETVWGRGYVLKEYIDDDEYSNVNV
GESSDGYQAEQVKDNA
>ELAGILAN_00067 hypothetical protein
MSILRRLLGINSNTPEIKEAIGFNPTNVELIEGNGVAYGLSYQDNGNGSSKVKLLISPLY
QSKTYECGTNISVANEFKDQLSLTLIEDSAEIDKVGVIFPEEGISEEGEKCVKGLSFNTY
GIKQSVNTPSVEHLDKRKLQKNIDNNSLANVGNSYFQPRAVKVGNGDVIVIAHNLKDQTL
VSWYLKSSESGKFKVLTGEKGVTERKLFNFDNQGQLALNGNTMLYSQVSKRITKENQEVR
KTRIFKFDMAKVIQGLKDGVNGFLLGNRKGQIDNKALSLSREHEISFLQYVEQTEGNDLV
AFLENDQSANEQRLHIATPLKNGSVSDFPIYQFTDPIEQLYIKGNGQGGFIVTAVSGENI
VTFNQNGSGKSSEATIIPANSIKTLSDFVNIINGRLTPDIISSSTVAPITVAETVVTSKK
TPTAAITSTAETDAVKTTKLTTEAVAPTSTISKPSTESTTVAKTTTTSQATTVATTSTSV
PIVTSGTETSTVKPTAATGASTSTMSKPSTESTTQTSTVTVKPTTEAVAPTSTTNKPSTE
STTQTSTVTVEPTAPTTSSEKTTQTVFSIPSTRTKESTTPIFTTTLLPQSTSSPQPTQLA
IGSNKAGMIGGSLVGAIGIVGIIGFIAYRYVKGRNAAPVLELTDLGYRRRSSSSSDEEIF
TTGNRMRTIYQSETVLNSISVESSSRSRSSSSSSSGGPGS
>ELAGILAN_00068 NADH-quinone oxidoreductase chain 2
MIEKEEQFSFTSENLKKAGKFIEMYPKGREGSAVMPLLYLVQEQCGWVSESAMRYVADML
HIPHIRVYEVANFYTMYNLKPVGKYLIQICRTTPCWLCNSEEVLNTFKKKLGINIGETTK
DNLFTLKEVECLGACINAPVVQINNDFYENLTPEKVENIIAELSGK
>ELAGILAN_00069 Queuine tRNA-ribosyltransferase
MKEEFAFKIIKQSGSARVGIIKTPNGNIETPAFIFCATKAAIKAADIERIREEGTQIILS
NTYHLMLQPGENTVAKLGGLHKMMGWNGPMLTDSGGYQIFSLGHGSVSEEIKGIRKKQKT
LIKINEDGAIFRSYINGKTYCLTPEKSIQIQQKLGADLILVLDECTPFHVSKEYTAKSML
MSHRWAERSLNEFEKNNNGKQALYGISQGGIYHDLRRESCDFINNLPFFGQAIGGSLGQS
KEQMYDVVSFTMDHLKKDRPTHLLGIGGIVDIFHGVSLGIDTFDCVHPTRLARHGGALIK
VKNRDSISSKCKEHINLRNQQFELDDNPIESDCLCFTCRKHSRAYIHHLLKAKELLAYTL
VTIHNIFFMNKLMASIRQAILDDRLDQEKNNWISEIPLHFDLASL
>ELAGILAN_00070 hypothetical protein
MANISIRYKIAQKVRSWRLKRGYTQKDLAGKIGVTYQVVLQYEKGTRKISIEKLYAIAEV
LSVGIIDLIPVSSEKICLKNEEEEILNLVRKYKTINDQELRKVFYLLTKFTRVGEKSSKK
AEKVKIAKGMVKAGISVDIVSQAIGLSANECVEEKTGSIYYQIGKKIKEWRLVREYTQKD
LAEKMDTTRDEISNYEQGRVAIPLEKLYAIAETLSISITDLLIEEDEIVESELPDLIKEY
KKIESQELRYALIKSLFESIQICEEKVKRAEKMKIAKDLVKGGISTDIILQITGLSLGEI
QQI
>ELAGILAN_00071 hypothetical protein
MNKSKEEIEFRILESKGKALLAREIMETFLSAVHESPQAQEIAKNLVNTYTGVGRILGRE
MDDLKVIEGVTDSAVAMIMCVKETLERVLKEKLKSEPIMDLQGIVEYLNVSIGHSERECV
KILYLNKRRQLIGEESYIGEMEKAPVYIKEITRKALMKNATSIIMSHNHPGGSLEPSEED
QAVTKSLAAACSTVSVKLFDHIIITSGGYFSFRENGLL
>ELAGILAN_00072 hypothetical protein
MTSKDRNKKTNVNHKKIFGALEGVDIKQSKFVSKINNQKEINREASPSRNIRENKINYGK
SLDYVYGTKPLNDQAEDLNPFASNLQKIKPSASESEKLSWFKSAVVETKNVNALHKVIEQ
VLASGARVNACNDGEWSFAEYMILGTHFHRLEKSDRKKIMRKLMLSGAEFHDTLLQNKLI
GEIYNELQPEVQPQIDERLEELEKAGESAVQEGELIDVEIDNTTSYIEFSGNSKVEVAKI
LRELGSNILKMGNNAVEIRREEGGARNYVDVSDGSSVVLEFPTSLGKLNIVLYQDVKNCS
QVQVKVADKEMWAELQKRGEEIGKNCLFGGVKLKKVVERGNFTRCGIWSEKQKEVSEKLF
SWADKVRENSKETCRAL
>ELAGILAN_00073 hypothetical protein
MVLFVEKSLDYKVGEKLKSWRLERGYTQKDLAEKLGVKYWVILQYEKGNRRISIERLYAI
TEALSISITDLIPISKSCLEDEGEEILNLVREYKKINDQELRKMFCLLTNFVQVSEKSSK
KAEKIKIAKGLVKAGVSVDIVAKTIGLSADECVEEKGGSIYCQIGKKIKEWRLVREYTQK
DLVEKMSTTRDEISNYEQGRTAVPLDKLYEMAEALSINITDLLIEEGSKVKNELPDLIKE
YKEIESQELRHALIKSLFEGLRICEEKVREIERIKVAKDLVKGGISIDIILQIIGLSVDQ
IA
>ELAGILAN_00074 hypothetical protein
MFVSVSDISSISYKIGQKIEDSRLMRGHTQVELASEIGLTYQEVNSYENGYIPIPIEVLY
VIARVLSVNAIDLLPEPVIVREDSYEDEEILYLTKIYENQKLGKIVPSLVRFVHISEKIN
QEEARLEIAKNLVKEGVSVDIISQATGLSIYEYDNTEREICTDSIYYRIGQRIREWRLIR
RYTQKDLADKVGVTLKEIHEYERGYTTILFDKLYEIAGALSVNIKVLLPETRESKKLLSL
INEYREPESLDALVKSLSEDMKSGKEKVKKAEKIRVAKNLAKAGVAIDIIVRASGLTADE
CEN
>ELAGILAN_00075 Riboflavin transporter
MDHRLRAYLLGVTWFILSLLSSVANDTISKYLSLHLQSFEVIFFRFLFSTITLVPFMLYY
GREAFKTSQISIQITRGVLLFVGITLWTYGLAIFPIVTATIISFSIPLFVILLAIPLLNE
NIIWQRWSVTVIGFVGIAITTKAYSEDFNPKILIFIVSTLIFAILDILNKKLAIKESVIS
MLFYSALTTTIFSTVPLLFYWHLPSLLELVLLLILGINSNLILFFTLKAFTLADATALAP
YRYIELIISAIVTYVMFNELPDKSALYGILILIPSTLFIVYSESKVIKKNNVCNARVKIY
DSNC
>ELAGILAN_00076 UDP-glucose 6-dehydrogenase
MYITIIGIGYVGLVSCAMLSEQGHNVDCIDINTKKIELLKLGKIPIYEPGLADYLENNIK
LQRIRFFDSYSQINPNTEVVFVTVDTPSDSLGNANLQNVYNAVSEVSERVNQDCLIVIKS
TVPPGTAENIYNYLSNKGYNFDLGVNPEFLKQGSAVSDFLYPDRIIIGVKTKLARAKLEV
IYRSFIDKNIPLIVTDTVTAEMIKYASNAFLATKVAFINEMAGLCELLGADIDLLANSMG
MDHRIGKEFLKAGPGFGGSCFPKDLSALIRLAEDHNVKLQILNSVKESNYNHITNIAKKV
EYVLNGVQNKKIAIWGLTFKSGTDDVRNSPAIDIAQLLVNNKAKITAYDPMGMDNARQVL
KDIEYADNAIGAARDAEALLLLTEWKEFKNQDFASLKSIMAAPNVFDFRNLLDSELLLRY
GYHVYSLGKKSIYKV
>ELAGILAN_00077 Glycerol-3-phosphate transporter
MLLYLSRQSIPIALPLLIDTDHVKLSYFFACFSFFYGVSKFVNGIIMDSKNNPLFMFGLC
NIATGLLTIGITLSYNNLTLLLLTLILLAWTQGLGWPAITKFMVTNSSISSIASSWGVMS
ASQQLGSCITLIVLPSIIKIYNAKSAFLYSGFLCLLFGIYIILKAYYKESANFTTYYKVQ
KSQIGIKVTSSIWFLCCATFCAYIIKMGIFFWFPIILKNKLQISLVQSSLITGVYDLGGI
LGTLITGRISDMYFFQNRSLLASLYMLGIALTFIAMNFGQNIILMNLCAILSGFFIFGVQ
VLTGVIAVEIAPQNNVCAIVSLTGLFGYIASSIFSCVLLGVLVKHCGNSIMFSFFSICSV
VALVCFSILSSKDLKKLSKAV
>ELAGILAN_00078 L-allo-threonine aldolase
MRVKIDFFSDSNTDPSAKMREAMAKAKVGNEAACEDPTVNELVATACKILGKPAGIFLIS
GTMSNVIAYKVHIQRPGDYLLLDETSHPLIVQSGLIAAQAHAPPLPIKGTRGIFTGEQIV
EFITRPSLRNIPRVGLVSIEQTTNFGGGAVWPLEYIQEISSLCKENDVFTHLDGARLFNA
CAHTKISPKEYASYFDSVFIDFSKGLGAPMGAILLGSEDFIEKAWYYKFQIGGGMHQAGI
ISAACLYALRNNVNSLEEDHKKMQHLIEGLDSIDQVIIDIDLYKTNIAYFSLRTNCISTQ
ELINVLMTNYGIRMANIKGKIRAITHRDISYEDINTTVSAIRKILSNFLH
>ELAGILAN_00079 L-allo-threonine aldolase
MAKNKMEKIIDLRSDTTTLQSSNVIHAISNATVGDFAYGEDKSCNDLSEYCKQLFKVEEA
LFATSGMLANRLAIASQTSPGDELITHYNYHVNFFDSAGNAKVNNIVFNCIRNNSGILDV
AEVEYAINSKPRYKIFAQVSLVSIENSINGFNGKIYPFEKQVELYHFLKAHNVNLHLDGA
RIFNAHVETNIALADYAKYVDTMSFSFTKGLGAPFGSMLMGKREIIERAKKLQVWLGSGY
HQIGYCANAAKYVLQNNISRLKEDNKLAKLFADKIKEIPHIKLVLPYPETNIVSFSIKAL
NVTNEVFLSKCQAYGLLLFPWLESHIRAVTHLGTKETDIMKAAEIIKEVVLNLI
>ELAGILAN_00080 Vitamin B12 import ATP-binding protein BtuD
MNKSRVGSFKYILVFILNILSKFKLNVLVMFLVALVVAVDLSFRKYLVKNILDTAVKYQE
GNVIENLLLPVSAYVCMALLITTAFRFYGYFVDIRMFTSMRQKIADMSFYRLLQQDHSYY
QNNLSGSLVYKVSNLMDSVIELIRLLIDCFFSYSIALILAIYTLSLVNIKFAIATFIWVN
IFILISVFSFRVLTGLADDHSKQSSQVIAGIADSILNVISVRLFSRQAHERHKFFQVCKK
KTIAERKLQWAYFWLWFIYGYSFDILQAVNLYFLIHDYQLNKIAIGDIALVLGINISIIE
FLNHLTRNLTQFSTHFGKVSDALPILTTVPEIQDKENAKKLNLLSGRITFNNVSFSYEGQ
KSLFQDFSVTINPCEKVGLVGYSGGGKSTFINLIIRLFDVKKGNIQIDNQVVSEVTQSSL
RQQISVIPQEPLLFHDTILANIIYGKLQSTIEEIIRAAKLAGIHDFIMTLPDQYETVVGE
KGIKLSGGERQRIIIARAFLKNAPILFFDEPTSQLDSITEKTIQMSLFKLMENKTTITIA
HRISTLLHMDRILVFNKGKIVQDGKHAELVSKQGLYKELWNAQIGCLNGKK
>ELAGILAN_00081 hypothetical protein
MKALQKNGFFIIKNLVPLELITQSLNDIISKISKLSQELGVSTSDYLNCTGRWGTSSQVT
RIVSQVLDKIIKNYLEKSLQCQILQKKSNVICKTADLIDAVPFHQDISYSFNDPYHFSVW
LALNNVNKTSGALQVIEDSHNWKIQPLVDFWHPYFLDQYSDNRENYKIKSLRISAGDAIV
FDSRLWHGSDKNIDAKDRFAYVTRWVVKDKSLPCVPKPQPSVFGILNCGALTEFILREYL
SLFRRQESIKTKNMEELIKSWLAFITDTTTNISEVNTAEAKRDLYKLLILNQASALHDAG
DISGKIYKNLWFSLLVFLNKKVNVVELAL
>ELAGILAN_00082 hypothetical protein
MQNMQHEKTISQLMKDSEYLKSIRVSPCERFHQLSENPLYKNRFIRVDKFHEPGLAPVYD
ETGAYHIDAMGEAIYRDRFLKTFGFYCNRAAVEDDTGYYHIDPSGCRVYKHSYQWIGNYQ
EDICVIRKHDKFFHIDLNGNRVYEQEYNYVGDFKDGIAVVHKDGKATHINNHGKLVHNKW
YKKLNVFHKGFAIAEDKHGWFHIDINGNPVYRQRFKMVEAFYNGMAKVETFEGVLGQIDI
TGNVKFSIFDLDKESQVHKISAELSAFWKTYLANVAIELDLLNILPATMPVLSQKLNIIV
PNLERLLRALWEIGFIDYDKNKDLWQLSSKGKCFKEIPFLPKAAAMWARVAAEKNWLKIA
DILRQESISSFESFKEKETSEDRKIAFYQALLGYSRFNTKEFNSRVNIDGAKNILLFGVH
SLFLAYSDIHNKGSIGLYYYNEHKVPRQAVEDLKIKLITQEELSATNYELGVFCRFLQHY
DDNKVLSYLKLVKNKGIPRVLVIETILDYYSPVGGSVDINVMVETGGKLRTLSDWKRILK
QVKGLKIFSIVPLTDYLSVIDIRC
>ELAGILAN_00083 D-inositol-3-phosphate glycosyltransferase
MKILKVIHGYPPYYSAGSEVYSQTLAHELANNNEVQIFTRHENSFLPDFHYTIALDCSDS
RILLNLINIPTTKYRYKFINEEVNIKFKRIIDNFQPDLIHFGHLNHLSITLPEVAFKENI
PTIFTLHDFWLMCPRGRFIQRNSEDLLRLCDGQKDQKCATQCYKGHFTGDEEFLNSDLNY
WEQWVATRMKQTKKVVDYIDYFIAPSKFLMDKFTQDFNVPINKISYLDYGFDLNRLKNRN
RVQEKGFIFGYIGTHTPEKGVDLLLKAFSRLSSKAKLRIWGAAREETKTLKAIADQFPHA
VKERIEWMGSYNNKNIVTDVFNKVDAIVVPSIWGENSPLVIHEAQQLSVPVITADYGGMA
EYVRDGINGLLFKHRDTNSLSEKMQVLSTDQELYSELTQRGYLYTKNGNVPSISEHTEKL
NKIYRNVIENKGKSVATKPGPWRITFDTNPDYCNFACVMCECFSPYSKVKEEKKAKGIKP
KIMSIETIRKVIKEADGTPLREIIPSTMGEPLMYKSFDEIINLCHEFGLKLNLTTNGSFP
IKGARKWAELLVPILSDVKISWNGATKETHERIMKGSKWEVVTENLKTFLEVRDKYFSDT
GERCTVTLQLTFLESNLHELYDIVEMAIKNGIDRVKGHHLWAHFKEIKDLSMRRDELAIS
RWNTEVGRLYELRDNMLLPNGKKIKLENFTILSQEGIKDLAPGGQCPFLGKEAWINNEGK
FSPCCAPDELRKTLGDFGNVNEVKLEEIWQSSENLNLQKNYLNYELCKTCNMRKPLVN
>ELAGILAN_00084 UDP-glucose 4-epimerase
MGILITGAAGLIGSALVEKLEKQGYEVISCDIRFRDNPLSFFSEDIMPLLAKCTGVIHLA
AISRVIHGELYPELCQKVNVDGTIQFLEFCKSLPNKPWFIYASSREVYGEQKELPVAESA
SINPINNYAKGKAFIEEQVINLKGSNFNVAILRFSNVYGGLLDHSSRVIPALCINALKGD
PIRIEGKECVFDFTYLDDVIEGIYLTVKYLQNEKSSLPAIHLTTNSPCTLENLAKTILKV
TESDSRIDFYPPRNFDVTKFHGDFTRAKELLGWSPKHSLKVGLGKFIKSLQNNTQEYPNN
IDMVIYENIKSYSWLPSLL
>ELAGILAN_00085 Bifunctional protein GlmU
MDNTLIILAAGKSSRMNSQYSKTLHLVGNFTLLEHIIHNAKPLSLKSLSIVISKPFLKEL
ERFSTLKDIIDKYNIKLIIQENITGTGTAVKIALESLERLSDQDIVLIQYGDTPFISSDT
VMRMTDCLKCNNKNLVLLGFNSQDKQYGRLVIDDNDNVQKVLKSEDEILLANSGIMVSYA
KDLYTLIKEVKFNDSTNECCLNDIIPIAASNNLRAGYVVADEKEAMGVNNKEDLVKAERY
FQANRRRQPTLLS
>ELAGILAN_00086 RNA polymerase-associated protein RapA
MTIYGRTWWGKKWLQSFDGIDYDNRLPRGRTCANTGRAFGIKINGHIVTAKVHSSGSYPY
RGSKPQPYKVKIILNELSSSEQQTIRQIIETSPAILAKLINRQLSASLFDKLNDLGIKLF
PSNWQEMNASCSCPDWAMPCKHIAAVIYLIAAEIDKNPFMIFNIHNCNLSALIDDFGNGK
LENAQNILKIDDIFKACSKIRIHNQAILNDIDLSTIPNLFDCISSILTDNPLFFEKNFHN
ILQIAYKHWQKYPAGRLVYYPASKKELSEEELFIKRWGNIENWQTFQLFIDDQHYLTQVS
NGTTNLFRLSGNVLRDVARFLNDIPSSLLHKLNPELRFMHMISQFAHMLMEKSALIPQVL
QNKRGEVIIRWIPALFNESVKEIHSKISSICPPLLIKYQEIVMEPEEQVNVAISLILLGY
IEDNFPASLDKHRDKSIFELFFTGRSYKFTEFSNKEIPQAINLWLSRLYLADKPYKLYLM
IKDHHEKFELEVQLSLDDEKSFIKLEKALSNQNAKLSILSDLALLSEYIPELEKSIDDNS
TLSFNLDNFAPLFLHILPVLRAIGIKVILPKSLQKILKPQLSLNLSTKDKIKEDRESFLT
LENLLKFDWKVAIGDKKLSVTEFKKLLKDSRRLVRIVDQYVLLDDKEVEALLKKLDKLPD
YLSQAELMQAALTGKVNETKVAFDQQLTSLFNKLNTYTPVTTPNNLIAQLRPYQERGFSW
LVQNIENGFGSIIADDMGLGKTLQVIAAILCCKNTGFLDRDRVLVVAPTSILSNWQREME
RFAPELKLFVYHGQNRELASDYDVALTSYGLARRDKKELNKIRWFLLVIDEAQNIKNPNT
EQTKAIKTIAAKHKIAMSGTPVENRLLEYWSIFDFINKSYLGTPKQFKSSFATPIEKARD
KTCLERFMKITSPFMLRRLKSDKSIIQDLPDKIENNRYCSLTSEQTALYQKVVDTTMEKI
EKSEGIERKGLIFKLINALKQICNHPSQFGKKKRASIEQSGKMQMLEEILISIGEVAEKS
LIFTQYTEMGEIIARLLEERFESEVPFLHGGLSRKARDTMINDFQNLFQSNILIVSLKAG
GTGLNLTAANHVIHYDLWWNPAVEAQATDRAYRIGQERNVMVYRLLSTGTFEERIDEMIQ
SKKELANLTISSGESWITEFNNDQLRDLVNIKNAL
>ELAGILAN_00087 hypothetical protein
MVQDFLTDVKQKNTLNDEYYDFNNTVEPLEQFDVEEIKRQLLLNIRSCLSYLFPRGTFHG
DEFRIGDVHGNKGQSLRVALTGGKAGLWQDFATGQKGDVLDIWAGAQGKDTKRDFCEVMA
SISECLGYNKKCAKADEDFEKFITHSWNYYDENGQVIVKIYRSDPPKGKKQYKPFDVKQS
RYGAPKVRPLYNIPSILKSDKVVLVEGEKCAEALIEQGITATTAMSGANAPIDKTDWSPL
KGKHIIIWPDNDEAGNKYAKNAEKKLLEIGVASLAVLEIPRGKPEKWDAADCVEEGIDVK
EFLASTPLLTIDTPATDTSNMKSLERSTKQPLNILDWSAERFVGPVPEQKFLVEGLFPLG
VTSIIAAMGDTGKGMLLLDLALKVASDKDQMCGFGSLVTEHGSVVIFSAEDDASEIHRRL
ERLDPKCERLKHKDKLFIVPLPNVRGSLTILRNVRGKIVEVSPEFESVMKQLEEIKDLKL
IEFDPLASFIHADINADPAVGDYLMCLLSDLACSTGASIITAHHMRKPKGEKPILTAEQA
RDAIRGTSALVNGVRCSYAFWPIENTARLEIFKAVGETPRQNALFHGAVVKANGLADRTV
RTYLRNQETGLLEDITIQLTVKNASEKDLKICLTDAITRSAVAGHPFTHTGSTGVYKQRH
RLPEIFHSMGRDRLERIVQELLQAKQLVKGMSTGAKEDKWLDIPTGPFACGIGKFTLGAE
DFSYRQNLMLG
>ELAGILAN_00088 hypothetical protein
MNAVLWSRVREIRKHGSFGETMVMRPNRWFQGHESLPDPLPSESPISLLFLTTTKEAFLL
ET
>ELAGILAN_00089 hypothetical protein
MQGKLNQIAVRAKQDKRVKFTSLVHLINEENLAESYKELKRNKACGIDRVTVEAYGENLE
EKLKTLVDSMKRKQYQPLPVKRVYIPKAGSKEKRGLGIPSTEDKLVQVMLKKILENIYEA
NFMDSSYGFRPGRNCHQAINALDKAVMHKPINYIVEVDIKKFFDNVQHKWLMNCLRERIA
DPNLLWLIKRFLKAGIVEVGCYKATDQGTPQGGIVSPVLANIYLHYVLDLWFEKKFKPKA
RGYLQLIRFCDDFVVGCEREEDAKEFLELLKQRLSKFGLEIAENKTKIVKFGKKEWYQAE
REKRRTASFNFLGFTHYCGKSRNGKLMMKQKTSKISLARKIKEIKEWLKMVRSRICLKDW
WQKLKAKLTGHYSYFGVSGNYRCLIQFYRPVTKLAFKWINRRSQKKSMDWEQFIHYLKVN
PLPKPKVYVSLYTGALV
>ELAGILAN_00090 hypothetical protein
MDENKIVFYTTPGGNIEIEVLCRDENLWLTQKRMAELFDVQLPAISKHIKNIFESGELQE
KEVVSTFEVTAADGKNYPTQLYNLDTIIAVGYRVNSKKATLFRVWATKVLKDFIIKGFAL
DSKRLKNGKKFGKDYFNELLEKIREIRASERRFYQKITDIYAECSADYDPNSEITKQFYA
KVQNKLYWAIYGLTAAELICSRVDHKKPHMGLTTWKDGPGKKIHKSDVSIAKNYLTEEEL
SELNHIVSMYLDYAELQAKKNRLMKMQDWAEKLDAFLLFNDYEVLKDAGKVSAEVAKALA
EGEYEKYRVIQDKLHESDFDELIKASKESEKITI
>ELAGILAN_00091 hypothetical protein
MSILTLDLGKQTGWAILTDGIIESGSKSFHGSRFSGGGMCFLNFCNWLNSLKDISAVYFE
EVRRHLGTDAAHCYGGVLAVLSAWCEENNIPYQGVNVKTIKRFIAGKGNASKSEVIEAIR
EKSFSPRDDNEADALALMFYISKDINKTKNP
>ELAGILAN_00092 hypothetical protein
MNLAIHYYPVENLVEYKRNPRKNDDVVNRMCASIREFGFRIPIVAKSDGTVVDGHLRLKA
ARKLGMESIPVVLSDNLNEPQTKAFRLLANQSANWAKWDDELLKVEIQELEDLQFDLKMT
GFELEKVQRFLDDFDGKEEVERGVLELIDKKVEIAKPGDLWILGDHRIYCGDSCVVESFK
AVLDDKMADITVCDPPYNVDYGSSQEREDKKILNDNQGEKYELFLYDICSNILAYTKGAI
YICISSSEFSTLQKAFEEAGGKWSTFIIWAKNHFTLGRSDYQRQYEAMLYGWKSGNKREW
HGGRNQSDLWFYDKPIHNSLHPTMKPVELMEKAIVNSSRPGDTVLDPFSGSGSTLIACER
TGRICRTIELDSKFVDVAIKRWQVYTGREAILSGTGKTFAQIQEEKQQ
>ELAGILAN_00093 hypothetical protein
MEKITQTEWAREIGVSKQYVCYLVKKGIIELENGLVNREQANEAVAAIRDPSQPLRRKNP
ENENTSNLSTMLLKTRIKNEMERGKLLEAKAKAEIGELVAVEEVKRDAFNVARVVRNNLL
NIPNRVSALLASLSDTEKIHMALTEEITNSLQELSNIKF
>ELAGILAN_00094 hypothetical protein
MSANLSLELIKCLINQPGVDVNVRGLNGKTPLHYAVEINELSMVALLLNRKNINPLITDD
NGKSALDCAREEILQALINHKYGLEKDSLLHLAAMLNEANAVRFLLDKGTNVNEQNALLH
TPLHLAAGAGHEQIVEILIREGNADKDVLDARNHAAIHYAVNNKKLGVVKLLSNLGANVN
VVGSGRNAMKLSSLHVAISSSNYDERDLCLDIVRCLINVPNAGVNLQDYENKTPLHYAER
LKTIEVLLTREDIDPLIKDDNGKTPFCYAKEANRLDIVKILASNRYGADKNSLLHLAARK
GYEDLIDGILGEGVEIDAVDESGKTGIYVAVKHGHFNVVKLLLKRGADATDVFQYAIITN
NAKLIKLLSKEKEIVLFGRQKNFPTFHLLSNKYFEERKIADKKIKKYINIVCVSITVCAI
VIVGIYPNIIAAVMVGIVALIAAIAMSNLTQKYIEEALEKKMFIELESEKTSECSSILSD
VEVSSNDGEELAI
>ELAGILAN_00095 hypothetical protein
MIYATSFSEGLKPDPLLKVSEWANEYRVLAPTAASEPGKWRTERTPYLKEIMDSLSPSSP
AEKVVFMKGAQIGGTEAGNNWIGYIIDQTPGPMLVVQPTVEMGKRWSKGRFAPLIESTPC
LKSKVKAPRSRDSGNTVQSKEFPGGIVVITGANSSVALRSMPVKYLFLDEIDAYPGDSGG
EGDPVLLSIARTNTFARRKIFLVSTPTIHGISRIEKEFEATDKQYFFVPCPYCNYYQVLK
WSQIKWENNDSRTAHYVCTECSGKIENHQKTEMLERGEWRPTNRVKGEKKGFHLSSLYSP
VGWYSWTQAVEDFLHAKESEQLLKVWINTTLGETWVDKGEVPDWKQLFNRREFFPVGTVP
RREVVLTAGVDVQKDRLEVEVVAWGKSRESWSIEYRVFEGDTGRGEVWGKLSELLNHHFI
GENGLEYMISMMAVDAGYATQEVYNWVRGHQGSGRVMAVKGVNKALVPLSSPSRVDITVG
GQKLKRGIKLWPVGVSILKSELFQLLNVLKDGEEAPAGYCHFPEYAPEYFKQLTAEQLVS
KVVKGYTKQEWQKVRERNEVLDCRIYARAASIALGIDRWPESKWNSLSEKPESKKSKKIV
KSKWISE
>ELAGILAN_00096 hypothetical protein
MYNEDYLIQVEEAIKKLQNGERVVSIAYGDHVVRYAEVDINDLLSLRQRIKAELKIAGMK
PKRKIVFSTNKGVDKIM
>ELAGILAN_00097 hypothetical protein
MDQSQGRLNVNVNFEGEFAQYLTEMAKVQNRTIEEIVKDLVEEELEVSKLSEGDEMDEGE
IALLELAAKRNVPGAKIIRHEDIKWE
>ELAGILAN_00098 hypothetical protein
MGIIYQIGYLEGVDTEDLPSLPKTIRLRVQKAIEKRLTIIPDKVGEALSHKWVGYFRLRV
GDYRVIYLIDNSEHMVKIAAIGHRKEIYKRSPE
>ELAGILAN_00099 hypothetical protein
MLLKSFKQLFNKPKIKSSAWDAAGSGRRFFHFQPELGSINNLLSQNLETLRSRSRDMVRK
NPYAANIIDTIVSNSIGTGIKPQSKARDGEFRKRVQELWLRWTDEADSNGVSDFYGLQAL
VCRSMIEGGECFVRLRTRKLEDRFSVPLQLQVLESEHLDNKTNQTLGNGNVIRNGIEFNK
LGQREAYYLFKEHPGEGSFGESVRVPANDVLHIYRPLRPGQIRGEPWLSSILLKLYELDQ
YDDAELVRKKTAAMFAGFITRLDPEANILGEGESNEQGVALSGLEPGTMQLLDPGEDIKF
SEPSDVGGSYEAFMRQQLRAIAIGTGITYEQLTGDLTGVNYSSIRAGLIEFRRRCAMLQH
NIMVFQFCRPVWSRWLELAVLCGELSIDKKVAKAAKEEVKWIPQGFDWVDPLKDQQAQQM
AVRNGFKSRSEVVSELGYDVEEIDQEIAEDQRRASSLGLSFDSDVTTNQEII
>ELAGILAN_00100 hypothetical protein
MKNQAIWLNRCVMVEPRSFELLSLQTGKQPIFKNIKHAVRNSERGIIPIHGILTKKSEVF
DDVLGMTSYEKISEEIEEALIDKEVETIILDIDSPGGEVNGLFDLSDFIYQARRKKRIVA
IANDDAYSAAYAIASSAEKVLVTRTSGVGSIGVIASHIDQSGFDEKQGIKYTTVFAGSRK
NDLNPHEPITSESLESLKSEVNRLYGMLVELIARNRNLSVEAIKSTEAGLYFGEKAVEIG
LADGITILSEFKSINKKGDITMNEKTTNDLETDNLTKYRTEVLELIRLCNLSRMPEKIGE
FIEQSVSVEQAREVLMELLAERTKKTEILSAIPQNSGEELMMQVAKSRAQSNI
>ELAGILAN_00101 hypothetical protein
MISITEGNNLGDLLKYEVSNLYSRDQITVAKGQNLKLGKVVGYDTKDGFIKALNPTATDG
TQTAIGVIASDVNAKENSKGVIIARGAILADHAVVWPANIIEEQKTAAIKHLEGRGIIIR
KGA
>ELAGILAN_00102 hypothetical protein
MQNPFTNTAFSMTALTNAINILPINYGRVENLNLFPSRSVRFRHITIEEQNGVLSLLPTQ
LPGAPATVGKRGKRKIRTFTIPHIPHDDVVLPEEVQGIRAFGSESELKALADVITDHLQL
MRNKHAITLEHLRMGALKGIILDADGSELLNLYNEFEITPKVVNFALGTATTDVKRKCLE
VLRHVEDNLSGEYMTGIHALVSPEFFDALISHSKVKEAYERWQEGAALRNDMRSGFTFCG
ITFEEYRGQATDPEGTVRRFIERESGNCFPLGTASTFTTYFAPADFNETVNTLGQPLYAK
QEPRRFDRGTDLHTQSNSLPMCHRPGVLVKVVVT
>ELAGILAN_00103 hypothetical protein
MQENIKRLLQDCFAHLGKVALYESKDKSYMVQVLKQQPDKLYEIGEGQFVGEILLLEVSV
FDVLKPMVGDTFSIGSCRYRVHTPPLRDNSGMVWKIQASGV
>ELAGILAN_00104 hypothetical protein
MSINIEVTDNINKVIENVNAERKKVEKAAVRALNKTALWLKTQAAKEISEEKKIKLTVMR
KRLRIFKAKTSRLDVLMRANLYDIRVSAIGKMRQTRKGAKVGKHKFIGGFMATMPRGNSG
VFRREGRTALPIQEVKLGLEPEASKIIKELVNYETEGIFEKYFERELNYIVKV
>ELAGILAN_00105 hypothetical protein
MILIELHKAICRMLKKEIPAIQTCEIYPMIRREIVAPAVFVELSSLEQGKDSGTEELALK
ARFEARIVIDSTIENAAIIVRELAAEVARVVNKNTWNVKNVSPGEFISAEIDGFRPELDA
YLVWMVDWVHEVHLGRSIWEEGKFMPHKIEIGEINVGK
>ELAGILAN_00106 hypothetical protein
MLESNFAISELQRKLANIVRIGLVKEVDYEKARVKVQIGEFLTDWLPWITSKAGKDRNWS
PPDIDEQVIILSALGELSLGVVLAGIYQEKYPAPENKKEINSVKIQDGTRLLYDKEKHHL
EIEVVDKITLKAGESSIEMTRSEIKLKADRIELN
>ELAGILAN_00107 hypothetical protein
MNKSVVRVGDYCGEATPHFCISGSNNVFVNDFPVCRKGDNFNEGKVMIQGSKTVFANGHG
VGRVGDSVSCGLKVIKGSKSVFAK
>ELAGILAN_00108 hypothetical protein
MKGMDGKTGKALEGIEHLKQSIIDILTTPIGSRIMMRNYGSRLFELLDKPVNRDLTLEIY
AATAEALEKWEKRFKLEKVKMTEVKEGKVTLDLEGLYVPMGKKIRFDEVVV
>ELAGILAN_00109 hypothetical protein
MQQTNIIEPLNFEEIFSRMKEELISRDESFTALVESDSAMKVLEVAAWRELLLRQRINEA
VKSNLLKFATGEDLDNLAEFYGVERQKEEDDERFRKIIKAKIIGWSTGGSKEHYRYHALS
ADSRVKDALVESPIPGKVQVSILSTELSTLQEELLEIVKNQLNREDVRILTDTVEVVSCN
MIEIDIHSKISIKRPDIIETVKKKFIEKFGTTKRLGWKVTRSWIIANLFMEGVENVELIE
PREDIVVKGNECAFLKSLNVELN
>ELAGILAN_00110 hypothetical protein
MLLPPNATKKEKALVDAIDYKVDPGCIRGFKFSQGEKVLPWIIEEYGLGEILHWVKNKRK
AIKKGIKFQRLRGTPASLKIALKWANIEDITIIEEPSGKHFFELQIGIKDVPNDFFVDAV
VELAKLSLPARSRLMRIFNDYYNISRFILDESFFGSLLSDYSGVKIEKDGPVLSFGRVNF
FRSHGPVIRIVENYLRDHYERALSNDIYRLDVAILGETEPHTKNYNGIYERNHVWYNFKA
LYPLPQSLLPKIKFAKAQIVLSDSWNLGEINACFPVTSGEEKGSKFLLGSDKLSEQLWNL
KHKPILERFSVTHHYKVEDFTNQKVIIFGVAEHNIHFERDLNSEQKDSIHEPENYVLVFY
PGVLTWHEHRHLNRGWEEKQVICLMH
>ELAGILAN_00111 hypothetical protein
MGFSEEKKESFNKFFKEVSRNGFKNINKRDEKGETVLHHAVENSDHKTVRLLIEKGAEIN
ARDKNGYTPLHCAVFAKSLENVKVLLRSGAEINATQYVSGCTPLHSACKIGGAGVEIIKE
LVKAGSEVNQLNKYGSTPMYYIWESEKYCLCDREESEKASKFLRAKGGVTKSRKLTCYGI
EGLVGEIADKLDRSYMPELKIMEIEEIRKRDKSLIKKECQNLATKIMCQVNEMIDEVVRI
KKGT
>ELAGILAN_00112 hypothetical protein
MSKKEKEDALKELLENSGKNIKGTKKELHYAVDGKTVSLLVEKGANVNAADVEGYTALHL
AITEKRLETVRELIKSGGNVNAEEYGSKCTPLHLACMVGKVEIVEELVKAGAEIEQADKF
GMTAMDYAKNSKEVTEVLKKETDRIEKLFEKL
>ELAGILAN_00113 hypothetical protein
MERKEEIEKKVMNLEKKALEEVRKIWKKVYGEGAPRYSKKYLIPRLAYRMQEKAYGEISR
KGAKRLEYLADRLEKGKRISSDKLPVEGTELRGCPETSKRL
>ELAGILAN_00114 putative protein kinase UbiB
MIQNILRLLHITTVLTRYNILPYLLPPSKKSINKIQGHKLKCALEKLGPVFIKFGQSISS
RTDVLNEDITNNLLLICDRLPSFSHKIAVKTIESEFNCKLSDIFSSFSEKPIAAASISQV
HRAVTTEGKEVAVKVLRPNIEKTFSRDIKMLSWLAEIAEKFSEQSKRLRPIELVKTFAEI
CRLELDLRFEAAHSSELKENTKNDRGFYVPEIDWNRTAKKVLTLEWIEATPIYEVEKLNN
HKQIAINLIESFCNQVYRDCFFHADMHPGNLMVDSNNNIIALDCGIMGRIDRETCYYVIE
ILKGFLNRDYDHVAKMHFKAGYVSSQHRNFVTACRAIGEPIIGQPIQKISFASLLAQLLK
ITGDFDMKVQTQLLLLQKTMILLEGTCRKIYPEINMWKVVEAWISSQHESKIGYREKIRS
SYPVKTIQGIFSLIEKLNLIADKKLENIQIKNKSNGKVYFLLWFVIIILIVKLLIS
>ELAGILAN_00115 Zinc import ATP-binding protein ZnuC
MNNVNNRVLKIENLALAYDGKRILDNINMFMERGDIITILGPNGGGKTSLVKAIAGINKS
CTGNIVFADNIKIGYMPQNFSISNLMPITVEYFLLNSSLKRLKKNQSIITETIELVGIGN
ILKNQVLEISAGQTQLLLLARCLIAEPDLIILDEPVSAMDINARAKFYDIINKIAKKRLV
SILMTSHDLNSALPSSDYIICINNTIYCQGKPDEIMKNRTLNEIFSSYAAK
>ELAGILAN_00116 High-affinity zinc uptake system protein ZnuA
MRHLLTFFLLLSFTLYYNIAFSSNLKVVATIKPIHSLVASITEGILEPELLGYATSAHNY
ILKPSDASNLESSDVIFYVDDNLETFVQTFAKNNKELVQLSKAINLLPTRPHSFSRKITH
IKDEKDLHIWLSPENAKSMILSVSATLSNIDKENSHRYNSNATKAIKKIDQEVKEIMKEL
NDFKNQKYIVTHDAYQYFEKYFGLNHPSAILSIEEDSYIGMRSLMKLKKIMKEENVKCIF
AHSQEDSIKPNALSNDAKMVVLDPIGSDIEPGKDAYLAIINNIAQNFKSCFVE
>ELAGILAN_00117 hypothetical protein
MQNLQLSYPIIVELGDVKDTKLKLIKVIAQLISKKYTTQKKAANALKIDQPKVSQINRSK
IEGFSLEYLLNLLIVLGQDINVRIKHNSKPA
>ELAGILAN_00118 50S ribosomal protein L33
MAKKNASLLVKLVSTAIKTTKTGEEKSTGYFYVKKRNPKKLTKKLEFRKYDPVVRRHVLF
KEEKLK
>ELAGILAN_00119 Ribonuclease E
MVNSGKRLLLIENSTCSNEVRVALSVNNKVVEFEQEFKEKKQLRGNIYVAYIKRIEPSLQ
AVFIEYGKNKQGFLSFSEISLDYFNIPEKEKETIFESYSNDDYTEKGNDTIANVSSDSAA
SKNVNESGSGFVREVPLYKKYKLQDVISVNQKVLVQLTKEERGNKGASFTTYITLVGRYC
VFMPNSMSKGGVSRRIEDANVRKQLKEILSSINLPKRSGLIVRTVGSGKNKKEIEQDYNY
LSSLWQSIQKNAFSVNVPSLIYNEADVIMRSVRDFCSDGIEVIVSGKEAFEAVRQYANNA
LKGSKLRYRLYRGYAPIFTYYGIEDQISELYSNRVELPSGGSLIITLTEAFVSIDVNSGK
MTGEDSIEETAYRTNMEAVPEISRQVNLRGLSGLIVVDFIDMLKYQYCRAVESAIKQAFK
DDKAKVQFSYINDFGLMVFSRQRIKPNIQEINTTECLHCKGTGRVKSNEVIVSSILRDLQ
HIANKNRNKSFDLVAHSAVIAHIFNNKRNTVSTIEKEFNITLNVSIDNSLDVNTFVLKQG
DDVNLNGYKPLQNSGYQVGDSSNEEADNSNKLRGNFWLTKWLSRLLSSNN
>ELAGILAN_00120 Chaperone protein DnaK
MGRAIGIDLGTTNSCVAIMQGKDTKVIENKEGARTTPSIVALTSSGERLIGAPAKRQATT
NASNTFFATKRLIGRQYSDPEMKNLSVPYKVFAAKSGDAWVKTTDNKEYSPSQIGAFILQ
NMKEAAEAYLGEEVKDAVITVPAYFNDSQRQATKDAGKIAGLNVLRIVNEPTAAALAYGL
DKKHGHTIVVYDLGGGTFDVSILEIGDGVFEVKATNGDTHLGGEDFDNGVVSYLLDEFKK
SNGIDLKNDPMAMQRIKEAAEKAKIELSSAMETEINLPFITADASGPKHLNMKLTRAKLE
SLVNDLIERTMAPCKKALEDAGLSASQIGEVVLVGGMTRMPKVIEKVKEFFGKDPHRGVN
PDEVVAIGAAIQAGIIQGDVRDVLLLDVTPLSLGIETLGGVFTPLIERNTTIPTKKSQVF
STAEDNQTAVTIKVHQGERKLAVDNKLLGQFSLEGIPPAPRGRPQIEVTFDIDANGIAHV
SAKDKATGKEQKIRIQSSGGLSDDEINRMVKEAEEKAQEDEKRKKFIEVKNQADSLVHST
EKSLTEYGDKVSPEDRSAIENAVNELKEVSKSDNIDDADSIQQKVTNLSQLSMKLGEAMY
QASQQNSAENGFSSEGNPNDKEEKVVDSDYQDIDNKEENK
>ELAGILAN_00121 DNA-binding transcriptional regulator BolA
MDIIKTIEEKIHDSIDVIDINIIDESAKHADHYFASSSTLPSHIKLILISDSFIGMNTLK
RHKLIYELLKSEIELIHAISLHLYTQNEYNLKNK
>ELAGILAN_00122 Cystathionine beta-lyase MetC
MKEESLLVKAGRKFKDYKGSMNPPVYHSSTILFPTYKDYLNAANGESIYDVINDDVARDY
SYSNVGTPTVHYFSNALAEIEGSGQALIFPSGLFALTFAILTFTKAGSHVLIQDNSYYRL
KRFAENELPNRGIEVTFYDPTQDITDLIQSNTSLIMIETPGSVTFEISNIEHIVKVAKER
GIVTVCDNSWATPLLFKPLDYGIDVALYAVTKYLAGHSDLLMGTMIAEGEIFKLLYESYK
NYGVTIQSHDCYLAHRGLRTLHTRMKKYQNTAMEVAKWLEAQQKVRKVLYPALPSHPQHE
LWKSYFKGASGVFSIVLGREYSCEELSCMVDHMKIFGIGASWGGCDSLILPIDRRSMSRS
VMNSDYGGSFIRIFCGLEDPEDLIFDLNDALKRLPCLDFQNDEVGHETERITA
>ELAGILAN_00123 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MKLRELLHNIIDVNFDIEIKGVTCNPKKIKEGYLFVCVSERDRIYIDQILSCGAKAIIAS
DCITEALSLGIIPTRDAGICIFHPNPQEIYSEIVSRFYQFKQPKYVAAVTGTNGKTSVVE
FCRQIWQNSGYNAASIGTLGTCINNGRKGNSNSLTTPGAEDLYATLRGISVEHLVLESSS
HGIDQYRIHGLKLSAAAFTNFSQDHLDYHKSLGGYLETKKRLFYEVLPEGKTAILNADID
EYGALLKIAEKRSNKVVTYGKKGSDITLLEQTSTPNGQHLTVKIDNQIYNTFFPVLGKFQ
AYNLLCAIGISGLNYREICVEKLVSPPGRMEKVKPFAFVDYAHTPSALKQALLSLKWHIN
KKIILVFGCGGNRDQTKRSEMGKIAQMYADKVIITDDNSRDEDPAKIRHDILLHCPDALE
IGGRREAIEKGVDIAYNEGMILLVAGKGNEKFQIIGNQTFEFSDVEVIKNHALTY
>ELAGILAN_00124 hypothetical protein
MNLLLLKKATNLIFPSVCVSCECIIDENLNLCSECNKKINFLTKHYCNVCGVVISDNIYT
CGKCIINPPPFKVLRSVFAYDQHSRNMIINFKFFDNLNYVKIYAKWIHQANQDTFQNAEI
IIPIPLHKMRLFKRKYNQAALLAKELTKLSNLSYTPFAIKRLRHTAPQAGLSLKQREKNL
KKAFKTSNKKIIENKIVILVDDVVTTGATVRSCSQEILNSGAKEVRVLSLARTVNDWTSC
IKN
>ELAGILAN_00125 hypothetical protein
MSVYRYFRRYVEYGVVPAKKAEDNTLVPENSFYKSVHYVDNVLGSVKDVICGVESKDDYN
KYYKNNDKYEYVGHRAERVYSLCTLGAVLAANIILQPLLLIVACLSYFPVKLLSKITGDY
CFKTDTKSFVNYSNIFLEMGQDCANAVARVFNKIVSYACAAIIWAAASIITPLVWACDKV
QSKLSEVQKPEKHQFLSKDNSKTTSVNGIPQTEL
>ELAGILAN_00126 UvrABC system protein A
MDDFIRVKGAREHNLQGVDVNIPKNKLVVITGLSGSGKSSLAFDTIYAEGQRRYVESLSA
YARQFLNIQDKPDVESITGLSPAISINQKSISKNPRSTVGTVTEIYDYLRLVYARIGVPY
SPATGLPITKQTVSQIVDTIIALPLETKIYILAPVVRGRKGEHLKEILEIKRQGYVRFKI
DGEVYNVDDLPKLDKNKKHDVFVVADRISILDDIGNRLPSSIESALKLGNGLMYVEIVNL
PDNHNSEYKNGQILIFSENFACPESGFTLEEIEPRLFSFNSPYGACGSCNGLGKKLAVDV
KLIVPDETLSISKGALKPVGSMFRQVHTSYGFLKSAILSLAENCKFSLDVPWKNIDQEVK
DMILFGFGKFQGLVSILENQMDYDETLVERYCSVTHCRECTGYRLRKEALTVKIDSKHIG
EISGLSIDESLKWFENLPDKLTEQQKQISSKILNEIIKRLAFLKNVGLNYLTLDRESSTL
SGGESQRIRLASQIGSGLTGVLYVLDEPSIGLHQCDNDRLIATLKNLRDMGNTVIVVEHD
EDTIMAADYAIDIGPGAGVNGGKVVAEGTPDQVQRNSGSITGQYLSGEKKILIPRRRKQA
TQFIKVINACENNLKNVNVKFPIGNLICVTGISGGGKSSLIIETLYKYSAHKIHHSSARY
GQCDKIEGLEYVDKIIEVDQSPIGRTPASNPATYVGMFTHIRNWFAGLPESKARGYNIGR
FSFNTRGGRCEACKGDGHLKIEMHFLPDVYVKCEQCKGRRYNRETLEVTYKEKSISDVLD
MTIDQACVFFENLPMVKEKLVSLQEVGLGYIKLGQSSTTLSGGEAQRIKLSKELSKRFTG
RTLYILDEPTTGLHFEDINNLLKILHRLVDLGNTVIVIEHNLHVIKTADYIIDIGPEGGI
KGGEVIATGTPEEVVKIPESVTGRYLKTYLL
>ELAGILAN_00127 hypothetical protein
MSILSILLFISLSLLNTSNKLMICAALFVGAALVVNSMVEFYGRSKATYNLIVCTALCCV
FKWQSFNLMILISYTAILVSLLSSIIIFEKLKSKLNFHMANFITLIIASVVDSAVVCVGL
LYKFSAGKCLSIYIRDLIFKFSYVSVLSICLFVGMYLFCLANKKYFKIST
>ELAGILAN_00128 Phosphoribosylformylglycinamidine synthase subunit PurL
MANIRIEVLNKCEQVGRRRVVNVYLIYISKELPSKLHEEICGLFYNKVIQDCRYYSYNEN
LEEVQYNFIEPQAKWGLEISFLPGMTDNVGNTAKQIVREYLINKDYIDENVCIKARSSKL
ILSQATEDDIKQEFNPITEYCTLICKENNNYSWKYYGKYKANSSALSYLSSQCPDTGIQK
KDVDSSVSYSNDTINGKAKSVNLNVIDQELEKISRDGIDGNGTLGLSLAAMRAIKDYFKK
LGRNPYDIELESLAQTWSEHCKHNIFSSPIDEIKDGLYEHYIKRATREINSDICVSVFSD
NAGGIIFDDDYLIVDKVETHNSPSALDPFGGAMTGVLGVNRDIVGFGKGAEPIMNTYYFC
FAKEAKGKFYRDKERTDEILPPKYIMKEVIHGVNVAGNCSGIPTQLGSVYFDDRFCGKPL
VFVGSVGIIPRNINNAPSHIKGPKNGDKIVIIGGRVGRDGIHGATFSSEALSGNSPSTIV
QIGDPITQKKLSNAVIKARDLGLYNAITNNGAGGLSSSIGEMGKDGFEVDLSKVLLKNDG
MAPWEIWISESQERMTLAVPEENLPMFKQIMKKHDVEVCVIGEFNESGKAVVKCPKGTVI
MDIGTEFLHDGNPKMHLQTKPWSKGLPAPRAGMTTSSPSLEIELKEMLSRPNICSKEFIV
VQYDHEVQGSSVLKPLQGKGRMCSEAIVSRPVLSSNKGVVKSQGFGSSYGEIDTYHMAAC
AIDTAIRNYVAAGGNINHLALLDNFCWCDAYNPERLWQLKKAAEACYDFATAFKTPFISG
KDSMFNDFKGYDENGEKVIISAPPSLLISAIGIIENIENAVSLDVKMPGDLIYVLGETLD
ELGRSEYQLYSGIGNNNVPKVDAKSARKLYERYNQAIKDGIIASAIAPNLGGLVIALAKS
LIAGDLGAEIDLSLVPIGKIQNTDIINKIIMFSESQSRILVTIAPQNQKRFEELFEGAVY
SCIGKVTEKKVLNIKDVLKVDLKDVAC
>ELAGILAN_00129 hypothetical protein
MGRVFTVNVDESLFDVLVQHIFSEYEREKIPEIKVILPCKRDVIALLNAFKNYNAEKCII
LPEIVSLENIDEEDLILNLDRVKVISPIKRTLLLIQFILEWNRKNNDNFPIDLAYSLPSL
LDKIQYTQMAEFDEHSKKIESFINLLIETWNKILKDLGVVDILEHKSDYINSMITSLQKD
QHIIFVGIGKDKSLIKAIYDLPFGEIILPNLNLKIKEKDWKLLDKKHYQYCLKDLLDYLN
VDRRDVSFLPEACSPVLRHWDPENLTLNERTRWLYNRNWIPVSSTGMTPSTTQITCKLQC
SYTKNQRAGMTGSPELDYVFDTTADLSKVSSGHIGNIEVITCDSREEEAQVTSLIIENEG
YENVSLVVFDKLLAARIACLSRQHSAIPENYPYITLLLYSIEVLTSNWSSVALLSLLKHR
LVTFGYTQEEYSRILSEFEIEILRNFSTNGLSDIINAINAHKKLKHKEDILLIISKLEII
FNPLLNIINCPISDVVATHLQCINVLSGINFSELNSEIGNFTCNFLNACEGIEIKCSLEL
YSQILTLFLEKEFFSVASDLNKFSLYHNKVVILAGFNEAPSFQSPLLNALTREKFNLPSA
QEEQGYFFYTLHNLFCASKVYITRSLSHRKPILLQRLEILLKEGKQPYRDWLRVLNTPEC
TVPCTQPMPKPQTEVRKEKMQVMSCSAIEKLIRNPYSFYVEYILGLKQLRDLNFKPSILE
FSTMVHNILARYLRNKKSPMSIAREAFSTSQFNFSNMWWVRLQKIIQSFVEFDETRSNYV
ELEKNFSCPIFHIPARDTGSCDQYETAWMTNRPQEILLTARCDRVEYLPSGQVAIIDYKL
GSPPSNEEVMSGFFPQLILQALAVEYVTGREVSELAYWKLDYDKIKVISLRDYRQKMQEF
QNDLPDFLSNYLSNSTPFIASPYFDKFLRFNSYKQLERVGEWL
>ELAGILAN_00130 hypothetical protein
MELSLPTSEKQSTLVALCQRRDDITQMRTQEKCRLEAPENDHIKESCQKTIGFFNSQIDE
LNNTIQKIIDESRELQQRQKILKTVPGKVISRLSVFNARAWLLKQKRSSKSCWRIQKKVE
KLLVIEE
>ELAGILAN_00131 IS110 family transposase ISWpi12
MVTSYQNFIGIDIGKFKNVIAVHTQKSVVEFDNNASGWQQLFKKFSDILPNSLVTLENTG
NWFIAFSY
>ELAGILAN_00132 Release factor glutamine methyltransferase
MKTISTLIQEGSELLSSHKVESPHLDCEIIMQHVLGVERSFIIVNHADQVPMEKELLFWK
LTKKRAERYPISQIIGNREFWSKNFIVNQHVLDPRPDSETLISTVLKYYPNKKQRLKIAD
FGTGTGCLLISVLSEYKYAVGVGFEKSLEAYKVAYQNTKKHDLLSRAKIFPSSWIECSDL
FDLIISNPPYIKRSKLKDLQAEVQKEPKTALDGGIDGLNCYLSIFPILRRCLKKNGFAIL
EIGEDQSNIDKIIPSYELAFQEYVYDLAGMKRCIVVKQCIAPLL
>ELAGILAN_00133 hypothetical protein
MISKKTLAVTALALLLSQQSFASETEGFYFGSGYYGQYLNYTGELKAKIGDTAATATNNV
SVNDRSAQNTEGQSLSKYKGDYNPPFAANVALGYTGELNGNSYRAELEGMYSSVKVDNIG
LTSGQMTISYTKDKTRPEESYGAIVNHDQIENISVMANVYHHWKSDRFSFSPYVGVGVGA
TRMTMFEKSSIRPAGQLKAGLDYRINEDVNMHIGYRGFGAIGSSEYKLDTLKWDPNHDNG
KDKPKGGMAEQTGDNQVSTTIQNDFFHTHGIEAGLTFHFASKA
>ELAGILAN_00134 hypothetical protein
MSNGNHLRNILIGGVVAFSVLEFCFYLSGILFVLFADGPDAVDFKAINPSLTPFPQALWP
TIFDHIQYCWHHPELYSLELKITLIISSALPIIVLMIILWNLRERIIEWRPFKKKESLHG
DSQWASEKDIRKAGLRSKKGLLLGKDKRGYFISDGFQHALLFAPTGSGKGVGFVIPNLLF
WTDSVIVHDIKLENYEITSGWRERQGQKVYVWNPAQPDGISHCYNPLQWISEKPGQMVDD
VQKIANLIMPEQDFWQNEARSLFVGVVLYLLAAPEKVKSFGEVVRTMRSDDVVYNLAVAL
DTMGKILHPVAYMNIAAFLQKADKERSGVVSTMNSSLELWANPLIDTATASSDFNILDFK
KKKTTVYVGLTPDNLTRLRPLMQVFYQQATEFLCRKLPSDDEPYGVLFLMDEFPTLGKME
QFQTGIAYFRGYRVRLFLIVQDTEQLKGIYEEAGMNSFLSNSTYRITFAANNIETANLIS
QLIGNKTVQQESLNKPKFLDLNPASRSLHISEIQRALLLPQEVIMLPRDDQIILIESTYP
IKSKKILYYSDSTFTKRLLKQTRVPTQEPYDPNKVLSAAASKDKVNNEGNNALEGPNSVD
YPAETKTEDAVYDESNEFADEDIDDEDIDDKFEDDDDGFDDEEKSDDGFDDEEEEDEFED
EDIDDKFKNDEK
>ELAGILAN_00135 Type IV secretion system protein VirB11
MNYAALDTYLEPLQGIFQEEGVNEISINKPKEVWIENRGEIRCEKLEIFDLNHLKSLGRL
IAQATEQKLSEEAPLLSATLPNGYRIQIVFPPACEPDKVVMSIRKPSSMQLALDDYEKMG
AFSETVTEATDNPVDRHLDLLLRQKKIKEFLEYAVISKKNIIISGGTSTGKTTFTNATLR
AIPAEERIITVEDAREIVLNDHPNKVHLIASKGGQGRAKVTTQDLIEACLRLRPDRIIVG
ELRGAEAFSFLRAINTGHPGSISTLHADSPTMALEQIKLMVMQANLGIPPDQIIPYIKNV
IDIVIQLKRTGGGKRSISEILFTRSASENA
>ELAGILAN_00136 hypothetical protein
MNKERRNNSEDESEIENKVVTVGSNQGHRALMVMILVLLVGGVYYFYFSPSHKEDSEVIK
KEETKQNVQEFKGKLEQVPDNVIVPERIITDPLPPLPPLPTPQIVPEIKQIKKEEEKPKE
TPVSNIPILPKQNFPSNNVISNLPTSFPTIGDGGYPRERRSAQMLTISGGSGENKAADAI
LSDTSVQSSKATRVGKLGLMITQGKIIDAVLETAINSDLQGMLRAMVSRDVYAETGDTVL
IPKGSRLIGSYSFDSNVAKSRVNINWNRVILPHGIDIAISSLSTDELGRAGIAGIVDNKI
VSALFSSVALAGVSISSAVIGQKASNLIDVLTAMDVVKSITATEIDISSLKGAIVERLED
AIKTEVGKVGDEKWKLGLRAIEKIRNAKSDQDLLRIIKEEIVSVIKSSGASGVDAITSDN
IGITLDDVRQLLRQTQKRSKSVYDEAIGKSINDFSKDMRDIVGRYTDKKPTIYVDQGTAL
KVFVNQDIVFPPQAILNQ
>ELAGILAN_00137 Type IV secretion system protein virB9
MNMYRILLVLVLLVSSNLNASINYNEPISVDSRIKTFVYSPNEVFTVVFSQGYYSYIEFA
EGEKVKNIAVGDASSWKINPYDNKLLIMPFEVSSRTNMIITTTKKRNYIFDLISRPNYDK
YPDTDAKKVDHDYSAEKDISYVVRFYYPQEEGEFDVDLDEVSLPTQMQYTTDKLEKIIQE
NDTKYNYTYIDEGGNADIVPIELFDDGYLTYLKFRNNNKIPQIFVEEEDKPCKRLLFDDY
VIIKGVHKKLFMRYEDGEVEIINRSL
>ELAGILAN_00138 Type IV secretion system protein virB8
MLRFFKREKSTESLDKDINWNSNRYSTVIAQRNILLLFALILLATISISILVIFKISTSS
TIEPFVIEIDKKSGIVQLVDPVTVKQYSADEALNDYFISEYIKAREVFDPYHYNYNYYTK
VRLFSSPNVYNEFRNYIGSQNMDDLFNLYSDTKNEFKIRSIQKLGNDALQVRFFVEFIRK
DGSSTRKNKIVIMSYRYASLEMNDQQRYINPLGFQVISYRVDDEYV
>ELAGILAN_00139 Riboflavin biosynthesis protein RibBA
MFIGNQSSNKVERAISEIRRGRPIVIYDESNYLLFAAAEALERDLFNQYKLISSNVYVTL
TSSKVKYISQNKEHNSKRLLVNNFDELLHLINCSKEDCIKELQCSKTIDECAIALLKFSE
LLPYALVADMTFENKYEMRNWCEENDIIALDTLLVNDFQQNQSVYEVCKTSLFLKQTQEV
DIISYRTESGGREHHAIIIGNPDKDDEPLVRIHSSCYTGDLLDSLSCDCRSQLHQAIQMI
ADFGSGIILYLMQDGRGIGLTNKLRAYSVQREHNLDTVDANRILGFEDDERSFVVAAKML
KKLNINKIQLLTNNDRKLSELESSGIEVTKCLPLIVERNKYNDSYMETKFGKLGHKLRVF
>ELAGILAN_00141 hypothetical protein
MNIANIFIFLALSLITSFHFVHAQILYTWSQVIPENKLSIRAITDNDMCPIVYVDGEETE
MLNRSSINNGDHNETVCELTVQTSAKNISIEDLRVPILPKKVNKIAFIGDTGCRINMLFQ
QECNSVDSWPLKKNLDSIALHKPDLIIHVGDYHYRQTKCRNTKKCGDIYGYNKEVWYADW
FEPAKDILSQSPFLFVRGNHESCDRAYEGWFRYLDSYPFSSEKCGNFVSSWSLDAGPMKF
FIFDSSSGEDIFTTQSTIDAFERQFDKLIQNSSDKPMWFLTHKPLWRSPKKEFLTLKSHG
NLTQIEAFGDKFPSNVTTIVSGHIHIAQILLMDNVPDQIIVGNGGASLHAQDQESVYQNV
EFDYLNGKNYLAHEVRNFFGFGFAILNLDDHEFTFYNQHNKEMYSAKLTEDFKLKRIKTI
VDSF
>ELAGILAN_00142 Chromosomal replication initiator protein DnaA
MNLTSPKVSTMFFDQIITVTDHNVTWEKIQNCLYNLYGEATYNSWLSSLKFVSSRNGEVL
LSVSTRFIKEWITVHYMKKILSLWQSEDKSIRSIDIQVIEERNSNFNVILKNREESNHNL
GSPLDPRFTFDNFVVGKPNELAFTAAKRVAESIDPILGSNPLFLYGGVGLGKTHLMHAIA
WHIVNSPSAKRKVVYLSAEKFMYQYITALRSKDIMLFKEQFRSVDVLMVDDVQFISGKDS
TQEEFFHTFNALIDQNKQLVISADRSPSDLDGVEERIKSRLGWGLVADINETTFELRLGI
LQAKVEQMNMYVPKDVLEFLARNIKSNIRELEGALNKVTHTSLIGRSMTVESASETLIDL
LRSNHRSVTIEEIQKKVAEFFNIKVADMQSNRRLRSLARPRQIAMYFAKKFTQKSLPDIG
RNFGGRDHATVIHAVKQVENFIKTDSKFADEINRLKKMFK
>ELAGILAN_00143 hypothetical protein
MIILSNLSCYAVFGIELEFYIEGIEKEYLFLNSIKNKIASLEFSCEKENSTHQYEIKSGC
YTNSYNLIKHFELAKQSLTETAQKLGGNVSFKAKPYLDRAGSALNVHVNLVNSNNGNLFY
INEQKYSDYLIHSIGGLCAMMKKHMLFFAPNDDSYLRFQYPDIHTPTTISWGVNNRTAAI
RIPYFGNDFKRCRLEHRVPGADCDLEKVLTAIIEGMVFGIENKIAPPNRVYGIASDPQYE
MERLI
>ELAGILAN_00144 hypothetical protein
MVAILNITKGKNKVIVSGLAGALSALIFLTAIHIAAKIAIIVSAAAVTYLLLSLIHKIRT
KKEQPEITGVSGEKVSEDEGYSSVDEGEEKDTAKEPERTETELEEEIIRKRAQERMEKGS
LGGPINAFGEPIHVTIDAENSNPVDYTKTMVVPEEIILSMLNDKTLTQNNSSSIKDQMKP
LPEHMDVPGNPLPGQVLSNLELESKSTQKLSALDLLLQCKNVDNDVKKMLKQPITQKGFN
GLGFDR
>ELAGILAN_00145 Toluene efflux pump membrane transporter TtgE
MQSLLIERNRAVVLLLIVIFIFGSYVYVKMPRESNPDIQIPIISVFVGLPGISAQDSEKL
LVLPIENELRSIEGVREFRAFATNDGAHMILEFGTEYDNKEVLDNVRSKLSNIKSKLPVE
AESPIINEINLSLFPILNVGLIGNLPERALTEIARKLKKEIESLPNVLKVEVAGMRKETV
EVIVEPTVLTKYNIQSNEIFQAISSNNRLVGAGSLENDTGKYSIKISGLLKDIEDIMNIP
IRSQGDAVLRIKDIAKVYPRFEDHQGFARINGLPSVMLEISKRNGKNIIDTVNQVKYLMD
KAKDQLPENLKVVYLNDQSKNVRDVLDDLENGIIFAVLLILIIMMLSMGTRIAILVALSI
PGSFLIGIIALYFMGITLNIVVLFSLIMAVGMLVDDAIVISEYADRKMICGMNKVEAFYT
SVRDMFYPVLSSTLTKLAVFFSLLFWPDTVGKFMQYIPITIILTLTGSLIMALVFIPTLG
AIFGKPSITSKKEIKKMSAIESGEIKNAGPIIRAYVRMLEKVLDHPKKFVCATVFVLFSF
SVLYFTFGPGVKFFPKVDSDNILISVKAKESLSAKERDLILKEVEERILSIEKEIHVSYA
RSGAFSDNVIARIQLELMDWRFRRKAKHILNDIRSSVQDMKGIIINVQEEKPGPSADKPI
QINLSGSVSSLNLAAEKILEIMNQPSSGFINIQDSRSAPEIEWNMSVDKNKATSSEVSVA
TIGDFIKMVTNGVLIGKYRPNNTDEEIDIVLRFPGKDRNMKTIDNLFINTVNGPYPMSNI
VKYAPEKKVNKLNRIDGLRTVTISADVDTGYLVDERVKFIQNSIAQDWDKGVKIDFKGDK
EDQQKSGAFLLKAFILAITLMILVLVTQFNNVYHTFIVMTAVFLSTTCVFFVFFLIQQVF
VVVMCGVGIIALAGIIVNNNILLLDAFHHQIKVHKNDIKRCVINAAISRVRPILLTVATT
VLGLIPMITRLNINFFTLQITYDAPSSQWWVDISTTIASGILAATVLTLFFTPALLVIQK
HEKT
>ELAGILAN_00146 Transcription termination/antitermination protein NusA
MIANRKSSVKQKSNKNNIVGSLDVIKTAGELSLQKGLDFDVVIKALESAIEAVAHQKYGS
KSKIVVDIDRNTGKVTSYRKLKVIDDESNEKENTECESITLTQAKLIKGDAKVGDTVSEL
LSLNTDLASARIAQQTIAQIIKDEESKKQYEEFKDKVGEIRYGIVKQVEYSDLIIDINGT
RAYLPLRNLTGGESFREGDKVKAYIQTVKRSDDGRQIILSRTHEGFLEALLNQEIPEIAD
GLVTIKGIARDAGSRSKVAVFSPDKNIDPVGACVGVKGDRIKTIIHELNGEKIDVINYSS
DLGQFVIKAITPAEVSKVIIDENENCIELIVAEDQLSLAIGKKGQNVRLASELVGWKIEI
LSTQQESERRSKELSQCSALFAEALNLEEIMGQLLVTEGFSSVEDISSASIKELASIEGF
NEDIANELHNRANKYLKAENDRKIEELKSLGMEDDVINLTLSIDNKIALSKHDIKTLEDI
ADLSSYEFCSILSSSSDSKEDLKDIVDSIIIEARKKLGLI
>ELAGILAN_00147 Sulfate adenylyltransferase subunit 1
MNNEDISDKKLTLQGLSKLKLDLNLNSSASPSTGATVVKKRRKKSHDAEEHNLFDESKLG
SLTEKEQIFRINAVQNAALLKERNQREEKEKTAKEDSNKETDEKNEADALSKEINKQVLS
NTHLVEPKEDSIDHEDNDKKSFKVNKDIYSKHSKLVIAQAIDEKTEQPPVFKQRFGIRGR
KSKFTKGKNISREVIIPDKITIRELSIRMAEDSKSVLKMFKEEVGESYRVDDLVDPDIAC
EIVEKFNHTAKRVSDANKEKDLFFIEGRESLPKKPKPPIVTFMGHVDHGKTSLLDAFRES
NVAERESGGITQHIGAYQIITKDKQKITFIDTPGHEAFTAMRACGANITNIVVIVVAADD
GIMKQTVEAINHAKAANVSIIVAINKIDKSEPGDVEKIINSLPQYDLIPEGLGGDVMIVP
VSAKKKTNLDKLEETILLIAELMKLEAIEDCRALGWVIESKIDKAKGISATLIVEEGTLK
VGDILVVGTTYSKVRSMVNHLGQREKAALPSAPIEITGLNGVPNAGDKFVVINSEKQARE
IVEYRLELIKKKKEDLGDNNLDIFSRNNSETEELSVVLKCDVTGSIEAISSSIDKLGKDQ
VKLNILHKAVGGITDSDVLLAEASSAVILAFNVKVDSKIRDLAKQKGIEIHTYNIIYELI
DDMRMYLTKMLKPVTREVRVGFASVRQIFNVSKAGNIIGCYVSDGVIRKDSLIKVMRGGK
LVHEGKLKALRRFKDDVKEVGVNFECGVSLEGNIDIKVGDILEAYQLVQEERVL
>ELAGILAN_00148 Ribosome-binding factor A
MKKEIRNLKIASVLHRAISRVLMEGKVFNKNVAVSDVKLSKDLKKADVYIVLSSLNIQVA
DYLDPEKRRTGDPSENNCDINTVVNEMNQSAWSIRKSILCYVDLRFIPELVFKPDLAFDN
FVNVSKILHNHT
>ELAGILAN_00149 4-hydroxybenzoate octaprenyltransferase
MHFNRYFSLMRLHSLTGLWLVLFPSLSGILLASTSLSYQALFLLVLFTIGAFLMRPAGCI
INDIFDRKIDAHVERTKYRPLASGALNIKQALALLSLLLSIALVILLLTNKTTLILGIIS
MCMIATYPLLKRYVWWPQLFLGFTFNMGSLMGSAAITNQISIESLLFYIGCVFWTLSYDT
IYAHQDKKDDEKLGMKSTALYFGDTTKSWLKRFYLISLMTWLYAGILSSLNNIFYIALLA
VGFIFHRQCKNFNPDDPSQCMSIFKNNSYVGLLLFFGILLDRIIT
>ELAGILAN_00150 putative chromosome-partitioning protein ParB
MKDDRRLGRGLAGLIGDNYDNKEDRQEHLPISLLHPSKFQPRKHFDEESLRELANSIKKS
GIIQPIVVRKDSNDDGYEIIAGERRWRASKIANLDSAPVIIKDLSDKECLEVSIIENIQR
QDINPIEEGEAYRKLIDEFFYTHEELASAIGKSRSHITNMIRMLLLPDRVKTMINEKKLS
MGHARALINVENAESIAEKIVSQGLSVRQTEKLIKDLHQNNNQKEQRYTRNQDMTVIEGA
ISSQLGLKIKINDNNSKGKVMIRYDNPNELDLILKILNRKLEA
>ELAGILAN_00151 Chromosome partitioning protein ParA
MSKIIAIVNQKGGVGKTTTSINLSTAFAAVGKSTLLVDLDPQGNASTGLGISYRSREEKN
IYKILLSSENKLIESAIFNIKEIPNLSLISSVVDLSAAEIELSQLERGKFVLKSALEKIR
DNYEYIIIDCPPSLGLLTINALTAANSIIVPLQCEFFALEGLSHLVKTVELIKRNNLNPF
LAIEGIVLTMYDRRNKLSEQIKNDICQYLNDKVYKTIIPLYETVIPRNVRLSEAPSHGKP
AIVYDLKCPGAQAYISLAREILKKHASSCKEKKLVSEGVV
>ELAGILAN_00152 Sensor histidine kinase RcsC
MNKRYIDNKKENRVDFILRNYGMSIVVMAVIMLLPPVAISILYFFDIYSQHINIEINLLV
SILTTLFMMYNVKRYRYLLNTIEFQNAIFANALNHNTEFCLILHKDEGVIYADARFYERF
KDHIIDDDITLGKILEIGDVSEADKKVLYHALKNNSSVQVCISLNKKNRVSNFLLLFESI
PDNPQIAINSNKILNLSLVPIARPDGYFVLKATQINKEQIYEELIEKHSIGTYIANAKGV
ILSVNKRFLDIFELKKLEKGSSISDFISQSKYNNTTTDNEILFFTISGIPFKAYMSTAIF
CDKYNHSYIYGFITPTESNIVDYQLHPCFANSSIAIAQCDINGNFVKKNTALIKLAGSDN
NSIFTLILDSYHVKIREYFSSNRINNASFDVQLNGGNNIKIYFNKFLHNKMIFILCYFID
NTEHKNLEIKLEHYQKMQAIGQLAGGIAHDFNNILTGIIGFCDLLLLQHSAGDPSFGDII
QIQQNAKRGSNLVRQLLAFSRRQTLQPKIIDVNNTIANLYEMIKRLIGENIKFNIYYGRD
LGAVRADQGQLEQVILNLAVNASAAMEKGGELTIRTFNQKIDSLNSTPQDMFSPDKEAIE
HGNYVVIEVIDTGCGMTSDTTEKIFDPFFSTKDITSGTGLGLSTVYGIIKQTEGYIYVAS
KVNHGTKFSIFLPMVYISDENDREEDSEETERPVVSEIKGNGIILLIEDEDSVREFISKE
LKRKGFDVIEASIGSEALEIISKKSQHIDLIITDVIMPEVSGPEIVKEALIHRPNINVIF
ISGYAEDAFLKSDDINIEDFHFLPKPFTLNELGNKVQSVLHKAKKTV
>ELAGILAN_00153 Oxygen-dependent coproporphyrinogen-III oxidase
MEKQKTQAFKWFCALRDKIIESFLLIEKQSSAEPKIEKRKWDRPGGGGGESTIIFGNVFE
KVGVNVSKVHGKFADSAINEIPGASESNGEFWASGISLVSHMQSPLIPAAHMNTRLIYTS
KQWFGGGMDFTPIYRNEEDCKYIHESIKMICDRFDTGYYPKFKEQCDNYFFLQHRKEPRG
IGGIFYDNLSSGNWENDFEFTKAVGEAFLEIYLHIIRKHIQKSWTKEQRENQLIKRGRYV
EFNLLYDRGTRFGLMTDGNPDAIMMSMPPLVKWL
>ELAGILAN_00154 hypothetical protein
MVVSFYIGGIIMGIIDNFLIKSVKNNDIKGVKLTLILYDALNSFRKFFSKTMSLKNTGSF
DINNNQALNQALGHATDHKIMELLINRGADIHSIDENGKNVIIRVIESLAESKNLKLDSE
KNLPAEIILHPTVSFLLGKGAEYYSTDDLNIEAIQQKPPRTFEYKSKNTSYDALPSKEPI
YAEVYDAKVSNSLGENGYLSVSEESIYAEIYDSHKKSTENLSLEDSGYLSISEEPIYCTI
DDLSEQKKPTSLKQKEPEQSSEPIYARVDLSKKRAERKAKDIKANSGTCHGLVQDKVNDW
QVKLNELSANKSISQQQTNDQKIKTKAGFSVEEIRQKYERRDSGYDSGYDSDTKVEQQLE
LAPKSEIGSVSIEHGVIGGCRYKITDISL
>ELAGILAN_00156 Ribosomal RNA small subunit methyltransferase E
MGKIRLYVEEALSQGVSLALNPQQSHYICNVMRLKKYDNLSLFNGKDGEWLGEVVNISRK
LTEVTPKECTKQQQYEENLYLYCAMVKSAALNNIVRQATEMGAICIQFISTERTVVKNIN
LSRAKLQAIEAAEQSGRISIPEILPPINFCELPDSQSKNFVLCDETGKADKVLKGKKNVA
IIVGPEGGFSSYELDLADKFCQKLSLGKRILRVDTAVVAALTFTNWCS
>ELAGILAN_00158 30S ribosomal protein S21
MIEVSVHYGDVDRALPVLKKTIQKEGRGLKMKKQYHEKKSEKRAKKKAEAKKKRYQQECR
RQRYGW
>ELAGILAN_00159 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQAKEVLHKFNVSVPKGFVATSAEEVKTQVSQLKSDVFVVKAQIHAGGRGKAGGV
KLAKSAEEAQQFVKDMIGMTLVTHQTGPSGQQVRKVYVEEGSSIKKEYYLSLVIDPKLSR
PIFIFSSEGGMDIEEVAKNSPAKIVKFDIDSATSFDSSKLSSSFHLSPEQIEKITNVAKN
IYDAFIATDASQIEINPLVETSSGDFIALDAKINFDDNALYRHPEIMELRDYDEEVKEEI
EASKYGLSYIKMDGSIGCMVNGAGLAMATMDIIKYYGAEPANFLDVGGGASKETVTEAFK
IILSDSNVKGILVNIFGGIMRCDIIASGIVAAAKEMSIKVPLVVRLSGTNFEEGKKILEE
SGLNIIAADELGDAAQKIVKEVK
>ELAGILAN_00160 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKDTRLICQGFTGAQGTFHSEQAIDYGTKMVGGVTPGKGGSTHLNLPVFNTVAEA
KEKTGANATVIYVPAKFAAAAILEAIDAKIELIICITEGIPILDMVKVKRALIGSKSRLI
GPNCPGIITPEECKIGIMPGHIHKRGHIGIMSRSGTLTYEAVAQTTAVGLGQSTCIGIGG
DPIHGMTFVDCMELFLKDNDTHGIVVIGEIGGNEEEDVSHFVKAEKTKKPIVGFVAGQTA
PPGRRMGHAGAIISSSGGSAGAKLEVMRSAGIAIAETPAVIGKKVLEVMHH
>ELAGILAN_00161 Diaminopimelate epimerase
MMSGQNSENFIKMHGTGNNFVIIDSCSANDLNWNYKKIANQNGCDQVIVITNSSLADCFM
HIYNADGSKAEMCGNAARCVGYLLMSEKGTEYITIELVNKRILECFKVGDKSIKVNMGKP
LLKWHKIPLSTECDTLHLPIELEMLKDPVAVNIGNPHIVFFVDSVNEIPLQSLGPKLENH
ALFPQKINISIAQVEKSGEIALRVWERGTGITASCGSAACAALVTSTLRGYLTVQQTSVN
LPGGKLLIEWANNVFMTGDIGFL
>ELAGILAN_00162 Putative NAD(P)H nitroreductase
MNYLCTIKLKMMSKQDLLSLMKARHSGRSYDPTRAISQEDMDILMEAVRLTPSCFGDEPW
RYVICNKQNNQSAWEKLLNCLDESNQKWAKDAQVLIISLSAKNFRKQGKGENLWASHDTG
AANYGLMLQAAVMNLMAHQMGGFDRDKIVKEFNIPNDFNVMSVIAVGYEEEGAETSKKKR
RPIEEIFFYDEWPKF
>ELAGILAN_00163 Biotin transporter BioY
MFITQSSSRSTLAEILSCVLLLFLMAQISIPLQPVPITLQTLGVMLIGLKFNRRTAFYSV
LTYLSLGAAGLPVLANFSGGYHALLGPTGGYLIGCLAAVMVMSKVNELLNSKYKSFVCNS
LSCLAGTVVIFICGVSWLAVYLGLEQAIMVGVLPFILPGLVKIFLLVAALQYLKK
>ELAGILAN_00164 hypothetical protein
MCTLAFRGYGYSQGFVENYRKIASEVVSTQIEVVGNLDSICSACPNQTKQGKCTTQAKVL
ELDRRHMEILGVKIGETLTWNEAVKKIREKMSLEKFEYACEGCNWQPYGICKNALLNLQR
>ELAGILAN_00165 hypothetical protein
MLHIAQRNKVYWLHAAANATTLGPMFICMLICVVILWRSSVTYASENLEIQKAFDSVVKH
IKADKKYKDLDVIERKSDKFNIKIAQNSGKSFDIYSTLKKAKDSFESGDNETAISLLNQI
IAKFPYHKNALIGLGNIYYANKEYKKAVEIYTRLLKEHPSNPYILKNFLTIISQYDPDLA
LSEMLKLYDIHKNYAPLLANLGLIYMKKEDYVKGKEYMITAISLDENNIFYTYNLAVILD
KLSDFQNATIFYLKLLNMATTSKDVSEKIPLYKVTARLKFIKLHSTHPKIS
>ELAGILAN_00167 DNA gyrase subunit A
MQDNIVPISIVKELEDSYLSYAMSVIISRAIPDVRDGFKPVHRRILYAMSRAGFDAGKPY
KKAARIVGDVMGKYHPHGDAAIYDSLVRMAQDFSLLLPLIDGQGNFGSIDGDPPASMRYT
EARLQKVSHFLLNDIDEDTVDFRPNYDGNETEPVVLPAEFPNLLVNGASGVAVGMATNIP
SHNLGEIIDACMLYVDNPEVTLDELLEVMPGPDFPTGGTILGRSGIRSAFATGRGSIVVQ
GKTHIEDLPQDRQAIVIDEIPYQVNKVKLIEKIGELVKEKRIDGITEIRDESDKSGIRVV
IDLRRNAEASFILNQILGLTPLRSSFSVNTLVLNNNRPALMSLKEIIEAFIDFRKEVLIR
RTEFRLRKTREKAHIYIGLYIAVLSIDEVIKIIRGAKDPAEASRELLNKEWKTSNEINTI
IELISDSASFLKDGVYRLTELQIKAILDMKLQRLTGLEKDKLEAELSSMINLIKEYIAFL
GSGEKLMKEIKNNLQEIKNRFAVPRKTSIEESDTDIEAEDLIPQEDMVITVTMNGYIKRV
KLSHYRTQRRGGKGKLGQGLKEEDVITELFVTNTHTSVLFFSNIGRVYRLKVYKLPLAEP
TARGRALVNIFPLAEGETITNIMPLPSENDENQNIVFTTAYGNIRRNSLADFHYIPSNGK
IAIKLDEGDKLISVKVCNEIDHFFLSTRFGKSIRFVVSDVRQFKSRNSDGVRGIKLAKND
SVISMTILNGIGVATETKELYLKVPLAKRLGTAINNSIDSKLEKTLNDLGIDNELFLKLA
VNEEFILTITENGFGKRTSAYEYRITNRGGVGITNILTTSRNGNVVASFPVEQGDNIMLI
TDKGKLIRISVNDIRIAGRSTQGVTLFKTESREKVVSVAKIEDPDSTEDSISEVENSISS
QL
>ELAGILAN_00168 Ubiquinol-cytochrome c reductase iron-sulfur subunit
MDKKLTKNKKPLANKEDKKTPPVKDLTKNKSRRDFITLTTCAMAGIGAVSGLWPLVKSMN
PSAEVLATSTVEVNLSGIQEGHGVKVKWQGKPVFIRRRTKQEIEAARAVNVKSLRDPQLD
EQRVYEGKDEWLIMIGICTHLGCVPVDHATRDGNGWFCPCHGSYYDTSGRGIGGPAPKNM
VVPDYFFPSENVVVIGKKA
>ELAGILAN_00169 primosomal protein N'
MLNSITMAKTVDVLLSLPIDQLFSYAIEENTEILLGDYVVVPFGKKRLIGIVWKYSDKSN
RELKFIEQKIDLPNIRPKLIAFAEWVAQYNLIPIGMLAKVIMGGVLKVNHIDKLVCVEQK
QETSEISCQLSPEQQIASDKIISNLNEYSVTLLDGETGSGKTEVYLSVIAQLIKNYTAVP
NAAQTLPSQCPETQLYEHCNLGLPRGCYPSSLTLGSSFSYNLITNVYFNLKPIPNLQSKF
LDSSVKHWNDTFILKAKPTVTFSIPSLPRTSMTPEYVEMTSGEGNTQILILLPEIVLTSQ
LVNRVRGQISKNLVEWHSGLTPKTRRNNWLNIANGNAQIIIGARSALFLPYKNLKLIIVD
EEHDSSFKQEQGIIYNARDMAIILAKFENIPIILSSATPLLETIHHVKNGNYNHVKLTKR
FGGAELPLIKVVDMRNNKQWISSELFESIKQTIEKKQQVMLFLNRRGYAQLAICKKCGYK
ISCLNCAVWLTYHKKKNALLCHHCSYQLKLPEKCSNCQSEQPLSLYGIGIERLLEEMVKL
IPNAKTAMISSDQKSVSNIIDLVLKEEVNIIIGTQIIAKGHNFPKLTLVGVINADLSLEN
SDLRAAEKTYQLLHQVAGRSGRFNEKGMVIVQTNNPESSIIKALLHQKRDSFYEIELKSR
REAKMPPFSRLIALIICGKNRIATQKAANEIVKSLLCHPSSSTTCIQEKNVSADKKEFEI
LGPSPAAINFLNNKYRYRVLLKIHNKHSLSIQKKLKYWIKNCNLNSSIAVIIDVDPVSFF
>ELAGILAN_00170 hypothetical protein
MVNDKITLNFEIEKGEPIDRYYFSAHIKLTDESKNLLREKLGSTIQFDNLDDHFNLNHEN
FYIYYNKYSEHNGRSELHVRDDNGKYLTSNLPLNYYGFSMELSPDGASIADYGFYPLYAI
YNPNHYNKAKEKVFDDHGELSPIASNVLDNFLSNTNSLTTQDILQNVFSQLQKKADEEAE
RLAREREAERQREEELNEKNEELKELVEKDEIKIFKVVKGNDLGNGHSAVVLQLDGEEGD
KIPLDSSKYYIAEYRHHPEWEGDEYLNFVSPDSDMLVNYENLFFVLNQSSYSDFESGFYS
ENRTDPHNYAKYAKEPYLSGDQLSEKLSNELEEDSNQIGTEFTIDDEQVDEEVVVESEAK
SGEKGTVGEDNAKNTIQEEESNYIDQMQADDSSSYKPALQSNRDDYADTKKALQEKLHGD
EIHKQSNEKAQKDIEVKKVTVETDSSSNKTEKQTKPTEDEQETVMASVIENMDKNSDIEA
ETSNSVANSQHPLKIKTGSSLEVGKYKVELQVTYDDVKNFYDTVRGKYHAGDGYNYEQVM
VLYNEIVRPAHNHHYELFTLDEAHVANDHLFIKGQDFGTLNDFNEMFYKSDELM
>ELAGILAN_00171 Phospholipase D
MCFSLYYYAGFIFSPCPKATVCFSPGEDCAVPIINVIDQSKKSILVQEYTFTLGTVAKSL
INAKERGVDVKVILDKSQLYSKYSVINELFSGGVPIWIDDKPKIAHNKIMIIDNQKVITG
SFNLSKTAKKGNAENLLIITDYPELIQQYVKNWEARMSQSYKYAPN
>ELAGILAN_00172 hypothetical protein
MDYINDAAGSYTAIHDFFQNNGVGDYKVQCNYGGVPYATDEYVHSGDKFWSNNFIDSHFG
REIKMYPQSELLAKEYAGNTLPVSISLDKDLIKMKECQKKTKFVELERESGDLVHDKQKY
VKCYTTKLSYDDVHIYNNDKVSTFSIKYDVPNDPKYSLNITFTKVNDNKPGFWQKFKNMF
>ELAGILAN_00173 Ribonuclease 3
MKSLNDAISKIIDYKFTNYAILEEALTHPSVNKRNSKNQIVSYERLEFLGDSVLNMVVSA
TLFKLFPEEKEGALAKRKTDLVCGNTIANVAKEIKLGSFIIMNNSERCNGGRCNLKNLEN
SLEALIGAIYIDGGLENVEKFIIQYWEKLAKGMLDPPQDPKTSLQEWTQKNKLPLPEYEL
VKQTGPAHNPEFTISVCIEDYGKVSACASSKKIAEQKAAELMLEKIGKDASV
>ELAGILAN_00174 Dihydroorotate dehydrogenase (quinone)
MVKNKLKISKVFYKRNLLFLLPPEVAHSLAIMALKKMPYKNPIELPESLSVNFFGNKLRS
PIGLAAGFDKNAEVIRPMLSFGFGFIETGTVTRNPQYGNKKPRIFRLIKDQGVINRLGFN
NKGIDYFLKQIGETKLDDCIFGINIGKNSTSKDQISDYVDLIKIVYGKSNYIVLNISSPN
TPNLRNLHNKQELSELLKSVTLTRKSIDNSKSIPIILKISPDVDQQTKENIAELALEYKI
DGLTVSNTTVSRDNLHSHHNESGGLSGKPLFKLSTELLGDMYKFTKGKILLIGCGGISSG
ADAYKKIKAGASLVQLYTALIYHGPQVVNKINLELAELIRRDGFSNISEVVGCIH
>ELAGILAN_00176 Fructose-bisphosphate aldolase class 1
MNFIALMSKEIRQILNHYESENPGVKANLTRILMHGKLGGTGKLVILPVDQGFEHGPIKS
FEVNPDAYDPHYHFQLAVDSGVSAYAAPLGMIEAGAATYAGMLPLILKLNSSNSLHSKNL
TSDQAITSSVKDALRLGCLAVGFTIYPGSAKCFDMMEEARGIIAEAKSYGLAVVLWSYPR
GEGISKEGETAVDVIAYAAHIAALLGANIIKVKLPTKYLEREKIETENIESLSKRIEYVK
RSCFAGKRIVVFSGGESKEVDNIYNEAKEIKQGGGNGSIIGRNTFQRKREEALSMLKDIM
DIYT
>ELAGILAN_00177 hypothetical protein
MASLTRNQYYSNRDLQNLFSRLEIKAEEVISQEFDDILKLVERSFRKLSLKCHPDKEKDE
EKKKIATEKFQKLSADKKELEKHLNALKEGKTPSQYERLSSEEERRRQTKIYGILSRRSK
AINRALLFFILANAVFTPSLKVEYCLSQLANSGTVQSIAYQFYAFSIGIWPLLFIISFCG
IIYAASKQKGSQEENLDRLNRRYNLLIAADNYVICIAATFAICGLVSEVAQNGWPAQYGT
MLMINLALDLLLIALLRTFTKASELYSEHCIQRLYEEDAEFSYKEKFAWYDYKLVLMPLV
LPIVKMYFRDLIQKKPQQHTTNPNVTSLGTPAGQEP
>ELAGILAN_00178 ATP-dependent Clp protease ATP-binding subunit ClpA
MISKNLEASLNRALFIASNFNLKYAKVEHLLLALTKDVDVNYVLSRCNIRADEIISMDNI
LSRCNIKANDYNNNIKGFLQSSSELIISGVKPSSMFQCIIHRAIIRAHSLGKKEINGASV
LVEILSGQDLYVEDLLQKQSAKDSNLIYHISNMKYSNDIDEYTTNHKVKLDKNNDAPTTV
NKGELLKDEEILQSYCKNLNDYARSKKIDYVIGRDYELNRTIEILLRRRKNNPLYVGDPG
VGKTTIVEGLVLKIIEGSVPSVLRSSIIYALDLGSLLAGTRYRGDFEERIKSIIKAIEAK
PGAILFIDEIHTIIGAGSTSGSFLDAGNLLKPALARGTLRCIGATTYREYSTSFEKDKAL
ARRFQKINVKESSVNETIKILDGIKHYYEGYHGVYYTKNAIRSAAELSHKYITGRILPDK
AVDVIDEAGAYCKLLRNRGKIVNSRDIKNTITRITNVPCGSESDDLQKVKSLKANLEKVI
FGQEQAIESLVNSIKIAKSGLRNYNKPLANYLFAGPTGVGKTELAKQLAESMGMNLIRFD
MSEYIESHTISRMIGSPPGYVGYDQGGLLTESVSNNQYSVVLLDEIEKAHSDIYNILLQI
MDYGCVTDTYGRKVNFSNIILIMTTNAGAAERSKSFVGFGHKKFNTGDSKKAIEQVFSPE
FRNRLDAIISFSDLNADIILHIVDKFIQELKKQLTQKGINCLVEDEVKSYLAQTGYSKEM
GARPIERLIEKEIKSYLAEEILNRKLIKGKKLRIYMNKVENKIAFDIV
>ELAGILAN_00179 ATP-dependent RNA helicase CshA
MNNFHEMGLPASLRQALDKNNLFVPTPIQIQAIPLALQGKDILGSAQTGTGKTLAFAIPL
VAKLLNEPNTGSALVIVPTRELAHQVTNEIRKLLSQNSALRVALLIGGEPIFRQLNQLQK
KPQIVIGTPGRIIDHIERKTLITRNVSVLVLDETDRMFDMGFGVQIEEIMKHLPKIRQAL
MFSATLPGDIVKLAEKYLNRPERISVDCEVTTSVKIKQEIVYASESEKYEKLVTQLCQRE
GSIIIFVKTKRGADQLAHRLHKDDYSALAIHGDLRQHKRERVINSFRRGRNQIMVATDVA
SRGLDIPHIQHVINYDAPQSQADYIHRIGRTARAGAEGYALSFVTPQDKRRLPVLADKEG
ELNFDCSVQFKKRNSKKVFKRPSTLKTKYGRKKINAFKKKSRVLEKAY
>ELAGILAN_00180 Cold shock protein CspA
MEFGNVKWFNAEKGYGFIKPEGKGGDVFVHISTLERSGIRPEALKGENKEKGIKGERVSY
EVKEERGRNGEDKKSAINLRLED
>ELAGILAN_00181 Metalloprotease PmbA
MNILNIAADITKLIKKQNQDAEVTIYETNKTSVSQRLSKIEQISQSKNCTVGIRAIAGKN
KAAYISTNDLNNLSDTVSQVVEMAKNAPEDPCINFAVNGSNYISSADLSISDNNVVTVDN
LKEIAEAAENSALAHKSITNSEGASSSYALVNTVLSTVSGFIGSFSKSTFANQVSVVAGR
ESEMKVGYDYDIACNFSDLKLPELMGKEAAKRAVDQLNSRTMKTGKFPVIFEKRAAKGLV
KSFASAINGSSIISNSSFLRGSLNAQIFNDRINIIDDPLLPRGIASRPFDGEGITSKKNI
FVKNGILQNWILDLYSARKLDSETTGSATRASNAAVIPAASNLYIENGDVSFEELIQEVK
EGIYVTDLFGFGVNLINGDYSQGASGFFIENGKITYPIHEITIASNLKDMFSNLVVADDL
TFCGQFNSPTIKVSEMTVAGSLND
>ELAGILAN_00182 ATP synthase gamma chain
MKSLKELSLRIKNIRSVQKTTKIMQMVSAAKLLQSQKKLSNSKLYISKLHSIISSLMLSV
DQELLAKILNVSNNGSYLVFIVASDRGLCGNFNSSIVKFSQNKLITNGKKVDIVFLGKKA
FDIGKNRFDSKSILKIENSKGITLKHVEALVGGIDLSKYDKVKVFYSKFYNTFTQKPMLE
TIKPWSKDSSLIDNSLAGPITDYGYEYEPQNIEFILKSLVQDYVVIALYSALLESATSEN
SARMVAMESANRNTKEILNKLALLYNRSRQAAITTDLIEVIGGAESL
>ELAGILAN_00183 hypothetical protein
MIYFIIFAFSFLFGIWVKVSGEVIKLELGNYTISIDLYFIIFTCVVLLFLLITLVRFFSS
ISSTFANIRNRRRDREELLLFEAFFSIDLDNIENAQKLVKSLSEESDRLSLIKLFNSGKT
GNYSFFSNGLTNIANKNRNLALLLANKLIVHLKQEKVVFQKFIEYCSSSINDKMLSIPFQ
IEHCILKEDWINAILRLKEAVKSNIFLPFDHKEMFAVFYCALAKQYESKGNFKEAIKSLF
RAQRYSAIFQPINYLKAELYIKLGKIRKASAVLEAEYTVNPTPQSAKMYINLNSKGAERL
YNLRPDYYFSYCLLALSSMSSGKYDLASQYLDTAMKKANYMSIYFIVIQLKVTLQEHDKV
IYWLNKMGSEALPDPGWKCKNCNRELEQWDHKCSSCNSFNCVYYIL
>ELAGILAN_00184 hypothetical protein
MNDTQQKYIGWFLIVLLFTGYITINNIIFLKINQQESENNVKALTENMDEFRMLLEVNQS
RIEKKIFDLKRSQHTQCEQGDNNSRCKNLAKLLLLVVKMKNSLLREAKFYNHINSIKPLI
SELDDPEIENAVDELENLKEINTLHELKLSFEKTIDTIDYNKSTLSKKIISNWIKVDDRN
DPLRVKFAEIEESINDNDWQNITVTVSNLTHSEFKPWLNKLNGFIVASKNISTIYHHLLQ
YIS
>ELAGILAN_00185 Lipoprotein-releasing system transmembrane protein LolE
MSIAFEITMAACYLRAKNARFCSIMTLFSIIGIALGVATLIVVMSVMNGFRAKLLDSILG
IDGHINVYFDRNINSDYYAVSKSIERIPGILKATPMTNDQVIIVANGKIAGSVVRGVSTK
DLLDSTAVTNNVIIGDVKKFDEGIIIGARLAEALNVDYGDEITFISSEEFDALLGEMPRM
KKYKVIAIFDMGMFEYDNTLIYMPLKSAQAFFNYKNSIKNIEVLVDDVTRADKLADAIEK
EIGMEAESWQSQQSHYFSALKTERNVMFLILTLIIVVAAFNIISNLMMIVQEKKSAIAIM
RTFGATSGSIMRIFCACGLLIGFTGTCLGCIIGVVFSLNIESIRVFLENITNVKLFDPMI
YFFSSLPVILVPQDVVNISALAFLLSFLATIAPALQAAAQDPAEILRYE
>ELAGILAN_00186 hypothetical protein
MYMEDFEILMLKILYKPAKFKEAKISSFQIKKSLQLYEVSKI
>ELAGILAN_00187 Alginate biosynthesis protein AlgA
MRPVILCGGSGSRLWPLSKPKQFQKIFSQNTMFHNTLLRLKSDYMPPIIATNIQYESLVM
EELHALQEYKVIFEPVKIGTAAAILIAALLCNENETMLILPSDHFIGDLNSFYASTQKAS
KLASETNSIVTFGVKPHEFNSEYGYINAVYDQKEKCHIVKDFTEKPERKLSNDHYWNSGI
FVFKAKRYIDEIKKSAPNLYNLCFKYFTPQERFLYLKQRDFAGIEGISIDYLVMEKAKNV
AMIEANFDWLDVGTWNSVLELSEKFSKEPVSFQHVIREKEPVSTTKSNKNLLGGACKQPN
KSLISFIHKVKKVKVIRKEVKPWGFCSIILMSENFLIKYLFINPLSCTSKQFHHYRDEYH
IVLSGVGYVSLEDKEYAIAKDHMIEIPREVSHRIENRSISSPLEIVEFQIGEHLSDNDIV
RLDDVYGRF
>ELAGILAN_00188 hypothetical protein
MFEALKKGAIDLTLKAKGLLTSPESQVYVEDLRKVMMYDGRKCQYPKNYDQIVQSAKIIE
NRDMHGNAILDKDKNPTYKLLYGQKEENGEQPSFRLSLVTKDKDNDRSYFTINYIDNQGK
QIPINELHKSYFEPLGFSRMDLKKHVPIFEAEKTKDPQYPFELTNSSVLTKEVKNKEGKV
QEVVDEKGRNGELLYTSDYKKLSTHFSEIRDQNGNLELDKSLISVPIVFATSLAKVCTKL
LTSLPIKLGEHLISEQNPIAKSFGYLLFTPAAAVKNLVDMGATILKAPILLFVANEKKYG
DAYYTMWKHQLKGCLEEAKSDFNVIKGEERLKPDHGNRDSLVGTWDELNARRPKKQGDDK
EVSKSNEILKSPEEEQNKGNEILSDKRKGHVEELQNRRNSQQGQGATHDHSH
>ELAGILAN_00189 hypothetical protein
MSDRPLSPHLQIYKVQVTSFFSIMHRLTGILLFLLLMILSWYFILHVYFPELLIVRYLNA
LLFTPVAKLAYVLCFISFVYHFLNGIRHLLWDAGLNLEITGVSRSAILLTVTLLLSTMAF
LFMFI
>ELAGILAN_00191 hypothetical protein
MKKYIFLLALAPMLVGITLYLLRNIDNTKQSITAGDKFYEVLFLKKDNKPLLEEIDSNWE
YLANFERAFNHISDSMPTDTASIYNDLADDKDAPGVLRELAQYLEVMSLLHSNGEKINKD
KIDNLESSAVYPYSSQEAIAVVKIHNNDVKGATEILHSLLNDRKCPILIKANAQELLRIY
GS
>ELAGILAN_00192 Type I secretion system membrane fusion protein PrsE
MECLNYRFFVFVCYLELTQIHSSIMISKLKKLSAGFSLTGLIGHGDNINMQGAKNKKKKY
PKFLDKTFALIDAVINFILKRESNNVNEVLKVTWGPLFFGLVVILIFFGIGGIWSAIAPI
DGAVHASGEVIVSSNRKIVQHLGGGIISKILVKESQAVKKDEPLVLLSDVNEKANLSIIK
EKLLSFLATEARLLAIRVDLDTLEFSDEVKKLSNDELVNKVIKNQVKLFNSQRKSILGKT
DILQQRIKQLNDELAGLNFQLNAAHKQYDLITEELETKRQLLDSGHISKPHILALEKQFA
EIEGRVGHYRSAISQVQQKIGENELEIINVKNDSQERANAELKEVSTSIADLKERLMVAE
DSLARTIIKSPQDGIVTDIRYHTEGGVIQSGVPIMSVVPSDDDLIIDAKIQTRNIEEVLS
AQKKDSNIVSIDGLEGLKVKVRLSAYSARRLSLISGIVSHISPDALDDPRLGRYYSVRVV
IPKSELAQFKNVYLYPGMPAEVYIVTQSRTLLSFLFTPIIATVDRSFIER
>ELAGILAN_00193 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MFGLESRKFLITGASGGIGQAIVKIMHKAGATLCISGTKKEVLEEVAKQYEKNIHILPCD
LSNAEEVNQLINRASELMEGFDGLVCNAGITRDSLLLRMTDEIWQKVIDINLSSTFKLSR
EACKRLIKNNWGRIINISSIIGLTGNAGQANYAASKAGIIAMSKSIAKEVASRNITVNCI
APGFIDTKMTEVLNEVQKGKILDNIPMKRMGTGEEIAAGVLFLASDEAKYITGHVLNING
GLFM
>ELAGILAN_00194 hypothetical protein
MSSIIGFFGVLCVVLLFSFSGYADNPGVDMDDTTKVICNIIGYVWGIGGPLMTVVIIGAA
LLAIFGRMPWPALFALGMFCGVFFGAKTIITKIMPNVSDEAKTMLEKCGQK
>ELAGILAN_00195 Beta-barrel assembly-enhancing protease
MFRVAKFLTLLFFFAYCNNAYSINIIRDSEVEAIVKELAQPLFSAADIDHEQIKVFIIND
NSINAFVINNNSIFIHLGLLQYSAKPYVLLGILAHEIAHISAGHILQMSSAMGYFQSIAM
ISYMVGLVSSIIINPQVAGAILLSGVAFSSRLFFNYSQEQESVADSYALRYLDESGYDNS
GMKEIFDYFKSIEHENTEEYFRTHPLSEKRIFAVQNYKVKNNVKPIFADKLLKFERVVAK
LVSFFAPIHVLSNKYEDNSEYVNAIVCYRQGKIEEAIAKVNSLIQESHSDPYLYELKAEM
LYKAGNLSEAIKMYEESLRYLSEKNSYLVKLALSHTLLLHGDAKKAIFYLEQILNVEPNN
AFVWKYLSIAYKCEADTAMHYFALTKKACIEGDLKQFMKYAELAVKTLPKDSPYLLQVED
MKRFNG
>ELAGILAN_00196 3,4-dihydroxy-2-butanone 4-phosphate synthase
MVQATYASMSLPGISSVEDVLEDARSGKLFILVDDENRENEGDLIVLAEKIKPEHMAFMV
RYGTGVVCLAMTKFHMKRLGLNFMEKKNIGENHTAFTTSIDARYGITTGVSAEDRTKTIH
AAINKDGTQDDIITPGHVFPVIAHKGGVAQRAGHTEASVEMAKLVGFDHSAVICELVNDD
GSMMRLPQLLKFAEQHKIKLTTIDKLISYVKNLN
>ELAGILAN_00197 Transcription elongation factor GreA
MASSIINKFPMTREGFENMQAELEKLKEEKPSVIQAISDARDQGDLSENAEYHAARERLG
FIEGRIMEIESKLSHAEVIEVKNLSGDSVMFGATVTLSMLSDNNGEVEYVYKVVGEYEAD
VSKQLISTSSPLGSALIGKKVGEYVEVTVPNGEKLYKIVKIEFK
>ELAGILAN_00198 ATP synthase subunit alpha
MKNSMNVSEIASIIREKVETFDNPIKRENIGEVISVTDGIALVYGLEKAKFGEKVFFASG
VEGIVLDLDHDTAGIVVLGNDRDVKEGDVVKCSGDVVQVPVGHELLGRVVNALGHPMDDG
GEIRAKNRMDIESKAPGIIDRKSVHEPLQTGIKIIDLLIPIGRGQRELIIGDRQIGKTTI
ALDTIINQKKINDEVNENQKVYCVYVAIGQKISTVAKVVNKLKESGALEYTTVVVASASD
CAPMQFLAPYAGCTIGEFFRDNGMHCLIIYDDLSKHAVAYRQMSLLLRRPPGREAYPGDI
FYVHSRLLERAAKMSDKKGQGSLTALPIVETQAGDVSAYVPTNVISITDGQIFLESELFY
KGFRPAVNIGLSVSRVGSAAQLKSVKKVAGSIKLSLAQYRELEDFAKFGSDLDASVQLSL
NKGKYLVELLKQKQHLPMSIEEQVVLMYIFSNLYNQLSKIQISYINKFEHDLINYFHTVH
PGVLKKLSNDMSDDIKGDIFNIVSNFVTQFNCV
>ELAGILAN_00199 ATP synthase subunit delta
MKKTQYNNLVSSYARVLFHVSGSRLGIIREEVEFLLAFFKDQRDVFVYLSHPMISFAHKK
EVMLSINEHLSENLVKFIMVIFANKRSSLLILILEKFLSLARENENEFEITIKSAETLKE
SDIKIITESLSFLGKIIKVSNVVDPSILGGFVVRYGFNLIDASLKSYLDRLVDLSKMEIL
KVRNFV
>ELAGILAN_00200 hypothetical protein
MVSRLRYFVGYFGELLVLVYLKLKWYNVIKRRYRCKFGEIDLIVSKKKELIFIEVKTSLL
GKEIPISHLQCQSIINSSKYFLSKNLSFLDYSVRYDLYFLSLKRRPVYIKNAWIEE
>ELAGILAN_00201 50S ribosomal protein L17
MKHGIKKRKLSRCTEHRLSTLKNLSISLINHEQIVTTLPKAKELRPYVEKFITIAKNKNT
LHGRRLLLSRLHNSKLAVDKLLNVLASRYQDRKGGYSRIIKFSTRKGDCASMAVIELVDR
DIAARGKVYSKNKEGGKVVTQS
>ELAGILAN_00202 DNA-directed RNA polymerase subunit alpha
MYYNNDVSLCSNLDKLIKPSSVKVISDDSSEKSDIVLEPLESGFALTLGNALRRVMLSSL
KGSAVYGIKIEGVTHEFTSIQGVREDVTDIVLNMGMLRCKLNGASNKCLNLNAKGPCQVL
AGMIETDDQCSIVNKDLLICTLGQNVELNMTIYVASGKGYLPVTKYKENELLKLMSEQDL
IGFIPVNALYSPVNRVSYRVENSRVGQVTDKDKLILSIETDGTISPSQAVDSAARILQEQ
LQPFISSDVSYKKSQVSSSSGAKDLGYDPVLLRKVDEMELSVRSHNCLKNENITYIGDLV
QKTEGEMLRTANFGRKSLNEIKAVLTNFGLSLGMNVLNWPPKDIDELAKQHTDED
>ELAGILAN_00203 30S ribosomal protein S11
MKKVKTVGKSKKEFITGVVHIRATFNNTFVNVTDVHGNTLCQTSVGACGFSGSRKSTPYA
AGKAAEAAAKNAIERFGMKVVSVIIRGPGFGTEAAVKALQSCGLTVTSIADKTAIPHNGC
RLRKKRRV
>ELAGILAN_00204 30S ribosomal protein S13
MARIAGINIPVRKCVPFALTYIYGIGIATANVICHACEVDKRKRVSELRDEDIEKISSFI
RQNYVIEGELRKEVAMNIKSLVEMGCYRGVRHRKGLPVRGQRTHTNAKTRKGRSRLPIAG
KK
>ELAGILAN_00205 Adenylate kinase
MIITIFGPPGSGKGTQSSLLIAKYNLKLISVGDLLRNIISSSSELGKKIKGTVESGNLIQ
DEIICGLLRDQLALVDDNCLLDGFPRNLNQAHFLTQVLQEKYNRDVDIVVELQLDDNIAI
DRLKNRLACLDCKSIYSVSSFKSTTCAKCKSTRLEKRIDDADMSAINKRISEYHLQMKGL
REYYKGKLLTIDANLSVDEVTQEIESKISCNLV
>ELAGILAN_00206 Protein translocase subunit SecY
MGNKSAFNSLDPTLLYKGDLLKRIFFTLIALICYRLGTYVPIPGINLDVINDIFPKDGSG
VFGVFNLFSGGALARMTILALNVMPYIMASIIIQLLSSAIKGMKEVKNDGESGRRKMNSY
IRYLTIVICVFQSIPILVGLEGMNREGVLVVIEPGVMFRTIGVFSLLGGTMLLIWLGERI
SASGIGNGISLIIFTGIISELHSALSSLLTLNKNGSVSLFIILFVLVLFFLLLLLVIFVE
SSYRKVIVQHPKKQFKRLHNDDFTYIPLKINLSGVVPTIFANAILLTPISIANFYKGHAF
SDFILNYFMANKVVYIVAYLVLIVFFNFFYTNFIFNPEENADFLKKNGGFIPGRRPGKHT
SDYLQDIVFKLTFIGSAYLVVICTVPEVMRYYYDIPFIFGGTSLLIIVNVITDTIMQIQS
YIFSNRYDNWIKKYESKTRKVR
>ELAGILAN_00207 50S ribosomal protein L15
MNNAVKLNSIFTKLSKKKKPKLLGRGIGCGKGKTSGRGHKGQKARSGVSINGFEGGQQSI
YTRLPKRGFKPIRRSIYSIINVGDIQRLMEAKKIVKDSVIDKERLYKLGFIKSIKDKIKL
LNKGKLSEKFVFHVDFASEAAKKSVASVGGSVEILS
>ELAGILAN_00208 30S ribosomal protein S5
MAIKNLQNNNDLSELLVSVRRVTTVTKGGRRFSFSILVVVGDEKGRVGCGIGKHAEVAEA
RVKAVNAAKKSMIRVYLREGRTLHHDIKAKFCSGEIVLRTARAGTGIIAGGAIRSVFEVL
GIKDVVAKSTRSNNPHNVICAVFKAFDSMLSPRQVASKRGKKISEIVGNR
>ELAGILAN_00209 50S ribosomal protein L18
MKRSYNFLSNSEKRKLRNRAKLDKSAERLRISIFKSNRHFYVQLINDVKGITLTSASTLD
AKIKDVCKGKVNAETIKQVSSLMVERLSGMKLEQQLTFDRGAYKYTGLVSQFAEALRSSG
FEF
>ELAGILAN_00210 50S ribosomal protein L6
MSRIGAAPINIPAGVSVEYNNGSMLIKSAKAEKEVSLIRDVVCQIIDNQLLLSVDQDKDN
YDKIKPMWGTYRSNINNIINGMVDGFSVNLEINGVGYKAECDGKYLTLYLGYSHNVKYKV
PKDVEIKCIKPTHLVVSGMDKQKVYMVASDICKIRKYDPYKGKGVVIKGKFMLRKVVSKK
K
>ELAGILAN_00211 30S ribosomal protein S8
MALSDSIGDFLTRIRNAQLAMHRATRVLFSKMNSSILEILKEEGYILDYEKQVVDNLPSF
IVKLKYYEKSPVISDIVRVSKPGCRRYSKYKDISKAYNGLGIFIISTPKGVMTDYNAHKL
KVGGEVLCRVF
>ELAGILAN_00212 30S ribosomal protein S14
MAKKSMIERNLRRIKLCDQYKEKREKLKSIINNKNLSIVERFTAQNKLIKKLPRNSSKTK
IRNRCALTGRPRGVYRKFGLCRIVLRDLCSFGQIPGVTKSSW
>ELAGILAN_00213 50S ribosomal protein L5
MFKELYKDSIVKSLKDKFNYGNIMQVPKLVKVCINMGVGDAATDSKAINEPLDSLYLIAG
QKPLSTFAKKSISGFKIRKGATVGCKVTLRRDKMYEFLERLIYIALPREKDFRGFSVKQF
DGNGNFSFGIKEHISFLEIDYDKISKIRGMDINIITSAVSDKEAKELLLALKFPFFD
>ELAGILAN_00214 50S ribosomal protein L24
MSAKIKSGDDVIVLTGKDKGKIGKVIKVIARDAKKKVIVSGVNVHKRHTKPKAGSSGGIL
NKELAIDISNVATLDPKYKTPTRVGFKVIDGRKVRFAKVSGEVID
>ELAGILAN_00215 50S ribosomal protein L14
MIQKNTLLEVADNSGARAVLCIGLLGGRKSASIGDTVIVSTKSITPRGKVEKGKVYRAVV
VRVKSPIRKSDGSVIRFSSNAVVLINDQGEPLGTRVFGPVKKLSSGSFMKIMSLAVEVL
>ELAGILAN_00216 30S ribosomal protein S17
MPKKVFCGTVTKAKCDKTVKVSVLQVYKDELYKKVIKKYKKYTAHDENNSCKEGDKVLIQ
EHKPISTTKKWVIVNSSH
>ELAGILAN_00217 50S ribosomal protein L29
MDIADIESRSSQELHEILVNLRKEFVNLVFQKKLGQCNNISRFSLIRKSIARILTTLNKR
RREEKNA
>ELAGILAN_00218 50S ribosomal protein L16
MFIPKKSKYKKVFKGRIKGNTKGGSTLSFGDYGLKAMEAGRIQSKHIETARRVISRTLKR
SGKVWIRIFPDTPVSKKPADVRMGKGKGSVEFWVFKAKPGRMLFEISSDVPMHLARLALE
KATAKLPMKCKFVSNHN
>ELAGILAN_00219 30S ribosomal protein S3
MGNVNPKGFRLKIINTWSSIWYAEKGYKQGLHQDLSIRSYINESFKHAGVSKVIIERTID
LVSVIIHSSRPGVIIGKKGSDIEKIKQKIAEKVKNNVEVNVVGVKRSEIDAVLISNSIAQ
QLEKRVSFRRAMKKAIQSCLRMGARGIKVSCSGRLGGAEIARTEWYKEGRLPLHTLRANI
DYAFAEAKTIYGIIGVKVWVYIGN
>ELAGILAN_00220 50S ribosomal protein L22
MKNRDVIVKAGSRVLKSTPRKLNLVAGLVRNKKVSFATVQLRFCEKKAAGLIRKVLNSAI
ANAQNYGLDIDNLYIKEILIGKSLTLRRVCPKAMGRANRVSKRYSNITVKLGEII
>ELAGILAN_00221 30S ribosomal protein S19
MSRSAWKPPFCHPSILKSVNNALNKGFVNMAIKVHSRASVILPNCLGLKFAVYNGKDYIP
VNVNDQNMIGHKFGEFSPTRKFTGHSGDKKATRR
>ELAGILAN_00222 50S ribosomal protein L2
MGMKFFNPVTPSSRGTVLVSKVGLSKDEPEKSLTSGKKSSGGRNNHGRITTRHRGGGHKK
KYRVIDFKRNRSGQGIVEKIEYDPNRSGFLALISYKEDDIKSYILAPQGMKPGDVVTAGN
DADILPGNCLLLKHIPVGSFVHNVELKPGNGAAIARAAGCYAQIVGRDGQYVLLRLRSGQ
IRLILSSCKATIGVVSNPDHKNRKLGKAGRSRWLGIRPTVRGVAMNPVDHPHGGGEGKTS
GGRHPVTPWGVATKGKKTRKRNKSSDKYIKQLKG
>ELAGILAN_00223 50S ribosomal protein L23
MIKYNNIIKSPIITEKASFLREKFNKYSLYVFVNVNKRQIKLAIESLFDVKISSINVVRI
KPKYRRFRGVIGCEKQKKKVYFSLMGGQKLDIMSV
>ELAGILAN_00224 50S ribosomal protein L4
MECNLVNLSNDNVGTAQLNPLIFSAKQKLSILHDIVRWQLAKRRAGTHKTKGISDVSGTT
AKPYGQKRTGRARQGSLRSPQFRGGGIIFGPVVRSHTYSLNKKVRKFGLKIALSLKYLNN
QVIILDNLNIDVKKTSEMCKCIKNFKFSSFLIVGDYGDDLLRAAKNLHYVDLIKPIGLNV
FDILNHECVMLTKDTLKHLEGRLL
>ELAGILAN_00225 50S ribosomal protein L3
MKRINSLRRIGLLMMNIGHTAMYSDNSRMAVTLLHLSETYIIDIKGQDKCGYNSVILGTG
DFKNIAKPQLEYLKKKGINNKCKLYESRLNDLSGIECGKKVGINHFVVGQYLDITGYSIG
KGFAGVMKRHNFSGLRASHGVSIAHRSQGSTGQCQDPGRVFKGKKMAGHLGNSRITAQNM
KILSIDHENSIIAVKGNNVPGFKNSYVFVRDAVKKSLHKDVPFPVGLLLDVNDDASNLVS
>ELAGILAN_00226 30S ribosomal protein S10
MKQDIYINIKAFDCSLLEECVRKFVDELKRSSAKLSGPIALPRKDSKFIVNRSPHVDKKS
REQFEMRTSRRLIVLHDLTPTMMQMLTGLSFSAGVEVDLKVKEVKV
>ELAGILAN_00227 IS66 family transposase ISWen3
MTKVLQEKIVAENANLKEEIKALIRENDSLKAKIVELQDKLGLNSQNSSLPPSRDIYRKK
AKKKSDKKPGGQPGHKGHKRELMAADEVVSCTIDTICMCGGKVTLEDEIIHQKAELPEIK
PTVTEYRLQRGHCRVCNKRITANLPEGVARDLLGSNAKTIISSLSGFFINSKREVQQILG
SIFNLNISLGLVSNTERRASKKCASEYEKMKEELQGSEYLHIDETGHRNQGKRGWSWVIT
NKALTLLKVSESRGKKVLKSLLPEYDGIVVSNRYAVYNYFNRENRQICWTHLARDFERFA
HSKNVEVSKTGQALKSLSNKVFVVDKEKKHNSIDNLRFYRLMRKIRKRVKHFLRKMTRVV
NSTQASRMAAKMLRSEDMMWKFLRKPEVIETTNNLAERQIRRYVIYRKNSFVSVQESGLR
NNR
>ELAGILAN_00228 hypothetical protein
MKKGANINFQDANYELNTPLHAAVRKQEPKVVKLLVKNGAIQIKNSKGKMPLDIAKSLNN
EGIIQELGRASLLKRANTGENKPEIGSSKKPRISVIAHRDKVIYKVNIKV
>ELAGILAN_00229 hypothetical protein
MLKVERSIDYLEKEKNNSEASKILEKAQRIGQAYKSSELKRYRRFDSDGEREKNTELFSA
IRNGNLQKVQDLLKAGVKLNIIDKNNKDNTPLHYAVERDKKEIVRKLLQEWKADVNAKNN
KGDTPLHIAVSRNNKKLVSLLLDKQARSDIKNNEGKEPYELAKNQEVSYIFKHRSSHSSD
YNDIMSQANLNEELIKIVKSSTSEK
>ELAGILAN_00230 hypothetical protein
MGAVLKKSVKSKSIVPLRAENQDYRQVVPKVEVPVIVVNRKMKSKVKATVENFEQNQARE
CVGMQPAKSSAIIAAQSDVGIKKNPLKVASQAQSSFMRNKRSLENPAK
>ELAGILAN_00231 hypothetical protein
MPKKMERHAAVLSKLKSVIQHTDSKVMAERRSAIERWVKTYIRQVEYLKDDKLQFLYNIF
RDESCWSGTRLNNTILGQRFTEEKIGEIKNPLPIYDMACRYCVIDKIPLLFQKQFESSKS
SFSSEEIDDDGKPATSNNKYVKSELLGYMKSQDPVFSFWVDKKSGEFKKHVSATEGFKKA
IELKWSEGVEYFYSLLNEKERERERKITDAVTILSSVQCDHNGAVTLDFCLSKMSDQAKN
KLFKDSELSKKDKGVYSLFSALIHQGFFDTMQAILPMFKDKILEDKILSPRSYTLLLSSL
SDMMLENSESTIQAREAIMNLIKCGNFNNHEGREEKAAVFFSNGRVPIKRALAGLIVDWQ
LGCTKKEEVLKVLQFAKEFCAVESFMYFKKSVVDNLKMVGRDGMRKNIDYGKLAEKLFAE
LDTVSVPNGRGDFGGAGDPQSTLGSTEVSSFSGRNK
>ELAGILAN_00232 hypothetical protein
MHGLVRSLINGNCGEFTEKFEYFLDSCPSFLHSVGKDHFFPAFFFGMFATAHDSGVANND
ERIFFRFDNDPGSPGRGNLKVAILTTDGNNRRVVRCYTIADRENSYGSRFSQQEREQLEG
ILRDEELEWQEYKTFIWADNQGEDEEEEAVRCRIFQAGQGPFTGNHASYLTRRHSFQEIT
RTPGLQNNYLPDLMNQLESDDADDVHDTTEEVFQHIIGVYDRYSQALDFYGRESDYHGFV
SGVLMHFRYRNVANIYLELFVGGGYADITSIVRGTQRLINSVPCVTELKAGRRADRNAGR
ALEQAGNYVNGCPVSSISIPTLSPRAVSAGVNFDFGNPGRLQLGVRAFLAKGSSLMERLF
EPVEDEEIGENVRDYLLHPAFGVPAVPGIRNRGGVNARDRRIFLYTSGFAFASIAFAKGT
VPIEGNRAIVDKHLFHYDGNAKMLDEQRYNTQVNIGDRALTMVLHVSRGRDQKEEAIVFH
VRHVLANQLFPDNGLDLSRWPNAMVHEVVCNLTINRRTRGVNDNLGLTVNVETFDSPADY
LLDRGNQPFQGELLRIGGVSNVHRAANVMMNTGWENEDPDSHERFYQAISNVLNPPQPNN
AGLQSLAWVVNRDNAREAGFHAALHGLFYTCDNPARVVSEFQVGGGGKLDLVLSRAIGRM
GGTYPIGTELKFAATEADVQNREEEADEQVEGYLQSRGFDRITDGDKMVFSYAVFNDQAP
APAQNVPNTLIAVSNVLRIKDNLGIDTVDDFPYR
>ELAGILAN_00233 hypothetical protein
MASYTNSLNVIGMLISKLVLYIQDSRNLLINITIICIRYTGCELEVFFSFTIQPRQ
>ELAGILAN_00234 IS110 family transposase ISWen2
MINNFLGIDVSKDRFDVFLSFISKKGKRETRKRSFKNDDHGFQGLLSFLQKHNVEQVKAC
MEATGCYSEALAEFLHNTGHFVSVVNPYCIKSYARSKLTRQKNDQTDAEIIADCCQRQEP
TRWTPPSPELKKLKHLYRCSVALKDELILVNNHLEKKERLPKEVANAWEDLAMNIAQKIE
TIKNSVRELLKQHKELLENFQLLLTIPGIGEESAVAILAEVPDIEVFRNARQLAAYAGVI
PRNITSGSSVYAKPRLSKSGSQPLRKALFFPAIVAKNHNPIIMSFCQRLKEKGKHNMAIV
GSAMRKLLHIVLVF
>ELAGILAN_00235 hypothetical protein
MVIAEAINGQSKQASKKLEEKLSPGQEWSETDKLLDEEYELIKKYLWVPSELNGGRSLVD
GQCSFEELVCIWLAHTTNLNENQKKLNKELLKTLKGIGSYLHEYDTKKLENFLKNNKDDQ
DLKVVLNLKRGESGLTLLHAASRLNDDQSGPTLVNLLLQAGADPNIESNEGKTPLHYAAD
SNYRYLTINLLLEGKADPNIRDNKRKTPLQTAIDNNNCHILECFLTDNQKKLSKELYDIL
LGILSPEYYKKPHVIGEVFNRQAIENLGKFLDKHKNSQDLKMIFIVQDRVGMSKVLSYAR
ATCKEAVDLLLKAGATDPKKDANMCNKKKKCLLPPRTLWSIPNQQIVLGGFLNDISQVES
MDQLEKVVDRAIDFGVMLNFAKKSSQGEKYNFTDYVIKEISRLEKNPKVASDIVCKLVSW
GAACYTKNSIDVIGELELEFKDHKANMIKAHEKYVNCTQKFLKIAKNATNGKLNRAKMDN
ATFYLEYSEDSTIDVAQITDGTRDLGLTHGDVKCGRNIVKIGNSEVEIITKDGVRNYTDL
TEGGDIVLTFYTIQGELEVRLYPDTQNKDLIRVEVNDQDLLEELKNCNEKIGKNCLLGGL
PVDQAIERGFFTRSGKLCQYSETVSSAAQTVNEKQQLLQDLRYIESNIVKKEKNFDIKTH
LVEIFKTLSRFCEEKGDISKTDLAKAAEKESKKLGLEGKYNWSKIFGLEKGVIEKAEKQG
DKEQKSNIPDNFYLGQAIEDGNCFFDSFRQELEQQLGIKATVEQLRQYCKEFARNNPPEW
FINAITNSHDNNGVVRRETPDFYAKNILNNNRWGDPEVEGRILCGKYGVKLHVVESNPLH
ATDEQQDPSLHQLIDSLGSRSTGEYNRIDYDDNNVLHIVNKGHDHFEPLFNSNKILAKCY
SSLPRCSMDELKIESHQHKSLLVSGS
>ELAGILAN_00236 hypothetical protein
MTIQHPIDKQIGERIRKRRLMCGFSQRDLGKKLEISFQHVQGYESGEIRLVVDRLYKLAE
VLSVDMSYFFTKASEDLHDKAFHSDVGSEEISRLVREYRKIEDETLRDIVHLVIKALANT
GFKA
>ELAGILAN_00237 hypothetical protein
MQLGKKIKQLRLDRALTQTELGKRIGVSYRQIQKYENGSNCVLASRLYDLAKALSIDVAN
FFTDMHTDSHEAYDEEILKLVKGYNEIKSKRLRSAVYILVKSFSQSDNT
>ELAGILAN_00238 hypothetical protein
MDILSYSTEKLKKHCQLLDDEEKIVLYEQLLDKAKDILENSRDDIAKLKEVSKAVVAIEE
TTDKQLLEKFNDDHPLREVDILIYSPQGNTEYLFSIDNSSELYDLKEDKEKALYNAVKLN
DVELVKKLLMILSPTEVSNFDTKYLEELKILLSGIHKELQLSQDMKNYLEKTIKFYSFLC
SNFNLLVTNPTDVKAIIDLFAAQPNIDYQIDKLLLSFIVRDVEEKKLNSEISHMIELLEQ
HERFAELEYKVRRLRSEFASGKSRYSAEVIRNSIAEREKEMREIEKKYVRPNDLISERQK
LLKQLLC
>ELAGILAN_00239 hypothetical protein
MKKINGKKLSSKMLKAVERIAKEGLLPNFIKAAPTANKKISKLPVLTYPEELNPFRSALC
KIRLSEYENVKLNEFLEKAIAAENLDKLSKIVDEALDLGIRVNARNEDGFSFTNVTMFKM
YRDEFKENKQEDIIRKLALHGADFNVQVDKKIAEMYQKVQKEIEPQIYSRLKKLREVGED
ATIEGTVEDVEIDNKTFYIEFSHSCIVDVAKVVEGAKNLGLSKGDLNLGGSIIKIGDGEV
EVKTGKDGKRNYVDISDNSAFTVTLCTSLGELNLMVYHDTEDYHQVQVEVEDEEMWNELQ
EIGEIVGKGCLFGGMSVKEVVEKGSFTRCGRWGDQNSKSSETFSWVSKLKDTKTTSVGRS
>ELAGILAN_00240 hypothetical protein
MIVQDEQHPIDKQIGERIRKRRLICGFSQRDLGKKLGISFQHIQGYETGEVRLVIDRLYN
LAEALSVDMSYFFTKASEDLHDKAFCSDVGSEEISRLVREYRKIKDETLRDIVHSVIKAL
ANK
>ELAGILAN_00241 hypothetical protein
MELGKKIKELRLYCGLTQTELGKKIGVSYRQIQRYENSSNQILASRLYDLAKALSINVAD
FFTDVHVDSHETYDEEILKLVKGYNEIKSKRLRSVVYILVKSFSQSYNES
>ELAGILAN_00242 hypothetical protein
MNNSERKEKLETRILSSRGRSLLDHELLERTLSECEEGREVAKKLIELFSSLGRVINADF
HELKNVTGMNDGAIASIFCLKEIFDRILKGKLKKLSILDNREELLKYFKTAIGQSRKESL
RVIYLDRSGHLIYEYIQDCGTIDRVPLYVREIIKQGLLIDASSIAISHNHPSGDTEPSKE
DEDNTLTLAATCENVGMKLIDHIIVTQKSHFSFYDSGLL
>ELAGILAN_00243 hypothetical protein
MIANINTVALQGISTVNVNAQIHMANGIPAFKATRTTLQI
>ELAGILAN_00244 hypothetical protein
MFIRIITFFLLYSSTAFCSDCNFNLPYCGLSCNLDLSYRNLSNIKKLLNNDDKFVALTFD
DGPSNNRINDIINVLESYEAKATFFVLGERINEKTSEIVKKIHESGHELGNHSWSHRKLT
SLSSEEQLQELEKTNTAIKNAIKQDVKWFRPPYGCYDDNLIENTDQLNMYSILWTVDSLD
WQGDKPETLVERVLSNVHNGAVILFHDHNNRSNTIEALPHIIKILKKSGYKFVTLSEWEK
RVCNTVKARSVTIKEGKKVRFEGMLCGQKIKSLTAEHSY
>ELAGILAN_00245 Peptidoglycan D,D-transpeptidase MrdA
MWTKNKVFNRRAFILGGIQLTISAVFSCRLYNLQIRNRQKYEALSNSNRIRVATIMPKRG
KILDRNSIELAVNKISYVVLFDGSGKEVDLQTLSEVESKIAKSSEKITALYKRYYPFGSM
CSHVIGYTKRQQGISEVGISGIEYTYDHILKGKSGKSEQEINSKKRVIKELSSIPQQDGQ
DVQLTIDINLQEKTAEVFKDHQGSAVVIDVNNGEILALYNSPSYDNNLFASRLSNETWES
LNAPSLPLVNRALSYQIPPGSIFKVIVALAGLKDGIITPEEKFSCKGYMKIGERKFRCLK
SKVHGYVSLNEAMALSCNTYFYNIGKKISVDSLVEMARKFGIGSGPLIGTFKEEAPGLLP
DRDWRTRKLYSQWYLGDTINLVIGQGYMLTTPLQLAVLAARIATGKEVIPRIKMNETIQD
FPDIDVDCEHLSIVRKAMFDVVNSKTGTYKKGLSGIQIAGKTGTPEINSKGESHKLFIAY
GPYHNPRYAISVFIEHGKAPRQDVAIANEIFQYMLETMSIKLLA
>ELAGILAN_00246 Phosphate import ATP-binding protein PstB
MSNTRASVKDLNLWYGSKQVLFDINLNIYKRKVTTFIGPSGCGKSTFLRCFNRMNDYVPG
CKTVGELDIDGLGDIYSRDMDVVLLRAKVGMVFQKPNPFPKSIYDNVACGPKLHGMAKDK
QKLNEMVENSLTKVGLWEELKDRLQDSALNLSGGQQQRLCIARAIAVKPTILLMDEPCSA
LDPMATNAIENLIQELKLRFTIIMVTHSMKQAKKLSDSVIFFHNGRIVESGSTQEIFENA
QSPLTKEYILDH
>ELAGILAN_00247 4-hydroxy-tetrahydrodipicolinate reductase
MKIRVGVIGCLGRMGKKILNELITNTKVEIAGAVARSGSKYIDSDIGPIIANLGIKVTSS
ISDVFESSDVVIDFTTKECMLDCLKAAVKFKTPLVSGTTGIEGVDLKEYAAEVPILWSAN
MSVGVNVLLKLVKKAAELLGNEYDVEIWEMHHNLKKDSPSGTAIELGKTIANASKVDFQS
NQYLHSGSNIRKKGGIGFAVSRGGGVIGDHSVMFVNSDERIELNHKAIDRTTFARGAVQA
AVWLYENKREIPGLYSMQDVI
>ELAGILAN_00248 hypothetical protein
MFDISKIVITPEMLKLVAEIDEFKGAWQLFGNLAPERLQMLKKIATIESIGSSTRIEGAR
LSDREVEQLLSKLDTRSFRSLDEREIAGYAYVCEEVFQNFNKMPFTENTIKQFHIWLLQF
SYKDQRHMGEYKKSPNHVEAFYESGKSLGIVFETASPLETATQMQELIYWTSQQLEVKSL
HPLLIIGIFIVTFLAIHPFQDGNGRLSRILTTFLLLKLGYIYVPYSSLESNKESYYLALR
RTQQSLKTSSNDFNPWLMFFLRSLQKQKFYLEQKVSHEKVLNLYLPPLSAKVLALLSKHG
RLTIKDLENITKANCNTLKKHVSNLVKSNHITQHGKGKATWYVI
>ELAGILAN_00249 hypothetical protein
MRVTPSKVKRFLEKPDALSGVLIHGSDNSRVDFYVQEIIANLGEYSVQVMDFAIVNKLPS
LLFSELANVSMFTSKKLIKLINVSGGISKELKNVLDYNVSGHYVMMVASDLPYNSATKSY
MESSKIFGVIACYKDSNSNLYDIISSYLKQNDIKCTNEIIYHLQSYFNHSKLPICSELEK
LVLYLGERKDLKLTDIELCFSTSGNDYATLDDLCSAIASKDMLRFIRISDALISQENFSP
IALIRIISNYFLRLENVLLSVQGGMSEQAAIDQLSPPLFFKQLQSFKSHLKSLQLSELKK
ILEKLISLEVTCKKTDLDHKMIFQHALTGS
>ELAGILAN_00250 hypothetical protein
MSEEGFFSKYISQPVKKFYNYITGKTEESDNVQSTADDIVQESSESLDTHVQSNENDII
>ELAGILAN_00251 High-affinity zinc uptake system membrane protein ZnuB
MLTQDFFINSLVAVVVISLVTGALGSFMIWQRLSYLGDSLSHSSLLGVALALIFKISPSL
SIMLIAITFAILLSLNFNRLYSADTILNIVTNVVLSSSLILMSFLPSGNNSIISSLFGDI
LTLDQSDIVLIFLTSAVVTLILIFRWRYWLMISINQDLAVVEKINVTFVRLEFLITLAIF
IAIAAQLIGILLIAAFLLIPAASARLISKTPMQMIIVATVFSVISGISGLMLSASFDLLT
GPAIILVAAVYLIIAYFIRLVLSRLA
>ELAGILAN_00252 hypothetical protein
MDVTPLISENKNLINGYREGKFLVNNREYCGSIIIFPEKVIKLKESDINSKEHFKSFLTE
EIEILIIGTGKTRNILSSSVKSYLMEQKGLNFEFMTTGSACRTHNVLISEDRFVVSYLIA
I
>ELAGILAN_00253 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MKSFCVKAPAKINLFLHVVDKKETGYHLIEGLFVFANLSNFLEIKVGEKDSRYDNSTVEF
INSESKINNQYNTVMKAVNLLLRHAPVRTKVTVKVVKNIPIAAGLGSGSSDAGAVVRTLG
KLWEIDRTILNEIALNVGADVPASVDSKPVFVRGIGEELCHIKKFSLPTNVVLVKPKKRF
LSTPEVFSKHEGKFSEPIKWSDDAEKDLLKLLKETRNDLQEIAISFVPEIKDVISTLESQ
EGSILSRMSGSGVSCFGIFDSEENAKAAAVNIGKKQPEWWVCDTQLIV
>ELAGILAN_00254 ATP-dependent helicase/nuclease subunit A
MYNAILVNFYKVLALLMRSNAINPNFSVWVNASAGTGKTKILIDRVLRLLLENKRNILCL
TFTNAAANEMENRIHSILSKWAICSDSVLAADLEQLDFFPMSSQCVTLGSQHPYLSSQCV
TLGSRKNKDYLTRARRLFSELENLGLTIQTIHAFCYKLISSFPIEAGIAPNCTLSECKEL
HSIIFNKVLHNETVQDDINLIATEIDENKLRDLLYTLCIKRSISANDSKYIKDKLSAPDE
IHDLQSETIEHVERLAEILSEGSKRDQSYSAILYSTVIPVLDTGIQKKRTSVSYSDDTGI
KWNDTKIENLAKVFLKSESHEKKSISSIATKSILEKFKDAEQIIESVQNVVFTHIRDMNS
YQIFKRTSSLLGVFKVYVDLYNSEKSKNALLDYNDIIDLATNLLSDPDHKDWVLFNLDQK
IDHILVDEAQDNSISQWKIITNLCDEFFAGNDEKRTLFVVGDVKQSIYRFQGANPHLFNY
MQQYFHTKTGGRDWISCQLEKSFRSTPEVLMLVDRIFNNFRAEISFNDNEIKHVPHREND
QGYIEIWPALPRRKEKEQRALQIPLTFKEGYTIADRLLAQTIANRIHNWLNEGRILVAKD
RHIEPRDIMILVRQRNVLVDYIISELKKANVPVVGRDYFRIMDYIAVQDLIALAEFLLLQ
ANDLALANALKSPLFNFTEDDLFNIAYDRKEHSLWERIQDYSVVIYSELNYLINLSRTES
PLALFTHILRTGKKKFAARLGLECFEVLDEFMNLVLQFENPSLQAFVQWIKENNPEIKND
MQSERNAVRIMTIHKSKGLQAPIVFLVDTNTVPRNSESIIFDGTEAPFWCGKNNNAYCDQ
VKREKKLEDYNEYLRLLYVALTRAEDELYILSKEPVQKGSWYDLITKYGEPYEKKQRGLR
PIFKEKVEVLCVNANYPYIYKKRDYFDVPVISLPPALAHSSVSSQRVTLESSEKEGAEWI
PVSATWMTDGYARGLIIHSILQYMPKIEKERRKNWVRKYLDNINISEDKDEIYSKILAFN
EKYGYLFDLEGKSEITLSGIIDGEPVLVRLDRLCITQDKAIIIDYKSHRNVSVSLLNEIK
KQMLTYKTLVQEIYPNKQVEFMVIWVEDLTLQSDF
>ELAGILAN_00255 hypothetical protein
MKLSYIYILTNKANSTLYIGVTANLIKRIWEHKNKIVSGFTSRYNVNKLVYFEEFEDISL
AIARERRLKEWPRQWKINLINQKNPSWVDLYYLALR
>ELAGILAN_00256 hypothetical protein
MKNYKKGHRKRLREKIILDNGQSLLDYEVLEHILYSAYSRIDVKPIAKSLIENFGSLNKV
FNADLEALQNVDGVSNAAISAIFCVKQAFVRSAREEIKDLPIIDNWEKLLDYLRISIGSL
NKENFRVIYMNKKYRLIAEDLQNIGTVDQTPLYVREIIKRALLIGSTSIVISHNHPSRDT
QPSNSDISLTRQLAEACQSIGIELIDHIIITFSSYFSFKENRLL
>ELAGILAN_00257 hypothetical protein
MLHKFFNRLFSIFSSINVIQKVKKDENGICYVTGLRRYISVLLDLIIIVLFLQFCSQALN
QLFMNSEDSKILSQIAAKSPMQAPLSAEEKTTQSRLIKLLILNQIVQFIMLFCYVTYMWV
KFATTPGKLLFGLRVVDAQTFRKMTLRQATKRFFSFILSVAPLFLGLLWSNFNKRCQTWH
DKIAGTVVVTSKSLRRQS
>ELAGILAN_00259 Replicative DNA helicase
MNKLADLLDSRGVDKEICKLPHNLEAEQMLIGAMIRDNRICDAVEDTITAENFYDPLHQS
IFTQISKTRKHGIVANELSLKMFFENDQAFTECGGVEYLAKLAAKASIALDIYSLTRIIR
DTYLRRCLIKLGQEIVGDSYNYDIENPAQAQIEQAMTKLFNLAVKKQGEKTYIKLASSIK
DVVEKISTLKNNPEALGVTTGLQDLNQLLGGLQKSDLLILAARPSMGKTALALNIALNAC
KMLQKRADKQHYVAFFSLEMSAEQLTARLITIDSGISYYKALTGRISDFELHEFINTSTE
LSELPFIIDDTPALSISALRTRIRLLYQLYNVEVVFIDYLQLIRGTTKRSNENRVQEISE
VTQGLKAIAKELNIPIVALSQLSRSVEQRDDKKPQLSDLRDSGSIEQDADIVMFLYREEY
YELRKQPNEGNNKHREWQEKMEKIRNIAELIIAKQRNGPIGSVKLYFDSNRGAFKDYTER
HSS
>ELAGILAN_00260 hypothetical protein
MYPNIGFLAPVAALSVGLPFIIGGAVFSAVAIALSYAAVSKNKTISEKEAQLSDEKSKVE
AKGKIISEKVKEISEKNTQLANQAKEIEDKDKTISEKDREIFRMKNELAATRRINASQPG
DAVEIGSVNQQLTKRDFEV
>ELAGILAN_00261 hypothetical protein
MPSAEFAKDIKTASEKAFTSTKEAFISGRVTRIVKDGLKDVYGTSFEPVKSALNSFGSSL
KNTCDTSIESAKGTISSVGNKLKNVYDTMPSTKIEFSWVSEKFSPYWNSVKNLMFGNKAD
QASGASQLSSESQGNGIVIPEGAKLELSPILFDFLFREKQKMVRQFLREQTDEKKNVATQ
ENLKTETPSQENQMNIDNVPKQPDHLNVDAAKSYLMSLSEDQDVFYDAESGDEKGTEISS
PESQPTKEENGQGRFAWSLGKVKSAITEVVVIGADVTKPYCAKVTKALAT
>ELAGILAN_00262 Methionine--tRNA ligase
MEQFENFYITTPVYYVNDKPHIGHAYTSLLCDVVARFMKLAGKNVKFTTGTDEHGQKIEK
AAKAKEMQPKEFTDDVSVSFKELAKFMNFEYDDFIRTTEERHKKAVIALWNRLEERGQIY
LDSYSGWYSVRDEAFYQESELIDGKAPTGAEVQWIKEESYFFRLSNWQDKLLELYKNQPS
FIFPESRRNEVISFVRSGLIDLSISRTSFNWGIKVPGNDKHVIYVWIDALTNYLTSIGFP
STEGEEYKRFWAEPETQIPVSSTGMTPNQGKTQIPVSSTGMTPNLADNSFNVHVIGKDIL
RFHAVYWPAILLAADLPLPKQIAVHGWWLNEGEKISKSLGNVIDPIGLAQEFGVDQLRYF
LLREASFGQDGNFSKKNMISRINSELANNIGNLVQRTISFLHKQCSGIVPTIDQILLKGE
ESLPGCKAILDQVMNHLSKYEFNHIILLIINISSEANAYIDKSAPWTLSKTDRERVNLVI
YKLLEYIRIIGILLQPIVPKSAEMILNQLQIPKEQRDLKSLCNACVSLGITLPKPTPVFL
RVDAKEEK
>ELAGILAN_00263 hypothetical protein
MIIERTMRNFLVILFIVFYAFDAHADGATDVMCNVIGYVHGIGGPMITVVIIGSSLLAIF
GRMPWPALFALGMFVAVFFGAPQIVTKVTEKEVCCLFKVKPWRMESVLLLLDMNV
>ELAGILAN_00264 Ubiquinone biosynthesis O-methyltransferase
MLGIVSIASDHSGYELKSEIKPYLEALGYRVVDQGCTAQQKCVDYPDYAVKVVEDITSKK
ANYGILICGTGLGMSTVANRFEGIYAALCNSVEIAKLAREHGNANVLCLGAGFTASGLAK
DIVKQFLETEFSKESRHKKRLDKLSNITSKKKKTKTYNEDEISKFAKMAGQWWDENGKFK
PLHIMNPVRVSYIIEKIKELKKCNLKELSLLDVGCGGGILSESMARVGINVVGIDVCEEN
IKVAHSHAKKVGLNIEYIHTSIEELSNDKKYDVVLLMEVVEHVDNLELFMKKAIELLKPN
GLIFISTINRTIKSFCLAIIGAEYILNWLPKGTHNWNKFLKPSEIANHLRENNVTLQNMA
GMEYNVIKREWNLTKGVDVNYILCGLLDLTL
>ELAGILAN_00265 Chaperone protein ClpB
MDLNKFTEKAKSLIQSAQMKALGAGHQIFMPEHLLKVMLEDESGLVQDLINACGGSVQSI
SDAVDSAIKKLPVIEGPGSGGLQLSREIAKVFEDSIGIARRNKDSFVAVERLLQGLTAQK
DDTVGKILAENGVTLQKLNSVIAEMRQGSSADSPNSEEKLNAAKKYTKDVTELAMQGKLD
PVIGRDEEIRRTMQVSLRRTKNNPVLIGEPGVGKTAIVEGLANRIVANDVPLGLHDAKVL
ALDLGALIAGTKFRGEFEERLKAVINEISRAEGKIILFIDELHTLVGAGATSGAMDASNL
LKPALARGEIRCIGATTLDEYRQHIEKDPALARRFQPVFISQPTETDTISILRGLKERYE
VHHGIRITDGAIIAAATLSNRYITDRFSPDKAIDLIDEAASRVRIEMDSKPEVIDELERK
VIQLKIEAEALKKESDENSKQRLKKINEEIENLNSKFADLNSKWQMEKNKIARIQETAEK
LDNARKELELAQRSGNLGKAGELMYGVIPQLENELKNQEKVTDSFLKKEVTGDDIANIVS
KWTGIPVDNMMHSEKEKLLNMENEIGRRVIGQKDAIEAISNAVRRSRSGVQDTNRPFGSF
LFLGPTGVGKTELAKALAEFLFDDQSALLRFDMSEYMEKHSVSKLIGAPPGYVGYEQGGR
LTEAARRRPYQVILFDEIEKANPDIFNLLLQILDEGRLTDSHGKLIDFRNTILILTSNLG
AEIMLKGNVDSVRNEVMQIVKSTFRPEFLNRLDEIIIFHSLTRDDIYKIIDVQFSYLQKT
LAKRKLSISLSQEAKELIAQTGYDPEYGARPLKRVIQECIQNNLAKLVLSGEVVENDELI
VYALDNEILVKKV
>ELAGILAN_00266 NAD-specific glutamate dehydrogenase
MCIDHNVDTESLFKLADQENQQDKEKIKKFIKYFYSFVYKSDLKANDKFLLYIVNDAYNF
VSQKEKDESKLVVSNIDDIPGIEGDFTTIKITNDDMPFLVDSVIATIKSHDLTICYYSNS
IINIKRKDGLIDEIYPLEESNGIKESVIYVIIKGISDSFVDTLKESLQKTLKAVNCVVKD
WHLMLKKLDEASLSVIPVLDTGIQEKDTWIPVSRTGMTPDRNQEQKDFLVWLKNNNFVFL
GYQEYIAGKDEKLVCDSKKDLGLMRVGQSTLIPSANLDSLYILRSDLISIVHRRTYMNCI
GVKEFDDQGNVVKERRFFGLFTSVAEVQDIRTIPIIRDKVKVIEKNAGFVTGGHNNKALI
YILQVFSCDELFQSNEEELFQICTSIMSLAIRPRVKLCLRSKGAFTSCIVLIPMRYASSR
LMLKISNILKDEINAENSDIYNHHIINEYDLMKLHVVLKAKNASVPDDEVLRIENKLRNI
TEKWEDRFIDNLYNTFSTVEDIFIRYCKAFPISYQESFEPHDAYYDMKKLEIVRKKGVSE
VDLRLTRDNLNYQLKVYTPNNGGLELSKILRITKNLGAKILSHNGYYIEINGGIWIHHFV
LSRVDELIDNITLKEQFEITLAKVFSKEIKNDYFNSLIIIAGLKWKEVLLIRALSAYLKQ
TSFNYNPEYIQKVVSEYPKVVKYLIQLFHARFDPNIDIDRAETTDIVREKIEELLKEISN
VSHDYVLRSIFNLIMAILRTSYYQDNKPYLSIKFDSSKVNGLPDPRPYRELYIYSNLFEG
IHLRGGKLARGGLRWSDRTEDFRTEVLGLMKAQMTKNAVIVPVGAKGGFVIKQAYKDKNI
LREKSVECYKSFIRGMLDITDNVVDGEIIPPENVIRYDEDDPYLVVAADKGTASFSDYAN
QIASEYNFWLGDAFASGGSAGYDHKKMGITARGAWIAAQRHFWKMNKDIYQDATVIGIGD
MAGDLFGNGMLLSKNIHLIGAFNHMHIFVDPNPDAEKSFTERKRLFKLPFSTWMDYNKDL
ISKGGGVFERSSKQVNISQEIKKCFDITEDMLPPSDLIRYLLKAKVDFIWNGGIGTFVKA
KSENHSMVGDKANDELRVNGKDIRASMFIEGGNLGCTQLGRIEYAERGGYINADFVDNSA
GVICSDLEVNIKIAFVSAMKAGGISLEKRNEILASMVDEVASKVLENHNRIETKALLLEC
LQAKERLEQDHRLLLSLEKSGLLNRSVEFLPADEEVARMLTGAEGFSSPQLSILISYART
AIKNKIIHSDLPEKDLISNDYLLGYFPKKMLTEFKDFILKHQLRREIISTCIANDVVNRM
GCIFINNLVENTGIKVHEAVNIYIVVNHLYDLNNLWQKIDELDGKIDINSYLQIVRNVQK
FIGRVSFWLVKNLSFVELDDVTKFKDAIETLGHDVLDEHLLKVYNHGYTSLVELNIDKDL
AKKIADLCVLTYALDIISVAEQTSLSILDAGKIYFELKSLLRFDLIRTIAIKMKSRSSYW
DRSLVNDLLDDLSNYHHKLAVKVIKATDNPEDKVQTWACNDKDYIERYNSFLDEMVASKL
DLSKLIFIIRRIKVLAS
>ELAGILAN_00267 hypothetical protein
MFNIGLSEILVVALVSIIVLDKNKVPVFIDFIKTIYRYFTIVKSKAKRLLKDAGIEDLYK
ECNTEKVNYIVGKNGKLYPTYDIDNTSKDNDSEDSGSR
>ELAGILAN_00268 Response regulator PleD
MTAKILVVDDVLSNVKLLEARLKAEYYTVIVAHDGEEAIDLVAKQQPDIILLDIMMPKMN
GFQVCKELKSDPLTTHIPIIMVTALHDTHDRVQGINAGADDFLTKPINETALSARIKSLT
RLKMIIDELRLRGETNAEIGGVAGNSIMDYSNQIFDANILVVDEDVFQAEQIYNVLKQRF
RSIKILSDPIEALKVGIKDNYDLIISDMQFSKTDGLRLCSGFRSKVETRYTPILILSEDY
DKNNLVKALDVGANDYLTVPLDEGELIARVNSQVKRKRYQDALRMNLFNNAEMSIKDPLT
NCYNRRYFDAHLRNIVKDSVEKDRRLSLMILDIDYFKMVNDNFGHSAGDELLKQIQRRIS
ENIRVTDLLARFGGEEFVVVMPDTDTSDAYTIAERIRKIIAKKPFILADKNTTHNVTVSI
GIAEMQGSDLDNIKEFIVRADKYLYKAKNSGRNRVVTG
>ELAGILAN_00269 DNA repair protein RecO
MRWKDEGIIIAAKKYGDKNLILSLFTKNHGKRRGLTKLTNNSNYKFQISNLLHAEWSAKL
PENLGFFKCELIESSFHHFFQDRLKSITIVSFSSILEKVLPESEPCAVLYDNFRYFIDVI
KHNNQSWQSHYLNLELLLLTQLGFKLDLSKCAVTGVKENLQFISPKTGRAVSKKAGDYYA
DKLLPFPQMLHDVYNNNLQNSYSFQEFQLGLKVTGYFLNKYLFLQLNVKFPELRNLMLSL
>ELAGILAN_00270 hypothetical protein
MLLKSFKQLFSKPKAQYEMHQAQEEEWQPITYSLIALKLWKQTVTE
>ELAGILAN_00271 Putative nuclease YhcG
MVMQIELGLHKRQGKAITNFKEKLPYPTSDLANQTLKDPYIFDFLSIGKDAHEREVEKGL
VGHMEKFLLELGEGFAFVGRQFHLDVGNKDFYIDLLFYHLKLRCFVVIELKDKDFKPEYA
GKMNFYLSAVDDLLKHSTDQPSIGLILCKSKDDVLAKYTLRDMNKPIGLAEYRITENLPE
NIKTALPTIEELEAELSKISDEEK
>ELAGILAN_00272 hypothetical protein
MTKIIAKEYTEFLEQLKDHIATNRYKAALAVNSKLILLYHHIGTEILKRQKEHTWGAKVI
DQLSKDLRSTFPEMKGFSMRNLKYMRKFAEEYPDVEFVQEPLAQLTWYHNITLLEKIESH
EIRLFYVKKAIEHT
>ELAGILAN_00273 hypothetical protein
MRFFYSNYILFLSLCCFLLFSLSSTKAQTNDTLAVPIPQRKKEIVEHTVVAQPRQIIEMQ
EEVIINEGKEFIPIPKRKKSVEKKLRRDVRGAKNEIGNEKSVESKKDELVVTEIINSIRE
KLTKCWSIPESIAYKENFNIKINLLLSSQGEIIMADVADSDSYRNNPLFRSIADNAMRAV
YKCSPLTGLPTQHHHIWREVTLDFIL
>ELAGILAN_00274 Outer membrane protein assembly factor BamE
MRVLISFILLFTVSCTHTIHNHGAPGISVELWSKIKVGDDKEKVVHTLGSPTLVSKFDDN
VWYYVSYKIKQANFLGKRKYSSKSLQISFDQDGKVEDTKETDILERSLAVSD
>ELAGILAN_00275 Ribonucleoside-diphosphate reductase subunit beta
MSLLEADPIYKPFNYPWAYDAWLQQQRIHWIPEEVPLADDVKDWKTKLSSVEKNLLTQIF
RFFTQADIEVNNCYMRHYSNIFKPTEICMMLASFSNMETIHIAAYSYLLDTIGMPESEYQ
AFLKYDAMRKKYEYMLEFEESKKHDKKHVAKTLAVFGAFTEGLQLFASFAILLNFQRFGK
MKGMGQIIAWSARDETLHTNSIIMLFNTFIKENNEIWDNEFKEELYSACRTIVELEDEFI
KLAFDLGDVEGLSAEEVRNYIRYVANRRLMQLGLESIYDVNDNPIPWLDEILNGVEHTNF
FENRVTEYSRAATQGTWEEAFTENDTNNK
>ELAGILAN_00276 hypothetical protein
MLQLLILLTVITSAAFFGHLVPMEVKTFLYSTSLSIKEVLLFIMPFIIFALIFSSVNNLK
QSAIKFILLLIIMIFLSNLASSLIAYSVGHFIIQNTYSIQDITYEETIVPLWSFRLPALL
SNFYALACGFVSSIVVSTLLPKKSRELSNKMLDLTLFILKTFLTPIIPIFVLGLALKMQH
DQVLSIIFKDYSIIFIIIASATYLYVFLLYGAANSFKITSWIASIGNMIPAFITAMSTMS
SNATMPLTLEGSKKNVKQPDIASSVVPITASFHLVGDCFFIIILSMIIASGYSLCTTDYV
TFLLYFLLFKFAIVAVPAGGIMVMLPILEKYLKFSPEMLSLITALYIVFDPIITSANVMG
NGAFAIMFTKLYDKLK
>ELAGILAN_00277 tRNA N6-adenosine threonylcarbamoyltransferase
MSILAIDTVGIGSSIAIVDYDGNCFVEHNSASNNHAESFFQILNTLFDKHNYNYDKIDHL
VVVVGPGSFTGIRVGISAAQGINLATNKPLYGVSALEVQAYAISLLCTNNKKNIRAIVKN
AQGFYTQLFDFNLLPLSAPGSQCHATSSTHMDCNLNASHAGLLVRYRLGNKQKLNEVEAL
YLNEPQYMKSL
>ELAGILAN_00278 hypothetical protein
MVNINTKKQPAGFFIYLSGLSGSGKLSTAIELSNMINALIVNSKFYNNVQACSIYDGVFE
RDQIPKEVQDRIYGIMQIMLQVIENYPIHSKNYIFIDELMENNDQNMRMYDSIVRLSKKM
NTEILPVVLRCDLPTLQKRIALKRQRKNRKVINLNSIVEKFRTDDLFIPPSAIEIENSDM
SIKEVAQEIVNQMHKLSNIACTRKNSL
>ELAGILAN_00279 L-fuculose phosphate aldolase
MLTKSRVKRDLVYAYQILSYLKFDDHTYTHLSVRSEDQKSFYIYPFGMRFDEVDERSLMK
VSFDGDVVEGKEYQYNRTGYIIHGFVYQARKDIQAIFHLHTPSIVAVSSLKDGLLPISQW
ALHFYNKISYHNYNSLALSDTEGKRLIADLKENFVMLMRNHGSIMCGRSIQEAMFYTYHL
EQACKTQCLTLAMNKELSIPSEEICSKAVKDLLSFESNLGERDWHAWVRLIKSKL
>ELAGILAN_00280 Lysine--tRNA ligase
MTSWPFQEAEKILQEFPNKKEIIFETGYGPSGLPHIGTFGEVFRTTVIVNALKKIAPGIK
TKIIAISDDMDGLRKIPDNVPNQEMLREHLNKPLTMIPDPFGTHQSYGHHMNSLLCKFLD
MFEFEYEFRSATECYKSGVYDEKLLLLLKNYDKVMDVMLPSFREERQQTYSPFLPICPKT
SQVLQVPVIETNTEKGTITYEDPNGGKIEVPVTKGKCKLQWKPDWGMRWAAFGVNYEAHG
KDLTPSAVLSSQICEILGEKPPLLFCYELFLDKEGKKISKSKGNGISIEEWLTYAPTESL
ALYIFQSPKKAKRLYFDVIPKSTDEYLEFVKRYHENKEKDINNPAWHIHQGNVPSIETSG
INFSLLLNLAAACNAENKEILWGFISSYAPNVTPENNKMLDRLSDFAVKYYHDFIKPTKS
YKTPNEKEKAALLDLKDTLHSLSTTATAEEIQSQVFSIGKKYDYTNLRDWFQLLYETLLG
QKTGPRMGSFIKLYGIGNTISLIESATKCIL
>ELAGILAN_00281 hypothetical protein
MSTGSIQTDQLFKGLTRPAMLFGVSYMFAILNVLICMLIFINSNDLRVILLMLPGIHGLG
YIASAKEPLFIELFMVKLGKCSKCLNRFYHGANSYDIA
>ELAGILAN_00282 Type IV secretion system protein virB4
MLRFRAIQSKNKSTLNREVHAAEFIPYSCYWNSTTLMTKENWLVKVIKLSGFAFETADDE
DLVIQNNIRNQMLRSISSPAFSLYFHTIRRKKNIFSDEFASQGLPNFFANHVNLKWREKH
ATRQSFINDLYITIIRRADTKGVEFLSHLLKKFGHVTSKHAWESDIRATYEDLEETTNRV
VTSLRNYSPKILGVKETPDGLFCEIMEFLSRIVNCGFVTNTLFPLRTEISRYLPVHRLFF
GRKMIQVVTHNESKYAGIISIKEYGNHTSAGMLDSFLQLPYEFIITQSFQFINRQMAIGK
MQIQQNRMIQSADKAISQIAEISQALDDAMSGKIAFGQHHLTILCIEKSPKSLDNALSLV
ESELSNCGVYPIRERVNLEPAFWAQIPGNFDYIVRKATISSLNLAGFASQHNYPTGNKFN
NHWGDAVTVFDTTSGTPFFFNFHIRDVGHTMIIGPTGAGKTVLMNFLCAQAMKFSPRIFF
FDKDRGAEIFLRALSGIYTVIEPRTKTNFNPLQLDDTSDNRTFLMEWIKSLISVYNDKFT
SEDIARINDAIEGNFKLRKEDRFLRNLVPFLGLAGPDTLAGAISMWHDNGSHAAIFDNKE
DLLDFSRARVFGFEMASLLKDPVALGPVLIYLFHRISISLDGTPSIIVLDEAWALIDNPV
FAPKIKDWLKVLRKLNAFVIFATQSVEDASKSTISDTLVQQTATQIFLPNLKATSVYRDV
FMLTEREYILIKHTDPSTRFFLVKQGVNAVVARIDLKGLDDIINVLSGRAESVLLLHDIL
NEVGDNPKVWLPIFYQKVKNV
>ELAGILAN_00283 hypothetical protein
MFKTKLSLLLIAIFLLNIDFLLSYPVLADGVSGTDKTEFVSRFNSIGSFSRASNPDCGAF
KTAAALAGIAIAVGAIFTGIVLIVSSAGLFTALVIVGMIAAIVGVWKAIGGLVVCEHSFV
KHPVARDHDGKYKNFKLEDTGYSGCTNENYQTEEEYFSCLQNKAREDVNKKDYDGKRAEK
EALNSNVQESTESYYWPKNGVQYSEYIEVCHRNPLTFGNLFNKVDFNSRGKPGYIDFDVR
EKDTGYVDGSWSSKVDGGLECRVLKAGQSEPIHGATFKAVRKMGRLCVELASVKMLGIEM
TPWPQGVDMGCTELPPDPLAPMCEKSVMIFKNKDGTGEEKVPIGNNDDYKTIIRSKEKRL
NGQGGKIFVGYDNAGCFSSYVSEACYNQAGSKSLAPIPVTSMIVQCIKESLDNLVAGKGA
PNGESFISVAQKRLKNTVTAVLVLALILFSIKAMSGGVQRPQEMYMLIIKFALVIYFTTG
STMSHYYGELTRLSNGLSEIVLKASSESKGICNYKAGTDYEYTRAGKRVSYSYLAPWDRL
DCRILFYLGAPLDGIGGKIGTGGVATLAVLLGAAPVLLVAGSVIGIIFAGGQILVALVCI
FMAVLMMMVILWLCYVFILSLVALSVIIILSPLFIPMVLFQHTKGYFEGWVKELITYSLY
PVILFAFLSFMFIACDKIYFKNLNFELDESYKNEQPDKSYEKKQAEISYSKKKQWFKLKD
GECDKNETTLACMMQNYSFKKSSILGLFDFTYMEFGSSLIGELLKLCLVLFLFYHFLNIL
PGMAAELAGNHRAALGSGQTPGQIVGKALSAAKAAAGGVAGVAGAAAKKLSGGDKSKSRG
SGSSSSESVNKSTE
>ELAGILAN_00284 hypothetical protein
MLKFLLIIPFFFLSGCGEHHCIKPENLSGLREKLDIVSTEQKWVDSGVNISDRIRVTEID
IVPSKVNFCPKQYADFAIGPGRNDVALPFALKKGDTISFSVIGSKVCKDKESETKIRYLK
IDEKCSEQETEHFAHVLNQEKCQGGKDGICPNKYIIGDAQWLSGREYWFSKLDQDERKKE
IENIINSIKQGENIDCSKLSESSASKIDTHILNSLCRRICKFSSGRRGEDCVYIEYNNIE
IELFNALNSSGESVVAEIISNVLKGKQVKTDITFLKVGMDNETLEHIPGGGLCTSCDHKM
ENDHQIPSLTFSLCSRNDKSCYNTNDKGGFNIRVTKNHSLENSLYISVSDKFPEHKPGEN
QADISVDISKVHDMENLKGKLKDKTGTIYYGIRDHGCDYKNEGQFSINLTTQEPPTKTFS
AIYNFFDEKVKTAFFGSNYKDPNAIHSDTSPVKSLYESFIKSSRTNTIRSTIISLLVLYI
ILYTLYYFFGLTHISIYEFLIICVKIGIIAQLLQDNSWDFFYNNAFSIFINTPKQLIEIA
NFRGTTSNVFEFLDLPLNRFLSSHSVLLIVSLIFSGPLGIVSFCLVIWGLITVSLSIFNA
LFSFITSIAIVALLLSLAPIFIICLLFAYTRQMFQNWVKNLARFAIHPVVLLIFISLISQ
VMDYIVYSVFDFEVCSTCILNINLKIFNPCIFYGYASKYTPNITAMMAFVILGHAMKALV
EASSAISDSLFGAYVASEPGRQYQQSLMGTVGLDEQSVQRRERGDASQQSGTSRPQIPQG
TQRSTPQIPQPGRQQ
>ELAGILAN_00285 hypothetical protein
MISKRSLLLILCLAITGCNMDCVEPGLQSKNTSVNVDVPVRKADKIHWVDSGQVISQGEK
IKFTLDGSVNFCPFKEDKNPRKVLVPASFCADGSEPNYSKAADINSVPNNYGVNESKNEL
CGGKGFGSNRRYVDTGIKVNPGDKLSFSLVPRKITIDYDNPEGKGINFDDNCYKAVENDR
KETVYKKATVSEVHQGGEFFCDGKDGTKNKIQFLPLDKTKAKESKVLVGNGYTPYDNKVH
FNKGYIQDNEPWVYGSLLDLRRAKIGLNELCDGKNCSLDERKKYSSYELNCYHQNICYTE
KGIWNYGLGQAGERNCVSSIRYKKYDKGNKCDMYSYLEKMEGNVKAGSFTEDDKSWAEAL
VAKIGDPDDKNTAKGIQCLPKKEGAKGDNMCSQIGDNNKFEDFSLELNNDYPVNDEVTPG
SSVMLAIADYGHYYYNRGGYHVKVTRSCEYINGEKLYVYLGDEPPKDLHGVGTNDFKVVG
VRERVNGKDEYTILDVISGEHFQNEESKKIYFGINVSNVERDDITDKNGKYYENNKYTVT
LFVKRKINDFISSNVNGVFKLIKEEVIGDSVKDSYKGYARGLLQGVRALLTLYVIFTVVG
YMLGTIQLSKFDFIVRMFKIAFIAFAFSDRSWELFGTTLSRLFIDGSTYLVDSFSGYVGE
GERKFAFLDLTAGVLFTAETWLKFLSLMLSGPFGFIAFWVIFCATYAFLKCIISATFKYV
ISTVLVAFLLSLTPLFIVFILFQKTKPLFDNWIKTLAHVSLEPVILFSFLSLLNQLMYSV
LYNLTNFSACYQCLISVNFLSYDLCLMKSILPLGYSPGTSVDVALSTGERAGGHFAALPI
DLIQAFIYLIIAGAMEAFVSISETMVQTLFSSGYGVTGSVGTVAKSASQAMLSTVGLDDK
TQSMIQSIKQKMSKDRGKIEAKLPNTPKQPDKKEDSKGSSDKTTSDRPKTLKQSDQQKNS
DETIRSDPSAKAKNKEENGEE
>ELAGILAN_00286 hypothetical protein
MQSRLGKCWFRVLLLAAYVLITGCSKNDMPFPRCISADYFGPEPIAVSAHFSSDHDAFIP
EGEDESVIDPDTGEINSGFHHNQVVKWKDTGLETNGDSLIVRVNGAWTSWSNNNKKESKK
GSYTLQSLEQLKYATKFEGKQSDNSLPNFHLVCNDYKPSIQKFSSKSDTSCTVNCKCINE
DDSANTVSRGAPCWFTNGHGAYLLFQTGKDDPNENLKLMRDPQYPTVHLGYNSVAENGSG
LFTLDRDSTKLKDRNCNELKLKKGWKIYVKILDRYYLDNVGGYSFEFLSGVQQPSSFGFF
DYIYNYLKCVLLINENCKEHFNSNDPAVAQAMFENIAEKSTSFHNFVLSLLVLFVMISSL
LYLFGMIQETKHDMLIRMMKITLVIVLISPGSFRFFYDHFLVLFVKGLEQLISVITNFAP
NMNTGSIAQEDEAKLFSFMEDMFNKFFAYSVWKKFAAFLHYQMWASLLMIPAIFIGIVLY
FLLCLYAYIIFLSGFMGIAFLIAIMPLFLISILFSPLKSLFEGWIKFCISFCLQSIMIFS
LLSLLAAIIMNTFYRQLGFTVCYNKWFEVKLCAPKWVFGGFCIVDKQYFGWTPGQIFVPY
TLGEASSLNIDKSIEGIEKISREGGTIKFTGGAGYIPLPPDYPKDKNGEHIKGFRYIDYP
FFNPMPGTKDNPADHYIAESDMVVSNGCSEKDLVRLTNSLSHASERADIILLINNIEKRI
GDVSEIIKRYCQDINKCNSYREIINEIRSLVRSAIEKQGCRILKLHDLYKDPNSEYCQKC
KDCEDCKNYQENSDYQRVQDIQRGYLINAGEIFVLFLLSFLMFSLREFVQQMGSSIAGGG
FSVYNISRMYEASPLVGIMEGLKQHYWQDAIGGKLESLGNWATHLPDRLAGGTANLLGRI
PRVGGVLKYAIDVPRKFVGATIEATKFATSPENDVDKLEEKIYRAFGVDKEDITHRRIGK
YLDYYKGYVGSHLGYTIEDAMKFTWEHGLGSIGKHGYDHNLLYRAKEYRRDFLEKLHDYT
IGRKREPEKDNPDQSNKVERELGTELVRDNHDQPLEEGDPLRLRGGGQPDKVVRELSTEQ
EDKPNQLQHDQPTEEDKPDQSNEVTRNLGTEPKGSDEIDDFGSAFEGMEKRAEREGRRNQ
DKVYNLSPLFEMNTPEAVEKRAERARRKEERDRKDEVYNLKPLFKEPKNPEEYVKALFEM
NTQEAIKKRAEREEKRNREDSKRKLPEPMRKPDAKGDEKRIEDED
>ELAGILAN_00287 hypothetical protein
MQKEMRRGLKMKTNKNFKGLDYYKLQQDKDGNIKLNDYDDILNARRARVDLLRDNTSLDK
DVNFAKLNKALSEKFVDNHGLLSEFDKEDKEIVQERIKVFSILESLEDLKSVKSEDLLEV
SLLLSDLSFIERNVVLNTDQNSDLAGFKNLFIEKKASGEEYSEEECRGFLDNIDKINTII
KLELESRIEGLNHDEKNDHDDLQDEIGQAINAAGKSEKDN
>ELAGILAN_00288 Ribosomal RNA small subunit methyltransferase D
MLRIIAGKYRGRKITTGKHLAARPTMSIVREAIFNMLSSRKPIYNLNVLDLFCGSGSFSF
EALSRGAKHAFMVDSDYYNLQLPKKTAKDFGITDNVTLICCSANCLPQPISKCDIVFIDP
PYNSNLVESTLNGLAHSGWLSDDALIILEIRKNEDFECNKNFSIILERTYGIARIIFLSL
LT
>ELAGILAN_00289 hypothetical protein
MLCLPYFAAPLNGYNIHADHKEHLVYREDNNGTTKYTSYEEKENKFIEEAHEYLIDSEFN
KNFDLGQYRISNFSGNLTKIELELINEKYMQVQVNRERKIILAIP
>ELAGILAN_00290 Phosphoribosylamine--glycine ligase
MKVLVIGSGGREHALLWALKKSPILTELYVTPGRQAMKDLGALVDVNIQNSVDVTQFCKR
ENIELVVIGPEQPIIDGLADDLVAEGINVFAPSQATAKLEGSKSFTKGLCKRYGIPTAKY
ECFVDEGLAKDFVRSNKIKFPLVVKANGIAAGKGVVICNTESEAFSAINSMLVEKKFGES
GEEIIIEEFLVGEEVSFFALIDGLKVVTLGCAKDYKRVDESNESQNTGGMGSYSSPSIIS
KDMEQKIIQKIIYPTAQALVNMGTSYKGVLFAGLMICKDSPKLLEYNVRFGDPETQSILP
RFDSNCDLLKLMLSVAEGKLNVKMVELNNKSTVCVVVASKGYPGDYQKGEVIKGLDKIES
IPGVLVFHAGTKLDESGNLVSDGGRVLNIVAEGSTIEEAKSKVYSALNFLEWPGGFFRYD
IGS
>ELAGILAN_00291 Serine--tRNA ligase
MLVIAQYMHDIEYIRKNPEGFEKAMKSRGIRESTAEEILEIDHEKRSLTTKLQDLNRQRN
EITEEIKKLKMSKSPCEEQIELSKSITNEIEAISLKEQAEKDKLVNVLSNLPNIPAQDVP
IGADENSNLEVRRYGGKRQFDFVPESHYELGEKLGLIDFEQAARISGSRFTILKGQLAKL
GRALINCMLEMHVNEFGYTEVYHPALVKNEAMYNVGQLPKFSDDSYLTTDELRLIPTSEV
FLTNLVADKIMEEKELPIRFTAYSECFRKEAGSAGRDTRGMIRQHQFGKVELVSITTEDQ
SNDELERMTSVAEEILKKLELPYRVMLLCSGDMGFAAQRTYDIEVWLPGQNKYREISSCS
NCGAFQARRMNAKYSSETDKKIKKYVHTLNGSALAIGRTIIAIMENYQNSDGSIAIPNVL
QKYMSNDTVISK
>ELAGILAN_00292 hypothetical protein
MLGITKNNQKESTDFAGEKFVIYATCVCLAATFAAGCLGAVIGSPLLTFPLAMLISNPVV
WVLMGIILTVAYKMVVEPLFYLAKNYINGKRASKGEKSEEKDTELQDLQGKTPEKQARPK
TPDRDSGIFDCKENKDSFVYKTNKKEDYKFWLSNFDIAEIAKSYYGWMPYRKKGHREFSK
GVFFSCLDNLTSFLGNRLQEYKDKVKGDNNLVLSSILNLNNNHWVTLVISHDEKSKKFRA
YYCDSFGEPLPEEVSSALQKTLGIDNSSIRNSKAKQQDDKYNCGIFALENAKKITDMLKA
GKSFDEIDDQLKYELSSEQLIEKRKEFAKALKKDEQSRAGTPSPVLGGPGNISRKDSGVS
LDSVESKQTKIVQYNTTGDGNCFFHAVFGDNSSGQYKTEKAQDMRMGWHKFLSQFNSLND
PRMPELLKGQMQKVFGAFLENPNHLIGMSDSIKDLVQHTNRRVEKIKKKTNKLIKKLCCL
TTLKENEVIGDLRSISASNLNISERKYDRNYNSDTAANSFLNGKSIYRSYLEAISSQSYH
VFIEEISILASLANIEIDVYYKNNGNDVNTLFLPNAGMINEGYQQNNELWGNKEQETVYL
APGHYERAEIVEVEPSLMEKVSSAIQSVVTVCVNALGLNT
>ELAGILAN_00293 putative tRNA-dihydrouridine synthase
MCKCARFEHIEYMSLQVGNLTIDSPVILAPMSGVTDYPFRSIVKKLGASLLVSEMIASRA
MIMQTRQSLQKAKVDALTAVQLAGCEPDVMAEAAKLNEDMGAKIIDINFGCPVKKVVNGY
AGSALMRDEKKAAEIIEAVVKAVNMPVTVKMRTGWNDENRNAPRLAKIAEDLGAKMITVH
GRTRAQLYNGQADWKFVRNVKEQVKIPVIVNGDIKNLNDIQNALKESGADGVMIGRGAYG
KPWLINQAMNFLSGSETSEPTASERLSIILEHYDNILEYYGNDTGIKMARKHIGWYSSGL
QGSSEFRVRVNNMTDSTEVKENIIGFFGQETH
>ELAGILAN_00294 Bifunctional DNA-directed RNA polymerase subunit beta-beta'
MVDSSYMYASGAFVPRVSYSRSIDLKDSLLDLVKVQKESYDSFTPKNKGNERLEVIFHTI
FPINDPLRRATIEFISCRVDDPKYDESECIKRGVTFSAQVIASIRLVVMQDGISLDEYKS
IKESGDHSKLATVVKSIEEQKVHFCGLPMMTDKGTFIINGVEKVIVSQMHRSPGVFFDSD
KGKTYNSGKLIYSARIIPYRGSWLDIEFDVKDHLYFRVDRKRKLPISVLLKALGLSNNDI
LDRFYEKIKYVKHKDGWKVPFVPDKFKGVRLPFDLMDIEGNVLLKANVRITSRLAKKLYD
NELKEYLVPFNSICGLFLAEDLMDSASSTKILSAGESIKLEDIKKLELLSVDEISVLNID
NLFVGPYILNTLFLDENMSYQDALYEIYRVLRPGEVPVLEIVEEFFRNLFFSPEYYDLSN
IGRLKLNSYLGLNYDEDLTVLTHEDIIEIVKKIVLLRDGQGSVDDIDHLGNRRVRSVGEF
IENQFRTGLLKLERAIVDSMSTSSLDKVSPSDFINPKVLTNVLRDFFNSSQLSQFMDQTN
PLSEITHKRRLSALGPGGLTRERAGFEVRDVHPTHYGRICPIETPEGQNIGLINSLAIYA
RINKYGFIESPYRKVVNRVVTDQIEYLSAIDEGSHHIADTSVKLDENNCFVDDMLYCRYA
GSFVMVSSDQVSYIDVSPKQVISVAASLIPFLENDDANRALMGSNMQRQAVPLLKPTAPL
VATGMESFVASGSGAVVLAKRDGIVDSSDSNSIVIRAFDKERVNYLDVDIYHLRKFQRSN
HNTCINQRPLVCVGDYVKKGDVIADGPAINSGELALGKNLLVAFMSWQGYNFEDSIIISS
EVVKKDLFTSIHIEEFDCVVHDTPLGSEKITRAIPGVNEENLYHLDDSGIVKIGTRVGPG
YILVGKVTPKPSLSLPPETKLLMTIFGEKSFDCADSSLYTSPDVEGTVIDVQVFTRRGVE
ENERALLIKQKEINDFEEERDYIINVTSEYFYDELKKLLINSGSQDREKFDSIEREQWWG
IGLKNQSISEQVKSLKKDFDEKVSHAIAQFKRKVEKLHEGYDLPQGVSMSVKVFIAVKHS
LQPGDKMAGRHGNKGVISRVVPVEDMPYLEDGTPVDIILNPLGVPSRMNVGQILETHVGW
ACRKLGEKVSNILDEINKIKSAFCKGIRSLNDDNFTQFAVAYLDNKKIENIDDDEITASV
LNTPNKNALNDELNELVENYLNSCKSSYSNLRNFLIEVYSYGSNVSICNDIRNISDNNLI
EFARKLRDGVPVAAPVFEGPKDEQIAKLFELAGLDNSGQAVLYDGCSGEKFDRKVTVGYM
YMLKLHHLVDGKIHARSVGPYSLVTQQPLGGKSHFGGQRFGEMECWALQAYGAAYTLQEM
LTVKSDDINGRVKIYESIIKGDSNFECGIPESFNVMIKELRSLCLNVDLKQNDVVIEDIS
HTNIAQPFNEVSISIASPESIKRISCGEIEDVSTANYRTFKVEKGGLFCPKVFGPVNDDE
CLCGKYKKRRHRGRICEKCGVEVTSSKVRRERMGHIELASPVAHIWFLKSLPSRIGALLD
MSLRDIENILYSDNYIVIDPLVSPFEKGEIISEKAYNEAKDSYGIDSFVAMQGVEAIREL
LTRLDLHEIRKDLRLELESVASEIRRKKIIKRLRIVENFIKSGNRPEWMILTTIPILPPD
LRPLVSLESGRPAVSDLNHHYRTIINRNNRLRKLLSLNPPEIMIRNEKRMLQEAVDSLFD
NSRRNTLVNKAGAVGYKKSISDMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPTLKLNQCG
LPKRMALELFKPFVYSKLKMYGMAPTIKFASKLIRAEKPEVWDMLEEVIKEHPVLLNRAP
TLHRLGIQAFEPILIEGKAIQLHPLVCTAFNADFDGDQMAVHVPISLEAQLEARVLMMST
NNVLSPSNGRPIIVPSKDIVLGIYYLTLQEPKEDNLPSFGAFCEVEHSLSDGTLHIHSSI
KYRMEYINSSGETHYKTVCTTPGRLILWQIFPKHENLGFDLINQILTVKEITGIVDLVYR
NCGQSATVAFSDKLMVLGFEYATFSGVSFGRCDMVIPETKATHVDHARGEIKKFSMQYQD
GLITRSERYNKVIDEWSKCTDMIANDMLKAISIYDGNSKYNSVYMMVNSGARGSTSQMKQ
LAGMRGLMTKPSGEIIETPIISNFREGLNVFEYFNSTHGARKGLADTALKTANSGYLTRR
LVDVSQNCIVTKHDCKTKNGLVVRATVEGSTIVASLESVVLGRTAANDIYNPVTKELLVK
AGELIDEDKVKQISIAGLDVVKIRSPLTCEISPGVCSLCYGRDLATGKIVSIGEAVGVIA
AQSVGEPGTQLTMRTFHIGGVMTRGVESSNIIASINAKIKLNNSNIIIDRNGNKIVISRS
CEVVLIDSLGSEKLKHSVPYGAKLYVDESGSVKIGDKVAEWDPYTLPIITEKTGTVSYQD
LKDGISITEVMDESTGISSKVVKDWKLHSGGANLRPRIVLLDDNGKVMTLASGVEACYFI
PIGAVLNVQDGQKVHAGDVITRTPRESVKTRDITGGLPRVIELFEARRPKEHAIVSEIDG
YVAFSEKDRRGKRSILIKPVDEQISPVEYLVSRSKHVIVNEGDFVRKGDLLMDGDPDLHD
ILRVLGLEALAHYMISEIQQVYRLQGVRIDNKHLEVILKQMLQKVEITDPGDTMYLVGES
IDKLEVDRENDAMSNSGKRSTHYLPILQGITRASLETSSFISAASFQETTKVLTEAAFCG
KSDPLSGLKENVIVGRLIPAGTGLIMNKIRALSLCDNVDKYEKYFDIETYDEEWLMDNGC
HLHSGEEESVVAYDQSN
>ELAGILAN_00295 50S ribosomal protein L7/L12
MSNVTSDLVDKILSLNLLEASELVKVLEEKIGLPAGSFLGGAVGAGAPIGDNAAAPAAQE
KAEYKVVIKEIDASKKIGVIKAVREVNSTLGLKEAKELVESLPKDLTANVPKDEAEKIKQ
KLIEAGATKVELE
>ELAGILAN_00296 50S ribosomal protein L10
MKRKDKDEFIQSTINVFVNNDFLILVNFKSINANDSLTLRNSLKSIAGGVLVVKNTLARL
ALGRTGKFSYLSGKFSGPVAIIYSSGIVEAAKLIVDFTNANKEKMSVICAAHLNELLTVE
DVNKLAKLPSLDELRVKIMRLISYDIPARLALSINSSSMRLMRVLDYYSSKK
>ELAGILAN_00297 50S ribosomal protein L1
MNTYNNNPKQCLKKIVESASAKFNESVDIVVNLGVDSRKSEEQVRGTVVLPKGIGKNIKV
AVFAQDKHLLEAEKAGADIAGGEDLVEEIKKGRKLDVDWCITTPDFMAKITPIAKVLGAK
GLMPNPKFGTVTSNIAEAIKTIKSGQVKFRTDKNGVIHGKLGNIKFDIDDLLENLKAFLK
VIKDNKPISAKGIYFKGVFLNSTMGKAYKIGKVEDII
>ELAGILAN_00298 50S ribosomal protein L11
MSVIVAKINLLMEAGKAVPGPKIASVLGPRGIPVPKFCEAFNKVTSAANANYKVGDLVTV
RISIKDDRSHDFTVSGPPVAYLLKQEAKLSKSSGNPGKELVAKLPMSAIIKVEKCKMVDM
KVDNEDSAVKMVVGTAKSMGIEVVEG
>ELAGILAN_00299 Transcription termination/antitermination protein NusG
MECEYKWYIIKVDYGYEQGIRELVSNAVYFKEVFIPYQTVCNSKSDIKELCEVYVYMHLC
DESKNILNQTPGFCSGESGNFEMILDDEISLKCKEFNRYKWYILRVASNCEEKVRQHILE
NSMRLGVNDYFKEVFIPYEELSEVELKSKKIATRRKCFPGYVFLYVNLCDEVLNFINSIP
KSLKVYGFLKNGNIPKVILDDEIHSMCNALYNAQETKKLGYGYEKGEKVKINDGLFQNFT
GKVNMVNDEKKIINVEVSILGKPTIIELDLAQVEKIED
>ELAGILAN_00301 hypothetical protein
MNPRKVFNILFIVLFISFSHVGSAAADTNTDTTAQVICNIIGYVWGIGGPLMTVVIIGAA
LLAIFGRMPWPALFALGIFCAVFFGAKTIVIKVMGGIGSTGNTSLMDQCGTGDTKKNYFF
LKQT
>ELAGILAN_00302 2-oxoisovalerate dehydrogenase subunit beta
MATLSVREALCTAIREEMQNDSDVLIMGEEVAEYDGAYKVTKGLLKEFGENRVVDTPITE
HGFAGLAVGAAFAGLKPIVEFMTFNFSMQAIDQIVNSAAKTNYMSGGQLGCPIVFRGPNG
AAARVAAQHSQCFAAWYSHIPGLKVIAPYFASDCRGLLKAAIRDPNPVIFLENEIAYGHE
HEVSDSELSNKDYLLEIGKAAVIREGKDVTITAFSLKLMDALNAADLLSSEGIEAEVIDL
RTLRPLDTQTVINSIQKTNRLVSVEEGWPFAGIGAELSAVVMEQGFDYLDAPVVRVTGKD
IPLPYAANLEKKALPQVEDIVEAVHQVCFRKK
>ELAGILAN_00303 ATP-dependent zinc metalloprotease FtsH
MKKIEISELLKRISICLLCVATIISIAFLFAYMHTMLLSKGYELAAHYVSEAMPCVLLVV
FFFIAWFIYDQIFSKLKEVELPISIELANSDDKRITFADAIIDDSLRQRLQMICCDQMTE
EMRKLFGNKSINSLRGYILYGPPGNGKTLIARAIAGESNMNFISISGPELIGVYIGHGAH
AVRELFKIAKKYSPCIVFIDEIDAVAQKRSTANNSAYHCRESLTQLLTEIDGFKSRKDII
VIGATNLIGGIDPALIRPGRLGQKVYVPNPNIEVRQKILALYMRGTKTDEKLSLQDIADK
TEGYSGAELEQLVNEAKISAGAQRRLIVSEEDFSYALHRLSPEQERDRIRLVSNVKTPTE
VSYSI
>ELAGILAN_00304 hypothetical protein
MNLVNFGDILFLVFNKLKYVLDNFSERSNQAKIGKLDKIILSLKLV
>ELAGILAN_00305 hypothetical protein
MFKKLTSTWLKFSLKDKYRKTRISIAYCFSIYDKAVSILRLVTNLVKFKTFNNLPKI
>ELAGILAN_00306 hypothetical protein
MVGVIYLAMLGVAAIIGAIIGTLIGLLLSFTSLSPLIIGGTVGAIYVVPLIAAFITILLY
PIPYERHSGLTLKETACLAGLFIGSVAAGVGLVACGLTPIIKVDSLSTTVSSLLAMGATI
PVLLIATAIGVAIVIELAKQAKEYISGKIMQAEKEPVTDTHEEPGSKMEEAKEEKTARNK
QAVRECSKNSPQPG
>ELAGILAN_00307 Proline/betaine transporter
MLFIDLVNIISREFCCAKDVYNRILQLFGIAGLGAMVRPLGAFIFGHIGDRYGRRMALTI
AILLISIPSSLVAFIPSYSKIGITSTILLLAIHVTQGIALGAEQGGSSVYLIEHLPNKKK
LGMFFGIISFGRSIGILLSVIVVIICKKNTDFNAWGWRLPFTFSFVLGLISAYSVYTLGE
TPAYEENRKQRNLSDLPIIELIKRYKRALILAILISVPVNVVVGFTIFLRTIAKEIVSVE
TYVTTYVNEIVLIITSILMPVSSIALGMLADKVGKERTTILFTVITMVLCCPVLSTAYYY
KSYLIIMLGVMALSIIERGINPIGIVAAELFPTNVRFSGVSLSRNISYALHGGFTPMICT
WFTITFPQVNFAAGLYVVFCLLVSLVAILQIKPQDKKFDWS
>ELAGILAN_00308 hypothetical protein
MTTNTENNNRINIVREQAGNAVHSDIAYSERIQKSVENEALCDAWSNFEYFEDVLRIKNS
TDRENRIKQLIKEDLDINATKNGKTILDVAIEKKCSSKVISSLISNGSRIDTINASDRTV
LHRSVRNENRKVVELFLEANEKEVSQYLVARFLPLSMLYQKIEVNAKDNDGCTALDYAQY
GSEMYSLLQKYGAQHSEKFLYSRNLNIGELDLNKLVSDHNYCFDVLTKALEIEDRCEKEE
VIDWLLKNGANINVNKGDQALLSVAAEKGDVENAVLLLERGAHEGVNSQDAEGRTLLLNA
IIQDKLGHAKYLIKQRVNVNIPDNNGNSSLHYAVVNFIKQRLIECDETYTANATFYDFLK
NGADLYIKNHDNLTAFEYAFHARIAPREAVYLFKLYIERGDQSENMQLVKNFKLPSGETL
LEYFFNNKLFDSAQSCIDLGANVSHNGSSLLIQALQNRDIEGIGFLYETEQTFQITQTFQ
IIRKTVSCISK
>ELAGILAN_00309 hypothetical protein
MFSLGMGAAATFTLIKMSPLVLVIVAVTFFLTAIASMSLFVLYKKVKGERKHEGIVNNAV
FNISLEEAANDLFSGLSTIAERGAEAGALYLEVKEKTESVAKKMTSKKELIEARFQNIQE
NFINKLSNFEELQGARDSSTLKKFYAAVKDVLKIRSSIPISNLHLLSLVYHLSLEVSYAI
FQAITDPILGSTILTAISERKLPEDKQWAKVLKNTVPNLIRNQEVVRNVIVPTLTDILKS
LSESREERKFIIYTLVCLKEVIDEVYTTSVQESLYRILGVELANSLNGMVQAISNLLGCY
GHKEVERARTANELDYRVGKLTPEETQQFVINLGERVGSLREFEGRVTNKQSISKLIDYC
LDPKLNDREAAATLLNYILTCTEDGRYLAAEAGTNNNLSSNSNVVLITHVAANRSAQLD
>ELAGILAN_00310 tRNA-specific adenosine deaminase
MELAIEQAKLAQKNDEVPIGAVIVSGDNIISSAHNISSNPTAHAEMLAIRQAFSTSTLCD
TDMYVTLEPCPMCAQAISFARIKRLYFGAYNPKGGGIENGAKIFQFCSHIPEVYGGILET
ECSFLLKDFFEKLRT
>ELAGILAN_00311 CTP synthase
MKEAKFIFVTGGVVSSLGKGLVASSVGALLQAHGFKIRIRKLDPYLNIDPGTMNPTQHGE
VFVTEDGAETDLDLGHYERFTGIKATKDDNITTGKIYHELLKKERRGDYLGKTVQVIPHV
TDLIKSFIFNGTEGLDFVICEIGGTVGDIESQPFLEAIRQVNYTLGKQRVILIHLTLIPY
LTAAQELKTKPTQHSVRELNSAGLQPDIILCRSEKEIFDNQREKIAKLCNVSLSNVIPAP
DVSHIYELPVLYSQCGLDTQILEHFHLSKPKPSLTEWDQIVHSIRHPTQEVTVSIVGKYT
EFPDAYKSLVEALNHGAISNKVKVKINWVNSREKEEKPINEKLIGEKLQNSHAILVPGGF
GDDGVEGKILAINYARTNNIPFFGICLGMQLAIIEFARNVVKLEDAHSEEFRNCKHPIVK
LAGDQDDDLGGTMRLGAYKCNINANSKMMDAYSNTTISERHRHRYIINSDYKDDLEKNGL
LCSGISEDGTCIEAVELESHPWFIGVQFHPEFQSKPFSPHPLFVSFIEAAIDKK
>ELAGILAN_00312 hypothetical protein
MSVAVLSIFQIILVVVLVILVLLQPPGSSSLSGFSNTQQGVNSMIPVKSSENPLSRITAI
VAGLFIINTLLLSGLCSKDVHKKSIAEKIILEKKQESESTSVPFEN
>ELAGILAN_00313 Protein YrdA
MYHILKYKDYEPKIDESAFIAGGSHIIGKVEIGRDASIWFNCVIRGDVGSIKIGNGTNIQ
DGTVIHVDRNPGGDTIIGSMVTVGHFCVLHACTVHDKAFIGMGSTVMDHAVVEPEAMVAA
GSLVTHGKVIKSGEIWAGRPAKFFKKMSNEEIKHIAQSAQNYIMLMKEYKN
>ELAGILAN_00314 Chromosome partition protein Smc
MLSLKNGTIQVADDKIVLVIKKDDYEEFKKYKNVDKSGAIIDDTFYVGCTLNDQQLYITG
SYPQEELGDNTIMNVKSVGKKGGKYFSRLEEMKNLLGLNDRKEEIMVKALSCHPTVQLLE
EKNVKTTELEAAEEQLKGKNEELEAAKKKAEEELRIKTQELQDQLDTAQQEKQDLEAEVE
KLKAIDSTALQQQLEEKNAKITELEALDAVALQQKLTEKENKITALKAQPDAAVTKLEGE
KTTLTNKIKDLEAQLNNQPNAAQLKDKDEKIKDLEAQLSNRPDAAQLKDKEDKIKELEAK
INQPNAEVESLKKDLQARNARVHQLEKENKELEAKNKTTEQPKQGNGGRYTATVGMGLAA
GLIAFTALERTVRLDIWVMVGIAVVSTLAVGSITYAALPSTQVNGAEVQGVSGGKTRQLN
TVC
>ELAGILAN_00315 Valine--tRNA ligase
MLKEKYGFKEVEDKCNILWEGSKVYRWNGGKDNTFTIDTPPPTISGKLHIGHIFSYCHTD
FIARFQRMLGKDVFYPIGFDDNGLPTERLVEQTYKTRAKEVGREKFIEMCHEVIEKSKQE
FKELFKSVGISYDWDLEYHTISKETVTLSQMSFIDLYNKGYAYRKMQPILWDPVDKTAIA
QAEIEDKVFESSLNTIVFSTQENEQINIATTRPELLPACVAVFCHPEDARYTHLIGKTAV
VPITKEKVLIIADDKVKIDKGTGLVMCCTFGDELDIYWQQKHNLPMKIIIDQDGRMNLDD
VIPPHPGVMKVADTGIYDEINGLKVTAARKRMIEILSGKGLLIESTSISHSVKCAERSGA
PLEILPTYQWFIKTLEQKAQVLDKVKECNWHPATMRKRMEVWIEGLNWDWCISRQRYFGV
PFPAWYSKRKGEEGKIILAEVKDLPIDPLKDLPKGYSKEEVIPDQDVMDTWATSSITPQL
SALAVNSEFSLPNHRYDTIFPADLRSQSHEIIRTWAFYTILKAHYHANSLPWKNIMISGW
CLADDKKKMSKSKGNIITPHVILETYGADVVRYWAANSRLGVDTVYSENIFKIGQRLVTK
LWNASKFVSMFMEKHQTVSINSISETMDKWILSKLYKVIGRATNNLLQFEYCEALGAIEE
FFWKDFCDNYLELVKKRAYGSSEATLSAKQSLAYVLNVILRLFAPFLPYITEEIYHQLYS
YNSVHNQSNWPSKEELIYDKYSEEMGDNVIQILNIIRKIKADNNVSVKHLIKKLVIKADL
REDKLNQSARNDLQAVCNAEMIEWMQSELETENGKYIVNIDLY
>ELAGILAN_00316 hypothetical protein
MSVTITITLTYEGTIVGNLYNKTNAPYLIAGTLATLALLASGTLAVAPYVAFLSSIAAFN
VALPVALSLSILSTLILVLSCKMISRNKKLAAQGAELNEKTELAAEQENTIQSLEPQIKG
LNKKVSDLETKLDEISRQANGAATKDEVEELKAGLNGAAKDAVKKLIEDAAEELKKELEV
KIGNAATKDEVKKLIEDAVKEVEVKEELQMKFYEKGKKRYKTTFDDVILQNEKKQELKEI
YESQKESDAALKKGEG
>ELAGILAN_00317 ATP-dependent zinc metalloprotease FtsH
MYGLPGTGKTMIAKAIASETKDTSAFISVSGSSLFNIKNIDDLFKKAEENAPCIVFIDEI
EGFGKAYSSDDNVQYLKHFLTKIDGADHVKGVTVIAATNHIGILDKALVRGGRLGNHIEI
PTLGTDTRKKIINKYCQKENLQSIAHTILNNTSEGFSPANLISLLKEIEGCASKVRDKTK
TAAICRSFKRTHNIKKVSNKQTNRKIENSIGESQQYTSRPSHKLNDALCDSGYTSICSTL
INS
>ELAGILAN_00318 hypothetical protein
MGKPACCVSKGGSSSNTTSLPNQLAKTKGFEKRAQYYAAKAYSRQADKGDQYHDLKEIIF
IAIADCILFPDKSEYKSKHTIRDEDTNEHDLKDFYFIFIELPKFPKTKEDQLSSIVEKWV
YFFKYADETSEEELEKIIGSDLIIKKAYEELNRFNWSEKEFIAYEQEIKRILDEQAVLAQ
KLDDATAKGILIGHEKGRKEREIEVAKNLLKAGVSIDIIAQTTGLTANEIKDLSSLDV
>ELAGILAN_00319 hypothetical protein
MNIFVLDENPEIAAKMLCDKHIVKMLLETAQLLSNVFSIALKVPNPLVSITDQNIEVPYK
LTHKNHPCSLWARQSKGNFFWLIKYGRELCKEYTWRYKRKHRSEEVIDWCDSNKNLLVFQ
STDIKPFVQALPDQYKSSHSVKAYREYYLKEKMRFAKWEKGREVPDWLLSRIVRLKSRK
>ELAGILAN_00320 hypothetical protein
MTLTKCVLTSPLSSVQQYLLVLGKVMVVNTKSDQQRAEDDLYTVLRFKEKGDFERRIREL
LVNDYKKLKKPLSKLLGKLESKIRTDKENNQAARNVYDQIKKSKTNEDKLSNLLNFKKQL
KAFLKNQDDCSIVLNAIDSASVIPVIEVNGVHPKDSEIKKLKKAQPLTSNRQDFEEALGY
IESQEKVMGITLEEIMEYKQHSVKIFLLNRVHSCKNGHSQLHPDVKEAIAILSNDKLRAF
YDEEVKKKTLQPILSYKECEQLYDKINYEKNESRIIIEREELGENVRRVMGVKRFTNESS
REDQKNGTSPTGTSTNYRQEQVASSGDRTLYNSDIPSLGRSIKSSRSALFMPFGASVDTS
TPIKPANPSNLVTTGENYTSNADLSDELNVSEVTKIVERMELLSNSLKKIQEIVEKLGNT
TLSEEVIVHERHFKKFMDFVGEILVNIGTRLPQSDSKSMYLEQKLKGLEKMNESLNNSVQ
ELEKKVDKLEKENKDFLAENDELKEKLATAKEEKELLFNKKEKMQEVINGLNENNQRLMQ
KINGLEDDYEYLLRAEKTKRETEDSCIQVEDADIPEGKAELCKDYEIKLVKLEQEIDAKG
KQCEELLLENSILRGNIERLKEENKRLEGIEESFSIDPSHFCSVKNLHDELILANEQPEN
IDISIQDEMDSKVATESVGVNVKQGYSKRTSNLSRVSEQSSAVKSQFSEARAQSRKQIIY
ASASLILSGVFAVGTSLTMSHLGISISLALTALTFLTLGCYCSYKASTTLRNIELDRTFK
MADHEAVFMVPSL
>ELAGILAN_00321 hypothetical protein
MPIETKRQAEVLKKLQDVIKHTDRDIAAGRKLAIKRWVETYIEYIKLFKDDKLEFLYNVF
RDEGCWLGTRLNNTVLGQKLTEEKIGEIDNPLPRYGMASRYCITGKIGDFFNKQFVLSRG
QFTSEEVDSQGNPISDQYVRNILLSSMKRNGPVFDFWIDRESGELKKYDAVEGFDSAVKL
KWSEGVEYFYNQLEEKDKEKKLTEAIVALSRPQSVKKDAPILDFCVRNIGDKDTLLQKLL
QKDKGVYSLLAELIESCFFDTVHDLVQCWCYKGVSAGGDCSDKIFSQQDYELFLYSLSNV
MLKNPELSVQARSLIMEIWKCERFAEYRETSVNTSNYTVPIKSVLGGLIINWKREDVCKP
DRKIEKEEILDMISFAKGCFPEKFDLFKEVMIENLRICGREGKRKGVDYGKFAEELFLQL
EKVTLPSVGDGPWNNLRSQSKVSLPLDGSGDGPQSEFEAPSVSGISGSHKKRKI
>ELAGILAN_00322 hypothetical protein
MSLIRSLVDGDLDGFRQEFESFLDQCPFFLYHVSTGRFLPVFFFSMFATAHDANILKANE
RVYFRFDNHGIDTGGRNRNTGNLKVAVYRDGQQVVRCYSISDRLNSDGLRFSTRERNALV
REIRGQNPNLREEDLNFEQYKVCMHGKGKSQGEAIATVFEVIREKDSQGRDRFAKYSASE
ISLLRHIERNRLNGINAPAPRSLLTVKEIGSI
>ELAGILAN_00323 hypothetical protein
MEVLASNQRINIERGINEGILPYITRIYRSYLGSLQNDIQNRSQKFESHGFFLGLLANFI
HLYTIDIDLDLSPGNSYVAFLICHQAERENIPIVINVTRWRTSSDIALNRARADAKRLHA
SSFISIHTESRNAVCIGLNFNLNIDPFSIDTVEFLENRFPLVQRLFECLEDEGIRENIRD
FLLQHLPNEIPRNAENYNRIFDCITGFAFGNSILEEFRLVNAVQQRVRKYIFRYGDENHA
LTMVFHTQGSDIVILHIRDNNAVQQGAINLQDLNVDGNNVHVREVSCTLNNQLGLNIHTD
NLGLYHNYQNNNANNFLGGNLVQVPNAGNVHNALNQVMNDGWQDRFQHQELFRNISAVLM
PEDTHGNMIIDVNSKDKFRSILHGTFYASDNPYKVLAMYKVGQTYSLKRWQEEEGERVIL
TRVTEQRLGLLLLRQPTADTHPIGYVLGFADNAEEVEQEQDEARYKITELMSKQRGYLPI
TSGNEVVLSYAVFNRGAQRAEDFISLPQQAVYVHRLDRRGHDSRPEVLVGPESVIDENPP
ENLLSDQTRENFRRFYMEKRPGQNSIFLLDIDDNLHVPFSYLQGTRAQAIETLRSRIRGG
GTSTAQGILQQINTILRRNNAREIEDVHNLLALDFATENQNFRYWLQTHDMFFAARQYTF
HDDRSNPTNDRHDFAITSVGVDGNQNDPTGRDLLSSNIDNFKQKVDSGEKDRLTAIINVG
NRHWVTLVIVHQNGNYYGYYADSLGPDSRIDNNIRGALRECDISDDNVHDVSVHQQTDGH
NCGIWAYENARDINQAIDQALQGNSNFGEKGEGIIGYIRGLLSAGIGNDTRQPQRNEQYF
RNRRRNISQLFQNDSLSSPRGRLIQGRPGIQHEIDPLLLQFLELQYPQRGGGGALQLGGE
RVISIDFGPQSVLDEIDGVNRVYDHSNGRGSR
>ELAGILAN_00324 hypothetical protein
MDTGSVKYIAEPISEQSKHTDEQKLKCDLSAGQEFSEIGSPKTEATGLPVDSYYEFIKRD
LFSADRSLIDDKKYLEDLIDEWLIHAPNLGLEESQKKLNQKLLNSIIKDFNMGNYDSFSN
LKQFLESNEKNKDLKYVLNLKRGHLGTTILNVFLEYDEIIPSLLKAGADLNMQDNKGKTL
LHDTAIYSSGYEDLGYLLDAKADPNIQDEKGNTPLHYYAAKCSDQSRKTMDLLISKGADL
SIKNNDGKTPLQVAIDNDNIIGCLLTNSQKKLREQLGKMLLATSSDEDWDNAYDPEVENL
RKFLNQYENDNDLKIVLNVKDDSSVLLDSPSRQFPNVKALLLKAGAADFIGKKQDNYEKC
DSFLSEIYQINYLAKRNEFLSKVVKAKSMIELQEVVNEIIASGMRLNFAKDKDYYFADHV
LEKIAQIEGSYGIASDIVCTLISRGAKLKRSESLKVIDTIELKFKAHKANMISAHLEYVS
NAEEFFRIAKAATSGQLYDGKIDNNVFYLEYSEDSIIDVARITNRTRNLELIQESYRRDI
IKIGKSKVEIITENGIRYYTDLTEGSDIVLTFYTSLGNIDLRLYPDIQDKSKIIVEVSNR
EEILEKFKGREEELGNDCALGGYSVYNAIEQGYFERSRKLMRPEVISESNNKWTEREELR
RDSMEEIARRHKLLQDLRNIESNIVQKEKNFDIKTYLIDIFKTLSRFYEEKGDISKTDLA
KAAEKESKKLGLEGKYNWSKIFGLEEEIIEKVEKQGDKEQKSNIPDDFYLGHTINNGSCF
FDSFRQSLEQQKGIKVTVEQLRNECKRFAQDNPPEWFISKIGNDFDKVESELVNRGITCN
QYINSIGKNEFWGRSDIEGRVLCDKYGVKLHVAESNPLHTIDKQQDPFLHQLIDSSGSKA
GKIDYSHNSALHMVNGGHDHFQPLLYRNKALAKQTQEQKDSLCYSSLPSCSMDELKIEKA
NIRHCL
>ELAGILAN_00325 hypothetical protein
MLKEVRCAIYTRKSNEDGLEQKFNSLDAQRVVCEKYIKSREGWVALAKKYDDGGFSGSNL
NRPAIKELFEDVKVGEVDCVVVYTLDRLSRETKDCIEVTSFFRRHRISFVAVTQIFDNNT
PMGKFVQTVLSGAAQLEREMIVERVKNKIATSKEQGLWMGGTLPLGYDVKDKELIINEKE
AKTVKHIFERYVELKSMAELARELNREGYRTKAKSDIFKKATVRRIITNPIYMGKIRHYD
KQYEGKHEAIIEEEKWQKAQELIRNQPYKKAKYEEALLRGIIKCKSCDVNMTLTYAKKEN
KRYRYYVCNNHLRGKNCESVNRTIVAGEVEKEVMRKTEQLYENWKEKTEEEWKNLSFGKQ
KEVVKKLIKGVMVKGDGIEVSSEDKIEFIPIKKKGNKCVVMEPEGKTNNALLKAVVRAHL
WKRQLEEGKYGSIKELSAKINIGARRIQQILRLNYLAPKIKEDIVNGRQPRGLKLVDLKE
IPMLWSEQREKFYGLDL
>ELAGILAN_00326 hypothetical protein
MNLLVSGQPLILERGEETHAVMVTDKGLIYKEEFYTSLSAVAGKIMGMSYNGPLLFGMRD
KEKEC
>ELAGILAN_00327 hypothetical protein
MAQTSKESVEKKFKDVFERSPGAFPEGTSLEKKVNYIAKGTKALKAVKSKELENKMKNVA
ELSQKFESQKGRADEKVRQDFERIAELDQQYKGKGIFTSEKVAEPKSDKKLQDTPRKTTT
AVKDLEHNTQKKTTEASVQTASEHDSQTVNPSVSKSSVKEKLNTEPDKKDNTPQPQENQK
EEGFLSLLKRFVKKILEKFLGEGEKDVENARGMKEDAQRDTSNNEEQQKSKQLDEILKDK
SVSEGLKQATKLENPAITPVNTPKVNEVNTGRER
>ELAGILAN_00328 Phosphoglycolate phosphatase
MKDSSLAVVFDWDNTLVDTQDNIFNAIKHTINSMGYSNKAADRNSHESRKSYMVSLFGDQ
WKKANQIYQQYLDNALLQNIALNQGVEEMLQTLKSHNVYLAIVSNKKNTNLRKEVAYFKL
DSYFERVVGSCDTAEDKPSATPLLFALEESTLPINRENVFFVGDSITDVLCAQNANCLPI
IYGQSISGYEDLLCFQHFDKLTDFIIKYLEDR
>ELAGILAN_00329 hypothetical protein
MTEIASIKRRFCAYLVDVAILLIPTLLIILLLEDSPLILHLSYMCVICSYFTYFISSKAQ
ATPGQQLLNIYTINLDNSKIDLNLAFDRSTSQFFLPLLNSVAVILTEFLQDQEVLVNVLS
ALKVMIVLLTLYWYLVACFSKKKQTYHDMLFNTVVIKGTIK
>ELAGILAN_00330 Bacterioferritin
MNEEIVKHLNKLLTNELTSVRQYLLHFAILKNNGINRLAEKVKNELNEELEHANKLAERI
LLFKGVPNFQDTNEISKHDGKFTKDTIRKILEANLKLEGKGIKDIKETISIAEKEKDFVS
VMLLEEMLKNEEEHFHWIEKQIDLIELMGVENYLRTQI
>ELAGILAN_00331 hypothetical protein
MSLPVVHLLPNNDLEKFNYRHVKIDGILSDIELYVFAGQHGYHVLSPMLLTTGNYMLVNK
GIVKEKKEERAKIEKVAAGGVLYCNSSKSKNWFIKNDTASNTWFTLSTEEISNELGIKLE
KCILWPNNFGSKLAIQPMKHLEYAITWFALSLTWLIMCIIYHRQNLNKA
>ELAGILAN_00332 Glutathione-regulated potassium-efflux system protein KefC
MHSGSQHLFDIIILLSAAVFIVIAFWKMNISPVLGYFVAGAVIGSHGFNLIHSAEAMDNL
AEFGVVFLLFIIGLELTFERLIAMRIHVFGFGSLQVIVTMVAIWCIALAFGVNTNIATVI
GGGLALSSTAIVLQVLQEKGSQASQVGRLSIAVLLMQDFAVVPLIVLVPLLTGNSEHSLI
SSLAGSLVQAAIALVLIFITGRLLLRPLFSVIAKMESNEIFISTTLLIVLGAAFITEQFH
LSLALGAFVAGLLVAETEYRHSVEHAVLPFKDLFLGLFFMTVGMSINTELLLNKLPLITL
LSIILIVLKTSIIYILCRFFGFKSAPAIQAGLLLSQGGEFAFILFRLADELNVLPSEIAQ
VLMMVTTVTMAFTPLLSGLGDWIANSFSTEKTILDDEAVETDTQDLYNHVIVAGFGRVGY
MVTKMLTAEHLSYVVVDIQSKIVKEGKSDSFPIYLGDVTRCEILKSVGIERAQALVISIK
NEVTIKKVVSLVAANFPHVNIVIRLPDLSNVEVYRDLGASKIIPETSEIGLQLGGAALSL
SGISESGVTSLKSRFRKGNYSMLKDLGSDKDE
>ELAGILAN_00333 hypothetical protein
MVALNTPKVDFSFTAKDFNLLGVDNKYYTLSDCCGKNGLIVMFICNHCPYVQSIISNLVS
DVDQLKKDYQVNTIAIMPNDVNEYPEDSFENMINFAKENKFTFPYLIDSTQKIAKEYGAV
CTPDFFGFNSNLNLCYRGRFNDAKKEKVQSYEVGSSDLFQAMKFIAETGNSPIDQKSSIG
CSIKWSNSTG
>ELAGILAN_00334 Thymidylate kinase
MYTVCIFFFSIIIIKLMFITFEGIDGSGKTTQSKLLANHFKQIHGENNVVLTREPGGTNF
AEKIRGVLLTNNIDPISELLLLISMRREHMKKLILPALAEGKIVICDRFIDSTIAYQGYG
LSVDLGLIRDLHKLVEIKCPDITFILDIDVKVGLNRAKDKNKYEEMDVNFYNKVRKGFQE
IAIKEPVRCSVITGIETKNDNHVHNEIIDKIT
>ELAGILAN_00335 hypothetical protein
MIDIASIGVSTVIDQNYRRKAQLCLSGLFVTVSIATVTWFIFPASQNVLAPFLLPAMFLL
FTLSMGYYMFIFSCEEKSLVKNVLGMVEPAESVKRVHCQENIKSLLAEVRSTTKDRFRNV
LVNLCFEDRSKAHKLALYVKEIDNIVSSIKNKDLLDHFDQFFTITEVSNKKNRSELMNLA
RAYKMISEEDPDKIQDFLATQTKSYSYEIMLPEIDNFLSQAR
>ELAGILAN_00336 ATP-dependent zinc metalloprotease FtsH
MKKFLEGLLIWLVIIVLISVAYIQFSGNVGKSKTIIPFSEFLTRLEDNDVENIVIKNQSI
EGKFRDGSSFNSSGVIYSDLIKNLHDRKVRFSFSTGDSAMNVIGGLLISWVPTFIFIGFL
LFFLKQTQAGGNRTISFGKSRARLMTSGKKVTFDDVAGIDEAKEELVEIVDFLKQRQKFQ
ILGGKIPKGCLLIGSPGTGKTLLARAIAGEANVPFFSISGSDFVEMFVGVDASRVRDMFD
QGKKNAPCIIFIDEIDAVGRHRGIGLGGGNDEREQTLNQLLVEMDGFESNEGVIIIAATN
RPDVLDPALLRPGRFDRQITISLPDINGREKILNTHIKKISIAPDVNVKTVARGTPGFSG
ADLANLVNESALIAARRNKKIVTMDDFEYARDKVMMGVERRSLIMTEEEKRLTAYHEAGH
AMIAVNMPASDPIHKATIIPRGRALGLVMRLPETDRVSLTREKMLADITVAMGGRVAEEL
IFGYDKVTSGASSDIKQASDLSRAMVTKWGMSDKIGPIYHNREQTIHGSEIISEDTLKLI
DEEVKKVVSSCYEKAKDILTKHKKGLDLIAENLLEFETLTGDEIKDILNGKKIVREENEK
NEKIKKSSLYES
>ELAGILAN_00337 tRNA(Ile)-lysidine synthase
MELELLFQNVVNSFAFYNNQVAVAVSGGVDSIVLLHLMTNWAKKNKLSLPTALTVNHGLR
PESQKEADFVVSYAKELGAKESFILNWEKQNIKGNIQLQARKARYKLLAEWCKNNNVKYL
LVAHHKDDQAETFLLRLERGSGVDGLSSMDYKSFLNGIYIFRPLLNFSRSEIEKYAKLHR
LKWIEDRSNYDLKYRRTLYRNLLKASDNQEILTERICLTALHMKRAAKALMHYTRLAFND
CVNVHDLGYIEIKLSEFYQLPEEIALRLLLYSIMAIASKHYKPRYNSLIVIFNKILQKDS
NVNCTLSGCKIRKHGENILIIRESSKIQEITLNLPLNEPTQWDNRFSCTILGNQECSVII
APLKKTQKVPEFLKDYNCCPEVFYSLPVVLKDGKVLAYPDVNYNGKNTNDDKVQCIINST
IKQNLVSLISI
>ELAGILAN_00338 hypothetical protein
MWSRLVIMCCFCLLLTGVSSCPKKGANTTNKINSVVKQIGNKRVFFGYDESSIAEVSADA
LLDVMEVLQDNPDAKVTLTGHTDNRGSHEYNLALGARRADAAKKFMVSCTPYIENRIKTA
SKGETEPLVNVKDDSRNSKYEKEHAKNRRVEFSFSGIKK
>ELAGILAN_00339 Thermostable carboxypeptidase 1
MQSYKFLEEVLYRVKNIENTLKVLNQSQLNIEDKVEQMSLLEEIRHEIISHDAIKESLAD
ALGNKKSANTQQLKLIERIHKSNSAVPIDLVKSLSKAKVECQDLWKLSHSETSNLEKLKE
RFTDLITLIREVASIKSQQLKCSKYDSLLADYDSDITEKNIREVFPKVGKFFSENVDKII
EKQKKDKVTNIQKVATQKQIELGSLCLQQMGIALNEIRTSYYYPIDYDESDFCYGLFSLL
RHSGYAIYQKCLAQNSISSPITRHVMYETQGLFMERMIGTSREFIEFIQPHIKEKFAIKG
KTNEKVSSVENLYLIFNEINLSSFLKNADEFSLLAHIMLRTRLEQDIINGTLEVKDLHDA
WLEGMKHYKIPVKAENELNTYFQDEYWASGVMGYFPIKIIALIAAVQIFSFVKKNHYESL
SAIIKGDFSLLISWLSQNVYSAKCGLELLKKVTGKGLDVECVTYYLSEKYNLS
>ELAGILAN_00340 Rod shape-determining protein MreB
MNFVRKLTGKFYSLFTFKGLFASDIAIDLGTANTLVYQKNQGIVLDEPSVVARIKEKGSY
VPYAFGKKAKMMLGKTPGEIEAIRPLKDGVIADFKSAEEMLKYFIRSANTKFTVNKPNII
ICVPSGSTPVERRAIQDAAESAGANEVFLIEEPMAAAIGAGLPVTEPEGSMIVDIGGGTT
EVAIISLGGIVYSRSARVGGDIMDEAIKSYIRENHKLLIGETTAEKIKKSIGSASLPGEN
NKEGMIIKGRDLVSGMPKEMLLSEYQVAESLIEPVHQIISAIKTALESTPPELSSDIVDR
GIVLSGGGGLLRNLGKVISETTKLPVRVADDPLCCVALGSGKVLENMDYFGHVLFKQD
>ELAGILAN_00341 tRNA-specific 2-thiouridylase MnmA
MLKEFEIEPLLKDKAPHQIKAIVAMSGGVDSSVAAALLHNLGYQVIGVTLQLYGTDGNAN
ARKGACCAGQDIYDAKRVAESVGFPHYILNYEEIFKKEVIEDFASTYMRGETPIPCVRCN
QTVKFRDLLQVTKNLGADVLVTGHYVRRLEKNGEVKLCRSIDKSKDQSYFLFATTQEQLK
LLRFPLGGFYKSDIRKLAKYFSLQISEKPDSQDICFVSESYSKTIAKLAPQSVQKGKIVD
VNGKVLGEHSGIVNFTVGQRKGLGIAHNEPLYVIKINTENNEVIVGPINVLMQKKILIKE
LNWLEQPKEGMEVTVKLRSSHAGSLATIHSTDEKNKACVILNDDYFGISPGQACVAYKGE
QVIGGGWICS
>ELAGILAN_00342 hypothetical protein
MLNIQDNAPLCRKWMFLAVCALACSGLLSIIVIFLRLPFISSLVPSAQYIFDNALVIHVN
LSILVWMCSIISLLFIINLQNTNSWFNFSWVLSTLSMLLIFISAFVPNTEVIKSNYIPVL
QNKLFLLGLSLFIASILVNTMLAYTSKKEVSFLSVGQIGLVIILVSSFLCFVLAYNNMPP
GLYHSDNNLFYEYLFWGGGHLLQFAFTQGMFLVYLMISDVSLASSNKITILPLFINTILA
VGAPFVYFVYPVDSAKLIQFFTWHMRIAGAVLPCFLIILVCCNIRTFINDKSNYLLHSFL
LFTYGDVLGVLTIEGNVTIPAHYHGSVVGITIAFMNFVYWLLPKLNFKEIKSSMVRLQIY
AYSIGHFLHITGLVWLGGYGALRKVADLPSISSMLARTCFIIGGAISVVGGMLFVIIVLL
HLLKGKARTN
>ELAGILAN_00343 hypothetical protein
MFYLTNFLPILLFLFLFVGSGIYFTILGVSNAFYQLSPLVAIVPAIALGWVLYKGNTEEK
MYAFLDGVRDRNIITMCIIFLLAGAFSEVTKAIGSADATVNLALSFIPTQFLLIGLFFVA
AFISTAIGTSMGTIATIAPIAVELTQAGISPSLGVATVVGGAMFGDNLSIISDTTIASVM
SQKADIKKKLKLNAKVALIASIFTIIILFYSSSNSAAISVKEYSLLLVAPYIILILLANF
GINVFTALVLSITFAGIIGFINNNNYGLLFLSQNITKGFMSMHEIMLLSLMVGGLSGLVG
KNSKEFADKLSSWVMIQRGGQKTAQLFIAKIVSIFDILLANNTIAIIFSGEIARDIAKKY
EIPPHYSAAWLGIFSCVFQGLIPYGAQLLLASTIAGVSPLAVVPHVYYCYVLGIIAVLYI
VLNKIEKKDCA
>ELAGILAN_00344 hypothetical protein
MNDITTKQVISLWDAQVGGFLPDRKEGEEIECSNESSAT
>ELAGILAN_00345 Putative multidrug export ATP-binding/permease protein
MNHQLPKTLYSFIWHFLKPYKLSVSIFVSLAIFAGFWGPLNSILIKNIINLLPHVQNGDI
SILILPSSLIVVNFIVFDNFTWRGIGYIRCRFIPVVINSVIGKVMDHVLGKSNKFYQDNL
SGKISRQITNLADGIEILISRVAPNFLRGASLLLAAFIAAYSVNSIFYFILVVWFIFFAS
ASIMMSRKLISLSDVQAKEESIVIGELVDSLSNQSNVRNFSRKSYENSRMIPFLCNQQKA
YTATHFYSFIMHSIQGGLIAIMMASSACFLIYLYSKNLVAIGDFALILGLSMETGHMMWF
TMSEVDEFNKAVGRCKQSLISLMIHCEIQDKLDAVSLKCNSGQITFNNVKFHYDGTEPLF
QNKSIAIKAGQKEGLVGYSGGGKSTFVNLILRLYDVTDGAILIDDQDICNVTQDSLRAKI
AMIPQDPSLFHRTLMENIRYGKTNASDDEVIEAAKKAHVHEFISKFPQGYDSLVGERGVK
LSGGQRQRIAIARAILKNAPILILDEATSQLDSVTESNIQESLWELMQDKTTIVIAHRLS
TLLHMDRILVFDQGKILEDGTHQELLDKNGMYKTLWNAQVGGFLPDKKEVEIV
>ELAGILAN_00346 Lon protease
MNIERAVSSSFTALPVLPLRDVVIFPNIMVPLFIGREKSVNALEYAISSSNHQNEIFLVA
QKDGSVDNPEPEDLYEVGVLASIVQPLIKLPDNAVKVIIRGIRRGRVVEYISSHTLLQAR
VELDNYYKEDEDNIDLEALRRSVVDAFDSWCKLNKKNQPEVAINSIDQIKEVDQLVDTVA
SHLNIKVSDKQSILEAYDPEERLKKAFAFIEREMSILNAQNRLYKTIKSQVESTQKVYYL
NEQLKAIQKELGEFENGDEGNILNEFEKKINETKLSQEAREKAITDLKRYKKMNPISPEA
TVISSYLHWLLELPWGKYKDAKINLNAAKKILDENHYGIEKVKDRIIEFLAVLKRVKEIK
GPILCLVGPPGVGKTSLAKSMARAVGRDFVRIALGGVRDESEIRGHRKTYIGSMPGKIIQ
HMKKANSCNPLFLLDEIDKMGSDSRGDPASALLEVLDTEHNKHFTDHYLEVEFDLSSVMF
VATANSLNLPHPLRDRMEIIQLSGYTEDEKISIATHHLIPKLKKEHGLYQKEWDITNEAL
YELIRLYTRESGVRSMERELAKLMRKAVKEILTDKNKKISVGVDNLQDYLGVRKYTFGIA
ENESLVGIVTGLAYTETGGDILMIESVLIPGKGEIKYTGKLGEVMQESIKAAYSYIRSNC
LFFGIKPEKFQNNDIHLHVPEGAVPKDGPSAGGAVCTSIVSLMTNIPVNKNVAMTGEVTL
RGRVLAIGGLREKLLAALRGSIKTVIIPSENEKDMQEIPASIKEGINVVFAKNIDEVMKV
ALMHPTTPIDGDDNQNSVPSSIENKDDTFPMSETLKH
>ELAGILAN_00347 ATP-dependent Clp protease ATP-binding subunit ClpX
MDNNNDLHYCSFCNKAQDEVDKLITNSSDGLKVFICNECIELSHKAISQKKDRSFNSDRI
SDMKLLLKKPEDIKNFLSKHVVGQEHAQHVLSVAMYNHCQSMVQFHAISDIEIEKSNIML
IGPTGSGKTLLAKTLAKVSDVPFAMADATTLTEAGYVGDDVESVLSRLLQAANYDVVKAQ
RGIVFIDEIDKITRKSESTSITRDVSGEGVQQALLKIMEGTVAYVPPQGGRKHPQQEFIQ
VDTSNILFICGGAFEGLDKIIEARKKGTSVGFGADISQSKEQKKKNALHDVQPEDLIKFG
LIPEFVGRVPITAVLDELDHEDLIHVLTEPRNALIKQYKALLAFSKVNLEFSDEAISAIA
KKAISYKTGARMLRAILESLLLDIMYTSGNGGFEGSTIVITKKMVELGKATVNHNNNGNV
ITVND
>ELAGILAN_00348 ATP-dependent Clp protease proteolytic subunit
MTLIPIVVEQTSRGERAYDIYSRLVKERIIFVTGPIEDNMASVIVAQLLFLESENPDKDI
CMYINSPGGVVTAGLSIYDTMQYINPDVSTLCIGQAASMGSLLLAAGTKGKRYSLPHSRI
MIHQPSGGYHGQATDIEIHANEILRVKKKLNQIYEKHTGNSLKKIEGMMERDKFMDPEEA
RKIGLIDRVIAERTDIEIENIKVKQKVG
>ELAGILAN_00349 Trigger factor
MMSNNIPQNTVEVSSVYTYKELSIDKLKYEYEITVGSDYIKQKVNSRLQEIAENAKSPGF
RAGKMPYDLVVANYKNEALEYVINNTIDYCSSDLMKKIEVKSHIYPKVDVISLPDLGKEN
EEGNFVYKLSFESMPEVPMIDLDKINLKKIEAKIEEEDIKEFIDSIKTKFPNFASVDDAS
YQAKDGDKLIIDFEGRIRNKLFQGGSSKNFAVNLGSGTFINGFEDQLTGMKKGETKNFKL
KFPENYQAISLAGQEADFSVRVNEIQIAKDFENDDEIAKSIGFKDYSLLINHAKKMIGDQ
CTEMRNLLIKKELFDYLDANYSFDLPTDIVKQEQQRMEGELGAQNDSRKEAEKRVKLAML
FMKFSAEHKISLTQNDVLSVIVNQYVSKDVQFDRVLKHFESNKQFQELVRGQALEYKVTD
YIIEKVSKEEQIISVKELKELFDNI
>ELAGILAN_00351 hypothetical protein
MRLITSFLLAIFLITQSGCTTLIIGGVVATATATAITMQDKSLGNIIDDTTMVIRINKGL
LKHGLFSSIKVKVSEGRVLLIGSVDTPEKQLTAEKIAWQQKEIKEVINEIRVIPIQMASM
LDTTVDGMITAEIRTRLLGKRNIKSINYSVNTVDRVVYLMGIAQNKAELKAVIAIARKVK
GVKQVVSYVRYRYSKLRH
>ELAGILAN_00352 Glutathione synthetase
MKVAFQMDENINFETDTTFVLIKEAQRRKHEVFVYAPNNLALKLNHPIALAQKVSVDDFS
FISKEDVAINLNEMDIIFIRQDPPFDMRYITTTYILEKTSALVINNPTEIRNCPEKLITS
LFPELIPPTLITENISMIRDFYYNYQDIILKPLYSYGGNDVIRIQDENSIQVVVDLMIAK
YECPVIAQSFCKNIDKDKRILLLYGQPIGVMKRIPKISGEIRTNMRLGASFEPAQMNDRN
NEICNKIGPELKKRGLIFVGIDIIDDFLLEINTTSPTGVVYINKLYNISLEKDLWDVFEE
KASSHQLNL
>ELAGILAN_00353 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MDIILATGGTGGHIFPAIALAKALKTQGYNCILFTDKKTNKNTDIESYTLPLRRPSSNKF
KFFLFLIYSSMLALYQVRKLKPKSVIGFGSYASFPTLLAARVLSIPIILHEQNTVLGRVN
RFFFKSAKLIATSFPETKYAEGNKCIFTGNFVDIKAQSHSSTEKILNILVIAGSQGANFF
DDVVSSVICDLPIKMKKKIRVTQQCTKKNVNKVKSLYKSEKIDCELSEFFDDMENRLANA
HLVISRAGATSIAEITLARRSAIYIPYPYSKDNHQFYNAKYIEDSRAAIIVKQNSEAKKN
LTEVLFDLLNNSQKLRDMTNSTEKTGIKNGTTEFVKVIVHRFS
>ELAGILAN_00354 hypothetical protein
MIVELKMPKSNSKKEPNEKNKPQEQREGRSGGFLELLKNIIKILFNSVVDLPEHEQHNKM
KSTNLQQGLDTKGKGPEDLHPKAKLEVKEAAKGLKEELQNSDAGGNQSIETKVPNQTTTQ
DIDNSKTMER
>ELAGILAN_00355 Dihydrolipoyl dehydrogenase
MNEYDITVIGSGPGGYIAAIRAAQLGFKTAIVEKEKNLGGICLNWGCIPTKSLLRASEVY
RLIKRSKEFGIEVKGANFDIQSIVKYSRNVVDKLSSGVAYLMKKNNIKVHQGFGKLAGNG
TIKVAGDKEEQEIVSKHIILATGVRARNLPGIEADGDLIWNAQHAMTPERLPKSLLIIGS
GAIGIEFASFYSTLGVDVTIIEIKSTILPLEDKDISDLAQEIFTKQGIEIYTSSSVKALT
KSKDSAQVLLSSGESKEFERVIVAVGIQANIENIGLENTKIKLSPSGFIETNEWYETSES
NVYAIGDVAGPPCLAHKASHEAVICIEKIAGKNAHALKKECIPNCTYSHPQIASIGLTEE
QAIKGGYDIKIGKFHSNFNGKSVALSETEGLVKTIIDKKTGEILGSHMIGAEVTELISNF
ALVKQLEGTDFDIKSTIFPHPTISEMIHESVLAADVK
>ELAGILAN_00356 tRNA N6-adenosine threonylcarbamoyltransferase
MKTILAVETSCDETAVAIVNSDKQVLAHEILSQAEHKKRGGVIPEIASRAHMEHLSGLIK
SAVEKSNLNFCDLNAIAATSGPGLIGGLIVGTMMAKAIAHVAQKPFIAVNHLEAHALVIR
LLHEVKFPFLVLLISGGHCQFLIAQDVGKYIKLGETLDDSLGEAFDKVAKMLGLSYPGGP
LIEKLAKKGNGARFKLPRAMIKRYGCNFSFSGIKTAVKNLVQELKMSEQDVCDVCASFQE
CISDILLDRVSNAIIMAESLNIKINDFVITGGVAANNFLREKLKQHINLNIFFPPNDLCT
DNAIMVGWTGIERLQKNYIDPLNFAPRPKWELESY
>ELAGILAN_00357 hypothetical protein
MLIRNLIKQATQVGSSENAIRYVEYLYQFEKFRNTLNLTLSLIKQNRLSFEIYQEGLVDM
EEGVCKTIRSSSVNRYVIVLRKSNPYIIVHELSHMVENELNLNLEQEFLHKVYQDIEQNL
KQANILVQKIIGQVIFKEIQAYQTAKSRASELFARYFELFAWAQEVYPKDKEYLIRTQDL
NKVFLATGQWKKSYLDSQMMERIDKEIKEYSNKTATKDVTKVQSSWTNKFSPGGKKISSI
FGDDD
>ELAGILAN_00358 Cysteine desulfurase IscS
MSPFSLENSGCVYADYNATAPISENVKKSIFEVLLKQTLNPSSLHKRGQEARKILQDARD
NVRGAIGVSSDKEIVFTSGATEANNLVMRGIAGYLHVISAIEHPSILNSACNPYIIPVNQ
EGIVDFLELEKILSELKGNKAIVSVMMANNETGVIQPIEEIAEIAHKFGAICHTDTAQSV
GKIKVNMEDLGVDLLTLSAHKFGGVAGSGVLIFNKELAIEPIIIGGGQEKGFRGGTENIV
AIAGLSAALQNIPDLLSKMDEVKELRDQLECELLNFASDIRIFGKNSKRLPNTSFIYMPG
VKSDVQLMHFDLNYIAVSNGSACSSGKVEPSHVLLAMGATKEQAECSIRISIGPETKPQD
IKKIVDCWYNIYKQNTLV
>ELAGILAN_00359 hypothetical protein
MVEVFLNNATRKIEGEYHQSKDANAPVVLVLHHHPQYGGHMDSKIVHSTYTSFIDNNFSA
LKINFRGVGKSTGTFDKGIGELTDAAVAIDWLQEHNPSNVPIWIAGFSFGAWVAMQLTMR
RPEIVGFIALSLPVTKYDFSFLSPCPVSGLIIQSSNDTISEESDVTELAKRLINSVRSDH
MKYHIIDDTNHFLKDKEEEVTQIVDNYIKLRLNSATISSQKVKKEVRVKEYA
>ELAGILAN_00360 hypothetical protein
MFKKLLFFVLAVFMLSGCSLSKQRKLKSPCIKSNESISCELYSVNDHWLDKYKA
>ELAGILAN_00361 Lipoprotein-releasing system ATP-binding protein LolD
MGGNVALELTSVDKSFKNNSAVVKDINLSVTRGQVVALIGDSGAGKTTILQIAGLLDKPT
SGIVTIDGINCTQASNKHKTHVRRNFLSFVYQFHYLLQELSVLENIMLPQLIAGKSKAEA
KKNSQAMLEKFGLENKASSMVSEVSGGERQRVAIARSIVNSPKLLLADEPTGNLDPTNSF
KVFLLLHSYVKENNSSMLIVTHNHLLAEKADCIFQLRDRSLVKL
>ELAGILAN_00362 Iron-sulfur cluster insertion protein ErpA
MSTNYNINLTDNALKKIHSLAEQEGDKSSILRVAVSGGGCSGFKYNFLMDQMNKNLSLDD
EDDDYDDEFDDEDEDDDYDYEESEDYRSHSSFSEKGKDIVINDENGNPVLMVDNCSAKFL
NNSVIDYTEDLSGSGFQIKNAFAKSQCGCGNSFSV
>ELAGILAN_00363 Deoxyguanosinetriphosphate triphosphohydrolase-like protein
MSNNNFLLNYACFPSKTKGRYFKEPEDENRSCFQRDRDRIIHSNAFRKLEYKTQVFINYE
HDYYRTRLTHSLEVAQIARSIARRLGLNEDITECIALAHDLGHPPFGHAGEDALKKSVQD
LNLDNEKYEFDHNVQAIRILTYLEQKHADFDGMNLSWEVIEGVAKHNGPLLGQNAESSTS
NQLLLEYNKKYDLKLEEFSSIEAQVASIADDIAYSVHDLDDALRANLVTIEDLLNVPLIE
KMFKDIRSRYSELPQSKLIHESLSGTIGTMISDVVSQTERNIEDHKIKSVEDVRSLNKML
VTFSPEVASATKEMKRFNMEKIYRSYKLSRTMNKAKRIIQELFQCFYENPGLLPTEWSKL
ACESQRSVIICDYISGMTDRFAIHEHRRIFDTSYEMTSF
>ELAGILAN_00364 Riboflavin biosynthesis protein RibD
MTDDHFMSIALRLAEKNLGNVAPNPAVGGVIVKDGTIVSEGYTGIGGRPHAEVVALQNAK
DSTHGATIYITLEPCCHHGVTGPCTAKIIKASIKRVVIATIDPDSRVSGRGMKALKEAGI
EVEQGIMQKEAKELNVGFFTTKELHRPFIACKVATTLDGKIATFTGDSKWITSENTRNWV
HELRTKYDAIMIGSNTLINDDPLLTCRLPGLGSRSPIRLIIDSQGRLKEEHNIAKTADKV
ITWVITNKEVEKKIKNINYLVVNSSNAGKVCLKDMALKLVSEIGITRLLVEGGGVLITEL
LKCNLIDRLIICRSGKILGNDATPFVGDLGIQFINNCYQFKKTKIIEFSEDIVEVWDRSS
>ELAGILAN_00365 hypothetical protein
MSDLLASLLKLCESFKIEIEQLKAEIKRLEIENENFRSENKALRIENAELKERLGLNSQN
SSIPSSKELYKLKKKKKKSDRKIGAQIGHEGKYRPKMEADEVVKIEFLRVRRRNCDIERA
IHSSKS
>ELAGILAN_00366 IS66 family transposase ISWen3
MEYQLQNGRCCKCGKRKSSRLPEGVTADTFGPKVKSTIAALSGFYKNSKREVANIIKNIF
NLDISVGSVSNSEARVAEKCQEAYEQIEQEVSKSEVLHIDETSHYNKGKLGWCWMFASNT
ASFIKLTESRGMKVLQNSKFCNRNSLRQVRSIQLLCR
>ELAGILAN_00367 Ribulose-phosphate 3-epimerase
MSIKIAPSILSADFAKLGEEVRKISDLGVDYIHIDVMDGNFVPNITIGPSVVSAIRKYSN
LPFDVHLMVTSPGNHIESFINAGADIITVHAEAEIHLERLIRKIKSYKNVNDEKKPIQVG
VSIVPSTSPSVLEYIIHELDIVLIMTVNPGFGGQEFIHSQLNKISTIKKMIQERNLKTQI
SVDGGINFSNAADIIKAGADILVAGSAIFKAEDIKKAVNDLKNLLL
>ELAGILAN_00368 hypothetical protein
MKIQCYNCTKTYLVSPKQIGASGRKVKCTHCNHIWHEYLEEVSNKSHSANIQEKKVSGRN
FLQNLAFTTLAFATATGLCIVIANGIFPREMNKAYKTISSYKDSISYKLGYKKEQTESPN
VKKLAVNKFYQDYLFLSNLRSS
>ELAGILAN_00369 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MEGLQLKKTQSEIKDIWKNREKFNDCNLKKTARIAIKEVIELLDSGKIRVAEKLSSGEWV
VHKWIKQAILLHFLTEENKIIDNTNCWFDKIGNKFSEWNEEKFRRLKIRAVPGCFVRRSA
YIGTNVVLMPSFINVGAYVDSGTMIDTWSTIGSCAQIGKNCHISGGVGIGGVLEPIQASP
VIIEDNCFIGARSEVAEGVVVREGSVLGIGVFIGASTKIIDRETSKVFYGEVPPYSVVVP
GSIPSKNNISTYCAVIVKKVDEKTRSKISINEILRD
>ELAGILAN_00370 hypothetical protein
MAESIKKFTVQCDFKGQSSPFAIYIGNPKSDAHPIHHQDSWLVKERGGNIPNKVKESLQK
LYKLSQENGVSFSELCAYAITVVSNNDKKSDDKQ
>ELAGILAN_00371 hypothetical protein
MDDKNTDYVALIPQDDSIEYKFEEAVNFIENKVINADGLTLAEVFQVLVQMLNGDLELVK
KVLACANIMAKHGMKVAKESQLSRADVRRALEGRESVVNRQDFIKKPPLPPAIKSTKKKS
RGL
>ELAGILAN_00372 hypothetical protein
MLTYIHELIDKSQGSISISDFMNAVLYHEKYGYYTSKLPLGKDGDFTTAPEISQLFGEVI
AVWIMHTWEKLGKPSKFSLVELGPGKGTLIHDIIRVTKKYSSFFNSMLIHLVEISPTLRK
IQKEKLKSLNVNWHKNIDNLPEQPTIFLANEFFDALPIDQFVYHDEGWYENMVTKQDDGS
LLVSCQCVTLESRKKESWIPVSATQMTNGKFFNGAVVEICSVGVEILKKLEKKIYNNKGA
ALIVDYGYVYPAYKSTLQSIKQHKYANFLENVGNSDITALVNFQALRDSLKHVDCEILTQ
REFLYLFGIKERTQALMKSASDEQKNRIFSEFLRLTENMGTLFKAMLLI
>ELAGILAN_00373 Recombination protein RecR
MNINIKNLVHAFSKLPSLGPSSSRRLVIHLLQNKEKVMLPLASLIKELADLIIECEVCGN
LDTKSPCSICTNPKRDTKLLCVVEELGDLWAFEKGNIYSGLYHVLGGRLSAINGIGPKEL
NLDTILKKVTESKIEEIIIAINPTLEGQVTAQYIIELLKNLDVKISRLACGIPMGGEIDY
LDEGTLRIALTSRQEYELNIK
>ELAGILAN_00374 hypothetical protein
MCLKKLISLITFKKKKIVPPLKVVAWENDRLSYKQFSGKFNTIIKTIDQSFTIISLEGYD
GWGKTFFLKEWVKELKQQNEIVAYYSAWDINALDQPLPSFLNFLFEDLFASYEVKRSVIQ
QFKNINQELFSLNTLGKLISKSPLAMLSVLLDATKEADRKDIGSVLRELNTLQRREENIK
DFKTQLAKIVNRIRKDKNIYIMVDNLDVCRPKFVVDFLESIKYMLDVEGLVFIISVSKDK
SNVQRAISTILGPNFDLKSFTDLSLHLPKQPIEKFTKELFENIKLPKKSKNLIVDSFIFY
AESLSLSLKTIEYCVKKIKLCLLNHTREELPDPNLFAFLVILQSINIDIYEELDSSCQRS
LEKIENEYKSLVLNGQEEWEKLKTSLETAFAERESKINKAIKDILF
>ELAGILAN_00375 hypothetical protein
MNTTVEKNNPKIFPQNEGKINSKGMVAPPVPPKSSQAKFAGIKAIFERNVPHSQANDSNK
TVSSNLGRTFGPTMQKLMEDNIHSTPNKQRRNSGDSGISDISSSTSDDEDRTIKDKMMEN
VKQDNHQKSFDLHKVQATDELETVKFLKTLSKKEREKLGFSPKQQNNQKVETSKKTYNPL
DWNPIYQGKKLFSLGNMSSNSSSCSEKSNISDVSDKSNNSNIVRCNITRSNSKEDLRKPD
ASHNDKSAGKKLSNVNVSELIRKFEQGNDIVKGR
>ELAGILAN_00376 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MPIEILMPALSPTMSKTGGKIVKWHKKEQDKVEVGDVIAEIETDKAIMEFESIDEGVLAK
ILVTEGTSGVPVNQPIALMLEEGEDESALNNYTSTSINSAVKKEVTKSAVDNQKSEHQDL
NGKPISHSSVSFQRVTLESNPSMSSQCLTLGSRKEEWIPVSATQMTEGYAEGRTKISPLA
KKIAQNEGVNVQQLKGTGPYGRIIKADVLEFLGSGIHTESPEKDTIVEVSNMRQVIAQRL
TESKQNVPHFYLTVDCQVDKLISLKNEINSADENNKVTINDLIIKAAAFSMKKFPDINSS
WIDNKILRYSNIDISIAVALEDGLITPIVKNADKKGILSISKEVKDLVSRARSGKLKPEE
FQGGGFTISNLGMFGIKAFSAIINPPQSCIMAVGASKKQPIVMNEKIEIAEIMTVTLSVD
HRAVDGALGAKFLNAFKHYIENPLVMLIETAVIY
>ELAGILAN_00377 hypothetical protein
MMNKSVTLSLTLSQCVTLGSWFSTIILLFLLFSHSLFANNFVSTKSNKINMRTGPGFHYP
VKWIYTCKNLPLKVIEEFESWKKVCDIDEDCGWIKGNLLSDKRYAIVKEDTYGYQKQSVD
SKITMKIDKFVVMKIEKCNEEWCFLSTPKRKAWVQKKHIYGVD
>ELAGILAN_00378 hypothetical protein
MSLKNKISELIEQQFSIKYHDNYLAYAIHKWAASEISDSITFCIIGCGNCKIGYQDVAKS
FNITKEEIDQGNIASIESKIKSEAEKSGSEFSELISRVDQSLREQSEKSIVQILDSSAEE
MLRSFCDSPVQSPEPQEPSASSEEHATEGPETSVNSDLLST
>ELAGILAN_00379 hypothetical protein
MSGYRCFMRSVKLNFLLIFLLIFGLSYQGSADCPWNAKSNTEVSSTFGWTGWRKEIQVIA
IKDQGIDGYFNPKIKVCSKGGENYPEYCYELYSGTSCKIIYGNGTTQASGAGVSAMTFID
WEGNKTSIGAKMGEGFKWKWADGLTDEEKEKFANSPKICACMQKGACMSGASAWGAKAFS
GYNIFRPGNMENVCDTCYQTEIKCAPVPLAPGPPPFCEQLAMSLPQVRIVPITDKDNDYF
NPKVKVIAGDLIEEDGKIGKELDFPKGYGENKAEWRSILDKDGITYYFKTYRKKGQLCAE
YHGTQSIDKKNPQFVRCFPAPPAPEPEVVEIVQSNTSGKQSDTLKIRMKMSESTCTYEAR
GTYSDGLCTFNVNTAVNIGPLSLKVVKPAIVAKTTDSNISNIIEGILESNPQQFKVLKEY
GYVPDVQIKCSKGGSFYSFNDFEKKLKDKSIQCEFNNSGQPEIEVKYKGNSNSKMLCLSG
WQPEPEEFVLKRENKIIPLKLMGTRYTKYNAVYSKESNQFYYLPSKENKRADLLNRDQSE
LDKIIFNKQGYVFFPDENKQEKGKCSYCVKRNDEIDDTFKSSKGLKEVYKLTDVEHREKC
NQGDDGCICFNGTCSRSTRYVDKENTQSFYTKVSQDANGVVTQQEAPIKTNRTEVFYADK
LCRFDLEGLKKKLKEKLKEIIKEHLKNKKPDLEKNNEKSYDHKNKDVYTDDLSIKFDRIK
IEAWGSGEAGHIQGSGCDNQKCHSTESRVGMPGDYIKAKLKIDPNYPIIKVQVTEGGGNQ
ESNLSDKDGGPVFIEMCNSQKQHCQQLITVAGGGEYRTYGGKGYEETVIHKQDLKLEEKI
VKADKLKSTQDNQIAYIENGEIKYETVECGSGLRSSRSGAGGCINKSKGIYGKGSPGYVK
IRPIIKEFDEEEINAAIKKVIEDLYDLETMTDFWVGDLNVNISGIIKEEVKKELSR
>ELAGILAN_00380 Type IV secretion system protein virB4
MQLKVPTVNSKLKKKNNLALLESIDLDFVPYACHYDEETILTKQGELLKIIKLEDYSSVD
NYSDLRTEIRKSISKNINSLYFTVWIHTVRKRNKLSLKWNKTEDFSDNLHSTWFNKLTDS
KLQYINELYIVILFSDFGKHTNNSFFFNRIKNKHKLSLQESHQELQKITDVIQNDLGPFG
AKKLSLRFSEGKIYSEMIEFLHYIVTLTHKDYPIHERDLSQYIRNFKIAFGFNTFQTIFE
NQQKFGSIFSIKEYREISLGNIDRCLQLESEFIITEIMIFTSNNKAIKEFKKQINMLQIS
EDNTLLKSSGIEEIIELEKTSSIDFCQQKIIFTIFADDRNKLAESISDLSSIMSLVGFMM
FRTDLHMESHFWAQLPGNFAFITQPKNILTKYACSFAMLHDFTSGTLKGRRWKEAVMIFF
SKKGNPYFFNFHGKRNNGHTTILGAPNSGRTSLINFLLSESRKFNPRIVILDNTGKSIIF
TKAVSGKYYIIDPKYKDKSLKFNPLNIEDSASNRNMLVELIRRMVADTSLVDVEEKIRKI
VDSIFAIPKESRSISQISEVLLLLGGKISRWCDDGDFAYLFQDGDESDIDWETKIISLNT
ANLTKQKECMSVILYYFLYSFEAKCDGSPAILVLDEAWEISNIFPTEKEFDNWMQRMTEL
NVVVILSTENLNLAFASKFTQYLDKHVDTRILMPNVNANRLYMKAFSLSKEELNIILQTP
TQEGLFLIKQYKGLVTLNLDLKDMQEIHVLSANKETIKYMYEAIKEKGEEVNEWLPVFYE
KCKA
>ELAGILAN_00381 hypothetical protein
MRIQLNKVLVFIALLSFIFASYSSEASSVSDELKDVQETVKNFISSFSVKDTVENMSPST
IIGLCIAAVILAVVFRGLIFFMIMFGVLVLMFGSTEKATDYLKEKFNFAKDIKLQSDSEK
KDKN
>ELAGILAN_00382 hypothetical protein
MLSSKKDINQQLHDTIYKKVTKENHKYGSPQKGDGTIKKCIELFKEGASPEVLTELEKSL
REQLEKSPEKQEEYQKHYKYYIENFLPALKDEVIKSEELAVPTVFNNEREQSQRPQTIRG
KIVKTILDITNRSSSVSSIPNAVEENIEDQMQLKHIEEQNNTQETPLNVAEKKSGDNKIL
GQLDIPKGVSRKYSKVMEQLKKNIKTPKLGNGSGSDSGINSPGLSEKNSISPINSRKNSL
TSIASTSSEESLNSTLSSVEEDNGLQPEGGEKTELLESNLESPKENETQVQPEQTVKKEP
KMQENENSDGQANPDQVKKDILLKNQPNNRNLHVALVAGCALSTIGCIVAGAMTSGLIGA
GLLAMAAVFAIAAVAELHSNFLSSKLTSINVSPLVDDKELTAL
>ELAGILAN_00383 Nitronate monooxygenase
MLSSLWKKGTDFLGSEFAIMGGAMSWVSERNLVSAISNAGGFGVIACGAMFPDLLKKEII
ETQQLTNKPFGVNLITMHPKLSELIDVCIETKVSHIVLAGGLPTKPNIEKIKGAGIKVMC
FAPALSLAKRLVKMGVDALIIEGMEAGGHIGPVSTSVLAQEILPHFKNEQIPVFVAGGIG
RGEMIINYLEMGASGCQIGTLFVCTNESIAHKNFKEVFIKSAARNAIPSVQISADFPVIP
VRAIANKASDDFMKRQKEVIDEYQKGQISKEDGQLEIEKFWAGALRRAVIDGDVETGSLM
AGQSVGMVDKEKPVKEVVDMLVQQAKNHINSKSVEVESPESK
>ELAGILAN_00384 Cytochrome b561 
MEDNKYSLGLRVIHWLMAVFIIGMLCSGLYMKSLPLSNEIKFNIYAIHKACGITILGLII
VRIFFRVFTYVPPLPANFSRFVINTSKAVHFGLYSLMVLMPLSGYVMSSASGKQIKYFFH
IPLLINQNKDLANTANELHSMLAYFMVLFIILHILGALKHTFIDKQNIFKRMI
>ELAGILAN_00385 hypothetical protein
MPYRNGVAYYGAYGGGDNTASQARNPTTSRQLSESTKQLFKAIDDGNLEDFKEALAEGAD
VNAFDKEGMTPLMSIVTNLSAGSETEKEYQNMIRLLLLHRSIDVNISEQNNNNTVLHLAM
CFQQKKTLQLLLSHPNINTYLTNKNHQNPEECARQNRAGHLIIEIQKAQKGKELLAALSS
GNICQAKRLLNQELHPNCWRRTQDGRIKTPLSLIIRLCLRTITEDEKEVLTKLLKHKDLD
FSYEQYAQLKQTIEQAIQSRLTDTINRKDLDDVKKLVEDNCFINRAVVTAALGGVDNPVN
SIKDYLNEKFPANTNNIPEDFEKFLQGLERTKAQLVEKEQELTNKTGKISQLEKDLVQVR
QEKSAQQSELIEFKRIVCGRASDTVEISRLKRDLKQVREERDRLSSENRLLRSNKNEKSS
QAISSGRKLSNYASACFILLGVYTVVACLVIEDYPGIISAFFTAVALAFFLLGCCNLYKA
NTILSDVESTQLGGLERS
>ELAGILAN_00386 Tyrosine recombinase XerC
MRDLKDLISFLNTHIGGEVNVGTLKNLSIPELRSWLTSRYARGVNARSNTRALSVIRNFF
KYIKNNHNIDNEAVFSLSRPIQRRTLPKALSIPNIKTLLKEMKLSDLGEPWVVKREIAII
VLLYGTGLRISEALNLRVSDINNESLIVTGKGDKQRQVFILPVVKKCIQEYIKACPYLDE
AQHLFVGVRGKKLGRTYVANRLQKIRRMLNLPEILSPHAFRHSFATHLLQEDIDIRSIQQ
LLGHSSLETTQIYTHLNYQDVFNMYKNFQQGLEKKSKL
>ELAGILAN_00387 Dihydrolipoyl dehydrogenase 3
MTDYDLIVIGGGPGGYKCAIAAAKLGLKVACIDKNSIFGGTCLRVGCIPSKALLHSSYQY
AHTKNDLSKLGIKIKDASFDLKEMLGYKDARVQELGKGIEYLFNLHKITKINGLASFDQG
NLEVSVEGKVLKTKNIVIATGSDVISLPGINIDEKNIISSTGALSLTEVPKKLVVIGAGA
IGLEMSSVWSRLGSEVTVVEFFDRIAAAMDGELSKSLLSSLQKQGIKFLLSTKVEEIKQR
SNSLSVKVCSVKDNQTNTIEADKVLVAVGRKPCTESLEKIEKDSRGFVQVNNRYETNVKG
IFAIGDVIGGAMLAHKAEEEGVAVAEIIAGQVPHVDYEIIPSVIYTHPAVSSIDKTEEEL
KSVGRKYKVGKCQFAANGRAKITDDAEGFVKVLTCSRADTILGVHIIGAYADTLINEAAV
AMAYGAAAEDIYRICHSHPDINEAFRDACIDAFFKK
>ELAGILAN_00388 Outer membrane protein assembly factor BamB
MKVIIVMIMLLCSSYTMASERISLVDKKLSQGYVAPVLIENSVILSDKHGALYSFDIDNS
KAMNWKLHLSHRKKIGNMSLSHYEKNVFFIVDNTLHAIGAKTGKIEWEKELRAPVRGKAA
VINNKLVVLTIDNYLYVFDIKDGSSAWAYQNGINEVRGLYSISPTISNDKIIAPFSNGEL
IAFNEDGKKLWSQKLATNLLDTQLTDVTTTPRVLGDTLIATNNSYIYGIDVKSGNILWSK
SLQVKSVSDIESYYSPLIPAEKQKEGGRIFIVTKDDKIIGLDIKNGETVWASDLIENTQL
FAPIMHAHTLWVTSNKSSMFAFPGSESAGKEVKVPGNVFHTPVFTRNKIYVTTEKNGVYS
LENRFVFYD
>ELAGILAN_00389 hypothetical protein
MPQKMRVSNCHEYNKFLEKRGNIFRYIDKAIENWYENSPKMQGGNYIYSDKVVILVHIIV
NLFRIGLRQTVGFIKGYLQQIGRDLAVISYSQASKKT
>ELAGILAN_00390 hypothetical protein
MVERNAAIRLIKSYSEDGMKRWKRQTNYGKRSYVESFFSRLKQTFGFNFRNKSEINRGKE
LLLKCYLLNQFTDIGMAKFEMAT
>ELAGILAN_00392 hypothetical protein
MQTTLKNHLAGELLTTATCWKLTLAGGEVMGFTDYDEDLNIDNILYKSSSGFTASSIILN
SNLKTDNLEIEGILNSVDIKKKDVLSGKYDFANIEIFLVNYKDLTQGTMNLHSGIFGKVT
LSSGRFIVEIRGLSAKLERSIAELYSPACRAQFCDDKCKADTKKFSKISTITKVIDERRF
EDTNLTESDEYYKHGVVKFFGSIAFEGVVKEYKNKVVTLFTSPPYQIFAGDKYSILAGCD
KTFPTCRSKFNNTVNFRGEPYIPGFYIV
>ELAGILAN_00393 hypothetical protein
MKKSMYTRTALVSLLTLCSFSSFAADFPDESMKEIKKQESTKTSGKTEVMKTSNKKLKEK
MDRICNADPRKKAEELKKKEELRLAAEQKKKEEIRLANEKKAKLIEDSKAKALNAKNSNI
EKGKVSKTKRSKTKNAKVEAKDVKKDIKVVNKNTEEKGKASPVVSVGGVDIIDTNQGQSN
LRITFGGVVDAQGYGKAGPSGADYKRYNVMPNRSTEYYNATPDITKGANPIFYEGIGNIG
DYSNDMGMIADAILHLRAENKNEDLGLLYGADVQFHVPVTEGKGASQGVYAAKGRSAHVF
VNSKYGDVKLGYQFGPEALMRLDATRIATVDGAADSDWFRKVNLEGSAASFPFYVTPRLY
TESFSSESEKFSFRMAGKYNKGVMTTLPFRVAYYSPNYMGARFGISYSPRYDSGLFTVKE
TVSEDKGGKIEHKETIKHVGPDYEHIVSAGASYEYDFDKHNIKVKTSAVGEYGFPKQPSK
DKHLYKEFVEYNDLMGVNFGVSADYKINEDQGVKFAASFAYLGKSGQPKGIKKLIGDTYT
EIDSKDATDGKRVEGLKAQFGKDSIDTMYWTVGAGYQHENIYTSLTYFGSRMNDKDMLHD
GALGVQYDLSPACSKNKFVPYAALHYFMTNETGKLKDESDADVPSNQGILLLTGVKFSF
>ELAGILAN_00394 hypothetical protein
MLNSLLVFDIETIPDVNSCKNLLNISDDSSVEEKRDALTKYHLEITNGQNSFLRQPFHLV
VVISFLLCNISYQSGYEVFTLQEIRSGGTLNSSEKELVKGFFNYISEKKPRLVSFNGRTF
DIPVLKYRAMVHGIQAEYFHKAGDKWNSYNQRYSSDWHCDLLESLSDFGASARVKMNEVC
AAFNLPGKIGVDGSQVMGLYDSGKIQEIRDYCETDVINTYLIYLRFMHHQGRITTESYNK
SVEELLLECEKKEYLKKFKEEWQITCGGKILLP
>ELAGILAN_00395 GTPase Era
MKEQKCLFVTIAGLPNAGKSTLINSIIGKKIAIVTPKVQTTRTQIRGVATCNNTQVVFTD
SPGIFSAETKLEKALVKSAWSAVKDSDITLLLVDVSNYLKNIERIKTIFMRLQRTKGRCI
LVINKTDLVKRPELKMAHEHLNLLYKFEKVFMISALKNDGLSDLMNYLSEVASVSPWFYE
EDQITDSSTNFLSAEITREKLFLNLREELPYSTAVITEQFEEKKDKSLVIKQIIFVLKDS
HKKIVLGKDGSNIKKINIEARAELEKLFECKVHLFLFVKVRPWIDRTEEYIGNA
>ELAGILAN_00396 hypothetical protein
MVKTLPLNQAVVQAMASTQEPSLANPPMDFLKSF
>ELAGILAN_00397 Cytochrome bd-I ubiquinol oxidase subunit 2
MFDFSSLINLPLIWGLLIAIAVLLYILMDGFDLGIGILLPFAPSDKCRDHMISSIAPFWD
GNETWLVLGGGGLFAAFPLAYSILMPAFYIPIIIMLLGLIVRGVSFEFRFKAEGKYRRLW
DYAFHFGSLGAAFCQGMILGAFIHGVEVNGRNFSGGQFDWASAFSVMTGIAVIFGYALLG
STWLIMKTENITQEWARKVASYTLGFVGIFMGLVSVVTPFLNERIKNFWFSMPNFYYLFS
IPLLTSWLFFMLWFDLQNTKREYRPFFLSIAIFFMGYLGLGISIYPWIIPFQYTILDAAA
SGPSLSLMLIVIIPLLPIILTYTGYCYYVFRGKSNYEHTY
>ELAGILAN_00398 Cytochrome bd-II ubiquinol oxidase subunit 1
MAIICNTWVLGKMFKFDPLLLARIQFAFTIGFHIIFPAFTIGLASFLAFLEWCWLKTGDT
RFRDVYKFWIKIFAVAFGMGVVSGVVMSYQLGTNWSIFSDRIANVLGPLFSFEVLTAFFL
EASFLSIMLFGWNRVSSRMHFASTCIVAVGTLISAFWIIAANSWMQTPAGFTIGENGLLY
PTNWLEIIFNPSFPYRFIHMVTAAYLTTAFVVGGVGAFYLWRKRHAPQARIMLGMATIMV
ALAAPFQLFMGDRHGLNTLKHQPAKIAAMEGIWETEKGAGLLLFAYPDQQNEINHYEIKI
PNLASLILTHDFLGEVKGLKEWKKEDRPPVVWVFWSFRIMVGVGILMIIIGSVSVIQYLR
GKLFQSCFLHGWWISMMPSGFIALLAGWFTTEIGRQPYTVYGIMRTIESFSSAITGPQVA
WSLIAFIVMYTLIFGAGSYYILKLIYKGIPVIKEEEQFYKHGIGASVIDAGTSGKDNNHV
>ELAGILAN_00399 tRNA (guanine-N(7)-)-methyltransferase
MLFKNSKWIRSFSRRSRLKPDVDEILEKYSIQNSKESIEKIVNSQKRIWVEIGFGNGENM
LYQVLNEPDLLFIGCEPYLKGVSRLLTNIEIQNIKNILMWTEDARELIANFPDNSVERFF
ILFPDPWPKRSHNKRRLINTEFLNLLAKKILITGEIFIATDHQDYAEWIASHIKQCNSLI
YREDDFTSYTLTKYHRRALKDQRKVRFFKVSVINNLQTMDQ
>ELAGILAN_00400 30S ribosomal protein S1
MNNNNPVVNLPVTIRKLSSNKFIEEICQGQFEDQDNTLFEDSFVNKIKEGDVVEGVITRI
NPNDVVVDIGLKSDGRILIKELGCNDEVIIGSKIRVYVERIEDYHGNVVLSREKAIRDEK
WNKLEEDTVTRAEVSGVIKRSIKCGFIVDLGDGISAFLPLSHVDLKQVKDAKHLIETEQK
FIVLKMDKKQGNIVVSRKLVLEKLHAGEKIKFLESLNEGDIIEGKIKSITHYGVFVGIHE
SDVVGVIDGLLHITDISWSRVSHPSAVFTCGQTIKVKIIKIDKENAKISLGVKQLEDSPW
QDAESKYPVDSVHKGYVTSIEDYGLFVELRPGIEGLVHSSEITWVKSNLPVSSLVTRGQE
VYVKILSIDIAKSRMSLSMKRCVDNPWQVFINKYPPGSIVSGEVKNNTGSYVSVAFGDSE
IDENVEGTIYVKDFSWSKNGSDEIKKYNVGDKIEAKVIRANVNRARIYIGIKQIEYDPLE
ELIKKVKVGDKIQVIVGKREDNGLVVEVENDVTLLIDQEHLPENKKFSISEKIEVEVLGV
EEYNIALSAK
>ELAGILAN_00401 Integration host factor subunit beta
MATKSDIIARVAKRHPFLDKIVIAAIVDRFFGILSSTLKHHNRVEIRGFGSFSVRSYNLK
ETSHLMLQKFTKNQYFKTYFRSSKKLSDLVNE
>ELAGILAN_00402 hypothetical protein
MQVVEIVIRNNTYKISCESGKKSHLLRLANSFDKLVGSVSQKIGGKGSDALNFLLAALIL
EDKILELTKRLDEVNQERKKYRNEKRIEYTEVLDKVNKIITNLECIKD
>ELAGILAN_00403 hypothetical protein
MTDTSLLRRKLIYRSWHRGCKETDILLGHFALKYLDKFSLSELIEYEKIVDLDDYELYCY
ITRKTNLPPGLNSQIVNLIACFIEANPLCTQD
>ELAGILAN_00404 Metalloprotease MmpA
MELISNLIHQFSDGIYYFLSFSLIISVIVFVHEYGHYVVAKACKVKVESFSIGFGPEIFG
FNDKSGTRWKLSAVPLGGYVKMLGDTNAASVPADQQELTEEEKLYSFHTKPRHKKAAVVF
AGPFANMVFAVIAFTIFFSIAGYYRTPPVIENVIEGSAAKQAGLLPGDTITQINEHKIKY
FEDISRVIMSNPKTRMEIEYSRNNEKHRTSLTPLIIKDKDVFGNTIERETIGIISVNTLK
QSSFLGAVSLSVSETYHTMCLTIKALFHIIVGKRSINEIGGPIKIAKYSGQSAKKGFIMV
LYFMAIISANLAAINLLPIPLLDGGHLFHYIIEAVIRRDLSLKCQKYAAIFGALVLFLLM
ATGMSNDIRDLF
>ELAGILAN_00405 Outer membrane protein assembly factor BamA
MKKLFYILVVVFISFPALLVALGTAEKVQVKDVKCIGNERVSNQTIGFYIKLKSGDYIND
DDIDSIIKDLYKTKLFASVNAYIDDKKNLVIKIQENPLINKIILKGNKLFNSKELLNNVI
QSKSLTIFTETKLQNDLMNLITTYRNNGKVGVKIEYELEKLDSNRVNLIFKIKEGKTSKI
KDIRFIGNKNFSENELEQVIKRHSNDIFSKLFRAIFKGENHYSPQYLLINTELLDRFYSS
KGYIQNNIQPIVEVDNNNQTELTFLIDEGQQYLFGNNEVNIETEIQDLSLKEEILDFITE
ENDKIFNRVKINNTVEKINKYLNEKGYIFAKVNPEYAQRDNVVDVTYRVLPGKKIYINQI
TIDGNDRTLDKVIRSKLSVAEGDAYNISEIQKSRKKLMSSDFFETVKVNSYAVNDNAVNL
DLSVKEKNTTSLYLGGGVSLPGGALIKIDLKDRNLFGTGKELSFALEKSQYVFSTDLEFV
ENNFNDSDTSLGVDVFYEKQDKPNTTFDSCDMGFFTKLSYKVTENLTNSLRYSYKYNHIH
MDNKGGQDTDISEIILDRKGEHQISSVGYTLAYNKLDNLYTPKEGYLLRLSQDISGLGGN
VNFLKSEFLSFYTHPILSKIDDDITLRFKMAAGHIFSYTDENLNIGQHFFKGGNEIRGFD
LSGIGPRAEDKNKSSLGGKTYFNLTQQVDFPLPKLYDYAGIKGSLFVDYATLFGLDDKNK
KYEGKYYDSKLVRVSPGFGFSMLSPFGRLRLDFGFPLVKESYDIIPSPNVKFSIEAGI
>ELAGILAN_00406 hypothetical protein
MKYIQLFISVIALIISLFVGYKFVGYQPQNTKAAIIDSDKVINESLALQNIQQQIKEQNS
RLQQEFENELEKLKPSKEEFELLSEEAKKEKTGQFNKHTVNTRDNYAKKMLHLEESYREA
VESVFNKIKEVAKRTAEKNNIDLVLFISKKNQVLYSMDEVDLSDVVLKNVNKEVPEFALK
GIE
>ELAGILAN_00407 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MQFNISDIIKILPHSYPFLLVDRVIECDPGKSIKAIKNVTFNEPFFIGHFPGHPIMPGVL
IIESLAQASAICVLGKETIENKVVYLRSIENAKFRKPVTPGDTLILQANIQSVCLGVHKF
RCIASVSEEKVAEATISAVLQNK
>ELAGILAN_00408 hypothetical protein
MKLNFKISFSNLYTRNGLIKLDETFLNYIKSCDESLFCSLIEARENRIGDSQLIIDLSYL
LDEFIAKLFNIKKEIEELKKKHNDFAVIYKCKRLFVQRYALKKYTNVENIDITNKLSHFL
TLPTTEKNFAEQVMHWFEDKENHKEEIELAAQYAVWRVKNKQSILFSIHKKIDHENLIPF
SKKEVDKVEVLHSNEVKRRYGFDLTSKKVSLNKALDNAHYCIFCHKQSKDSCSKGLINDD
NTFKKSPLRVELHGCPLEQKISEMNLVKSEGYSIASLAIVMTDNPLCAATGHRICNDCMN
SCIYQKQEPVNVPAIETRILDDVLSLPYGFEIYSLLSRWNPLNFQRSLPRGNTGKNVLVV
GLGPAGFNLAHHLLNDGHNVIAIDGLKIEPLIDNFQLIKDFKHEKLSERTAGGFGGVAEY
GITSRWDKNYLKIIRLLLERREHFALYGGIRFGGTINVDDAFNLGFDHIALALGSGKPRM
IKIKNILARGVRMASDFLMSLQLTGALKFDSIANLQVRMPIVVIGAGLTAIDTATEALAY
YPIQVKKFLLRYEILVDKYGKDCVEKDWTEAEREIANEFISHAKLIQAEQELAKKENREA
KILELMQSLRGVKVVYRKELKDSPSYRLNSEEVQNALSEGIYFIENLEPVEVVTDKYNHA
ESIKLIDTKSGEIKRIKARSIFIAAGTEPNTVIATEDKRHFKLSNGYFTQLNSLGKEIDP
IFSPKMQNKDRILVYKQGNKTISFFGDLHPSYSGSVVKAMASAKNGYPIISQLLNRVNSF
VSVIPVCDVVGQKKNAWSSIEDLANKEFFNRIKEQFAAKVIKVQYLTDKVIEIVIKAPLA
AKNFKPGQFFRLQNFETNGRKTNLAMEGIAVTGTEVDKKKGIISTIVLEIGGSTNLCRHL
REGEQIILMGPTGRPTEVY
>ELAGILAN_00409 NAD(P)H-quinone oxidoreductase subunit 2, chloroplastic
MQLYKSSLLLLLTVLIVIVLKLPENLSIAVNWSLPILDFDLSFRTILISFLSVAFLAVLP
AQNLTFSEMLSFAAYTISSLYAVLSEHMILVIIFCELMTISAFFIIAASCRDSGPAIRYA
CVHFFVGVILIAGLALQSTNLIILGLLINCACFPFSFWVVDAYPAASLYGTTYLSLFTTK
VSFLVMLLHTYNLWQNCAEMLALVGTITAIYSIIFASLEQNIRRFLCYNVVGQMGLLIIA
GGLLSPSEKAIPILILHIIFSLVYQSLLFVVSNSIISRTKTISFNGVGKLMSVEGMCAII
AILTMAAFPGTAGFISKSYITAEIEASGANLEVYKNLYKTLNLLLYLSVGLKFLYYLFIA
KSKSKPLAEEGGKMTMIILAFICVIAGNPYLPIYNKPSIFDFVYNTKNILSQFNLLLCTT
LLFILLRKLFYPRINFKMDVDWIFRAFIPYIILLFNQLVFKVREMSANVLQNLTNSLTSL
YFDNITKLKEVLGYNSVSFVSASSLFLMSILLMLLCLSR
>ELAGILAN_00410 Signal recognition particle protein
MFKSLTESLNSVFSKLRGKSIISEDDFNLAMREIRIALIEADVSLEVAKKFINDIKDKVI
GEKVIKSVSPAQMIIKIVQDNLVAVLGSEKSDLNLAVKPPAVIMMVGLQGAGKTTTSGKL
ALKLKKQKKKVMLASLDIYRPAAQKQLEVLGKQIDVQTLPVVIDEKPITITKRALAAAKN
DNYDVLILDTAGRLHIDNNMMNELKAVKEIASPAEVILVADAMIGQDAVNIAKSFNEVIG
VTGIILTRVDGDARGGAALSMKMIADCPIKFIACGEKLSDLDDFYPDRIAKRILSMGDVV
SLVEKAAEIVGQEEIDKLQKKVKKGKFDLNDLVGMLKTLSKMDGISNIMKFIPSSFTKKL
SSSVPDDNKVKKYIAIINSMTEKERQNPDILNGKRRLRISKGSGTTVTDINLLIKQYNQM
SSMVNKFSKVDHSKLKESDLMNMLSRK
>ELAGILAN_00411 NADH-quinone oxidoreductase subunit F
MLKEQDKIFTNLNGKETPLLEGAKKRGGWQKTKELLDLGSEKIIDEVKKSGLRGRGGAGF
STGLKWSFMPKNLPKAYLVVNADESEPGTCKDRDILRYEPHKLLEGILLASRAISASVAY
IYIRGEFYNEYLVLKKALEEAYKENLIGKNACKSGYDLDVFIHRGAGAYICGEETAQLES
IEGKKGFPRMKPPFPAGVGLFGCPTTINNVETIAMVPDILNRGGEWFTSLGKPNNTGTKV
FCISGHVNNPCNVEEELGIPLRELIEKYAGGVRGGWDNLLAVIPGGSSAPLIPKSICDTI
EMDFDSLRTAQSGLGTAAVIVMDKSTDIIAAIERLSHFYMHESCGQCTPCREGTGWMWRI
MKRMVAGDIKPDEIDKLLDLTTQIEGHTICALGDAAAWPIQGLIRHFRHVIKERAII
>ELAGILAN_00414 hypothetical protein
MSGKKHVFKMIPGKEVFRKTPTTRIKWPEGNDPTMPIKKVELVSLDDKNDVVLGLLPIKL
CSSSCLDSYICLEEENEGNLVAKDYKSDSNLDYVKGNHTFVYYGNELAKLSYTRELVQPF
KTMCSSSIKSKKLEYKYVTWEDSDTGNNKYYFSDEAGNIIDSPDNEVLQDIMLYYGERHI
RDVLLLLSNAFTKVFIQGLTDGQLKTLANTLSNEQLQKIIPELSSSQLQALAENLTDEQL
QALVDHLTNHQLKTLAQELNPEKLQIIVPILNDTQLEALVRKLNSEQVKEILPHLKVDQF
KALIKTLNDEQFTVLAKDLAEHHLTILSKELEGDQLKALVNSLQEDQLKDLVNKLDPEKL
EAIAQDLTDSNRIQIIIKSLVDNPEKLQAFARNMSNEQFKELLDNIGAEELKDIIHKLPY
EKVTAVIGDLGSKDQSKAIIDALKGELDEQSKQNKEMIEMLKQIKDDMPEIGQASDFTIV
DINNDSLLFV
>ELAGILAN_00415 hypothetical protein
MSKNTELYSSEEVESNNTLQLPKPAFNKPNFAIPEIKKITTKSAPDGIDITKVMEEKEIN
AIPTITVSVKNLKNFYDGLMKSINKYNDDVSDVMTSGIVEPLSSTIENIGTKTSEIDAKL
KDLQARLDDIPEIGEAPSLLHITGGENGLL
>ELAGILAN_00416 hypothetical protein
MNNSKQESKNELKVISKIEVNAKPKGYDETVARNPAQLGYVHKALDKLIAELNTKFVPEL
DDVLHNNSNSISQLNDMLTEERSKLDELIKEINDLKSSLEPPPMDAPEFI
>ELAGILAN_00417 Cytochrome c-type biogenesis protein CcmE
MKKKHKRLLITSGIFCFLSCIVFFILTTLKENISFFYTVSEAIVLQNSQKLIRVGGMVVE
NSVIRSESEVIFQMTDFNKSVVVKYQGILPPMFSEKSGVVVQGKMFDNSTFLADTVFAKH
DENYMPKVLKQIP
>ELAGILAN_00418 hypothetical protein
MNTYVIFAYLISLTLITGELILTISCYIKSKKILESLKDNNEEET
>ELAGILAN_00419 Bifunctional ligase/repressor BirA
MIPEGFHIHHYKEVSSTNKEALDLIDKGISNETAIIADKQTEGRGRTGKSWISPEGNFYA
SLVINLFNDYLNESQLSVSFQRVTLESRKKEEWIPVSSTGMTSEGIGMTEKGLVNKIADV
SKLTELTFVTALTVGNTILSFINGLNLQYKWPNDVLIDGKKISGILLEKRSNSNWLIVGI
GINVSHAPLPGTTCISNYGESVSNIDLLKELIINFNKLRKQWLFDGFYAIREMWLKKAFK
MNEQISVKLADKLYEGIFADIDKSGKLVLQQKDESLIYFDAGELFINDIL
>ELAGILAN_00420 NADH-quinone oxidoreductase subunit N
MNYIQILPETFSIISSLVLLLLGIIFNRRTINLLALGCTVVTLIILIISAENNEIFLFNS
LLKLNLYIRSAQGLILSTGILILLMLNLSKYDYKYEFSILILFALFGMITLVSANILISF
YLAFELMSISLYVLASFNKDSAYSCEAGVKYFTLSALSSCIMLYGMSLLYGYTGQVNFSE
LSSFLQNHQITYGIVFGLVFVLIGLCFKLAIVPFHMWAPDVYQGAPTIVTAFFSTAPKAA
LVTFLIRLMNEELVNVKSYVQPIFLYVSALSVLISAFGALRQQNLKRLLAYSSIGHIGFI
FASLSIFTQAGTDSALMYLVIYIITSIGLFSYLVQIDDDDCDIANLSGIGKKRPIVAFHL
SVLLLSMSGIPPLAGFIAKFFIFKSLINSGFISLSLILVIASVISCYYYLNIMKVMYFDK
ASGNKVAYSKGLFIITSVASLINLVLFLYVLLTH
>ELAGILAN_00421 NAD(P)H-quinone oxidoreductase chain 4 1
MLLLSIFLLPLIGALILSLIRINHQSIHLRFLALFFAVLPFLLSIVACIEFDYNDADFQF
VSYPIRNVGIGIDGISLLFLLLTTFLFVICILYNCKMSYTTLRPYMALFLLLESFVVGFF
VSLNAISFYVFFEAVLIPMFFIIGIWGGKHRVYATFKLFLYTLTGSLLFLLGLVYIYSTF
GTFNIQKLATLVPNLDLEVQSLLWIAFFISFAIKVPMFPFHTWLPDAHVQSPTSGSVILA
GLLIKMGGYGFLRFSIPMLPQASLYFSNFVVVLSIIAVIYASLVAFAQDDIKKLIAYSSI
AHMGIVTAGLFSFCEEGVLGSIFQMISHGLISAALFLCVGMLYTRTGTLEIAKYFGIVNT
MPKFGFMFILFSIASIGLPGTSGFAGEFLAMVGMFKSLGFFTGFIALGTILSAVYMLNLC
KQIIWGVSYSKLLNNRLDSIEFSVLILLAVFVILLGFYPTLALNYLKPCMANLLVKYNAL
>ELAGILAN_00422 NADH-quinone oxidoreductase subunit L
MTYILKLIVFLPLFGSLFAALFRRDVFSQLVTTAGIGISAVLSWYVFLTFSENYHLSLFP
LFSLSILKVNWAISVDALSSLMLIVITTVSLVVHLYSIGYMEHDKGKSRFFSYLSLFTFC
MIVLVVSDNFVQLFFGWEGVGLCSYLLIGFWFQKYSANNAAIKAFVVNRVGDFALLIGIF
LIYYTFHSLKFTEVFDTADLLGTQNIRAFCCEFKVTHIICILLFIGCMGKSAQLGLHVWL
PDAMEGPTPVSALIHAATMVTAGIFLVAKCSPLFELSNVARELIVIVGALTAFFAATVAI
TQNDIKKIIAYSTCSQLGYMFMACGLSAYNVAIFHLMTHAFFKALLFLGAGNVIHAMHHE
QNIQKMGNCWKKIPCTYTLMWIGSLALSGIFPFAGFYSKDLIIEHAYSTDSFAFVISLVV
AFFTAFYSWRLLLLVFHSQKQSKINIHEAPKIMLIPLLILAFGSVFSGVWGANILNITSN
AFWKSSLVVIDEHGVHNFFIKLLPTLASLSGIALAYLIYQYQVIRQIKSKFLLKFLQNKW
YFDEVYEFVIIAPIRFISRLLWKFDVKAIDSFGPNGIVRLVNECSKSSIKLQTGYIFDYA
FIMFVTLIIGALYIIGIK
>ELAGILAN_00423 NADH-quinone oxidoreductase subunit 11
MEIGLNHFLIVAAVLFTIGVCGIFINRKSIINILLSIEILLLAININLVAFSAFMNDIVG
QIFVMFVLTVAAAESGVGLAILVVYYRSRGNIDVEQANLMKE
>ELAGILAN_00424 NADH-quinone oxidoreductase subunit J
MPFFFYFFSILSILSAVCVISVRNPVHAVLFLIFTFVNSAVLFILLGAEFIAMMVLIVYI
GAVAVLFLFVVMMLDIDYIRLRQGFAKHFTLGAILCVVFFLVISFVIRSSTLNISNVINY
NTNNVKAIGNLLYTDYMYAFHLSGILLLVAIVGAIALTLQDKKKGIKRQNVLKQLTQSSS
VKLVKAKFGKGVEWK
>ELAGILAN_00425 hypothetical protein
MYNIFGYFQSNNTCNTQSGKLNRESYQYTTRDYVTIYFNNIPASLGRSLREFKEKAYGFV
YDIGAWLKETYENLTERPATHNHYTPKEKPLVEEIEMKELNCTYKPFQTPPIHPTTGANT
SNQVVVTRHTPETTKTK
>ELAGILAN_00426 ATP-dependent DNA helicase PcrA
MNDYLSLLNPEQQSAVTNIDGPVLILAGAGTGKTRTITSRIAHIIRNGHAYSDEILAVTF
TNKAANEMVSRVLELTGTNIPWLGTFHAIAAKILRLHAEIVGLNPNFTIIGVDDQLQVIK
NIINEINPDYLSEKCKTIMNIIQQWKEKCLLPSEVEDIQSFRPVYVTALKVYHQYQERLR
FLNSVDFGDLLLYNIQLFNQKTEVLSYYQNKFKYVMVDEYQDTNAIQYLWLKYLAKEHSN
ICCVGDDDQSIYSWRGAEVENILKFSDDFKNAKTVKLECNYRSTSHILATASYVINHNKT
RLEKKLWTTNIEGEKVNLIKLWDGKAEARFISEQILKLNKYRFSDIAVLVRATFQTRVLE
EYFIKYSIPYKIISGVKFYERQEVRDIIAYLRLVTNNNDDLAFERIVNRPKRSIGATTLK
KIYTTAQDNKISFFEAAKILVNSNQVTERIKLSLNDFLNKIKAWEEIVSVKPLHEFVKIV
ANQSGYIEMLENEEVTGLARIENVKELISSLKNFDNATTFLEHISLVMEVDNMNNDDTVY
VMTLHAAKGLEFPCVFLPGWEEGLFPHQRSFDDKSGKALEEERRLAYVGITRAKERLIIS
CADRREINNQWQPMRTSRFIKELPRENVEVIKSNIAYC
>ELAGILAN_00427 hypothetical protein
MIREGKAEIDVFDARNQTPMHYAVNNKKLEIVKLLLKLGADVNSARMGQNSMKLSPVHIA
VSNTNYDERDLCLDILKCLIREPNAQVNLQDYENKTPLHYAERLKTIEVLLTREDIDPLV
KDDSGKTPFDYAENRPEIKKVLMSSKYGSEKNSLLHLAAQKGVVDTILKEEIDINILNNK
GHSPIYLAAEKGHLHVVKLLLKKGANYTPVLHLAIKSNNLELLKTLFKEKSIKLPDEIGR
SVPIYYRCIERRDAKVRKYNNVICVSTSVSAVAIAVYIGLTAITISNAIIFATITGIFAL
IIAIMISEVSKRYIENEFQKKMFMELEECSSTVNDVEIEPVMSRCR
>ELAGILAN_00428 hypothetical protein
MIYARAFSEGLRPDPQLKVSEWANEYRVLAPTAASEPGKWRTERTPYLKEIMDSLSPSSQ
AEKVVFMKGAQIGGTEAGNNWIGYIIDQTPGPMLVVQPTVEMGKRWSKGRFAPLIESTPC
LKSKVKDPRSRDSGNTVQSKEFPGGIVVITGANSSVSLRSMPVKYLFLDEIDAYPGDSGG
EGDPVLLSIARTNTFAHRKIFLVSTPTIHGISRIEKEFEATDKRYFFVPCPHCNYYQVLK
WSQIKWENNDSRTAHYVCTECSGKIENHQKTEMLDRGEWRATNQVHNSKVIGFHLSSLYS
PVGWYSWQQAVEDFLHAKESEQLLKVWINTTLGETWVDKGEVPDWKQLFNRREFFPVGTV
PRREVVLTAGVDVQKDRLEVEVVAWGKSRESWSIDYRVFEGDTGGGEVWGKLSELLNHHF
IGQNGLEYMISMMAVDAGYATQEVYNWVRGHQGAGRVMAVKGVNKALVPLSSPSRVDITV
GGQKLKRGIKLWPVGVSILKSELFQLLNILKEEEGKALPGYCHFPEYAPEYFKQLTAEQL
VSKVVKGYTKQEWQKVRERNEVLDCRIYARAASIALGIDRWPESKWNSLSEKPESKKPKK
VRQSKWLNEK
>ELAGILAN_00429 hypothetical protein
MYNEEYLIQVEEAIKKLQSGERVVSIAYGDHVVRYAEVQINDLLNLRQRIKAELKVAGMK
PKRKIVFSTSKGII
>ELAGILAN_00430 Putative nuclease YhcG
MIKIVERNFMTKVIAKEYTEFLEQLKEQIATSRYKAALAVNSKLIVLYHHIGTEILKRQK
EHGWGAKIIDQLSRDLRDAFPDMKGFSIQNLKYMRRFAEEYSENEIGQQAVDQLPWGHNI
VIMYEVKNKEERFWYIKKSCEHGWSRNILSMQIETNLYKREGKAITNFRNNLISPQSDLA
QQTLKNPYVFDFLSLGKKAHEREIEKALVAHIERFLLELGEGFAFLGRQYHLRVGDRDFY
LDLVFYHIKLRCYVVIELKAGKFRPEYTGKMNFYLSAVDDLLRQPGDNQSIGLILYRSKV
GVIAEYALRDINKPIGLAEYRITENLPENIKTALPTIEELEAELSKVSDQEK
>ELAGILAN_00431 hypothetical protein
MLLKSFKQLFNKPKIKSSAWDAAGSGRRFLHFQPELGSINNLLSQSLETLRSRSRDMVRK
NPYAANIIDTIVSNSIGTGIKPQSKARDGEFRKKVQELWLKWTDEADSNGISDFYGLQAL
VCRSMIEGGECFVRLRTRKLEGYVPLQLQVLESEHLDSKSNQKLANGNVIRNGIEFNRLG
QREAYYLFREHPGEGSFGESVRVPANDVLHIYRPLRPGQIRGEPWLSNILLKLYELDQYD
DAELVRKKTAAMFAGFITRLDPEANIMGESESNEQGVALSGLEPGTMQLLDPGEDIKFSE
PSDVGGSYEAFIRQQLRAIAIGTGITYEQLTGDLTGVNYSSIRAGLIEFRRRCTMLQHNI
MVFQFCRPVWDRWLELALLSGELDIGEEWTKGKEGAKKEVKWIPQGFDWVDPLKDQQAQQ
MAVRNGFKSRSEVVSEMGYDVEEIDQEIAEDQRRASELGLSFDSDVTANQEVL
>ELAGILAN_00432 hypothetical protein
MKQQWLNRCVMVEPRSFELLSLQAGKQPIFKNIKHAVRNSERGIIPIHGILTKKSETFDG
LLGMTSYEKIHEEIERALEDKSIETILLDIDSPGGEVNGVFDLADFIYESRAKKRIIAIA
NDDAYSAAYAIASSAEKIFLTRTSGVGSIGVIASHIDQSGFDEKQGIKYTTVFAGSRKND
LNPHEPITSESLENLKSEVNRLYGMLVELIARNRSLSVEAIKNTEAGLYFGEKAIEMGLA
DGMTILSSINKNRSITMNEQTTNDLETDNLTKYRTEVLELIRLCNISKMPEKIGEFIEQS
VSVEQAREVLMELLAERTKKTEILSAVPQNSGEELMMQVAKSRRS
>ELAGILAN_00433 hypothetical protein
MSCISEQNNLGDLLKYEVSSLYSRDQITVAKGQNIKLGAVVAKKTEDGLIRVLNPAGTDG
TQTAIGVIVSDVNAIENTKAVIVTRVAILADHAVVWPANITEEQKAEVIKQLEGRGIIIR
KGV
>ELAGILAN_00434 hypothetical protein
MQNPFTNTAFSMTALTNAMNILPINYGRVENLNLFPSRSVRFRHITIEEHNGVLSLLPTQ
VPGAPATVGKRGKRKVRTFTIPHIPHDDVVLPEEVQGIRAFGSESELKALADVITDHLQL
MRNKHAITLEHLRMGALKGIILDADGSELLNLYNEFEITPKVVNFALGTATTDVKRKCLE
VLRHIEDNLSGEYMTGIHALVSPEFFDALTSHAKVKEAYERWQEGAALRNDMRSGFTFCG
ITFEEYRGQATDPEGTVRRFIERDTGHCFPLGTASTFTTYFAPADFNETVNTLGQPLYAK
QGPRRFDRGTDLHTQSNPLPMCHRPATLIKIVAT
>ELAGILAN_00435 hypothetical protein
MQENIKRLFKDCFAHLGEVACYKSKDKSYMVQVLKQQPDKLYEIGEGQFVGEMLFLEVSI
FDVLRPMVGDIFVIDDRKYKVYSPPLRDNSGVVWNIKCTVFGEKDV
>ELAGILAN_00436 hypothetical protein
MFNIEVNENIERIIHNIDANKAKIELAAVRALNKTALWLKSQAVREISEEKQIRLKVIRK
RLRIIKARKSTLKVLIRAYLYDVRMRNIKQAKIRTAFNDAFMATMPRGYRGIFKREGKTA
LPIQEVKLPLEPEASRIIENLVNYEVERIFEKYFTHELFYDGILD
>ELAGILAN_00437 hypothetical protein
MTAFWTNLHEVICNTLKAEIPAIQTCEVYPAIRKELAAPAVFIELSSLEQGKDPGTEELA
LRAKFEARIVIDSTIENAPIIVRSLAAEVARVVNKNTWNVKNVSPGEFISGGGDDFRPEL
DAYLVWMVDWAHELHVGRSIWEVSKIKPHLIDVNVGK
>ELAGILAN_00438 hypothetical protein
MLESNFAISELRRKLANIVRIGIVEKIDYEKAKVKVKIGELVTDFLPWITNRAENWLPPN
IDEQVIVLSPLGELSLGVVLPAIYQEKYPPPENKKEVNSIKFQDGTKFTYDKGKHHLEIE
VVDKITLKVGESSIEIAKNEIKLKAKRINLN
>ELAGILAN_00439 hypothetical protein
MNKSVVRLGDHCEEALPHFCISGSRDVFINGRPVCRQGDSLSEGKVMTQGSKAVFANSKA
IARTGDLISCGAVAEQGSNDVFAG
>ELAGILAN_00440 hypothetical protein
MRGMNSETGKTISGIEHLKQSIVDILTTPIGARVMRRDYGSRLFELIDHPIVPGFAQELY
AAVAEALEKWERRFKLKRVQITEIKEGKVTLILEGIYLPNGKLIRLDGIIV
>ELAGILAN_00441 hypothetical protein
MKTPNIVETLKFEEIFSRMKEELVRRNASFSALTESDPAIKILEVAAWRELLLRQRINDA
AQANLLAFARGNDLDHLAEFYGVLRKESENDESLRKRVKAKIVGWSTAGSKEHYRYHALS
ADTRVKDAQVVSPIPGSVQISILSTENDGVPSEELLEIVRNHVIRDDIRVLTDTLTVIGC
GIIPITIHAKVHIYPTASKDVIEAVKEQFIKDLESAKGLGWNVTRSWIIAHLFIEGMQNI
ELTEPIEDIVVQDNECVTLNNLSVR
>ELAGILAN_00442 hypothetical protein
MILPPNASKQEQILTDIINYSLDANSLRGFKFNPQTEMLPWLVAEYGLGEILSWGKKATK
SALKEWVLAKQNGIRFQRLRGTPQSLKMALKWANIDNITIQEEPPGEHFAEFQIGISDVP
NDFFVDSVIALAKLSAPARSRLMRIFNDYYNAQRFMLDESIFGDLLSDYSGVRIAKEGPV
LSFGRKNSFELKIGNPRFKFSTFRSHYDRSYSNDLYRLDVAVLGETEPHTKNYNGIYERS
HEWYNLKALYPLPQGLLPEIKFAKALIVLSDSWNLGDINACFAPTAYKEIEHTFYLSEDK
LSEQIWNFRRTPILERFSITYYYEAKSFTDQRIIESNLREYHIDCQNDSDLKQKDPIHEL
ENYVAVFYPGMVTWHEHRHLNRPWKNFEPIITKKLDVFSTNLVYI
>ELAGILAN_00443 hypothetical protein
MSILTQSGRAAIAASIKEQPIHLAWGSGDSTWESSYKVEKTFTAGGKISLDHHTIKDVKV
YTGQTIYQSSIDYIVDGSSGAIERVENGAIIADSVITIEYTQDTPPELITSATLIKEVGR
RVVDEVLFCSGDENGELVTPSGRFKPSNVPINNLYLKFTFDFTDAANQVIRELGVMVGTK
IKEGLPEGQRYFEPKDVENPGILLVLEHTVPLIRTSATRETFSFVVTF
>ELAGILAN_00444 hypothetical protein
MTLNSYYNRFNPDKEYEKSLFLAGRGLQSAELNETQEYALSELKGIGDAIFRDGDVITGS
NCIIDRETGKVTLESGKIYLRGAVRKVEEEEFVIPLSTTVRIGIYYVESTITELEDENLR
DPAVGTRNYQEVGAARLKVSTTWSYQAEGLSPRFSEGEFYPIYNIENGVLIEHSPPPQAN
IVTTALARYDKEANGSYVVNGLEVMFLQKEEGEGGKKIFVINEGKAHVDGYEIELPHSIR
VSFDEDPDIKAVESEPHTFQPNSQRVMELKVRGCPETSKRL
>ELAGILAN_00445 DNA mismatch repair protein MutL
MAIILLDTKTINRIAAGEVIERPASVVKELVENAIDAGSLEIEIKIESGGRNLIIVTDDG
NGVEKNDLELAFMRHATSKLSDSELIEIKHLGFRGEALPSIAAVSRIKLSSKAREASEAW
SISYEGGEKIGEQTPYSLSQGTHIEVRDLFFATPNRLKFLKTERAETQSIVDIVNNLAMI
NYHIGFTLTSGNKKLLKYAKQTSLFHRLCEVEEEFQGSSLEINEEEDGIKLTGHICKPTV
NRGKSTQIYTFVNGRPIKDNLLIGAVRYAYHDFIPSDRYPFAALHLEIPYDQVDVNVHPN
KSEVRFQNKKLIYEIMTRGLIKALSRRIGTFPAHDQKMDSTLPDPFDKPDVQNERRPSPF
ENQLIKEFASPNEKAKGLSEQSKSFDYTGIQKFPAQAEAMVLEKKVLEQVDLIESHPLGF
ARCQVYNTYIIAEVRDKLIIVDQHAAHERLVYECLKQKSSIKRQKLLLPETVEIKNQAGM
EMIEIYKDKLFEMGFDIEIKSENKVIVKEIPAILGAIDVKEMLINIIDRLTEIEDTLPVE
DKVNKILATIACHGSIRAGRKMRLDEMNELLRQMEKTPYSGQCNHGRPTYIEMKLSDIEK
LFERR
>ELAGILAN_00446 N5-carboxyaminoimidazole ribonucleotide mutase
MTKIKKDVAVIMGSESDYTTMVHTVDMLKALEVSHDIFIISAHRTPERLFNFAKSAQEEG
FKVIIAGAGGAAHLPGMVASLTCLPVIGVPVHSKQLNGLDSLLSIVQMPKGVPVATMSIG
ENGAYNAAITAVSILSISNSEIAGRLKKWREKQTKEVKEKPVS
>ELAGILAN_00447 hypothetical protein
MEIISLNNLDSAGIKTKLLYIINKIVEKNAWTQAFAAEKLGIDQPKVSQIKNGKIDGFSL
ERLLGFLKKLDHEITITMTESQEIKSEAEKVKHEVESQ
>ELAGILAN_00448 DNA-directed RNA polymerase subunit omega
MAESIVEKCIERVSNRFKLVLLASQRTHDLNTGASNPIQAAKFKGHKNTIVSLHEIAGKQ
VDTHELFSLLVGRCKEYMKGNMNNVYSSNTSKLANLLNFSDNTDLDASQESQDYEVDGEI
DDEINDQDGDEEVSV
>ELAGILAN_00449 hypothetical protein
MSVMLCCIVSKSNDVYNKVLAFNNFSTQVVVLITAISIILNNFFLIDIALLYASVSFIST
IALMRLMLF
>ELAGILAN_00450 hypothetical protein
MIGSIFIFLGICLIIISNIGVIRFPDFYTRLHAAGITDSSGATLLLIGFALQNGFSINTV
KIVLLIFIIWVANSTNSYILARTHYKVKKKTVKEG
>ELAGILAN_00451 hypothetical protein
MLEILNVVLLLLLLTVTVFIVFSQHLVVSAVLMCVFSSLIALIYLIMNAPDVAITEASVG
AGLSTVFTFAALSLIKNHKVNLSHNPITLFFMLFLAVCLSYFMIQLPDFGSHNAPIHLHV
APYYVENTEKATGIPNIVTAILASFRGYDTFGETIVVFTAALCITLILKEEKEND
>ELAGILAN_00452 hypothetical protein
MIKDPILNAVTFLMIPFIILFGLYIQFHGDYTPGGGFQAGIIIASGIILYSMLFGVSTTL
KAIPYSVIRLTNVLGILIYGGTGVATTLLGQNFLSYDILLTNNRTGQKLGIFLVELGVAF
TVCSSMLIIYINFARRKKQ
>ELAGILAN_00453 Na(+)/H(+) antiporter subunit C1
MTLYNYTIIIVLMVLGLYIIINDKNLIKKMIGVSVFQASVLLFYISLGYIKSSLPPILVS
NFYSYSNPIPHVLMLTAIVVGIATFSVGLSIAVKMEEKYGTID
>ELAGILAN_00454 RNA polymerase sigma factor RpoD
MSTINDAEDKKKIIKDLVTKSIKKGGFITFDDINDKLSDENFSSDFIDDAISLLQDSGIN
VLESSEDEEDIPSNSDDSKLDDDDTSPNVTATLVQNDDPVRIYLQDMSSVKLLSRADEIE
IAKKIESEKHNMLRAIIETSVTLKVIKVWRDDLSNGALLLREIIDLDAIYNSDFNVVPKE
ESEESEESAEDVEDSEDVSEDAEYCSDDEKDSKKSDDEKDGNNEDISSVNLNVSILEMES
DLLPKVIVALDEIITLTNEALILRKNSKNFSNELENLYNQIWSIALQIKLSDAAVARITQ
ELYKINRSITLEEANLIAEARKYDIDRESFYKVYDDVLLKHELKKISLLKINENQSSFTG
ELKNKFLRFIDDNSEHIASTLNGIKQHIQEDNVQEFKELIKRIQKHEREVSEAKQEMIKA
NLRLVVSIAKKYSKRGLDLLDLIQEGNIGLMKAVDKFDYKRGYKFSTYGTWWVRQSITRA
IPEQSKVVRIPVHMVEIISKINRALRKMTHEMGREPTLEELSVELTMPLERIRKVMKIAR
DPVSLEAPTGKDDSSTFGDCIEDKRVSRPEDAAILADLRGITTNVLATLTPKEERILRMR
FGLGKDGKEHTLEEVGKIFNVTRERIRQIEAKALRKLKHPSRARKLRGFF
>ELAGILAN_00455 Phosphatidylcholine-sterol acyltransferase
MTNKNDNSNSKYRNFYVLGDSLSDNGAIIGILNNLSFAKSVKFDDPFYQGRSFSNSPTAV
EYIAKYLDLDEFKPGWSYSFFGRCHEQQGQNYAVSYATASEIFDPIFSYFFNKFRLANQL
DAVIKHHPDIGKEDLFCIIIGGNDVMVATAYDDTKAEEVLEQAVSEICNALKVLNEHGVK
HVVVANAPEVGSIPAFNRDEEARELATKLTESFNAKLAKGLDYMKKSTNLEIKAFDLNSK
MRSMFSEYKSKGLNCQDACTSNIADQVGRFKENIKILLKLIFKGELDVHYNPGCSKETLK
DYFFFDYFHPTAELHHEVGNEVYELI
>ELAGILAN_00456 hypothetical protein
MVLKCTSFNQGGRDYAKSLGITTKTDKIDCSIISRYINNTDMRVTPLTVSNGNIDCLKQK
LSRRNQLVEIAKIQKTQIQQVTDTSIIKQIEELLAILRNQIKTLEDEMITFIDQNQELKR
KYISITI
>ELAGILAN_00457 hypothetical protein
MNSSNIIAGIDVSKSKLDLHIHPLEHYKIFENNVQSIDEMLDFLRLHNVTKIGLEATGGY
EKLCAYTLLSNGFKVYVIQPRWERLC
>ELAGILAN_00458 hypothetical protein
MLRTSLYKYQSSDIKDTQRRGTVTPLDYKNRCSARFSSLVYYTESSEQLIELLGSYIRLE
NAVYVIITEEL
>ELAGILAN_00459 Carbamoyl-phosphate synthase large chain
MPKRTDIESILVIGAGPIVIGQACEFDYSGTQSCKVLKSEGYKVILVNSNPATIMTDPEF
SDATYIEPVLPEIIEKIIIKERPDAILPTMGGQTALNCAIKLADDGVLDKYNVELIGVNR
EAIKKAEDRELFRQSMDKIGLKYPKSIIIKNQERIKEALDYIGLPAIIRSSFTLGGAGSG
IAYNKEEFFNIAESALKISPINEVQIDESIIGWKEYEMEVIRDCKDNCIIVCSIENVDPM
GVHTGDSITVAPALTLRDVEYQQMRNASIAVLREIDVSAGGANVQFAVNPKEDGSLVVIE
MNPRVSRSSALASKATGYPIAKVVTKLAIGYSLDEIRNDCAPIIPAAFEPVIDYIVTKIP
RFEFEKFKGTNCELSTSMKSVGEVMSIGRTFNESLQKAFRSLETDLTGLDEVFPENIDID
HVKSQLAKLLPNRLLIAADAMRHGISIEEINSITGYDLWFLQNIQQIILTEQKIKENGFP
GTAYEMLELKKMGFSDARLAKLSNRPTSVIPVPSNVIPVRDTGIQPALHAGDRVKQIEEI
RKKFGIKQVYKRVDTCAAEFESSTAYMYGCYEGDVENKTECEANISDREKVVILGSGPNR
IGQGIEFDYACVHAASAAKEMGYETIMINCNPETVSTDYDTADRLYFAPLIAEDVLEILS
KEQENGTLVGVIVQIGGQTPLKLAKVLNERGFKILGTSFDSIDLAEDRMRFKNLALQLNL
KQPGSSICYSVEEALTNAEKVGFPLVVRPSYVLGGQSMSIRHDTQSFKEYVLNQTKIFEH
GSLLLDKFLVNAVEVDVDAVCDGEKVFIAAVMEHIEEAGIHSGDSTCSIPTNTLSDEVIK
EIKLQTERIALALKVKGLINIQFAVQENRPLAEPVCDEKFLGKVQMSTTEYSNVFEERRQ
ALTTKLPSEIELCKRSSDVYILEVNLRASRTVPFISKVINIPIAKLATQVILGKKLNQEN
KPFNHFAVKAAVFPFTRFAGVDTLLGPEMKSTGEVMGIDSSFEAALAKVHMAAGYKLPTE
GAALVSVKDDDKEYILPVVRMLKELSFEIYATKGTALYLNNNGIAAKAVNKVREGRPHIV
DMLKDGKINLVINTSKGVKSVSDSKDIRRTAILQNIAYSTTASGSKALVLAIQYVKNSKL
EVKSLQQIQNV
>ELAGILAN_00460 DNA replication and repair protein RecF
MATHCYIKKLKLHNFRSHSNFELDSDDSSVVITGKNGIGKTNILEAISLLAKSNGMKKAK
ASEIQNRFSNEDWVVHYDFFNGMDFNSIGIAKSFDKKLIQIDGKTQSSYSSLYKISNVIW
LIPQMDYVLLNSPSDRLKFLDRIVSLFEENYTCCYMKHRKAKRERSKLLRENTLDKNWLS
SLENIMAVNAVSILRMRSSVLKTLQDTIDNHSGELFPKASLKFSSQLTLDDTAEYFQNRL
KENREKDSLTGRVTFGVHNDNFRVFCQKRNVPINLCSTGEQKLLLLSIILSSVKARCIHY
NKAPLLLLDDIMSHLDKHYRKALIEEVLSIQCQTWITDVNQDNFNSYLYSFKFFELSNEL
NAKLP
>ELAGILAN_00461 Putative peroxiredoxin bcp
MELAVGNNAPDFSLPTDSGENLSLSEFFDKKNEVLYFYPKDDTPGCTMEAKGFRDKIDDF
SFLDTVIIGVSKDSVKCHTNFKAKYSLPFSLVSDENAEMLGKYGVWVEKSMFGKKYMGIE
RTTFLIDKKGKIVKIWKNVKVSGHVDEVLEEVKRI
>ELAGILAN_00462 Sensor histidine kinase RcsC
MYKIGKLMFSALGKNKYTKVIALFSSIFMILFSVIYCNYLLRSNFLSSYRDSSVNLKSVL
ENGIIKKYHYLLIEKHHIKYKNFDYINQLVKLRAELLQSVSKVKDFSLILYDQNGRIIFS
NFNTQDYDYEQLLTNDEIDKLLSDQEILYTTGNTLTSIFPIFHENSAKPSFFLKILRSYN
NSYVIAYGLFLIFLGLLLIILILIMFYLHFSNTKMLAKQHKTNIELQQIKEALEQENANK
LKFFASVTHELRTPLNAIIGFAELIKNETLGSMDDSQYKEYADDIYNAGTHLLALINDVL
DFSKAESSSLTVEKVKFNLNKIIDSCVNMLLPKLKEAGINLKKEMTNKQLLVIADPKRMK
QVIINLLSNSIKFTPKDGLIRMVIKENIEKNLLTIEFHDNGIGIMQQDIYKVMSVFGQAD
SGYRNEGTGIGLPLSKKLVELMGGTFDIKSEAKLGTTITLNFFYEEQTCEDSIDF
>ELAGILAN_00463 Acetylornithine aminotransferase
MTISPILPVYSPININFSYGKDIYLYDIDGKRYVDFHSGIAVSSLGHTNSRLISALKLQG
EKLWHISNTYNIPAANNFAEKLINNSFADTVFFSNSGSEAVECGLKIARIYQNGKGNKNR
HRILTFHGAFHGRTFLTCATNDKQKFSELLNPYIDWCDNIEPNIESVKKAISSGIGVILI
EPIQGQGGIKVMNEVFMKELRRLCDENDILLFFDCVQCGAGRTGKLFAYEHIGVEPDICA
LAKGIGGGFPLGACLATEKAAKYMAVGMHGSTFGGNPLATSVGNAVLEELLSPGFLKNVE
IRGKYLKNKLEDLASKFPIIEEVRGKGLMLGIKVKADNQKFAEELSHRGLLTVGVTSDNV
VRILPPLIITEKEIDEGIEILTQYLSEKSSD
>ELAGILAN_00464 Ribosome maturation factor RimM
MNDNLVCLGIITSPHGIKGAVKVKTFTEKPENISLYGKLISGDENYKIDSVSVIGDNLVI
ATISGVNSRNEAELLRNKKLYIERSKLPELNDEDEFYQSDLVDMEVRLKSNELYGYVKSV
YNFGSGDILEILVISTKKRIMLSFTKEIFPHINIKGRYIVLNIPEFID
>ELAGILAN_00465 Elongation factor P
MAERANDIRPGQVLEHNGGLFLVVGIMHTQPGKGGAYIQAEMKNIKTGAKHYERFRSDAT
IRRAILDEEEYVYLFTEGNIVNLMHPSNYEQITINLDLLGEKKIYLQDNMKIKVVAYQDK
IISAHVPDYVTLAVKETESVIKGQTATASYKPAILENGMRVNVPQFIKEEDKIVVYTPDD
SYYERVKE
>ELAGILAN_00466 Inositol-1-monophosphatase
MSISSPRINVMLDSVRSASRQLMRDFNELQISNVKSADFINKTYSKSKQTIYDCLHDYKR
DYDFIFEDDTDQEVKDDTYTWFIMPIEGRENFSSCMVYFAVSVCLIHKNKVVAAVIDAPA
LRETFWAEEKKGAFLEDFRSRHIKMRVKSREGGLIDVSGNLLNKLLPGNSSVRSIGSTIL
GFAYLAAGRHRGTVYSGVNKYKTLLGRLFLQESGGRLTEDNGLIIAGDIKL
>ELAGILAN_00467 5-aminolevulinate synthase
MVNYEEIFLNKIKDIKEEGRYREFTHFASLPGRLPHIMDYERNREVIVWCSNNYLGMSQN
ESVIAAIQNSSVGAGGTRNISGTTKEVVELEKSLACLHKKEAALTFACGYLANQTTLSTL
SSVIPGVVIFSDEKNHSSMIEGIKSGKRPKHIFKHNNVNHLEQLLKSIDKKTPKIIALES
VYSMDGDIAPLEAICDLADQHNAITYLDEVHAVGMYGSHGGGIAEREGLMDRITVIQGTL
SKAFGVMGGYIASSKSLVDVIRSSAPGFIFTTAMSPVLAAAAKASVEHLKSSNIEREKQK
QVVEKVKNSLRNAGINFIPTETHIIPIIIGNSELSKKASKLLFDEYGIYVQHINYPTVPR
GTERFRITPTPYHTDEMIEHLTESLVKVFEKLSISLACLCYS
>ELAGILAN_00468 hypothetical protein
MELSPSMTRNEYQKNRDTLSHLYLIRNLLESSKLINTSSKANIHTQANTQVNKRSSSDNA
VSPVIKGDTAVVNEENNNQPSSQRNPKSKSAGSQQTEKNVLAGEEENAILNNTGVSTQEP
LINNFEEGEIKKGSGKKGVKQLASPVKKKIDGLISKTSTNSREELENILKSNSPTLVLQY
VKNKEGPFKGKVEEIKKEIKNHNTKQGNVNISLNNDLPNSGDQSTSSNNTGSNSTLTTTP
EITGCEKKLGVSEVSSNADNVSTIGGVINSKEKPAAVEKTSAINNQSTSITATQNTQKSK
WPTIATWTLAVAGVVSGVAIAVYLEMLAAGIAVGACCLVAAAVIYCCTPKSQVENNKVDK
PFNTKEASTTVSV
>ELAGILAN_00469 hypothetical protein
MFGSNFRDFVSQDATSQGQSNSERLIKSWHGFERSDSEDSGIEEGFEVLDGKSQEIPANP
CDTPPENLSLENAILANFPDGCDRSFTVELKDEDSYGIIPKNLTFAEIINILNQAIQEDN
CEELDKVVQNIEDYEGRSITLDNENLKDFCSNQLNLELQNGSNHQHIYSNVLSQYKFDQE
GFKYDYSVKELVLLAIAANDKLVEQYQDFLFAEGNLSLLPILVGGQEYVKAFIGRFHDTD
GIYGRLKDQTIQLVEPNKIDFFSVIALRKEQELLNAVFVEYVLRDFGQVLKTSNPDSLYG
VLETASLIKNEEFITIVLGAFERYINKLTKKASTEELLKKSFVTLLETAISQEHTSVIEY
LCKRYTNSADHAIYDVYEQAFADDKVITILGQQILKNIGARGRKEIYDLILKTALDAGNI
AFIEHLCKECAECSNDVINYFDHKLKNNEFDETYESILVALSNTGSQNIIASVLAHVQIY
QSIPNNKQQVVRQTIQSILRNAIKEANCEVVVLLCQHVDLKFAALQAICKEEF
>ELAGILAN_00470 Chaperone protein HtpG
MHNVQETENLKFDAEVGKVLNIVIHSLYTNKDIFLRELISNASDACDKLRYESQLNPNLL
DLSDELKITISSNKDKNELYITDNGIGMNRQDLIDNLGTIASSGTQKFLDAIKNSKDSSQ
TVELIGKFGVGFYSSFMVASEVIVESRKAGEEESWIWQSKGDGKYSISKSDNQVPRGTKI
TLIMHPEENEFLDKFRVENIVTTYSDHINFPVEFIDEEGKSEKLNSKAAIWTKPKNDVTQ
EEHNDFFRSVAHVGGEPWMILHNKNEGAIEYTNLLYVPSIKPFDLFHPDRRCSVKLYVNK
VFITEDNVQIIPQYLRFLKGVVDSPDLPLNISRETLQNNRVVEQIRKSLTKRVISELGKK
AKENLEEYTKFWTNFGAVLKEGLCEAMPTDEREALLSICRFHSTGDEKLISIDDYISRMK
PEQEHIYYLTGNSLDSVKNSPQLEGFVSKGLEVLLFVDPVDDFWTSVIHEYKDQKIKSVT
RADVDLEKFSSEEDKTDEENKSNGEKTEETILQYFTTVLGDSVKSVKISKKLTDSPVCLA
VDEGAMDLRMERFLREQKQLNYRTPKVLEINTKHPVIKSIMKSHAENGENPTLEDMIHLL
FYQACIVEGEEMDDASSFAKRLNNLLGKISV
>ELAGILAN_00471 hypothetical protein
MLVSEQIESVDREELKQQNHIHKDTECSEETTIYGHINQHMEKNISNTLHEIYDALMSYN
ESEQPMAST
>ELAGILAN_00472 GTPase Der
MLKIAIVGLPNAGKSTLFNRLVGRKAAVVSNIPGVTRDRREGMGRISDLEFKVIDTGGWN
DQTSFSLQVIEQIEFSLSSSNIIFFLVDAKVQNERNKEFAKWLKRKINKPVILIANKCES
HKSENVDYLQFFDFLGPVYISAEHNLGMVDLYDALAGVIENFNENTELPNNELSRLRIAI
IGRPNVGKSTFLNGLLAENRLITSSEPGTTRDSVDITYDHDGELITLIDTAGIRRKANVV
DGLESRFVEKSMESIKRSHVVVLMLDSLVGIEQQDLSIGEAAIKGGKGIIVVLNKWDLIG
KDDRSRLIKFVKQQEVTRLFLEVPTITISALKGMRCGDVIDKCLEVSESLNKKISTAKLN
KWLIDAVGKHSHPLVKGKAVKMKYIAQIGTKPPAFSLICNIPESVDESYKRYLINDLRKN
FFADGVPVRLLLKKNKNPYVK
>ELAGILAN_00473 Disulfide bond formation protein B
MNTLLYTFRDNLLKVMCNNSRIPAIFLLSSAAALIFAYVLKYFFNMLPCKLCTYERIVYY
IAGLLAVACMLKDNKILIYAMFCSYLIGAVISFYHIGLELHLFHDVLGCTEQASGNVSIE
ELRNNLLNPNYSPSCDRPHYVLGVSLATWNLIYLIVALFVSGKVYCGERKKSK
>ELAGILAN_00474 2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase
MEKERNLNNLRYSNNQFLQQAIRVDHAGEYGAICIYSGQKFILKKSSIINEIIEMEEQEK
KHFHYFNEKIKEQKVRPTVLLPVWRVLGVSLGVATAIMGKKAAMACTAAVEEVIGEHYKE
QVSHLEDGELRETISKFRDEELEHKDIAIQHNAESAFGYNILSSFIKTGCKTAIYLSKLI
>ELAGILAN_00475 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MILATKVFFTSFVFGFILFPYFIKLLKKISKDGQPIRSCGPESHLITKKNVPPMGGIIIL
TSSLLPILLWVQLTPEILLLILITLFFALLGFIDDYLKLKTNHYRGLSAKTKILIQFIVA
LVGVFILKLYSAECFTKTSLFKGVIIDFGYLYVPFAAFVIVGSSNAVNLTDGLDGLAATQ
VITSFAFLGLIAYITQADMNITLFCIAFIGAILSFLWFNTHPAKIFMGDVGSLSVGAALG
LTSVLIKREMLFAVIGIIFVIETLSVIIQISYFKYTKFKYGEGKRVFLMAPMHHHFEKKG
WSENVIVMKFWIISIICSVFTITFLL
>ELAGILAN_00476 Ribonuclease HII
MKYPDFTLENKLSGVIAGVDEVGRGPLAGPVISAAVVFIDRNTIIDGINDSKKLTPQCRQ
VLYEKIISVAKFGIGMASVEEINSYNILQATKLSMKRALIDLDLELDYVLVDGNQPPEVK
WQVKSIVNGDNLSTSIAAASIVAKVTRDRLMQELHNKHPEYNWYKNKGYGTKEHLNAIGL
YGITEHHRRNFAPISRAL
>ELAGILAN_00477 Type IV secretion system protein PtlF
MIGLLFAVLLFLCGSDALAKQEPRSIAGDNHIKVINYNPQAIHKYTGFYGYQSSILFEPG
EVIQNLSMGDSTGWQLLPQGNRLFIKPIDDIADTNTTIITNKRVYYFEFHAEEATGLDDP
RLAYEVRFLYPLFSSDEIYTTNNGDILEQASHTIIPDINDIEVVKKGLNFNYSISHVKGS
QSIIPIKVFDDGKFTYLQFNKINSDFPAVFMVDSAGYESLVNFRTVDNYLIIERVSSVFT
LRNGSSTVCLFNETIPFKKG
>ELAGILAN_00478 hypothetical protein
MRRSNILEITAGLFVLIFTIFLIFFAIDKLSYIKKNYKDCYKIYGLFANANGIGVGDSVK
ISGVDVGSITGVSLDKATYVARIDMCISKDIKLPIDSSALITSSGVVGSKFVNISPGSDI
KLILHGGKIEYTQAEANMGGIMDRILGMFTK
>ELAGILAN_00479 hypothetical protein
MLSKICNAIKRLLRREDKFVGRDENGNSYYESSKGKRWVMYSSVSEPTTVPPEWHIWLHY
TDNVVPVNNKKRKVKHTPNLTGTKDAYYPNQKVKNYYKSWSPDN
>ELAGILAN_00480 Na(+)/H(+) antiporter subunit D
MQLPILQVIIPIIASMFCFLAKKHKVSWFISFIATTITLIISSILLIKTYRGEIITYHLG
NWAPPYGIELRIDVLNSLILTLVNFIALISVLYSFYINEKEISKNKITGFYSLFLLCLSG
LLGILVTNDIFNLYVFLEISSLSSYVLVSMGRDKKALVAAFEYLISGTIGATFYLFGIGL
LYSMTGTLNMSDMAERIVPLYDNNIIKLGTLFIFVGLSIKMALFPLSRWLVNAYSEAPSF
ISIFFSGTVTKVMIYVFIRIFYTVFHQNFFLFKPLLDNVIIILALCAIVFGSIFAITAKD
IKRLLAHSSISQIGYIILALSFNSKTGVFAAILHIVNHSIIKTSLFMAAGCISYKFDTTK
IENLSGLKKSMPYTALAFTLLSLALIGVPLTNGFVSKWYIMKAIIESHAWISLVTFAAGS
FLALIYMWKMVEKMYFENDATSRTGMTLGKINDVPFPMLFCLLFMAALTVVTGIYSTPIR
LVVEKLVF
>ELAGILAN_00481 Peptidoglycan glycosyltransferase MrdB
MDRLKKIHWLLVINVIALFCVGIVVQYSSAGGKWVPFAIHQLIIFSFFFLLAIAMSFIEL
DFYLKYAYFFYIAAAISLLAVNFFGSHIMGATRWIRIGSISLQPSEFAKVGLILALARYF
DKQSVYKMMEFKRLLKALIIIFLPVFLVLKQPNLGTAMIMLFIGISIIFTTIIKRSHSVI
CGTLGIFAVPAIWPFLRPYHKQRILSFLDSSVDPLGIGYNAQQSQIAIGSGGLFGKGFVN
GSQTQLGFLPEKRTDFAFAVLSEEWGFLGSMTLILLYTTLLAIMLSIAYRSKNYFSKSVS
IGIFAFFSAHFFINIGMTMGLLPVIGDPLPFLSYGGSTTAASLICIGLLLAIKADEQQNT
CILPMLK
>ELAGILAN_00482 Amidophosphoribosyltransferase
MLDEMREECGVFGISCNQSAAFNSILALHALQHRGQESFGVVTSNNDKLHSYHFQGQVSS
IFDDIDEIKKSLPGDCAIGHVRYSTSGSKFGVQPMFGKSGKFGDFAIAHNGNLINISPIR
EQLIKQECVFQSDIDTEVVVHLTASGEKDSFLESFIYALKQIQGAYSFVAINQEVVIGVR
DPSGIRPLVLGKLNGSYVLASETCALDIVNAEFVREIEPGELVTIDRNGNLASAFPFPQQ
KSSFCIFEYVYFSRPDSIMENRSIYDIRKEIGRILAEESPPKNNMDMVVPIPDSGIPAAI
GYAKHSGLPMELGIIRNHYIGRTFIQPTAEVRKVRIKLKFNANKHTLKGKNIILIDDSIV
RGSTLTNIIVMLKDAGVKEIHLKISSPPIKHSCFYGIDTPECKDLIAANKSVKEIKEIIG
VDSLAFLSIDGLYQAVKGEVRNNAIPQYCDACFTGDYPIGK
>ELAGILAN_00483 Putative 3-methyladenine DNA glycosylase
MGSTILPRNFYERPTLTVAGELLGKVLKFSNFSGIITEVEAYIGMNDPACHAARGYTNRT
SVMFGMPGFSYVYFIYGMYYCLNIVTETEGFPAAVLIRGLKLIEPLEANLGGPGILCKRL
NITKEHNKQDLTISHKFCVYESHLKPDYICTPRIGISKGQEKFWRFKIF
>ELAGILAN_00484 Holliday junction ATP-dependent DNA helicase RuvB
MKSISCGKEYTEDVRNINIRPEQLDDFVGQKDLIQNLKVFINAAQTRTEALDHVLLYGPP
GLGKTTLAQIVSKELRVSFRATSGPLLSKAGDLAAVLTTLNAKDVLFIDEIHRLNRSIEE
VLYTAMEDFCLDILVGEGPSTRTLRIDLPPFTLIGATTRLGLLSAPLRDRFGIPLHLEFY
SFEELVNIIKRGARVLSAEIEEDAAREIACRARGTPRIALRLLRRIRDFVEVKDDKKITY
EVADSVLLKLGVDKMGLNKLDMNYLRFLFNTSGPVGIDTISIALSEDVGNIEETVEPYLI
KISFVKRTPRGRVLTDQAKEYLSL
>ELAGILAN_00485 Holliday junction ATP-dependent DNA helicase RuvA
MIGNLSGIVDEVRSDHIILNVNDVGYMVYLSAKTLSACAIGSRIKLLIETYANNRENTTQ
LYGFISEEEQQCLRLLVKVSGVSYKTAMSILSKLTPEQLFLAIMNEDKVTLKMSGLGLKL
INRIITELSGKVSKLEINNNNFHPINEDALSALINLGYEKMKAYDTIKKYRPNLDTKDII
RMALKELSTL
>ELAGILAN_00486 hypothetical protein
MLDHNFAIAELNRKLANIIRIGLIKEVDYEKARVRVKVGEFITDWLPWITARAGEDRSWF
APNIDEQVVIFSPLGELSLGVILAGIWQQKYPAPESKKEVDCFLFEDGTKISYDKKNHHL
EVSVVDKITFRVGESSVKITKRGIKLKAKRIDLN
>ELAGILAN_00487 hypothetical protein
MIVDGTVEDSSVVVRSLAAEITRVVNKNTWDVENVSAGEFISAGGDDFRPELDAYLVWMV
EWVHEIHVGKSIFSGGVTPHVIEIGKAHVRP
>ELAGILAN_00488 IS110 family transposase ISWpi13
MTKAKSKLEIVNPNASGIDIGSAVHYVCVPEGRDKQRVQKFGCFTADLHNLARWLKKCKV
TTVAMESTGVYWISLFQILESYEFEVKLVNARHVKNVPGRKSDVQDCQWLQQLHSYGLLR
GSFRPDNQMCVLRSYVRQRKKLTESASTHVLRMQKALIQMNIQLHKVISNITGVTGMKII
EAIIEGERNPEKLAEFRSSNIKNDKATIAKALTGDYREEHLFVLKQELELYNIYQEKIAE
CDENIENYYKTFETKFCGNKQCSKIKNRSTKNRPNFSIHEELHRVTGMDFTKVPGLDALS
IQTIISETGINHNKWPTEKHFSSWLGLSPANKITGEKVFSTRTCRVINRAANAFRMAAHC
VSRSNSGIGAYCRRLKKRLGAPKAITATARKLACIFYSMLKHGQEYVEKGIDYYEKLYKE
RVLKNLSKKASELGYVLTKKHELI
>ELAGILAN_00489 hypothetical protein
MFWGNLHQAICNKLREEIPAIQTCEVYRAVRREIIAPAVFVELASLEPGKDPGTEELALR
ARFEASNEQIKSVKR
>ELAGILAN_00490 hypothetical protein
MKNGHIGIFKRRYTTSLPIDEIKINTQARETMKELVDNEVERVFEKYFDQQMSYMK
>ELAGILAN_00491 hypothetical protein
MRINIEVTDSIEKVMQSIDAEKAKVEKATVRALNKTALWVRSQTVKQVSEEKQIPKKAMR
KKLSGDKANRKRLWSIVKLSSQ
>ELAGILAN_00492 Outer membrane protein assembly factor BamB
MKLAIFFIAFLLSTSCVIAKDGVEPSLEIKNKYRCHPWNNPSREFSQGYIQPIPIHESYE
LIIGGDGVLYNTGWYWKDVDLSGSHKTIGRMSATCSEYCREIYLAIDNVLYAINRDNTQY
EINEDAVMWKKELKSLVKGNPTIFNDRIAILTVDNYLYMLNIENGNTSWFYHMSNGSNQI
NYISPVVIHDKLIVPFSNGELVAFDKDGKKLWSYKLPSTNILDTQLADITTTPVVKNNTL
IATNNSTIVAIDIGSGDLLWLKAMEAKNISGGGIMPWLYPDDINGNEFFVVNTKNEVMKV
AIPDGQIIWSTNLVVNDELNDKLKDTYYARPVIDGKLFIVSNKGIMFLLDENSGMIEEIV
SIPEDVYHTPVTDLGVGDYYFTTEKKGVYSCIDPNISR
>ELAGILAN_00493 hypothetical protein
MFRDIKRLFADCFAHLGEQALYESKDKSYMVQILKQQPDKLYEIGEGQFVGEMLILEVSV
FDILQPVVGDIFIIGDRRYKVHSPPLRDNSGMVWKIHAVRM
>ELAGILAN_00494 hypothetical protein
MQNPFTNPAFSMTELTKAINILPINYGRTESLNLFPSRSVRFRHITIEEQNGVLSLLPTQ
VPGAPATVGKRGKRKIRTFTIPHIPHDDVVLPEEVQGIRAFGSENELKALANVVTDHLEL
MRNKHAITLEHLRMGALKGIILDADGSELLNLYNEFEITPKVVNFALGIATTDVKRKCLE
VLRHVEDNLSGEYMTGIHALVSPEFFDALTSHAKVKEAYERWQEGAALRNDMRSGFTFCG
ITFEEYRGQATDPEGNVRRFIEKDTGHCFPLGTASTFTTYFAPADFNETVNTLGQPLYAK
QEPRRFDRGTDLHTQSNPLPMCHRPGILVKLAA
>ELAGILAN_00495 hypothetical protein
MTSITEGNNLGDLLKYEASNLYSRDQITVAKGQNLKLGTVVGCDTKDGLIKSLNPTATDG
TQTAIGVITSDVNATETTKAVIITRIAMLADHVVVWPTNITEEQKAAAIKQLEARGIIIR
KGV
>ELAGILAN_00496 hypothetical protein
MLTYAAVNCMSEPIIGREKETAILENKLLSQSAEFIAVYGRRRVGKTYLIKQFFSKRDVV
LFEQTGLNKGKLKAQLEIFVESLSRAFYNGIRMAVPKNWMDALHQLTLSIDIYRDKQVVI
FFDELPWLAARKSGFLVALEHFWNVYWTYRKKLILVVCGSAASWMLENLIYNKGGLHNRI
TARIGLQPFNLRETKKYLRYLGVNLNHQQILQIYMAMGGIPHYLKEISKGLSATQNINEI
CFQKEGLLFDEFDMLFHSLYEEPETYINIIRTIAKKPKGISRKELIKATKITEGGYLTTK
LRSLEEAGFIGDFLPLNKATRGAYYRVMDEYVLFYLTWIEPFREVMKKAITRDVHYWELA
IKKPAWLTWTGQAFEAVCFKHANTIRRKLNIEHMGFICGDWQYHSGKNSKESGAQIDLVF
DREDGCTTLCEIKYSDKPYTITKEYIEQLRKKEAIYKEKTRSKKQIFWVLIAANGATENQ
YLKDIINNVITLEDLF
>ELAGILAN_00497 hypothetical protein
MMIEQRSFDLLSLHAEKHPTFKNIKHAVRNSERGIKVIPIHGILTKKSEAFDDVLGMTSY
EKIREEIEEALIDEEVETIILDIDSPGGEVNSLFDLSDFIYEARGLKKIVAIANDDAYSA
AYAIASSAEKVLVTRTSGVGSIGVIASHIDQSGFDEKQGIKYTTVFAGSRKNDLNPHEPI
TSESLESLQEEVGRLYEMFVELVARNRNLSTETIKSTEAGLYFGEKAIEIGLADEVITYS
EFIDRRNNMSKAEFNYKGHTIDADELMEESKRIGYERCRKEVLEVIRLCNLSKMPEKIGE
FIEQDVNAKQAQEILMSILAERTKKTEILSTIPQSTPEDLMMQVAKSRAKSGI
>ELAGILAN_00498 hypothetical protein
MLLKSFKQLFRKPTKPKSSAWDASGSGRRLLHFQPETGSINSLLSHSLETLRSRSRDMVR
KNSYAANIIDTIVSNCVGTGIKPQSKAKDAEFRKKVQELWLRWTDEADSSGVSDFYGLQT
LVCRSMIEGGECFVRLRTRKREDGLCVPLQLQVLESEHLDNKSNQTLANGNVIRNGIEFN
RLGQREAYYLFREHPGEGSFGESVRVPANDVLHIYRPLRPGQIRGVPWLSSVLLKLYELD
QYDDAELVRKKTAAMFAGFITRLDPEANIMGEGESNEHGVVLSGLEPGTMQLLDPGEDIK
FSEPSDVGGSYEAFMKQQLRAIAVGTGITYEQLTGDLSGVNYSSIRAGLIEFRRKCAMLQ
HNVVVFQLCRPVWDRWLELAILSGELDIGENWAKETAKEVKWIPQGCAYVDPLKDQQAQQ
MAVRNGFKSRSEVVSELGYDIEEIDQEIAEDQRRASELGLSFDSDVSSFDSNTEII
>ELAGILAN_00499 Lysozyme M1
MRSYMVENEYPDFLEHLKYIIATGNMASGKFINALVDLSHWDRNIDFKLAKEDGILGVIH
KATQGVEYVDPEYAKRRKTAEEEEILWGAYHFGVGENGKDQADHFLETIGDSSDVLLALD
IEENKGGKSITAKQAEDFVNRVYVVTGRLPLIYGSPYFLKDFATPILTECPLWLSKWGAE
PTLPIGWKKWTLWQYTDGKTGPKPNSVEGIGPCDRNKFNGTLEELKDFWIS
>ELAGILAN_00500 hypothetical protein
MYSEEYLAQVEEAIKKLQSGKRVVSIAYGDHVVRYGEVQINDLLSLRQRIKSELKVAGVK
PKRKIVIATSKGVI
>ELAGILAN_00501 hypothetical protein
MIYSSSFYTGLKPDPLLKVSEGADKNRQLSTIASSEPGKWRTERTPYLREIMDSLSSSSP
AEKVVFMKGAQIGGTEAGNNWIGYIIDQTPGPMLVVQPTVEMGKRWSKGRFAPLIEDTPC
LRSKIKDPRSRDSGNTVQSKEFPGGTVVVTGANSPVGLRSMPVKYLFLDEVDAYPGDSGG
EGDPVLLSIARTNTFTRRKIFLVSTPTVHGISRIEKEFESSDKRYFFVPCPHCDHYQVLK
WPQIKWKDKDPSTAHYVCIECRGEIKNHQKTEMLARGEWRPTNPIKGEKKGFHLSSLYSP
VGWYSWKQAVEDYLHAKENEQLLKVWINTTLGETWVDKGEVPDWKQLFNRRESYPIGMVP
KSGKIVLTAGVDVQKDRLEVEVVAWGRNRENWSIDYQVLEGDTGSGEVWEKLSELLNHHF
IGENGLEYMISMMAVDAGYATQEVYNWVRGHQGSGRVMAVKGANKALVPLSSPSRVDVTV
SGQKLKRGMKLWPVGVSILKSELFQLLNVLTEGAPGYCHFPEYAPEYFKQLTAEQLITKV
VKGYTKQERQKIRDRNEVLDCRVYARAASIALGIDRWPESKWESLAGEKAKKSKRVRKSK
WLSEKNVQ
>ELAGILAN_00502 Beta sliding clamp
MSEVAGVDTEIKKQNSVCEQMRFSVSRTSLLNTLSRVSGVVERRNSIDVLACINIKAQHG
SIKLMATDLDISMFASLAATVLTEGEVKISAHTLHDIVKKLPADLDVNFEVNNQGKLLMS
CGNANFSLPNVVSSSFPALEEDNYKHDFILLNTDLIDLLTKTKFAVSLDDTRYNLNGIYL
HTDEQFLYCVATDGHRLSCIKRPKPGNINGEFGVIIPRKTVMELLKILDDCNEIKVKLSD
RKIKLTCGEYILISKLIDGTFPNYKAVIPASQDKHMIIESKKLSDVIDRVSVVVSDKVKS
IKFSLQEKLLTLHSNSQECSDATESIEVDYNEAPIEIGFNSRYLLDVLSCIKNKCKFSLA
DGNSATIITDEDDSSVLYVVMPMRT
>ELAGILAN_00503 hypothetical protein
MRSFFIFLIFFSIGAFASVSDVQLKEKYKDWLVYTALEDGEKVCYIVSYPKKKSEYYTTN
RKPYVMVSYVDKKADEVSVTSGFQYDKEPVALNIDKKIKYTLPIIQGSFAWAEHTKIDQD
LILKMKQGLSMVVNGKTKTVTIDDTYSLLGFQKAYQKMHDLCHTK
>ELAGILAN_00504 RNA polymerase sigma factor RpoH
MLTSMANLCVDSRTNLMQYIARVQKFPMLSQEEEVRLAKNWNQYKDVSSAHKLITSHLNL
VVKIAMKFKNYGLLLMDLVMEGNMGLMHAVKKFNPDLGFRFSTYAVWWIEASIKDFILKS
WSFVKIGTTQAQRRLFFSLRKIKKRILQYTNRETLNNEEIKAISNELSVSEGDVLQMNYR
MACKDQSLNDCIKIGDDSKRELQDMIPCNLVSQEVTYQNHEEKELKEAILNNALASLNER
ARDIFISRYLSENIQTLDELSKKYCVSRERIRQLAEQAMAKVKQYIQSESLKFCLHA
>ELAGILAN_00505 hypothetical protein
MHYKKFFSAAALATLLSLSNSAFSDPVGPISDEETSYYVRLQYNGEILPLFTKIEGIEYK
KATDIHNPLKASFIAGGGAFGYKMDDIRVDVEGLYSQLNKNDVTGAAFNPDTVADSLTAI
SGLVNVYYDIAIEDMPITPYVGVGVGAAYISTPLKDAVNDQKSKFGFAGQVKAGVSYDVT
PEVKLYAGARYFGSFGAHFDKDTAAASKDKGELKVLYSTVGAEAGVAFNF
>ELAGILAN_00506 Nucleoid-associated protein YbaB
MDFSQIMKQAQEMQKKLAEAQEKYVGKEFQGISGGGKVSVLVEVIKIGSYKAKKVNIDLE
LMRNEEKDIVEDLVTAAFNDAVKKAEEDMANATSDLAGMMGLPSGFKLPF
>ELAGILAN_00507 hypothetical protein
MNIALKHRPSSFKDLVGQDILVRVLENAFILNKIPQSILLSGSSGVGKTTTARIIDLCLN
CSLGPIFEPCGSCENCLAIKNSSHPDVIEIDAASHTSIDDIKVILGDICYSPISSKFKVY
IIDEVHMLSSSAFNALLKTLEEPPSSVKFILATTEIKKIPITIIARCQRFDLHNIPVAKI
VERLNDVAQKESYSIEKGALELIARHSGNSMRNALFLMNQAVLYSKDGAISTKNVTDILG
LVDKDIIFDLLGAILEGDLQKALSVFDKAVKTANPLSIFEGLLQTIQLVCRFLITKEIDN
AVTEHEKNRIKDLSIKRSLIFFSRLWKMLLKGIQDIKTSTCNDVAAEMMLISLCYLSDLP
SPEQVIKKVLSQNVEQGNRQGRPVAPSPSVIQVADYSDPKKYVESKQQPHSVIPVRDTGI
HVENKQQNYDFDKILQLLRRSNQIYLYKQLCNNLQLIDCKPGYLKLKAVSKLDSNFCNDL
KNYLNQVTQQEWVIAVDTGYINREVSNLNYAPAVKDILDTFKGAKVVNIENKE
>ELAGILAN_00508 hypothetical protein
MLDLLQHYFGVNNCYPKYSSSVIPVLDYLDPENLILNEYIRLLYNKSWIPVSATCMTPPA
TQTSVDYKESSYSCRSSHRVTKKGYWDNKRGTL
>ELAGILAN_00509 Stringent starvation protein A 
MILYHFPLCPFSRKVRALLKEKKLGCDLVYENPWEKRNEFMEINPTGQVPVLIDNNFVIA
DSNAICEYIEETYNSNVKLFGSSTIIKSKIRALINWFDNKFYNEVTKYIMNEKVITNRSP
DSRFLHAAQHNLPCHMEYIEHLINKNVWLATDKFTLADITLASHISVMDYVSSFPWEKSK
ILKEWYSIVKSKPCFREILLERVSGLIPPKHYADLDF
>ELAGILAN_00510 Putative O-methyltransferase/MSMEI_4947
MRNNFSIKLSYIRNLFAKEYKTIEEYCILEKKQHIQISPEEGKLLSLFIKIHKIKSIVEI
GTLYGYSSICMAKALLEDGHIYTIENNPQYSRIAKKNFSAFNLSDKITLIEGNALEKLNE
LSAKAPFDMIFIDADKGGYPKYLDWAESYIKQDGLIVADNTLLFNTVFLESPPKEVSEKS
WHAMREFNNRLSDEKKYFSILIPTDEGMTVALKLT
>ELAGILAN_00511 hypothetical protein
MSYTIASEVETLNKKSNKNEGVMLLNNPAYREKYKERFDEAQRKVMDMVQFYDGTIVLIE
NKIAMYYYAWHSKKREFERKKQQTVVKNNDSA
>ELAGILAN_00512 hypothetical protein
MIFRLLLLSIFISVNSYAVVNQHIQKETNEITSKELLSLLPDDKLLGNPKAPILMIEYAS
LTCYHCSLFHKNVFPKIKEKYIDTGKMLYIFRHFPLDYRGLKAAMLSHCYEKQEDYFNFN
KAVFNSIDSWNYYNLSDLTLLQRIAALSNLKQDAFNQCINDKKIMDKIINDKSLAINKLG
ITATPIFFIKLNDGKSYIEHNKVKHEGYKELKYLTDVIDKLYGKAIVK
>ELAGILAN_00513 hypothetical protein
MPTLTSGLRNLLRLTVDTDPFLIGTKFMLHQYREQGTFLCSPNEVFQIVIDVERYPDFVP
WCKAVYIKEKIDNQMVVDLLAAFHGIKGRYTSEVTFLSPSRTNEGWIKAVSSNGIFKHLC
NKWQFIPIDENKTMVKFYIEFKFKSNSFSTLLNSVYKYTQSKIIAAFKDRAESLAKQKLP
>ELAGILAN_00514 hypothetical protein
MNITKVLTIIVFIVMSSSAYTNCTDHKIFVHTMKQQVDSISTKGNRKNLGHVHEKLQEVI
QNNVNLKEISRFVMGKYGVLTTQKEREDFLREYEVYLTRLCVKILSKYMSNSEMIIMSTK
AVDDETCLIGTRFSYGDEEFTNIDFKVTKNHSSFLISDVVMSGISIAINQRSQFSEKIDT
HGIASVIGELKCNNNL
>ELAGILAN_00515 Folylpolyglutamate synthase
MPHWPKPLGSRPNDFSLDRIKSFLSKLDNPEKKVPPVIHIAGTNGKGSTLAFIRYIMQAA
GYKVHAYTSPHLVNFNERIVIAGSYIDDNELYSLLEECRAVIAEQAITLFEAATIAAFLA
FSRHKADITLIEVGMGGRLDTTNVIDSPILTIITSIALDHTEYLGPTIEIIAGEKAGIMK
PNVPCVIAPQEKSIMNTLEYHAINKKSPLYRGGFEWNCEKQDNRMVFQSAIQSIEFSLPS
LKGDHQIINAGNAIAACSILSGKYGFDIGEEDITSGLQCTYWPARLERIKEGNLISLLPK
DWQLFLDGAHNNDGARVLFQWVKDNFAEGIYIIFGVTRNRNVEEFLEHLKPYIKLLCAVC
VKSEPKATNTNLIREKANNIGIKAIECESIGDAISNHILKASIQNVKTILICGSLFLARD
FAMENS
>ELAGILAN_00516 hypothetical protein
MARNVLNENEYHALKQLFLTFNIQKEDVVNSDIKHIKKKLSQQYRKLSLKYHSDKNPNNK
EAEEKFKVIALNKPFFEEFIIEPLEKGLNKRNNLIKELRGKLWSRSYEELQKYLDDKSRN
KLYNKQQSINNNVTAYVKYSSYSNLLGVLLVSFTSIAFLIINGISSNVPIAVGFLAPLLA
GSILSLAVKSIYTRNGKEFNHQTNILLLFNFDQECENFSKSDRTKLKWLKNSVILSNTIC
TPLMFFSVGLDLVANGFGITNSMMLSGLLLSLPFTLLIVTSPILNAASNYILKKTAINSI
EEQFKGDDQFIEVGNEKPSSTMSNQSYFPIGQLISSKLAILHSEVSS
>ELAGILAN_00517 IS4 family transposase ISWosp2
MRYLTVVSIIAWRIFFITSIARTNPTLPCTALLAEEEWKVLYVKIHRKPCPNIAPTIKEA
VS
>ELAGILAN_00518 IS110 family transposase ISWpi12
MVTSYQNFIGIDIGKFKNVVAIHKQKNAVEFDNNASGWQQLFQEFSDILPNALVTLENTG
KYELGLSHFLTDKNIAVHRANTRKVKSFILSHGTLAKSRCKSSCSIWI
>ELAGILAN_00519 IS110 family transposase ISWpi12
MRTQEKCRLEAPENDHIKESCQKTIEFFDSQINELNDTIQKIIDESRELQQRQKILKTVP
GIGKKLSQDFLCLMPELGYLNRKEVASLAGVAPHPKESGKAVGYRRITGGRSNVRSKLFT
AAMAATRSKSILGAFYSKLVESGKKKMVAITALMRKIIVIANTRLKEAINLHT
>ELAGILAN_00520 hypothetical protein
MIAEKSPIVKLAYDELDKFCWNEKDLVAYEERIMDLRKEEAILEYKLEEGIEKGKIEVAK
NLLKAGVSVNLIAESTGLSQAEIVQLKQEVA
>ELAGILAN_00521 hypothetical protein
MVASYSVLKRYALAYIKKSGSNSDVKEFLQFCNTQNTTNWSEENFKNAYEKFTHPNSSNR
HDTGSRNDQYNAGNNAQPTGSQITHIHVHNRGLDFWDYLLLQCWMDSLFGGRGHTTVNNI
TNINNGNTTHQGRKENKKESEDSRKLLALGIVAAVVCVAFHAGMCFWYNSSRKVARKKEK
IDYLDSKFKTFRNIEFAVGVVSLAALVACAVYPVLPVWGLAILGVNSLVCFAGGLAFHMK
HEEESENIEKAKGAVDSCLRQGHGYGDSSRYDAPPPYFSQDPNTTPTAPPQNAFDNPYLQ
QKFGNCKGFTRDKN
>ELAGILAN_00523 Chaperone protein DnaJ
MSKKDYYDLLEVGRNASIDEIKKAYKKLALKYHPDRNPGNQEAEEKFKEVTAAYEVLSDS
EKRAGYDRYGHEGASGGFQGFSSAGDFSDIFNDFFGGGFGGGASRSRAKRSTTGVSGADL
RYDLEITLEDAFKGIQAPIHYVTNVKCDTCQGTGGEGAIKPVQCHTCQGSGRIRTQQGFF
TIERTCTTCYGEGEIIQNKCKKCGGSGRRRDEVNISVSIPKGIEEGAKVRISGKGEAGTK
GGKRGDLYVYVKIIFHKIFARNKADLHCKVPIRMTLAVLGGEIDIQSIDGAKIKVKVPEG
TQTGTKLRCREKGMPYMNSHARGDLYVQVIVETLNPKNLTKKQIELLKALEEEENASVQQ
QSEGFFSKVKKK
>ELAGILAN_00524 Ribonuclease J 1
MLFSGFNNLNLMNINKNEFLFLPLGGVGRIGMNVSLYHYQGKWIMIDLGVGFADETMPGV
ELLIADIDFIAQRKKDLLGIIITHAHEDHCGAVPHLWEELQCSIYTTKFTVNFLKEKLKE
FRLEGIVPVKEVDINGSINLGPFTVEFINVTHSIPEANSILISTEMGSALHTGDWKFDPK
PVVGLTSNMERLKEIGDKGDLLAAICDSTNILSKHHPESEGEIYNNIYNIIKRSKKLVAV
SLFASNVARIETISQAAKALNRKVVLLGRSLWRIVKVAQDSGYLTDSPQFLEAKEAVNFP
REELVLLCTGCQGEPLAATARLAAKSHQAFKMQQGDTMIFSSKIIPGNETRAHNMLNAFI
EMGVEVITEKTEHVHASGHPTREELKEMYSLIKPKMSIPVHGEYIHTHAHVKFAKECGVA
KAIMIAPGDIVNLENGEKVDSIDVDYFGIDGMLLRHPESSVIKMRKRMRDAGVIVVTAVV
NKKNKLLAKPKVFVPGVFEVLEDAATIQKIVKKVESLFSLQPTKKIKNKIESSILSILKE
YLLKRPIIEVQIEQV
>ELAGILAN_00525 Protein TolB
MKLFVHLVLFISLFIPYFTKAALYVDIKKSSVGNIGLVVSKCTCKTALESELSENIAKVI
GTNLSNCGLFNVKRGAEAESKSWKSDTVVTVSLSEISGSALELSFRLFDTFTKRELLTQS
VVFPAKDWRKIGHLVSDVIHDRLIGEKGHFNTKITYIAEEKDSNYKSVRKIAVMNQDGSN
IKYLTNGDRFVSTPRFSPNGKGIVYISYANGKSYIILKNLKDNTESIISTFEGVVSAPRF
SPDGKSLLISHSLGGETNILSLDLSSKRTKKITKGSAISTSPSFSPDQKYMAFSSDISGS
QQLYVIDFTNKSKKPKRISFGSGRYATPVWSPKGDLIAFTKIQSGKFYIGVMKPDGKEER
LLSEGHKIESPAWLPNGREIIFTRTESPSNSKLYLVDLVKKNQKMVSTPTNASLPDWSYF
>ELAGILAN_00526 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C
MPAKSTEDVITSLIEFANKRKITITKEEMLKIAQLVRIKLSNDEIDHYSKELTMLDWIHD
TLLQVNTEGVSPMRYGSIDKDIHVRDDVINSQNIKEEILSNTKPEHGYFVVPKVISD
>ELAGILAN_00527 Ribose-phosphate pyrophosphokinase
MKIIIGNASKELGESVVNRLDVQPSSAWISKFTDGEVNVEVANDLYNQEVYIIQSLSPPV
NDNLMELLLIIDAVNRLGAKRIVVIIPYYGYSRQDRIIKNNNMQSALSAKLVANLIQTAG
ASSVAVIDLHSSQIEGFFDVPITNLNCFEAFVDSIHTENLAIVAPDVGAIGRARAFAKTL
EEKYKIGLSDKIIVVDKYREKAGTSQVMNIIGEVANKNCVIVDDIVDSGGTLCNAALALK
SYGAKSVTSCITHGVLSGSAVEKISSSSLDKLVITDTILHKLEKTGKIEVVSVVNILTHF
IQGGRNAS
>ELAGILAN_00528 hypothetical protein
MTEETKDGYASLYVAIQEGNIEAAELLIKCGTNVNDHYERNRTPLHIAIGRKQLEIAKLL
IKNGANVNAKTQNHGKDDLTPMHFAVFANTPEFIELLASHGALINERESTEGYTPLHFAA
LYGNKNIIQALIDKGQDIEDVDNNGRTALFLAARQCTEAEDDSRIEIIKYLIDKLKADVT
KKDNNNNAVLFPAANNCPGKVVEFIIEQYIKIFELENFINHKNNDGMDALDIALNSGNEK
AIEVLRSYGADIKNKVDGSIQKITAEKPSSTLDRAESAEVAPPIKQRV
>ELAGILAN_00529 hypothetical protein
MTHQVNDSKLKEKDEKSILKLASKIKGKKSSIAEELEKISKKEKQRILTTEVSKHRGKEP
TIISLAYAILRKDSIAVEKMLRVAKENGILKDILDATTTIKYPGGQEETCTPLTYAILCK
NSKTIEETLKVSKENGILKDILNATTTIKYPDGRRATVTPLAYAILYEDSIAIEEILKVS
KENGILKDILNTTATIRYPDNKEVTYAPLAYAMFWKDSKAIKEILVADEENSILKDILDA
TTTIKYLDGQEEIYTPLTYAISCKNSKTIEEILKVSKENDILKDILDATTTIKYLDGQEE
IYTPLTYAISCKNSKTIEEILKISKENGILKDILDATTTIKCSDGHEETCAPLTYAILRK
DSIAVEKMLRVAKENGILKDILDATTTIKHSDSREVTYTLLAYAILRKDSIAVEKMLRVA
KENDILKDILDATTTIKYPDGQEETCTPLAYAILRKDSIAVEKMLRVAKENGILKDILNT
TITIKHKNNQKVTDKLLAALHDRKVIQEILDIARENDILKDILNATITIKYPDSEEKIYT
PLTYTISCKSNEAFNTTRAINQDGQEKTHIPFPTVSVLDERETELKLKEKRQSRRDEGLN
FNNGSSDKNVEIKVNGDILLQHSSGTKNEINHTAVRNDVGGVKPLIESRVNVKVQNINAV
IATSVTFKMIATSVTLELVASKITCVLSKPTTKLEEVAITYFQGLALYL
>ELAGILAN_00530 hypothetical protein
MAFSKFLDPKNNFAFKRIFGTEKNKDILIHFLNDILGFAGKDEIEEIEFLSTIMDAEIAS
KKQSIIDVFCTDSAGTQLIIEMVRPESLRSYCLKGEEFLQKETKRVLKLIKPDVLPSEST
HQCESGNRLVPSDADNEPPLEKEDAQS
>ELAGILAN_00531 GTP-binding protein TypA/BipA
MNEFKSIRNIAIIAHVDHGKTTLLDNMLKQSGTFRENQEVQERVMDSGDQERERGITILA
KCTSIMWGDEKINIIDTPGHADFGGEVERVLCMADGVLLLVDAAEGPMPQTKFVLSKALK
ANLKPIVIINKVDRPDSRIDEVLNEIYELFFNLDATNEQLDFPVLYASGRNGWCAKELSD
ERKDLSPLFSTVIDYIKPSVYDQNAPFAMLVTLLESDKFLGRILTGKVYQGVAKVNSDLK
VLDLDGKVIERGRLTKLLSFSGLKRIPVEQAVAGDIIAIAGLEEASVSDTIAAPEVTTAV
SSTPVDPPTMAITLSVNDSPFAGQEGTKLTSTAIKDRLYAEAETNVAITVTLAPSGEAFE
VGGRGELQLGVLIENMRREGFELSVSRPRVLFKEEDGKKLEPIEEVVIDVDDEYSGIIME
KLSFRKGEVTDMRPSGNGRTRLTFLVPSRGLIGYQGEFLTDSRGTGIINRLFHSYAPHKG
PISGRRNGVLISTDKGEAVAYAIFNLQDRGIMFIKPQDKVYCGMVVGQHSRDNDLEINVL
KGKQLTNVRASGSDEAIKLTPPKIMTLEDMIAYIDDDELVEVTPKSIRLRKKFLDPNERK
RAGRAKNKE
>ELAGILAN_00532 Orotate phosphoribosyltransferase
MILDENNLIIKEFKEAEAILHGHFILSSGLHSNTYIQCAKIFENPSRAMKVCALLADKIK
KELNSSIDLILSPAIGGIIVGYEIGRQLGIRTMFCERVNGKFELRRGFEIKKGEKILLIE
DVITTGKSSLEAVECAEGEGGKVVAEASLIKRNSETKLPFPVISLIELNIKNYSEEELPS
ELKQLPITKPGSREYLTK
>ELAGILAN_00533 Proton/glutamate-aspartate symporter
MHKFAILFSILLAIVAYYLNNEIIFEIAKLFSDIFISLLKLISLPLVFLSIVSTISGLKD
SIEIKVLVKKTLFYTLLTTIIAAFVALSFYLLIDPARKNFISNTIGSINSNNHSYFSYLK
SLIPSNFVQVFLENNMIGSILIAFLMGGAIVSLSKEKQDILYQVFSALFDTLLKIAQGLL
KFIPLAVWSFITCFLHELKGGSEFYSLFWYFVCIMSANFVQAFLILPLLMWYKGISPIQT
LRGVMPALTLAFFSKSSSATLPTTIDCVQNKLKVPKKLSSFILPICTTINMNACAAFILI
TVMFVAEMNGYAFSLSEMLIWIFLATGAAIGNAGVPMGCYFMATSYLVSMNVPLHIMGLI
LPIYTIIDMFETAINVWSDICITQIINKECNSET
>ELAGILAN_00534 Dihydroorotase
MTQTWNLLQTGQKEGYKIAYTNARIIDPETKLDIKGSLLTEGDKIVDFGESLFSTSGVDE
TIDCKGLVLMPGLIDIHVHFREPGQEHKETIYTGSKSAAAGGVTTVVCQPNTIPAIDSVV
LAKYLKYRALETSHVNVEFYAKITTLEEKLTEMALLKEAGAVGFTDDGMPVMNPMIMRQA
LLYSSMLGVPIAQHAEDLNLSAGGAINEGKISEELGVKGILSASESVMVNRDILLMKDME
NVHYHILHVSSKDSLDAIKRAKDLGLNVTCEVTPHHFTLTEDIVKQHGAIAKMNPPLRTE
EDRLAMVEGLKTGVIDCIATDHAPHDRSSKDLPLENAAFGIVGLETMLPLSLELYHSGQM
GLLDVLAKLTYKPADIIHIPRGRIQKNLAADLILVDLNHEWEIKTDNFASKSKNSPFDGR
KVKGHVVRTVVSGKTIYSQKS
>ELAGILAN_00535 hypothetical protein
MGTTKISKFPFNIKGKVAKQHAEPIIEKNLYTILGFKDIEDFENKTSKLVNKKVWQSFVD
CFAKEIDYAATEKVVKSIVCNIAKSDRGDAFTKAERLILNEKQGDKKREKAIREAISILR
KINPEKAFNELSVIKKQAEDFLQTDFYKAQSKPLQGFAPSGGQLFAEVLKYIETLEKLAE
VKKEELVKDFLLNHVSSLNKKYPKSQSKREDAITILSNDELKNFYNKGVKEGILQPMASY
KECRNLYDKMNQIKNESKSIIKREEREENLKKIDKSIISAINDIKKHREAILNCKDFQSS
YIKEKKEHPFRGNACQKMIDIYQERIVGYQEKIRQNLNQIKAILKSAPQEMDDVEELEEI
IDGIHEAKQFDEDFDSALICLSNMQNELDIQLENPPTELRVSHINVKTELTRL
>ELAGILAN_00536 Cytochrome c-type biogenesis protein CcmF
MPELGNILLLLACLLSLTYLFLPLSSCRFITTAIFFCVSTSMAILIYCHITNDFSLENVY
YHSHTTKPLIYKICGVWGNKEGSMLLWTLVLTMYLLLMDIYIPSVIPVLDYLDPDNLIAN
EYIKWQYNKNWIPVSSTGMTPERTNGSKLKKISLITQGLICFCFLLFTLLESSPFTKMPS
VEKDGLGFNPILQDIGLAIHPPILYLGYLGFSVPFSLSIAGLIAKVEGNVWAKIVRPWVL
ISWSLLTLGISLGSWWAYRELGWGGFWFWDPVENVSLMPWLIAVALTHLLLVVRNFNVLR
NFAILLTLTTFILSVTGTFLVRSGILTSVHTFADDPRYGLYILALLGVITVSSLVVFIAF
AKKNRSLTPPPVIPVLGTGIQEKNIEGPNYTPKQNFSVFSRFTMMLMNNLLFITAFFIVF
VGTLYPTVLEYLTGELISVGAPYYNSLFNPIALAILVLTMIGQYCSWQGNSLLPIFREYR
FSFCSAAAILPFIFHMELIIVLSITISIALLIFVLEAYSKRIRLFKSESILLAKKVSKSY
YAMMAAHAGVAILVLGIAYSVGWQEKKENYLKIGDSITVNKFKVTLRNIELIKEKNFHAV
RGTMDIRNLLNNKILGEITPEYRFYLVEGQKNVESSIYHNLLSDIYVVIGEIDKSKSKIA
AKVHYKPGMSIIWLGSFLIAFGSLLAAFPFSKRAKVV
>ELAGILAN_00537 hypothetical protein
MNGEVSGKEEVMHTPYSDLCQNLESNAQTPLQHSDDSCTSDNSNNHRSGDSDSEEGDGHD
SGISSDDEDNRTTDTEVQLTNDSLDSQRYTGICIPTPTDGWAGENNHQTGLSGDLPDVSN
NPQIFESTDSVEHNSTCNDHVICDSGHNSDDEDQIPEDFPSRKRVRSIEIDQFEPLYKKR
KIEAQNNQKYTENVCNPTNGGLLGESDNQQISEDTEITSDCNPDDSDPKGNEGYGSDGSC
ESKENLTKGAGGSNQTFEGEQKSSEFPKVNNWSDSDGNSEDSSDCGDDNVGHYDTDCGER
YSHLSFHDENTNIIRKKDSFFLAQIELNKAEREKYENIWQEMDKILSSSHEVGLCEDDIE
ELKGRLDEVISQALEQRIMFTFPYRDGESFVDCIINTTQELYWVDSTENSRLLEEKKILQ
VISEGATLNKFTKERYDDYVNCIYREKEILSQRNKNILGLNNLAYESIVNKSKQTQNVLG
VDKDNRYFCIEYSQDSIVEVAEILNNEKAKDLNLRVGILKIGESIVRVENVEEIGEKRNY
MDVSKGGIEMSFTTEVGKISVYLSPSEKGSNKIKVEIDGENRARLNELKDKGKSLGENCL
LGGKSVEEAIEHESFERYGSVPNTAMKEPSLDCVANITRGG
>ELAGILAN_00538 Protein translocase subunit SecF
MALRLIPDNLNIKFSKYRNLTALVSIILIIFSMLIVVLRGVNLGIDFAGGILIEIKSSDE
NHSILDALKENGFTVQSSKAGDNLVMRFKDEGDEDKIKKIKSILEEKLGSSISYRKIDYV
GPQISSTQIFEGMLSMLIAIVGIFFYVWFRFNWQCGFSGITALIHDVILTVGFISLTGIE
FNISSVAALLTVIGYSINNSVIIYDRIREYCKSGKSGRMSEIVDASINATLFRTILTSGT
TLLAALPLALICTDAVKDFSLIIFFGILIGTCSAIFISAPILTYRALDCRSV
>ELAGILAN_00539 Amino-acid carrier protein AlsT
MDTVKFVLLLPTILLMLVAGVYLSIKLKWLQVFRLPYALSLLGAKKGENKFSSIAALFTI
LGGNLGVGNISGTAVALKTGGPGSILWMAIIIVITSVIKYVTCYLSIKTRKEKNGRFIGG
PVAYMADAFNSRKATIVFLVVMIMVSITVGNLVQVNSLSIPLNMIDVPVVIGGIVMAIIF
FVVAALSLKKIKIFISAMIPIMTVSYLTLCGIILFKFSENILPSLKLITSSFFTTSSFNS
GLSLGLILEMLTIIQVGTLRGIFATDIGLGLEGIVHSSIVPKKNNNKFIIEQSLITIISP
FIVAFIVFITTMVLLVTDSWVTDLESTNMCIFAFRKAMNWPYIDYLIMAIMFCFAFTTIF
TWFFCSKQTIRYVSMDNKYTKIWVVIFTLIIPLGAIGKVQLLWDVADISIAALLFINILA
ILKLTSQDPEVFTMSSRYLKLQKQSYS
>ELAGILAN_00540 hypothetical protein
MGTNDTQQEHIYNERIQEIFPLFDKIKKEDDPIYNARVDFNTVKFLTKHANWNWDEEENK
DKAYGVILQKCDKTKKAGQELESEVKERLKEYVDDVAGVSIYGNHASITLGDNKKEFKIS
EFLNSDFCEKNEISGFSTLHSDGKSGMHGFVAEEEGKKIRHYVVTDGSYEMTLKWYAEGK
ECKIKIKIDANGVDLVKGDDFSLERLEVNRDVKIGGLFLHEIEFREKGKVNEVQHNKDSN
ELSSETTTRIDVNRDVSVQATDITRKKEDHHSHFGPQSNSRGQSYDSGIGKDFDDKINSQ
EAKEKRELRQAAREANSGGQVYNLQSLFEENPQNKKTPPPLPPRTSSLPPKKGVFDEQGG
AKSGSQKPDDLRENEQTPNNQQKGATSDSSDSSTFTKSVSHNQDNRQEDERYDNPTFGHA
VPGSQKPDRSEQTPNDQQQPKTQQQEGNSKGDLLQDIRNFKKNNLRHIDVDDRKASIAGS
RKNNPSPLETLKDRIPYSSSPDNSDNQDASDAKWKESEQPLSATALNNKSDSGYSSPTHD
NNEQSQVNPEQLKKSLENIEQSDQTPPENLLKEIRDRSQQDNRGLRQVDPTDKLSQDKED
GLQKDDLADVKIVEGPTVSVSASTPNSISDSGYISPTNSDSKSQTDLKQVGRKLEEHIRQ
SNLTLFEELKNTLGQENLGLKPADQSQISEETKKRLREVGLLKDSSTDIKANDSGYSSPT
HDNNEQSQVNPEQLKKSLENIEPKEIGDTRELKGALGNPDKGLREPAQQATKENIPKDSF
SENILEKIGEGKQYDPIRKWLEKTVAERENNDTNPTVDQNSELYKLLEKDEAQLKAGVIE
EERGDTLTEHTDGYDRNRIALANRNKRPLDWAKQVAESQQKKDTNKGISI
>ELAGILAN_00541 Maf-like protein YhdE
MTERSLNNLILASSSKRRIALLKQINIEPGLILPADIDEAPLKKELPKDYSIRMAKSKAE
KIQSSNPNYFVLGVDTVVACGRRILLKAENVEQAEKCIRLLSGRRHRVYTSVCLLTPDQS
KQHIRTVVTIVKFKRLSEQEIKYYLASEEWKNRAGGCNIQGLAGVFVLFLRGSYSSVIGL
PLHETYCLLSNYFNFNLY
>ELAGILAN_00542 Translation initiation factor IF-1
MIKDEKSKTIFEVEGAVTALLPAAEFRVKLDNEHEIICHVSGKVRRSKIRIIIGDRVLVE
MSIYDRNARKGRIIRRLKGTSDRTISK
>ELAGILAN_00543 hypothetical protein
MTGSLAKEEKTAEAGKTSNQSENYDVESVIRVASCAWNAIHCLLASYEYDLYSSWLESHF
TSLKDCINKMEKDNSFTKDSAIIKFCRSIAENNKLYKELKNLNNPAEKFSQLEKIITGFK
LKDLEDKVSFLMLLKEESDFTAIQKAYRDEWSFYDLINDRDFKKTYIDKAVTESANKSFK
KDIDKCIKLAEQGKKAASKYLGRKGVELQAYYTETDNAYRVLNINSINYNRSEPTRMSDI
LQQEKDIKELNIYCNKKHEIHAHRKGKERYYEFKEGAYYEMKSTWPVKDGSEMCTMIINV
SSDGITEVLKFNDEDFVLSDEILELIKQNDELYIQGLSLYDAVLEKGKAADVVPTANNNF
QNESIVAYRKEPEGELDPKVDADNSLPPSINSNASTQTEVNLQHTETQTEVASQQIETKT
EVNLQHTGTQTEFASQQMDELILNNQMLSEKNVELKQEMSNLKKEAVELKQEIEAGLQVI
NKKHHELIQENQRLQEKLETTQAEANQTIVKLEKQNSNLQDRFEKEEQKNTELQTELAQK
NEELAGVLKELQGKAQELKGVYEEKRKLKEELKIVNAGKKNLEKELNQAREDAEQIMVER
RQQKERLKDQLRELDQEYKVQVEIEQKIKESDRQDSDLQDTLGEERLKLNIEELENEYEE
FPGDKVLTLELTKDEDKVEELRNELEREKEKCKQLLEEENEWGDELVGMLDGLEEKIRAD
EQRSFNNQLTGEISNESGNAPRQKKRLSKSSSVDNESYVPLREKTTLLRSLSVDSGLDSD
EENCDNDLSFNISPISSIEKVAESRNVGRVSL
>ELAGILAN_00544 IS5 family transposase ISCaa8
MVENAKENLSGVKNVLVDAGYTGENFVTQIKTIIGATVEVIKRNELRSFVVLPKRWVVER
SFAWLEKCRRLWKNCERKLNTSLQMVVLAFTALLLKKL
>ELAGILAN_00545 hypothetical protein
MVSKEFPKWRNCYDYFKKWSEKPDVNKESVLELVLKKNNCDKTMVGKASA
>ELAGILAN_00546 Adenylosuccinate synthetase
MMNNIVIVGLQWGDEGKGKIVDYLSENADVVVRFQGGNNAGHTIVVDDEVYKLNLLPSAV
LRPGKISIIGNGVALDSHALISEIESLKVKGVDVNYNNLMVSESCPLILSVHKDKEKLFE
DLNGNHKIGTTNKGIGPCYEDKVGRRAIRLCDLENADELNKRLDTLLNYHNAIRKGLNYQ
VVKKEEILKEIQEISEKILSYKKPVWKILNDLMKEGKKIIFEGAQGAFLDIDHGTYPFVT
SSNTVASQAITGSGLSSNAYIIGVVKAYTTRVGNGPFPTEQKNEVGDSLFTIGKELGTVS
NRRRRCGWFDAVLVRQAVQLSGVSSIVLTKLDVLNSFDTIKICTGYKYSGKMYDYLPASH
SIQGELEPIYEEFPGWKENTQGKRSIETLPINLIKYIEGLEKLIGVPIHLISTSPKREDV
IKLKDF
>ELAGILAN_00547 hypothetical protein
MFLLKPTNFSYFSKKALPWLGVICFACFLIGMSLALFFSPEDYKQGEIVRIMYLHVPSAW
LALGIYGLIASLSFISLVWNNSIASVLAHAAAPAGTVFSAICLITGSIWGKGTWGTWWVW
DARLTSMLILFFLYVGYLSLWSAFDNEARAEKSAAVFAIFSAINIPIVKFSVNLWSTLHQ
PASILRRGGVAIEGSLLLPLIVMFMFCATFFLVVWILYSLYLINLYKIKREISVRY
>ELAGILAN_00548 Putative pyruvate, phosphate dikinase regulatory protein
MTLKKLNLHLVSDSSGETVISVAKSALKHFRSVETIEYVWSFVKGEEQIDKILEEINRKS
DEHNFVICTITDDELRKYLKDNCIKLKIPYRAILSHIIREISSYLEIEKDEKLDLHTEIN
NEYFQRIEAINYTINHDDGQNIQDIDKADIILVGVSRTSKSPTSTYLAYRGYKVANIPFV
SGVPFYVDLAKLKNKLTIGVTIDVSRLIEIRKNRLTSINNEDNNIYANPEKVEKEIKEAE
ELFKQNNWPIIDVTQKSIEEVSATIIQYFNKMLSID
>ELAGILAN_00549 50S ribosomal protein L36
MKVKGSLKSHRNRDKNCKVVKRGGKIYIINKVKPRCKARQGS
>ELAGILAN_00550 hypothetical protein
MLISKKKQKLLCLSAALLISSLTLYFSISTITGKRGLLTLIDLKKEIEYNKLLLKDVSSE
KEKLDNKVFGLYEKSLDLDLLDEQAKNALGYVNPNELMVVLDVE
>ELAGILAN_00551 hypothetical protein
MITSKPVSASTKSFEAWKQLPWKKCQKVIVRLQRRIVKAVQKGRWGKVKALQHLLTRSFS
GKALAVKRVTENQGKNTAGVDRQLWSTCNAKFQGIKQLKQRGYKPSPLKRIYISKSNGKR
RPLGIPSIKDRAMQALYLFALEPIAETISDRHSYGFRPKRSCADATVACHLLLASRNQLQ
WILEGDIKGCFDNINHEWLMKHIPMEKKILHSWLKAGFLESKTLYPTTAGTPQGGIISPI
LANLALNGLEKLLESRFGKLGSRRRNKIRSGVNVIRYADDFIISGFTHEVLENEVKPLVS
SFLHERGLILSEEKTKITSITTGFDFLGCNVRRYNKKLIIKPSKESIKRLLNKARTLIKA
NIENTQAIVIKSLNSLLRGWGNYYHHVCAKKAFRKIDNEIWHSLWKWAKKRHPRKGLRWI
KNRYFKVMGQRQWVFAAPICKNKPKEIRYLRLLKLIDIPIRRHVKIRADANPLDLKWKKY
FDERVKRTRMLASSFSREGSLLLVSPLRMMFPEES
>ELAGILAN_00552 hypothetical protein
MYANNNSTGIEKSPNPLLYDRRNRVSLYFRLHGKQTARNADGSAGKGEWRKRMPFCNEMD
RICNINSRENEQTSVWSLVTRNFVNHLR
>ELAGILAN_00553 hypothetical protein
MALSKFLDPKLDLTFKKIFGTEKNKNILIHFLNDILGCTEVNTIQEVEFLSTIMDPEIAS
DRQSIVDVLCRDSSGSRYIIEMVRPESLRSYCLKGEEFLQKETERILKLIKPDVLPSEST
HQCESGNRLVPSDADNEPPLEKEDAQS
>ELAGILAN_00554 hypothetical protein
MLKRYLKAAVYLSLLIYIYISVFSYNYKDPSLNTATNEKVTNLGGIVSSYLADILVQFLG
LTSVTIATTIVYLLIFRPSKRLLKILYLILINLGICAILPQLSLGITARYRHSGIIGNAL
INNCPFYIFVIVTSIGLVGSVGWKRTIYSLFFLCKKIACLFVNVPFFRSHKTTEYSIAPL
VVEEKHRTKITTKQQPKERQKKATEEVLSEFKFPSIHLLSKAEESLQRKQLNEMESNKNL
SLLEQVLSDFGVQGKIISVCYGPVVTLYKLEPQAGTKSARVIGLADDIARSMSALSARIS
IIRGQNAMGIELPNKEREIVMLRDLLESPEYQNANLNLPIALGKEISGKPVIADLTKMPH
LLVAGTTGSGKSVAINTMILSLVYRLSPDECKMIMIDPKMLELSIYDAIPHLITPVVTEP
KKAVVALKWIVKEMENRYRMMSYLNVRNVINYNQRITEAMNSGIELKRVVQIGFNSTTGK
PLFEKLPIKMETFPYIVVIVDEMADLMLVAGKEIECSIQRLAQMARAAGIHIIMATQRPS
VDVITGVIKANFPTRISFAVTSKIDSRTILGEQGAEQLLGMGDMLYMASGGKIIRIHGPF
VSDDEVQDIVDHLKMQGEPNYMEEITKEDENSSVESEGETEDEENDLYNQAVAIIQRDQK
VSTSYIQRQLRIGYNRAANIVERMEKEGVVSAPNYSGKREILVE
>ELAGILAN_00555 hypothetical protein
MGLERYKVKSLKSVVEKDLPNLPKIIRLRVQKAIKERLTVDPINFGEPLHHNLKGCRRLR
VGDYRVIYRVNQLDHIVTITEIGHRDDIYKK
>ELAGILAN_00556 hypothetical protein
MANSGINIALSEETLKHLAELSEFTKQPVQGLAGKLFREAVELEMEDFLVSKISDERDVE
GAETVDFEDIKWD
>ELAGILAN_00557 hypothetical protein
MPDRLKKSYPTQMLIILQHQFYDLKVSEDKFSVSLSFQGKQERITIPFFAISEFRDKISG
DVLIFDKISIDSDKEYKSEKCTEKLSNGSIISIDQLRDE
>ELAGILAN_00559 hypothetical protein
MLFDSLIIFIVVLCVIISVTRGFIKELCALMFLFLSVFLTANHYDFFTPNYSKYFDSKVT
LNILSTISVFIILNLIFMIINNWLMYILLPIRLGFIDRVTGIFLGVLKGILLSYVLFFAV
HLYCYTVYDKKEGEYKIEAEDILPNWIINSHSYQALFVTAEEVIDIYVPESLILKIKEIG
GEMVDQEKPKNNKKEE
>ELAGILAN_00560 Riboflavin synthase
MFKGIITDIGTITDTTTHSNSDQIFHIKTQNLSSINKGDSIACSGVCLTVVDIMSDTFTV
QASQETMKVANLNTWRIGKKINLEQAMRLSDKIDGHLVQGHVDGIVKFLTINQNLDSHEI
KLSCPQELIKFVAKKSSVTLDGVSLTVNSVVNQEFTVNITPYTWENTTFQYNKVNDYLNL
EIDMIARYLDQLMQHKYN
>ELAGILAN_00561 hypothetical protein
MHNSNTETKNKYKIEDLPKLFKEKSRNISKAFSSETIKISTIRSRSIESNIQEFSFELTA
TDKDTFNIRLFRINSLINFFKICLSREKNFTANIKVPKESSELYNNYCKTNSYKTVKEFV
NNAPPQILLQGTTITLQTDVENINLDNLHQIELFLNEKLQHAEKTENEDKKEQSEANQKN
AQNRQIVPVTGSFGFDVTNNGKQVTRASIAVAVMHENVFWFRSFFCLPNLFNTSQFFSQQ
LPKFSIQSNNILFGVIPALDQEKRNMDPSSQATRMTGGSIENPIPQEAEQNVGQTTSHTE
YFKANRKKKSKKQTKELSEKEKPLAIKQAQNDARVAMIDNQIEHRGKKLDKIFIEVMSGY
KNQDPETFCNIFSSVFNIVYFQDKQLHAILEPGEISEVLQILERPQPLSNSLLGKEYLQK
QVYRKKEQLLKLVSGVYIQQPSPQHENTPHKSTNPLPIKDLSPATNEAKTLPPTNITLKS
PLKTVFSSKKAYFCLFIILASASTLCLWHFPLGKVSMLKGLVPPEKRESIGLALNIGLPI
LIALCILNLARFIYSEYSIESIKQVSENDPLSRAYS
>ELAGILAN_00562 Phenylalanine--tRNA ligase alpha subunit
MNKELLDDILSLEDKAVSEIENASSLQDLEKVRLSYLGKKGVIKAYFDNLKEIEDAGKKR
NLGEVINVLRNKLDQLIMNKENILKAEEVNFKLQNEAVDITLPARPEKIGKVHPLSKVIN
EVKLIFAHMGFKAVDGPDIEDEFHVFDALNTPSHHPAREEQDTFYLKNKRNDKRMVLRTH
TSSVQIRTMEKTKKFPIKIVAPGRVYRNDFDATHTPMFHQIEGLYVDENVNMGQLKFTIH
HFLNKFFGDKGLKIRFRNSFFPFTEPSAEVDISYKGSKWIEVLGCGMVHPNVFQNVGIDH
TKYNGFAFGIGIERLAMLKYQISDLRSFYDNKISWLDHYGFHFSSLR
>ELAGILAN_00563 Bifunctional protein GlmU
MISKTHTFVILAAGHGRRMNSDLPKVLHKIGNFSMLQHVIYNAKQLNPENIAVVVDQPLI
ERLKCFEDIQLITQESTLGTGDAVKTAMRNLKELPDSNIVVVQYGDTPLIKSSTITKMIS
YLEGKALVCLGFRASNKEYGRLIIENGSLREIVEAKSDKNNHEEFLANAGIMVAYAKNLR
ELVEKIECNSSTHEYYLTDIVSIAVKSNLNVGYVITGGEEATGINNRNDLIKAEFYFQEN
KRKIFTDAGVTLVAPETVFFSLDTQIARDSVIYPYVFFGTGVKIESGAKILPFSHLENCL
IKSNAEVGPFTRIRGNTTIGNKAKIGNFVEVKTSEVGQNTRIKHLSYIGNAKVGQESNIG
AGTIVCNYDGKNKHETNIGSNCFVGANSSLIAPLNIHDESVIAAGSVIVEDVPEKSLAIA
REKQVTKRIK
>ELAGILAN_00564 hypothetical protein
MLCLPYFAAPLNGYTYLVKLAISRDDNKKEVGLNGQKFGHTPSQEPQKFVCKNCTNLENK
SNVPTPQSPPVTLGTQPNPSVSVPPPPPPPLPQDAALPPPPPHFFTASKRTEQPKNDAPK
KAGEPENNNHSTLFEQIRGGTTLKRVSSNKILQMN
>ELAGILAN_00565 hypothetical protein
MKAKLESSGGTDKKERPEEFAARIDREQAERKKSDDNDSEWTKRLKERAAVMRFSDSESE
HSDSISDSDWTTGESKDTQKEIEQEKEEQTKHTNPPSSKEERSKSSDSGIESRATSPIHP
EQKTEESPSSCVDSPQVNNVDPVDNEVQDPPPLSVEDCIAQFGGKALPWQKQFVARRQ
>ELAGILAN_00566 Proline--tRNA ligase
MRLSKYYLPTLKEKPAHAKIISHQYSLRAGLIKQIASGIYSWLPLGLLVLKNIEDIIRDE
MDKSGAIEVLMPCVQPANLWRESGRYDDYGKEMLRIKDRHEEDMLFGPTHEEVATDLIRD
VVKSYKDLPLCLYQIQWKFRDEVRPRYGVMRGREFLMKDAYSFDVDYEGALNSYNLMYKT
YIKIFKRMGLTPIGGRADTGPIGGNLSHEFHILANTGESTLYYDNKFSELLESEDVESLK
SIYAVADDMHDPETCPISQEQLNVSKGIEIGHIFYFGDKYSKPMKASVTSQDGKNVNIHM
GSYGIGVSRLVGAIIEAFHDDKGIIWPESVAPFRIGLINLQTKVTEAADKIYKALKSDEV
LYDDTEGSVGVKFSRMDLIGLPWQIIVGKKAIDEKIVEVKNRATGEVKEMQIEEAINHFS
TK
>ELAGILAN_00567 Holo-[acyl-carrier-protein] synthase
MIHGIGTDIVYIPRVSRILQKYGEKFLNRIYTEKEIELSRKYNSQEMRARYFAKRFAAKE
AFVKARGSGQGIIMKDIEIYNDVRGKPYLTVSKDFISKIHLSLSDDGDYATAFVVICV
>ELAGILAN_00568 Na(+)/H(+) antiporter subunit A
MNYLMDCVLTSLSLPFSITENYLLITALIPLLSALVIFFTGKWPRVNNSITVTSSVLLFT
YTCLCTLYWVYGDHSQFILMDFGNNLHISLKLESTGVIFSLLISFLWILTSIYAICYMQN
NYADSNHSSFLCFFSISISCAMFIAFSGDLLTTFVFYELLTISTYPLVTYNSTNESMIAG
RYYFGVLFFSSLVLFFPAIGLLYNEFHTLDFVSGGIFKFDTSLITFIAVCFAMLIYGIGK
AALMPMHFWLPKAMVAPTPVSALLHAVAVVKSGVFIIIKVILYTFGVDNMQRFVQQNWFT
GGGLPYVAGFTIITASLIALKQKELKKLLAYSTISQLSYIILFASIFSELSMRVAIFQLV
CHAFAKITLFFIAGAIITRAGEKYIDKIYGIGRSMPISMTAFAIGALSMIGVPPAPTFWG
KFLIFQAVFNSGNVILSVFVTLVLIVSTILNALYFLPIIYNAFFLKPSQNYFIKKTPILL
VLPPVITAMCTLVIFFSYQVIF
>ELAGILAN_00569 hypothetical protein
MEDKLLESVKNKSYFSKAVEWYCHRYLFCVAERSWMALIVSLLLVCLCLLTLNIYLLFPV
KKDLNFVKYMNHTEDEFSAMHKLSFSKKEDEYTSTARYLISKYIEIYESIKTVEPKYQEN
FIRNNSIHKIYQGFQEKTNNEAGNLSLSKRKIANINVITLSIDRSTKDLVTFAGNATVVF
TTEQNKEDTVEISFTLSNIKATLAGIIPFKFIVNGYKYRF
>ELAGILAN_00570 hypothetical protein
MTDNKLTVWQSIEVLTKAILNMQKKLSLIKNIASDQDITLEKGKELLSGIYEANFKLNKT
INIATLPKIGYHMLNGELVVRNHITEEEVKIPGDFHYLKVVKSDHDNYKLTFCNFLGNEF
FEYKKYDPQYSGISDEYKFVDFGSVKKTHNLKFKEYIGHAPKFFAAEGPIEPGSQNHVID
LFELVKSGKGSKVGTFADEFGYFDDQNKLHYYNYHKSVESNTYDPENFSVKMINIDVSKI
DKFYLIAEQGDIIIHPILENLDIF
>ELAGILAN_00571 hypothetical protein
MKKVIGHNQAKKKIMNNLSVQSWLICGKKGIGKATLAKSFSNWLLIKNYNEVALDLHIVE
GDTIGIEKVREMKNFLHLSPIQSEHKIAIIDSLEAMTNNAKNAILKILEEPPKNSKIFII
SHKPYDIQTTILCRCFQLNLLPLTYDETKQVVSSQCKFDNQTFDEMITLFPGMPGMIINT
ISSDAYEAYKCFYKFLHDLKNPNMINKVINSEIELELASYIIQAFILESIKREVNGVEIL
LSQWKKIDELFVAAKQLHLDKKHVLANVVNIMT
>ELAGILAN_00572 Threonylcarbamoyl-AMP synthase
MVSKIITAIQNNLLVCFPTETVYALACNALDNESIGKIYQIKKRSQNKPLSIFVSDIYNL
TKIAKVKERYIDLINHFSPGPITYILPLKNNNILPNEFFKDSIGIRIPEHPIAISILNKL
KVPIVATSTNISGKESVCKANDIPQSIKQHLSVVIEDDELVSGIESTIIDLTEDKIKVLR
EGAISLQTVNNAFSN
>ELAGILAN_00573 hypothetical protein
MAENNDNNSFTKRFTNRTPGGTGEGFSSKYSSQNTKERALGEKGKISELAGKKTESKEAF
SESGGIKSKSRTVNERSFADATKRSRSDLIYLVRGKDRGKSAWHYVLVDKEKREMFLAKS
RTGSIDVADYGEILYSGWGEDPPQAIIDKVNEEFGL
>ELAGILAN_00574 tRNA dimethylallyltransferase
MKNNIVIITGITASGKSELCDNLIEKYGNISIINCDSKQVYEEIPIITAQPPKQEVFYKL
YGYVSAKENYSVGLWLEDLEKEVNHALENAQIPIITGGSGLYISSLIKGLSSMPQISQKV
RKNVSELRKNLSKEEFYKLALSKDPRIQGKVFMNDSHRLSRALEVITETGKSIFVWQENR
QPPLFNNFKIYTILPKREDVYRKINSRFITMIENGAIDEVKKLLSMNLAPHLPAMKAHGV
PEIIKYLKGEITLDEAIQIAQTNTRHYAKRQYTWFKKQFLNAEVIDCANKLKIF
>ELAGILAN_00575 hypothetical protein
MSSPISEEKENPIVTLRAQAEKFDFSKLRADEKDISANSGKQMYEDFDRMNFVINKKNID
TILIKALINRDKEEFDKFWEKYCEGLKVSNDKETDRYKEEVEKFYNIGKGYTNLLTKEED
ENKSYRAFAKEVFKEIFKYAEAQVPSDSILEELVINCNQAGYVGALYAEDKPLFHVAMAY
ELVFGSSHTTHINCSDPSHATIRIEEKIAVCTLAKSEEELCKLDSSLEFTLKSQGDKNVT
YEDGKLSLTVPKRLKDYNIGDKNLFDVIKECFQKFCERLGFFKIKIEHGLGDPLEVSDHL
ENMEPPIRSNEHGLN
>ELAGILAN_00576 ATP-dependent DNA helicase RecG
MSNQIFLNSRLENIPKFHSTILPKLCGGDRVMDLLFYRPLSYVDRSKSLPDAQVGEFITF
IAKVYEHQSPTFRGRPYKIVVESESQYIFIVFFNYSVKYLYKLFPIGASVIISGKLEKFA
EHWQITHPDYVSLDINQFKKIACIEPVYQLCRGITNKRIGNIISSNLKELPDLPEWIDDT
LIKQKKWLSWRESIIKLHRPSSLAEAEVCRKRLAYDELFAYQLALKLARKNHVKERGREF
IILSKYKEQVLNELSFQLTNDQTRAIDEISERQKSKYRMISLLQGDVGSGKTVVALFAMI
NVVENNMQAALMAPTTILAEQHYNWIEEVLSCTDIKVALLTGKTSRKERKIIMNELASGV
LNIVIGTHALFQANVTFKNLGLAVIDEQQRFGVMQRNRLVGKGENADILFVTATPIPRTL
QQAMYGDVECSILKEKPKSRLPIKTVTMNISRVPDVIEKLKGAINRGEKAYWICPYIEEN
EETNIAAAEMRFQELQKTFLDKVGIIHGKLTQEQKDQVMFSFKRNEFSLLVATTVIEVGI
DVPDATIMIIENAEQFGLSQLHQLRGRVGRGNKPSFCVLLYDNLSKSSSSKLKIMCESQD
GFYIAERDMMLRGSGDILGTKQSGCMEFKFADLYQDKELLNLAYNNAKGAMADFELLLDI
FEYRSRLHFSKFQ
>ELAGILAN_00577 Bifunctional protein PutA
MISSIQEPNELRKRLQGFYRTDEKSYIRYLVEKAELSADSKNRIYNIAKQVIEKIKHNKL
SIVDSFMQQYSLSNDEGIALMCLAESLLRIPDDYTIDELIKDKIANQKWSKYLGYSSSLF
VNASMWSLMIGSSILRDNEGDSKFYYAISKLLKNLGEPIIRKAVKQAMSMLGNHFVVGET
IEEALRYAKLDDNSKFLYSFDMLGEAAHTTEDAEEYFNSYMHSIKAIGESTEINDCFKSH
GISIKLSALHPRYEFSQFGRIAGEIFTKVLELCREAKKYNISLCIDAEETERLEISLILF
EQLRLDESLSEWEGLGLAVQAYQKRALSVLDFVEDVAIRSKHKIMVRLVKGAYWDSEIKC
TQELGLNDYSVFTRKSYTDVSYLVCAQKLLSKPNSFYPCFGTHNVYTFASIMELADKNPP
GFEFQRLHGMAKDLYDYAMSELATNVSCRVYAPVGEHSDLLPYLIRRLLENGANSSFVNQ
ISNPNVKIDELISDPLEKAINFNYEPHPGIPLPQDILGPERKNSLGMDISDSVIVSQFAD
DIKGFSEKKWQVGPIIDGKALFDNAEFIEVVNPAHLENVIGEVSSATSDQALNALEIAHS
AFAKWQNVSAEERAKCLEKAADLLEERMKELIYILIVEAGKILSDAIAEVREAIDFLRYY
AMIAKNELSDWKKLPGPTGEDNFIFFEGRGVFLCISPWNFPLAIFIGQVSAALAAGNAVL
AKPAEQTPIIAYEAVKILHEAGIPKNVLHLIPGDGGYLGKILVPDNRIAGVAFTGSTQTA
QIINKMLANRDGPIVPLIAETGGLNAMIVDSSALLEQVTTDVLLSAFRSAGQRCSALRVL
FIQEDIAEKQIKMICGAAQELKIGDPIQLSTDIGPIIDKASIDMLTQHTQKMSEDKDSNL
LFKVPMDTNSHNGYFFPPYIYEIQKISQLKQEVFGPILHIIRFNKSQLNEVISDINSTGY
GLTFSLQSRIQSQIDTISKKISVGNVYINRNQIGAAVGIQPFGGRGLSGTGPKAGGPHYL
QRFSTEKVVSVNTTAFGGNTTLMCLD
>ELAGILAN_00578 Aconitate hydratase A
MNNSLNAKTTLNIDGKSYNYFSLSSASEFLGIDVTKLPYSLKVLLESLLRNEDGVNVKLD
DIRVLADCVNKHTNHEISYKPARVLMQDFTGVPAVVDLASMRDYVKKNGGNPSNINPSVP
VDLVIDHSVQVDSYGSVSAFSKNVELEVKRNLERYQFLKWGESSFTNFRVVPPGTGICHQ
VNLEYLAQVVCNNDGVIYPDTLVGTDSHTTMVNGLSVLGWGVGGIEAESVMLGQPISMVI
PEVVGFKLIGRLSEGVTATDLVLTVTNILRTKGVVGKFVEFYGDGLDYLSLADRATIANM
APEYGATCGFFPIDQKTLDYLSLTGRPEKLIKLVEAYAKEQGLWRSSDELAFFDALELDL
SSVKPVMAGPKRPQDKVFLSQVAESFSKSFSVNESKESDKLQDGSVVIAAITSCTNTSNP
SVMIAAGLVARNAIKLGLKSKPWVKTSLAPGSQVVTEYLEKSGLQVDLNALGFNLVGYGC
TTCIGNSGPLNKDIEDGIKNKNLTVAAVLSGNRNFEGRIHPLVKANYLASPPLIVAYALA
GTVQIDLTKDPICKDKNGSDVYLKDIWPTNNEIEDCVKNVVTREMFIQKYKDVFSGDKHW
RKIKCEKSEIYNWDANSTYIQNPPYFDNLSPKNNKIDIKGAQILAMFGDSITTDHISPAG
NIASSSPAGIYLKNLGIEPQDFNSYGSRRGNHNVMMRGTFTNIRIKNEMVSTEGGYTKYI
PSQEIMSIFDAAMRYKENNVPLIIVAGKEYGTGSSRDWAAKGTLLLGVKVVIAESFERIH
RSNLVGMGVLPLVFQNGITRKIFDGSKVISIKGEIVPGGNLECIIKRKDNSRQSIQLKCC
VQTATETKYLMCGGVLSYILAQSF
>ELAGILAN_00579 Protein-export protein SecB
MPQQKMRIHGQYVKDLSFENPNSPFLSSSKAPDINVMVNINSAKLEGTKNKEEVNEEKSF
HEITLHIEVKATVKDEGIKDGVAFICETKYCGIFSIENLKELSEEEVRQALFIGGPTFLF
PFAREIIARVTSSGGFPPLMLDPIDFETMYEQQGQQQKSNGSNSNFN
>ELAGILAN_00580 hypothetical protein
MIELVIYALLAAFIFSRLYNSLGRSANLNLKKLTSVLDVSRSREDVVENIEGYIDSNDEN
SIKVTYEQILKKNKDFSISHFIEGSSIAFELIIKYFNQGNLSQLKPLLDKDLYDNFAEKI
KHRKEVHESIIVSIVSQKILEIKLVKNVVFIAVYFLSEQINFVKNNEGDIISGSTSTINK
VEDVWQFKKNVNSSDPSWLLVSIHYKKTSNDKTNDK
>ELAGILAN_00581 DNA polymerase III subunit epsilon
MESKLRELVLDTETTGLDTESGHRIIEIGCVELINRIPTGKVFHRYLNPERDIPYHSFKI
HGISEEFLEDKPLFSDVALEFLDFISNDILVIHNAEFDVKFLNMELSKLNAGLISSDRVL
DTLPLARKKFAGSPASLNALCKRFDISLENRELHGALVDAQLLAKVYVELTGGLQTFLFD
NECNQDSNSTFVQHKVRNLTPREHSPNSEEIDEHKKLLDKINNTLWNKYIE
>ELAGILAN_00582 SCO1 protein 
MVRFIRLLSNVLAALAVVFLGYCYFTKKGIFAPAAIHNAEVKIGGDFSLINQDGQILRSS
DFKDKYMMIFFGFSSCKRICPMNLGIISETLARLDEKTNNKLQTFFITVDPERDSTERLK
EFQQQFDHRIQMLTGEREKIDEVVAKYKVYASKVDGEEEINHSSIIYLIGPGGRYVTHFA
ADLNSDESQSDKILAEIRKYVN
>ELAGILAN_00583 DNA gyrase subunit B
MNVILINIHKRSNTMENSYNADAIKILRGLDAVRKRPGMYIGDTDDGSGLHHMVYEVIDN
AIDESLAGYCDKIEVSINKDGSVSVTDNGRGIPTDIHEEEGISAAEVIMTQLHAGGKFDS
NTYKVSGGLHGVGISVVNALSSWLELTIWRNKKEHFMRFEDGESIEPLKVVNENTNKRGT
KVTFMPSTETFNGINFSYSTLESRIRELAFLNSNIDITLRDLRNEPYTESHFNQSNQSKD
NFGTANFVQYLDKNKTHVTKIASMKGDAEDLGISLEISMEWNDSYYENMLCFTNNIRQRD
GGTHLAGFRSALTRCINTYATNEGFLKKAKVNLTGEDVREGLTCVLSLKMPDPKFSSQTK
DKLVSSEARAVVESIVSDKLSTILETDPKLAASIVERAIRSAKGREAARKARELVKSKNN
IDIATLPGKLADCQEKAPELSELFIVEGNSAGGTAKQGRNRKTQAVLALRGKILNVERVS
LDRIFSSAEIGSLITAIGAGIGSEHFDIEKARYHKIIIMTDADVDGSHIRTLILTFFFRH
MREVIEKGYLYIAQPPLYKVTKNAKDTYIKDDETFEEYIINSAVKRLTLSSTATEFNDLR
LILNKCVSISNISKNYDREIPQNLLESLLILSKKNALSSADDILKYLKLMYSEYTWEVEI
KDEEKEIHISKLFQGLADKYIFALSMLEGKDMQNILSLLDGISNLFNGDSFLKSQETEIR
ITSPSTLAKIIMDYGKKGLTLQRFKGLGEMNADQLWDTTLNPEARTLLKVEIKDCEEADS
IFSILMGDIVEPRRDFINSNALNVHDVDI
>ELAGILAN_00584 hypothetical protein
MPAAYSYDLRKKAMEALDEGESRATVAKRFKIGKTTLYEWQKRREETGDFQSKKPGSVA
>ELAGILAN_00585 hypothetical protein
MAAGGKAKTASKNNPTQRKKAEQKMYKDKPVKPVRYIDRDSRMNYMSAQYDNGNLVEDEV
SGNPIKWEAV
>ELAGILAN_00586 NADH-quinone oxidoreductase chain 3
MGSCIIVVVKVTINSKECEVEHGLTIIQACEVVGVEIPRFCYHERLAIAGNCRMCLVEVE
GGPPKPVASCAMPVAEGMVIHTDTPKVKKAREGVLEFLLINHPLDCPICDQGGECDLQDI
TMAYGKGTSRLDEHKRAVPKKHFGPLIETAMNRCIHCTRCVRFLSDVAGTNELGGIGRGE
NVEISTYIKRHISSELSGNIIDLCPVGALTSKPYSFTARPWELSHCETIDVLDAVGSAIR
VDYRGPEVMRILPRLSEEVNEEWISDKTRFAYDGLKVQRLDQPYIKKDGKLAPVDWNEAL
TVAAKKLKNTKSNKIAAIAGDLADCESMLLLKEMMQKLGSGNIDCRQDGAKLIPSNRGSY
VFNTTIEGIENADLCLLINTNPRIEAPIINVRLRKRYLQGNFPVASVGPNIEYLYHVEKL
GDNPDILSEIANGNHKFCELLVAAQNPMLIIGQDALIRDDSESVLILAGKIAEKFNMVRD
DWNGFNVLHKAAARVGGLDIGFVPEKGERDINQILEHAESGETEVVYLLGADEIDTSKLE
NTFVIYQGHHGDKGAHVADVILPGAAYTEKYATYVNTEGRVQRTNLAVFPPGEAKEDWLI
IKNLSQYLDLSLPYDSLFDVRKKLDTIGPQFRNADQVIKNTWVPISNGKINLSDTPFTLK
ECNFYMTDSISRASKIMADCTKAFYEHAS
>ELAGILAN_00587 NADH-quinone oxidoreductase subunit H
MNTLVNILFILVPLLLSVAYLTYFERKVLAAIQLRHGPSVVGPFGLLQPFADAIKLLIKE
PIIPFRASTILFIMAPMLTFILALIAWAVIPFGAEVIVENGQQVVIPKVIANINVGVLYV
LAISSLGVYGVIIAGWSSNSNYAFLGAIRSAAQMISYEVSIGLIVATVVITTGTLNLGEM
VVAKHNMPFWVDLLLMPIGIIFFISLLAETNRHPFDLPEAEAELVSGYNVEYSSMPFALF
FLGEYANMILASAMMTIFFLGGWYPPLELGLLYKIPGLIWFVLKIIILLFVFIWIRATIP
RYRYDQLMRLGWKVFLPISVFWVILISGVLLFTGNLPGSNV
>ELAGILAN_00588 Delta-aminolevulinic acid dehydratase
MFNFPNTRLRRRRSSKWVRNLTSENSLSVNDLVLPLFVHDREETTEPISGLPDVKCYSID
GLVSIVKEAKDLGINAVAIFPVVDSKLKSENAEEAYNSDNLICRAICAVKLKVPEIGIIA
DIALDPYTIHGHDGILKDNQMDVENDETISVLCKQALALAKAGCDIVAPSDMMDGRIGRI
RKSLDDNNFQDVLILSYAVKYCSSFYAPFRQVVGSCGLSHSIDKSGYQMDYKNAREAMCE
IEMDINEGADFIMIKPGMPYLDIIKTASDKFNFPIFAYQVSGEYAMIKAAANNSWLDYDK
VIYESLIGFKRAGASAIFTYAALDIAKNLSA
>ELAGILAN_00589 hypothetical protein
MGIFFKFLGKMLGKVFPAKTVSSLLGIGYLPSWQNYWSSFLILFIVDVILILTYGGEYLL
YKMPGSGIVVAAVFTKLAIVMLVMQLIGIFIFHAQDPSANSGEEIVIQIASGQVLTVALS
MPAIMSIYYAVSKLYGNICKQMFQCPFWFNDFMHFFFFLMIPYVFFNVVEVIKPWPISSI
QLSYNNAMSITFEGIFHTFYAVILLYLTAFIFCDLTMHDAIVLNKSIIQYVRESSAVLGD
YLHDTVKKIGIE
>ELAGILAN_00590 Glycine--tRNA ligase alpha subunit
MNLQSIIKELQDFWASEGCVILHSYTSEVGAGTLHPATIMSAIDTKPTKIAYLQPVIRPA
DGRYSDNPNRLYQHHQYQVIIKPSGNNLQDVYLDSLKVLGISTEKCDIKFVEDDWENPSV
GASGLGWEVTCNGMEVTQLTYIQQVGGIDCKMIPGEVAYGLERLAMCIQGVDNVYDIIWN
DNGVTYGDIFKQREYEFSYLALDYYDTKVVQQQFEDTEKLCKFLIEKELPMAAYDQCIKT
SHLLNLLDARGVLGVNERTAYIGRVRELTKKCCELYMSK
>ELAGILAN_00591 Glycine--tRNA ligase beta subunit
MSLQLLFECLSEEIPPRMQNSATVQVKSCIANVFNKNNVKFTSMEVFITARRITLFVDNI
NALELKDSNNEVKGPNINAPKSAIEGFLRKYQKNEEDLLVRKVNNEDFYFIKRESCSFNI
REFLKNQLEEMLKNFSWLKSMRWGEGKERWVRPIKNILCILNDEIIPVSFAGITASNTTY
GHRFLSSGTALTVKAPKDYFELLEKNSVILQMDKRKQFILDQINKFTKEQNLQLEKNDYL
LNELTGLIEWPIVLFGEVNQEKSFGLPKEVILSIVNTQQKYLALSNGKRISHFVTVVNVN
NGEVVKGHERILEARLADAQFLISQDKKENLDYYVKKLGSILFHASLGSVGEKVKRITAL
SKYIAIFIPHASLIKVERAAYLAKADLATSIVREFPELQGGMGGYYASYFQEDREIVEAI
TEHYKPIGPEQECPKSPSAIAVSIADKVDSLVGLIAAGEKISGSYDQFGLRRMTIGIIRT
ILENNLHIPIRLMIDKSVSLYSRLLFNKNTTSVDKPNRKQISELVFRFCLERFKVILKNR
DIRQDIVDSILYKIGINDLLTAEKQTVILDRYLSMPEGEQILSTYKRVSNMMSKVRKSDG
TTYSASYGKRFLIENEEIALSNCAITACKNIKQAIKNNHFNAALDELAGFAPFINQFMDS
VKINCDSDKLRRNRLSLLENVVSIFHLVADFNLIQVKQWINAQAI
>ELAGILAN_00592 UvrABC system protein C
MLRQYKEQIKSSPQSCGVYKMVGDKNKVLYVGKAKNLKSRLSDYLQFENLSERIRVMLSQ
VIKVEIFITENEIEALLLEAQLIKSLKPLYNIVLKDGKFYPYITISKHDYPRIAKYRGKF
KKNEFHYYGPFTSAAAVKQTILSLQKAFLLRVCSDQYFSSTKRPCIEYQIKRCSAPCVDK
ITKDDYCQSVKQARNTLLGRNKEVKEQLLFTMRKCSSEENYELAAIYRDRVKFLEQIQIQ
HTDFSFEKDADFFSIVREEDLACISVLSFRNKDNYGSTPYFAENCGDHSNDEILSTFLVN
FYNSANIPPIQIYVPDSIVDKEIIEQALYKVAQKPVKVLHAKNKKERDLLKFVYDNSQHS
LEQKLIDYRNNLEKLEELSKIFLLPNIPKRIEVYDNSHIFGNQQIGVMVVAGQEGFLKSE
YRKFTIKEKFSGDDYKMMREVLTRRFSGNIKGIIPDFLLIDGGPGHVSIVQNVLEVLNIN
VPFACMAKGPDRNAGNERFYMLGREEFSLANDSKVMLYLQSLRNEAHRFAITSHRKKRDK
QFIVSQLSKIPGIGNKRKKALMSYFGSVKNISKASLAEIQNIPGISKGLAEVILKHVNYK
RGVLE
>ELAGILAN_00594 Fe(3+) ions import ATP-binding protein FbpC 2
MLVNNIGYFYNNQNDFALSNINIKVKKGNVACLLGHSGCGKSTILKLIAGIENPKSGTIF
INDRLVASNKASVAIEHRNIGLIFQHSALFPHKTVVENITFAIRSSSKREKHLIALEILK
LLNIEKYENMYPNALSGGQQQLVAIARVMAQNPDVVLLDEPFSNLDILLKCRIRQHILSL
FRSKNIPVLMVTHDPQEALKVADFIYVMKNGKIIQSGVSSDIYHKPKDDTLAKFFSELSS
TLQLSEKFPLIRCKKII
>ELAGILAN_00595 Sec-independent protein translocase protein TatA
MSLGPWQLFLVLIIILVLFGAGRLPQVMGDLGKGIKNLKQELKDSEKLSSNEPDR
>ELAGILAN_00596 hypothetical protein
MPLPEHLPNDEAIENIAKRLQKSIDDAKKHKVMFSVDVFQGEKSHQ
>ELAGILAN_00597 hypothetical protein
MEQDKNVTETGKEKLRPLMLEMFNLVSTGTDVSQEVRRLLPEDILKERGEYLSRLKQIVS
DSIENDKKKEIVVERDNKFYCVQCPEESVITPAKFLSNPEFQNLDGALQIGEGNVIRTQN
RQYRDMKGRFQMTFPISNSEKIVMTLSSEKAEGFGKIMVHMDDKSCEIFSKYLKELEKEP
HISKVVEAAKSFVQNKSPLSSVDNANVQQLQSNVKSLQSSDRNRG
>ELAGILAN_00598 Propionyl-CoA carboxylase beta chain
MQDFKILENLKTKALEAEKGGGSDRITKQHEKGKLTARERLSILLDESSFAEYDKFVKHH
ANDFGMQNANFLGDGVVIGHGTIYGRKVFVYSQDFTVFGGSLGASHAKKICKIMDMAINA
RVPIIGLNDSGGARIQEGVNSLAGYGEIFQRNVNASGVIPQISLIMGPCAGGAVYSPALT
DFTFMVKNSSYMFITGPDVVKKVTYEDVSFEDLGGAKIHTSKTGVADFAFNNDVEMLLKM
REFFTFLPANNQESPKSAPICNDVDDIDESLNTLIPTNPNTPYDMYELIEKVCDERNFFE
LKPDFARNIITGFGRIGGNTVGIVANQPMHLAGCLDIDSSRKAARFVRFCDAFNIPIITL
IDVPGFLPGTNQEYNNIIQHGAKLLYAYAEATVPKISLITRKAYGGAYIVMNSKHLKGDI
NYAWPTAEIAVMGPESAVEIIFRHEKDQQTLIKEYKEKFANPFFAASHGYIDDIIVPSKT
RYHFCKALELLKNKKVERIWKKHDNLPL
>ELAGILAN_00600 Formamidopyrimidine-DNA glycosylase
MPELPEVEVISNFLLDKIKNKQISNVIVNNWNLRAPITKNIDDMLKGKVIRNIKRRGKYT
IWNTDGSMAVIIHLGMSGKLIYAEHDQAQNKHDHVVFLFSDNTSIIFNDPRRFGLVIVLN
KEQEINFFDDFGIEPLTDEFSGDYLQELLKNKKANIKSALMDNKLIVGVGNIYASESLFR
ARISPLRPAKNLTYREYEKLAAEIKNTLSDAIAAGGSTLKDYAQPSGSAGYFQNNFYVYG
KVQKPCKICNNIITLIRQNGRSTYFCNACQN
>ELAGILAN_00601 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MAVALIFATRARIKILFFDMIFSSEKDPIDLFSKWYKEVLNSSYREPTAMTLATCSKDCI
PSARVVLLKEYSKEGFVFFTNINSRKGKELTENPKAALVFHWIEFSRQVRIEGEVKLLNS
KKADEYFSSRARDSQISAWCSKQSSILKDWQDFEQAIKLKEKEFHNTQVSRPDFWVGFCV
IPKVIEFWQEGEYRKHIRFRYTLVEGSDWKVEQLYP
>ELAGILAN_00603 hypothetical protein
MVTDTQDPFKDYFDFLGFRKLSDQPSRILSSIRKYSGTISIASTIAALIAFTTFSIQPVI
VSIAGFAFTPAPLAFIPLAVLLFTAVINFINTQKIKENEIDKKVGNCQVDEQYSQIVQEA
EKIEIVTNLDRKRKKLLIVLPISKTQREILEDIKAENRNRIFLFTGSYVFGAIIVVSAIS
QSINAPITLISLLVVVLVCIISTLSNLISNSVDHENHTIRNHSTLGLLLPYWSGKGMVVS
VIENKLGKKENELISLMKELLSPFCDSFGSNLKKACDLLDNSLLKPASIDIKETLNDIRG
DLKVLLNNLEEIIEQDVDKVKKNANTEITTCLKGISKSIGESLKEIRTELKEKLNQLQPS
GIGNYLVKFVPTTSNRQAGNTGDSHDQNHSLESDDDEEEFFDCFALTEENKKEIIQEVRK
IINDVVRNKLEPIQEQLATLQANGRPDSALGSEDVDNIDQFPLTLEDTVKARRKTVRNLE
LEEENNRLIKKEQKLTQRKPEQEKTDEWKEKINGKPSDFLYYLLESIKLEEKDNKEKKVE
ATLRDFDNKVTIYWKDGSQTICHIKKQGDLQIESSATMFTDPNVQAAWEMARGKSL
>ELAGILAN_00604 Ribosomal large subunit pseudouridine synthase D
MKLLGIPIINNDHIVKPGEEYIVHLVQPDISTSIEPNYDIKLDIVYEDEDIIVLSKQSGL
TVHPGAGTNNDTLLNAVIAHLGKIPYSHVRPGIVHRLDKDTSGLMVIAKNEEAHGFLSEL
LSNRKIKREYLAIVWGILSSQQGTIKTNIAPKRGNKEMMCVTKITGKLAITHYLVQKVIG
QVSLVKCTLETGRTHQIRVHMSHIGHSIVGDQVYGKNSSKSTKYAKNSSFIRNFNRQALH
AYTLGLYHPKSKGYMEFVSDLPQDIKTLIGEFDNIS
>ELAGILAN_00605 Diacylglycerol kinase
MKKGIIRLIKAIQYSCEGIKSAFISEIAFRQELLLFIVCVSILFVLDVSNLERAVMISSL
FLVLIVEIVNTAFETTIERISSEQHILSKKVKDLGSAAVFLSLINFLITWMIILIG
>ELAGILAN_00606 hypothetical protein
MDTHITFMPIISATKAFKELGKDGMCLYEMEDDDYQSVFVRKNDAILTFYPDLTPKCDDK
STYCSCSKS
>ELAGILAN_00607 hypothetical protein
MLKLKKINGQVQFGILCNKSDIKPPVYTFGMKYLGKDGEVKVKCPNGYAYNLHADNFCN
>ELAGILAN_00608 hypothetical protein
MITPDADLELLKDELANIWFTNSGSEKETIGFGHIFCGEPNDKLGGMHFVGRYVEAQEDK
WAGAIWNPMQ
>ELAGILAN_00609 hypothetical protein
MSKTVKLILCLIIPIIGFIFYIKDHYFHTGYVEENVEVNFEPFFSSQPATVSELTDFDRG
VLKVCGDWGAHPDKEDFKILLSCPQHQEVVKGIYK
>ELAGILAN_00610 Phosphoglycerate kinase
MNIPSIENCDLHNKAVLLRVDFNVPIKDGEIRDVTRILRALPTIQYLVNASAKIIIISHF
GRPKARDNNLSLKNVIDTLSQLLNKKVKFIDDCVGEKVQKAVSAMDAGDIILLENLRFYE
GEKENDANFARQLASLADIYVNDAFSCSHRAHASISRITEFLPSYAGFCLQDELKYLEKA
VSFKAKPITAIVGGAKISTKIKVLMKLTEKVDYLVLGGAIANNFLSFSKVNIGKSFFQNG
VDDLLHNIVETANKNNCKIVVPEDVLVAVNSDYSTSISRKTESILDGDIILDIGSQTLST
ISSIIASSKTLLWNGPIGVFEHSAFASGTIGVMKIVSDLTHKGKLTSIIGGGDSLSAISA
AGLTDKDFTYVSTGGGAFLDWLSGDEMPGVAALQKRLD
>ELAGILAN_00611 2-octaprenylphenol hydroxylase
MNYDVIISGGGLLGLITAIGLSCDSVSVAVIEKNSLPRVVDDNRAFAISQGSKKILEKLG
IWQFVESEAEPILDICILDAVTVHYNHKMVSEEPMGYVINNATIWNAINNNFLNKLNIYS
PHSYKTIVCDSGYVEVILDNNQELISSLLICAEGKNSKLPELFSIPTVKFDYKQSSIVFN
VKHELHHQNLAVERFFPGGPFAILPMKGGYTSSIVWTEKSEISKMLMDLSEEEFIIELKK
RFGSYLGEIKLEGERKLYPLSFAFAKKLYKGRVLLIGDAAHSIHPVAGQGLNLGIRDVES
VIKHVVAAKAAGTDVGSSYLLKKISRNRYFDNFTMALATDGLNRMLSNRIFCAKALRNLG
LIAVENSNFLKKRFIRHAMGFI
>ELAGILAN_00612 IS481 family transposase ISWpi4
MGQILHGCAKTTETIRRAIQNSKESIAKLSRYYNLNPKTIIKWRKRSFAKDADMGPKHAR
STVLTLEEEAVIVAFRKHTLLPLDDCLYALQTSIPHLTRSSLHRCLQRHSISRLPDVDGE
VKPKKKFKQYPIGYFHIDIAEVRTEEGKLYLFVAIDRTSKFTYVELHKSATKPIAAEFLR
NLIKILPYKIHTILTDNSVQFTNQKRHKYAFQHIFDRACEENDIEHRLTKVSHPWTNGQV
ERMNKTLKNATVKKYYYQSHQQLKEHLYDFVMAYNYAKRLKTLKGLTPFEFISLQWTKSP
ELFILNPHHHPLGPYTPCVS
>ELAGILAN_00613 Peptidyl-tRNA hydrolase
MHLIVGLGNPGSQYELTHHNIGFITVDAICKYWGFQLFSKKADYLITSGMINDNKIMLIK
PYSFMNNSGIPVAKIRNFYKLSLDNIVVIHDDADLELGRIKVKKGGSSAGHNGLKSIDSF
IGNDYWRLRFGVGRPEDQRSLADYVLSKFSNFDNVTPLVEKIAKNIHLMLQGDNTAFINL
IV
>ELAGILAN_00614 50S ribosomal protein L25
MTQQEIVTINAELRDITKTKAMHSLRKKGNIPGIIYGKGHDNVNLTLSAKEFTKQYKSGS
LSAHLIELNISGKKEYALVRDIQLHVVKDTVQHVDFQFVDKGSEIKIDIPLSFVNESKAP
GIKLGGVLNVLCRSIAVKCSPDKIPQVIEVDLSGKMIGQSIHINDVKLPEGVKFVAHEEE
NFTIVTISAADSDVEEPQAETEE
>ELAGILAN_00615 hypothetical protein
MGIDDKVIFRIYKPTRTATQSGLGNTNFWHLKIESGSYYIEPLMGWVGSKDPKKQIVLKF
DSLEKAVFYAKKRNVKYIIEMPKNVKRLPKSYASNFILK
>ELAGILAN_00616 hypothetical protein
MRTFCIISIVMFFLSIVGLFKVKLHVQSLNRELIKIKSEINLVQSDIKVLQAEWSYLNNP
KRLASLVKKYLKNNSLILASQVKNLDSLNGRSVLAQLKIHDQQ
>ELAGILAN_00617 Ribosomal RNA small subunit methyltransferase H
MTHTPVLLKEMLSLLSPQDGGIYVDATFGAGGYSKAILESADCKVYAIDRDETVTKFYDD
LSVRYPDRIKLFIEKFSNIKNLLDSNNIEGIDGIVFDIGVSSMQLDNGDRGFSFLHDGPL
DMSMDNSSYINASTFVNALREEEIANTIYNYGGERHSRKIARAIVNARKKKTIKTTFELA
DIVRSVVFRGKSKIDPATRTFQAIRIWVNDELGELEKGIKAASEILSENGKLIVVTFHSL
EDRIVKTFFKDLCATDCKTFSLLNKKVIEASIEEVSANPRSRSAKLRAIQRLS
>ELAGILAN_00618 Proline/betaine transporter
MQQITKVIFSSLICNTLLWYDHMLFGHLINIIGGVFFPSDDQLTSVLKAFGVFAVGFLMR
PVGAAIFGHIGDKHGRRVALLLSIILMTLSTVLIAFVPGYQSIGILASMLVVCLRLLQGI
SLGGEAGNAPFLIEHAPKNKKGFFGSIEVLSAIFGSVLSLIAVLICKKVSDFESWGWRLP
FIFSLAMGLISIYMRYILDESPEYKRQKNPSKLPLKELLNNYKKPVLISIGIDLVENASL
YIYLVFFNVLTNKILTVNTHFNHIVEILSQIALGGLTILFAILSDKVGREKVMKFAFIAF
VIVSYPVFSMLCSGNYLLAHILFIIPIAASLGPVSALMCELFPTKVRYSGFGLSRNIAAG
FFGGLAPFICTTIIKVTGQETSASFYMIFCALIGLVAISQIKGELSSKSPKVNQV
>ELAGILAN_00619 Methionine aminopeptidase
MENMNITIHSQEDFEFMRKAGRLSAKTLDFIAPYVKVGVTTNELNDLCHDFIINAGAIPA
PLNYRGYPKSICTSKNAVVCHGVPDNKPLKDGDILNIDVTVILNGWHGDTSRMFWVGKPS
IKAKRLCDATYHALMEAIKQVKPGNKLNEIGLAIEKYIRDFGYSIVRSYCGHGIGKVFHA
PPNVVHFYDQDENLVLKEGMFFTIEPMINAGKHETLLSKLDDWTVTTRDLSLSAQFEHTI
GVTKDGAEIFTLSPKNWHFPPYN
>ELAGILAN_00620 Cell division protein FtsA
MYSAVIAKPKRNVFAVLDIGTTKIICLIVKINGNFSYKVTGTGYKIAEGVNGGSITNVKH
ANYSISSTIGLAEQVSEETIDQIYVNIAGCSISSFNVHNEIIAANHEISDRDIKRVVFQT
FEKYIEENVIIHNIPLKYHLDDMTDIKEVGGLYGKRLSADVNVVTASRPALTNIENCITN
NGGLNMAGCIASAYSAGLACLSGDEKELGTAIVDIGGGCTAIGIFKRGKLVYASSVPIGG
VHITRDIAYGLCTSIERAEYIKILYGSTIVTSIDENEYITVQNSENDEPTQVFKSELINI
IRPRVEEILEMVREQFQEQKDPINKVVITGGTSQLTSMKEIAGYIFNKQVRIGSPESLSG
LDGEYDKNPVFSAAIGSIKLIVDTFYKNNSGILGQDGKMSKLYNWVKSKVTV
>ELAGILAN_00621 Peptide deformylase
MSILPIVIAPDERLITRASEVTDINDKIKELVNDMFETMYDAEGLGLAAVQVGVLKRIFV
VDVQLETIENEPAGYGSTGKFYMINPEITELSDEQVILKEGCLSIPEQSHEIKRPKYLTV
KYKDLDNEEQTLKASGWLARCIQHELDHLNGILYIRHLSKLKYDMAITKAQKIKKQHEQ
>ELAGILAN_00622 hypothetical protein
MSNEDLELLKFYHEVGVDCTLMEGEEEKKLESKEPSVIQTGTQKKDADTRWGDTKDGKDM
FPSDWIIEARKLAGKCGSVDELRSAVKSFEGCEIKKTATNTVFSDGNPNAKIMLVGEAPG
ANEDLQGIPFCGASGMLLDKMLNAINLDRTKVYISNTVFWRPPGNRKPTDLELDMCRPFV
EKHIALVSPQILILVGGIACYSLLDSTKTISNLRGRFHTYTNQYLSNSITTAAIFHPAYL
LRQPAQKRLAWEDSKKIREYLDNTNNCTNT
>ELAGILAN_00623 Tyrosine--tRNA ligase
MKHASEFLNFIQERGYLYQCTNIEGLDQLLLQSNYIVAYIGFDCTAPSLHAGHLIQIMML
CHLQKFGYKPIVLLGGGTTKIGDPSFKDKARSILPVENINQNTSSIRRILEKMVSFNDSK
TGAMIVNNADWLDNIKYIDFLRDIGAYFSVNRMLSFDSVKTRLDREQTLSFLEFNYMLLQ
AYDFIELNKKYDCRLQIGGSDQWGNIVNGIELGKKLNLPELFGLTMPLLLNAQGKKMGKT
ESGAVWLDDNMLKPYDYWQYFRNVDDQDVGRFLRLLTDVPIDEIRKLESLKDQEINEAKK
VLATEVTKICHGDKEAELAQFAAISAFENEDSSLLPDYIIKKEQVASGISLVDLLHDTGF
EPSKGAAKRLIQGNGCKINDNVVNNIDHVINFESFKDQPFIKLSAGKKRHIKVVVD
>ELAGILAN_00624 hypothetical protein
MELIAWIAGAQLHKRCNFEGNSCTGSGVMKVADTGIQFFMQFHRKRCIVCLFIIKFQCLG
TGFSIRVTFGINDRIDWGL
>ELAGILAN_00625 Ribosomal silencing factor RsfS
MLSDMESIRSTIEEIIDQNKGHDIVTFDVQNKTVIAKYMIIASGDSSRHVKALAEHVIKS
LKPHDKIDVEGMDEGNWVVLNFQGIMVHIFRPEVREYYKIEELWN
>ELAGILAN_00626 hypothetical protein
MYNVYTFYIIENSFLLVFIMGKTLIYLIGFPGSGKFTTAKELCKIIGAVIVSNNLFNNII
FDIVKLQNAEVPDDLWEKIFAVRENVLAILEKHYVKSKHYIFTNELIEGDPYDQRLYNSV
VNLSKKMDMEIFSVVLHCNNEKLVRRVQSEERYQENKITDPDFAIKKIEGKRLFIPQGSL
EIDNSNLSAKEVAKKIVEEMKKEKNGKLIKTSVTNHLKTERTRG
>ELAGILAN_00627 RNA pyrophosphohydrolase
MVEQKDKYRPCVGIMLFNRQGHAFIGKRFDSDSYWQMPQGGVDDGEELEQAALRELLEEV
GTNKVKVITKSKDWIYYNLPEEVIPICWNGKYSGQKQRWFLMKFCGEDEDIDINYTGHPE
FKEWRWQGIDSLVASAISFKKEVYKTVIEEFSSIIKASTISS
>ELAGILAN_00628 putative metal-dependent hydrolase YcfH
MIVDSHCHLIYFSDDEIPKVISRAEQNGVKVLHNICVSIDDVPKLLKISSSYDQVYSSVG
IHPLDAAIENGECIHVDELVEFTKNQKVISIGETGLDFYKSDNKDNQKKSFALHIEASRI
TGLPLVIHTRSADNEMIDMLRSEMKAGAFSGVMHCFASSKELAYQSIDLGLCISFSGIIT
FKNASLLREIAQNVPRERVLVETDAPYLSPEPYRGKKNEPAMVKYVVDCLAELWNESPEQ
VAKVTTSNFFRLFEL
>ELAGILAN_00629 Malate dehydrogenase
MTVQRKKISLIGAGNIGGTLTHMIALRELGDVVLLDISDGIPQGKALDIAESSPIDGFNV
NITGTNRYEDIKNSDAIIITAGIARKPGMSRDDLLQTNAKVMKEVGENIKKYSPNAFVIV
VTNPLDAMVSVVHKFSNLPTNMIVGMAGVLDSSRFRYFLASELNISVEDISAFVLGGHGD
TMVPLINCASVAGVPLTQIIDMGLITQKKVDEIVERTRNGGKEIVDLLKSGSAYYAPASS
AICMLESYLKDKRRILPCAAYLNGEYGVEELFIGVPVIIGKNGIEKILEVKMNDSEQEMF
NKSVNSVRELVKSLGS
>ELAGILAN_00630 NADH-quinone oxidoreductase chain 5
MDKTAKYIQKKTKCECIQKDDGIIVIYSTLDEIEKHLFFLRDDEKCRFELLVDIFGVDYP
NREKRFELIYNLLSIVHNIRVHIKLQLCESDMPPSVAKIFSTALWFEREVFDMYGIEFSD
HPDLRRILTDYGFKGHPMLKDFPLTGYEEVRYDIETKKVVYNPIDLPQDFRMFDSLSPWE
GKTIKVNTKE
>ELAGILAN_00631 NADH-quinone oxidoreductase subunit B
MTNQILSNDDWGRYKKEGFLVTKFGDLTDYVMNWARSGSLWPMTFGLACCAVEMMHTASS
RYDLDRYGIMFRASPRQSDVMIVAGTLTNKMAAALRKVYDQMADPKYVISMGSCANGGGY
YHYSYSVVRGCDRIVPVDVYVPGCPPTAEALLYGMLCLQNKIKRTRNG
>ELAGILAN_00632 NAD(P)H-quinone oxidoreductase subunit 3
MSEYLTIVIFICVSIVVSFVLGILPMFLAVSKPDSEKLSTYECGFNPLSSARKNFDIKFY
LVSILFIIFDLEIAFLFPWAVSLSKISYGGFWSMMVFLAILTIGFIYEWCKGALEWE
>ELAGILAN_00633 putative HIT-like protein
MSNEVYDSDNIFAQILRGELPCEKVHENENVLAFHDKYPDAPVHILAIPKNQYISYDDFI
LKASEEEIANFFKTVREIAHKYNLEKTGYRLVTNYGENGEQVVPHFHVHILGGKKLGKHV
NS
>ELAGILAN_00634 hypothetical protein
MSEAKKIEERHHSLTVPGDMYHLQPGVITGKRVSGIEPFLKEQQDMVKVRELVSSLNLED
ASGEAIKPLSTPNVEKNEERGKGRS
>ELAGILAN_00635 hypothetical protein
MAESIWAKIGGAVKTGVEATGRVFALVPKALIYPIKKPFASTGEMKHDATVSLKKAVGID
VPEEEREYDPPIETTQASKDLGVQITEQKKGIGKVSFLVSRTLTGDIPYLNDEQLNKIKA
LKSEYSNITIHREENKIVIEVDVKKIIEDIKTDSKNKGKSPEEIKKLAIEEIKQKVDGNL
KDLAKITGGEFKVHTDLKLLYGIAEKLYKEYDNQKQSSDKVVKSDVGQPSETIASGEKKW
AQEAIKAGKSQSCGMQK
>ELAGILAN_00636 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MFKWNTNNIIDATGGRDVNGCNWIHSSNISTDTRSIKKGDLFIALKGKNFDGHNFLHEAF
LKGAVAAIVSEGKYKSFPLMIVQDTLKALHDMASYYIRNVLIDAKVIAVTGSVGKTTTKD
MLHTVLSQYGVSHASEGNLNNNIGLPLTILKAPKNCQYLILEMGMNKVGEIKELSKISNP
NIAVITNIEPAHTENFSSLFDVAQAKLEILYGMKNNGTLVLSRDNKYYDYLSSHANRNVI
SFGKDKNAEVCLLNLIRNDESSVISALSSVIPVLDYLDPGSSIANEHIRRLYNKDWIPAS
RAGMTSNRVANRLSLKIRLSDNQIINCNLRVQGEHFAYSLLAVAAVVQSLGLDLSKLPLA
LKNFSVAKGRGNIHKVKCNKKYIHLIDDSYNASPASMKTAIKTLSTYSNQRKVALLGDML
ELGDESIEFHTDLVKIITENNIDKVYTVGKFMLELHELLPDNIRGTHFNDSNQLKSDLAN
IIQNNDAILVKGSRGMKMDLIVREFVIKY
>ELAGILAN_00637 hypothetical protein
MTKRVIIFGGTGFIGKHIVRRLAAEGYLIKIFTRNQEKAACLKLCGNLGQISIFKGDFFD
EKSVLEGMEECDVAINLVGILYEAKKHDFYAVHVKIAERIAKAAKMKNVPMMIHFSAMGI
ENSKLSKYAKSKLEGEKAVTSAFQKAIIIRPSLVFGKEDNFFNKFARLATILPFLPLIGN
GTTKFQPICVTDLAEVVYRIISFNKQDKKIYNMGGPKVYSFKSLLKFILNVTNRKCLLIN
VSFPMAKLIAFFLENKIISMLLKPITGDTNPMLTQDQVKVMMNSSIEKSVDLETMKVRPL
AIENVVPEYLKIYRKY
>ELAGILAN_00639 hypothetical protein
MKLSLYAILSISLVLVLLHVAATFKDWSGYRQYIIKELEKTYDAKVHIGGKVEVSLITPK
LTIYNVYVQYNENKEQKLSDLISVRKIEIRPSFLSLFLFSLQPKSITLFGMKSNKENLIN
IINTKASGNTVDIVIKDSQVSFKSDFADIVNIKEVAVKKNRQFSGKVKVGDNNYDFSGKV
DITKKNVHISVESNFVNLLFTGNRNQEELQGNLTLTINNSSGSVSDLAKIINLSFLSHVI
PSENIKISSNISLNESEFTATDLKIDSKSMQASGTIQNDRKGNHTNFNISFSKVDLDSIQ
NDSQRTMNMKDLLECFRAVVPKNLSLNFNMEASNIQYQNKILDNFRAVLKSTDGKVKVNT
LLKFPGINNISYLSGEISNNNVLSEFNGDLLVEGNDFGSFISCFFPSIKMKENQKNQFTL
SSKLHLAPRILSISDIRLLNNKESLQGSIRVSHTKKRSVVDGEFSMHNLDADKYDHSLFS
SLPKMQWLKNFQYDANIKARVNNLTLNDTKIKNLDFLLKMEKGKLVADKIKLSGEDFDIT
GNAKILADQKYAKPLLDVNLTGSKFNGKIITLPNLVETKRNSRNEIDQIQWSTKQLDFLD
DKEGFDANVQINTAEFKTKQNVLKDFNLDAVMRNNTITIRQASYVLEHGQVFFQGYLRSD
SINTRFSIVNLDTKKIGKVIGIDNVNGQVSLNGEIKTQGKSFHDWASNLSGDVNLQAQGI
EVTNVDFNSFITNLLSSKNKSEISTLAYIDIYNGKTFFENISGKASIKSGICSTSLQFGI
DQASGSISSNLTLSNFALASIFRFFFIPPNYSNPIYIDMHLDGPIWRPKMSFDVDQIFTA
LVGKKNS
>ELAGILAN_00640 hypothetical protein
MYKPDLLLKEQQTVSSQCLTLGSRNFVDCMIWKTLFKSHWISVSHIQLYECCDLKAISTG
KGVIPVLDYLDPASHATSSKMLCFNIRLATFLLTNLMSNQIFWIPVSSTGMTGVGAGMTG
IGTGMTRRRDAGMRGLL
>ELAGILAN_00641 putative lipid II flippase MurJ
MIQIFAPGFDQSKFTLTVTLSRIMMPYIIFVSIASLIGGMLQVKQHFASTAIAPIVLNLC
LIISLFVPYVKTPAHNLSIAVLIGGIFQLLLILFSAYKLKAAFSFSLELSNEVRLFFKRV
IPAIINNCVTQISLWIDTIMASFIPNAVSYIYYADRLNQLPQGIIGTAIGTVLLPLISKQ
VNNTENIVKIQNKALNIGLMLIMPTTAAFIIIPDIILLTLFSYGRFDHYAVQQTVPTLIA
FSLSLPAFIINKVLLPTFFAKGNLKIPTIFSLMCLGINVVLNLLLMNKYQHTGIAIATSV
STWINSILLISYLTINKMYKVSQALLLNIMKIFVATAVMSIALYIFNSLLAGLFFDKMLA
RIVYLATLIALSVIVYFGTLYLTFRGSLNNLKYV
>ELAGILAN_00642 hypothetical protein
MIRQKITKIINVMDITLLAKLNAFLLSYDSVEYNGMNEVVNAPSAKNARNRLAKRNEEKN
MSAREFAPITVAINTSLINPEILEIAVKKLNVKILLNIPLLH
>ELAGILAN_00644 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MHKYDVVVVGGGHAGCEAAAAAARLGTNTLLITHKISTIGEMSCNPAIGGVAKGVVVREV
DALDGIMGRAIDRASIHSVILNSSRGAAVWGPRAQADRKLYKQAIQEIILNYNNLTVKEE
SVDDFLIESNNNGELCIKAVITSSGEHILTGKVVLTTGTFLQGVIHIGEQTTPSGRMGDK
PAVELANTLNKYDFRLGRLRTGTPPRLDRGTINWSILQEQVGDNPPVPFSYLTEKINQPQ
VSCFITHTNENTHKIIRENLHRSASSYLSDVVAPRYCPSIEVKVKKFAEKSSHQIFLEPE
GLDDDTVYPNGISNSLPIEVQREMIKSIKGLENAEILRPGYAVEYDYIDPRELFHTLETK
KVKGLYFAGQINGTTGYEEAAGQGIIAGINAALSAFEKKESFVLHRTDSYIGVMIDDLVT
KGVIEPYRLFTSRAEYRLAIRSDNADRRLTQKGYDISLVSHERYSVLQNKLESIKQLEEK
LGSLTITPEQLRSYGIKISYDGIRKTALDLLSYPNIDWNKLQEIWPELSSVTRWNDKMGH
TKADNRAKNEICEAVEIEAKYKPYLIRQEADMKFLREEINTQIPIDFNYSQVKGLSSEVI
EKLQTIKPATIGIAKQIQGITPAAIVSILVYLRNRKTKVAANFV
>ELAGILAN_00645 hypothetical protein
MSKIEEFRSFMHEINVDAFMLHTKDEYLNEYSEELTKLCGFTGTNGLLIVTKDNKCPFFT
DGRYITQARNQLDRGNFQVYNIQEEDPREWIKANLTSTASLGYYLQYFTIEDIRKYENIC
KLIPCLAGKKVTIENKQWFYILLNMLVKVVRTNVKKSLKV
>ELAGILAN_00646 hypothetical protein
MLLTDPNSISWLLNLRNENAKYTPCILGRAILYKSGNVDLFIQDKEHSTIEANLGNHINI
FDISELENSLHKLNSIVMDPSTTPMSIMAVIKDKQVAEREDPCLIYKAAKNQTEIAGAIN
AHIRDGVAVTNFLYWLENNVGTELEAEEKILEYRKEQNLFKQLSFPTISAFNENGAIIHY
RASSKTNKVIQKDGLYLIDSGGQYLDGTTDVTKTVAIGNPTDEQITHYTIVLKAHIAIAS
VIFPPGTTGGELDILARTHLWKFGMDYMHGTGHGVGSYLSVHEGPQAISKGNKVKLTPGM
ILSNEPGYYIPGEYGIRIENLMYVDKHKNGFLGFKQLTSIPYDRRLISVQMLTKDEIEWI
NGYHQFVYKNLENSVKDKEWLKKVCDPL
>ELAGILAN_00647 hypothetical protein
MIDKGQEDEFMKQYMDTCKEQIEKLAKDPELLNQALKPFMQMSQQLMAGGMLEGAMPGMI
PDLGSMDVNKMIAQMKEMIDYIRGNYKELMKERSSQIQELNESSKKLRGLVKKLIEKIES
K
>ELAGILAN_00648 hypothetical protein
MIELRGPEICAGGNKKNLIVFLHGWGSSGDNFIHLAKVMSKFLLGSYFAVPNAPFEREIG
DGYQWFSLEDRSEEALYNGVKNATSIVNHFIDTKLKELNLKDTQLSLVGFSQGAMLAIHT
ALTRSQSCASVVAYSGRFLSPSKTAPEIKSKPNICVIHGDADDVVPFSSLDLAVKALKEN
GVNVEGHPIHALGHIINEEGIKLGVEFIKKNFKN
>ELAGILAN_00649 hypothetical protein
MHLFCFGYGYVAKFLSKKLLNLGWKVSGTSRSKNIQDVILFNYEKVSQDLLKSATHVLIS
IPPDGDDVVERYGDCLQNVKWLGYLSATSVYGDHSGNWVDEESETRPIEIRGEKRLKSEK
KWLNSKLPVHIFRLAGIYGPGRNVLIDLQLGKARNVKKEGHFFSRIHVEDISNILFSSMQ
NIKPGEIYNCADDLPTTQSEVVIYATKLLNVSPPEPIELPDYAQSFYLGSKRVSNVKIKK
DLNVSLIYPNYKVGLESLHVNKTEITSE
>ELAGILAN_00650 Protein ApaG
MIEYTLTTNFVEVTVLPIYIEEQSIPYENCYVWMYNVKIKNKSQSTIQLLSRHWQIIDYK
GKVNEIAGVGVIGEQPVIKSGEVFKYTSGTYLNVPSGIMQGKYEFLNEESIKVFEVMIPP
FSLDSPYIKTRPH
>ELAGILAN_00651 N5-carboxyaminoimidazole ribonucleotide synthase
MNEPDALSKKVIGIIGGGQLGKMTAIAATKLGQKTHVFASAKDDPACSVADDFTIADFSD
KKALESFAQSVDLVTIESENIPCSAIDIDVNFYPGKKALHISQNRLREKDFIKNLGIKTA
NYKSIQNYNELLKSSRAFGYPTRLKTTEMGYDGKGQYVLENDSEVKQFASFDWNTEYILE
ASVDLLKEVSIVVARDKNGKVAFFPIAENYHVDGILDTSTVPAKIDSKLTQEVQRAAKKI
ANALDVIGILAIEFFVTKDNELLVNELAPRPHNSCHWSLDACNVSQFEQLVRIICGLPMQ
EVVLRFPCMTKNIIGNDIYDSHKYLSNEKASLTIYGKKEVRDKRKMGHVNIDLS
>ELAGILAN_00652 Bifunctional enzyme IspD/IspF
MINMHTNRLKKYKIAALIVAAGVGSRCSSTIPKQYTELVGKSVLFHTIKRFLTNQYIDHI
RIAINRDHENFYEKAISLITDTKLLSPIYGGENRQSSVKLGLESLQKVNPDFVVIHDACR
PFVSNVLIDNLAQSMINDQYTGVVPAIDVEDTMSLVSNNFIESTISREKLRAIQTPQIFN
FKELLSCHQSTKEFTDDSSLMIEHKKRVVIIKGEKSNFKLTTKEDINMAKLLFEEPKFRV
GTGYDIHKFIKVQNGAESFIKICGVKIEHNMAIEAHSDGDVAIHAIVDAILGALGYGDIG
EHFPPSSSEWKDCNSSHFLDFAAKKAKEKGYSVSNLDITIVCEEPKISPYKVEMKKFISK
ALEIDDEFVNIKATTAEKLGYIGRNEGIAVHASVLLHTNFYWK
>ELAGILAN_00653 hypothetical protein
MHITKCNKENEIHLIFFHGIGDNYKSAHNYVQGLNGSNNNHAHKYPSAFQNYITYAAVSF
LFLVASVSAPIAILLLISPITAGVVGLASLAALTCIFLSLMLIFIPFINRDQSLLKPSIE
EINKLMDKGVRPENIILFGHSFGGAVASAVLKHFADKNVKLGGVIFTSTFSSFHTAIEHF
PIPQAKILSMLPPSIFKKLLKALDLDFDLVNDIRKLRDEGKLNTPIIVINSKEDYLVPQP
AQLAHAIENDVLLRGKLIKTVNSKRCEDDPHNGVLSSWELGENLTDLILNKIDKTMNRQY
LQ
>ELAGILAN_00654 AI-2 transport protein TqsA
MQKRHITICFILLFIIGMLFLMRPMIFPCLISVVIAYLFNPLVVKFEKYRIPRSCSVIFI
ILILLIAFILVITFVLPIIYVQITSILNFLVSKVPSLKLKVIPSVLEFLNIKIEDSLFDH
LSKNLAENYSNYVSYFMNALDIASNFIIQVLSSSFNTVSLMVITPVVFFYILRDWPLIIE
KASKLIPIPYRGKIADYFSKVDFIISNYLKGQVNVCIVMMVFYSVSLSIIGLEHSIVIGI
LSGMLTFIPYVGPLLYTIIGFLSAITQFSGWFESAAVLLLFGVGQLIDSNILVPLLIGKK
VHIHPTVIILGITICASYFGFTGILLFIPIIAMFNVSVEYAINKYFKSELYKNG
>ELAGILAN_00655 Chromosomal replication initiator protein DnaA
MQLNLFNNNQADYSRQNYIILDENKHVYNSVVNDLSWKCLILFGPKSSGKTHLAHIWQSI
NDAIFINVNNFVSEIRYSDAFILEDVQNIKDEAMLLHCYNYMKENDKRLLITSSISPKKL
NFKLRDLSSRILSTISVKILPASEELLRIMLIKRFSDKQLKIDLKVINYILARIERSFYS
IDKIIEKIDNESIGSNVTVPFISTLLKKDAI
>ELAGILAN_00656 hypothetical protein
MIRVRLNLRKRLKQKFVMFTLLINALFVSYFLIRNTGNTSNQIIAKEINIGTDNEK
>ELAGILAN_00657 Tyrosine recombinase XerD
MKNKQSQNKKENLYITYYIDALASERFAAQNTLESYRSDLHQFEEFLLESGTTLVGVNKT
NIKDYVKSLCTQKKYKSSSISRKISAMKNFYKCLFNDGIIDFNPAPANDAELKNPKVSRP
LPKYLSVEEIFLLMDTVRKSASESNKEISSKRLCAILDILYSSGMRVSELISMKLCEVSH
LINSNNKECYIIIKGKSGRERQILFNEQALQSLRNYLSVRDNLISKEKESDWLFPGDKPN
KPITRQRVGQLMKELARKCNIDENKISPHVIRHSFATHLLNSGANIVLIQKVLGHTNLST
TQIYTHIANEKLKDKLADSHPITQMINN
>ELAGILAN_00658 hypothetical protein
MISSLLFNFFLILWEVFYTFITLPVIFFSECVITIFLVCSVRVVLFMLRLLCGIKYEVRG
MENIPKQPFIIASKHQSPFETFIFILLFRKAVFILKRELKWIPFIGLHLIALKMIFINRS
DGISSIRHIVKLAKMRIKENRSIIIFPEGTRTTINQNIKYQPGIAALYSVLSVPVLPVAL
NTGLFWPKSILSLRKNPGKAVIEILPPIYPGLNKNEFLQSLEKIIEERSSRLTIGKTDIA
N
>ELAGILAN_00659 30S ribosomal protein S20
MANHKSAKKMIKVIAKRTLINKMRKSKTRTSIRKLVDIIKSGDKENVVLAFRNAESNLHK
CVNKGVIHRNTAARKISRLNAKVKALMTA
>ELAGILAN_00660 Citrate synthase
MDKKVLLELSNGLKIELPVLSGTTGPDVLNIKDLYKMTGLFTYDPGFVSTASCSSTITFI
DGDEGVLKYRGHNIADLAENNNFTAVIYLLLYGELPSSEQHKKFLLKIQESSKVSEQVTN
VIKAFPKTAHPMSILVACFASLSASYHEKHGNNVNGEDLDFGISAIAQVSTIIAMICRHN
NNQEFINANNELSYSENFLKMIFGDAVDNDKSALFAKALDKIFTLHADHEQNASTAAVRL
VGSAGSNLFASLSAGVATLWGPAHGGANEAVINMLKEIEQSGDIDKFIEKAKDDKDPFKL
MGFGHRVYKNYDPRARILKGACHEVLSKLEQNNELLKIAKKLEEIALKDEYFIVRKLYPN
VDFYSGIIMNAIDIPSNMFTPIFALARTTGWVTQWYEMINDKETKICRPRQLYFGK
>ELAGILAN_00661 Prolipoprotein diacylglyceryl transferase
MSLNPVIFSIGPVSIYWYSLAYVLGIVFAYWYLHRLDDQKIFTKNFYDSLLTATIVGIIL
GGRLGYVLIYDPVLYISNPIEILKTWEGGMSFHGGAIGVLLAVIISCRRHNIPIFYALDL
VSCGVPIGLFLGRIGNFINGELFGRVTTMPWGMVFPESGDNLLHHPSQLYEALFEGLLLF
AVANSLFFLTRIRLYHGALTGIAVMWYGIARFFVEFFREPDYQIGYLWLDLTMGQLLSIP
MVLLGMLVYLGALNLKFNTKSVT
>ELAGILAN_00662 SsrA-binding protein
MEVIAENRKARFEYFILEEFEAGMVLLSSEVKSLRERKVNISDAYVVEKNSEVWLHNMHI
AEYKAANRKNHKPKRERKLLLHKKEINKLIGQIKTAGITVVPLSVYFNDKGFAKTKIAIV
KGKKLYDKRATIKQREWDREKSRLSKNNL
>ELAGILAN_00663 hypothetical protein
MLKDITTKLYLLSEEVMEYNKFMEILKKINDLSDLSKDNIVEKIKAKLQEEDPDLCQEWE
KSKPDNDSGSGINYIFTISRGQNSKEVKLLHLASYWNCANVAKALIENGADINAEHDNKI
TPLHIAAHYGHEDVVTILTGKGAIVDAKNGDGWTSLHFAVEKNHKNVVNTLIGKGANVNA
ENDKGWAPLHLAITNGHKEIVQVLSKAEGINVDAKNSDGWTSLHLAAANGRKDIVETLIE
KGADVNAKDHYKWTPLTFASQKGHKAVKEALLKAQENIKALHSAVKHNNEEEVKNLLNKG
VNVNAKDDDGCTPLHLAAREGHKDVVDILIAKGAKVNAENDDRCTALHLAAENNHIEVVK
ILVEKADVNIKDADRWTPLHVAAENGHEDIVKTLIAKGAKVNAKNGDRRTPLHLAAKNGH
EDVVKTLIAKGAEVNAKNGDRRTPLHLAAKNGKIKVVEVLLHTEADPSLKDVDGKTPRDL
TKYQGIIQLLEEAEKKQTLKNENKKTPKDLTENKDVMQLPEKKEEKQIGKNAIVKEKEQS
AKNAIVKGVIVCFVTAVIVGVALAFATALSVPAIIGLAAGSALIVGAGQYIMSKPKTEMK
EVKELVPRETEKALT
>ELAGILAN_00664 hypothetical protein
MKNLNFRKEIKFFSLSFIILFVLWTVLSGYFEPFFIFCGVFSCIFTSFIFRRLINAERAL
SQILNSTSRLSFYKLVSYIPWLMYQIILSSVYVTKKVLQLKSKLEPIIILRKCKGHNDES
IALFANSVTITPGTLTINVESKQKTYFSTMYLIDKDLESGISEIENKILKILRSVK
>ELAGILAN_00665 hypothetical protein
MSKLPNNAKIGKSQVTQWEVIKNCEYADNCLSKIVTLYVIRITQLSDFYTSDEPEINTVL
ARISVTSENVFLNKATTIEVMEGIFPYKFNSKKRNNILRLEDLYNYLCSIVNNSLPKEML
ESLVREYKDAVNLFKAIT
>ELAGILAN_00666 Phosphoribosylglycinamide formyltransferase
MKKIKLGILISGRGSNMQALIEACQDQNFSAEVACVITNNSEAAGLKIAEQAGISAFIVK
DKPLDAGKIHEILVQHKVDLICLAGFMRILKADFLSKWHNKVINIHPSLLPSFKGLNAQE
QALKAGVKITGCTVHYVTPEVDAGAIIAQVVVPVLPADDIQSLSERILAEEHKCYVEAVR
SIAESINY
>ELAGILAN_00667 putative zinc protease
MRISKFVLLFFFCLSFNLQASGSLNIEEVTTRKGFKFLFVENCALPKVSLNISFKDAGYV
YESAEKQGLAWFTSLVIQEGAGENDAKDFAKKLKIKGINLLFYPDLESFGVSLETLSENL
EESISLLSDAIIRPKVDSEGLNRVFEKAKVDFNNLEKNPYFVAGKELDTLLFKKHPYSKS
VYGTLDTIMSITRDDVLTYIKRNFAKDNIVISVAGCTKKEEIITLLDKYLSKLPSKRSKV
RKIPVKNDFGSAESKNIFMDIPQSVILFAQKGIAYEDPDYYNAQVLVNALGGMGLNSVLM
KELRQNLGITYGISASMASYTHANIIAGGLSTDSSTASQSISAIRDTLSRIKKEGIDEQL
FKDTKISMVNNFIFSLSNNANTAVFLASMQVRNRDINRLNNFVSLINDVKLEKVNELASS
LLEPENLFFVEVGKNAQGQ
>ELAGILAN_00668 putative zinc protease
MLHKFFSFLILPVLFFTYPISSNALNIEHNIKYTKLSNGLDVYVVSNHRIPAVLHAVIYK
VGGMDDPIGKAGLAHYFEHLMFETTGKFTDIEATMSSIGAQFNAFTTKEYTCYYELVPKK
DLPLAMEVEADRMGSFNVTQDKIDREKNIVLEERKMRFDNHPNNLLWEEMNSAFYRTGYG
RSVIGWESDIKTYNLDDITRFHDNYYHSGNAILLIVGDVELDEVVKLAEEKYGEIKAKPV
MRNYPNQDPVHNAGLSVTLESTEVKEPVLYFRYRVPLFEHINEASAAHLAVEILGSGKSS
KLYNDLVLDEDVAVSVFAYYNSLAFSDGYIDIQVIPKSGVNLDIVERELDNAINNFMSKG
ITDEELQSSKYRYKAAQFDNLSDLTHIAMFYVPHLALGIPLDEIDISYSKIDDVNLEDVN
NKIRTIFSSNKLIGRLLPKGDNNENK
>ELAGILAN_00669 Lipoprotein signal peptidase
MKKLCLVVILIIVLIDQTSKLYINSLIDEGESIEIASFIKLVEVWNSGISFGMCSALPHG
GFFFSAFSILIIGILAYLIYKSDDQSTYLGFSLMIGGAIGNVVDRIYWGAVYDFIYFHID
DWYWPAFNLADLSIVCGMFTLLYKWYIYDMLISKQNEE
>ELAGILAN_00670 Riboflavin biosynthesis protein RibF
MKIIYNCEQGIENNIALTFGNFDGIHLGHEFAISTLKKVAQERELPSAVLTFEPHPSTVL
FGRNNFRLIDQEQKKELISSYGIDYLYIINFNRGFSEVSCDDFISEILIDKYGAKHIIVG
ENCTFGHKRLGNILTLEKYSEIYGYSLTKLEPLTIDGKICSSSSIREYVQRGEIEIANKL
LGRPYQVSGVVTKGACRGREIGFPTINIPIEDCMIKPKFGTYYARVTFPDSNPNWLYGVV
NIGMRPTFKDLKKPIIEMHIFDFDEDVYSHKVNIQLLKFIRSEKKFHSIEELTKQINYDI
LKVYRLKANL
>ELAGILAN_00671 hypothetical protein
MKNVVIYVKKGCPYCIRAKDLLDKKGVKYEEIDVLKNSDLFNDIKSKYNVRTVPQIFIND
KHIGGCDKLMDLEKEGKLDDMLNNNDNHTDVTTYTNSNDECGECVIPHDDFM
>ELAGILAN_00672 hypothetical protein
MTKNISIISRNLISIELVNKQDLENFIKIFTVLDKHIAAKTLFTEEVRIEYKQHNGIEVV
ELLKDTDFTYHEVENVLNHLSKHGMKVPSSVIAHTLFAAYNHALEFKDVAFSFSEGSPQF
NIRVSKNTFIITPMSEENLELNSQSSKKLIESLQSEKNIYDCIVEENTIKVIVHSEIHQA
INLIIKSLIKSRLLAKEEEGKFKEKLRQLAFKDQAFVEYSSIKTISRYPHNHPLRKHESV
TKDIENILCDFIANENSEFAIERLNRLSSAVSPDTPRIITKTIDKLVKFH
>ELAGILAN_00673 Quaternary ammonium compound-resistance protein SugE
MNWIYLLLSSLIEVFWVITLKHSCGFTHLVPSIISIFSMALSTYLLSLATRSIPIGVCYA
IWTGVGAIGASILGVYLFDEPVNLFEVICFILVTFGIIGLKLFDTAKQTVDKME
>ELAGILAN_00674 Quaternary ammonium compound-resistance protein SugE
MCWLYLLLSSILEILWAVTLKFSNSFTKVVPSIATLVIMIISIYFLSLAACFLPIRVCYA
VSSGICTIGITIIGATTFTENINLSQVLCIVLIVIGTIGLKLSI
>ELAGILAN_00675 D-alanyl-D-alanine carboxypeptidase DacA
MLSRLVILLLVFILPFSSYSYQFRTKAKQAVVLDLASDSFIFDHNSDEKMAPSSMSKLMT
LYIAFDYLKAGIIHMEDKFRVSRKAWERKGSSMFLKEGQFVTVRELLEGITIVSGNDACI
TLAEGIAGSEENFVAEMNEVAQNLNLNDSHFVNSSGWPDGDHFMSAKDLVMLAKRIFTDF
PEYYDLFSEQYLTYNEIVQKNKNLLLFHDIGVDGLKTGYTNAGGYGIVASAKRNDRRIFA
VVNGLNTEKERIEEAKRLIQYSLNHFNTKKIFAQDSVVEEVNVLYGKDKKVPITVANDVT
ITYNRKLHDQIKVRIEYKDMIPAPIKKGQEVGKVFVEIPGIEQQTTPLYAANDVQELNFV
EKFFRMLF
>ELAGILAN_00676 hypothetical protein
MNRGMTVRGGIPVSGHWDDRKRGYLDYSRSPLHKNFISNTHINNTPIAESKISCIV
>ELAGILAN_00677 Cell division protein FtsQ
MLSSITRSQRSFLRKCALVIITALFLTLILYSSLDKIINRFNYYFTWYNDCLSSLLLSSG
FSIDEVVVSGNKFTNKKDILSLTDRTQPILYISLSKLAGNIQSVSRWIKHVRVHRILPNT
LHINIDEHKPFALWKDNNKTSVIDFEGKVIVDDYLVDDLVVITGQNSLSNLEFVRDVLES
KTQLRDHISSFAYIGNRRWNIILDNDSTVKLPEDNPYSAWDYLNHLHNTTDFTFSDWSII
DMRITDKIFVKR
>ELAGILAN_00678 D-alanine--D-alanine ligase B
MIPTIAILSGGFSCEREISLMSGKAVKKALDSLSYNAIEIDVDSNIAEKLKKINPGLAFI
ALHGPYGEDGCIQGLLEILGIKYTHSGVMASAVAINKVMSKHIFRSLNIDTPKGYVISRE
DVLKNNIKIDYPYVLKPINEGSSIGVYIIFSHEDYLELKDNSSTIMEKMIVEEYIPGIEL
HTAVLLDEAIGTIEVRPKNKFYDYEAKYTDGFAEHIFPAKIPDNIYKMTLEHALKIHQFL
GCKTISRSDFRYNPKNNTLKMLEINTHPGFTELSLVPEIAKLAKGINFNELVKIIIEDSL
QHKNIRDLSHVEQYY
>ELAGILAN_00679 hypothetical protein
MSINKRETIKKIEGLLFQANGNLEKACDLLSTVELTEDDIKILLEEMIKEYHSLSEKISY
SCGITAGGAQDANANSFNEVFKLGSQELALAMMSDFRKSYDQELFKKYKKEEMSYPEGEG
IQFIRELRVLSRILTISLIRKLDEVYKFTPEEIERLKEYMLVSNYDTSKSLSDIDKYMHA
LSALIRNPSLDTKKIFELNNRMIIHTTALIDLVTSGVVKKEEAKEQSAEDLEKLICEQYK
GAANKPLPLPSTLFEVDKKSA
>ELAGILAN_00680 Ferredoxin 1
MTHFVTDKCIKCKYTDCVEVCPVDCFYEGKNMLVINPDECIDCGVCIPECPVDAIVTDDS
VKDILELDEELLSSEQKTFKSFYNINVEYSQKWPNITAKKQPLYTAEEYKEKKDKTAYFD
ENLE
>ELAGILAN_00681 hypothetical protein
MKINKLNNKELEVWLSLARTIGPIKFFSILKTHGSLDEVLKYLNRVANNKVYGIQDAREE
INNAERIGAKIIPACDPDYPDLLRNISSCPPVITALGDISLLSREIIAIIGGRNSSMNGR
NFANKLALDLSEAGFVIVSGLAKGIDTAANSVIYKNHSTIAVTASGIDVVYPKENFDLYK
KITGNGGLVITELPFATKPKPQYFPQRNRIISGLSLGVAVIEASKRSGSLITADFALNQG
REVFAVSGFPLDSRCSGSNYLIKNGAKLIESADDIIESVRFSLPPQQKNLFDVEHYAVNQ
KQEKLQQAKSVIVDHINSVPVDIDELILASGLSTNIALMALLELELENKIERSPGNKISL
IF
>ELAGILAN_00682 Triosephosphate isomerase
MNGMRSSFVDFIGKLNNKSNEITSKLVICPPFTSFPSSIELNNNINIGAQNCHHKKFGSY
TGEISAEMLKELGCTYVILGHSERANEKDSEIKLKSEIAIESGLHPIICVGENSEDYKNE
KTKEVIEYQCKNRLPTHGEYTVAYEPIWAIGTGHVPNNDAIAKVIEVIKLCTSKKHIIYG
GSVSSENIENLLNISNLSGVLIGSASLDFDHFYKIIQQVEKKFSLINSKISN
>ELAGILAN_00684 Ribosomal RNA small subunit methyltransferase A
MNFSQLIFKILYNENNMKKFLLKPKKSLGQNFILSSEITKKIVALAGSLENFNVIEIGPG
YGALTREILVHNPKSLLSIEKDRDLVKHHDQLLNEHQGKYRIIEADALHVTEEELIERPV
KVIANLPYNISVVLFLKWLNNIKFFTNLTLMFQKEVADRITARPNSKDYGSLSVLSQLLC
DIKKEFDIEPKEFFPRPKIHSSVITVNPLPIPKFAVNLETLTRLTRAVFSQRRKMLRNSL
QNITNHTETVLENAKLSGNERPENLTIEQFCLLANNVECLFCKSPIAI
>ELAGILAN_00685 Inosine-5'-monophosphate dehydrogenase
MKKMEACYSFDDILLLPAYSNILPCGADTKTYLTNNIELNIPLISSAMDTVTESGFAIAI
AQHGGIGCIHKNLSIDEQVLEVRRVKKYESWIVYNPITISPDKTVAEAISLMREHNYSGI
PVVDQRKLVGILTNRDVRFIEDQNMNVKVSEVMTKDKLVTVREQGVNSASAMKLLHENRI
EKLLVVDENSCCIGLITVKDIEKYNRYPNSCKDSKGRLRVAAAIGTGKKDGIDRCEALIG
EEVDVVVVDTAHGHSENVINTIREIKKMYPNTQLIGGNIATKEAAEALIDAGVDAVKVGI
GPGSICTTRIVTGVGVPQFSAIKNVAEACRARNVRLIADGGVKYSGDVAKAIAAGADSVM
IGSIFAGTDESPGEIIMYKGRAYKGYRGMGSISAMKRGSASRYFQDKDSKLKLVPQGVEG
RVPFKGPASGVIHQLIGGLQAAMGYTGNRNIEEMKKNCKFVTITASGLRESHAHDIVITQ
EAPNYAYQTSNLSTDSE
>ELAGILAN_00686 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MEIILAEPRGFCAGVKRAVDILAITLEKYKNERQVYVLHEIVHNKYIVEDFKKQGVVFVS
SIKEIEDNGGILIFSAHGVSKNIEDEAKRKGIQVIDATCPLVNKVHKEAKRYENSGKELI
LIGHENHPEVKGIRGRVNNPITLVQTLQDVYDLKVKDPDNLSYVTQTTLSIDDTRDIIAA
LKLRFPGITGPDLKDICYATQNRQNAVKKLAEIVDMVLVVGSKNSSNSNRLLDLCTARGK
RAYLIDNYRCVNKSWFQGVEKIGITAGASAPDILVDELMDYLKVSMNVEVSVMPGGIIEN
VQFKIPNLV
>ELAGILAN_00687 putative peptidoglycan D,D-transpeptidase FtsI
MQALLKNKLRSLCFIVPLFIFYIIIIFRIFSLTFDQLTTSENFRKDNIVHKQPDILDRNG
VVIATNVPTTSLYIDATKVKNPESIAAQLCSTLHDLEYKNLYRVLTSEKKFAWIKRHLTP
KELLAIKNAGVPGVNFYDDIKRIYPHSNLFSHVLGYTDIDGNGIAGVEAYISKNNEQEKP
IILSLDTRVQSIVHEELTKAVSRYQALGGVGIVLNVRNSEVISMVSLPDFNPNLQNKAED
VQKFNRASLGVYEMGSVLKYFTIAAALDANATKTSDLYDVSTPITIGKYKIQDFHKSKIP
KITVQDIFVKSSNIGAAKIAVKLGIEKQVEYFKAMKLFSPLKIEIPEKSTPIIPDKWSEN
TLITASYGYGIAVTPIHLAQTAAALINNGIFHNATLMLNKRSIGEQIISRRTSREMRKLL
RAAVTDGTGRKAKIKAYSIGGKTGSAEKVVDGKYSKDANIASFIGVLTMLDPRYIVLIAI
DEPQGMHHTGGVIAAPIVRNIINRVAPILNVTPEM
>ELAGILAN_00688 hypothetical protein
MSDLFYIETTCCVDGQCDVYTGEVSFNDVMLGKFSLNSCSGKEAMINLDIITFDINIAID
GQNGKTIKKDLKGLEFVTKDDGSWYINKDFGNDKFEIIVKQS
>ELAGILAN_00689 Glyoxalase ElbB
MGEKKLKAAVVLSGCGHLDGVEVREAVLSLLVLDQQEVDVKCFAPDINITQVMNHRTKEA
TKEKRNVLVEAARIARGEIYDLKEAKAENFDMLVVPGGYGVAKNLSDLAESKDMVTVMPE
FERLVSEFFVTKKPIGAICISPAIIVSILSSKIGKEESKVKVTIGDDREQLIERLGGEHI
KCDTELSIEDEEHNVFSCSAYMRSDESTYSVYQGIKHMIDSMVKKINKKTKQPFL
>ELAGILAN_00690 hypothetical protein
MESSNSMFFDTDYPELRKAISDIIESIAQSSQEGKKELFTTLSEQVKGMNLKDLGLAIND
QGLQKKVNKELFIKLIEEALKDLTSENVDSKIIEEALKSVNQQAISNVINNNKGPLDNLV
NYFKSASANKKIGIASAVMVLGAAFSPLIVLATLIALVAIGTRYVGIGIGRAGEKIKEGA
IETGKAVKSSYKDLIDKLPTVQARENNFSRLRTNVLETIANISLKDNKNVDTKKGFDDGK
KILEMLQNEGQRSAIQELVKNGTIQNFSKDDMSRLLEKGLSTHVADMKALNDLINKFQPV
IMAIGSDIKEVEQKVNEKAQEMKPNSHLGISSAARVSEGGITGPS
>ELAGILAN_00691 5-formyltetrahydrofolate cyclo-ligase
MFKDIKQHKKEIREQYRAIRKDIDESYSSYAANSLINLFNQNLSYVKGKTIAAYIPMDGE
IDVVPLMHSLLDLDYKVAIPNKNKLLKFEEWNKTNEDVIPDTIITPVIAFDDHFNRLGFG
GGWYDTMIKKLRPLGKIFIGVAYEKQYCKNLPVEQHDQKLDIIITEMCVRFESGLLKKVD
KKE
>ELAGILAN_00692 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MKNIMLIGGGVGNAVLFSIGKACLENNNKVLYFAGYKKLSDVFKRALIERASNAVVWVCE
EGLIETSRDQDKSFHGNIVDAIVSYQQGRLGINLNVIDKIITIGSDKMMKAVNEARKTIL
KPYLKSSHIAISSVNSPMQCMMKEICAQCVQQHINKETGERSFVYSCSNQDQDMEFIDFD
FLSERLKQNSLQEKLTAKWIDHVQRY
>ELAGILAN_00693 Chaperone SurA
MYKILILLLIVLPLRLLATEIEIVADVNGEPISNLDIEKRINFINSLFGTQSVNQKEAKP
QVLRELIDEIVIINEAQRLNIKLSNEELDNAIMLFLTQSFKLKANEVDQYIEKHNIDLGI
LRKQIKCQLLWSKIIEVRIVPFINISDKEINDVKRQTEKPNYLITFQEFIIPDQKDKDVY
GIAEDLVKKLRNSNNPESPIKMRKATVNLSQLKGKLKSVLEGLETSDIAGPFSFSEGYSV
IKVIDKVQLNHALLESTLKLKQIVVEGSESLLDNLKEQKVNCLNFDKLADNFKLPNAKEF
EIKMRDLNPDLQILFSKTSVNEIVELRENGTAKLMMLCDIKSNVAGIEAIKQKMYQQKIM
IQSNLLLDDMRKNAAISYRYS
>ELAGILAN_00695 Inorganic pyrophosphatase
MDLSKITAGPNAVNVVIEISANAEPVKYEFNKEFGLLQVDRFLSTSMTYPCNYGFIPNTC
AGDGDPVDVLVLTQFPLASSVLISVRPIGALLTKDEKGEDEKILAVPVSSVDSYYDNIKD
YSDLSKSLLDKITHFFSHYKDLEKGKTVAVGEWVGVEEAKQIVASSIKSGN
>ELAGILAN_00696 hypothetical protein
MIKEIEELIKIVGKGNLLETLFIFLGSFQHADLGRFMDHRNHFGLSEFIRKKEEPLDKYF
NLKFSLQGLFLIYAQAYRILSENNNLNTKDVIDKIYEVIKGSELNEYINEVVDGRKLDLL
NILANPKREPIFKTEEDFENKVLIGLRKLLSEGNTLNKYDREFALNKCVISSYYSIHDIK
ADKDIALFFSLGGHYKELSSSNKTVKREVLEICENQLIESYIMFLAGKLHMIGLSSRDKY
TIDHENVDRQEKALKMDGLIYPINTKNTLEQLLKNQNSDEFEQLITSPDNIYYSVLQEEN
ECRPNPITSKKKEKDHKNTVCKLILGMFVLSVGLYVADYFFMEQKLFNPIKGVLPQDNFV
NLVIAAVLTIVIVYALFQLLKPPQEPPLSTVNKMMNENLGPLHAKQA
>ELAGILAN_00697 hypothetical protein
MLLQRIIIDQLEKISGQSFLHKLATDKEYFKEVSRYLEENHKMSLEEFIISVYRSSGGDV
NFRDYKDEAALYSASENDNQDMVRILTSCGISIDDFNCEISNRIQEKSEQSRRISLSNNA
NVSHIYEIIRRITNIRDAFQHLDLRHSDKRPCILKKASSVFKLKH
>ELAGILAN_00698 Glyceraldehyde-3-phosphate dehydrogenase
MTVRVGINGLGRIGRGVLRAIFEIEEYSKQIEVVAVNGSLSAKQHAHLIKYDSVHGKFSG
DIDFNESQNWISINGKKFSLYRERNPENIPWNVDVILECTGAFNKREEAIRHNAEKVIVS
APVPDADVTIVYGVNDDMLEKEHKVISAGSCTTNCLAPIVKVLHSSLSIKSGFMTTIHAY
TNDQNVLDGNHKDLRRARACGLSMVPTTTGAAKTIGSIIPELKGKLDGTAVRVPVSNVSM
VDFKFTTDKKATVKEINEMFKDAASNVLSVCAEPLVSIDFVHNPYSAIVDLTGTYVTGDI
CRVAAWYDNEWAFSLRMLDIALLSYSKV
>ELAGILAN_00699 Sec-independent protein translocase protein TatC
MNWNSNKYASFYEHFAELRKRVIFCFLFFCVAFGFCYYFKENIYRFLLAPLIEATKGSEG
FSLIYTDLTEAFFVYLQVAIMSALLFSFPVFAWQFYMFLAPGLYKSERAVLLPYLIATPV
LFVTGATVVYYYIFPLAWKFFITFEHSGKSFGIPIEFMPSVSEYLDLVLQFMFAFGTAFQ
IPVILTLMVRVGLLTTQSLSNKRRIAIVVIFIIAAILTPPDVLSQVGLAIPMLILYELSI
LICRYIEKKKTKI
>ELAGILAN_00700 Arginine repressor
MHDNTLGEHILNIIQNHEILEQSDLQTLLKERGHNIPQATLSRKLKKLKIAKVAGVYKVI
DINQYQLPLILNMQISDFGLIVLHTQPGQASSLAYFLDQKYVIYSLNNSKNIGIIGTIAG
DDTVLLIIKSKTELNKVLQSIYKTFPYLSLE
>ELAGILAN_00701 Arginine-binding extracellular protein ArtP
MKKYILNAIIVISILLTGCKEDKHDNIIRFAISADYPPFEYYENGKFTGFDIELAQLVAK
ELGKEAIFKDMQFSTIFAALQSNSVDAAISTIGSTEEREKNFDFSNSYYTGEFGILYHKN
KPIAGINNLTHKKIAVQLGTVMEIWLKEHVPTTAQIIAIDNNNQAVETLKSGHVDGVLID
EFQGKVFSKKNPGLSWSAIAKSDNGYSIAVNKRSDLKDKINEALKSLESKGVIQKIAEKW
LGDN
>ELAGILAN_00702 Arginine transport system permease protein ArtQ
MQELISNFLFVGTGLAFTLKLLIGGLLLGMSLGGLFSVLRYNKICIPLINGIISVIRGTP
LILQLSVVYFMTPTIAGIKLNIFSAGIIAFGLNSCAYIAEILRAGIETISKNQFEAAKTL
QIPSFYMWRDIILPQVIKNILPAMINEIIALLKETALISTIGGVDIMRSAQMLAAEQFTY
FIPLCLAGAYYYALVLLIEYIGKKIEQKGIYDKNA
>ELAGILAN_00703 Arginine transport ATP-binding protein ArtM
MIKMHNVCKLFNNIPVLNNINLIIEQSIVGLAGPSGSGKSTLLRCIQKLEVLDSGSIECN
DSTGFVFQDFQLFPHMTVWENLTYAPKLKNKTQDQSYSLLESLGIASKKNDYPNNLSGGQ
KQRVALARSLMMNPKILLCDEPTSGLDVATIVDVVELLQSVRDMGITMIIASHNLDFLTK
ISDRIILLKNGKIIVDINPKEIDEPTNYLKNNY
>ELAGILAN_00704 hypothetical protein
MSLTDIAHRINELASSWEQFKLINDRKLKEIESKGRADSATIEQLCKVNNAIDGCKERLD
LIETAAQRPEVNTDFSTSDKYFSDYIRKGMESGLSHKTLSGDDNDIGGYLVTPHIVKRIS
KRVIDSSPMRQICSSQRISTETLDYIIEDFDRAGAGWSSETVDDEDGGNKSKYDFAKDTD
TPKIQKISITTYELYAQPQISQKLLDDAFVDVESWLVEKIAETFSKEESEAFIKGEGTFQ
PKGILAYENGNSYNKIEQVKTEKLDSDSIMMLYYSLDEYYSKNASFLINRSTLKDIRLLK
SQTGQYLWQPSLSLEAPDTLMGIPVYQSADMPPAPNNQLPVIADGRFQTSL
>ELAGILAN_00705 hypothetical protein
MSNINRIIREVIKEFRSKLPDKEIEEYSGKLNKLHIYQCNKHIIENKKLYHYTINGKTHA
MGQHGHNFVKSLEVILRNKPQISLEEVIDFMEKIINFGIDSCYGAFEMIFESRSGVTIDD
AVNFVKDSLSSKFYGFHGSGIFKVILELNPESSLEEIEKQFSKVVDPYFLNAWSRESERA
FAKICRLCREGHVENMQKFDFSNFNLDQDSAGALRALLQYCVDVSNQKALGDSHELHREE
MEGIYKFDDNYDLNLDSDHNDSIWH
>ELAGILAN_00706 Orotidine 5'-phosphate decarboxylase
MNPIICALDTQDLNKAISLANALRGKVGMVKLGLEFFAAQGLSGVQEVAKCNVPIFLDLK
LHDIPNTVAKTVEVIKVLNIEMLTLHISGGTKMLEEALSVVQGTKIKLIGVTVLTSMSNE
DLNELGVAREAKSQVILLAKLAKKIGLHGVVCSALEAQEVRRECGEDFKIITPGIRIDPG
HDDQKRTATPKEAINSGADYIVIGRPITKTTSSAELILKSMKEF
>ELAGILAN_00707 hypothetical protein
MPLPLILALATLSILVLALSCKIISNNKKIEVERNKFAQKEQELENKITLGKEAEKAANK
EVEKLKHELTREKQNLDKRAKKLNQKVNESEVERESLLEEKESLEKKLETAKNHTFEINN
ELDKTRKEIGKLSEQEEKLKLEISCLKKQLEERSRFIAKLKMEVDDNKHLELENKGLNDR
IETLREVQKALREKKHELSEKVEVLNKEKNKLSKEVKELREEQEKLYISLDKLQCKIKEV
NKEKEDLRQVLSCSYSWQEFSEEMERCSSREKRMRESCSNELKRLEDLILEKSSEIEQLE
KDLLREKEEKMSYVARITEYMLCKLEESIKRSKVIKNDDKTVILQEIPVMKSVLEEVVQD
LRGKTSGKDSEYASLPDETSVPLHAGDPGYESEEDSGYNSRSSTPIKLPNSLLTESYERS
QFNQSESICKTQQ
>ELAGILAN_00708 Phosphoribosylformylglycinamidine synthase
MKITVLSGYGLNCEKETAFAFMECSRKLGIGNIEVKIVHINDIIDNPGELKLSNILAIPG
GFSYGDDTGAGNAFALRIKNNLLDEFQEFLSQDKLIIGICNGCQILVKLIPEFSNLALIH
NDIGNYQCRWIRVRVNPQSNSVWLRGLSELYLPIAHGEGKFFMDQDILNQLIESNSTALR
YIDKNGNYANLQFPYNPNGSTYDLAALSDKSGRVLALMPHPERGIFFTQQDNWSLEKEKS
KRLGVAVPKYGDGMLIFENALKYFC
>ELAGILAN_00709 hypothetical protein
MSIKKKFLKLLQSRRVHARIKRKNKKNRALRFCSFTALVISLGCPVCILLSILVNSYSAL
TVTKILLPVEINADLALASNPSDLRYKSIGLLNDSLRKVFGGTDFKDGDEILSRNSYKEL
EKFFRKKVKDSGEYEIWFTASSIINSINKDKYLNDRYAKLLDWLKEKRRVKKFFNKSLFL
KSDSREPENAGILGAFIGSLMTIIVCLALALPIGIMSGICLYEFMPKNRLMTNIVEISIN
NLAAVPSIIFGVVGLTLYLGIFGLPRSSPLVGGMTLSFMMLPNIIIATKNAFANVPITIK
DAAFALGAPHIKVILDHSLPIALPRIIHGTVLAIARILGESSPLLMMGMVAFIADTPTSF
FDPATVLPVQIYIWSSNPEIAFVELAAIAIIALLLVLFALNLVANFVKRKFEFFNF
>ELAGILAN_00710 hypothetical protein
MQVADTGIQQALPANNFYIFHESTNQKENNECWIPVSEHWDDTTAGGKHNVRTVVCHALR
>ELAGILAN_00711 50S ribosomal protein L19
MTNLLKKFNEQQMQVLAKEIPEFRPGDDLKVTFKVVDGTSERIQIFEGVCISKRNRGLHS
SFAVRKVSHGESIVSQFFVYSPALVSVQVTRKGKVRRAKLYYLCKLFGKAARIKERTTYV
KKKSK
>ELAGILAN_00712 tRNA (guanine-N(1)-)-methyltransferase
MAFNVTILTIFPEMFPGFLNYSLAGKALEKKIWNLEVINIRSFAKDKHSTVDDVPYGGGA
GMVMRSDVVGDAVDSMLSVHKNTKFIYMTPSGTKFNQNIARELLEFPHITILCGRFEGID
QRIIDAYTPYELSIGDYILSGGEPAAMVVLDACIRLLPGVVNNTDSITEESFNYGGGVLE
YPQYTRPEQWKGYKVPEVLLSGNHKKISDWRQKQSHVITKKRRPELLSGEINDKFT
>ELAGILAN_00713 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MSLNKTIYEGKAKAIIETEDSSTVIQHFKDDVTAFNKEKYEIIESKGIINNHISAFIMEK
LEKAEISTHFIKTLNEREQLVKKLKIIPLEVVVRNVAAGSFCKRFNIKEGERLASPIIDF
FYKNDDLADPMVSENHILYFDWLSSKEMDEVKTTTLKINEILVHLFSNASIYLVDLKLEF
GRLINDSTKIVLADEISPDNCRLWDKNTYKKLDKDVFRLNLGDLKEAYLEVAKRLSVKLG
>ELAGILAN_00714 Phosphoribosylformylglycinamidine cyclo-ligase
MNTYTRSGIDIELYNKLIKEVKPIAQETTREEVISEIGSFSALFDFAALSKKYDHPVLVS
STDGVGTKLLIAQEVNKHDTIGIDLVAMCVNDLLAQGATPLFFLDYFATGVLTKDVLLSV
VKGIAEGCKQAKIALVGGETAEMPGMYGNNHYDLAGFVVGVVDRKQILPNCSMMKAGDYI
VGLESSGIHSNGFSLVRHVFKSLGINYNDTSLWNNKSWSEILLEPTKIYVDSLLPIMSQV
KGIAHITGGGLVDNIPRILPKNLFANIDINSWKWPDIFLWLTKEGKIEKKEMLKTFNCGI
GMVLIVSSENMQNVKNHFQKRGEKIEIIGKLDEACNPPLDRVVFS
>ELAGILAN_00715 hypothetical protein
MNENTKNILLITELLSGRLLHDFANSMNGITFGVEELEVIDKNDADAQKEALLFLKESSD
DLIYKHKVMKQAYSSSMDNYSFDKTKSNIENYLLKKK
>ELAGILAN_00716 hypothetical protein
MVLTIASAVAEVELVSVLLSQTEDKMLLTIKILNEHKPISKSLVDKLIKKNDTNLNTKDI
NIYMTSLLLEYYNTEMHYTCENNLLEIGLTIT
>ELAGILAN_00717 Hemolysin C
MKDLPDLNIFNGLLKFRDCGIMDIMTPRTEICAVDIESSEREIIKKIKNTCHTKIPIYKN
NFDNVIGFFYVKDVIFNRDKNFNLKHIIQSVIFVPPSMKTTNLFVRMNSSKSCLAIVLDE
YGGTDGLISMTDLIEELIPNIDSENEINSEYTITELSQNKFEVSARALIKDIEEDLKIEL
RDPEEDYVTLGGLILSIAGKVPSVDEVIKYKNGMKFIIKDANERYINKIVLDLSDYKN
>ELAGILAN_00718 Uroporphyrinogen decarboxylase
MESGKTTIAKIIKRNEPGGRVPIWLMRQAGRSLPEYRKAVENMNNFMEICYNTDLVTELT
LQPVTRFDMDAAIIFSDILIIADVLGCDVNFVRGVGPIIKPVESPKELKGPQEIETKTLP
ILNAIKKVRSQLPKEKSLIGFAGGPWTVASYIIEGGSSKTFSKVLNFYPSCLKEIIERIT
EVTIIYLIKQIEFGADVIQLFDSNAGALSEPLFKEYVIEPTKRIILAIKDRFSDFPIIGF
PRSAGNLYKDYCEQTGVSAVSIDYNVPIKWAKANLNIPLQGNLDPNLLAYNKTEAIKEAK
RIIDCFRDLPFIFNLGHGVLPDTPVENIAALVNLVKSY
>ELAGILAN_00719 Aspartate aminotransferase
MSDLAKRMFLIKPSPTIAVTDKANKLKNEGKKICVLAAGEPDFDTPDHIKKAAIQAISEG
KTKYTAVDGTRELKEAIINKLRKDNNLEYTLNQICVGTGAKQVLFNLFMATINSGDEVII
PAPYWVSYVDMVSLFGGLPVVVECKQNFKLTAELLKSRITKKTKWLILNSPNNPAGAVYT
CDELKDIAQILLEYPHMNVVTDDIYEHIIYDEKFFTIAQVEPKLYDRVFVVNGVSKAYAM
TGWRIGYIAGRSDVVKAISTLQSQSTSNPNSIAQAAAAAALNGDHSFLKERTRIFKSRRD
FMVKELNSAPGLSASVPQGAFYLFVSCEGLLSKSTKSGKIINNDLDFTEYLLGDHLVAVV
PGIAFGLENFIRISYATSQEQLEIGCDSITKACQELK
>ELAGILAN_00721 Zinc transporter ZitB
MTAVHNGKHSAAQSKRLIYSIIIVAITMFMEIVGGIISHSLALLSDAGHMLTDLFALVLS
WLAHRFSAKKSDLQRSYGYHRLQIIAAFVNGLTLFLIAVIIIIESIKRFIFPVNVEWKVM
LIIATLGLVSNIIVFFILHSKCESNINIKSAVLHVIGDILGSVAAILASIIIMLTGWQIV
DPILSVFVSVIILNSGYKILKNSCHILLEGTPEGISAEEIKSKITSELPEVIDVHHIHTW
SLSDNYFIITMHAKIKQNVQHTNVLYEIKKILLDKFEIAHSTVEIEYDECADNKILKH
>ELAGILAN_00722 hypothetical protein
MIGISQIQFPSKDSSKLKFVSYFGAFVSLSIITNPVNVLFSLGTMFFRSEIKTLYIYKEI
KTAKQQKMSKREYWEIFFKNNTIKVAAFLLFSAFITYLTFTTTFLLISLLGTIPLTMLLI
LLQSELRPKDFNPFTLLKASINFFLEGIKENLRGMVNSFDVKLEHLLPHQLNDDIIKNID
KLKDKYGEEVSEDVINDREFKQFIEYINDLYELNYRQFSDEDKGRVIAFLNDFCKDDQKH
SSRFTGGRILLLVLKACNDGDREAVKNKKDALITNLLDSQTFSRQERIPNTCFTGIVYRM
LSTLEGIHPDPEIRFTPPRQILLPEAQNEARKFMLDRLKNKKNNKEIFKAWYDVQNGYED
DESQKIVDDFISEVSIPLMRKLLSITSQYSEQIVLTLMKNISSIKLNKLQCCELVQHMRN
KLQEHGLGDQESLLENIGKKVFLELLNRDLLETDFSLKDSSLDGAKRIANKIIIGEVEKF
RSEAAEKAREVNSIEVQVDVTLRGLSTLPREKKCCIAYSRLSGQYEGDEREIMENILLKK
LEITKKEMNKMLEENDIRKLKLALDDACKKSGKNMEEMIKEVEEVVSSRFSHEVSVSNIA
TESAHL
>ELAGILAN_00723 Glycerol-3-phosphate acyltransferase
MLVIVLTLSYILGSIPFSLIITRIKGINLREVGSGNIGATNVARTGNKFLAALALFLDSF
KGFIAVYIAQQFCDNNDFYIYVSAILAVLGHMFPIWLKFSGGKGVATTLGILIAFNIDIT
LVFVIIWIIVFLAFRYSSLASLSATSTAVAWSFFFQRNLFLTLLIIGALVFLKHHRNIVN
LLQGKENKFL
>ELAGILAN_00724 Amino-acid carrier protein AlsT
MIYRLLCMVLFCLLFNDVYAASGFYEGYDAVLNGINNFMNEVLFFKIFYIPFLLLLLSFG
YVFLTLRFKFLNIRMFKHAFAILCGKYDTNHHDGHITHFQAFMTALSSTVGLGTVAGVAI
AVSMGGPGAVPWMMITGFFGMSAKFAEVTLAFRHRTEDQDQLFSGPFQYIRNGLEEFGFK
KLGIVLAAMYAVFFVLSGLGGSVAFQTNQMVSILSGYSSWVDGPSWFLSSIISALLALVI
IGGIKRIARVSSALVPIMSLIYIFSCIIIIAFNIHNLGYTSKILFSTMIDFNAVGGGMVG
AFVAGIQRAIFASEAGVGSASITHATTKDEEPVRTGLVAMIEPCFDTMLICCLTGITIVI
TGAYQTSVGEGILITQKAFETVSPWFPILLTIAAPLFAFSSVISFVYCCEMGWLYLFGAK
SIVIYRIAVIIVAFFSGLSKDIMAIANIGGTLFSCLALINMTALILFSNQINEEVQCYLK
RLRNNKIN
>ELAGILAN_00725 Amino-acid carrier protein AlsT
MIVKVTDLLNSLLYIKIFNIPFIIIWVIATGIFCTAQFKFINFRLLKYGIQTLFNLKCNN
SNNGIITHIQAFATVISGTVGLGTISGVAIAITIGGPSAVFWMVITGILGMSIKFAEVVL
AFTYRSENTTGGAFYYMEYGLAKIGFAKTGRFLAFTYAIMLLIAMILGGIPFQANQIAAL
SNNLLEYNASIIISLLVFIVILGGIKRIAFVSTSLAPIMIVLYVGMCIYLIYVNRSNLLN
ALSIIFQDIFNKSAIGGGVLSGLIAGVRRSVFANEAGTGTAAIAHSAVKEEDPIKVGCVA
MIAPLIDTILISFLTGIVIIITGMHSTDNVGDITLISSVFSTALPLFSKLVFPLMMFSFA
FSTIIAYCYYCEVALLYLFGNKKILILFQILIVVSVYISCMSKNIEFISYLGDSLFMCLM
IPNAAAIYLLRREVLNTIDSYYNSKRY
>ELAGILAN_00726 hypothetical protein
MNNDESNSRSLPITKLFPNFITLLGLCSGLTSLKFTFNEQWEFSVIFIIIAAILDGMDGR
IARILKSTSDFGAQLDSFADFLNFGAAPAFLLYFWKLNEIKVIGWILVMIYVICISIRLA
RFNVSLHSEQSHWEKFFFSGVPAPVCALLSLLPIIITFQSHESEYLLLIERFFNTRNVAC
YFLAISFFSISHIPTFSAKYIYIPKSLSYIFVSFFGVLIVFFISKPWMTLPILGIVYTLT
IPISIGFYIYFTYKTR
>ELAGILAN_00727 Phosphatidylserine decarboxylase proenzyme
MCFGLPNINREGYSFIVVSFIVTCIAFSISWGFGVTCLFPTLLCTYFFRDPARAVPNNKN
LILSPADGVISKIEEVNYPLSAENGEEKKFTLVSIFLSVLNVHVNRIPISGTIKEMSYKK
GKFVSAMSNRSSNENEKQVIVIEYEKGKEIIVEQIAGLIARRIVCNLGISQNVKAGERFG
IIRFGSRVNIYVPADTEVRVSEGQTVIGGETIIANLNKENVQEKLTFDVI
>ELAGILAN_00728 Protein RecA
MASNPEERNSDKQKALDNAISQIEKAFGKGAIMKLKQNPVEKIDTISTGSIALDSALGVG
GLPKGRIIEIFGPESSGKTTLALHVIAEAQKKGGSCAFIDAEHALDVLYARKLGVSTDDL
VISQPDTGEQALHIVEYLVCSGAVDVIVIDSVAALTPRAEIEGDMGDQHMGLQARLLSHG
LRKLTSAVSKANCILIFINQIRMKIGVVYGNPETTTGGNALKFYTSVRLDIRKIGVIKDK
ENITGNETRVKVVKNKVAPPFREAKFDIMYNEGISKLGEIIDMGAKLGVLEKAGAYYSYN
NTRLGQGRENVKTYLKTNKEVANEIETKIRDLLRNHDNSIIIDEDSEQLLEESVF
>ELAGILAN_00729 hypothetical protein
MTSLDFVKELVNAFNVSNYGSKVNTNFVVEGDNIVVKFNCGRRSAKRYLSQMARDLVREY
YSDESVARYAFDLGSFPFHFDKEWLKYDGKTRITKLTVPIDSGVIFNLKVHFAEEFKLDV
KNQVIKAIDEKHHLGKKHIEEILNASIGQVEIDSFSGYIKCLLFNSPNLQTYFIGALQEQ
IKKHGYNYSGFYDIDDNKVYFKDVENIGFVRSVTETSKKKTAYNFNLQGVGNLKVKAERY
KGAMGELIFRLAGVSICGYYRDNFISEDRISNGDHFAFIPMVKEGNSLRYLNYMEANKIN
AKFSHDLFTNVRGQTKDTESNEFDEVYALSDRQIALLIPVIIENSVINKDGQIEIDPGLP
RTLLAEASPTQEFPTQSQGVVKDSSRQGSEREEGKGGLFQLVPGKIDSSQSTGDQSQLSL
SIPSPTAWNDSTFLNLEGSNEEPEKQQVTDESDRKSSDECSEAKSQDSKSPKKHGGGVQK
MKKWLSSTFSKQYDVNLKRHDEGRGTTRSTPETPVTKKSSVSKLFSSFPARIRARSNPSS
AVTSPTHEGGPEWQQRLNPDQREELRPFLSPELRKKLDSNSLSPEDEQLKHLLYTPSGQE
KMKKNFESQELQLRRLAEAQLSSPDNSNRDSGFSSMGSPVSPVVQHKGSAPLKVTECSVQ
QVNSHSVERT
>ELAGILAN_00730 hypothetical protein
MDKKQQASSSSQGDPRFKVGSGGYDSAAWMAANRGTGGGGPDMHKDPSKFDRCYNYPYTG
MSDAKVESAQGSNKKK
>ELAGILAN_00731 hypothetical protein
MKKKFIKMQKSSCTYDLFIIYRLHNIFINGGYYG
>ELAGILAN_00732 hypothetical protein
MVESFSGNNKGSNFIEEAKIMENFSDNNGNGSSIFQGKLREQDFSAEQKLNELKAAIEEL
TRQDLLRRLECERQASSCIDEISSQAELHIGEGDDEDYFTGEKGRVLGDFWNFFESLFTL
FEVDVDDPKIYQMLKEKKEKNLIAAIMKFLRDKLKELIKKIFARDLSFNQRLDKEIKELQ
EKLGSGELSEEEFTRALERLTALQDLKLRLQMAVVGWIVTMFAEMFGVELAAAVAASTEK
EDKKAEKTSLKEENKEVCENVEMKVDEREKPKVPVFLFDVSPGFVRPVPLSKPELDLLPK
PIMPSIFKEVINNENREVKETKPKVEEEKKAKQEEPKKTEPALKQKAPKKEPVIFRDTGQ
SSERGQWENDASRQEIPTIGSVGEQNMRNSGNIGKETIDIDKICGELFAGQDQISPESEL
NSINVQPKGGYKGK
>ELAGILAN_00733 hypothetical protein
MPKSIIKSISNTLQEKVVIEAKANINKDNLRKAHARV
>ELAGILAN_00734 hypothetical protein
MLRGPHGYWATARIIVASYSKLLSEKHSLDTRCIMQSDWYKELFPEVELSKDQNTKYKFQ
TVQRGFRIATSVGGTLTGEGGDFIIVDDPLNPAQALSETFRKRATNWFDQTLVTRLNDRK
KGVIVLVMHRLHLEDLTGHLLSKPKNIWHHICLPMISENKEVIYSINNHTGVIPTPPPVI
PVPRHLYLGSRSLTL
>ELAGILAN_00735 hypothetical protein
MNFLKFIELCFQTVVPGCEYNDYQYIKVIADRLEAANAGEVRRIIFNMPPRSMKSICMGV
AWPAWILGNCKNNSCKLF
>ELAGILAN_00736 Periplasmic serine endoprotease DegP
MKSKAFILSIFAYFLIAFSSYANMFDWNAKKVVDASTTACNCNQGLADLVEELIPAVVNI
SSEQIIKQENNSRTRVPSMPGNNFFDDFREFFEHFDQFFMDRGPSVNKEVVLLGSGFIID
KGGTIVTNYHVIKNAKDITVTMNDNTYFKAEVLGYDARTDLAVLKINSDKDLSSVAFGDS
DKARVGDTVMAIGNPFGLGGSVSTGIISARSRDISIGTMNEFIQTDAAINRGNSGGPLFD
LNGKVIGINTAIYSPSESGGNVGIGFAIPSNLAMSIIDTLKSGKKIKHGWLGVQVQPITK
EFAESLGLKDIKGALVASIVKDSPAEKGGIKVGDILLEFDGKKIDRMTQLPQMVSRAGPE
KKVQVKLLRKSKEVNIKVVIGESTNDGQDNNQEENKSTSDYVTGLTVSNLPKESKESNPT
KGVIVTNVDSNSNATLRGIKKGDIIIQLDGTDIENTNDFQKQVDSAVKKNGKDSIMLLIY
RNGNQFFTSIKLKK
>ELAGILAN_00737 Modulator of FtsH protease HflC
MSSNIKIVFVSVFVVLLIVLSNSIFVVQETKQAIVIQLGKVVRDVRESGLYFKLPFINSV
EFLDKRVLDLSPDKIPREVITADQKRIIVDAYAKYKITNPVTFYQAVRNESGLVRRLYPV
IEAHIRENIGRFSLISLLNEKRSEVMQLIQRGVYSEAEKFGIEIIDVRIKRADLPEENSS
AIFRRMQTEREKEAKEIRAEGEQAGQEVRSKADKLKREIISSAVKESYEIRGRGYAEATR
IYNEAFKVDEEFFNFYRSMSAYSKSFAENNTKFVLSPNNNFLDILNKGWK
>ELAGILAN_00738 hypothetical protein
MSNISVLIIESIIMFDENNPWNLGKKPVGNKTPNNEDILSKAVSDIGFFLNGLTKNRGKK
PYFIIFIILLLYACTGFYIVHPSEEGIELTFGKYSNTEMSGLRYHFPYPIGKVFKVNVKE
VNREEIGVSSSYGRDTDRGEGVMLTGDENIVNVNFEVQWRVRDAKDYLFKVRDYKPGFSV
KNAAESAMREIIGKNTISFALGQGRPEISRDTRILLQQILDGYQMGIEILSVQMKKIDPP
EKVISSFRDVQSARADKERTINEAYAYNNDIIPRAKGEAIKIKLDAQAYENEVINEAKGN
ANRFLSLYEEYRQNPSLVKNRIYLETMENIFSKVDKVVVTDDLKGMFSYLPLTNLGK
>ELAGILAN_00739 hypothetical protein
MRYRKRTLIFLAVITLIIMVLLFSYHFHFHEDVVHLKSDNKEFKKKPENSIESTILHREK
EVYDHVLRSDN
>ELAGILAN_00740 hypothetical protein
MSPNEKNSVVTEQGNDLGLNKTTQDSLNLEAAKDPKKLKERITDLLKGDTEFSKMKQGDK
ILVVSAASGLFTAVLPLLAVGATLAIPGAIVGLALYFAVKVAVKAVQSGYKGLKWSAEKT
VDGAKYTAGKVKDASVYTAEKAREGYYSVKGAISSVGRATREGTGATLGKMGRSLSNLSK
SMSSLEVVRKLVNSSIFPL
>ELAGILAN_00741 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIFGVVSSGDSVIPTLLTGLQKLEYRGYDSSGIAIINNEGKIEVKKSEGKVERLCEVV
DDSKMSHSTVGIAHTRWATHGVPGLKNAHPIRTNNVVVAHNGIIENYNLLKKGLEERGMP
FHTDTDTEIIPNMLTLYLDEGLSPIDSLFKCLNNLHGSFALVLLFAEYPDALFVAKRNLP
LAIGYNCNTVFAASDSNALSAFVERISHLEDDDIAVIKSSGVSIYNNGTQVKRSIENSSP
SDFLISKNGYPSFMLKEIFEQPCALNKTINQFYKQYKEVNKKLFSELNHITIVGCGSSYF
AGLIAKYWLESVAQVRVYLEISSEFRYSNVKLEEGSIGLFISQSGETADTIEALRYAKSQ
KQTIISITNTFSSSIEKISDIVLHTLAGPEIGVASTKTFSAQLATLACFVVELGKIKGVL
GGERIKQLSNAINSIPKHVEHVLNVMKIQHISGSILEHNNVILIGRGSSYGVAMEGALKI
KELSYINTIGIAAGEMKHGSIALIDSTVLVIAIIPYDSLFFKTLSNIQEIIARKGKVIAF
SDKQGAPFLREVCADVVQLPDADNFISPIIYSVAMQFLAYFTAAKKGLDVDCPRNLAKSV
TVE
>ELAGILAN_00742 Sec translocon accessory complex subunit YajC
MLISEVFAADATSNTSSIGASFASFTPLILIFVVFYFLIIRPQQKKLKEHRRMIDQIKRG
DTVITSGGIIGEVNKVDEANAQFIIEIAPKVEIKVLKSAISEVLSKETQKVAAKPIKKVK
SKE
>ELAGILAN_00744 30S ribosomal protein S2
MTNLPKVTVRDLAESGVHFGHKISRWNAKIAPYIYGVHQENRIHIIDLRKTLPLLQVAMK
VLYDVAFQGGRILFVGTKFQAFDIIASEAIRCGQYYVNHRWLGGMLTNWGTVSSSIKTLM
QYEKILNDEDSILTKKELGNIEKKKQKLDKALGGIREMGAIPDILFIIDTNKEHIAVKEA
KKLGIPIVAILDTNSDPDGITYLIPGNDDSRKSIELYCKLATDSILAGIESSLAKSGVKI
DDIRGDEFIQEKEDGIVQTKRRRSKVYKEEEREVVTNEDESR
>ELAGILAN_00745 Elongation factor Ts
MKMNPDDIRELRDRTGLGLSDCKKALEECDGDIKKAVDKLRTIGLAKADKKSDRVASDGL
VAMCLTENCGVLIELNCETDFVARNEKFIELVLNLASIAHQERCTSVDELKNAKYESIGT
VQEAIMNGTSVLGEKLELSKLCYLEAKDGVIAGYVHGDVCGLGKIGALIALQSPGDKAKL
QEIGKQIAMHIVAMKPEALSIDDLDQMKLKNERSIIEEQVRSLNKPEEVAKKIVDGRMAK
YYEEVVLLEQKFIKDDKMKVSDFIKSSEVSAVKLSNYKLLVLGGAN
>ELAGILAN_00746 Uridylate kinase
MFPSINEKSEIKYSRVLFKISGEALMGSQSFGYDMGIISQLCKDIADINRLGVQVCIVVG
GGNIFRGTSASLSGCERASSDYIGMLATIINALILQNFLEKNLIASRVLSAIPMATVCEP
YIRRKAIRHLEKGRVVIFAAGTGNPFFTTDTAAALRAVEMNCDVILKGTQVNGVYSADPK
KMRML
>ELAGILAN_00747 Uridylate kinase
MYDRLSYTDLLTRDLKVMDASAISLARENSIPIIVFSLKGEKIVNIIKGQGTYTIVSDCK
H
>ELAGILAN_00748 Ribosome-recycling factor
MLNEIKAKTKERMLKTIQSFHDDIKGVRTGRASASLLDGIVVNIYGGHQKLNQVAGVSVI
DNKTLSIKIWDINVVGEVKNAILNANLNLNPVVEGNTIRIALPDLTQETREKLVKLLHQF
AENARIAIRNIRRDIMEETEKMKENKEISEDDFHGAKKEIQNITDNNIKKIDGELSIKEK
DILNH
>ELAGILAN_00749 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MLNQESLPKHLAIIMDGNGRWANNQGRVKIDGYKKGSEVAYDIAKYCTDLTIPYLTLYAF
SMENWLRPKNETDCLFDLFYSVLTNEDKVNFICNCNIKLNFIGNLSLLPSKILDQIKKAE
EMTHKNDGLLLTVAVSYGAKQEITQAISNIIKENIAYVSEEEFEKFLYTKDLPKLDLLIR
TGGEKRLSNFLLWQAAYAELYFCDTLWPDFSCQDLSKALEDYTKREKKYGR
>ELAGILAN_00750 hypothetical protein
MVDNNFIVRMLSSIVILFIFSFATYFSDLSFYLLIFSIAVLSSFEWYNLTQGNKILYVFA
LLLIALPSASLIYLYNLPQGKYALVWFVLTIWGIDITAYLFGKNFGGAKICPILSPGKTW
TGLLGAILAGVVCTIFGSIFFGLFSIFYSPIIGLAIAILAQLGDFTESLVKRAYGVKDSG
NMIPGHGGVLDRMDSFIFTAPLIAIYIS
>ELAGILAN_00751 hypothetical protein
MSKVRVNNRKVCCHGDENDEGSGHPLIYLDMGEEEEIACPYCEKTFVHDCTVEAVGELTR
DEL
>ELAGILAN_00752 Phosphopantetheine adenylyltransferase
MNINDKIGIYPGTFDPITFGHLDIIKRACKLVDKLIIGVAENVNKHTAFDTKLRTSMAEN
EIKGLGIDADVISFNGLLVKFAKEQNASVIIRGLRAVSDFDYEFQMSWVNYKLLPEIETI
FLPASEDTQFISSGFVKEIARLGEDVSKFVSKGVQNELINLNRIKNGE
>ELAGILAN_00754 hypothetical protein
MTAENTVNNDVVVGLLKTEEAHELGLSQNIYEMFNNFVVKTVLIDYNKIISLKKIQTESL
NLAKQDKTLAKKLTLDRIKVEVAQFIKEHKINRIFIPDNLHSAPTPYRQLVTEAIVKIVD
DNPAIHLLGICEGIMNAKGIEVVSVVSDEEKQRSHLKSAPNPQKEDVPLQQIKIVPNSRL
AEVIAKFLIPNENGWFSTYFPDAHSGAVSNTPENRRKLESLGYKVAAFSSEGVIEAIEDK
HGNIYFQCYPEALVVKSYKNLYLSNYKERQVSTLVAIAIINDFLYRA
>ELAGILAN_00755 Chaperone SurA
MNVKNFFTKVTVVLLACLLIFVGVGNLLSGDDEKEEVARVGKEVITSDEYKSLYQNYGKQ
ISGSDASREQVKKLKYDLLNALIEQKLLFNLTSELGLTVGEESIKNHIKNTKYFQNDKGE
FDKNKFHETLNDLHMTEKEYIAKLEKILPAMMFMTSLFKDNYPVTFGEKIDEQIYNSRYQ
TRVVDIVKITEDAVTNIPEPDDQTLLDLYERNKSHFYYPEYRTAQYISLEQKYFEDQIKI
SDEEVDGIIEQQELRDQRDIFNIIFSTKEEAETARRAFEEGKTSFEQIVEEFGKAELEET
RVNNITKDFLPEDMREKVFALKVGEVSEVLASSFGWHIIKVESAHQISDEDLVDLKKDIK
SVLTNQKSFERVNDFINQVNYKIYNGSAIEEILSEYNLPIQTIGPVDASGKDQSGNNVGD
SSDLISFIFSREKDQKGYFKGVGDAVVSVKIIDIVPPKSQSFEEGRASAVELWQSEFIKE
RMFKIGQEFAVQLREKTDWEKIQGVELVEDQQMHRNEQNYPFSFVEEIFNMKTTGSVTDP
IQYNNEIIIGVLKEMHSSNGKLNMLDTGKRVMISLKEQLISYLESKYKVEVNHAILDDI
>ELAGILAN_00756 hypothetical protein
MGDAFLMSMESSKGNNDRNKQFLVQIVAWLVDNTGLTFNQIAQCCRLALEEVQDIADEEI
EVEKYNPIISGIITEKEIDDCKKNPNRVPNLIIKNIKKRSKAIGSILGFASTARRRDKPD
AIYYLVKKFPILDNNVIAKLISTTNYTVEQVRDGSHHNMQNIKPQDPVLLGLCSQENLEA
EVEKAKVEEEKQERLKKYKE
>ELAGILAN_00757 Transcription termination factor Rho
MTTINEDVLAKGKVTAQPEKSEQIYNNDTVKQMVNEGTEKNRKTLDLSELKEKTAEELLE
LAEERKISTNGKSNGRMLKQEIIFSLMKKMSEEGGITTGSGIVEILPDGFGFLRSASANY
APSTDDVYISNGQIKKFNLRTGDMAYGEIRPPGDKERYFTLTKVQSINSTEVSELRKYVH
FDNLLPLYPEESIVLECNNGDDKKGLSMRAIDIVAPLGKGQRALVVAPPRTGKTVLLQQM
ANSIAINHPEVELIVLLIDERPEEVTDMIRSVKGEVVSSTFDEPAYRHVQLAEIVIEKAK
RMVEHKKDVVILLDNITRLARAYNAVIPSSGKVLTGGVDSNALQRPKRFFGAARNIENGG
SLTIIATALIETGSKMDEVIFEEFKGTGNAEIILDRKLSDKRIFPAIDITKSGTRKEELL
VDKAILNKIWVVRRILNPMGPVEAMEFLRDKLLLTKSNADFFNSMNH
>ELAGILAN_00758 hypothetical protein
MDKNVNYSTMTRRILAFIVDCILFIAIPFALMAVGFSLTHAIQGIMGAIIVITTIVFSLF
LMIPCIFHIFMLVKFGGTLGHLLFSMRVRDKDTLEQITLIQAIKRTIAFFIIYCISLYNP
ILLLAILILVLVCAVDDEHKQAFHDKIANTVVIDYKPS
>ELAGILAN_00759 hypothetical protein
MDTKVSYAGILRRVSACAIDGVLWMIIALVSLLFLNYDVDDISTHRIILMATLLITYIVF
NILTITKYGCTPGRLLCGVRIKDANTFKNVTLMQATIRYIFREGIWVIYNFLSYLLPSYV
SGCLFIILTLVLMFAIFDQRKQTFYDKVANTVVIDYKPS
>ELAGILAN_00760 Isocitrate dehydrogenase [NADP]
MSTPITVAYGDGIGPEIMEAVLSILRGAEAKISIDIIEIGERVYSKEWSHGISPSGWESI
ERTKILLKSPTTTPQGKGHKSLNVALRKNLGLYANIRPCISYHPVIENKFGKFDIVVIRE
NEEDVYTGIEHRLTGDSYQCTKIITRSGSEKICRYAFEYAKKHNRKKVTCLTKDNIMKMT
DGTFHAAFDRIAKEYQDIKAEHYIVDIGMARVATEPENFDVIVTENLYGDILSDIVAQTS
GSVGLAGSSNIGNEYAMFEAVHGSAPDIAGKNIANPSGLLNAAVHMLIYIGQVGTAKLIY
DAWLKTLEGGIHTADLYKEKRSKQKVGTKEFAEAVIDNLGKKPAELTIGSGSDSKINLDS
KINKVQDNYEQDYKVKKLVGSDITLAWDKSSNVDQIVGLFESSNPQIIAIYSKGLAIWPG
SSKSSSDQITCRFIANSEKKPITNSDVNDLLIKLEENTFDVVRMDKLYLYDGKEGFFS
>ELAGILAN_00761 hypothetical protein
MGQHFKLTGQEFCDNADLFNVLEVEAKQVVDKNYEELSAILKKQHKQLILVNHPDKGGDK
NRFDQIYKAYQELKKYIEPLESGNPCVKVSIGAESDGRLTAREFHYRKNLFNKLKVSEEE
AVGKDFDGLISILKRNDYSFEKDLEKRIELEDKIERILQNPNLDDFEKNVKSAGLMEELY
QYIAKPSIQLFNYVTPLGKKRSLIEEDKKTLALKFIERKNALLFIRTLSVLPLGLLTTIT
IGCYFSWWIIALNIIISNASRLLIGHYMKKYANSEISTDEFMSKINYIALGSKLLINYPL
AAFSVYLLTTNFIANRLTVGGTILGSLLLLAVLIEMLAPVFSKGCEIYAEKHTKDLLEED
PRDRVQKETDLLGWYDPRKLLMPIVMPLVKKCFAEVASEFAERNFDEVKTDMSDVNAKGL
SKPKGIEFAQQPV
>ELAGILAN_00762 Endonuclease III
MDSKKVELIFEKFQQSNPAPKIELNYTNDFTLLVAIVLSARTTDISVNKITKELFSITDT
PEKMLSFGQSELRKCISSIGLYNSKAKNIIGLSKILIERYNSKVPTDFDDLVSLPGVGRK
SANVFLNSGLGIPTLAVDTHVFRVSNRIGLVKEKDVFKTEQSLLNVVPKKYLLYAHHWLV
LHGRYVCKAQKPSCETCIIHDLCEFECKRYKV
>ELAGILAN_00763 Succinyl-diaminopimelate desuccinylase
MKIDPVELTKKLISFESITPRDGGAIEYIATIFKKSGFDCEILEFGDKVKNLYAKYINGV
PNLCFAGHVDVVPPGQLKDWAFGPFNPEVRDGILYGRGAADMKSGVAAFIAAMVNLIVEK
FQFNGSISALITSAEESTEEYGTKAVLEWMKSKQKKADFCVVAEPTSSEKLGDTIKIGRR
GSVTFELICHGKQGHVAYPDLADNPIYKVISILSKVKNTTFDHGNKYFQPSHCEVTTIDV
GNNTSNLIPGLATTRFNIRYNNEQTPGGLYKLIDEICSSVTNDYKLSVHSSRDVFLSTPD
RNTDIMLDAINKVTSIDAALSTSGGTSDAAFIKDVCPVIEFGIINKTAHQINECVLVNDI
HKLTAIYKEFIENYLYPFRRVV
>ELAGILAN_00764 3-dehydroquinate synthase
MHYLKQILHQAEQTFLREVITDYHLADDIYEICTRHGNDIFLVADENTAKLLNKNVFNKI
SHLIIPAPPVIPVSRAGMTPGGEMTPSRAASLETVNLVRNKVKDSDLIVAFGSGTVNDIC
KYASYLEKKDYISFPTAASMNGYTSANASILVNGYKKSFKAHLPRAVYIDIDILVNAPLR
LTLSGFADFICRSTVQADWLLSHLLLGTEYNELPFTLVRDLEQILLREYTALTKRSRKVV
LLLMEVLLISGLGMVISKGSYSASQGEHMIAHAMEMVTRDHSLLHGEKIAVTTITMANLQ
EKILSIQNPIIKPTTLDVEHITQCFDNIEFVRTFEQKQIMQQKIQEIICKEWHNISSLIK
QNLLPAKHLQKIFEDLSIPHLPEHLSWNKEQYCKVVDLAFTTRDRFTFLDLANCIEES
>ELAGILAN_00766 50S ribosomal protein L9
MLIILKENIRTLGKLGEVVKVKPGYARNFLFPQRKAVKATKENLTKLEEQRLLLEEENIK
RLNVAKELALSLHDKFVVLIKQASEDGKIFGSVTTREIAKILLQEGHVIDHRSLSFGGIS
IKNLGEYQVNVELHSEVVVPITIYVVKSETDANELRQVKLQNQKSEQQEAEQDANKEAAD
GDDS
>ELAGILAN_00767 30S ribosomal protein S18
MMKRRNSFNNSYVSVNNRTGFRRSKVCPLAASKDEDIDYKNIDLLSKFTSDYGRILPRRL
TGVCAKKQRKLRLAIIRARFLALIPYCTKKV
>ELAGILAN_00768 30S ribosomal protein S6
MNLYEFTFIAQQGLLQQEVEEMVQELAVLLKNIKTDVMFQQIRDILKKGNDKLTKQELEV
RAENIKESLVAYSDFLEDLTKILWVELEEDLSNLKEVKSKIDKELKDDLKDLGITQDFTK
FLGGSTKSAFIHNAVNALKRNISEHLIKIFQDILKDFRINGPTQSSKALEMLLKNIEASG
LIKYEHWGLLDFAYHTNKMKSGHYCIMCISSTASILDEFVRRMKLNENVIRHFPVQVDKI
FEGKSYMMNKQIEEQSA
>ELAGILAN_00769 DNA polymerase III subunit alpha
MIRGLAEFVKEVFCILTLDLRNLIGFCSHENYVLMSKLMLSFFVDLKFLMFIHLRVHSVY
SLLESSVKIEELIGLCLRNKMPAVAITDSGNLFGSLEFAEYAASRGIQLIIGCNIIVKHS
EQNLPILLLAKNEQGYTNLVTLVSESFRKRKNNSDIPYVDFDELLNLSTGLIALTGGCLA
QLLLGQDKETVEKLLSAFNGHLYVELQRHGLSKELELEETLIDFAYQRNIPLVATNDVFF
PNRSDYEAYDILTCISEGSYALENNRKKLTTEHYFKSVAEMEELFSDIPEAIHNTLVIAK
RCSYMPRSRQPILPKFPCRENKTENEELREQAVAGLEFRIANETDIDLKQYYDRLNYELS
VITSMNYAGYFLIVSDFIRWSKANGIPVGPGRGSGAGSIVAWGLQITDLDPIKFGLIFER
FLNPDRISMPDFDIDFCQEKRDLVIDYVQKKYGYVAQIITFGKLQARAVLRDVGRVLQMP
YSQVDKISKMVPFNPVNPVTLSQAIEFDQNLQKERDSDEVIAKLLDISLKLEGIYRHVST
HAAGIVICDQKLENFVPVYYDPNSALPITQYSMKYVEKAGLIKFDFLGLGTLTLIDHVCR
LINRDRQKIDISSVPLDDQKTYEMLSSGDSIGVFQLESSGMREALIKLKPDCIEDIIALI
SLYRPGPMDNIPTYVARKHGLEKPDYIHPLLEEVLKETFGVIIYQEQVMEIARILSGYSL
AEADLLRRAMGKKIKEEMDKQRELFIQGATKNGVDYDRASYIFDLVAKFAGYGFNKSHAA
AYAVISYQTAYLKANYPLEFFTALMNLNIDDRDKLNLFYHAAKFSGVTVLSPDINKSQAE
FSIEDERIRYGIAALRNVGFSIAEGIVNVRSSACKDIWEFIQNSGHIINKRALESLIKSG
AFDSVHKNRKQLYESMDTLIYFANKNKQDRESSQAALFGSLDVLKPKLENVEDFDEEEKL
EHELFSLGFYLTNHPLEKFRTLLEKLNIGFIGENRTAKTAGVILNARMRTSERGRFVILT
LSDPHNVSEIAFYNNEIIEEKRDLFSPGTFVIIDLEASENTTRLAGKDISEFTKRVTSTI
KELVLTTECTDSQKAAMELNAILKDEGRTKIMLKLLLEKHKVSILLPGAYSIAPQVIYEI
SNLSWIKGVEINTNNLLI
>ELAGILAN_00770 hypothetical protein
MNVKNILLAFLVQMVFSLPLFAADPVLLNCIETPEIYDLDARPKNFNSSNNLRRKPGSPN
SAIGELIHIVGKITDINCLPIQNAVVSIWHANSRGVNHYDKNIEDDLNFAGSGRFVVNNL
GYYNFITIAPGKIGDRAPHINFLVQHPDFPEFTTQMFFADHNCDNCADPVLEDFVSNGLA
SLLITPFTYSDQVIKTYTFNITLGGYNKFSNKR
>ELAGILAN_00771 cytosol aminopeptidase
MKNILLMFLLCFMYSLQLFATEIPAMKITISKISPDFKTIVMGLFEDNETVNDDGVLQGK
QVIDNIKQFSDFNGSFGEFFSTALPEEKNVIVVGLGKKDEWNENKELNIGGKIYCELSRL
KIKKAAVLIEGSAANVAYGAFLRSFKFDKYKTKKDEKITEVEEITVLVKDEQLSNAERSF
EHLRQEGESIFLARSFITEPPNILYPESYADHIKKELTKLGLEIEVLDKKQMEEKKMGAL
LGVAQGSSKEPKLVVIKWNGASKEQKPIAFVGKGITFDTGGVSLKPSRGMESMKYDMAGS
ATVVGVMHALAGRKAKVNAIGVVALAENAVGGNAQRPSDVVTSMSGQTIEVLNTDAEGRL
ILADALWYTQDRFSPKFMIDLATLTGAIVVALGNNEYAGLFSNNDELANRLIDAGNEVNE
KLWRFPMNETYDKIIDSPIADVQNIAPAGSGGDSIMAAQFLQRFVNETCWAHLDIAGTAW
HEKGTDICPRGAVGFGVRLLNKLVEKYYEAND
>ELAGILAN_00772 hypothetical protein
MESRAKAWFIWLISNLVVIFSNMQIIYTFISVNLEKELGLTIAQVALANSVYTWTFAILQ
FFSGATFNVFSSKKIYFFSLSTMILGFFVLINSDNFSHLILSQVLIATGASFGFIGAAHT
SSICFSAAQFGLMFSLVQTISSLSALVIQILFSNLLAEDAYWKNLIVCIILFGVLIFVLT
LFCPNTLPESSSEKRTIKSSMKTVMCSILTVLKLRDIWITSVVGAITFGTFLALNTLWAP
RLLGNSELNAMESGIATAILWLGLAVGAPIADRISNLFKNRKHVISAFALLQGVSIIILL
YSHLTVHVVYFCMLMFGFFAGGHMLNFTVGSEIVKRKYISTSSSIINGFMFIGSGVIVSM
LALFTDHKMALFAIFAILIVAGILNYATKETYSKK
>ELAGILAN_00773 Integration host factor subunit alpha
MDHVTTKDTTVTKATIVGDINQEIGLSKEDSASIIDDILDEIKTSLAKDGIVKISSFGTF
LVKKKKERPGNIPNTSEKVMIQARNSVSFRPSKIIKKSINN
>ELAGILAN_00774 hypothetical protein
MNKEKLFYTIGEVAEELHLEQHVLRFWEGQFHQIKPTKRKGRRLYDRKCIEAIKKVKYML
YDKGYTIKGVQKEFGNDIKVTKNLLQELTDLRDYLTSKINSEESNKQT
>ELAGILAN_00775 hypothetical protein
MWHIASFLMLLAILIGCGLQKPAPVLLKGEEFYGKRDLEYTREYHLIREPSVQKESRKAI
INRIYRDNNNAQNVEVNCKFVMPVKGSATSSDETCKDGIKIAAQNGTNVIASAPGKVIYV
GKGLRWYGNLIIVEHKDNYMTVYSYLKNIHVEIGDKVKQGQVIGSAGKSSTQDKDPQMCF
TIRHNGQAVDPLAHTNCD
>ELAGILAN_00776 Leucine--tRNA ligase
MKYDFKNVERFCQDKWDFSVSKSSKQEKCYVLEMFPYPSGKIHMGHLRNYAIGDVIARYK
RARGFEVLHPIGWDAFGLPAENAARDNNISPEIWTKENIDNMRAQLKSIGLSYNWNRELS
TCEPNYYTHEQKFFLDFLKHGLAYRKESWVNWDPVDQTVLANEQVVDGKGWRSGAVVEKR
KLSQWFLKITDFAEDLLKCLQSLKNWPEKVKTMQERWIGKSEGATIEFEVVGLNKKLKVF
TTYPHTLFGASFCAVAAEHPIVQDLKNGSSVVIPVLDTGIQEIKSKRENDEKIGVYTGLN
VKHPFLDKELPLYIANFVLMEYGEGAIFGCPAHDQRDFEFAQKYNLPIIPVISSAHLGVI
PARDQNSYNGSQCQATQMTKEAYTGDGVMFNSEFLNGLMVSEAKEVIIKKLKEKGIGKKT
TNYRLHDWGVSRQRYWGCPIPIIYCKDCGTVPVPEKDLPVILPADVEFTSGGNPLDKHPT
WKFVDCPKCGKQAERETDTFDTFFESSWYFAAFCSEDKSIDKDACNRFMPVDYYIGGIEH
AILHLLYSRFFCRALTKCGYFDIKEPFSTLITQGMVCHATYKDENGKWLFLAEAKELIAR
GTKVQVGKVEKMSKSKKNTVDPNFIIEKYGADTARLFVLSDTPPEKDMEWSDDGVEGCSR
YVNKLWRMVMQLKPVNMHYDNKSVTGGLLEYRKKIHKLLHGLTDDLENCRLNCVVAKFRE
MTNLIAEIDVAAGKSLIDEGICILIRVIEPFMPHLAESLWQEIGGQPWPKADESLLVDDT
VTIAVQINGKLRATIEVAINLPQEELKKIAIDSVSSKIDQNKVRTVYAVPNKIVNIVI
>ELAGILAN_00777 hypothetical protein
MKRLCALAVLLTSSLAGTANNSASKSEDQYYAGLNFGAGWGGGLKIKPSVVFGYHHDKNS
KFELEVLTDISDMFGKEEKKMGASLLANYRYYPDLDIDPVKLYVSGGLGGYLQVIPFGFG
NSGTSEPASKDIEAAGEKASVVDKILGSISYKLKVGVDYEITPQIVGTVGITAGGQLSGF
KPPVQIPDAILEVGIRYNF
>ELAGILAN_00778 hypothetical protein
MLANNVDVNTIVKFTGLSISEIEELSVNGTE
>ELAGILAN_00779 Cysteine desulfurase IscS
MNVESKKIHDAKIKLPIFLDYQSTTKVDPRVLEVMIPYFGEFSNAHSRSHSFGWTAEEAV
EKARKHIADLVNADSKEIIFTSGATESNNTAIKGVAHFYKNKGNHIITVCTEHKCVLDSC
RHLENEGFKVTYLPVKQNGIIDLSKLEEAITDQTILVSVMMVNNEIGVIQPVKEIGVICR
KHNIFFHTDAAQSFGKVPIDVNEMCIDLMSLSSHKIYGPMGIGALYVRRKNPRVRLIPLI
SGGGQERGMRSGTVPTPLAVGFGEAARIAREEMKKETTRVEELRDILYNKIKEAFPDIVL
NGDYENRIPGNLNLSFPYIEGESLIMAIKDLAVSSGSACTSASLEPSYVVRSLNNGHDLE
HSSIRFGLGRFTTKEEVLYAADLVAKNVGRLREMSPLWEMVQEGVDLNTVKWDSH
>ELAGILAN_00780 Metalloprotease TldD
MPNLDQIFFAQNNVNINNVYKIVNNALSNSDGGELFLEFCQSESLVFEDNILKHMDLNTR
RGFGLRSFCEDSTSFVCSSEISEKEISNAASMVKSSVSLNKTNSINLNEETKSLYSRINP
INEMDLNSKIKLLNEVNEYVRSKNNCVKQVKITLSGEWQVVQIIKGDHRLSDIRPLVRFN
VLVIVEKDGRTERGSAGHGGRDSYSKFISEKKWKEVANQALEQALVNLEAIPTPAGEMTV
VLGPGWPGILLHEAVGHGLEGDFNRKKVSAFSNSVGKQVAASDITVVDDGTLPNLRGSIS
VDDEGTPPSYNILIEDGILKGYMQDHMNAKLMGVSPTGNGRRDSYKEVIMPRMTNTYMLP
GKYTPKEIISSVKKGLYAVNFGGGQVDITSGKFVFSSSEAYLIENGKITQPVKGATLIGD
GPTVLKKVSMVGNDLKLDPGVGTCSKDGQNVPVGVGQPTLKVDAITVGGTEI
>ELAGILAN_00782 hypothetical protein
MYGEKDKLAYRKKVRTYSKRLVTTLSTISFIGYIAALVLNIPVLSLYFSIAGTIFSALSF
ALNIWSLNDHSRQQNLNKKSGIKNTPGQKKLTKIYLDIASSASFLIGGIASMSLFESSVI
YFVSTPFFILGCVIMAANIVQTMISEPQTKNALENLSSNTARVQA
>ELAGILAN_00783 hypothetical protein
MKSILLTRPLLDSFNTRNILRKYGYKVYIEPVFTIKYLNPDISAYEFDVVISTSKNSVKA
FSQICKEDDFPIITVGNSTMQAAKNLGFSDIISADSNVDGLISFIKAHYSNAIKFLYIRG
QEVSCDLKKRLSEEDFNVREVVLYKTIIKRSLTNRCKNLLLDGKIDSVAFFSSQTARVFC
SLVLKSGLSHVMNNTVAYTMSKNIADSLKLIKWKKIITSRLPTGESLIDIINKDC
>ELAGILAN_00784 Exodeoxyribonuclease III
MLKIATWNVNSIRKRVNQLCSFIVDSQIDIVLLQEIKCTEEQFPYAEIEKLGYEYAIYGQ
VARNGVCVLSKYPILEKFKIDIVEGYQEARYIECIIKHNNQKVRVGSVYVPNGQSPDSQA
FEYKLKFFDNLYERMSTLLKNEELTIIAGDYNVAPDEIDVFDSNLLNGQVCFHIREREKL
RAILNLGFKDAFRISHPNLQQFTWWHYQGNSLRNNQGMRIDYMLLSPQAVDKLETCYIDD
RLRKLENPSDHTPVVCAIE
>ELAGILAN_00785 hypothetical protein
MTGPQVKSSKPPKLPTQVTNEDEKIFEKEEHQVIHDAFIQLLKNKVQPKELKEDDEAVLA
FMLSQNQIIFNNVKLEDVEPLSEENFSQFLLSVFEKIREKKLANEENLKNGKIKEVVDDC
VADIRGTEAKDSSIKFVLEMLLLLIGGIKIDPKNISGSFMDGMKEKIPFLGKDKKEEDEP
PLSDEEMVTTFLSKIFFPVLLSTIPMLIFGPTTLGVVLTAIGTIFAIKGGVEVLFSNDKK
GTLYNPHSRDEKERKEWGNEISDGINKILGTPVEKAKGSEQPISVSEQISQGKEKSEQQP
VPEQISQRNNRENEKSEQRDQSWTGKENKRREEPQSSKGKTTQVC
>ELAGILAN_00786 DNA polymerase I, thermostable
MKEKTFTIIDGYGFLFRAYYVLPHLITTTGMPIGGVYGFLNMVLKYIAHSDYLTIALDAG
KKNFRHDLYPEYKANRVTPPEDLTPQFTILREAVEAFNLSYEEIEGYEADDIIATLAAKY
ANHQDFKVVVVSSDKDLFQLLNYNILIFDPIKNIYIDEKQIVEKFGVNSNKLLDLFSLTG
DASDNIPGVPGIGPKTATKLLDEFDSLNNIIENIDNIEQTRIRNILAEHKEKALISRELL
SLCEKVDLQHDIAKCEVRPPNMEKLLSFLKKYEFNSLIGKMEKLFSYNGSSTKEKIEYSS
EELEKFLEHCRYEGKIAIHYHLENNVLSLSYSESNIFYIEQDSIQDALITINSTLLSNGV
LKIIHNIKEIRKIFPATEKMLDSVDDLMIMSYSLDTGKHDHSIPNIVAHNLSENAEIFSA
KTLIAIHEKLKQRLFQEKLFTIYERFDKPLMKVIFDMEKNGILLNIQKLQELSDKFQQVI
AVLEDEIYNLAGERFNIASPKQLSDVLFNKMGLNKKKKSKKSGSYSTNYEVLEALEEEGV
EIASKILNWRHLSKLKGTYTDALIKQVDPLDGRIHTSFSTTATATGRLSSSNPNLQNIPI
RSEEGNLIRQAFIAPKGHKIISADYSQIELRLLAHVANVAAFKEAFANEQDIHDITARQV
FGVQEIDEQLRRKAKSINFGIIYGISPFGLAKRLGITIAEAAEYINYYFSCYPEIKVYME
KAVSIARLHGYVETLFGRRCFVRDINNTIPYVRQFAERAAINAPLQGTAADIIKRATIQL
FDQLKVGKIILQVHDELLVEVEDEKVQETAKLMKDIMENAIEISVPLEVEIKVGDNWGLN
SLNYDLNIVNSRSINHLN
>ELAGILAN_00787 hypothetical protein
MDKGANVDAEDENGDTPLDLATTQDIRTLLQNTDELLKAAGSGDIQEVNSLINKGANVNA
TDQDGKTPLHWAAVKGHEEVVEALLKVNGINVNATDQGGKTPLHLAARDNNKEIVEALLK
VNGINVNAQDKDDSTPLHWAAVKGHEEVVEALLGKHGIDVNLVDKNKDTPLHLVLKKDNV
DINVLNALLGAEGIDVNIKDKYGEWTPLHWAVFKGHKEAVEALLGKDGIDVNIEDKHGNT
PFKLATDEGIKTLLQPAEKSDDGSAGGSSTDSEGGQEEEKRVGDDTELQSDNSKEGEKTS
TNSAEQGTDVQDNDVGPVASTEPAQTEEQPSSFFGSLFSILMKPFSLIGSFFSDFFSWLF
GSNTDESTSQTDASVSLLRSDSLDEEDSSGGHYSAMNTDV
>ELAGILAN_00788 Transketolase 1
MNHSHLESMANAIRFLSIDAVQKANSGHPGMPLGMADVATVLFAKYLNHNPDDSKWFNRD
RFVLSNGHGSMLLYSILYLTGYISIDELKNFRQMGSKTPGHPEFGLTSGVEATTGPLGQG
FATAVGMALAESILKEQFGDSLINHYTYVMLGDGCLMEGISHEAASLAGHLKLNKLIALF
DDNDISIDGATCLSCSDDVEKRFLAYGWNVDKIDGHDFDAISLAIEQAKKSDKPTMICCK
TIIGKFSSRAGTSSVHSGAFSEEDIKQMREKLNWNYEPFHVPEDVKNAWKKTVERAKQNY
TMSFQRVTRKEEKEWIPVSSTGMTRESTGMTEENAGMTGYHVELQRRLDKHLPDNIAGVL
ADLKKQICELMPNEATRSSFGKVMELLTKSMPELIGGSADLTGSNCTKYEHMQVIDSNNY
SGSYVHYGVREHAMAACMNGMALHGAILPYGGTFLVFSDYCRPAIRLSALMKQQVMYVMT
HDSIGVGEDGPTHQPIEHLASLRAIPNLYVFRPADAVETLECVSIALEKKESPALFALSR
QNVSYMRKFYSDIDQSANLSKFGAYILCECSKELKVTIFATGSEVEIAVEAREKLQEKGI
GTRIVSMPCWRLFDEQSDEYKAAILNNDSIKVAIEAGSEMGWHKYIGSNGIFIGMKSFGE
SAPYKTLYEHFNISADHVVKCVCEKLVYIQ
>ELAGILAN_00789 30S ribosomal protein S4
MTTVITRKYRISRRLGVNLWGRAKDPVNKRKYPPGQHGILGFKKLSDFGKQFAAHKKFKF
YYAISSKQLRRTFLDAYNRKGYTADNFIGILESRLSSVLYHSGLVPTIYSAKQLISHKHV
TVNDKVVNISSYRVKPGDIIKIRERAAKIPVVVEAEQKQERKAPDYLEADSKEHSVKYLR
SPQYSEVPYSADMEVNLVVEFYSR
>ELAGILAN_00791 Protein IscX
MKWLDIEDIVEALEEKFPNENIISIRFTELKKKVLSLEEFDDDEKRCNEKILEAIQAAWI
EERLTA
>ELAGILAN_00792 hypothetical protein
MLKRSGPKKLKSIIENYALKCMKNKISKNEIRLILNWRNIVGKEIAECTKPKKISYAQNI
NSGVLHLVVTNGSKALEIQHMISLIIEKITIFFGYKAVYGIKIKQESIDYLTI
>ELAGILAN_00793 50S ribosomal protein L28
MSRVCELTNRKKSFGNKVSHSNRKTKRTFLLNLHKVTLTSDILNKKFRFRVATRTLRTID
YKGDLDAFLLNTRTIKLSEKAQKIKRRLKKVLVKQEVELAVSDA
>ELAGILAN_00794 Lipoyl synthase
MHSKPQWLRAKAPTGEVFNETLNIVKLHNLHTVCEEAACPNIGECWNKRHATVMILGSVC
TRACAFCNVATGIPDKLDPHEPENLAKAIKKLNLKHVVITSVDRDDLPDGGANQFIQCIE
EIRKITSETTIEILTPDFLNKKGAFEAIAVASPDVYNHNIETVPRLYAKIRPRARYFHSL
YLLKMVKQINPKVFTKSGLMVGLGETKEEIFQVMDDLRSAEVDFITIGQYLQPTPKHAKL
DRYVTPEEFEHYKYIAYSKGFLVVASSPLTRSSYHAEEDFNRLKACR
>ELAGILAN_00795 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MSTIKIEKKSQLVKEVFDSVASRYDTMNDIMSLGMHRLWKDRMVNSVHFTKNSKVLDVAG
GTGDIAIRIVRKEPSAKVTVCDINQNMLSRGRDKAINSNQINFDWVCANAESLPFEDSEF
DYCTIAFGIRNVSDRKKALNEAHRVLKPHGKFICLEFAPMHYQNEIFTKLYDLYSFKVIP
KIGSIVAKDKSSYEYLVKSIREFPTQADFKMEIEEVGFKNVEFHNMSYGIVALHIGTK
>ELAGILAN_00796 putative peptidoglycan glycosyltransferase FtsW
MNIKLWYRTLDYYLILPVFFLLTISFILVYSASPVIAQRLSLPQDYFIRRHTIYIVLSLI
TLVTFSFLNTRTILNLSFAGFILFTILIAIAIILGIEVKGAKRWLHIVKISVQPSEFVRP
FFSVVIASILASEMRFKMHISIIIFLLVFVLLLLQPDFSMSMLLTYSFIGQMFIACIPFL
YFLCIIGMAATGTTIAYLCLPHIKQRIYNFVFFTQRDNFQVTKSLEAFKRGQLTGVGPGE
GSVKASLPDCHTDFVFSVLAEEFGLITCLATLMLFGIISARLLYIAYRENELFNLLVILG
ISIQFITQFIINIGVTLSVFPTTGITLPLLSYGGSSLLSSSIALGIMLSFSRNQAIALKF
RERVMLGRYMD
>ELAGILAN_00797 hypothetical protein
MGKPACCVSKGGSSSNTTSLPNQLTRDKGFEKRAQLYAAKAYSRQADKSGKYVDLKKIFF
IAISNCTLFPDKLDYISSHTIRDEKTNEHDLKDFQFIFIELPKFPKSRAEQLESVVDRWL
FFFKYADETTDEDLRKIAEKSPIIKLAYDELDKFHWNEKDLVAYEERIMDLRKEEAILEY
RLDLAKEEGRKEREIEVAKNLLKAGVSFNIIAQTTGLSMSEIKELQN
>ELAGILAN_00798 2-oxoglutarate dehydrogenase E1 component
MSSLSCLYGDNAEFVEEMYSRYLQGDKSIGEDWNRIFSSNLEVNKAETCGAQHVTKVDDS
VANFFRSYGHFFADLNPLSPNVNKEVDYQKYSNLYPASDAGIYRDIYCKNIGFEFMHISS
YEERMWLQEKIENQTYTLSSQDKKEILRHLIESEMFEQFLHMKFPGYKRFSIEGGESAIV
AIEKIISDSTVFGIEEIVLGMAHRGRLNVLTKVMGKEYAAMLSEFQGNLAYPSGLEVSGD
VKYHLGYSSDRALSGGKKIHLSLCPNPSHLEAVNPVLAGRIRAKQNIRSVLGISIHGDAA
FIGQGVVAETLTLSNIEGYRVDGIVHIVINNQVGFTASPSCARSSFYCTDIAKSIEAPVF
HVNGDNPEAVSFVANLAMEYRQKFKKDVVIDIMCYRKYGHNEGDEPNFTQPLMYKAISKH
KTPGTLYEEKLTAEKVLDDDEVNKLRSEFRAKLDKSLAESAAYTPKKADWFGGVWSKLRR
AKLNDLSEYYTDSGVPPDELKKLGVHINSNIPSNFNINNKVRKILDGRIDSINSGSNIDW
ATAESLAFASLLTEGIGVRLSGQDSGRGTFSHRHSRLVDQVTEEAFIPLNNINEKQAHFE
VIDSALSEYAVMGFEYGYSLDSPYSLVLWEGQFGDFANGAQIMIDQFIASAETKWLRSSG
LVLLLPHGYEGQGPEHSSARIERFLQLCAEDNMQVVNCSTPANYFHVLRRQMHRDFRKPL
VVFTPKSLLRHKRAVSNLSDFEGKFLTVIPECRKGLVSSDKVRKVVICSGKVYYDIIEML
ETQKINDIAVIRLEQFYPFPADKLSNELEKYKNAEIIWCQEEPKNMGGWFFVNPLIEEVL
SNLNIQAKRPKCIARPAAASPACGYASVHAQQQEEILRQIA
>ELAGILAN_00799 hypothetical protein
MNTKIFEMLIRRTGLRRDSKAEIIQLNRNEKAFVDEDKESIELAEAIFEENNMFHFRKPG
PAMDYILHKLINDRKLFEEMKDRGTSIIRLFSLLSMYHGRLNCCVIRKGGCITECGILDY
AGTYPELVPLEDFILIEPCSYLEYTVLDNDNIRNRLARDLTEDKTKLDIFLNGILATKNS
DLVLSCINKIEVLNEEDRYFVNRLQKNNMLDYILNKDDTTLAKSTLKELLKLSILQEGES
TKLESPQASSVNVSKAQQHCSI
>ELAGILAN_00800 hypothetical protein
MSFTEIRFPENISYGSAGGPEFSTDVVTTHNGCEQRNINWSHARTRYNIAYGVRSNEQLL
ELITFFHARKGKAIGFRFKDWSDFIAINQEIGIGDNKKTTFQLIKTYVSGEDKHIRMIKK
PVHGTVKIYLNGKEESEYSVNYSTGEITFMKPPVKDVIITASFEFDVPVRFDTDYLNASI
DDYGSNSWNNIPLIEVKF
>ELAGILAN_00801 hypothetical protein
MSRISFLLILILAVASLPVINNWLSHRGQTLTDDQISTRLDDYISRNFDKIVKTLKEESI
KSSYAARDNVTKSKISQYKDEIFDLTYPYSGNENSSVIVAGFLDYSCGYCKAMKNDIKQL
INDGKIKYIFRDAPILSNASLKAAKSALAVYFLDKEKYFDFHHAALSHKGEFSDESILDI
VKNIGIDEDDFNDSIKDNADKIEQMINNSRLLVRDLGVGGTPFLIIGDSLFVGATDLNVL
RKKVDELSHKQG
>ELAGILAN_00802 hypothetical protein
MSEPIIGREKEIAILQDKLLSQSAEFIAVYGRRRVNVVLSAFYQHNIEVM
>ELAGILAN_00803 hypothetical protein
MPMPNYTITSKIANCLMRIEAAKEKVLHLPLTVSMLSSLRETARLYTTHYSTMIEGNRLE
PKQIEEVLSGKSHFPKYRRDENEVKGYYAALTQVEQWAAREVPITEKAIQTLHALVMASG
KSKIKSTPYRDGQNVIRDSLTRAIIYMPPEAKDVPKLMSSMIDWIRNSEQVPCPIIAGIA
HYQFVTIHHYYDGNGRTARLLTTLILHLGGYDLKGLYSLEEYYAKNLGAYYEAISIGPSH
NYYMGRAEADITKWVEYFVEGMANSFENVLQRINKEEYHADQTDLIRKLDPKQRRALELF
QEFSAITASQVGELFNFKPRTSAQLCKKWVEMGFIKIVDFSNRGRKYKLSKQYEDLISN
>ELAGILAN_00804 3-octaprenyl-4-hydroxybenzoate carboxy-lyase
MYNNLRDFIKALEEKKDLIRIKEEVSIVLEMTEIHRRVLSNKGPAIIFENVVTENGKNSI
PVLVNLFGTIERIALGLNINPGELRDLGKLLAFLQSPEPPKNFKDAMKMFPLLKVVLSMR
SKVVSKAPCQEVVLTGDEVDLSLLPIQICWPNEPAPLITWPIVVTKGPTKDKQDNFNLGI
YRMQVIDKKTTLMRWLAHRGGAGHHKRWKEKEQNMKFPAAAVIGSDPATIIAAVTPVPET
LSEYQFAGLLRKKPLELVNCKTIPLQVPAHAEIVLEGYVSLDRYQDEGPYGDHTGYYNSV
EQFPEFNITAITMRKNPIYLSTFTGKPPDEPSILGEALNEIFVPILINQFPEIVDFYLPP
EGCSYRIAVVSIKKSYPGQAKRIVMGILSFLKQFLYTKFIIVVDDDINIRDWKEVMWAMS
TRMDPVRDTIMIENAPIDYLDFASPESGLGGKMGFDATNKIPPETKREWGKKIEMSEEIV
RKVAEKWEEYMD
>ELAGILAN_00805 1-deoxy-D-xylulose 5-phosphate reductoisomerase
MKKVSVLGSTGSVGKKTVDLLSKRKEEYQVEALSAHSNFALLAHQAKLLNAKYVAISDER
LYKDLKESLLGTDVKIAIGATNVAAIPVDLSVVAIVGIAGLGPVMEVIESGTKVIALANK
ESIVCGGKLLLKKAKEKNVQIIPIDSEHNAIFQILQNDDKCVEKIILTASGGPFLNYSLE
QLRNIMVDQALSHPTWNMGKKISVDSATMMNKALEIIEAHNLFNISPDKIEAVVHPESIV
HGIVTYKDGFNFAVLAETDMAIPISYALSWPERLVLNYKLDLTKQGKLTFQEPDHKHFPV
LKLSMEVLNSSTPQTNSIVLNAANEIAVNEFLKSRIGFLEIVEVVESTMESFGSYTDINS
LSDIINIDCESRIIAHKIVESKVVAYS
>ELAGILAN_00806 hypothetical protein
MSEAQGPNIAEWQAQQQHQEAAGEKSGFGLGHSDSVSTVVDGMKWLFNFHEGAIAAYSNV
FEGLVSGSSLVTLFGKSGNMFGIKFLEGLAEYFSGGGGEDMPSEGMDMAHGDDGHHSDDY
PHANNEIAHNADGLQDMHDAGDHHGQSFSPGPSPSVGDDHGHELG
>ELAGILAN_00807 hypothetical protein
MAVKHIRKRLYQAIMLPLIALFFIAAAPFVALSLLVFNIWNTESINKALKYIIIAPLVVL
YLPCAMLALVLHLSISTLLTVAKITLFPEFFLSLRIKEGIKFSRVFSLSITQFHNMDFYA
YIKDSKTFFKIKDSNRKLLVALLKDNDFSIQDDTPFHFYETHLEFVTDVTTKISDKEKSK
IIFDYLGLSNLKPLIQKDSYGERRLYEIYNTHEKLIKVVNDIDIGLLKTLLKLNESSVRN
PKYMCISRLSNVIDLFDNNDLVKNMSDAFRNKQILAVQMAEYLSIFLGHEYNGYYSKKVM
QDNLKKLFLKKDLIDNLSSNLGAQSSLMLIIKYFLRKEMSEREFDNLTSMLEDKNMIDNL
KHIDDINNVLPHTLECNGYSTFLGLREIFDLKTAASDISNLHLLLANNRLFYKFRGIPIG
VLRKICSTELYENCANVDEVLAFFDCLGDKSKNKNILDNLIVAFEKDPEATHALLNSKLF
NSRNEILRVLSDEKFDGNKVREILNHINLLWTLRKNSMFNNDMDLEDKLFYTFRPRFINS
EFRGCAQDYALLSGIHNNQRAERVFSKSVNLFQIFLKEAIKDRYELMFPIIEDTKVEHLV
DGRFISKVRDKINRYLSNLLIFKGNLFSDVSNILRLQVIIILFFPLFEFEEGLHTTLEER
WEKILKRKFTELFVAQKYQQITPESLAKIQDLTIQDLSAIPETEEIEEFLRKKGITNSDD
LSLLAKLIEDSIHIANVIGERVSLTQNITQTICDTFKDISVNHNTKQTPPSLLDLCKTNI
IGSSLTEQISC
>ELAGILAN_00808 putative ribonucleotide transport ATP-binding protein mkl
MRNPIISILNLSLSFDDRTVLKDLNFDILKGESLVILGGSGSGKSVLTKTIIGLLAPDSG
SVKINSKSKNKFGVLFQNSALFDYVTVWENISFNYKKRFNISKKEAKQLAIEKLNDVGLE
ESIADMFPIELSGGMKKRVALARAIAHNPEIIILDEPTSGLDPIMSDIVNEIIIKLSRDL
NPTIITITHDIHSAFKIADKIAVLYEGEIISHGTVQEIQNTNNQYIKKFIRYI
>ELAGILAN_00809 putative phospholipid ABC transporter permease protein MlaE
MSFFDINSVRIIGRYFINFLLRLGSAFIFFIQSLYHCLVPPYYFSNVARQIIEIGFFSLP
IVGLTGVFIGAAIVLQSSLSDPLINQEQIIPKLVTITIIKELGPVLISLIMVGKVGSSVA
AEIGTMRITEQIDALTTLNINPFKYLIAPRILASIIVFPILTVCADLIGIFGGCITAVFE
FNHNLNIYIKHTAQFFNTYDFITGLIKATVFGAIISVSSCYYGYHCKEGARGVGVATTST
VVLSSILIILANYMITLIHA
>ELAGILAN_00810 50S ribosomal protein L32
MEEVLAVPKRKKSKSRRNMHRSHHAIEPKNVVVCSTTGEFMLPHNVAVDGSYKGKRVFIK
QQAE
>ELAGILAN_00811 Phosphate acyltransferase
MAVTKENGFSSSNRQSDYYDMLSTVNNNIVIALDAMGGDFAPLSVIHGAGFFLDNLVDPG
IKVFFHIYGDKEEVSPLLLKYKKVSNNSEFTHCSDNVLANDKPSFALRHRKDSSMKAAIV
AVKEGKAFGVVSSGNTGALMAISRFVLGTLPNIYRPAIASICPTKTKSFALLDLGANVDC
NADSLFQFALMGSIFAKIALKIDNPEVALLNIGTEEVKGNDSVRGAFELLKNAPGINFKG
YIEASEFLEGNIDVIVADGFVGNVMLKTAEATASTFINLIKQEVFNSWIAKMLVGILLKS
KLNKALTRFNPKIRSGAMFLGLNGIIIKSHGNSDAISFAHAIKFAVNAISENLNQKIING
VSHIE
>ELAGILAN_00812 3-oxoacyl-[acyl-carrier-protein] synthase 3
MLSNNEIASIVETSDEWIRQRTGIVQRHIADEGELTSDLAVNAAKSAIEKAKISVDEIDL
IIVATTTPDKTFPSCATIVQSKLKCKNAFAFDVQAACSGFIYAVTVADSLIKSNNRIKYA
LVIGAEIMSRIVDWEDRSTCVLFGDGAGAVVMKSEMGRSGIISTNLYSDGNVDILCTNGG
ISSTGDSGKICMNGREVFKHAVDKLTASVEETLKCNNLKITDIDWLIPHQANIRIIEAVV
KKLDFPIEKVINTVDKHANTSAASIPLALDYAIQESKIKSGNLVLLISIGAGLTWGSVLL
HY
>ELAGILAN_00813 tRNA pseudouridine synthase A
MRYKITVEYNGSSFSGWQKQQHSANSIQEKIENAIFNFSGEKIALYCGGRTDAGVHALGQ
VAHFDMEKECELYRIRNAINYHLKSIPIVVLNAEVVDDAFHARFSAKKRYYEYRIVNRYA
PAALETGYVWQVFSPLDVNIMREAAKHLLGKHDLSSFRSKDCHAANPIRTIDDIDIVQNG
NHIHIKISAISFLHNQVRIIAGTLVEFGKNRTNPQEMLHILSQCKRSAAGVTAPPFGLYL
VKIDY
>ELAGILAN_00814 hypothetical protein
MPAAYSYDLRKKAMEALDEGESREAVAARFKIGRTTLWEWQHCRLDHKLC
>ELAGILAN_00815 hypothetical protein
MSIQSRSLTKFSVIPELSSVIPEPSFVIPVLDTGIQKKNKWIPASCTQLYERCIQHTVSF
HYLPLSSQCLTLGSRYKNTYKSCNGQQILGVHDNHNVSDEISWIPVSATCMTSIRNLLKQ
WLCMGSNVFAIFCMLFLSSLISAEEFKSLPNKKIDWKFDGIVGSFDRESIQRGYKVYKEV
CAACHSMNRVAFRNLQDVGFSEEDVKQIAASYQVKDGPNDLGEMFDRPGVPSDYFIAPFD
TKEAAAASNNGAVPPDLSLIIKARHDGANYVYSLLTGYQNGEHDENDLYFNSYFPTGRLA
MAPPLSEGMVEYDGARQATVENMAYDVINFLQWAAEPELERRHKLGLKVVAYFIILTVFF
VLTNNKVWSKLYKKK
>ELAGILAN_00816 Cytochrome b
MQEDNKKETIKEEKGILGWIEYRLPIFSFLRHTASYQVPKNLNYAWNFGSLAGIALILQI
ITGIFLAMHYTPHVDYAFNSVERIMRDVNYGWLIRYTHAVGASLFFMVVYVHIMRGLYYG
SYKRPREMVWFIGIFIFFAMMATAFMGYVLPWGQMSFWGATVITNLFSAIPLIGNKIVIW
LWGGFSVDNPTLNRFFALHYLLPFVIIALAMLHVIALHRFGSGNPSGVEVKSDKDTIPLY
PYYIVKDCITFGLFFVVLFAFVFYAPNYLGHPDNYIEADSMVTPVHIVPEWYFLPFYAML
RSIPDKLTGVLTMFASILVWFLLPWLDKSKVKSGAYRPVFKKFFWVFAINFVLLAWLGGQ
EVKEPYITMSRLSTLYYFAYFVIVLPLLSKYEKPKEPPKTLSDSVPEMR
>ELAGILAN_00817 hypothetical protein
MFRDGAFKVLGIDSGANQNEINKAYQNLMKLVHPDKGGSEYFAQKLNAARDRLLKR
>ELAGILAN_00818 hypothetical protein
MKNYLQSVYEDGMKIQLSKVNKYLLVLLITVSAFLISGQVSSSSNIENDFQDLQEKLPLL
KDQDLLFLDPASALNYGDRAGKKVLMVIVHHTETSTLKGTKDTLNARGLSVHFIVDRDGN
ITLMVPLEKEAWHAGISYARVKVDSKLEELRKLNNYSVGIEIVNTGLEPFPEEQMRSVKE
LILYLMERFKIKRDMIFSHSEIGTIVYDPELGYTMRKPDPHKLFDWELLEKNEIGLHISD
RINPKDAKHKMGKTLYKAGDRNEGILKLKQRLNRFFYKIEPWNDKKGNVIFPDNNADYSD
EFDENFVWVIYQFSIHNLPREIRKDLPLKLEQADIFPEFFSEYSHGISSSYLTFSEKIKS
TLQPCLSKVDYENLLSSLAQYENNISPDASTTLMYKIKLYYDSYLRYRIWSSLYKPFKLN
VLEELEILKSGVLSLKSLDSSKAAEVSSLIDSFKVDISLEFQGFEKQWFQEFKNAWRQEF
IPSLEEQITWTALHEAILEYLEKAKEEIR
>ELAGILAN_00819 hypothetical protein
MNSILSKFLNEFSSSRSYTENYTGDNMSKDEALKILGLNPEASQNEINKAYQNLMKLVHP
DKGGSEYFAQKLNAARDKLLKK
>ELAGILAN_00820 Fe/S biogenesis protein NfuA
MVNNMFIQIEETPNPNTLKFLPGFEILNEGETTDFSNANEIKNSKLAANLFQIEHVVRVF
FGHDFISVTKLGGINWDTLKVEILTTIMDHFTSGGKALDKEGVNDNNIPDEEFFDKNDIE
IVNRIKELMESYIKPAVAQDGGDIKFRGYKDGIVYVELQGACSGCPSAAITLKQGVQNML
SYHIPEIAGIETTL
>ELAGILAN_00821 Histidine--tRNA ligase
MTNQTVRGTKDFLFDEWYKFKHIEQTASRISNLYGFLPAQTPIFEYTEVFTKTLGDSSDI
ITKEMYSFNDKGGKSITLRPEFTAAIVRLLIEKKLQTPIKLFSTGPAFRYERPQKGRQRQ
FHQINFEVFGIEDPKADIELISLVQHLLTEFGINKNVKLEINSLGDGETITKYREALILY
FTKYQNDLSEDSKNRLIKNPLRILDSKDEKDKSIISDAPKISNYYTKGSSDFFEQILNGL
TILDIPYTVNNKLVRGLDYYCHTVFEFVTEDLGAQGAVFAGGRYDNLVSSVGGKHTPAIG
FAGGIERIMELINYSPKEERPIYLIPIGREAEKHALTLANELRRNGLYVIYEYSGTLRTR
MKKANQANAKAALIFGDEELSSKTLKIKNMNTGEEKIIARDNTIENIY
>ELAGILAN_00822 5'-nucleotidase SurE
MIILITNDDGFGSEGIKLLKEIARNFAPEIWIVAPDTDRSGAARSLDYPVKQSIGIKQHS
EREFSVSGTPADCVIIALNKVMNKKPDLILSGVNIGSNVGDDICYSGTIGAVMEGAARSI
PSIALSQVYHDKIDWHNTKVFAPKVIAKLVKVGWPKNIVMSVNFPATEKVKGVEFAEQGE
YNIDGDLTFTENSNGSFSLNWSREHSGSGSINKIKEGFITITPVKLDFTDYDTLNTMKNS
CADEFSSIAD
>ELAGILAN_00823 CCA-adding enzyme
MQVDQETSLIIDAIEEFGGEARLVGGCVRDSILQRDVHDIDLATNLLPNQTIKALKLRNI
KTIPTGLNHGTITAILNQRSFEITTLRHDVKCDGRHAKVEFTNNWQADASRRDFTFNALY
ADKHGHIYDYFGGIEDLKVRRLNFIGNAEDRIKEDYLRILRAFRFHAKICVGDLSDEILN
VCKKHSHMIQNLSGERIRDEILKLLECNDPFPTLKSMQESDVLQKIIPKEVKCEILSSSL
LFGTDALVKLALLLRTTKNDRLSLGEYVSKFLRLSNKQKKKLLFLLSNDIKTELSEKEQK
KYISLFGRELYCDLVKICGVESGENVDEYISFANTFNIPKFPLSGDDLISIGHQPGKSLG
RNLELLKQHWEDSSYTLTKEELVLYAKSLF
>ELAGILAN_00824 hypothetical protein
MAEPRKRKLPSDFHDVEVGIKRPRISGQEITLLNSNPYPDNFYVGQAIGNGSCFFDSFRQ
SLEQQTGEQVTAEKLRNDCREFAQKNPPKWFTDAIANGYDNNGQHRSETVDDYTANIMRN
DRWGDPDVEGRILCEKYKVKLHVIENQTVDNQDLFLHELIDNSGSKSAGEYNKVNYDDSS
VLHVINKGHAHFEPLLDRNKSLAKQEQEETKLKQEQEQEDCLLAKKLQLDEILEYCNLSK
DISERAEVEKRFDELLAENADGKICDVVEQCVSDIKQHIQRSEKQKSLSPSCSMEEAKIE
RLSHQQQQQQIPAQ
>ELAGILAN_00825 Ribosome-binding ATPase YchF
MSFNCGIVGLPNIGKSTLFNALTESSAAEAANYPFCTIEPNIGKISIKDQRLKQIAAIAG
SEKIIYNQLEVVDIAGLVKGASKGEGLGNKFLSHIREVDAIVHLLRCFTDDDISHVHSKI
DPISDAEVVEMELILADIDSIEKRLPQLEKKAKQGDKELKRQLELMQEVLATLKLGKPAR
SLENIDEDEMKSLQLLTTKPVMYVCNVEDTNVITGNELSKKVERMAEENKSKFYCISAKL
EADIANLDSEEEKQSFLSEFGLQESGLDGVARIMYEVLSMITFFTVGPKEARAWPVKIGS
TADKAAGVIHTDFEKGFIKAETISFADYIKYGSESACKDAGKIRFEGRDYIMQDGDIMHF
RFNV
>ELAGILAN_00826 hypothetical protein
MKNILYFILLAVVFGSLSLFAVEQFEEKKIESVHKNENVGVRKQDSTNQKDELKSNVDAK
QTQEAESKRLDDTTDKEKLQHNENKASVVEKTTSEGERIDKGLPNDQLEGSTDKFAQNLP
NVVNKEVNKDLKPEPLPLSADLNENTANPQKNLQADQKIDIKDNELSKSDASQLLEGKKE
KVENQSEEKKVKETNSNSKDRNRVKPITKKDEEEQSEKKSLQKWTKLNREPIKEWGHKDI
QSKSIYKRQYDSLNEHLPTTVFIDDYSKQFFYCIKKNNLTCLRGVISKLEKIGLTIQEIL
RFRNKLGDTPLIYSVKQGEVDIVRFLLLQGADLRVVNNNFQSPIDIAIERKQVKIINAIA
EMMPHLLEDRKIDNKESSAMYDWAVKTKENNELQCDKQDD
>ELAGILAN_00827 hypothetical protein
MIRFLILILVGHLCYGNETNDEKNQISDFLNALHDVKYVSYSKKDFAEFLVQCHKEGVPE
DFKKGFGSNLNGANFNQLYLSKSVFDGVSLIGADFSNTDLSDVSFIDVDLRGANFSNANL
HGIKIKGTNLSFTKFVSANLTDIVFDQSNVSYADFISSDLKKVSMHNVIGLHTNFSNVKM
NFSNLSNSNVSHVNFSDSEINDTVMQKNNLNNASFFGVDAYKLKIQFSSLKNANIYGAEL
KESDFTGSNLSDACLNSSIIIDSNFDETNLSNTQISYVNDDNSSFVQSILNGSKIKHAYV
SEANLHDADLSNIDFSFSELHQVNVSNADIRHGKFHNTKVANSNMNGSFFDHSLFTSAKI
EDSDLSTTSMYKIKIQDSQVYNSTLSRHNIDSSEIENSTFFNLLADNSSWSNLKVTNSNF
IESDFRSSLLHANAFRKTSFFLSNLSNSTISDMSFLSSSIYKSSVVDAHLTGCKFDNSIL
IDNQGQEKLTGSENAITSIKDLQEKISQGEKFNVNYSYFEFKDMNLENADFSNSTLSRAK
FVNVNLNKANFEKTDLRYTVFDNSSLIGTNLSNSNLEGSSFLNSDPKSTMLKNAKKNDRK
K
>ELAGILAN_00828 Guanylate kinase
MQRKMTVKSEGVLLVLSSPSGAGKTTISAKLLERSTNLVRSVSMTTRKPRPGEINGKDYF
FVTEEKFHELCKAGQMLEYAKVFENFYGIPRNFIEQNLSNGISVLLSIDWQGAFHLFKLM
RKKVVSVFILPPSMEELRLRLQKRNSDDASEIERRLAEAQKEISKRDKYDYVIINDDIDK
SVEEISSILNKERLKKLKEKPSLED
>ELAGILAN_00829 Phosphocholine transferase AnkX
MAREEDINQLVENGFDINSKDASGITLLHKFTKEGDLVGVKSLLEHEADFNVVDNENRNP
LHYAIMHGHKKVAKLFVNQLTINSKDKNGFTPLHLAALQDDTELIDFLITKGAKINEKDA
KEGYSPLHIASLYGSKKSVQILIDSGANLECEDNNFRTPLFLTIYQCTAHYDSRAEIIEY
LIKKGANIEAKDAENNTTLFLAAYNNKMQIVKLIAKKQQASNDKIKLKEFFCTKNNHGFD
ALDCAIEHNNRKMVTFLVSKGIEANDQDFNGNARLHKASHNGNTKTVKLLLKLKVNVNAV
TKCNRTPLLLAVKKGHTQIVKMLLEVRANMNICEQQGFAPLHLAVQKDYFDIAQLLTEKG
ADLNIKCNNGHTAIDMFISKAHSKKNIEENYKKFCRFLMLYLKELHSKHKACCILSTLAL
SLTIIGLPFIFKPIIKYRERSTIYKKIRAMLVYI
>ELAGILAN_00830 hypothetical protein
MIKNLAFLCLIFVLMSSCSFSNRFNCTAGHYKIGSSYTINGITYYPKNCKHYEEIGIASW
YGIEDHGTLTANGEAFNRHLISAAHKTLPLPCFVLVTNLENGRKLVTRVNDRGPFIEGRI
IDLSEKAAQVLGFHKSGLAKVKVQYLRKMSEQLIQNTPHYRKQYEKEMQKRHPKQDSAES
KGYVAFFKSAQAAKSAASKLRNQGIKNVRLLFKNDQYCVKVSYR
>ELAGILAN_00831 UDP-N-acetylmuramate--L-alanine ligase
MRILNYTIINLVMSKHLLLNINKTQKGIIHIIGIGGIGMSAIAEILHNSNYKVQGSDAQS
NNNVDRLQKLGIEVYIGHNANNISQAQIVVHSSAIESDNVELVTARNNNKTILHRSDILA
ELLRDKYVIAVSGSSGKTTTTAMIASIFDHSNIDATVIVGGILNSYQSNSRLGKRDIFLI
EADESDGTMLKIPANITVITSINDDHMDHYGTFDDIKHAFSQFINKADFAILPDSVGINY
DASNSMMFGFESGNIRASNIKQHANSIEFDVLIDNNHRIKNVVLSNTIGMHKVSNALAAI
SVAIKLGISDAEIKKGLLEFQGVARRFSLIADIKGVKLIEDYAHHPNEIYATLTAARSIT
KGKVIGIIEPLRFARIRNFFDEFIRIFMMFDYVILTPVHPPEDKPIPGCGIDDIQKALIS
NGFNNTKIMNDALLISHFISDSTSPSDIVLFIGAGSNIAKLAKETAALIAEVKV
>ELAGILAN_00832 Enolase
MNKIINNVFAREILDSRGYPTIEVEIELCDGAIGRASVPSGASTGKLEALELRDQDEKRY
CGKGVLKAVQAVNGIIADEIIGMNAADQNAIDKALIELDGTKNKSKLGANATLGVSLAVA
KAAANSFKMPLYRYLGGKQTSVMPVPLINIINGGVHADNKLDFQEFMILPVGAETFSEAI
RISAEVFHNLRSILKKKGYSTNVGDEGGFAPNIESTEEALDLIIYAIESAGYSAQSDFAL
GLDVASSTFYEDGIYEFESKGLTSEELTEYYCNLVERYPIISIEDAMSEDDYEGWKLLTA
KLGNKIQLVGDDLFVTNCELICKGIEEKMANAVLIKPNQIGTLTETFAAIEMAKSNGYKA
VVSHRSGETEDTTISHIAVASNCGQIKTGSLSRSDRLAKYNELMRIESTLGKDAKYYRGL
AWVL
>ELAGILAN_00833 GTPase Obg/CgtA
MGFIDEVKLCLKAGDGGDGCASFRREKFVEFGGPNGGNGGKGGNIVFISDANLNTLLHFR
YRRHIKADSGKNGAGRDRSGTAGKDVILKVPVGAQIIDEESEEIIVDLDKPGMEFQVAQG
GKGGLGNTNFKSSTNKAPRHFTYGQPGEEKHVLLKLKVLSDVGIIGMPNAGKSKFLTRCS
NSDTKVGDYPFTTVRPHLGMVKVDDSEVVIADIPGIITDAHLGVGLGHKFLKHIERCQIL
LHLIDVTHDDVVSAYSCIHNELELYNSDLVEKEEIVVLNKCDLLREAEILEKKNHLANYL
NKEVLCLSINGDLQPILRLLSEKLKKSNSKEIDVYDPFKA
>ELAGILAN_00834 Fumarate hydratase class II
MDRKTRIESDSLGEVKVPSEHYWGAQTQRSLENFKIGTEKMPEPLIKALAIVKLAAAHVN
MKQGSIDNKVGDAICAAAKEVIDGKFNNEFPLVVWQTGSGTQTNMNMNEVISNRAIEILG
GNLGSKSPIHPNDHVNYGQSSNDTFPTAMHIAAADQINRLLIPNLEKLHKVLDNKVQEFK
DIIKVGRTHLQDATPLTLGQEFSGYAAQIKKGIERVKSTLSDIYELAQGGTAVGTGLNTK
KGFAEDFAKQVAGITNLPFTSAGNKFEALAANDALVELSGTLNTVAVSLMKIANDIRLLG
SGPRCGIGEIMLPENEPGSSIMPGKVNPTQCEAVTMVCTQVMGNHVAVTISGSNGHFELN
VFKPVIIYNVLQSIRLLADASLNFTEKCVVGIKANEERIKDLLNQSLMLVTILNTHIGYD
NAAKIAKLAYKENITLKEAAAKLQLLTEEEFERIVKPEEMVNYCIRSAEWQNKVDKVI
>ELAGILAN_00835 Arginine--tRNA ligase
MNIFKRASSLILSKLNELKQRGIINTDTTNFIVEPPSNRAHGDIYTNVAMVLAKHEKKNP
IEIAEVLAKEFELFDEVAKVEIAGPGFINIHLKIKVWHGILKQINELKTEFGTLDIGNNQ
AINVEFVSANPTGPLHIGHARGAVFGDVLANLLKKVGYKVTKEYYINDAGAQIDTLIKSV
YLRYKEALGEKISIEKGLYPGEYLKPIGEGLAKKYGKEFLKKQDNQIIREYTLSFILELI
KEDMNLLGVNHDVFTSEYELQKSGKIEESIKILSDKGLVYEGYLEKPKGKESENWTSRKE
MLFRSTKFGDDVDRALKKDGGSWTYFASDIAYHFDKISRGFNNMIVELGSDHGGYVKRLK
AVVSALSDDQAKIEVKLHNIVNFFENGKPVKMSKRSGNFLTARDVVEEVGRDITRFIMLT
RKNDMVLDFDFAKVKEQSKDNPIFYVQYAHARAHSLMRNAPKELPTADPSLLRTGGELFL
IKTLAKWPDVVEIAARLCEPHRITFYLLEVAEAFHVLWGYGKSDLNMRFILEDNLNLTAA
RMFLVQALAHVIASGLSIFNIEPLKEMS
>ELAGILAN_00836 hypothetical protein
MPTNTFSCPNQKNANHVRILPLDTCYVSDMLKINLFTKLDDCKVNKSKLIYDKCGKDLKC
KIDDKTMNELKKCFKFEIDDKTMNELKENIKNELEKGLKFEIDDKTMNELKENIKNELEK
SLKFEIGDKTKNELKENIKNELEKGLKCEIDDKTKNELKENIKNELEKSLKFEIDDKTMN
ELKENIKNELKKEKEPDDVKEPDGVKEPDAGNDGYSEGMAFSYHDYDNVLI
>ELAGILAN_00837 hypothetical protein
MTYNFSSYPRMDSCTPVRTACITDPRYHHNFDPRCHNRFDSRHDGLELNIQLPEFDLNIP
PCPACPDTVCPPAPACPPAPACPACPPCPQVKPEPESKTIVDFSKLAITVNPITDDILDI
ETKEPTGYKFKECAKTIQNAKNNLQVIDGKLVGSCENNSECDKCVEVINSSILDAKSAEA
FFSTHNMSVLEGTVHII
>ELAGILAN_00838 hypothetical protein
MVYNYSHLPKLPCTAFNSPASVSPTPVSNCAQACAPAYAPCATNSCHNHFNSYHNYYDTC
HNPCDEFGFLY
>ELAGILAN_00839 Chromosome partition protein Smc
MLKHNYSDKINNRYSYTNKFSYSDEGVDETIKDKITTEDQVVTDDKVVTDDEVTTEDQVT
DPRDQIEKEKKDDEFTRETLEECKNRAQKAEDDAKKAVKRAEDDAARAIKRAKDDAEEEI
GRAKDDAKQARERAEEDAKAKKAAEEVAKQAQGEAEEAKEQFTKCEENAERIKDDAKQAI
ERAKDDAKAKAAEAVKQAHGEAKEAKEQFAKCEKDAERIKDDAKQAIERAKDDAKAKADL
AIKQAQDEIEKVKAEAKQAKADAGKAKEEAEGIKEAFVQCEKKVEKAKEEVVKCKIGMAK
AEVEWYKKEAEECKKEKGIGTGKPDTGKKGDETGTGKPDTGEKGDETGTNKPDTDEKEDE
TGKASVITSQEITLDCSQAENCGAHASWYTAYNKIGHQGFNTSDLLKELYPEMYSNPKIA
TYIEKGIEGYYGVVNFKFAFTELFDSAHYFSNMSCKKCMDNPQEIACQDDEIKSFCYPAG
YHNNKEYNKSFFMRESCPDLIRESDRTIVAKAKQIAPLILVNTLGQMIDKEGNNTQILYS
SLKPYLKANGKIKDCGVDKKCEDFAKIMKKVAWDSDKEVLLKTVFDSTEKTNPYYYDNED
SLVSVDTNFI
>ELAGILAN_00840 putative ABC transporter ATP-binding protein
MRSNIRQLFYYIKPNLSYFVIAFIAVLFSALTILLFGRGLSNIIDSGTEHDFTTKLLVAI
LIVLAISLTAFTRLYFIGIGSEKVIARIRYDLYSSITDLQPSFFENTGVQDVISALITDT
SVLQSIINSSLLTILRNFVILIGSVAMLLYTNIQLTAYAAAIIPILLIIVTSLGKKVRSH
ARFAQDKLSELASFSEENFRSIVTIKSFVLEENEKTRFKEYLNSVSKSYVKLVLLRAILV
TLVITCVIGSLVVLLFFGIKEVLSNNITIGELSSFVVYSALAAGAINNLSDNISDLQRGL
GIVERLFEFKNMKSSIVDPDDPIKICSVQKGISFNGVTFFYESQSDKPALNNVSFSIEAG
QAVSIVGPSGSGKSTILKLLLRFHDPNKGSITIDGHNIKSIALNDLRSLFGLVPQDHMIF
SCSIIENILYGKPGAEYEEVRQAAIGAYAMEFIDKLPDKFDTFVGKRGLKLSEGQKQRII
IARAILKNPQVLILDEATSALDYKSENLVQKALSELMQNRTTIVITHRLSTALKTDKIIV
INHGKVEEVGTHDSLISKDGLYAKLAKIQ
>ELAGILAN_00841 hypothetical protein
MLKLKNTRCFFQDTRYFVKGKNDKAVSDLISCLSSDKKAPLYLVLNHADQNYSLQFITRA
NKISAYLSAKTKMEHFSRNNDISSVFLVEKPNKFNQNWCYLLVSSKAKHLVEYWLNVFIE
IGSNFKGILMFPIEISNITKKILHKDPNNWKIIVAATKTGGYRQVVLKENKMVFTRLTSF
TNDNLPGIIAGGIYQEVQDTIRSLTKFGFEKNNPIDLCIIVSEDIKASLSVINFSENSVS
ILTPYELGKLLGAELAISEKDNFCDTIILFHSFKNKLAAIFNTKETKEFYLFNYLYLNSP
QTFLYFALVLVVINALCLLNLYSNFNVADNLSTKKSTLNNQLIKLSQSYNVKKIDEIYDF
ININNILSKIEYSPLTQVKYVEKLKIPGIELRSFEWNYNEAKSYITTTLKFNFQSGKNIS
HQYEKLRKNLNDNFRTYDINISSLPAAKEQNLSIDDEIGEAM
>ELAGILAN_00842 hypothetical protein
MTISQLKRKATIQFISYLLLSVGLIGLLTYVVIYNEKIYNKNQIEIDKIRFINLQITEIQ
KKEVILNKNLDLWKKISSSNLHSSRYIANLNFELSKLYKKYYILEPEISISIPEEVELHN
KSERTKVIKSEVALNLSSISDKHIFLFLQSIPNLPGYVMIKSLILNKQRNIDAATMNQIL
NGNMIEIVRANIVFDWYTILSR
>ELAGILAN_00843 hypothetical protein
MNIKLFFIFTLLISNVNAYCSCEDIIESIGICKKYSCRQYIGNEDFIEHKILGLNSGNLC
VYIEKQGNDEMVCHHSQYGMMIEKRYFESILKVGNQEIDDFIDIANLRAKECFFINNQKL
SYTDRDDIIREAVESDFDVLSQYSNVKSIFFDEEPVNKMVHEMEKFNLWSSKAAKEENFN
CKVVSLDSILYLSPDTWKIWVNGKLFINTKDLKVHSVTENYVTFVWTVDQKAIKKHANDS
QNVYFGYGSIMFTLYPKQKFNLDGLSIK
>ELAGILAN_00845 Single-stranded DNA-binding protein
MSGGTINKVILVGNLGKDPEIRTTQNGKEMASFSIATSESWTDKFSGTRSEKTEWHNIVI
FSEGLVKIVKDFARKGSKVYVEGSLRTRKWTDQNGGERYTTEVVLYNFNSALTLLDSRNS
APNSDYKPSEYKQGETEQKDKHESFDNDIKDELLDDEIPF
>ELAGILAN_00846 4-hydroxy-tetrahydrodipicolinate synthase
MQVKAENGVVLLGSTGESLSLTDSEKRTLVEFVCKLKLNTKIIIGVPGVNLYQTLEWLDF
CKGMPIHGYLMTTPIYAKPGIMGQTLWFEKLLEKAHVPAMFYNIPSRAGVSLYAETIRNL
SSDEKFWAIKDSSGTVDTLAQYKKVAPNIEVFCGDDNMISDMAAYGAAGLVSVASNVWPR
IAHEYVKKCLNDELSSLSFQRVTLESRRKPVQMTENDMKSSTDIWQQACEALFTASNPIP
TKALLHDIGLIEHKTVRLPLSTEDLPSVEKLRQVNKMILGWKELATL
>ELAGILAN_00847 DNA ligase
MTNLEKMREKLQDQINYHNVLYHQKNKPEISDAEYDELKKKLAEIEPEIYATQESVGAPP
DERFSKVEHQEPMLSLENAYDEQGVEKFLSKIKRFLIEDKIEILCEPKIDGLSFSAIYED
GRFVKAATRGDGFVGEDVTHNVATIKGFPKFLQGVQGRLEVRGEIYISNSDFLKLNENDE
FANPRNAAAGSLKQLDANITASRPLRYFAYSLIGGAEKSQSEVLNKLEALGFCVNEHQSL
TSSLDGMLKFYNEVYNCRYNLDYDIDGIVYKVNDLVLQNRLGNTHKAPRSALAYKFSAVY
AKTKLNKIFIQVGRTGVLTPVADLVPVNIGGVLVSRASLHNQDEIKRKDIREGDIVTIKR
AGDVIPQIVEVSRDSRLPNTPEFVFPEVCPECGSKVRQVEGEAAVRCPEEFACKAQIIEK
LKHFVSKDAFDIVGLGDKQIEFFYDLGLIKQIPDIFTLEERLDEFNLEEQSGWGKKSIAH
LLNAIQSRRVITLDRFIFSLGIRFIGQVAAELLADYYVSYDNWYNSMIELSSDNTELVGI
DGIGKKVAESLESFFSKEHNIKMLNDLTACLQILPVSSNSSNSVLNNKIIVFTGKLLAMS
RGEAKVRAKTLGAKVSSHLSAKTDYLIAGEKPGSKYKKAVELGVEILDEDQWHKVISLGV
FK
>ELAGILAN_00848 Glutamate--tRNA ligase 1
MLTRFAPSPTGYLHVGNVRTALVCWMYTRNQNGKFLLRFDDTDLQRSDVKYINDIIQDLK
WIGINWDASFKQSERFERYNEVFLQLIKEGHIYACYETREELDIKRKLQLKQGLPPVYDR
SALLLTEQEKISYEQEGRRPHFRFKLDRNEVVKWNDEVKDEINIATSSISDPVVKREDGI
YTYMLPSVIDDVDFNVTHVVRGEDHVTNTAVQLQMIKALKAKIPTFAHLSLLHFDDSKIS
KRTGVLNIKSIKEDEIEPMALVSYLVKLGTSNPIEACACMQSLIDSFNIKKFSSASVQFS
LSEIYKLNSKVLQQMPFEMVQDRLNQIGVDSSEFWYFIRNNIERFSEVAKWWKICKSDIE
PVILDKELIKIAFNALPQGDCNENTLSEWVKTIRQTVDIKAKNLFTQLRSALTGTETGPE
LAKLLIFIGKENIIARLKEK
>ELAGILAN_00849 Cytochrome c oxidase subunit 2
MVKLFALLIIFYSNISVASAPTSWQFGFPAPATEVMEAVVRSHSFVMLVMVTIMLFVWAL
LAYIAFRFRKSKVTNISKTTHSVPLEIIWFVIPTIIVGILAFENAKLLKLQEEIPKADIT
LKVIGHQWYWSYQYPEY
>ELAGILAN_00850 Cytochrome c oxidase subunit 2
MSFDSYIKGKEDFIEGDLKLFSVDNNIVLPINTNVRLQVTAGDVIHSWGVPAFGVKIDAI
PGRLNEAWFNIKKSGVYYGQCYELCGQGHGFMPIVVEAVSKEDFNKWIENRKLVS
>ELAGILAN_00851 Cytochrome c oxidase subunit 1
MSDVPKGVKRWLFSTNHKDIGTLYIIFSILAGIIGGLLSVIIRTQLMHINILNNNYQLYN
VMVTGHALIMVFFMIMPALMGGFGNWFVPLMIGAPDMAFPRMNNLSFWLLVSSFILLILS
VFIGEGPGTGWTLYPPLSQVMSHPSAGVDIAILALHVAGMSSIVGAINFIVTIFNMRAKG
MSLTKMPLFVWSVLLTAFMLIVALPVLAGAITMLLTDRNIGTSFFDPAGGGDPVLFQHLF
WFFGHPEVYVIIFPAFGIISQVVSTFSHRPVFGYIGMVYAMIGIAVFGFMVWAHHMFTVG
LSADAAAFFSTTTIFIGVITGVKVFSWIATMWGGAIEFKTPMLFALGFIFMFVGGGITGI
ILSHGGIDKLLHDTYYVVAHFHYVMSLAALFGAFAGFYYWIGKMSGKQYNERLGQIHFWL
TFISTNITFLPQHFLGLAGMPRRIPDYPDAFIPWNYISSIGSYMSFVSVMFFVFIVIHLF
KWGKKAGDNPWGGDTLEWTVSSPPPFHTFEKPPVVK
>ELAGILAN_00852 Protoheme IX farnesyltransferase
MYTSVLLNVESTILDFWRLLKPRIMYLVVFTAVAGMVTAPGSMHPFLALISLICVALGSG
SAGAINMWYDRDIDLLMERTKNRPIPSGRVSAESALEFGITLGILSVFIMAIAVNYISAA
LLAVSILFYVFIYTIWLKRRTPQNIVIGGAAGAFPPMIGWAAVTNSVSWESFILFLVIFM
WTPPHFWALSLNKSEDYAKASIPMFNIVYGPEKTRKYILIYSVLLVLTSLLPALFLKKAL
LYLSMAIFAGCIFIWYAISILRFKNHNSQKQMFSYSISYLFSLFASIIFCSIDLF
>ELAGILAN_00853 Ribonuclease HI
MSKKEVAIYTDGACSGNPGAGGWAAIILFQDYRKDIYGREENTTNNKMELTAVINGLKVL
KFSCNINLYTDSLYVKHGITEWINKWKMNGWKTSNKKSVKNMELWKELDNVASQHEIDWK
WVKAHSGDKYNEEADSLARKAIIDA
>ELAGILAN_00854 hypothetical protein
MLKKITVLFSVALLFILCFFIFLKPLEININYINFYVKHKISKIFVGSSVNMENTSVVWQ
KDGKDPYLVITDLAIANPNFTIKVPELFVHFKLSSLFKASTNLSQVSADNVHVCINQKEA
DFKTVNFNLQNSVKTIREFFFDLNADSKIEFTNIAIDKSTEDEFFIDRLYIGKGEDFNVL
DIHVNTKDEKGFLDDLSITIKNRNNLLNVYGTFYDLKLGLLSEFSTLVKSYNLDKNIGFK
GSFSVKINKKDEIVDGNIYVLNTENYLNKNLALTNVNINLTYSDGIISVKNFHFKLNGTY
LSLIGKMNFSTSHALLRINISKFAAKDLCTYVPDGVVNSKFKSWYCDNIDGDVLNTIVSF
NGKLVDDDLSDIVIVADIENGSVKFDEDFEQVKELKGDLIIKNNDLEITVNSAKFQNFTV
NGGDIEMKSLNKENSVLTINGQAVSDAYGLYEPIRFKLDDVVKVERDKVSGMAKSVFNFR
IFNLNADDKKVDFSANFHSEIDNLAVYNASLGKYDIKLSFGSDFIDLNGSGMVNNTQLLF
DLKSSNRNESFAWNLTGDLPAQIFNFDSGYVSANLESVINQDKTGYVNGDIDLSEFESHS
SYLGWKNRFEDHNKILFSTRLKGAGELLVDKLDIVGNDLDIKFSGRVENGNLYLNSSSFK
LPDNDFSIEIESGKEKNAITIYGEEINLSDILGLLGKNSNGLNKDIEISMNVDNVIMKEG
IVIKNAKLNVTCTKGNCKGSQFTGQFLEDSSNILAEYSGIGLEIYADNSGMLLRSLGISK
SIKNGKLSFYLSPQRESGEHYGTLSISNFYIKDAPLLTTLLSMSSLPGIVNAIKNEGVYF
YKCNAPFSYKDGTIEIEESWLEGAELGISTGGKLDIRNYKFQVAGQVIPAYSINKSLLKI
PIIGKLLTGGKSRGIVSIDYKASGDDKNNNVSVDLISSLTPNLLKRLLGVFDRIMTKTNE
SGLKGGVKKKFGSI
>ELAGILAN_00855 hypothetical protein
MSYGKRSYIESFFSRLKQTFGFSFRNKSEMNRERELLLKCYLLNKFTDIGMAKFEIVT
>ELAGILAN_00856 dCTP deaminase
MAVMPDKWIREKAENFGMIEPFVNHKSSKGVISFGLSSYGYDARVDNKFKIFTNVNSAIV
DPKNFSENSFIDKETDVCIIPPNSFVLASTVEYFRIPRNVLVICVGKSTYARCGIIVNVT
PLEPGWEGHVTLEFSNTTPLPAKIYANEGACQFVFLSGESECEKSYDDMKGKYMNQHGIT
LPLVK
>ELAGILAN_00857 Phosphate-binding protein PstS
MLRNLLLIFVFVLFTPLSNADARKYIRIVGSSTVFPFISFIAEEFNRVFSFKTPVVESIG
SGSGFKMFCSGIGEDTPDITTSSRPMKEVERELCKRNKINEVIEIIIGYDGIVIANSNQS
HRFDFTKKDLFETLSAYSQENDKLVKNNKKFWSDVNQALPKTEIEIYGPHQNTGTYETLV
NSIMLDQYSCMNSRIFKENYKDQEERKQACGNIRDDGRYIEVGINENIIIQKLKSNKNAL
GIFSFSFLMRNQDKIQGSTIAGIEPTYENISSGKYILARPLYLYIKKEHLDTVDGLREFV
KEIIDSIGIEGGYLSRLGLIPLSSEDIKKASAKVYDIT
>ELAGILAN_00858 hypothetical protein
MNHEGIGAGYKDNFLDFAIIGLDAGVKVQGEIGENVEIIKQIWKVANQKTRDFVCCRAIE
SFRGFGLYNIPALKTVIQEIEEHKRVMDLDMALRRAIRSLNVDQVKTALENCGEDVESVL
TRNVYWSDATDIDCLLIYPLMVDYERNLGKEEFEKIKEITKLLWDKASPDVRNFWLEDHM
VNREGQNTEDNYIIGSLEKQQKEYANIAGEGWLEDFIQEVKGYKKDREIKLNEYKGKIAL
GVVGLCVVGAIAAYVLAYPVVALVLEVLAVSALAVLAYIGGVCEKSESPNTKSSDPVVSG
VLQQRRTV
>ELAGILAN_00859 Trk system potassium uptake protein TrkI
MKNHQRLQNLRSIVFIVGIFLLLFSLAMLIPAITNKCLSYKWKNFLAGFIITCTSGAIFI
LLGKLSRLHGMPAIFAITSCTWIALSLFAAIPFYFDNLSYVDALFETISGITTTGATIFN
DIEKQSPGILLWRAMLHGMGGFGVITLGIAVFPMFKVLSLNNLLYSEYSDATKRKLPNTR
SVVIHVTAIYYGLILLCIFSYYLAGMPLFDAICHGMSAVSTGGFANYNDSIGHYNNPILE
AITIVFMILGSLPFLSYLKIIRRLDICYDEQVSYFVKIATISSLFACFWLYKNVDLGVSL
SFRCSTFTITSLITSTGYAICNHIDWSFISVLAFFLTFVGGCSGSSSGGVKIFRLIIFLR
SIENHFRLLLNPGAGDRVKFNGKTLENDEVHSVFIFFAIFMLTFTISSIVMSYLSNADFI
TSISSVSATLTNSGPGFSNLIGPSGNYSSFSNEVKLFLSFLMLLGRLEILPIYFCIGNLF
LFNRKK
>ELAGILAN_00860 Magnesium transporter MgtE
MNIEISSHYGLDKKAIDDLIESLDNEELENVRNIVKTIDSVQLAYFLSTSISDHREKLVN
ILDQHLLSDALVHVVPDLQIEIIETLGIENTAKLLMLLDVEDIVTIVKDLDRKSVENILY
YLPSKTQKSVEELLSYPEESAGRLIHKDMVIAPYYWTINQLTEFVCNYKKIPEKFHQIFI
INSKLEPIGSVNLNKVISHSGDTIIKEIMDHDIKIIKTGIDQEEVARIFKDYSLLSAPVV
NKNGKIIGVILIEDVIKVVQQETEEDVLKISGVSSKADINAPIHKTIIKRLPWLLFNLLA
ATMCSIVVGFFDDVIKSFIVLPIIMPIIASMSGNAGSQTVTLTIRAIATKYLTEQNAKRI
LMKEFLIGLINGVILSTISLVVLAIRFHNFKVEMIFVVSMIMMSIIATFIGTFIPIMLHR
LKSDPAVSSSILTSATTDILSAFIFLGLATIFLLNS
>ELAGILAN_00861 Peptide chain release factor RF2
MRLEELDSQASNDNLWQDNQKAQEILKERSKIKNDVESFLKLESDYNDAISLMKSAIDEN
DEEFFSEVENELAKLEKLIKYKETESLFTGEADNNNCFLEIHSGAGGTESNDWAEMLMRM
YVRWAEIYHNFKVEVVEKLEGESVGIKSAMIKIVGEKAYGWAKSESGIHRLVRISPFDAN
GKRHTSFASVGVTPVIEDSIDIAVDEKDLKIDTYRASGAGGQHVNKTESAVRITHIPTGV
VVQCQNGRSQHRNKDEALKLLKGRLYQIELEKKEQKMAEEYGEKCDIGWGNQIRSYVMHP
YQMVKDLRTGHEVGNINSVFDGNIDCFIVSVLTKQN
>ELAGILAN_00862 DNA mismatch repair protein MutS
MSFVKEKNTPVMEQYLNLKAQYKDHLLFYRLGDFYELFFDDAIKAAKLLNIVLTKRGNSC
GQDIPMCGVPAHSSESYLHKLIDLGFKVAICDQLETADEAKKRGYKSIVKRDVVRVVTPG
TIIEDSLLEDKSNNYLASIVEQNDEYAISWLELSTGKFFHTLTSLKALDSDLLRISPREL
LISEKFTEDEKIRSVLKNYKISITQHAQSFFEYSKSHRTLCEFYKIRELGSIGNFSKVEI
MACGALLEYVRVTQRGSIPRLEFPKTYKQQNFMLIDASARRNLELFSTQFGEKKGSLISV
IDHTVTASGGRLLKQMLASPLACSKAINLRLSTAQFFVNNHEPRRKIREILSNIPDIERS
LSRLILGRGSPKDMNLLKIGLGKTLELSEFLSTLHNYCLSEKSEINSQMSFQCLTKEKEP
VSTTQVISSDESELSTIHKSLGNHKDLFELLNSAILDNNLSSVKEGGFIHSKYNSELSEL
SYILNNSNKLVTKLRESYRDLTGIAALKILHNNILGYYVEVSANHKITSDIFIHRQSLAN
SMRYTTNELKELENKILTARDAAIGLEMKIFSELCSEVAKESEKIALAANALAKLDIRTA
FAELAVQNNYVKPIIDDSKEFNICSGRHPVVEVNNKFIANSINLAGIHLITGPNMAGKST
FLRQNALIAVLAHMGSFVPAESAHIGVIDKIFSRVGATDNITAGYSTFMVEMIETATIVN
QATDRSLVILDEIGRGTGVYDGLSIAQAVIEHIHNVNKCRAIFATHYHELTKVSKYLKNV
KCFCVKIREWNGEVIFLHEVIEGIADESYGIHVAKLAGFPDSVLNRASEVFEELKA
>ELAGILAN_00863 hypothetical protein
MINNLDSIILGIKDGEKAIEDLRVVLKKRKEEVITTQTFNYALRCPKTTKEAIVHEILLH
FIQNPGEQSLEQVIQCLDRAIQSGIYAKNNPIRNLDEEFRTHINFKDEEGNTLLHHAVIG
NKTEEITTLLVAYSANPLIQNADNKIPSDLAQGKTKEVLIKSMKKQAHTKKESAMIGSLV
PGIMIGGFLGVVLGAGVYVAVSLSGGMILGVMIASSLVASIAVGLAMYFLSQDYEQAKAI
EKTISTVSSEISVDDTTVANGKKGPQLT
>ELAGILAN_00864 hypothetical protein
MVENLGVVFTTAQRAIVKLEDLGIVSQTSQGKRDRVYCATDILNILEEPTKITENFDSTL
>ELAGILAN_00865 hypothetical protein
MYIKGSPSGKVFAGYQAFIPSPLPPKFEWDNDLVNSL
>ELAGILAN_00866 hypothetical protein
MLTDAWTLLTLTLLETILSVDNLIFISLAIDKVPNALRERVRLMGLGLALLMRFVILFFT
SSILSMQKPIFHTASARDLLMIAGGLFLIVKSSMELRDDIFVCKKNKKKANVKSKFFLVV
LQIILIDLVFSVDSILTAIALTYNMVIIATAFTFSMLAMLFLSSYTAQLIKSNPGLKIIA
ILFVLLVGVYLILHGFHIELPKGYLYSSFMFALLVEIISKIKKINRHTAIHSRYLSR
>ELAGILAN_00867 GMP synthase [glutamine-hydrolyzing]
MSAIAIIDFGSQFTQLIARQVRGMGVYCEIFPSNISFETISKFNGFILSGGPQSVNDDCS
ETSRVVHEIIKLNEATSVPILGICYGQQLICHYFGAKVKESFKQEFGRTKIKILKESPIV
KDTWDVNSEVDVLMNHADSVDTIPQGFTVIASGVINQTIAMIVNEQRKIYCTQFHPEVKP
TTNGSKLLSNFLDIANCKRDWTMKSFIEEQKEKIKNVVGEKKVIAAVSGGVDSSVAAALT
HKAIGKQLNCIFIDTGLLRKNQTIAMLKEIPINYVDKSNLFLSRLKGITDPEEKRKIIGN
TFIEVFEEEAKKIGDVDFLMQGTIYSDVVESGHASDNTSTIKSHHNVGGLPEKMNLKLVE
PLRYLFKDEVRLLGKEIGLSDEIIFQHPFPGPGLAVRIISEVDKEKVQILQEVDEIYINT
MKNYDLYDKIWQAFAVLLPIKTVGVMGDGRTYGYVCALRAVTSSDGMTADAFPFEDKDQH
LLVFWDFLRNVGSIIVNNVPGVNRVVYDITSKPPATIEWE
>ELAGILAN_00868 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MTKEDWEAVIGLEVHAQVSSNTKLFSSSSTEFGAEHNTQVSLVDAAMPGTLPILNYYCIE
QAIRTGLALSAEINKYSYFDRKNYFYPDLPQGYQITQFFEPIVKNGRVFINDNEKEIRIA
RIHLEQDAGKSVHEESKTYVDLNRAGVALIEIVSEPDLRSSAEAAECMKKLRQILRYTGS
CDGDMEKGSLRCDANVSVRLKGSNTFGTRCEIKNLNSIRHIVQAIDYEIQRQIEILESGE
EISQDTLLFDVASGKTKVMRSKEDASDYRYFPEPDLLPVEVSQEKIDLIQSSLPELPDQK
KLRYIEELGINEYDANVITSDKAIADYFEELIKKHDSKLAVTWLTVELFGRLNKANIDIV
SSPIKANALSELLDFIVDGTISAKLGKQVFDIMFETGKPASLIIEEQDLKQITDKCQISE
VIDKIINSNQDKVQEYKSGKTRLYGFFVGEVMKLTKGKASPDVVNSILSERLG
>ELAGILAN_00869 hypothetical protein
MYLEDDSTWGVKRIYHGITFQELLIVISLMSKMGKECSFSIDTELESAQGFDDIVVRHEQ
NKGIVHEFTQVKHNQDGTEKISVSSLLTKSGKFSILKLFPAYLKIKNSEKFSDGIKHFFV
ATNMDFDSPYSIQHKVRNLRAMLSGENKGKKLSFVRIDTKDEFLDIGDSARYRISDSDGS
AAQYLKQNMDFIKREIGKEVSNKEIEDFLNESVFVVNLPHEAQLRELLLGKLSSRLNKKF
DYIGNNQIFCNDLLKKISDWVKDIKARPLSYKEGEELFREVELWASTLGKIEQGVKEKNE
RIDKVIEQQHKDSKTLHKIYVAVTTQDNKRVGKPIQFNIKHPVEMFVGRKNELQEIYDRL
HKSTDKPMAISRIVVIGGSEGVGESELARKYACEYKEHYDGNLVWVNAGTQKDLEESFKG
LAKELNRRLPEGSKIFITDEDTEQEKGIRSIIKSVYRYFKDVKSLFIFDNAREYKDISKF
LPLSLYPDYKKPYVLITSRDNKWEARGDIEVIKLDIFNKTEALGFIKKSLNIDDPLQDKE
IKELMEKLQYLPLALKQVVVYIRNKNKESKLRGYGRFEISDYLKECQRYTGKSLKEGVCK
DEDCYAEAVSITCTITMTHIQKEYGCETLNILEIMAYLAPDKIRIEEIFLKLIANDEDKL
RGAVELLDRYSMIDLKEKVASIHRVVQRITRLKLQKEGREEEVLRKALELVNIGGLTQGG
MSHIASVWGYTSIYGKLIDNFYFNSSYVYGGTLFIRKSTPLHLLAESGDCKAISAIVTHI
EKHYPGEFVKTVNVKDNHGQTLLHIAAQSGNLGVMKCLVNKGASTNTKDKYDNIPLHSAV
YAGELDIVKYLVITNNNINAKGEDGRTPLHIAAINGDLDMVEYLIKSYANIDAKDNYGMT
PLHLAADVGELGIVEYLINEDAYVDARDEHYRTPLFFAAENGKLNVVKCLIEKGANVNAE
NEYGETALHRAVYRATFSGDLRIVESLINKGANVNARDRNSKTLLHYSALSGSYNIAECL
IQEGAGINAKDKDGNTALHLAVIRRKVDITKTLLKHNADVNARNNLGNTALDCAVDNCQE
LVELLLAHGASRDY
>ELAGILAN_00870 hypothetical protein
MENYFLLFTDSLVSSLVLPIHQGFVFNTMLYFRSYYTPLLMLFFGVLGSSLGGIVNWYLG
RITISIRKSYRKLENEHKTPKIVRNLLICAVASLSWVPALGSVIQILSGYFKLNLYILAP
LIILSNFFYLLYLILTFGV
>ELAGILAN_00871 Cysteine--tRNA ligase
MVRLYNTLTKKKELFIPIDKDHVKMYVCGPTVYDTAHIGNARSVVVYDVLFQLLKFCYGK
VTYVRNITDIDDKIINAASEKNSNIESITTYYIKAFHDDMESINCKKPTYEPKATENVDY
IIKLIEHLLQSGHAYESDKHVYFNIESYHEYGALSGKKTDELVPGSRVEVNENKKHPGDF
VLWKPANDIDYKLSSYWNSPWGEGRPGWHIECSAMSYAYLGKDFDIHGGGIDLQFPHHEN
EIAQSKSAFAGSMFAKYWMHNGFLTVNEEKMSKSLFNIVKVRDLLDSGIKGEVIRYALLK
THYRKPLDWTENVISDAQETLNKFYRLSRGLDTINIDESNAEISKDFIDALKNDLNIPEA
LAILHEMAAKINKMSNESEKLKLTESFVKSARFIGLLESSYQEWFTTGVSHQEIERLIDL
RRAAKQNKDYNTADKIRDQLKQIGVTISDNEDGTTTW
>ELAGILAN_00872 hypothetical protein
MPSWLERKSFQRSTLALVVEKTSPALKKIEKFMRPRMSFIFYGPGEKILAFIMLLCALSI
ALPLPLTNFIPAIGTTLISLGIMSKDGFLSILGVLISLCGLLLTLVVVVKGPQLIIGAFS
FLKSFVYG
>ELAGILAN_00873 Alanine--tRNA ligase
MKLNEIRERFIKFFVNNDHEQVSSSPLIPEHDPTLMFTNAGMVQFKNIFTGAQKTEMKRA
VSSQKCLRAGGKHNDLENVGYTTRHHTFFEMLGNFSFGDYFKETAIEFAWEFITKELSLD
KNRLSITVYHTDDEAYEIWRKISGFSSDKIIRITTDDNFWSMGNTGPCGPCSEIFYDHGS
PNLQEGDRIVEIWNLVFMEFNKDEEGNLHKLPKKCIDTGMGLERIAAVMQNVHDNYDIDL
FSALISKSQEYCGRTENKIAHKIIADHLRAAAFLIAEGVLPGNEGRNYVLRRLIRRAARY
IHLLGYNDSLLHRVFPVLIDSTSSAYMGDIYPELIRAKSLIETTLKSEEENFKDTLMKGI
SLLEKFTADLKSGDTLPGESAFKLYDTYGFPLDITLDILKEKKINFDQKGFDDAMGEQKE
RARAKWAGSGEKSVEQVWFDLIDKFGKTKFVGYEFNEVNDAKILAIVSSKNEVIDSAKEG
EKITIILDKTPFYGESGGQVGDTGSLIKSDRSIIIVENTNKVNDLYLHRCIVKFGSICKG
NTVAASIDKERRQTLRRNHSATHLLHFVLRKILGDHVTQKGSLVAPDKLRFDFSHNTQVT
QDQLFLVEDMVNSLIRENLSTSTKIQSMNQAIDEGAMALFGEKYGNQVRVVKIGDSRELC
GGTHVEHTGEIGLFKIVTESSVAFGVRRIEALTGQEAINYVRDNEINLKKVAEFVKAPVS
EIINRLNILNQERKESEAKIKNLYKKLISAESIKSTEINGINFVSHAFTNIPANIIREFV
LQQQKPKTIIAFTATEKDKTVLIIKVSKDLANKISAKELVSIAVEKNCGGNAELAQTGCD
SNKIDDAITAICSKIAASKHSTSYHHEPSYRRGANKQRDT
>ELAGILAN_00874 hypothetical protein
MEIYVGKEKRIANVVTQHWNDIKGSDRDWPERHEIDTAEIMESWQHCFIIEVKDQGYICE
NAGEKAVEFYGFEKKTRIDNKYAIDAPFLRLYKIDAVIDKLDTVIESKCPINEEEESESV
KMRQVLLPLGNKEGITHILGVITFKLL
>ELAGILAN_00875 50S ribosomal protein L35
MKKIKLKTKSSVKKRFHLTAKGKVISTQSGKRHGMVKRSKSNIRNQRGTTILGKSDSRIV
KLHMPYGI
>ELAGILAN_00876 50S ribosomal protein L20
MARVKRGVTTHARHKKILKLAKGYRGRAKSCYRIALQRVEKALQYAYRDRRTRKRDFRSL
WIIRINAAAREHGLTYGRFMHGLTLAGIDLNRKILAEMAVNYKDDFAKLVETVSGKLAEN
S
>ELAGILAN_00877 Methionyl-tRNA formyltransferase
MGSPGFAVNSLSLLLKSKSEVVAVYTKAPKPSGRGQKPMKSPVHVIAEESNIEVCTPISL
KFSAEQEKFRNFKPDVAVVAAYGLILPREILNIPKYGCINIHPSLLPRWRGAAPIQHTIL
AGDQETGVSIMQLDEGLDSGPILKQEKFLIEKNDNYKTLHDKLSKLGSDLLLKVLNEIEK
QLPLKQNDNDACYADKVEDYKIYASDACEVAYRKVKAFYPKAFIKIENKRIRILDADFEA
LASEQGKIVNDNMHISLKGGTLIPKVVQMEGRNPCSIEDFIRGLKSSMVKKFIE
>ELAGILAN_00878 Bifunctional purine biosynthesis protein PurH
MKIKRALISVYDKTNIIDLASFLTQQQIEILLTGNTYKTLSSAGIKTQEVSDYTQFPEIL
GGRVKTLHPKIHGGILCNREKHKTEIQNLGIKPIDLLITNLYPFWETVNSGSNEEQIIEQ
IDIGGVALIRAAAKNFRFTSVISSIQDYEALKAEMIKNNNKTTLEYRKHLATKAFALTAH
YDSNIHSWFLSQSKNNELPEFFALYGHKVQELRYGENPHQKAAFYSNQFTKYPLEKIHGK
ELSYNNIVDIESALNITSEFEEPAAVIIKHNNPCGAAIGNNALEAYEKALSCDEVSSFGG
IVALNREIDLKLAEKLNEIFLEVVIAPSVNNEALKILQRKKNLRVIIHKSFQQNVKYQTK
NVIGGFLVQENNDHKIKAEQVTECTTTKKGKEDLIFAWKICKHVKSNAIVIAKDGCAIGI
GAGQTSRIDSVNIAVKKAGEKCKGAVLASDAFFPFPDSIVESAKHGITAIIQPGGSLKDQ
DVIKAANENKIAMFFTGVRSFFH
>ELAGILAN_00879 Signal peptidase I
MEELSKNWVIRTGRFLSSLFFLLLIALSIRSFLFEPFHIPSGSMKSTLLEGDYIFTSKYS
YGYSKHSFPFSPNIFSGRIFYTPPKRGDIVVFKPTRNDSIRFVKRVIGTPGDKVQMIEGE
LYLNDQKVKRRQIESFFDYESNRNIPRYIETLLSGKEHEILVDDISNKLSYNTPVYYVPN
DQFFVMGDNRNNSLDSRFPEVGFVPMENIIGRVSIVGLSFKLGKVDWLPFNFRLPVALRL
NRVLHKVV
>ELAGILAN_00880 Chaperone protein HscA
MQPIQISEPNSSEVVFGIDLGTTNSLIAMVNKAGNVEIFKDEQGRELLPSALSYENNTLK
TGYDVGQNAIYSIKRLMGKSVEELNKEGLNFEIDHESEKVIRIKCAEEKYLTPIEISAEI
LKALCERVKKSKGLEVKKAVITVPAYFDDSARNATKYAAKLAGIEVLRLVNEPTAAALSY
SIEKNNSSGIYAVYDLGGGTFDISILKLHQGVFQVLAVGGDTKLGGDDFDHLLSSIVIDK
YREKTAKQLNSLLIESRIVKEYLSKNTSGIFEFSINGKPFECEITREEFEQAISPLVNRT
INIVTRTISDIDLKIDDIKGVILVGGATRTPLVQNSLVKLFGNKVLNDVDPDKAVAIGAA
LQAHDLISSSKDRNILLDVLPLSLGIETMGDIVEKIIPRNTPLPVSEIKEFTTYVDGQTA
MKIHVCQGEREMIEDNKSLAQFELKGIPPLPAGSARVEIEFTVNVDGILTVTAREKTTRI
EQTVEVNSSFGLSEADIQNMVDQSINSFDEDMKARSLAGAKINGNKLIHLVENNNNLSTD
QKLKNLLQNAKNALQGNDLNEINNTIAELENSSLELCELTNR
>ELAGILAN_00881 Co-chaperone protein HscB
MSSNYFALFEIEPAFNISFDELEKKYIELSRTDINERQSQNMENINRAYQVLKSPLERAE
HLLDFFDVKSQKDHLNSEILSESMEIREYLLDCDDLQFASRMIDEKIKDCVKNLINTFAV
KNFDGAATQVLRLKYLYKSFEEVKKNATNSNF
>ELAGILAN_00882 Iron-binding protein IscA
MGEYQEVGGGETVKKNKKLITITAEAVERIRYLLDQKKHTNLEKPEEAIGIRVLIKQKGC
SGLKYDIEYAYDTRPLESIIEENCSDGQKVKVLIDPKSVMFILGSEMDYVEEKFSSGFVF
KNPNEKGKCGCGESFHV
>ELAGILAN_00883 Iron-sulfur cluster assembly scaffold protein IscU
MSYNEKILDHYENPRNVGSLDKNDPNVGTGLVGAPSCGDVMKLQIKVNDKGVIEDAKFKT
FGCGSAIASSSLLTEMIKGRTISDVTQIKNTQIVEELSLPPVKIHCSVLAEDAIKAAIHD
YQSKQKN
>ELAGILAN_00884 Signal recognition particle receptor FtsY
MSLFGNLYKGLLKTSSRFSDGVKSIFSGKKKLDQSLLDELEELLISMDIGHKTSKLIIDR
LTSIKFDKEVEYNIITQQLVNEIEAILNPVVQPLILNKKPHIIMVCGVNGNGKTTTIGKL
AYKYKEMRKSVMLVACDTFRAAASEQLNIWAERSDCLIVTGEYGSDSASVAYRAVSQAIK
DNVDVVLIDTAGRLQNNVNLMEELSKIYRTIKKLDGTAPHDVILVLDATTGQNAYSQLEA
FSKMVNVTGLIVTKLDGTAKGGVVIGLAEAYKIKLHAIGIGENIEDLREFTSKEFAEALF
NCN
>ELAGILAN_00885 DNA repair protein RadA
MKTVYVCQSCGHSTGRWVGKCIACDNWDTVVEEIAVKTGKRSISAPILIKTLSGSEIITP
SRFLTGIEELDRVFGGGIVQGASILIGGEPGIGKSTLLLRIAANVVQLSSFECLYVSGEE
SLEQVSLRAKRLKINEPKIKLLSTVSLTDVVATIKENKSIKFLVIDSIQTMYDSRITSAP
GTVTQVRTCAHELTILAKQYGISLLIVGHITKDGQIAGPKTLEHMVDTVLYFEGENSNQY
RILRTIKNRFGPANEIGVFEMSEAGLVPVDNPSSLFLMAHDREVVGSAVFAGIEGSRPIL
MEVQALIAGTNMATPRRAVVGWDINRLAMIIAVLNACCKMFLHDKEVYLNIAGGLKIQEP
SADLAVAASLISSVVNLPLPTSSIICGEVALSGEIRNVSHADLRLKEAQKLGFKKAIMPK
NGNYSSHDIEIIKLGHVRELREIFNYN
>ELAGILAN_00886 ATP-dependent protease ATPase subunit HslU
MSSKQKTLCTNFSNQPITLSEGRSCSSDTYDEKDNLYKDTKSGFDSNDSDVQVNDSTQVL
LDDLPPQKIVKELDRFIIGQDDAKRAVAIALRNRWRRNQVPFPLRDEIIPKNILMIGHTG
VGKTEIARRLAKLAGAPFIKIEATKFTEIGYVGRDVDSIIRDLVDAAIVLVKEKARKALA
KKALILAEKTIVNSMVGENATEESKKIFRERLRNKEFEDGEVSINVRESKSMLPTFDIPG
MPGGQVGVMNVTEIMGKMFNGSKKTKTITVKVKEAREILINEESERLMDEDKIIKEAIDL
VSNDGIVFLDEIDKIAARTEVKGEVNREGVQRDLLPLLEGTTVTTKYGHVKTDYILFIAS
GAFHQSKPSDLLPELQGRLPIRVELKALTQEDLIRILKEPESSLLKQYIALMKTENVTLE
FTDDGIKTIAEIAFTVNRQVENIGARRLHTVMEKLLDEISFIASEKNSEKFIIDSKYVKD
KLESISKQLDLSKFIL
>ELAGILAN_00887 ATP-dependent protease subunit HslV
MIQHDNNKMYGTTILSIRKDKSVVVIGDGQVSLGHTVIKSGAKKVRRLSGDSVIAGFAGA
TADAFTLFERLESKLDKHPGQLMRACVELAKDWRMDKYLRKLEAMMIVADKSISLVITGT
GDVLEPEDGVAAIGSGGNFALSAARALIDIKGISIEEIAKKAMKIAGDICVYTNHNVVIE
KIEE
>ELAGILAN_00888 hypothetical protein
MQNIIHPDLEKSINNWFEAKFNGLTSPFYSSIDLRNSGYKIVPVDANLFPAGFNNLSEES
RTMAARLIKSYFKRHQYKKVLIIPENYTRNKMYIENVFVIEKILQLAGFETRIGLLYNEV
YNLIEQYETVVKENSLLKTTSGFVPDVIILNRDMTSHIPGTLKDVKQDIVPSPLYGWHSR
QKFKYFEIYQELASEFCGKFKIDPWLISVLTESCDGVDFDDDLSLGAVATKVDQILSLVQ
KKYEEYEIKTQPYVFIKASNGTYGMGIITATSGEEILNLNKKKRHKMKKIKEGIAINSVI
IQEGVPTIDMFKSSSAEPLIYYIGDTPTCYLYRCNSRKDVYSSLNATDCEFHDVSQVVEG
KILSLWSIVSKLAVLALAVEIKSFHP
>ELAGILAN_00889 hypothetical protein
MPNKLKKKSNILAQRVHDIYDHDFRKVICITTGLTALLCKISLQFCCEFIDNNRSNIFLI
RNVARLVKFPTSILYIAHSAFTLQDLIKDYRNPESKKELAKIVGKSANLASSTIEALMML
KIIHFCTGSNTDIISYINLTSTILFLFISEPISYYYTCKEYLDNKDPEKSAECKKDLIIS
TLTLSLGLLNFILRRIETPTIPINLGNGIIYNFNLSVTVSIIYSAVFLAVQLDKLFQQPV
NDDPSTELDDVHNINGHSNDSTVEV
>ELAGILAN_00890 Ferrochelatase
MKKAVILFNLGGPDSLNAVRPFLFNLFYDRRIINLPNPFRFLLAKFISAKRENTARKIYE
EIGGKSPILENTKMQANALELKLNENRNHVHKVFICMRYWRPFADEVIESVKQFDPDEVI
LLPLYPQYSTTTTLSSIENWQKNAKRYGLKCNTKMIHRSYDNQDFIEAHTNLIAKYYKLA
RKIGKPRVLFSAHSLPLSIIKKGDPYASQVERSVELIVEKLAINNLDWSICYQSKIGPVK
WLEPSTESELLRAKADGVPVVLSPISFVSEHSETLVELDIEYKAIIKDGYYFRVPTLSTD
PLFIKCLADLCINLP
>ELAGILAN_00891 hypothetical protein
MGKCCKNNTTKQAESTTKKLVSNFKSSLLCGTKGFLTFSLAFLSYLEYSSHHNTKLKEGA
AFAMKRNTIPFLEMTIIAPLVCFALPAMLGSMSLMQCALLCAALMIATCFIVRTFHLREK
LMEKITNHSRKEIDAEFKKDTIKFPIFDQNRKHIEYNSPNSGQPLNETSSTSLFVKVLLF
PLKVLLKVLQSCIMLSLAAVELLETVPSFCVDLFFDRSFESTQSNMQRFGHLLYANVRNL
VPITKFDECVANFIGTPKVTCCSSA
>ELAGILAN_00892 Nucleoside diphosphate kinase
MAIEKTLSILKPDAVKNNITGKINSYIESSGLKIIAQKMMLLTKKQAELFYEIHKDRPFF
GELVEFMTSGSVIVQVLVGENAVSKYRQIMGATNPKQADKGTIRGDFADDISENRVHGSD
SLENARKEIAFFFAECELV
>ELAGILAN_00893 IS66 family transposase ISWen3
MASIINDIFNLNISVGSISNSEHRVALKCEKTYEQIEQEISRSEVLHIDETSHYNKGKLG
WCWMFASNTASFVKLTESRGMKVLQDSTFCNRNSLIVTDRYSAYNYFNDKKRQICWAYLI
RDFERLAHSWNIEVKILGCYVRDVTTELFALKKALLKNEIDILRFARRARKLRKRTRYYL
KEISRLPEAIGASRVAKNILKSERMMWKFLDDPENIPLTNNHAEQQIRHYVVYRKNSYFT
QSKRGNAFLERIISLYLTWKQRGLNPFQNLLSIISYTA
>ELAGILAN_00894 hypothetical protein
MPGPVNEEQTVTLISSTSISEDGEITPGILPIPALRTSTPKKNDENTALEALLEEEFKEK
KNSNANSRDPLTLETQVSPPSLEETKGEETHVDVPQNPTLSRSPFQETVFSPPWNSEILE
DLQRTNSSSIPPTGSLPSYTSAADGSKKSLLTNSKFNINDDAILKNKKTNRFLPRAKYAM
QQKGFIIFGASAIILSISAALLYLQDKAKFIAFFTNSPKYITIPVIALAALLAIGPIFFA
TRQFIDTEEHSIQKKDADKILAEVLEHQPKDKAIKSVRLEYSNGTHSNFVLNAWEAKQGF
TNIDEKVITRTNKIKSVINDRPIFTALFTGVVAANIAFPLGLLATHGVNGVQKFYQNPLT
NNIGLSLLIGSGILALLIVGFGIHYYRKTNCTNLIYSEEEIDPKDVNGKFIEEIKRERTN
VLGENHSKDAKRSSLTLEQVVVQSHNCKDIVYSVG
>ELAGILAN_00895 NAD kinase
MHKYKNIGYVASPSPKSQEVSKLLKKLNFINITEENKSEIDLLIVVGGDGFMLRTLHNYV
IENKNMHVYGINTGNVGFLMNKCFSCSEDLIDHIEHATSTQLTLLKMEATDTSGKRYHYI
AVNEVYVFRKANQIVEMNITINDKLKVEKFRGDGVILSTPTGSTAYNFSAGGPILPLNSN
LLALTSINSYYPRHWNGALISNDTIVQIDINDTKNRPALVVSDYKEFHDISQIKIQKDHE
NTITLLFDKDYPLNERIFDRQFLY
>ELAGILAN_00896 50S ribosomal protein L31
MNYHKIIIVMTDGQEFETRSTYGKEGDRVKLDRDPLTHPAWTGSLTSGLASKTSKLAKFN
DKYGSIF
>ELAGILAN_00897 Malonyl CoA-acyl carrier protein transacylase
MIFAFPGQGSQFVGMGRSLYSEFSVARQVFNEVDSILGRKLSHLIFNGPIEELTITENAQ
PAIMAVSIAMLRVMEHMFGKSLFTDHNVKYVCGHSVGEYTALCAAGALTLESAIKLLKVR
SEAMHEASLKCKGGMVALLGAEINEVEDILKSVQIDGICEIANDNGGGQVVISGTREALE
MLPDLFKNSSVRKLIKLQVSGPFHSSLMKPADEKVLEFLKGIKITRPIVPLITNVTAKEE
SDPKVIKTLLAKQVVSRVKWREMVLYMSSRGINKFVEIGPNKVLSNLVKRIDQSISTKNI
DSIGDIDSFFNESLVLTAKNLKVGLS
>ELAGILAN_00898 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MGIKSVVLCILDGWGNGVENSKYNAISNANPPCWQYISSNYPKCSLSACGTDVGLPGGQI
GNSEVGHMNIGSGRVVIQSLQRINQEIGTIENNVNLQSFISNLKSKNGVCHIMGLVSDGG
VHSHQKHISTLANKISQHGIKVVIHAFLDGRDTLPNSGKKCIQEFIKSIKGNDIRIATVS
GRYYAMDRDNRWERTIEAYEAIAFAKAPRHDNAVSLIDENYQNNITDEFIRPAVIGDYQG
IKPEDGVLLANFRADRMIQLASILLGKTDYAKVAKFSSILSMMKYKKDLQIPYIFPPTSF
ADTLGQTIEDNKLQQLRIAETEKYAHVTFFFNCGKEEPFSGEERILIPSPKVQTYDLQPE
MSAFELTEKLVEKIHSQEFALIVVNYANPDMVGHTGNIKAAEKAVLAVDDCLAKVLSAVK
KSSNTALIVTADHGNVECMFDEENNTPHTAHTLNKVPFIVSCDNLKLRDGRLSDIAPTIL
QLLGIKKPDEMTGSSLISCITLCHSS
>ELAGILAN_00900 Protein translocase subunit SecD
MYNRLIVKSFSVLCICLFALYITLPNFFDNKLFISKKRINLGLDLKGGASLLLNIDLDFY
FKEKLSMLANEIKETLLTKNIESNVQNSVITLNNIDDYKKASVLINAINPNLELNRKDSS
ILISYKPHYKNSLISEVAAESINNVQRRLDKLGTKEVSVQKQGQNKILVQVPGVEDTKQI
KSLLGKTAKLAFHLANTNIAKVQDIDHETTVMLKDSLGNSYPIFRKTEIGGDSLVNASVR
FGNLGKPTVHFKFDSIASKRFAKITKENVGKPFAIVLDNTVLTVPTIREPILNGEGEISG
NFTEKQASELAILLKSGALPAPLKIIEEKNIGPSLGEESIKAGEMAATISIIAVALFIII
TYGKLGVLASVALFSNVVLILSILTLLEATLTLPGIAGIALTVGMAVDANVLIFERIREE
IKSGKRVERAIEEGFKNAIKTILDSNITTLIAAGIMFIIGSGAIRGFSVTLSIGILCSMF
SAITVTKLLIELCMNPKELVLC
>ELAGILAN_00901 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MTTSLLQGKKGLITGIINKRSIAYGIAKTLSEHGAELAITYQNEIIKEKLSPIADELNVE
LILHCDVSNEKIIDNAFEIIEKKWGTLDFLVHAIAFSDKNELDGKYVNTSLDNFLNAMHI
SCYSFTALAQRAEKMMSNGGSLLTLSYYGAEKVMPNYNVMGLCKAALEASVKYIACDLGP
QNIRVNAISAGPIRTLASSGISDFHSISEWNRNNSPLRRNVTIEDVGKAALYLLSDLSSG
TTGEILHVDSGYNVVGMKVVD
>ELAGILAN_00902 hypothetical protein
MLSEIIKQAGGSDTKALATIFSRKKFFRQVDGGEERYKNYLIDLVSESSGYQDNTVTLPR
EIIPDSVTLDALYFTHKKDPLTLPILLRYFTHKNLLQEAKDDLDKLNQKLQGAMDEELKK
LQDELKLLCEETVELSGKKVDVKQSKVLVTKSEKITETASKIEEIKSYKKNIKNLFNGSK
TKLNSYPSQYFSILNSGLIEIMEKKLTAYVKGDTDIGETYSSLNSRAKKIIRVRNVKNTL
VLSASLTFFIPCISVMCLGMFCMGVQHGPRPSFLFAMIDITLFYIVPIMLSIAVALYATA
GVAHLIKRRYEQSFEKEMQDFIEGPKRAEKATNEDVKKLEQEGTKVGDVIDLSGNCEMND
KVEPSAPPKRSGLYPDLSEELLASSCNKKDSQPNSNVDSTLSGVTQVRESNVQLLRGIVI
GKEQEIGV
>ELAGILAN_00903 hypothetical protein
MDDFIIARRKDDAVVSVCQDNKKKNVLILGLNQAARNLLKYEEGNLLNKPLINILSARAA
DDMKNYLEYTENGHDLLDILPKVIDFSLTDAKGEDIRTKVKVFRTAQFASNKINYELLIR
DISLSHKLGIFRDKYLMGKNIKTMTYSIYRAMSPLF
>ELAGILAN_00904 hypothetical protein
MIGLNSSCSETNNALKVVIEHFYKNCRSDDFLGYIDENKVLFVLINCDVKSTSKIINRIH
SAINKQLLKRKLPSVSIIYGNIAQKQAAKSTSGAF
>ELAGILAN_00905 hypothetical protein
MKLRYYLIALLSLLFSQNSASSRTILDKEIFYVELDGKIDLRFGYAFNRDSFNAKAKDKT
SSYSYLRFLYLQQVYPNTQMGVNVKAGVSGIANLKALDIEKLDMEEWYFIIKNQELGSVE
YGKRSLVSQSMLINTSKIYAAAGGINGHWTNYANLRGNKNKDNDPGYDKDKTFWVKPNIY
SDYNGLELGLRQSSINYISPEIYNFQLGFSYVPGKNNLQYSNLIAAGLSYKNSLSDDIGF
TTALTGEFARENLTGCSDGTPEGYKCRNQLLHWNFGLKLKLFDLDCIFSYGNGGKSGEKH
NPETNNTYYINAGIAYRSDSYKSSLTYFSSGRDIAGEGTNELTSYALSLENSLFLGTSYY
FDIVKFSTKEPKIENNNSGYVFLAGLKLSF
>ELAGILAN_00906 hypothetical protein
MFLRVFKNIFLFLVSILFVCPILSLISILFTDSANSEWVISTLFPEYILSTLILMVGVGG
ISFIFGVIPAWLTTFFSFPGSKIFEIALFFPISIPGYIVAFVYVNTLEFSGPVQSLLRDI
LDWSKGDYWFPEIKSLGGGILVMGFSLYPYVYMLVRSSLKNVSNSVTIASTLGFSSLKSL
FSVIIPSIRPSIIAGLSLVLMEVITDFGTPQFLAIDTFTTGIYRTWFLLHDKYSTTVLAV
AELIFVVILIAIEKKLQKKGISYSSINTNSDYHNKRSISGAIPLIFAYLMCVLPILIGFI
LPMIPLIYWSIEKGLFIYEARFYNIIANSISLSVITALISISIAIMIGYTARKNKVINNV
ARLISLGYAIPNAIIAISIIIFLSRISSFITQYIVEISLVGTIGALVYSYLFRFFAISFK
AVESGLKKTPNEIEWTAYTMGHGPISTCLNVHIPLIKKSILSGFLLVFMDTIKELTATLI
IRPFNFETISTRIYELVSDERYREAAPFSLIIVIIGLISTITLFTLDDKDKK
>ELAGILAN_00907 hypothetical protein
MSFVIATFYHFVELSNYYDMKDEIKAACNNVELKGTILLAEEGVNATISGERNAIDKIFD
FLRSDYRLRDLTWKESAAKYQPFSKMKVKLKREIVNLGVSNLDISLKGKYVDPEHWDDFT
SQPDVLVIDTRNEYEVKLGKFKNAINPHTQCFREFPQWTESFSESKDLKVAMYCTGGIRC
EKSTAYMKSLGFSDVYHLKGGILSYLEKTYNKNGNWKGECFVFDDRIAVDNSLTPSNTIK
CIFCSNQVSTDKLKSVPRGQVVCSDCKLQCYSYNK
>ELAGILAN_00908 DNA topoisomerase 1
MALLIVESPAKAKTIGKYLGKEFKVAASFGHVRDLPAKNGSVDPDNDFAIKYETIEKAEK
YIKELVKAASKTSDIYLATDPDREGEAMAWHVIETLKEKKAISNENNIYRVVFNEITKRA
VQEAIKNPREINMDLVRAQQARRALDYLVGFSLSPLLWTKLSGSKSAGRVQSVALKIICE
REDEISKFITQEYWSIKAEMQNSKDEAFFAMLSHYDNKKLEKFDIKNEEEAKNLVREIES
RQYAVSTVERKQVKRNPLPPFITSSLQQDAVNKLYFNVKSVMRIAQNLYEGIDIGGETVG
LITYMRTDGFHIADEAINSIRGSIKSLYGDKYLPQSPRKYVKKVKNAQEAHEAIRPTDIN
RTPGSIKDYLTPEQFKLYDLIWKRTIASQMESAILDQVVVEISSTDQKVVLRASGSSIFF
DGFYRVYQDNMEAENEGLLPAMKEGEACKLISVEPKQHFTQPPPRYSEASIVKKMEEIGI
GRPSTYATIISVLQDREYVSLDSKRFIPSSRGKIVTIFLETFFQRCVEYDFTAQMEEKLD
LISNGHADWKKELGHFWVPFFGHVNSVKQMTHDEVFSGIHNLVVDWFCSEEGRKEVNTKC
PACLGGILKLNFGKAGVFLGCSNYPECNHTKEITGSNDNSEYPKSLGVDGITNQEVMIKK
GPFGLYLEFNNELKKKKTVSIPKDINVNEIDLSTATQLLSLPKVIGEHPETGKEVKIGLG
RFGYYIFYDGKYFSLKKSSKEVLNTELSEAVQIIANSPRKELKSLGVNEKGKEVFICNGR
YGFYIKCGKTNVALGKSADIESIDLEKALELIKGKK
>ELAGILAN_00909 hypothetical protein
MHRLHQEDLTGHLLSKPKNIWHHICLPMISENKQVIYSIKKPMPPVPVIRVAQHCATRRL
YNKPASPVRILYSREEGQLLYPLDGGKEEVEMIKAELGSYAFAAQYQQNPLPLSSGIVKR
EWLKRYKNVPDNLSHVTQSWDTAVSTSDMSNFSVCTTWAKIDNKFYLLDVYRAKLEYPKL
KEQVLSLAARWSPHAILIEAKTSGQQLAQELKANSDLPIIEIVPHDGKLTRFHRIAPMIE
SGRIILPHQAVWLNDFEYEILMFPETRHDDQVDSTVQYLQWVRNSTSRVTAVRAL
>ELAGILAN_00910 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MNNITINYAKDSKLTDFGKAVLSDRYLIENESYQDLFARIANYYSDNKEHAQRLYDYMSN
LWFMPSTPILSNGGTKRGLPISCFLNETEDSLQGIVDLWNENVWLAARGGGIGSYWGNLR
SIGESVKGSGKTSGIVPFIVVQNALTLAISQGSLRRGSSAVYLPVSHPEIEEFLDLRKPT
GGDPNRKALNIHHAVIVTDKFMQAVENDQEWNLISPHNNKVISTVKARDIWIKILTARVE
TGEPYIIFLDATNNNKPESYKKLNLDIKMSNLCSEITLTTGYDHLNKSRTAVCCLSSVNL
EYYEEWKDNKLFIEDIMRFLDNVLEDFINKAPNEMQRAKYSAARERSIGLGVMGFHSFLQ
SKMVPFESVTAQQWNKKIFKYLREQADIVSKKLAEEKGACSDAKEVDLMERFTHKLAIAP
TASISIIAGNTSPGIEPYAANVFIQKTLTGSFVVRNKFLQKLLAEKNQDNDKIWSSISTN
EGSVQHLDFLSEHEKLTFKTAYELDQRWIIEHASDRTSYICQSQSVNLFLPANVHKRYLH
KIHMLAWKKGLKSLYYCRSQSMQRADKVSHDIFKKSEILQQKTDIDYDECLSCQ
>ELAGILAN_00911 Ubiquinone biosynthesis O-methyltransferase
MKSNLSFIKNVALNCMSKLIGVLNIKKVKHFIVNKYNTLHKEMTVLLKKSKNLLNTNIEI
GLYHFYKGSISDAKLRFWLISIFYPHLPIVWYNIGRCHFAVGNTNKAYNYLTRALKLDND
HEEASYYIKKMTNSAPITELPKNLIRQYFDYTGEYFVEHWLIAKQYRGHELVHMIITKIF
NNSTSELNILDLGCGTGICGHFLKINSIGNHITGIDISSRMLNIARGCFIKGKPVYNELI
HMEMKEFLKQEKNQQYDVIIFAEVLHYLHDFQEELELAKRSTSKKGVIVCLIRRKEGEGI
DFVNKGDYFRHSESYVQHVAKEINMQISYMSYCKIYGSQVDGILFALQHQQENPKNLT
>ELAGILAN_00914 Bifunctional protein FolD protein
MTIIIDGKKIANDLCERLSQKIDILKREYNIFPCLKVILVGSNPASQVYVRNKQKKAESI
GISSETIVLPDNISEDELIEKINELNEDPSVHGILVQLPLPNHISASRVINTVSVEKDVD
GFHDENVGKLVKGEKNCLIPCTPKGSLHLIKSIEENLSGKNAVVIGRSNIVGKPMFYLLL
QENCTVTILHSQSKDLAEYCSKADIVVAAVGKPNFVQADWIKKGAIVIDVGINSVNVGKL
VGDVDFEGIKGKAKAMTPVPGGVGPMTIAFLMMNTVIAACLQKGVDASNFIS
>ELAGILAN_00915 Flavin prenyltransferase UbiX
MNSRIVIGISGASGSIYGVRILEALKDVDYETHLVISRAGKITLAHEIKEKLEDITSLAD
FYYSEEKIGEKIASGSFKTSGMIVAPCSMKTMSEIASGVTSNLLTRAADVTLKERRKLVL
MVRESPLHLGHLQNMLKLTEMGAIIAPPVPAFYIKPKSLDDIINHSVGKVLDLFDIKLPD
FKEWQGSDNYY
>ELAGILAN_00916 hypothetical protein
MEDTVKITAEELKGYIERIEKLEQEKRDVQDHIRDVYAKATDEGWDIKVMKQIIRLRKMD
DDDREEQEILLDTYKRALGMSYEEELSE
>ELAGILAN_00917 hypothetical protein
MDWLLVLVSSAIFVLLVLSFLFSGAEIGLTSISRSRVNKLKLDGNKKARVIDRLLNRKEL
TIGTVLLGNTIINITCSALFTAIFINLFGNEGILLSTIIMTFCILLFCEVLPKTYAIQNP
EKFASFSAYFVLFFVKIFSPLTLGIQFIVNLILKLCGLHKDKEVISAADAMRNMITLHRS
EGTMLQQDLDMLSSILDLAETEISQIMTHRRNLFSLDIDRNKEELIREILTSSHSRVPLW
QKEPDNIVGVIHVKALINALREKNNKAEEVDITQVMSRPWFIPESTPLSVQLHNFRKNRK
HLAFVIDEYGALQGIVTLEDILEEIVGEISDEHDLITENFIKKISDNMYHIEGKSTIRDI
NRQLYWNLPDEEATTLAGMIVNEIERIPDEGEEFSMYGFRFKILKKDKNIITVVEVQVKT
GNISGSN
>ELAGILAN_00918 Acetylornithine aminotransferase
MDHVVNAYNRLDTPIVRGEGAYLFDKDGKKYLDFAAGISTTSLGHCHPYITDKLKEQSSS
LWHCSNIFTIPEQERLAERLTTLTFADKVFFCSSGLEATEAAIKFIRRYFYSKGQAKRNR
IITIEGGFHGRSIAAISAGCNEKSREGFAPLLSGFDKVPRNDIKALEEKINNEIAAVFLE
PIQSEGGVYPLDVEYLQKVREITKAQGIILCFDEVQCGYGRIGSLFHYQNVGIEPDMLTC
AKAMGNGFPVAACLVKDYIAEAITPGTHGSTYGGNPLAMTVGNAVLDIMLKEGFFDHVKR
ISKYLKEKLLLLAKEFPEMILEVRGEGLLMGIELATLVADKIISRSLDKGLIITRVLNNK
VVRVTPPLIIEDEHVNAACNMLYDLFFKIKGI
>ELAGILAN_00919 NADH-quinone oxidoreductase subunit D
MPDLKTMMLNFGPQHPAAHGVLRLVLEMDGEVIERADPHIGLLHRGTEKLIEHKTYLQAL
PYFDRLDYVSPMSQEHAYSLCVEKLLQCEVPIRAKYLRVLFCELTRILNHLLNVSSQALD
VGAMTPLLWLFEEREKILEFYERASGARFHAAYIRPGGIAADVPEDLIEDIAKFIEQFPK
YIDDVDELLTENRIWKQRTVGISEISIKQALDWGFSGPMLRAAGLAWDLRKSQPYEIYDQ
LDFDIPIGQNGDCYDRYLVRMAEIRQSISLVKQCIEKMPEGQIKTEDRKISPPSRAEMKK
SMEALIHHFKLYSEGYHVPEGEAYAVVEAPKGEFGVYIVSDGTNRPYRCRIRAPGFAHLQ
ALDFMAKGHMLADVAAIIGSLDIVFGEIDR
>ELAGILAN_00920 Translation initiation factor IF-3
MQVKKNNKNRINGFITAKEVRLVDHSGEMIGIVLIERALELAQGVGLDLVEIAPDSTPPV
CKILDYSKQKYDIKKKASEAKKKQKTLTIKEIKLGPNIGDHDYETKLRQARDLLVHGHKI
KVTMRFRGRELINTEVGLEKLERLIRDTEDIAKVELAPKREGNQYFLALVAK
>ELAGILAN_00921 Threonine--tRNA ligase
MIRITFSAEQKVKEYSGKVTGFDILQPDVLKEAIAFKVNGELHDLSREIEADAEIEVIQL
SDEAGLDIIRHDAAHIMAQAVKELFPNTQITIGPTIQDGFYYDFATGRTFTTDDLTAIEK
KMKEIVKSNHRFVREVWTRKQAIDFFSDIGEKYKVDIISSIPEGENLTVYRQGDFIDLCR
GPHSPSTGRVKAFKLMKVAGAYWRGDAKGPMLQRIYGTAWRNKDELNAYLECLKEAEKRD
HRKIAKDMDLFHIQEEAVGQVFWHEQGYILYNVLESYIRKKLINNGYFEVKTPILVSKEL
WEKSGHWDKFRENMFIVDESESKKLAIKPMNCPCHVQIFNSHTRSYRDLPIRMAEFGTCH
RNESSGSLHGLMRVRGFTQDDAHIFCMEEQVNSETIKFCDLLKEVYSELGFNEISVKFSD
RPDVRAGDDEVWDRAEKALLEAVKEAGLSYELSPGEGAFYGPKLEFVLKDAIGRSWQCGT
LQVDFILPERLGAFYIGADGHKHHPVMLHRAILGTFERFIGILIENYAGKFPVWLAPTQL
AILTITNEADGYATKISNVLKEQGVRVKTDLTNEKISYKIRLHSLNKVPILWIVGKNEVT
SKTVSVRNLGSERQESFSLEKAIELLLKSINLN
>ELAGILAN_00922 hypothetical protein
MLNVIACFASNTKVSSQCLTLGSSKIDCEQAHYTTFSMKLQKSWIPVSSTGMTKRGLDKR
VDK
>ELAGILAN_00923 hypothetical protein
MFRAYNPVIHYDLGAVPTRGGVIPVADTQLYEHLFARAVC
>ELAGILAN_00924 NADH-quinone oxidoreductase subunit I
MTDTSFKYFMLKKLAWYWSFVELIKGFVITLKYMFKPKVTLRYPMEKGPLSPRFRGEHAL
RRYPNGEERCIACKLCEVICPAQAIVIEAEEREDGSRRTTRYDIDMTKCIYCGLCQEACP
VDAIVEGPNFEFATETREELMYNKEKLLRNGEVWEDAIALRLKKNRPYY
>ELAGILAN_00925 tRNA modification GTPase MnmE
MTNTNETIFALSTVFGKSGVAVIRISGNYALKALNHFHIKKEIKPRFATLVDLYDDSSQL
IDNGIIIYFPAPNSFTGEDVIELQVHGSKAVIKIILEELSKVFVMAKPGEFSLRAFLNGK
FDLTQIEGIADLIDAETKMQAKQAIKQISGELERLYSNWRQRLITIQSKIEAYIDFPEDI
WAEKSELEKINNEVQSLVRLIQEHLNDNRRGERLREGLHIVITGEPNVGKSTLFNFLAKR
DIAIVSEYAGTTRDILEAHIDIGGYPIILSDTAGIRESSDPIELEGISRAKKRSFEADLR
IELFPFEQRPNINCNVVNSDTIYVLSKADDVINNHDIKINGIDLLPVSILKGIGTNKLIS
LIKEKAEEKFGHDRDTPVITRQRHRNHMQKALEHLQRFNIDNPIELISEDLRLAAFELGA
VIGIIDVEEILSSVFSNFCVGK
>ELAGILAN_00927 Ferredoxin--NADP reductase
MKTDIVIIGAGPVGIFTAFQAGMLDMGCHIIDVLDQAGGQCTALYPEKPIYDIPGYPVIT
AQKLIEQLMEQASPFKPIYHLSQKVEKISNNEGENFTIITSIGTEVKCKAVIVAAGNGMF
EPNRPPLSGILEYENKSVFYSVNKISDFQDKTIVIAGGGDSAADWTVELSKVAKKIYVIH
RRKEFRCTPETRNKLESLESDGKIELVVPYQLHELAGGNGQLSTVIVKNIASKEEKEISA
DFLLPFFGLSMNLGPINNWGIQLEHSRIVVDPATLKTSRDRIYAIGDIAIYSGKLKLILS
GFAESAMACYDIYKVIHNSPVNFQYSTSKGIHGKEKLP
>ELAGILAN_00928 50S ribosomal protein L21
MFAVIETGGKQYLVKEGSIIKVEKLEAEEKKEVEINKVICISNNGLSYSSNATVKAEVLE
QCRGEKIIIFKKKRRKNYRRKTGHRQYITVLRINEISLQK
>ELAGILAN_00929 50S ribosomal protein L27
MATKKSGGSSCNGRDSAGRRLGIKKNGKVIPGNIIVRQRGTKFHPGKNVGIGKDHTIFAK
IEGWVSFRRSANKKTFIDIVPTDNMKASA
>ELAGILAN_00931 S-adenosylmethionine synthase
MSLYKNLVTSESVAAGHPDKVADQISDAILDEYLFTDPFARAAIETLVTKDNVIIAGEVF
GPNIKNSRIESIVRNTIKDIGYEHDGFHWRKVKVNILLHEQSNDIAIGLDQGAGDQGIMY
GYATTETKNLMPAPIFYAHSILKNIMSAVKEAKLGPDAKSQITLAYENNLPVRAESIIVS
IQHPEDLDQSKVKEIIFPYIVSSLPEGWMCPEENLLVNPTGRFVIGGPVSDCGLTGRKIM
VDTYGGYIPHGGGAFSGKDATKVDRSAAYMARYLAKNIVFAGLAERCLVQLSYAIGVSKP
TSFYIDTFGANTVEEGVIKKFIENNIDLSTKGIIKHLSLNHPIYKRTACYGHFGKQSERD
GGFSWENMDLSADLCREFNIEGNSKISLDC
>ELAGILAN_00932 Aminopyrimidine aminohydrolase
MYNEIEGELYNVIVKEFSDLIDKIKEHPFNVELINNTLDYEKFKFYLQQDFLYCIDCARA
FLIVPARVDDIEMMSSLINLAQGAFYVREQYKKYFEDCDLSDDHKKSRACSAFTDFFMSA
AYHNSVNEALVASYSCFNIYQIVIRHMVNEITTKGVKNNKYKEWINIYSSETVNAVIDEI
TDITNKLYKKASDCEKKRMYEFFKKGLELEIMFWDEAYYSNISSKEY
>ELAGILAN_00933 hypothetical protein
MFSGIIRSCYGSNLLKDIIEHPFNVELVNNTLNIENFKFYTQQEALLLGDYIRATLIAAS
RMEDYSSIILLAEVAQRAVTASKVLHDYCFAIYGINRGKKSLECFNFTNFLLSISYSNTY
EAMTVLYSCMFIYETVVDSMKNRFKKNNRYRDWFNFCYSDSVKSGCIILENIVDGYCSRA
RENEKSRMLELFRITAQFVLDFLNGAYNFSRFNQFPKEH
>ELAGILAN_00934 Cytochrome c oxidase subunit 3
MKSKEHDFHLVDPSPWPIAVSAAILILALGLVGALHKQIVGMFCLVLGISAVSGVLFYWW
RDVIREAIYDKCHTAIVKHGLKFAMYLFILSEVVFFIVFFCSFFKAWLDPVFLFEAFSPA
KKVEWPPEGILPPDPWSLPFMNTLILLLSGTTITWANHSLLKNDKKSMIKMLSITILLGV
FFIIVQAIEYHEASFSLQETGEKLIYTSNFYMITGFHCAHVIIGIIFLSVCLFRARKGQF
TLQDHLCFEFASWYWHFVDVVWIFLFLFVYWLSVY
>ELAGILAN_00935 Crossover junction endodeoxyribonuclease RuvC
MVKIIGLDPGISKTGWAIISLNEKNNIEFLGGGTISTDGKLGTGERLHIIFEQLKKVISL
YSPNEAAVEKIFVNKNPKSSLTLGYARGVVILALKITKLTMNEYDANYVKKSITGNGHAD
KDQIIFMVKQIVKNLNIKCHHAADALAVAICHAYTKGSCFVE
>ELAGILAN_00936 Putative pre-16S rRNA nuclease
MLHRNPDEFLKSIPKDKRIMCLDMGEKQIGIAFSDKTQLIATAHSIYHRKNMSKDLGYLH
RIFKENEAGSMVIGIPLNIDEQETKWCKTIIQFANKIIKKYKVNTYLQDESLSTSIATHT
LKITGISITKSKKIDDKISACIILQRTLDKINTIK
>ELAGILAN_00937 hypothetical protein
MTYEKIKEIVTNNPNITAEEFGEKLKENRINIKKTNKYHYTLLGHIVNSKGPNITDNTND
RAIFLHIIKLLTELKTEGNTGQFKHVKAGLSEAITTKQADVVRILLDSGKFNEEEKFNAL
LCAVTQKYVQGVKLLLGHVNDENMQKALKVAMDKEQTTQVEEITQILLNFITPETSNVEE
NIVPAPPIVTEANANQPVSSSVNDQPGHSNENETPVIPEETNTKQTATPNNDNKANGFVD
AQFSMPNEQETKYKESKKDFYTSLTKDVVGVVITGLFITAAVMVPFVAGAVVCSVIAALV
AIYTGLHVKNSTLPSYREMRENEVERVTGCHPSAQTLGSRRP
>ELAGILAN_00938 Fructose-1,6-bisphosphatase class 2
MMEDLAYKLVKVTEAAALAAYKLAGFGDEKKADQVAVDAMRTVLNSMEINGTIVIGEGER
DEAPMLYIGEKVGTGNGPEIDIAVDPLEGTTICAHYKSGAMSVLAATKKGNFLHAPDVYM
EKIAVGKNLPEGVVSLKNSIEKNLDNLAKAKKCKVNDLVVTVLKRERHGELIEKIRKLGA
KIKLIDDGDVAAIVSLVNGNHDMYIGIGGAPEGVLAAAALSSIGGQMEGRLVLDTDQLRE
RAKNLNIDDPEKVYAVKDMARGESVFIATGVTSGELVDGVDNICSTSSLIILPNKLIKLQ
VIN
>ELAGILAN_00939 hypothetical protein
MVGLLFQLYNKVQSIIDPHDKKVQPIVDPRDKNATEGISQEKLIVQEVSKDECMFDNNPE
VQYILSDFDNLDFSNGPFNYSLYDINYNEGKEANPFDKIAKYYGRKKNVFLFISMLQNSE
QLEKIINIIGEKCNAQDRKKFTERLNIYLGRIREGDQDAKELLNGDFPGAFFNGPHIGKN
RNIHQNLNIKIKPGQTLEVSSLFNKKSELEREKIYNEKGQRIATIEKNEKQQRNYSFTKF
AICDTEISWGAKDESEKGLNCAVVLNINLGQVSIKKSTIDGKDVEPKKILELTKQNEAVL
IKGKALHEVLAAHFIKQTPCEEKENIQPHENIIVPDSGAPSSAIDEKITVEHPFGKAANK
MDREE
>ELAGILAN_00940 hypothetical protein
MNTGTNQSKKINEKWLAGGIGALLFVMMLPSILLLAKIAIGLIMVSVAAIAIKVALKTIS
NALEDKQADQSQATQQTTQSKIINLAIGLTSIFVGGLSLFIIAQTGLIAACAAITALALH
EYVKNQEIGKEINDKFDEVANSITNFIVSSVEKLISIKSPGITA
>ELAGILAN_00941 Carbamoyl-phosphate synthase small chain
MQDAVLILQDGKCFWGKSIGKKGKCIGEVCFTTGMTGYQHTITDPSFADQIITFTFPHIG
NVGINHKDNEGKKIFASGVVMRELSSMSHPSSYISLNDWLEKNNVIGISGVDTRALTRHL
REHGSQNGMICSSSKAHALDKLKEYKSVNGIEITNKVSLHSNFKSDLNAKYRVVIVDFGV
KISIVSRLIELGCTVELIRPSTGFAQKVLSMNPDGIVLSNGPGDPQEIGESVVSEIDIII
KSKIPIFGICMGHQLLAITLGAKTIKMDIGHRGSNHPVYDVSSGKVGITSQNHGFVVDSA
SLPSNVEITHISLFDNSVEGIMMKDYSVFSVQYHPEEAPGTHDSHYLFRRFIDNIVLYKM
KSA
>ELAGILAN_00944 hypothetical protein
MAIFKCLILLFIISCTHLPTKQYPINIDNYKHDYPLQQYNTSLEINEPAIPEIMPLPIEF
PDLTISNQLISINVSEEVSVKDLLIEIGKLSDVNLDMDPKISGNIILKLKDKDINEVIQS
IANSAKLRYSTSNGVIRIEQDLPYAQNYYVDFINIQHSAQSSFVINNNITNSDGSNVDRD
YNNVMKSQYSSDLWNSLEKGLNAIMDVNGGDDGEFLSSNREAGVIILNARKDIHKAVEEY
INKVKKLASSQVMIEAKIVEVVLDDKYLSGMNLNDLRDGTKSIINQDNSIINLAMNFGAN
DLGDLVKNLDKFGTSTVISSPRVHAINNQQAMISFTKNHIYFTSDIQKDTRNSNQTLITK
MNSVPIGIVLIIHPSINIDTSEIFMDIHPTLSRINGYVKDPDIEYVAQQSKMKLNSDIPI
VEIREMNSMLKIKSGEIMVIGGLIEHREDKQSLLHQKSKRLANNIRTVETVIFLKATIVP
TFGLLDRKDKNLYIY
>ELAGILAN_00945 hypothetical protein
MIIVNSFMITRISITLFLIFISCVYFFITYISNDTHIEQVQPLKLETDNNESVIRSEEVT
EKEILINDLKYQELESSPIKQPSILQVANQKNMWSRIADQAEPTKEKSKKLDFYVSANGG
KVYHDNSETFVKGIQEIGKRVLTLVESHYGFIIKNIVANEIKSIQQFDGKIDFQWLNSIS
LGYYAGENGRVDFETMYSRANIENSNSPLVFDKSASIFAFLLNFYYNPSVQDIQFAPYIG
LGIGPTVFRLKRISGSPQNSMPLNVPWFAYQIKLGVDYSIIPEVKTFLGYRYFSVPIPVA
DDISTHNIEIGLIFNF
>ELAGILAN_00946 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MNEVITFGCRLNFYESELIKEALKKAKRENVVVVHSCAVTNEAERQVKQKIRKIYKNDPN
KEIIVVGCAVQLDPEVYSSIPGVSKVLGNQDKLKAENYLLNDDKILVSDNQVEPVLINGF
EDKSRAFIEIQNGCNHSCTFCSITEARGNNRSVPINSIIEQIRIFVENGYQEVVFTGVDI
TDFGTDLLGKPSLGSMIRRVLKDIPELKRLRLSSIDVAEVDDELMDLIANESRLMPHLHL
SLQSGNNLILKRMKRRHNREQVIEFCHKMKSLRPNIAFGADIIAGFPTETDEMFQDTVDL
LKKTNIVYLHAFPYSERKNTPAARMPQVPENVRKERVKNLREVNKEIMSSFCQSLINTKQ
SVLVEQNNVGRAENFALIKLESKAQAKSIVKVNVKGVENNYLIGNIFS
>ELAGILAN_00947 Glutamyl-tRNA(Gln) amidotransferase subunit A
MNELRKLSITQMHDGLKKKSFSAVELVEAHISAVENEKLNAFITKTPEIAMKAAKAADEH
FSRQKDDLISPLMGVPVGIKDLFCTKGIKTTACSKMLENFVPTYESTVSDLLLKSGAAML
GKLNMDEFAMGSANTNSYFGPVENVWIRKSDGEKVVPGGSSGGSAASVAGFLCAGALGSD
TGGSVRQPAAYCGVVGIKPTYGRCSRFGMIAFASSLDQAGVITRSVSDSALMLEAICGYD
TKDSISSEKPVPKLSSFINGDVKGKCIGIPKEYRMDGISEEIVHNWERVASYLKENGAEV
VDITLPHTKYAIPVYYLICSAETSSNLARYDGVRYGLRVDADTLEEMYSLTRAEGFGKEV
KRRILIGAYALSSGHYNEYYEKAQCIRALIRNDFIKAFEKIDYILVPSAPTEAFGLNEKP
DPLIMCINDVFTVPASLAGLPAISVPVGLSNEGLPLALQVIGNYYDEAGILNVASVIEQN
CGRIIRPLA
>ELAGILAN_00948 hypothetical protein
MFLTLFLKILPIYITIFIGYLAGKYLKIDRNTISQILFYIANPIVILYGVSHTEVNLKVI
SLPILIWFIGSTMSLSVYYLSSFLFKDNTRNILAFSSGSTSMGYFGLPIAMALFDEDSVS
VYVVCYIGMALFENSLGFYIAANGIYTAKECILKLFKLPSLYAMVLGFFLSIYDIQIPTF
LTDVMMNIRSTFVTLGMVLLGVSIANIASFKIDWKLALITITAKYVFWPLFVLGIVLLDK
HVIGIYDESIYKALMLLAIIPVSGSSIILANILNYQPDKATLLLLISTAVGLFYVPLIIS
LFFTKLVPF
>ELAGILAN_00949 hypothetical protein
MNKNITFKALKEEHFLLLLKWLETPHVKEWWINWTLGLIKEKYDNYVKALTLCPNFTYFL
LLFQQSV
>ELAGILAN_00950 Multidrug resistance protein MdtM
MLLPFLLILSLIAKFIEIDISVPSFPDMVHYFNVSEGTIQLTIAYNFLGFCIGGLFFGPL
SECYGRRRIMIIGNTLLLIGAVGCVFAPSIFWLLISRFVQGIGVSTSVVVFAIVADSYKG
DEAVKFIGIMNSVLTVVMAIAPVLGSFINEIVGWRGNYATVAILCLISWVLLLLALPETK
KDRDIFSLKKMMKDYRKLLSSPRFVTLSLMSSLFSAAYMSFITCGPFLYMKTFGLSSTIY
ALHQGAIVGCFSLISLFAGKILQKLGAIKCVISGTSVGAIGSLLLVIFSIIVPHSFYLVT
LSMIIFSIGCAIFQPVIFNASINVFPEIKGTASSAVSFIRAFIMAIFIGLTSYIYNGQTI
SVAVLVLSAIVLELVFTVYLLRLKDPM
>ELAGILAN_00951 Peptide chain release factor 1
MDMENNLQDLKKKFNDIERNLENPTNLSQKEFITLSKEYSELRPIIKIIDEYNTLKEEIS
DLEEIMKDENSEGDIKELAKEEFFEKHKVLLPKIKAKLKLALLPKDEDDSRNAILEIRAG
TGGEEAALFAAMLFRMYQKYAERRNWKFEPISISNTGIGGYKEASALINGTEVFARLKFE
SGVHRVQRVPETESSGRLHTSAATVAILPEVEEVDFKIEEKDLRIDVYRSSGPGGQSVNT
TDSAVRVTHLPTGIVVIQQDEKSQHKNKAKALKVLRARLYEIERQKKEMERSTMRKSQIG
SGDRSERIRTYNFPQSRITDHRINLTSHRLEQIIKEGELDEFIEALISRNEAERLAGES
>ELAGILAN_00952 putative GTP-binding protein EngB
MAKQITSNCNFIFGASDIKSLPNESAPEIAFAGRSNVGKSSLINLLINSKKAARVSSKPG
CTRQINFYSMYNDKFRLVDLPGYGYSHAGKEEIIQYLNLIEYYLIQRRNLRRVFVLIDSK
VGLKEIDKDFIYWLICNNINFNVVLTKIDKVSQKSLGAVIEDIQRWINNENVSIHQMSIR
VKHKITKVRDEFFKFTR
>ELAGILAN_00953 Acetylglutamate kinase
MSFSSLQDKKMKSSEFLKGEVSFEQKAEILFEVLSNIPSFVGETFVIKCGGTIILDETLF
NTFVHNVVLLKQLGINPVIIHDGEYEINSVLKVLGMDSKFVNGIRLTDRDTMKIIEMALC
GSVNKKIVQHINSAGGSAIGLCGKDGNLIKVEKITATLREDRSNNIEKILDMGFIGRPTE
INPDILFFIEESDFIPVIAPIGHGKDGETYHIDADSTASAIAIAVSASKMIILSDTDEEI
DKIGGRKISVKNLNASIDCGKIKGEKFIERLMAYVKMAEECAGVVHIVDGRIPNIMLDLF
TESNSSISIVSDL
>ELAGILAN_00954 hypothetical protein
MGLIIAADVHSASVQDRDGALNLFTQAKYKAPTLRKFFADQGYIAKPLFIGDRIRLPRKL
LMLQDFSTIWTTI
>ELAGILAN_00955 hypothetical protein
MLVKEVRKMFGKNETPSVGIIDSQSVKTTQKGDPEDMMLKKK
>ELAGILAN_00956 hypothetical protein
MYPSDISDKEWEILEPHVAQGKIGRPRKHNIRTIINAIRYIMRGGCQWRMLPKDFPPWKT
VYDYFLR
>ELAGILAN_00957 Aspartate kinase Ask_LysC
MACKLLSLQKLYFSSEESYIVTMDKIIIKKFGGTSLTDLNRVANLIKNDIEKGCNVIVVV
SAVAGFTDQMAFQARQISNLSCRQELSEYDVMLSAGEQISCGLLAITLQSIGVNAKSWLA
WQLPIVTDDFYSESKIKTIKIDRVKRSFAEGYTAAIIAGFQGINDDRITTFGRGGSDISA
VAFTVAFGVRTCEIFTDIDGIYTADPRIVPKARKLKFISYDEMLEMSSSGAKILHNRSVQ
LAMKHNIKVQVLSTFKEVEGTTVLHKRDVLERYLITGITYSTNEALVTFTNLANNLRTLR
DIVGANVKIDMVHGSSFVISKFDIDLMEKLLNKNENYAINDNVAKISIIGIGVMSNTEVM
HRTLKVLSEKKIEILAITTSEIKISIIVQKEYVVALVKDLHTEYELDMQH
>ELAGILAN_00958 hypothetical protein
MNPRLKAFLVVCSIIAFLIALLFLVYYLNLLVNYILDPILVRPFERLYKNLIVDGLYAYL
STSTSSPALAFLATGFIVIAAFICLNKMLLPLQEKIINNYTSFKNNNIDSNSMLFEVYKD
PTIKLKDKILFFSIHLIYYLQLPFLYIASKVSALREFLIFNFGLLLLNYALLIPVALLEL
IKYPSVKLFSPLGLNVKQLSFLFNVSDVGTGSQSVHTRSFEESTIKCAKELKEKYGAPSN
ELDEEFKSYISGLTSQQKRMIEPYLRLDGYETGEWVNWVDSKTGLTLTQAINLVLIAARK
QNSDVELLKSILLVRFDESNRQCGPGMLLRIIYALNGLEAENNFAAQLEPWQIGELARYT
TKRFFERYVDKHYYKIKVLKENFDDLYSPSSEVDLSNVSDEVKDGISYTRDAIKEFVFKE
LYVKFYNDYGEHIQRGQIKQRLRELITDEVVDAAIYSKIDEIEIPAEPPTYLERVKAFFG
GHARSSAA
>ELAGILAN_00959 Arginine/agmatine antiporter
MSNKIDFWAIFALVISSQIGSGIFMLPISLAPYGMYSLISWIISGLGAISLALVFASLCA
KFPETGGPHVYVKHAFGPAAAFFVGWTYWVISWVSTTAVIVVGVGYLTPFFHEDIQNVHL
FLEMLLLTIITLINFRGVATAGRVEFLLTVIKISVLLVIPIAALFFFDRNNFIISEEISN
LTTSQILARSTLITLWGFIGVELATAPAGSVDNPARTIPRAVVLGTISVAVVYFINNLAI
MGLINGNDLASSRAPYVDAIKIMASGNWHLIISITAFIFCVGTLNAWVLASGQVALGLAK
DKLMPQFFAQRNKHGSPFWGITTSSVGTATLLILTSSNNFAKQITSIIDFSVVSFLFVYL
ACSLAFLKVIVQEKSCYKFLIGSIATTFCCWVIFETSVNTLLIASLFTASGVPLYLFWYR
RVSV
>ELAGILAN_00960 hypothetical protein
MSDDELDWQKNVKPIKCGKVTLKVDHKVNIKSMVDKGTSDLQGNFLNTNNGNSSFCLDQN
TKSKVDRGKYFISDKLDLHGYNIEDAYCKLIDFIIKNYRAGNRCLLVITGYGSATNKTDT
IKNNLNKWLNDTKIQHMVLYYQQATKKHGGKGAFYVLLRRLRSY
>ELAGILAN_00961 Putative TrmH family tRNA/rRNA methyltransferase
MKSSKTNENFWLYGKHTCMSALKNKNRRCIELLATENFYREHKKEIRQCVDSKGIKVRLV
ESKILNDVLPKGANHQGIALNVAPILYNLSIEEIAESSNDSSTIVILDQVTDTHNIGSIL
RTSACFNVDALVLPHNHSPSENASIAKAASGALDIVPLIYVTNIVKTMQYLKKVGYWCYG
FDCNTKENIDEIKSFEKKRVIIFGSEEKGVRRLVKENCDYLLKIPMSNAINSLNVSNAAA
IGLYSIYIKTNASA
>ELAGILAN_00962 Inner membrane protein YbhL
MSYMRNEQDIRSQGVYYSAGLRSYLTKVYNYMALALGVTGLVAFLTVFSGLFQVIYSNPV
LSLVVMLSPVALVFYMSYRIQHLSAQSAVTIFFSFSVLMGLSLSYIFIVYTAENIARAFF
ITSIMFGSMALYGNTTKRDLTSMGSFLIMGVLGIIIASIVNLFLGSSPLYFAISFISVIV
FTLMTAYDAQRIKDVYYKHNDGSEVATTKVAILGATNLYFDFINIFLNLLRLLNLFNNRD
>ELAGILAN_00963 Cytochrome c oxidase assembly protein CtaG
MFSFLRKGSKNSIVFFLISLVVLMLCLAYASVPLYSIFCKATGYGGTIRKVTNTTTNITN
QKIRVHFNADIMSDLPWEFKSETNYFDVNIGEQSLAFYYAKNLSDQPSFGMAVYNVTPFK
AGKYFNKVACFCFEEQMLLAKQKAAMPVSFYIDPEIMLDNNTKDLSEITLSYTFFKLK
>ELAGILAN_00964 hypothetical protein
MNRETWLYSVLYNVLYKVDEDNDLDTSNIIKKIKERLESGMRTSSKENYYEYLYASWEKK
GFDINHKFDLKDYDGFPVDSLFSIAINHKPHALPNLAQVLIKAGANVQNEKGYLHACALT
RSPDVLKALIEAGVSDSPHEHYGGNTALDCVTELYDAEKSIECKDCCKILIKHTLEKKPH
EKMPDSVKNNKELAQYWNACEAKNEGWELITPSTETQVVGAQKANKNSCSIQQICCIIII
>ELAGILAN_00965 2-haloacrylate reductase
MVRAIQIKKTGGPEVLEFVDKSVGEPKGEEVLVRHTTIGLNRYDLEHRKGTRKIKNLPSV
LGVEAVGVIEKLGKKISDGLKVGDRVGYCTAPPGAYCEKRIIHQKYLIKIPDDISDEVAA
AVLFKGMTAHYLVNQSYKVRPGAFVLVHGANGGLGQIICQWAKDKKGVVIGSVSSDEKMK
IALQSGCTYAINYNDKDFVSKIMEITQNRGVGAVYDPIGYATSKLSFESLGRFGIYVSYG
QISGNAPISFSLLSSRSLFATGTLIYHYKHDRFTLVLTTMEIFEMIRKKLLTVRINKKYK
FDEIIQAHRDMENRKTSGLNIIKISQIN
>ELAGILAN_00966 hypothetical protein
MSTIILSSIFGQAGSIFGPIGRIIGSELGALLGAQLDGAMFSLDAEQKVTHGARLKNLQV
QTSTYGRTIPIIYGTARVAGNIIWSQPIKEEAITTKSKIGRGMNVTYNYYATLAIAICKG
KVEKLNRIWADTTSLSFDEIDYTFYSGREDQNPDPFISSIEGEGNVPAYRGISYIVIKNF
PLADYNNRVPVFTFEVQTALKPVGFSIAENIRNINIIPGSGEFVYDTKIQKKIEQEKISS
NQYIPYGLAQRVNHNNHTKKSDAVLSLDQLKGDLPNVEWVSVVVNWFVNDLNIKDCKIYP
AVEFQDDSAILPDDWQVGGVTRDNAQLISKDASGNPRYGGTVSDSALIRYIEELHSRGYK
VMLYPMPLLDTKNKEWRGKLSGTPGDISDFFENQYNKFIEHYASIAKQTKVEGFIIGSEF
AQLTKIRDEQGNSPAVIELVKLAKQIKLNLGKEVTVTYAADWSEYHSYDGWYNMDELWSS
EYIDVVGIDAYFPLTDGPEPPFGYSAEDVMGGWSSGVGYDYFYDYSKSEPEKVKYNDSRY
AWKNIEKWWSETHINPGGSKTKWQPKMKKIWFTEYGFPSMNGCTNEPNVFVDKGSIESKY
PRYSNGEVSFLSQKIAIEGTLKKWQSSEMVEKMFLWAWDARPFPYFPNLCDMWTDCHNWQ
TGHWIQGKLSQLNISDVLSDLLQKAGLKSDQFDTSNVKGLLSGYVINDQQPVRSIIKMLQ
SCYFFDVVEQDSKLKFVQKGRGVTTVMPIGETVFSNNSKLANISQLDLNNKVNVVYFNRN
FGYPIDVKYAELPKQGAAITVEIPLIMEEGEAQNIAEVLLYSSWQERNIYNFKLPIKYAW
LVPSDVITILDSEKKHTVRIIKTKFESMSIQVIGVGYDHSIYKLSFPSTRSLMLKEYPPS
HISKTIVEMIDLPDIKGNSASFTLISEEKNWKGATLFISYNDKDYKPIASTNKQSTYGYV
MESTDEGLIVVLRFGNITSIADSNLALVGKEIVKFQNAELIDKNKYKLSNLIRGQEGTKE
TAGEKFVLLDDSIISFEVQRGKKFYLKAVTYGDSLDNTEAKVLNN
>ELAGILAN_00967 Multidrug resistance protein MdtL
MILSVAIVDMATDLYSVALPSIANYFKVEGSVVQLTISLNLVGFAVSGLIYGPLSDHYGR
RPMMLIGMTIFTLASVMCYIADSIALLILIRFIQGTGAGVAGVVGYAAIRDMYSGSEYSR
VISKLNMVVALSPGIAPVVGSYIISHGYSWKFLFFIISLAAIAILIFIYFKLQETLTVNK
NETSITNITTNIFKQYISIFRNYRFLGFSAIHGLTFMWLWAYIANYPFIFESMGIEVQYF
GYLISIIVIFYIIGTLINRRYVPKVGVSKMLIIGLVLPIISDSLLVYFYFADKLNIFILQ
TAWIPANIGLALIISNNVTSALETIKGIGLGSAVLSFCNMMFGAIGIYIVGKFFRYGILP
NLLLTIACSTIAILMYSQLKCTEKHRE
>ELAGILAN_00968 hypothetical protein
MSNSNRDINAELLEAVKNGEIDKVKSLISEGADVKVENDKGETPLHIAAVWGHKDVVEAL
LDKGVNVSAEDEEGNTPLVLTTDEEIKTLLQSTAKLLEVAKSGNIQEVNSLISEGAKVNV
KDQDNKTPCILKKASSVFKLKH
>ELAGILAN_00969 Coenzyme F420:L-glutamate ligase
MHVKAIYTHRIECGEVLEQVLDRYVSELLGEEVVLAITSKIISVCQKQVVCKTACSKEEL
IKREADAIVGVDHNSYGIYLTIKDNILIPSAGIDESNGNEMYILYPKDVQKTALSIWNYL
KTKHCIKHLGILITDSNVTPMRRGVTGVALGWCGFEPLYSYIGKLDLYNQPLQVTQVNLL
DALATSAVLVMGEGAEQTPMAIISGAPKIHFLTRPPTVEEEKSVKISMEEDLYSPLLMRA
RWLKRNLKICY
>ELAGILAN_00970 Dihydrofolate reductase
MLVIGIMAVDPKGVIGINNGLPWHYPSELDHFRQVTDKQVIVMGRKTFETMPQDILGNRI
PIVFSRDKLNSCFNRGVKCTIISSMQEFLSIQSNWSYPQIFVIGGAQIAHLFLEYNLISE
FIMTEIYKPYKGDVYFNLTLLDGWHKTILTKTKDYTICRLTR
>ELAGILAN_00971 hypothetical protein
MIYISIGSNMGNRFSHLQKAAQLLQERYFKNLKSSIILETKAILPNDAPPGWDRPFLNMV
VYGSCSSSPEELLKGLKQIECDIGRLQVYEKWAPRVIDLDILLWDDLTLDTPYLKIPHPE
LINRPFLLHLMAMLSPMAVVNKTFGTINPNIKDCFLRSFTLSPELVGIVNITPDSFSDGG
LYYDADQATKQALRLLSDGASIVELGAQSTRPGSSIQTPKAEYARLKPVLDNLNQYMKVG
DIKVSIDSFWPDVILNVLEHYNIAWVNDQKGDLDDNTLKAIASSGCSIVIMHSLSIPPHS
DNIIPSDIDPIDTINNWAERNINRLLALGFDQSSIIIDPGIGFGKSMYQNIQILRSIETL
QNFGCKVLVGHSRKSFISSFSTEPVFNRDLETIALSSALHNKVDFLRVHNVRDHMRFFVA
QAALQGC
>ELAGILAN_00972 Dihydroneopterin aldolase
MSACNLLISDLRLWVHLGYSAEEKYHSQLVSVNIDFTFKSPPLGLTTDRLEDTICYLEVV
QSIQSLVQSKQFNLIEHLTHDIYRTINNLVMQKKLIISSIGVTIHKVAPPVPSVHGGVFF
TYRNALQE
>ELAGILAN_00973 PqqC-like protein
MEFTKSLNNKLDGLHLLNHPFYQSWNTGSLSLQALQTYAKEYYHHVAAFPRYISGIHFLC
PDLKMRQVLLGNLIEEEQGDENHPELWKRFAEGLGVTRSDLHKDAQIKETQELVDGYFDI
VRSGFASGLGALYAYERQTPEVSKSKIEGLKKHYSISDERSLQFFTVHMHADEWHSEECA
NLIEDLDEKEQDKVMQGAQKGARLLWGFLDGMMNASVC
>ELAGILAN_00975 Thioredoxin C-1
MSDDITSVNDQNFKSEVTDYKGFVLVDFWAEWCGPCKSLMPRIEQLAKDRKGKIKICKFD
IDEGTEVPSKYGVQSIPTLIIFQDGKEIARKIGATNDLSSWVDSEIS
>ELAGILAN_00976 Ribonuclease D
MGIFLYKDDLPASSIPDDVRSIAVDTEAMGLLHGRDRLCLVQLSFNDGNAHLVQLKNDYT
APNLRKILEDKNITKIFHFARFDVSIIRYYLETWALPCYCTKIASRLVRTYTDNHSLKEL
CLELLDTKLNKQQQSSDWGNENLTDKQKSYAASDVLYLHRIKEKLDLMLERENRKELAQK
CFEFLPTRIELDLMGWENVDIFNHQM
>ELAGILAN_00978 hypothetical protein
MAFLPSLSICLPCNGNWYNDVFVNGRSVCRKGDILTMGETLTQGSNSVFVNDIGITRTGD
LASCGFHVMSISKNVFAS
>ELAGILAN_00979 hypothetical protein
MRGMSNKTGKELEGIEHLKQSIIDILTTPIGSRIMRREYGSRLFELIDRPINRDFSLEIY
AATAEALGKWEKRFKLEKVKITEVKEGRVTLDLEGVYLSEGKFININGVVV
>ELAGILAN_00980 hypothetical protein
MQQPEIIEKLSYEEIFSRMKEELVLRDPSFTALIESDPATKIMEIAAWRELLLRKRVNEA
AKANLLRFATGIDLDHLAEFYGVERKGEEDDERFRKRIKAKIEGWSTGGSKEHYRFHALS
ADSRVKDALVESKVPGSVEISILSTELSTNGIASEELLDIVGKQVTRDDIRVLTDTITVV
GCNIIEINIHSRISIKRPDIVETVKKRFIEKFETTKRLGWSVTRAWIIANLFIEGVENVE
LIEPRKDVVVMGNECVCLGKLEIELMGKS
>ELAGILAN_00981 hypothetical protein
MFRQARNRINGQKLMLLPPNSTKEERAIVEAIDYKVDPSRIKGFKFNSKDEILPWIIEEY
GLGEILRWVTDKRKAIKEGIKFQRLRGTPESLKIALKWANIEDITIIEEPPGKHFFELQV
GIRDVPNDFFVDAVVELAKLSLPARSRLMRLFNDHYNIGRFILDESFFGSLLSDYSGVKV
EKDGPVLSFGRVNFFRSSGPVIRIIENYLRDHYEQALSNDIYRLDVAILGETEPHTKNYR
GIYERNHVWYNFKALYPLPQSLLPAIKFAKAQIVLSDSWNLGEINACFPVTSIEEEGDKF
LLGSSKLSEQLWNLKYKPVLERFSVTHHYKVEDFTNQKVIRFGVAEHNVHFESDLNSEQK
DSIHEPENYILVFYPGVLTWHEHRHLNRSWKETQVICLMR
>ELAGILAN_00982 hypothetical protein
MLFTLNKKLEKLKENSFRGINEKDAAGCTILHRAAQVSDPEVIKLLIEKGAKTNIENKSG
ETPLHLAAFYGKVENVKVLLEEGVDVNARNGKRNTALHYASLMGYEETVRELIKGGSNVN
TGNYIGRTPLHEAVFMREIGNVRAILEAGGDVNARDQKGYTSLHIACKTGEGRITKEIIK
ELVKAGANVEQKDKFGKTAMYYARTEELLEKLRELSERTVDAILSLNLKEKGERRFEEIR
EKLEEAPLVKKALMEVEKELEDMDEKIKEL
>ELAGILAN_00983 hypothetical protein
MDLWKKRSARTIKIFTGETMRKKVLTVTCRYEPDELAEQHLADAYELLLRYAVKRNNEKE
MKENDNSSIICESFIEETSAEQYNREPNCRAQV
>ELAGILAN_00984 30S ribosomal protein S16
MAVKIRLARFGAKKRPFYRIVVADSRAPRDGRFIEKIGQYDPMLPKDNKNRVVVKADRLK
HWLSVGAQATERVLWFIKKGIVTLETEPKKTEKKKVENEKAQGQEA
>ELAGILAN_00985 Octaprenyl diphosphate synthase
MLITNSDKLDDIVSSDLSAMNDFVFKNVNDEDAKLATDIISHLVRSGGKKIRPKLVFIIC
KMLNYSGENRINVAASVEFIHNATLLHDDVLDESEARHGVKTANKIWGNKSSILVGDLLL
TLAFRWLIECGNLNILSILSKASHLLVKGEIKQMTARFDPHTVRENYFDIIGEKTASLFS
ACCEAASTVSGATNDETERLKNFGFNFGMAFQIVDDMLDYTANQGTSGKQVGKDFFEGKV
TLPAIIAYEKGSPAEQKFWEKCFSSARHNFDQALHYINHHNAIQLSMEKARHYINMAQND
ISTFSDSFYKTTLINFLNASIERRM
>ELAGILAN_00986 Protein GrpE
MSDSSKEKKKKFADMVSRQKGDDQQSDNHKQTDDLNEDLNTLKERAVQLEDHLRRAVADN
ENVKRIMQKQISDASDYAVTKLARDMIDSCDNLKRVMEILKDGDPVHEGIKVAYQKIIND
LKKHGIEEVDPLGELFDSNLHQAVVEREDNEKKPGTIVEVLQTGYTIKNRLLRPAMVILS
KKSADCGSD
>ELAGILAN_00987 Tryptophan--tRNA ligase
MTSIVFSGIQPSGVLHLGNYLGAIKQWIDLQDKYKSLFCIVDLHAITANKLPASELKSNI
FKTAAAYIACGIDTEKSIIFSQSTVSGHAELGWLLGCYTPIGWLNRMTQFKDKAGSDKQK
ASLGLYSYPVLMAADILLYQTKYVPVGDDQKQHLELARDIASAFNNHYKLDYFIVPEILT
LDCTSRIMSLRDGTSKMSKSDPSEHSCINLDDTDDLIVKKIEKAKTDSILGFATLKCRPE
ISNLINIYSVLSNVNAEKVCEEVNKHDMKHFKKELADLIISVISPIREKMNDLLKDQFHL
HEILKKGTKKAAEIATHNIKEIKDIIGFAQYL
>ELAGILAN_00988 Putative aminoacrylate hydrolase RutD
MDYCKLFDGNNGHIAYRKLQGKKASVVFFGGFASNMDGTKATAIYKFCQENDVALVLFDY
FGHGHSSGNFIDYTISDWQKNCAKVMSELTSDKQIIIGSSMGGWLMLLTALQFPEKIAAL
IGISSAPDFTEDLIFKQLSGKQKEELDSKGVIDFTSEHCTYKITKNLIEDGRKNLLLNKK
TIDINCPVRLLHSINDKDVPYQTSLNLAEKIKSTDVEVHLIKSAEHNMSDNHSLEVLFKT
IREFCNQTAFCDF
>ELAGILAN_00989 hypothetical protein
MELNKIAASILLSGLIIMIVSNVVDMLYSPEEYKIEHQTIVAAGSNEFQQKIEQVALDIG
ALMQNASFEKGKSAAKKCIACHSFEKGGMNKVGPNLWNIVGNKKAHLGNSFNYSKAVLER
GGKWGYEELFAFLKNPKAYIKGTRMAFAGIFNPQEIADLVSYLHQLSDSPVALPK
>ELAGILAN_00990 hypothetical protein
MKDCEEVLKNKIKKIVISGKEVWPIIEGGKGIAVSDGRSSGAFAAADAVGTFSGANAKLI
DDNGELVPLIYKGKTRNEKHSELIEYSIEAGISQARIANEISKGHGRIHMNVLWEMGAAE
RVLHGILEGAKGLIHGITCGAGMPYRLGEIAAKYQVYYYPIISSVRAFKALWKRAYQRIS
SYLLGGVVYEDPWLAGGHNGLSNSEDPELPQAPFERVAELRSFMNEIGLSETPIVMAGGV
WHLKDWEHWFDNLQIGPIAFQFGTRPLLTKESPISAEWKKKLLTLEEGDVFLNKFSPTGF
YSSAVRNNFIRELQERKLHQVNFSENASEEFNSEFAMGSRGRKIYLTAKDKELANTWTKA
GYTEAMKTPDSTVIFVTPDKFKQIREDQINCMGCLSHCLFSNWKDHGDHSTGRKPDPRSF
CIQKTLQNVIHDGDIENELMFSGHNVYKFKQDPFYENGYVPAVKELVERILTGY
>ELAGILAN_00991 Dephospho-CoA kinase
MIISLTGGIGVGKSFVANCFQEFGAVVFDADSVVHQLYKVDKSIISYAEKNFPGVVVNGE
IDRTVLSKYFLAYDENWKQFQSLVHSAVLRELEFFIAKEKKIDRKLLVLDVPLLLETKFY
LYCDLIVFVHADSVVQAQRLNERNIDKEKLNLISDVQLSIEEKRKMSDFIIDTSVSKEYV
FSQVKDIVDSLNLNT
>ELAGILAN_00992 Ribonuclease D
MTLIAKFNISSKIEPLNKKHMLINTTSELEDICEGLIAKKPKFIAVDTEFIRNNLIYYPK
LSLIQISYGEKSFIVDALVPEIDLSFIKKIMLNQGITKVFHSCRQDIESLLTVFKCIPTP
IFDTQVAAMFCHYYHDFIGYSKVVEQYQGIALDKIKAKNSDWLRRPLSEDQLDYAVNDVV
HLYDLYQILCNKLEENNRMGWFQEEMESIVDINKYLHSPKDAWKRIKFNYEVNPRLILTV
KAVSEWQETLAQRYNMNRNKIINNAVIADFIEKNVEHVDEILDDLKRNTKNIKDADLLEF
VNIFNENERNWMQQNNTLSSNYDKSVLDILSIILDSKCKESNISRKLVSSKDELTGSISG
QTDKLFKGWRYDFFGRSVESFLNTSSKFEISAVKSANNITKIQSNLVENNCC
>ELAGILAN_00993 hypothetical protein
MVDFIDLFQGSKDFTMCMHNGSGDAIYNRCISAVRMDPPCMHGESIQGLFESSFEQGVVT
VRVNLDLETLNVVVYKSPPTSDKLDAFSLAYQIDRYHIDENTIVFDEKVNTIKFDISNPL
KHKFITFEIFKR
>ELAGILAN_00994 UDP-N-acetylenolpyruvoylglucosamine reductase
MLISLPKVRGIYRYDILMSKATWLNVGGRADILFKPRDIEDLTCLIKNTELPVSVIGATS
NIIVRDSGIRGITVKLGKEFAYIKSKGNNSIVAGGAVLLSNLAHFAGNQQISGLEFLVGI
PGTVGGGIEMNAGAYGSDIASVVQSIKAVNLEDGNLYEFSSEEMGYFYRGHSLKGNWIFV
EAEFKGVNSEYELILQRLKEVIERKNKSQPIRGKTAGCIFKNPKNYRAWELIDKSGCLGL
NIGGARISKKHCNFLLNYDNATASDLENLGNKVKDAVKDKFNVELEWEIRVLGSY
>ELAGILAN_00995 Porphobilinogen deaminase
MNDIRQTIVHMLVKIGTRGSKLAVVQALEAKQKLLDSFPNLSIEIVKIKTSGDKYANANL
AEIGGKGLFIKEIEAELLENNIDMAVHSLKDVPAFFSWGLTIPCVLERLSPCDAFISHKH
NSLESLPQQATIATSAIRRKVQLLNFRPDLNIVPLRGNVTTRLQNQSFDGIILAEAGLIR
LEKHHLITEVLPPKVMLSAVGQGAICIQCRRNDVKIIDLLEKINNNMSFIGVKSERSFMK
TVNGSCFTPLAALAEYVSENMLYLRCMLADGKNIYFTERTSFIEDAEKMGMDAGLELKSK
CL
>ELAGILAN_00996 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MSKIIEIRAPKTLGGESVTEGIVKIKKGIGEAVKVDDLIFEIETDKTALELTAEASGQIT
EFLVKEDDVISPDQLLAKLSVGEVKEEAKKEDKSESAAKKDAPSARKIMEENAISAESVK
GTGMGGRITKADVIGHMNKAEQPAIKQYELPKSVVNGEQREERVKMSKIRQVIAARLKAS
QNTAAILTTFNEIDMKNVMDLRTKYKDAFEKKYGIKLGFMSFFIKAAVQALKEIPEINAE
ISGDEIIYKHYYDIGVAVGTDKGLVVPVIRSADQMSFAEIELTLVALGKKAREGKLQVSE
MEGATFTISNGGVYGSLLSTPIINPPQSGILGMHSIQNRPVAVGNAVEIRPMMYIALSYD
HRIVDGKGAVTFLVKIKNYIEDPNRLVLEV
>ELAGILAN_00997 hypothetical protein
MFERALAIKEKHYGFGHFQVAIILGSLGTAYYALGDPQKAKELFEQALAIKEKHYESGHF
QVAKLLTNLGAAYRALGNLQKAKELLERALVIDKEHYGPDHCEVAITLTNLGATYRALGN
PQRAKELLEQALTIQEKHYGPDHCEVAKILINLGITCYALGDPQKAQVSFTRALPIFKKH
YGPDHPEVAKLLVNLSDAYGALGNHKKQKELFARASSIFTKHYGPDHPEVVKLLAELDDV
>ELAGILAN_00998 Ribosomal RNA large subunit methyltransferase E
MQKTSKDGYRSRSAYKLVEMDNKFKLFQEGQKIIDLGASPGGWLQVASQKGANVVALDVK
PMNAINGVEFIQCDIINEFEILREKFKDQKFDVILSDMAPESCGLKSLDHIRIMLLCEAA
LNFAKHFLSHGGTFVVKIFQGESDKDFCNELKKMFKTVKYFKPKSSRSESTEMYLVSLGF
IGSRLSI
>ELAGILAN_00999 hypothetical protein
MHDEQGNQSVKDILEDIKKAISGKNASNDKAEIKDENDDVLYLEEEYPEEIEEDGKKENS
EKEDIDNDDQGEEMACNSNQFNGHSYNSEEKKDIYLYDNIQTSNKKVSNSGLQAQNNDHL
ILKENMEEIKALLGKMQNELQHKQQKKANLTVEELVTSLLKPQLSEWLNKYLHALVKEVV
EKELKDIINNK
>ELAGILAN_01000 Outer membrane efflux protein BepC
MFRLIITLAIIFNTISCYATDVGEVISKAIKNSSKIKSQFYQYKSAEKHYKSSGLAGFLP
DINLQYNFDSNFNLDTSEKKLTLRQKLIDGGGTFATFSRSSHLLKAEKMRFQQLKQELAL
NAVKAYVNVLQKTEILKLREHKERVSLEHLSAMKKRFSLGEGTNAEVLLAKAKFSSSISE
RVDAEGKLKLVNIAYYHLIGEDADDLSEANDKLPSVPELNECLQLAKTNNLSLKAAVYQK
RAAGMEVIAESSKWLPSLNLSASKNFGEDGMKVDKLLENVHVVFTLDVPIFKRGVNAFGV
SKAKMDAKKSTYDYYETVKNIEQAVVNAWNNVLTAKAIIKASQEAEKAAALALEGVEQEV
NLNLKSTSDLLDTEDALFKARSDLVEAKSNYVISVYNLLFMINSIDL
>ELAGILAN_01001 50S ribosomal protein L13
MKTFFLKEKQINKKWFVIDAEGLVVGRLAAFVATLLRGKHKPEYTPHMDCGDNVIIINAE
KVHFTGKKLKDKIYYKHTGYSGGLKKTTPDNILNGKFPERVIEMAVKRMLDDGPMARRRF
ENLYVYSGSEHKHQGQQPEKIDFASLNRKNKK
>ELAGILAN_01002 30S ribosomal protein S9
MKSSTINNNDWSEKTIKSAVDSLGRLYATGRRKESVARVWIKPGSGKFSVNKKGDLISYF
KRESVCQTVKMPFVATSMLDKYDVFATVKGGGLSGQAGALAHGISRALSSVSQDLHSILR
NGEFLTRDSRVVERKKYGQHKARKKCQFSKR
>ELAGILAN_01003 DNA-binding protein HRL53
MSKEDIIKQLKEDCSSQNIDITKSDLSKIHDAFIKIIKNELHGKGEIRLHGIGTFSTAIS
QEKQCRNPQSGEIMTVPKKTRVKFKASQTLLSILNEKEKAAVS
>ELAGILAN_01004 Pyridoxine 5'-phosphate synthase
MKLGVNIDHVATLRNARGTSYPDPLKAAEIAIDAGADFITVHLREDRRHIRDEDVFNLKK
SISTELNLEIAATEEMLEIAKKVKPYSISIVPEKREELTTEGGLDIVNMHSKLSSIIEEM
HSSSIKVSLFIDPNIDQLKYLEKLGTKPDIIEIHTGDYCDNPSEKKLQLITNAAEYVNKL
GVECHAGHGITYEHAKKMTRIPHISALNIGHYLISEAVFYGLHSVVKTMKMTMSN
>ELAGILAN_01005 hypothetical protein
MQNLHHDHVLHCSTQQQYRSIVVLNGKIPSSSFFKRDIPIIAVDGGANKLLSIGVKPDLV
VGDLDSVNLDLRANLNTIYLPDQDYCDFSKAMAHLKTVKLLPSIVTGITGGAIDHILQNI
NIFLSTGSIFYTPSPPMVGYTLQKGITHFFSLPKNTKISLLGIPRAQISTKGLKWELHLS
NLAFPGKNSCFNRSLGNKVSVEVHSGICLAMIYLETVDDAARHHVRQVKK
>ELAGILAN_01006 hypothetical protein
MYINIEECFGFIALIASLIGLSPQVYKAYITKVTRDVSMLMLVNYLICSLSWIGYGLYQS
SIFVVLSNIAGLVISIISIIQKCYYDAKPAP
>ELAGILAN_01007 hypothetical protein
MKKKFKDNMDKNTINDRNLSQIRAFPVLIALGLILSLLFLAYDSTIALGVAAVSILTFLQ
GFFINDPNEARVIEFFGHYIGTYFKSGICVTLPFSSKYIVSLKFQNINTEKIKVNDANGS
PIEISAVIVWRVNSPAKAYYNVNNYHEFVFVQSDSVIRELASNYPYDSESNEESLRKNSD
KISDELRSMLQQRLDIAGIEITEARISHLAYSSEIAQAMLRRQQAHAITSARRHIVQNAI
GIVEEVIAHFEKNKSLQLDGKQKVQLINNLLVALISEQDAQPTISLDNN
>ELAGILAN_01008 hypothetical protein
MRLVIFVLLCILPAYATETSTDLAQPFQHGIRKKKATLTTESDRKLLFISSTIKSSFFAT
EGLAPNTVVKLINIYKDFGVDFKKDIVPESKLEVLFERLPNNQKTEEKILYASLTINKKA
ISLYHYKSQDGKERYFNKEGISLKNGEIFANPLNGDYRISSKFGNRKHPVRGKIAFHKGV
DYAAKLGTPIYAAAEGVIEYIGKNGGYGNYIKIKHKNEYSTCYAHISRFSGDIKLGSKVK
QGQIIAYVGSTGVATGPHLHYEVIYNGKHIDPLTIAHKTEVKLPDHELREFKLFVNKINK
TINRESSSEKEV
>ELAGILAN_01009 putative transcriptional regulatory protein
MAGHSQFSNIKHRKGAQDAKRSQKFTKLIREITVAAKQGLPDPELNPRLRSAIFAARKEN
LPKDKIETAIKNATGNVAGENYEEIQYEGHGPSGTALIVHALTNNRNRTASEVRYIFSRK
GGNLGETGSVSYLFDHVGLIVYKAEGVNFDDLFSHGIELEVLNVEENDKEGLHVITCEIK
DFGKVRDAFYAKFGEPELARLSWQPKDLIEISDKELIDKLSALVEELEDNDDVQYVEGNF
TFVDKL
>ELAGILAN_01010 Outer membrane protein assembly factor BamD
MYKTLITCFIFLICSFTQSYADDLEKTETELYEEAVELFDQKKYKQAIRAFHKIEDLYPF
SYWAMKAKLLSGVSHYNMGNYSSAASDMDDYIYVYSNGEDLPYVYYLRVLSYYMQINKVQ
LGQQTAYKTLELATEYINLFPGSEYVDEIKERAKLITEHISTKEYSIGKFYLRRGEYLAA
IKRFQNMASYKDSKYFSKSINYLVAAHSALGLDLEAE
>ELAGILAN_01011 hypothetical protein
MLFSRYKSDLDEKSSKKTSNISVAGLALAGSSVFLIRRIMLIALASSLNPAVGPTLGLVG
IAIFMAVQVLTIHSYSKTLKDPKVEGRGESRNAGSSDRSYKEEGPAIA
>ELAGILAN_01012 DNA primase
MDHIDIIKSKLLLSDIVGKKVRLIKRGDSFVGLCPFHNEKTPSFSVSNTKGLYYCFGCLA
SGDAFEFISQTEGLSFKEALEKLASVTGVELPKNLSITKEDNKLFLALDLAANWFAQKNQ
GVVDYLKQRKISPKIIDKFKIGYAPSSGLKEYLNSSGIEDRILIDIGLVNKNFRDYFYDR
LIFPIQSIAGRVIGFGGRVLSSEQQPKYLNSPESQLFKKRENLYGLNFALSEIRKKQHIL
VVEGYMDTIALHQAGISNAVAPLGTAISAEQIKNLWRFAKEISICMDGDSAGRHAATRVA
ELALPILEPGYTLKFVTLPSNKDPYDICNELEYKKEDVLTALDHSTKLHSEYLWHHIIDS
NLQNYEKLAPEKYSILEHKFMEYVNTISNSSIRRYYRDYFYNKASELRSSFKKQIFNSKT
RATKGEYLHNKSPELIEAEQNQAVILRIAVEFPEILNRPIFFEQFSHFEFTNEMKRLQQR
IIDVISNKNKLDKEALLQELKQFNVIKYVFEKTSVLNSQLNERKSAEIVWNNIVLLKELN
ALRKERTEARLSGNLDLEERLIEQIEQIESSIQEMQMEFIEK
>ELAGILAN_01013 putative protein
MNWKNFRLSTRLNLEGPVIEQVYELITAVDSVKNSWQITKKLLPQTIERLTHSVIVTSSG
ASNRIEGNRLTDKEVEDLYKNLRVKKFKNRDEQEIAGYLEMLTLIFHDYTDIPISESSIL
HINNQMLLYSEKDLYHRGKYKASSNRVEAKDQNGKVVGIIFDPTPPYLVRKEVQELIDWY
HWSLNNKFKHPLIIVANFVFEYLAIHPFQDGNGRTSRLMTNLMLLQQGYDFVSIVSHEKI
IETNKLDYYLALNKTQSSWKSGKEDISPWLIFFLNVLKTQANEAHYILERENTEYLLSRK
QLFFWEWALSLADKEFSRKDAIEALGFPPRTVEAITKKLLGMKYLQRLGEGKATRYKVII
>ELAGILAN_01014 p-hydroxybenzoic acid efflux pump subunit AaeA
MQLFLTRLVNKFYCLKVRNKVIIISSIAFILLFFISSAFLKKDQAVHSDNATSSFSVKTQ
ECAPQNRTIYLNFSGTVNPLHRASLVSKISGKIIAIYLPDGEKVKRDDVVLKIEDYDRIE
QAQKAKALLKQREIEYDSSHKLNKKGYGAQIQVEAAFTALQSAKADLKRLELDLENTAVT
SPIDGYIDKINANEGDFVNAGQKIADVVNFDQILVVLYVSENEVNKIELGSTAQINLLDG
KELAGEVSFISKIAEPKTGSYRVEVKVTNNKMISLQGLTANVRLPSGERFAYKVPSSALS
LSDEGALGIKIVDDNNYVVFAPIEIVDHESDGVWIVANNEGKSIKLIVLGHLFVKPGDKV
>ELAGILAN_01015 hypothetical protein
MKIHIYLILFLFFSCTQLYADEEIAKFDLLIGEINEASFTLKGAIKVTVEPGRHIYYKDP
GDFGLPTSISYEGNASDINIHWPIPKEHKDKVGRETFVSNVYEDMVLFPFKMNIFLNQGY
IDLNFHINYAICKDRCIPKNVEIKIRQPLKDFIDSDINKLINEWYEK
>ELAGILAN_01016 60 kDa chaperonin 5
MTNVVVSGEQLQEAFREVAAIVDSTVAITAGPRGKTVGINKPYGAPEITKDGYKVMKGIK
PEKPLNAAIASIFAQSCSQCNDKVGDGTTTCSILTSNMIMEASKSIAAGNDRVGIKNGIQ
KAKDVILKEIASMSRTISLEKIDEVAQVAIISANGDKDIGNSIADSVKKVGKEGVITVEE
SKGSKELEVELTTGMQFDRGYLSPYFITNNEKMIVELDNPYLLITEKKLNIIQPLLPVLE
AIVKSGKPLVIIAEDIEGEALSTLVINKLRGGLKVAAVKAPGFGDRRKEMLEDIATLTGA
KYVIKDELGIKMEDLTLDDLGTAKNVKITKDNTTVVSENSDSDSVKARIEQIKSQIETST
SDYDKEKLRERLAKLSGGVAVLKVGGATEVEVKERRDRVEDALHATRAAIEEGIVPGGGV
ALLYASSVLDKLKGASDEEQIGINIIKKVLSAPIRRLVKNAGLESAVIIDYLIKQNDKEL
IYNVEAMNYANAFTAGVIDPAKVVRIAFETAVSVASVLITTESMIVDVPSKENASSPMGA
GEMSGMGGF
>ELAGILAN_01017 10 kDa chaperonin
MSSISLNVLDDSVLIKPISEEKQGGIVLPSSAEKKPTKGEVIAIGEGSRNSSGERVTLTV
KAGDKVFYRQWAGTEIEHNDEKLIVMKESDILAVIK
>ELAGILAN_01018 tRNA-modifying protein YgfZ
MSYIPFLSRGVIVLYGPDTRDFLQGIITNDINKLDSQKAIYSLLLSPQGKYLYDFFLIEY
GKYTLLECENMHLQQIIEKLDLLKTYLKVKIKDVSALYKVGVLFNTKLAECSSESQVIFQ
DPRHKLLGMRIIHKDEIKEPVGDFTQYEKVRIQNLVPDGAKDMVQNSSFPLQFLIDKVNG
ISFNKGCYIGQEVVNRMSRQEIFRRKLYLVEGDNALPDIGTKVTNENNEEIGELRSSVDN
IGLALLNTGKSYANLYAGGVKCVKTLKS
>ELAGILAN_01019 putative murein peptide carboxypeptidase
MIVYLLYFILTLCANTSIHAIDQVDIIAPSSKGKESDLTTIKEYVEALDFNPHISEKIYS
NDNPFYSNSDEFRANDLVSALTGDSKIIWCIRGGEGASRLIPYLEKLPNDKKERIAQNKK
ILIGYSDITALHIHLQAKYDWQTLHGTMLEMIVNNSVSESSVEKLKELILNKRDSIRFDN
LKTINNGIRLKDGRLKSKIIGGNMTLVENSIGTVWQINAKGKILFLEDIRVYPYAIERSL
DHLKQAHIFDGVHAVIFGDFVNCYNDNLVEVVKERFAKSVNFPVFTMKGVGHGHTNDPLP
FNTHAIISVQDEKEGLFFMDVQNVSYT
>ELAGILAN_01020 Octanoyltransferase
MTEWLISNQLIDYNCAVKSMEEKIQQIHNNSADELVWLLQHPPLYTAGISATDDDVVEKL
FPIYKTGRGGKYTYHGPGQRIIYLMLNLKKRNKCDIKLYIRDLSKWIINVLKQFNILGEF
KEDRIGVWVNNNGVEKKIAAFGIRLRKWVTYHGIALNVFPDLSHYKGIIPCGLQDYGVTS
MEELGVKVPLSELDDILKKEFYKIF
>ELAGILAN_01021 hypothetical protein
MANSKFSITFNNEISECLAGLAKIRNKSIKELAEKLIQEAIENEEDKILIERAARRNVSG
VKKIRSEDVDWNTILSS
>ELAGILAN_01022 hypothetical protein
MNFNIFQRKKSAVFTKYSALQLMMEPSWSKRDYVSFAEEGYIKNVIAFRAINMIASAASS
VPLTLCQLTDQGKLQLKAHPLLKLLYSPNPMTSKSEFIEGIVTYRLVNGNSYILMVESQN
NRKPPTELYLLRPDRVEIVPGRNNVPYIYRYAINNNSYDFKVDKLTGCSAVLHLKTFNPL
NDWYGLSPIEAAAYSIDQHNQAGAWNQAMLQNGARPSGAIVVKSAKDGSGGSLSQEQYQR
LKAQINDHYSGSINAGRPILLEGGLEWKEMSLSPRDMDFIESKHSSARDIALAFGVPPQL
LGIPGDNTYSNLVEARLSLWEQTVLPTLENIICHLNSWLIPRFGEDLCLSYDKDTIEILM
EKRQKLWKYVENASFMTLNEKREAFGLPPQPGGDKLS
>ELAGILAN_01023 hypothetical protein
MNLLVSGQPLNGVSGIANQLDSSLSPEKIEQICTKSDLLVDNLSSKLKGIKIENFSQALA
VAR
>ELAGILAN_01024 Superoxide dismutase [Fe]
MSFTLPELPYDKTALEPYISAKTLDFHYDKHHKGYLNKLNELVENTDYQHVKIEELITEV
HGNSSNLPIFNNAAQVWNHTFYWNSMKKMVVVSLKIVVF
>ELAGILAN_01025 Superoxide dismutase [Fe]
MELNEKNGGGKPKDSSLLAKKIQDDIGGFDKFYEEFSNHGVSQFGSGWVWLVLEKGRLGK
LKITKTPNADLPIIYGQVPLLTMDVWEHAYYLDCQNRRIDYIKVFLDHLINWDFAEENLK
KNT
>ELAGILAN_01026 putative zinc protease
MNVPRVTKLDNGLRIITEQVRDIDSVALSIRVGVGSRAESAKQNGISHFLEHMAFKGTKT
RTAFEIAKAFDDIGGVFNASTGRESTTYYAKVLKKDIKTGIDILIDILMNSTFPEDELER
EKGVVIQEIFQTNDSPSDIVFDKYFEAAYKDQPFGRSILGTQDTVKSFTRGDLDNYINEH
YFGENMLFAVAGNVEHEEVVALTKDFFSKIHSKKLKKSQNATSHTGGEYLEHRKLDQVHL
LIGLPSVSRHDDKYHTFQVLDSILGSGMSSRLFQEVREKQGLAYSVYSFNSSYTDTGMFS
IFAGTDSSNLDKLLKSITTELKKLSTDDLREEEVNRVKERVKSQILMSRESVSSRAETLG
HYYGNYNRYISKNELIEKISAVTTANVKKAAEELLSQHEKATLAAIGEIKSLPSYDKVVS
MLKA
>ELAGILAN_01027 hypothetical protein
MAKGNNTLLIFDFDNTITNGHMHNALSRLSKSDFNSTQNNAATDNDIKNFLENTDGIKNK
EGLKSVLQSALSSGIEVNIASYTKYPDAVKEVVKDHLGLFEEQTGSISVFGGFPGDYDNQ
LQELDVREQQSQVGKNLHICEAIVKYKNKHGELPKTVMLVDDDVKNIQKINEFVASMSKR
GGWLKENGLSVEDIKNIKFEGARVPKEDKNVGYLERVQEFISPRKEESPQLPPKLKNLNA
VSQNNEEPPQLLPKKRKSSDGMVADGENKKQDIKGMLSSETQANPTRSKRHAMMLDPQQI
ESIHQNAEEPPLGKKYAHTETISLSKAFDTIRDFFQDCGQKIINTIHRLLKKEVITGVKE
QGYDVNSEKGKSEITIYGNKLIDIDKIKTDFIDTSLIRIMELGEEKIKDLNNNYKGDQLG
REISKLLNAGSQKENINSNYNDGEPIFQTRKEALNYPPQKKDINSNSVRGNYNGGEPTHQ
TVQEARNYHRQKKGIDSNPVSKKPLAPPVPPKNYTEKVTQSRNAGGIKIGK
>ELAGILAN_01028 hypothetical protein
MKKEEPEGTKIEEDESRTYLASGLNNTLHGNIYQLKLLMLFLKRGLDKSYSFRLATE
>ELAGILAN_01029 hypothetical protein
MQAKHKQNKEDNKIGISDLLTKNKDGEFNLAKYFISYLKIKYNQDFINGELKDFVICTNI
DFDLDQSRTQDAVKKLKVQKK
>ELAGILAN_01030 hypothetical protein
MVETIKDNDVFFKDGGERYKLSYEVYNNVTKNNIIEFSRIIPRMFLCSKRGNLNNKINTL
LIYTEGIL
>ELAGILAN_01031 hypothetical protein
MSEANPIVTLKAKIKEFGFSELKAGESNKSANSGETMYFDFPRMNFVINGKIIDTVLTSA
LIEGAQYRKSNLFNSYDIYSSETAREKQREIDTDYGRAFVDSVLKDLEKELAHNALCELW
KSHCKNSEIPDYQKTTSYGKDFERFYNAGREHLHLLLKVGDENKNYRPFVKEVFKEMFQY
AEASVPNDPILEEIITNCNQAGYEFAVSIPILESSLLEYGLKGEYSKNKTMCIDCADPIS
TKVKSDMLVFVTKFDNPGEKICDLSTSLEFVLESQDGVTYKDGKLLLTIPKELKNYKGES
RNLFDVIKEYFQKFCEKLGFKFEIKTQKIEHDLDDSLKVNSHLESLRPPICSNNYALGH
>ELAGILAN_01032 hypothetical protein
MSNIVHSNKNNKCDNFSVRGLQRAVDNIFDSFFTGWDSELSRRGSSLLPACDFYETKESY
CLSLELPGISKESIDISISSDSLIVKGEKTCNNESKDKQFYHRERYYGSFYRSIQLPVNV
EQDKVSANFSDGILHVTIPKSEKHIKRIDVK
>ELAGILAN_01033 hypothetical protein
MLLNKGANANAKQKDGITALHIATQKGHKEVVKVLLECGAKVGSKIKSDITPLHLAAQKG
YQEIIETVLKFGADINSRDEYGRTALHIASKEGHEEVVTTLLEYGSDINITSRNNHTPLD
SAMAGIRSFYSQLNNYDSDDDGYYDPDRGVCSCEVTAEALKRHIVKMKTANLYVSEKNLL
SMSISGEISGFQDECEEEIARMKSEKINNPNISFYDILAKGTSSLAIYMRNENIVQVLKS
DDYKTKFPIYASMIESHFRKGMERKELLEQGNKIFHFLFNNFPELPYDCTEKIFSYLSNE
DLRILIDACNPLSISNPNTNINNVVITSSTSQVQYV
>ELAGILAN_01034 ATP synthase epsilon chain
MNTFKVQFFSPDDQISFSGVVSLSVTGLEGELMILAHHASYLIYLLPGMITVKMSNQTEK
KVVIDSGVLEVASNNCSIITSQIQVFDRAIHDEKSFKNKRISIYLSYLDEKFLS
>ELAGILAN_01035 ATP synthase subunit beta
MLGDKNKEMNIGRAIKVTQAVVDIKFEGELPKIFNALKSKLKYKDKELVLEVSQHIGDNI
VRCIAMDSTDGMSRGDEFVDTGAPISVPIGRSTLGRIFNVVGELIDECGPLKGKYNLEPI
HRAPPSFTEQRIQEEVLVTGIKVIDLLAPYLKGGKIGLFGGAGVGKTVLIMELINNIAKA
HKGFSVFAGVGERTREGNDLYHEMITSNVININEHEKSQAVLVYGQMNEPPGARARVALT
ALTMAEYFRDRENQDVLFFVDNIFRFTQAGSEISALLGRIPSAVGYQPTLATDMGAMQER
IASTTSGSITSVQAIYVPADDLTDPAPATTFSHLDATTVLSRQIAEMGIYPAVDPLDSTS
QSLSAEIIGEEHYKVASEVKRILQTYKSLQDIIAILGMDELSDEDKIIVDRARKIQKFLS
QPFHVAEIFTGMPGKFVSLSDTVSSFKGIVEGKYDHLPEAAFYMVGNIDEAIKKAELIQA
EAK
>ELAGILAN_01036 Phosphate transport system permease protein PstC 1
MILPFIISLLEDAIRSVPKSLRYGFMALGATPAETIWHITIPYAMPTILSAILLSISRVI
GETMIVLMAVGINANLTFNPLNSVTTITVQIATLLTGDQDFNSVQTLAAYALSLVLFIIT
WLLNAFALFVMKRN
>ELAGILAN_01037 hypothetical protein
MHGRMNSVIVIPVLLILLFCFSRFQEVNKVKSYLYLSCVWMLTWLLVFYNNCFVTFISIA
LLFFMLAFIFKNKRNKIIKLSLFVALAISFFITLFIMLSIFIQFISFFNKVAISEFLFCL
KWGHNVVTINEEKIGCFGIAPLLVGTLLITIIAMLVVVPLGLFSAIYISEYASEKVRYIV
NTTLQVLSAIPTVVYGYFAVVFLSFFIKQVANFLV
>ELAGILAN_01038 hypothetical protein
MLAKISILNISNIGHYYIILTHRNIMQASYKNLQKDLTICLKKIK
>ELAGILAN_01039 hypothetical protein
MVEHIKEVNNTGFGQMYQFLFLPKGTGTDWRSAFRQQEELFKKVGSNVILPEISNSPSKG
NQLGEVGTMLNNVENDQEHIRKKRYRG
>ELAGILAN_01040 IS630 family transposase ISWpi11
MKIIATKEPKNLVYIDESGIDNTEDYPYGYCQKGQRFYALKSGKKTQRISMVAALSGRKI
VVPLTFEGHCNMDVFNGWFEQFLTPILEPGQTVILDNATFHKSDKIIELAKGVGAEILYL
PPYSPDFNKIEHH
>ELAGILAN_01041 hypothetical protein
MPAAYSYDLRKKAMEALDEGESRETVAARFKIGRTTLWEWQQRRKETGDFQSKKLGNGGY
NHKITDWDTFAKFAREHGGKTLSEMAKLWNNVSIQTIYRALKKIGFTRKKRHMDTRKETK
KNVLNF
>ELAGILAN_01042 Thymidylate synthase ThyX
MNEATKRTIVKEIDAILYEEHKVLDHGFIRVVDYMGSDSAIVQAARVSYGKGTKQISQDE
ALIKYLMRHHHTTPFEMCEIKFHVKLPIFVARQWIRHRTANVNEYSARYSILDDEFYTPK
PEQVAKQSDNNKQGSGEAFDPDTSKEIIDSLTNDSNLVYSHYEKFIEQGLAREIARTNLM
LNYYTQFYWKIDLHNLLHFLKLRADKHAQYEIRVYAEVMLDIIKKWVPLAYNAFVEYCLE
SACISRTGLEIIRKLIKGENVTRKESNIGKREWGELMSILDKQS
>ELAGILAN_01043 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MHKILIRNNYKPLVGKIKINGPKNAVLPIMAASLLSSSPVILHNVPDLIDVHLMSKLLES
LGAEVNFMHNKNYKANHTLKIDCSNINNHVMPYKTASKLRTSFLILGPMLSRFGKARTAF
PGGCNIGKRPVDMHIKALEEMGAKIEIDGYNIIATVKGKLQGKEITFEKISVGATENVIM
AATFAEGVTTINNAATEPEVLDLIDFLKKMGADIEIDNTKVVITGVEALNGCVHKIIPDR
IEAGTYALAAIITGGKLELEGINLSDIRCITNELETIGAMVELYDGGIVISRKNGSIKSA
NVATDPYPNFPSDMQPQLMSAMCIADGISVIEENIFENRFTHADELRKLGANISIEKSKA
TISGIKSLSGANLYATDLRSTAALVLASLVAGGETIINNSHHLWRGYEAMHEKLNSCGAD
ISISS
>ELAGILAN_01044 hypothetical protein
MLKLKNTRCFFQDTRDLFKLSSPKNCLLGFILILVSMLISNGLLSIYCGFSFFRESFTLD
RVKDLSAVLSPLVMLFVLLSTFVMWIIMSLGEEIGWRGYLLKNLKSKISNFYIRAIIVGI
IWSVWHIPTYVVAGSALWKDGFTFPTICAYTLYICAMSIMFTWLFEKDNSIWPVTIAHAT
NNLVYSVLSILMPSPPLSTFDAVIRLTLGAAGYFIVAIGVIWFDKARERHLSNS
>ELAGILAN_01045 hypothetical protein
MEKYTNAWFNKKDNHDCANDGTCGQSITDFRIGNTDISFFDSNKNLIAKVPKLPKYSRDK
YGHQLYKEAESKQFNYFSTNIHDVLSNSFTVKYGYINCTIKYDNLSEQEQNQIETDIKTA
YEAFKEKFCFKDSSIIKDITVYIFNNRSDYTKYNNLLGIDEDGGPGYITRGVTDCQNILT
YKQSAMDFVLGHELGHIFQLRFSPSATVKDLSTQDTELIANVVGREVEEKNYKAICKQMG
VDEYKYDGWSFIFKYIGTTGSVYRLNLSEEEKFQIIQRVKSSGLDEYEDHGWMFKFKYKD
TTGSIYLKDLSEAEKFQIIQRVKNSGLDEYEDRESMFSFKYKGTTYRAEHRDYLSAEEEK
LQFIKDIKNSHESLVSECDGLGNENTTLVIYVDENKEISQMYFHNLDKNIFKWLDKTLIS
RSKPEEDVDDTAGKEPEPESAEEDTQQPSNFLSNIFSTIKSIIDSISSLFSWLFGSKEKE
SNQQSDDNPSLFKLDANELDHEVKPDANELGHDVRDHLSDNYNHYNSSDGLM
>ELAGILAN_01046 hypothetical protein
MHQNHNFITINIVAALHFWTILVPIFYGVIDITKNASSFLEKFVIFMAVTDSHFLWHIFS
STVKWLFIMNFVSNCQFFSLERCNKAHWDPENLIVYYTTFSIKSWIPVSSTGMTSQGHWN
FCFNICTLAMHLNRYCKLAILH
>ELAGILAN_01047 UvrABC system protein B
MEFQIATHFQPAGDQPQAIDSLIAGLNSNKRDQVLLGVTGSGKTFTMANVIARTNRPALI
MAHNKTLAAQLYEEMKGLFPHNAVEYFISYYDYYQPEAYLPQTDTYIEKDSAINERIEML
RYSTVCSLLERRDTIVVASVSCIYGLGSPESYRSMIIPLSVGNKIRINDFLSNLTDLQYK
RSDARFERGYFRVRGDIVDIFLSHYENKAWRLSLFGDEIEEISEVDAITGNVTKGVNKIT
IFPNSYYITPREALLQAIELVKKELHERLDYYYSQNKIVEAKRLEQRTNFDIEMMRTTGI
CKGIENYSRYLYGMEAGDPPPTLFEYLPKDVILFVDESHVTVPQVGAMYSGNEARKKKLI
DYGFRLPSAFDNRPLKFEEWEGVRPQTVYISATPGKYELAKTNNVFIEQVIRPTGLTDPI
CIVKPIESQIDDVIHEAQVTIGKGFCVLITTLTKKMAENLAEYMSELNMKVSYLHSDIAA
LERIEIIYKLRSKEIDVLVGVNLLREGLDIPECGLVAILDADKEGFLRSETSLIQTIGRA
ARNAEGRVILYADKITGSLDRALRETERRRKKQEEHNILHNIIPKTIIKPISNTLQERAI
AEPKVNTNKDDLRKQMIEHAENLEFEEAARIKKLLQG
>ELAGILAN_01048 IS5 family transposase ISCaa8
MVESAKENLSEVKNILVDAGYTGENFATQIKTIIGATVEVIKRSELHSFAVLPQRWVVER
SFAWLEKCRRLWKNCERKLNTSLQMVVLSFISLLLRRF
>ELAGILAN_01049 hypothetical protein
MKEKVTEIFCIVDDFCNTVDENFAEKLLPSGKKPTRTPEITHSEIFTIILLYQVRQF
>ELAGILAN_01050 hypothetical protein
MVFSALNAMVLRTVKSDRDFVHNLSLFAIQKGPRETKFSKGWQRLERLLMGGFSVHLVIN
ETGEIQGVTVIKGNVDTCAKFN
>ELAGILAN_01051 IS982 family transposase ISWpi16
MPNLTKKLTGLLFGDKGYIKKDLFHELFDRGLKLVTSIKKGMKNSLMALNEKILLRKRSI
IETVFGSLKNKFEIEHTRHRSPINFLVHIFSTLVSYSMQPLHF
>ELAGILAN_01052 hypothetical protein
MDTFFSSLPRTKISDIIAFYLFPDNLLDGIPYSIGNEGQTVVLKTEEKIRNFNSVKEMFI
KEVLEDKAVNNAALTKEIFSKLGEKILEKAYSVDGQQSAKKDQLINRLRQQVDFVNKLDA
KKLQNLLSKDNNSLYEIFSEHHNEIKEIIKKCKTEHKLSNSIENLNEVAGKYGIRKGSMQ
SFENSSSRSSSMSFLNSVSTDSTISSEAELLNPANHKEVKTATSLWDKVSSPFKSGKKSE
KTSEVKYQVLSESDTLPRKIGNSTFYVDTPTPIENTNKTATIGGRPGVARRNSTSNLTRV
ETPEVPTRSASLTNLNGQSSFSEDVLSDPKVNQYLGNSNKGTLTRSNSFDSARGSSGPST
PTSSLERLFQSFSKDEVGAAMEKDLKEFSLSAKTESTLHNSFSNRNGSDSGFNSPTSSPT
HTMFTENGKAKTQADLRKTGHLDKLVGQPSTKVAVDTDVQQQAAQTAVKTN
>ELAGILAN_01054 hypothetical protein
MISLFYKLRLLNYILGSLKDIIVKLFLFTMYLYTFSIVLMFLSNGFWYAVEFCSFKNAFY
RLFQYCKWYYENREDLGYGISIRILVAFLTPHFLYKLLLGTGWKSFLKEKIIQILNTRRK
KGSEFSNSSKPSGSSYSNKNNYSNSSGNNERQAQDAKRKVNMIKQLLIKDIEATIDRRLN
YIFFGKRSKPH
>ELAGILAN_01055 hypothetical protein
MSNNFNFKEFFNHYETNSTSDDIQRYYLLWKSVIAQAMIDAASHCKKTESLVEKRKAISW
LSDFSQDFVHTCILADCDPVYVKNKIQPTLKSLTR
>ELAGILAN_01056 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSRRVVVTGVGLITPLAADVDNTWSRLIKSESGIKAINTDRFDSSDLACKIAGQVPLQSD
NIEHHFNPLDYISEKDSKRTDRFIHYGIAAAIQAVDDSLILESQNINRERVGVTIGSGIG
GLPSIQENVITMQEKGPRRVSPFFVPASLINLISGHVSIKYEFTGPNDSAVTACATGAHA
IINSARTIKLGEADVMIAGGAESALCRVGIAGFASMKALSTKFNDKPEEASRPWDAERDG
FVMGEGAGILVLEEYEHAKKRGAKIHAELVGYGLTGDAHHITAPHPEGRGAFKAMQLALK
SAQINPNQVGYINAHGTSTPLGDKIEVIAMKQLFGDYVYKIPVSSTKSSIGHLLGAAGSV
EAIFSILALNNGIIPPTLNLHKPSEGCDLNFVPLKAQEHKIQYALSNSFGFGGTNASLIF
GQV
>ELAGILAN_01057 Acyl carrier protein
MNSELAKSTREDIEEKVKKIILEHISKDVEKFNSSSKLSEHGTDSLDAVEIIMAAEEEFG
IEIPDEDAQKMETMEQIVEYINNKKG
>ELAGILAN_01058 hypothetical protein
MLDETTKNLLIVEVNKLLPENSENKLISAMRYILLAPAKHIRSFLVVASSRVFNAEAKKV
ISVAAAIEFVHAYSLIHDDLPCMDNSDTRRSQLSCHKKFDEATAVLAGDALLTLAFEVLS
SLNEKRCEIIKVLSQAIGIRGMVGGQALDIDTDFNKIKEIHLMKTAKLFAASCEIGAIIG
GATDEQRRALYNFGINLGLIFQAKDDIEDYEQDKTNNLMSVLGKSEVEDYIDGLFKQGLD
NLSALSGDTNYLYDLLNQVKKDG
>ELAGILAN_01059 hypothetical protein
MVRKIILQMLISVVMILTLTSAFVFTIVYINKGKPEKKDKLYEINATHGGLIQTIAYYLV
KPILESALDRYIEKHGLTEYLEEMTQQKEEDSINFYEITEGSGSKAFCGLEVLLQIYKIS
NNNSATLPSKVSDVTLKIGQDDLKEVSLGVIGMKEGGERVVTIANENKMNFNSYYVKLIE
VKDKYPDSVNNLMVFNDLINKTGKQVRCGDEISVKYSVKEHNGEYIVKDQTVQFRVGDKK
IPLAIELGVVGMRAGNKRTILSPPDLLTITDDMLIKDIDYDEENISIIDLSLDVKQEVAA
HHSTVEKQPKEYS
>ELAGILAN_01060 hypothetical protein
MTKESLVKTDIVKVEDKKAVRSFFKILGGVADAVRSWIGNISPDLSNSRDIDSLVLKMNE
CLNPKGGEVSARKNAVSLGNLYLSLSEKGKIKFLQTLAEKFNPNKAEIDEKIKEYKKNQD
PELNYKFEQDLIKILESPRSKILKQFISLPEGLKFIVDMRSDVLKLKNQHRSLNPLENEL
KNILYTWVDVDLLDLRQITWDSPASLLEKLIKYEAVHKISSWGDLKNRLDSDRLCFAFFH
YKIPNEPLIFVEVALVDKIADSIQHLLDESVPSNDPSNASTAIFYSISNTQAGLSGISLG
NFLIKRVVEKLSQEFKSIKTYATLSPIPGFTKWLKNNLNQDVTLLGKLNIKQSSAEILES
AEQLKTNVECTNETKQYMLKLCAYYLLKVNNSNGNTYDPVAHFHLSNGASIKQLNWMADT
SEKGISQSAGMMVNYLYELPKIDNNHENYMVNKVISCSKKVSSMLKE
>ELAGILAN_01061 Elongation factor 4
MNNIRNFAIIAHIDHGKSTLADRLIEECNGLEAREMINQILDSMDIERERGITIKAQTVK
LNYTANDGNQYCLNLMDTPGHVDFSYEVSRSLAACEGSLLVVDSSQGVEAQTLANVYKAI
DNNHEIIVVLNKVDLPAADPEKVKLQVEEVIGIDASESVLISAKTGLGIKDVLEAIVAKL
PAPQGDVNAPLQAILVDSWYDTYLGVVILVRVKNGVLKKGMKIVMMSNNATYQIDNIGIF
TPKKVMTGELSAGEVGFITASMKEVADCKVGDTITEEKRPCSEALPGFKEVHPVVFCSIF
PHKTDDFKYLREALEKLHLNDASFTFEAETSNALGYGFRCGFLGMLHLEVIQERLEREFD
LDLTATAPSVIYRVTTRSGEILNIHNPSDMPDPTKIEIVEEPWITATIMVPDQYLGEILS
LCEERRGEQEDLSYIGNTTTALLRYKLPLSEVVFDFYDRLKSISKGYASLDWEISSYLVS
QIDKLSFLINGEPVDALACIVHKSRAEKRGREICARLKDLIPRQQYKIAIQAAVGGKIIA
RETINPYRKDVTAKLYGGDVTRRMKLLEKQKKGKKRLHSIGNVNIPQNAFIQALKISD
>ELAGILAN_01062 hypothetical protein
MTISQQVNKNITKEGYFNNNGKGFNSPHVIEVEDLNIKVEVYSHNLRASKVANIESEIRE
TATNFKNAFELERGSSEQTFKIYMFDDKDDYTHLGGSERFGSYLGDEGGKCYYKGKADVF
AEMYVYQQGGIHNLQHEFAHGLTYLATGGKSLPTVLMEGIADYFEHHSDHKFNSQGSSID
KTEAANLDLDKILSLEYSKDSEANSLVYKTGHALIMYLQEKDPSLLRDYLDALRQGDSDE
SKSFLKDIKGHDADFKSWLAENDTETAMEHLNALQVTKGDFIAIGQEIVGGEIKNVSYYK
ANIEKMDGENVGSFSPVEHVAFYDVARAINRATNDTLDISKEYHFLKVVKTSDGQDKLTY
SDEQGNEYRNSLEYKNQAFRMLSKYDENLKKAYDDALKNLDEQRQMEYPKINKEYSEGKI
SYEEYSDKYYSIPSKYEELKSTLLDETINTGLEQVKATKNIDVEKMLEEMINIDSNLIRG
TNHIDLQEGKIFSMQAHGQGDMGALSIYDGNTKLGELLSESGFFKQVEGQTKETFVFEDI
LHNLNVSYEGGAYMAVTKENGHHKASLIDGRTVERDEYFDEAHLHENELLHPSTGHIQKD
LDSLLLRGTKILNHQDSEHAQYSDEQKANGVIVEKGKLLDNKGTDRTDDDVYEAVVKQGD
ERLHEFKNMGFYITEKGDLFIHDHGANVRFQLPQSITHLKLVEKDGAYKLVPVTKDGNEH
PIGMPNISDEYRYIDPIFAHEYEKRDYSHKHVNVGLINLEKYGSGKLFAIKYDPNDYHIQ
RNSSGEIVRIKDQTYFTKVKLFDGDEEIGMLSNNFHNFKGKIFFSADYNYSYNDFLASVS
PQVEIEDMGNGSKKITFDQGSGDIGDTNRGYTDYQRIFTKEKQTESPKGQVSETKTEVHS
TTNVVAQAAEEKTASNDNSEMQSDQPQIPTRAKRSASVEEKEQEQVVLKDTILKIEKSYE
QDSEGKHKANVTINYNDVKALYDRAEGAEKQSVLDFWNKLHTSDYKVGALPEDKYYFEKG
KFVIHDSGTKKLIVLPEDKVSIKIMKDGDSYSLAISSGNGKVINSISKIDNPNYELLSDS
SHFNSGEQDNIVLSDQHHEYNLYLENGFVKMFDCASDHIYHDHNSAYI
>ELAGILAN_01063 Protein translocase subunit SecA
MLDSPLILTAILIFFIFTLSFFFIRKIFGSTNKKIIKSFRKIVQQINALETEMQSLSDEE
LAGKTEEFKRELKNGKTLNDLLVPAFAVVREASRRFLNMRHFDVQLIGGMVLHNGMISEM
KTGEGKTLVATLAAYLNSLEGKGVHVVTVNDYLAKRDTEWMSKLYNSLGVSVAFITNNLT
DEERKEAYSADIVYSTNNELAFDYLRDNMKFSQEDMVQRGFHYGIVDEVDSILIDEARTP
LIISGQIEENNQIYKHINKIVTKLVDYDYEVDEKGRTVFLTEDGISRVEELLRSYNLIPE
NSSLYDTDSMIMTHYIDQALRAHKLFTADKDYIVKDGKVVIIDEFTGRMMEGRRYSDGLH
QALEAKENLEIQHENQTLASVTFQNYFRMYNKLSGMTGTAATEAEEFSDIYRLNVVKIPT
NVSVKRVDIDDEIYGTGKEKFNAVLKFIEECHKRLQPVLVGTVSIENSEKLSALLQSHSL
KHSVLNARYHEQEAYIIAQAGVPGSVTIATNMAGRGTDIQLGGNAEMIAKVELKKIKNAD
EREKKYQEIVERVKKDKEIAIKAGGLCVVGTERHESRRIDDQLRGRSGRQGDPGLSKFFL
SLEDDLMRIFGSDRMRSFLQKVGLKNNEAIHHPWINKALEKAQKKVEARNYDVRKSLLKF
DDVINNQRKVIFKQRNNILGNEINDIFEVYSEVNESVVEGIIQSGYYEDYIENIVKEFHT
RNGITLDKEDLAKFLNKQEALNYINDKIQEFFTEKEKYFNSQHTTDLWNTIVKQMMIMTL
DHLWREHLSVLESLRQSISLRAMGQKDPLNEFKREAFLMFESMLEKWKELTIHRLAHFKL
ADNQEIGNRLHSARNSRLPKVSRNDKCPCNSGKKYKHCHGAVTVVS
>ELAGILAN_01064 hypothetical protein
MNVENKQSEVLSNLTFKKRDGTSTGDHGRKYEVKLLMLYLLHGLSGKIDFRLASNIKGFG
TFDDIFFEYKDQTDKSRVVLVQAKHREKPNLSENITFEDLFIDGEDRKKQKKDFRLNKYF
VESYPEIKQNSECKNSDITLVIHTNVNVNLKKGAAKQGSIETLEKYLEESKLIDDNILSI
YEGQKGTCYKIKNHTELKKYFSCGSERLSGN
>ELAGILAN_01065 hypothetical protein
MGKPACCVSKGGGSSNTASLPDQLARDKGFEKRAQLYAAKAYSRQADKNYINLKKVFFIA
ISNGMLFPEEVEYISTHNIRDIKTNGHYLKDFQFVFIELPKFSKSRVEELESTIERWCFF
FKHAEETTDEDLKKIAEESPIIKLAYDELDKFHWSEKDLLAYEERVMDLQKEEAILEYRL
DLAKEKGVRKGKIEVVKAMLANNVDVNTIVKFTGLSMSEIKELQN
>ELAGILAN_01066 hypothetical protein
MVKGILCNWLGVTELQESQKIDAEQFEKVFGALKEWQEAQKIDAKQFEEVFSALKEWQEA
QKIDAEQFEKVFSALEDKIGTEQFQAMQEHLNGLQEKVETLAEAVADQEKTLLICTIATA
VAVIAITSFVAFCIYQGVKCEREKEKNLSKDTPDAKLNNVDATDGTKKLRNDLKVANI
>ELAGILAN_01067 hypothetical protein
MLRIFSKVLFILMFLVSSFFTVHSAEAKSKLSKRYIPPGNPGGASFHTDEDFAESYKLYE
KRRELLKKKKSQDRAINKEDLIKKLKEKKIASLDNEPNDMEACIVDDEESAMINQHGINI
TRLKGAVFIDQEPVSQYENKQHESEQQEGKKVTSTREKKVSPINITIKETPSRRTCSHDS
IANLDNVDAYSLNGSSSFGSVADTVK
>ELAGILAN_01068 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (flavodoxin)
MLDKDLILNDNTYELSQISRHKTHVVEVGKVKIGGNNPVVVQSMALGVHIDADNIKSSAK
HYAKEITELARTGSELVRIALNSEEVARAIPYIVEEINKEGFDGKILVGCGQYELDKLVQ
DYPDNIKMLGKIRINPGNIGFGDKRDEKFERVIEYAIMHDLPVRIGVNWGSLDKYLLQKL
MDENSSLSNSRPSDVILRKALVMSALDSAKKAEGIGLNSNKIIISCKVSKVQDLILVYMA
LAKSSNYALHLGLTEAGMGNKGVVNTAAGLTYLLQNGIGDTIRASLTQRPGESRTNEVVV
CQEILQSIGLRYFNPQVNSCPGCGRTSSDRFRILTEEVNGYIKTHIPIWKKKNPGVEHMS
IAVMGCIVNGPGESKHANLGISLPGYGEKPVSAVYKDGKYFKTLQGDNVSEEFKAIIDNY
VKEHYT
>ELAGILAN_01069 hypothetical protein
MEEKPVDKKWRIKRSTARFLAVQIAYSNIFVGYNKSTFKLENCELKDYINKLKDIFECEE
FEHQFLENLLYKVIKSSEEYDKIIESYLHPSWSLSRLNLISLSILRVAICELANCDTPVP
VVINEYTNIASDLLDKPSEIGFINGLLDKAKDAVKLNKNP
>ELAGILAN_01070 6,7-dimethyl-8-ribityllumazine synthase 1
MSRILIVNSIYYTEIANLLLEGAIDKLKGSNASYDVVEVPGTFEIPATILFAVKSGHTNY
DGYLALGCVIRGETDHYQYVCKGVIEGLNEVVMHYAIPLGMGVITADSKDKALVRADKNK
KNVGGHAASTVLRMIDLHNKLK
>ELAGILAN_01071 Membrane protein insertase YidC
MSEAKSLILAAILSMLIMVSWRIIYDNFFSTNQNQPLIEHIESFNDLAPIIHQNRSEIIN
STREQRVSLTNNMIKGSISLKGARFDDLILTNYHLEPSSSSPQVVLLSPAESKDVYFAEF
GWLDPSNKIKVPDSKAVWRADKLNQKEVNLSWDNENGILFRMKINLDDNYMFKVEQVVEN
NTKDNVVLVPYGKINRKRDNINESYWISHEGVLGAFDNKLEEWTYKDISKKHLIKANTSE
KNWFGFADKYWLTVIIPEKSDKINVSIKHTNANDIDKFQVDFVKSYKSILPGASTSNVNY
FFAGAKKLNLLDSYKDTLNIPLFDKAVDFGVLYFITKPVFLLLEYFNFVLKNFGLAILLL
TLVIKLLMLPLSNRSYVSMFKVKSLQPELTRVKELYKNDSLKQHKETIALFKRNNVNPMS
SIFPMLIQIPVFFALYKVLFVTIEMRHAPFFLWIKDLSAPDPTNIFTLFGLFNYNFPISI
GILPIIFGATMIIQQKLSEKDQTSKDDIQVNVMKFLPYISVFIFSSFPAGLVIYWIFSNI
ITLIQQSLIKLFLTKKVVVNVENTNS
>ELAGILAN_01072 hypothetical protein
MASNFNDKLLFLTQVADTGSFFLDSSVTCTIVQTFVFEDSVLAGFTSSTKVSSQCLDYLD
PEKLIVHYTTFSIRKLDSSVKHWNDIRKCVVNFLLK
>ELAGILAN_01073 hypothetical protein
MNAVKNLVIWLLIIATTAMLIDSQRDKLSDRFLSTFLPYKGRIQNSGSIEFTKSYDGHFY
IQAQVNDSNITFLLDTGATDIVLSQKDALHAGINLQNVQEYPFRRVV
>ELAGILAN_01074 hypothetical protein
MAMEKKKFFEIINEVSKSEGLNENNLLERIGNKLKDADSIVYSTYNNLKIDKMFSILDSD
KIVDYMLVHLAVECNSVPIVKLLLAKEAKVNEPIYELDEAKSKLTALHIAALHGHQEIVQ
LLLNNDANPLLKDSQGRTPRDIVGDVKGKKAIIEMLEEGDSQGRTPRDIVGDVKGKKAII
EMLEEGEQRYAEAGATRRQNRQGTLPQPNNKTPGNLAVNGNNATAAVQACNARDQEENNG
TTPNNRKIYVQDEDEQTSSNSIINENNTDKVDDTLEREQALRERNAVEQKLQEVEQRLAN
NQKRIEQTGHNQHSEQYGATYNGEQTFLNKSNSGDSGIYFDADESEALGQSILENGEDIN
AQDKDGVTHLHYAATYGYVEIAEYLIDNGADVDAQDKDGVTPLHYAAAKSAKESVKLLIK
RKANINAQDKDGHTPLYFAVANDNKELAKLLIKYGADRSLIKDEDLIDRLNSMCDQPSEV
VSSTSSHSKTHNAMETPEEAEKVKKSKVKLKELRTQLKDKQKKNELLKQQIQDLESEKAT
LKDKLDKTESQHSKTEVLLEKAQKELEESKSCIAGYGTKLKEFNKENESLRQEIQDLESE
NTTLKGELGKTKTKTNEVSLEKAGKRQMSFLKVASVNLVTMLTVGATLSIAFDLSVLPII
VVFVTSALIASGVTYAISTKPTTELKEVDIQGSAQRCL
>ELAGILAN_01075 hypothetical protein
MKTFTKNFKNNEKKLEEFNKEIEDITTIAQDKFAHELENIAYDSVQKFRSLLAKELNSIF
NNIHSQNVNLLKSSLVEYAISSNFINKKGETALIRSLLNIFIR
>ELAGILAN_01076 hypothetical protein
MSIRSTSPRISVQRKSKPESFPVTLEEVKSFLRIENDQDDKLISSLIFMATDYAEWHMEK
SLVKQTWQVSYEDYVKDKI
>ELAGILAN_01077 Glutaredoxin 4
MSNFEQIKKDITENDVVLYMKGTSDFPQCGFSGLVVSILKKLNVKFKYINVLENDEIRES
IKKFSDWPTIPQLYIKEEFIGGCDITREMYEKGELQSLLKEKKIIAE
>ELAGILAN_01078 putative protein RP812
MVIAIHELERIVKQSFPDADIKIHDLAGDDDHYHLKINSKCFLGKTKIEQHKMVYKALEG
QSIHALQLETNT
>ELAGILAN_01079 NADP-dependent malic enzyme
MNDDLDSTTKQEALNYHSRGGKPGKISIMPTKPLSTQYDLSLAYSPGVAAPCLEIAKNPE
VVYDYTAKSNCVAVISNGTAVLGLGNIGPLAAKPVMEGKAVLFKRFADIDAVDIEVGTEN
IEDFINAVRYLGPSWGGINLEDIRSPDCFIIEKRLNELMDIPVFHDDQHGTAVVVAAGIE
NALDIVGKKLEDVKIIMNGAGAAGIACLEILKSMGAKNIVLCDKQGVIYKGRNEDMNEWK
EKYAIDTSERSLLDTIKGADVFIGLSAKDVLNEEMLKSMGKDPIIFALANPDPEVRPEFA
KSVRPDAIIATGRSDYNNQVNNVMGFPYIFRGALDVHATTINDEMKIAAADAIAKLAREP
VPGEISAVYGGRKMGYGREYIIPTPFDPRLISIVAPAVAKAAVDSGVARKAIQDWSKYEN
QLKSRLASALNMLKLLSSQC
>ELAGILAN_01080 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MNSGVLLYKFTYYVEWYYMLKKNVPNLLTISRALAVPAIILSFYIENKYAGLITISIFVF
ACITDFFDGYLARAWKVQSKFGKLFDPIADKLIVVSTIIMLVYKQKINDFTIVPSIIIIC
REILVSGLREFLIATNVSLPVSKAGKIKTFLQMVAVVALIMNDYYMIQYTGAICLWVAAI
ITMWSGYNYILAGIKQID
>ELAGILAN_01081 hypothetical protein
MKIPSGKFSSTKKVPGKNKKKRDFEPLEEFFWDFWPTVDKEVKRERLEQELLALKKRELY
RKCASLATMVPFTLLMAIELEKTYSDQVLLGVISGALSHTILPFTVLSLICTLYLIYNNR
KIAQKERELEIIENGEEVKEKEHNISDIGQCLIYIEAITTALVIVGMIMGETSSLEAAED
AILFLANAIAFLATLVSYIDKHEKNKKKETEKIPSC
>ELAGILAN_01082 hypothetical protein
MASLFYAYQYILRVIPNIIIPELVVRFNIGTTEIGQFCGLYYVGYVLAHIPVGILLDRFG
SKVVIPICIALTSLGALPLVSSNDWSYSIIGRIITGIGSSASVLGLFKIISIYYRREKFA
MMFSISAIIGISGGVFATKPLHILFNKFGWDYVFVTFITLGLLLALVSFMFIPKIDTSEE
RLNIKSLSEVIFNKNVLLISLFGGFMVGPLEGFTDVWSATFLHEMYAIDRQVAYNISKWI
LIGFGFGYLSLSYLLEKKPTKHYEIIISCAMAMIIVFLLLFICNINSLLASILLFIVGFA
SAYQIVLTAKVVNLVKDDAVASAGSVSNAIVMSFGYFFHTVIANIMNFYWDGKIVDEKPL
YGADVMVKSMLIIPICLLIGMIGFWLLKVISCKKS
>ELAGILAN_01083 hypothetical protein
MLQRNFLVWLLASLFYAYQYILRVIPNIIAPELITKFNISITDVGQFGGLYYVGYTLAHI
PIGLALDKFGPKFVLPICIILTFTGTLPLICFDEWYYSILGRIVVGIGSSASAIGLFKVA
SMYFAQEKSARMASLSIIIGILGGICGGLPLDFLLDKFGWNYVIYTFSAFGCLLALLLFL
VTPESNAQQEKVSIRDLKNILFNKHIILISFFGGLMVGPMQGFADGWVKTFFFEVYKMNE
DLASSLSSVILIGMLIGSFSLAYLLEKYKNKHYEVIIACSFAMIASFLLLFTQIGGLYVV
LPTLFIIGFTSGYQVVTIYKAISYVNNNLVGLATAVSNMIVMVFGYFFHTGIAKIVDLCW
DRTIIQGNPVYGAELLIKATSVIPVCLLVAVFGLLWLKNKDFREVDCNK
>ELAGILAN_01084 hypothetical protein
MDLVTKVKLKIKMNKGKIINILIICGVIFFIYLIHEPVVDMVEKIISKIKEILSTIQKNY
FSTYLPPNKTQLQLKQKYQSKIKYYIS
>ELAGILAN_01085 hypothetical protein
MNISTIDNTLQNYITKYIEQTFATHVLGNRYDKLYRKLLSGIEEIIKLAVNEAKHYDENL
EDLYNDSRFNKKFIQAVAKHQVSEFLNTYPKRKDTVLLVNKKVIKILQIA
>ELAGILAN_01086 Elongation factor G
MEIGISKYRNIGIMAHIDAGKTTTTERILFYTGKQNRIGEVHDGAASMDWMEQEKERGIT
ITSAATTCFWNDHRVNIIDTPGHVDFTIEVERSLRVLDGAVAVFDGVAGVEPQSETVWRQ
ADKYSVPRICFVNKMDRIGANFYRCVDMIKTKLGAAPLVIHLPIGSEKDFKGIIDLISMK
AIIWQEETLGAKFSYEDIPSDLLDKAQEYRNLLLDAAAEMDDEAMNTYFESNDLPVDLLK
KCVRNGTIKGKFVPVLCGSAFKNKGVQPLLDGVVDFLPSPIDVDVIVGIDPKDSEKKIEV
KPSEKEKFVALAFKVMTDKFVGSLTFIRIYSGKLKSKSTVSNALKNETEGIGRMLLMHAN
NREDITEARAGDIVALVGLKKTTTGDTLCSVDFPILLERMEFPEPVIEIAVEPKTTSDQE
KLGIALNRLVAEDPSLRMSVNAESGQTILKGMGELHLEIIVDRMKREFNVEANVGAPQVA
YRETITKSVEIDYTHKKQSGGAGQFAKVKIKFEPLEPGSGFQFESKIVGGAIPKEYIPGV
ENGLELIKEGGIISGFPLIDFKATLLDGAFHEVDSSPLAFELAAKGAFKEMANKAGPKML
EPIMKVEIITPEEYMGDVMGDINSRRGNVADMLDLGNNSKIITASVPLANMFGYINVLRS
MSQGRAQYSMHFSCYEQVPQYVVDELKLEYN
>ELAGILAN_01087 30S ribosomal protein S7
MARRNKAKKREISPDSRYGSVLLMRFINTIMKCGKKSTAEKIIYDALSLAEKKIGEGGLS
IFETAVGNVTPSIEVRSRRIGGATYQVPVEVRQDRAVSLALRWIAKATSAARKKSGKTTV
DCLQSEILDAYNKRGGAFKMCEEKYKMAEANKAFSHLRF
>ELAGILAN_01088 30S ribosomal protein S12
MPTINQLIRKGRLGLTHKKKVPALGKSNPQRRGVCTKVYTTTPRKPNSALRKVARVKISG
YGEVTAYIPGEGHNLQEHSVVLIRGGRVKDLPGVRYHIIRGALDLRGVQNRKKARSKYGV
KKSG
>ELAGILAN_01089 Polyribonucleotide nucleotidyltransferase
MFKIIKKSIEWGGRTLSLETGKIARQAHGSVVVNYGDTSVLVTVVSKKKEENVDFLPLNV
QFIAKSYAMGKIPGGFFKREGKPSDRETLISRVIDRSIRPLFPEGFHDEISVVCNLLTYD
TVNPPEVPALIGAVAALAISGVPFHFTIAGVMVGCDENNNYILNPSVQEMKASSLDLFLS
GDENSILMVESEVKELSEENVFNAIKFGHEHLKPVIKLIKEFADTIGNKPESFAPIDASD
ITQELEKYGKDFEKAYSQTVKQERVQALEAIRENILNTLKETGKDEKLITYAVKNFERSL
VREIIRKKSVRIDGRKHDEIRQIEVEVDILSKTHGSALFTRGNTQALVVTALGTTQDEQI
VDDIEGDRREHFMLHYNFPSFAVGETSAARAPGRREIGHGKLAWKAIHPVLPDKSEFPYT
IRVVSEILESDGSSSMATVCGTSLALMDTGVPIKAPVAGIAMGLIKDKDEYVILSDILGD
EDYLGDMDFKVAGTSEGVTALQMDMKISGISFEIVEKSLEQAKAGRLHILEKMNAVISEH
SDDVKDHAPRMLSFYIDKDKISAAIGSKGKNIRSVCERSNAKIEIGDDGKVSVFATSGTE
AEIAKSMMIDSITELEQGSIVDVKVVRIEKSIVELEFLNGRKGKMHISEVANEHIDSIES
VLKQDDTFKALVIDFEKGGCPKLSRRRVDQETGEFFEGELYNEERKDGPNDRDNYYNNSF
SRKPGGSHHKRPPRPRSGFSNRNRPKFGNNDSSSGFY
>ELAGILAN_01090 30S ribosomal protein S15
MSITSEKKKSLINIYAIKEDDTGSSFVQCAILTERISNLTEHFKVHKHDHHSKRGLLILI
GRRRKHLNYIKRKFGNEAYQELIEKLGIRK
>ELAGILAN_01091 hypothetical protein
MTEDDGVTGSNTKSFVIPIESALKSMFKVEISLEDAGKIRKGQEVVLNNLRNLKNHDICC
TVVGSVPIAICSFIYGCVKPIRVFNI
>ELAGILAN_01092 hypothetical protein
MSYGKRSYIESFFSRLKQTFGFSFRNKSETNREKELLVKCYLLNKFTDIGMAKFEIAS
>ELAGILAN_01093 hypothetical protein
MLNINNKVNYEINIKRKEKKYSWSTVFAWLYLKTIGRILPKRWNRWAENILYYDKTTANN
EVQTDAFKTIDGSVQVDLKPEVAVRESQSGVISKDGEVQTNKVTFHDIAMQTEYVETTDK
NSDQAQQVEDLQSKNGLLEVKIEELRSIIIRLKADLQSKNSSLKKENRELQSIIIRLKKN
YRELVEVTDKQEKGFLVKLKAKSEMIGCQGRELTELRAEFTNKINELFERVEEVRKEKSK
KKKEELQEQVEHLNAKLERARNVAIFSIGERTKTLDENLTLKNQQIESSPAKDEQQNGKL
TEKDTQGQTKTKAPDTVSTVSTAKSTTGSMKSKIPKGLSKLRGNENCDKFLSDKNKELKK
SFSEFEKKHFCHNVLNETIKSLSNQDDGKFESSKLLELLESNLKQSAREIIEAKVKEVVN
EHCNIGKNMGKELRDDTLKAKLSPSVRKCVKKLEFNKQEGVNKIVDSILHSFNSKNNNNN
DSGELLKEIVTGKLTEAKMKCFSNKIQELQLALSIRDKFLSPDQGMCNQTQGGVNEYQLT
EKAKKEHIPNSSMSSPNIASIHSLNSQKAVRYPFSGVAE
>ELAGILAN_01094 hypothetical protein
MNKKFLYSPLSIKSIGENGVFSGYASVFNIVDKQNDLILPGAFKENLNRNKIKLLWQHNP
DEPIGSIIDIYENDVGLYITAHLLLGIQKAEEVYLMLKTGAINGLSIGYIPIEYDVDHKS
GARVLKQVELWEVSLVTFPANLAAQVINVKNQNNEQEVLARAIEKANAVLADMYISA
>ELAGILAN_01095 hypothetical protein
MIPFIVGCITSFVSLMAINAIKGNYYNGPGSLTCIPVFHANMSNFSDFTTDRINTFASFI
IGTIAYKAAQNISTLVRDVSSLLHNRLEVQKNESEIARYKKIQENVISILSEVKVGSNLS
RDINC
>ELAGILAN_01096 Pyruvate, phosphate dikinase
MYNVFISENPEKMMGEKLIHYFSQGKCEGNAEMKNLLGGKGANLAEMCNVGIPVPPGFTI
STSACKVYYQDNRSSVIQVSDYSDPEKNVVTHWNDICSGIKNYMTMLENDIGCKFGDLNN
PLLVSIRSGSVSSMPGMLDTILNVGLNDETVVGLAKKSGERFAYDSYCRFIMMYSNVVLQ
LDHHLFQDVIDNEQQKSGAKSLADLDVDVLKRIVNDFKKIVYEKTEKHFPQNVEEQLLNS
VNAVFASWKNDRAVSYRRIHNIPENLGTAVNVQAMVFGNLNDNSATGVIFTRNPSTGEKK
LFGEFLVNAQGEDVVSGVYTPMPIDGEQKNTMEKLLPSVYRELCVVCEKLERHYKDMQDI
EFTVQDGKLWILQTRSGKRTAEAAIRIIVDMVNEGTITKEEGILRIDPKTFDNLLHPVLD
VKSDQKVIGKGLPASPGVASGYVVFSASDAEKAAEQGKKVILVRSETSPEDINGMNAASG
IVTARGGMTSHAAVVTRGMGKPCICSVSGLYIDKDGTFFSVGDTKVNKGEPITINGGTGE
VMLGILPTISPELSQEFKTVINWIDEIKTVKVRANADTPKDAKIAKEFGAEGIGLCRTEH
MFFASDRIEFIQKLIIADDENERANALIKLEEMQKSDFKEIFSIMEGREVTIRLLDPPLH
EFLPNDQSTIEKIAKSLSKSVESVKNKIAQLSEKNPMLGHRGCRLAISHPEIYSMQIRAI
LSAASELKKEKKIEVEPEIMIPFIMSEKEFILICELAKKESSVISQTQIPASRAGMTSDK
AYSIGTMIELPRAALIADKLAKHAEFFSFGTNDLTQTTMGLSRDDSVNFLDSYKKNNIFD
NDPFEVLDIEGVGELIKMAIERGKKTRKEIKLGICGEHGADPKSIEFLIESGVDYVSCSP
YRVPIAKLVAAQFSVRSKFAR
>ELAGILAN_01097 Succinate dehydrogenase flavoprotein subunit
MDKSAYEIIEHEYDVVVVGAGGAGLRATLGMAATNFSVACISKIFPTRSHTVAAQGGISA
ALGNIGEDDWRWHAYDTIKGSDWLGDQDAIEYMCKNAAKAVIELENFGVPFSRTEDGKIY
QRSFGGMTTHFGKGKSAQRTCAAADKTGHAILHTLYQQCLKFNAEFFVEYFVIDLIMDSE
TCCGVLAWSLCDGTLHRFRAHRVVLATGGYGRVYFSATSAHTCTGDGNGMVVRAGLPLED
MEFVQFHPTGIYGSGCLMTEGCRGEGGYLVNSQGEKFMERYAPKAKDLASRDVVSRAITI
EIREGRGVGPKKDYMYLTIAHLDPEVIKLRLPGISETARTFAGVDVTKDPIPVIPTVHYN
MGGIPTNYYGEVITLKQGKEEVVDGLFAIGEAACVSVHGANRLGSNSLLDLVVFGRAAAL
RAKEKLKSGTPHKKLHSDCTDWIVDRFNKMRFASGGLKVAKIRSEMQNTMQKYASVFRVA
EVLEEGKKAIKKVAKMMPDISLEDHSMMWNSDLVEALELANMIPQAVITMECAANREESR
GAHAREDFPERDDKNWMKHTIAWLEEKKGQINVKIDYKKVAEKTLSGEIDFIAPEKRVY
>ELAGILAN_01098 hypothetical protein
MLKNGADITVQDKDEKNALHHIALLKGEQKVTCLELILNSVEKEKFSKAANATNEKERTP
LQVALITKTTKDKHNLVNPKSRDNTIKFCVKLLQNGVDPKQLILPERLWSKEYYKTIKGI
EKSMGRALIPDDMRTELKCNFGRKLKARDIVKYINNVACKAVTTLVFAALACAAIFSASQ
GIITIATASSIIAVIGVCYLIYLNLENIYEGFGKIKGKFTEEKQLTLQDNAPKNDTQCNN
SVKDIENKSNDLEEQEVQKSPNQSEHTESPPDTKMSAISIYELVEKLCRDSVTSKPSSLA
L
>ELAGILAN_01099 Phosphomannomutase/phosphoglucomutase
MDNTIIRKYDIRGIIGKDLQINDGYEIGRKFGQTVASVCVGYDSRIDSPGIERELIRGLT
LSGANVIRVGLCSSPMLYAATQITQADLGIIITASHNPSEYNGFKFFSNKKVFSDQEMKE
IISSPIKNSTRIGSLININIYSEYISILKSAVKNNTTQKLKIAWDCGNSPASGIIRYIEK
ILPGHTHIVTNNSIDGAFPLHDPDPIEEKNLAQLIDIVKEYGCDLGIALDGDSDRVRLID
NKGNVVSNDHLFIIFAREVLEEYPESKVIANVKMSMKVHDFVSKLGGQVITCATGHSLVK
KKMVEEEAKFAGELSGHFFFSELSFDDGLYSAVKAVDILLKKNQSLSQVIEDLPKLYITH
EVKIVVKDEKKFQIIESIKKTLEQQNIVFSDLDGVKVTDNKGWWLLRVSNTQNCITARCE
GETLEGFELTKKVLFHYIDEARSLNCSYSQK
>ELAGILAN_01100 hypothetical protein
MPQENENVFIAESQSLDVDEQQKKDILDVIESCSSFQETIKQLEEKNLIWYFIGPLRKDE
DITGQINLKWEKEFQKFEQSINETHREFEASLPNQNFLAYSTKDDDFKIRFENEEKPIEI
SNILRASSEGKVYNISLGKDSQITATKKGSERHYDFTGSSSCEMTINWQAKDSEGNSIDC
SMTVKLDSGGIQSVIGEPKFGGITSSEEVLKLVGQNKEVFINGKTLYQAFTGISKSVDDQ
QVPAEEIFTKDLHISPQSPTPSSSGYSSPSTPSSRRSSISTSSEFSDEDEIFEDDMSGDE
EEYEQEGLKDEVDEIINEIEELKEGKETFAQHFAAQAKQLEDLRLERDSLRDKVNEQQRA
IFERGQRIKEQEEELQDKNDVIKNLNDQLKDKEGETNEANKELQRKLKQSEANLTVLKEK
NANLENDLKKIVEGLNDDHKKQLAEQLMETKKENNTLAETANQLSKELNELQREKIPSC
>ELAGILAN_01101 Aspartate carbamoyltransferase
MNKRRNLLNISDLTVDDVENITKLANQYLKKEVANSHILENKTVINLFFEDSTRTLASFE
IAAKSLGANVVTLPIRSSSINKGEDLKDMIKTLNAMNPDYIIIRHKSSGIINTLAKYVNC
SLINAGDGSSEHPTQALADYLVISNHKKQIKDLKVVICGDILHSRVARSNIRLLKMFGAE
INLVAPPTLICKHFPEVDSVHYSLIEGIKDADVIMLLRLQKERMNNSSSEKEYFYLYGLD
SQKLSYAKPDAIVMHPGPINRGIEISSDVADCVILQQVEFGLAIRKAVLHYYRPC
>ELAGILAN_01102 Iron deficiency-induced protein A
MKKAFIFTSLIAIILIVITYLYRNDGTNDSQVVNVYSSRKEELVRTLFDEFTKNTGIKVR
YIIDDYSQLLSRMENGGEADLFLTADAINLILAKKRGLLSQVDSEVLKSVIPARFRDSED
YWFGLTKRARILVYNKESVDPKDLSTYEDLANEKWKGKILVRSSTSPYNRSLIAFMIANN
GFEKTKEWVSGIVSNMARKPSGGDADQIYAVAAGEGDVAIVNSYYFARILLSENKKNVAD
KLGAFFPNRNDHGVMVNISGAAVTKNAKNRENAIVLLEFLVSKQAQELYAKKNQEYPIIE
GVETSDILKSWGNYSQSDLPLSELEKHLFEAVMIADECKWK
>ELAGILAN_01103 Serine hydroxymethyltransferase
MMSVLKKICGSKNSLKSFDNEVYQSIEKELQRQKSQLQLIASENFASKAVMEAQGSFLTN
KYAEGYPGKRYYCGCEHVDKIESLAIERLCKLFGVKFANVQPHSGSQANQAVFASLLTPG
DTILGLSLSCGGHLTHGAAPSLSGKWFKSIQYTVNKDTYLLDMDEIEKLALEHKPKLIIA
GASAYPRKMDFKRFREIADKVGAYLLADIAHYAGLIAAGEYPSPAEYAHVMTSTTHKTLR
GPRGGIVMTNDEILHKKIQSAVFPGLQGGPLMHVIAAKAVAFKEALAPEFKTYSKKVVEN
AKVLAQELQKHGLDIITGGTDSHIVLVDLRSQKLTGKDVVDSLERAGITCNKNSVPFDTA
KPTITSGLRFGTAAETTRGLEAENFKEIADLINEVIQGLISGNSSSVEKAVKAKVERICS
NFPIY
>ELAGILAN_01104 hypothetical protein
MPNIIAPVLITKFNISIADLGQFNGLYYVGFKLVHIPVGLCFDRFGPKIVLPICAVLVSI
GTLPLVCFDEWYYSVLGRIIVGIGSSASVIGVFKVASMYFSREKSAKMASISVIIGLLGA
IYGSLPIELLLDEFGWNYVIYILSGFGFLLALSLFLVIPYNAYNFRKEKISMKDLKTVLF
NKYIILISFFGGLMVGPLEGFADAWTKAFLCEVYQMAGDLASSISSVIYVGFAAGLLSFA
HILEKYPNRHYEVIIVCSFAMIASFLLLFTQAGGLYIVLPALLVIGFASGYQIVTLYKAL
SYVNNNLIGLTTAVSNMIVMVFGYFFHTGIAKIIDLCWDRTVIQGNPVYSAELLIKATSI
IPVCLLIAVFGLLWLKKQDKQS
>ELAGILAN_01105 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MVRISYLAVQLNKYKNQNVAVFGLGKTGLSAINALTKSGARIYAWDDHEEQIANAKMMYK
KCNFIHPKEYNWHEISALVLSPGVPTEPHWIVKLARRFDCKIKSDIELFLEAKTTNQKVI
GVTGTNGKSTTTSLIGHILKSAGKKVAIGGNLGVPVLDLERDAEIYVIELSSFQLELMNE
INVDISALLNITPDHIDRHGSMENYIATKLKLINGSEVAVIGCDNEITADIFNKFTGDKI
PISVTYSPMSFQRVTLESRKEKPLPTTQMTEGGARDLISLAGNNLLDYSEQITGIDRNYL
DPSVSYLDDKRGTGIQKISLKLENHSLSVSDVKINLISNAENIAATYAVCKVLGVDSNTI
INGIKSFSGLRHRNELLGKIRNVFFVNDSKATNAKSSEKAILSYENINWIAGGRSKKGGI
ESLSKHFTRVRKAFLIGESTEAFANVMENKVDYVKCCNLEDAFRLAFEEALNSAEEVTIL
LSPACASFDQWKNFEERGEAFCRMFENLRYNHTCCLV
>ELAGILAN_01106 hypothetical protein
MEQKLIIDKLIRVIPFEGISDETLLKVCTDLNLANSFCKFQNGIYSALEHIAEDLNSSME
AELRNSNLEDIKVRERVKLAIQIRLSNYAKLPNYRELLKNVLSFSVSPKNTYFSSKLLYR
TISAIWYGIYDQSTDFNYYTKRAILAGVYLSTILFFINDYSEDFADTLSFLDNRINNVMT
FQKFKTRLKGIIGNFL
>ELAGILAN_01107 Single-stranded-DNA-specific exonuclease RecJ
MLLEIEKRSITNALWKLQEADQRQILTLTQRFELPEILARILVTRGVNIENASDFLYPLI
RSLLPDPFHLLDMDKAVSRIIRAIKNDENLAIFGDYDVDGATSSALINRYLRAIDIHSII
YIPDRVDEGYGLSTDALLQLKKNGIDLCISVDCGTLAYQPIEDAKAFGLDIIVVDHHLGT
EKLPSAVAIVNPNRLDESSPYNNLAAVGVSFLLIVALNKSLREQGFFTNKKEPDLFDLLD
LVALGTVCDVMQITGLNRALVSQGLKVMSTRKNVGLRVLFDALGILEKPSVSRLGFSIGP
CINAGGRIGEASLGARLLSTDDDEEAHSIALKLIDLNNARKVLENEALLEATAQAEKSAQ
SGANFIMISGNWHQGIIGIIASRLKEQFHLPTVVISLNNGIGKASCRSILGVDIGAAVLS
AKFINLIIEGGGHSMAAGFSIKEDKINDLHDFFTERFSNSINEKTLKADSIVTAKAINLS
LWNQLQRLGPFGVGNPEPRFIIQGAKIRKPEVIGVDHIKCFIADDNVMVKAIAFRSANTH
LGSAIMQGNVKAILGKISMNYWNGNEFVQFLIEDVLTIS
>ELAGILAN_01108 Rhodocoxin
MPSVTFILPDGSKKSYEAAEGETLLNLAHRSDPDLLEGACEGSLACSTCHVIVDPKFYNA
VEIHNPISDEENDMLDLAFGLTETSRLGCQIKITKDIDGLCVTIPRGTRNISLDK
>ELAGILAN_01109 hypothetical protein
MRKIFIYIIISLLLFIPVAYSGFWYFSACKVKNLLAETILYINDEKFDISHDFSGFPSNL
IFRVTNPKFSNEQLTISSDALLIKNRLFDKSVYIYIPSNEVNIAVHDDEKKNIKCHTNDS
SHFVVRLNDLPSSLRFNKNSTVIDYIDTLRYEDYGLKCDVSENQQSVITEVNDKSNYIQF
HLDKEPSGNTKLGFDFYTYRYKNTASPENYLSIDTKFDYEFVNHISASRVNFNIEKFLIQ
SNNFSLAADGGVQNYNLVTSSFKDKINVAISNYKELISFMIGDSKTSDVFEKLMSSLSEK
TTDDGIQFSIKYDDDVGSSFIGKLSTTDFMNQLGKITQLTKDESSS
>ELAGILAN_01110 Cytochrome c-type biogenesis protein CcmH
MRAVVSLLFILIFHSGVNAFTLDNKLRDKSMEKRATSLFEIIRCSICSGESLSESGSQIA
YDMREAIRKKINDGYTDEEIISELKNSYGNSIIIVPPIKSSTYILWFIPLTTLLIGCFLI
QRYINTTT
>ELAGILAN_01111 Type I secretion system ATP-binding protein PrsD
MEITPSIKKELKQSTLYICLEKCKSAFWFIFWFSAGINLLMLFLPLYTSQVLDRVISSES
VSTLTMLTIITLSAFACSAMLETCRYLAMAKIGDWIDKTATPDLIVRSIRLTSVQSSTSS
GEAIRDLGVIKNFITGNGIFSLFDTPWSLIYLVVIFMIHTSTGFIAITGIIILVSMAIWN
ELATKRILQETNEETIRNINAIDVATRNAEVVEAMGMSEFIVSDWCKRNDQNRAMQIKAQ
NRSNVITGITKFLRSTLQISVIGTGALLAITAHKTAGSIIAASILMGRVLAPFDAAVHTW
KFLNQARMSYGRLQRLILTSPKREQTMALPEPEGKLEFDRVFFTPYGSNKPTVKGISFII
DPGDVVGVIGASASGKSTIAKLTVGVWKPISGVVRLDGADVYTWNRENFGNYVGYLPQDI
ELFNTSVKANIARMRPDPNPEEIIKAAKIAGIHELILSLPNGYDTIIGGPGGVTLSGGQK
QLLGLARAFYGHTKLLVLDEPNANLDSNGEACLINAIGIARKQNTTTVIITHKLPLLSVV
DKVILMSDGVIYAMGPKDEILSKLVAPSSSTTEDERSSANG
>ELAGILAN_01112 hypothetical protein
MRILTKLKKIMNDKDLFEEDGDDIEENNDDKREKSLENENQQNQEEQHKEEDKQYIIQYI
QDYLKVFEDILNQIDEGIDNSDSYERTMQIKRSIDRLIETLYSQAASEDIDAEFETTKHT
RDKSESMKRVREKRRKQVIEEVLSSMFAQQQKELMNAKHLSHGHETAKDGDVHEAKEKVK
SSIRGVLFSVIAHRMDPRRRAGETADGNEKQAHIYGREAVGGALGALLKTFLTAVVAVVR
EIAKPLQKPETSFAKQVEESRNADSQKGRSV
>ELAGILAN_01113 hypothetical protein
MSKLQLKIKDHDNNFIVLNNIRNLRFTLRNNREEVKDISSFGWRKVLDCAGSRHITIKIN
GILDSVLADELLRNSAMLNSNNDYEISFNAKEKIRLRCSVELYERYYDPVTFDSFTVVLA
SAEVVNAFH
>ELAGILAN_01114 hypothetical protein
MKKIQAINELYNSIYEALKANSDLRKYVTNIYDYLPKQVTIPYLRLRAVNYSNLHMLSNF
ATKARFSCDIYTYHINSMFAIIRHINLILKSIEGFSSEVILESNCAMDQHDEILHSTINF
DILIKGGDNEQITAKN
>ELAGILAN_01115 hypothetical protein
MSGQVLFNTVDVVYEAGYDNVPEQIKLGIMRHVSALYKNRESEVSSHLSEVKKVYSPFRE
PKVVL
>ELAGILAN_01116 hypothetical protein
MLFNSIALVVSLLLFFYIIVKKLSEKKANLEGNLCKLEQELQETKQTLLTKNEEIVDLRV
KRAELEVTLQKEREEKKKEIELLTKAEERLTNTFKALSLDALQTNNNNFLNLAKEVIDSK
LKETESDFKKRQATINEVVTPIKEKLEKFDNEIRELEKERVGAYEGLKEQIGALMNQTSN
LANALRKPHIRGKWGEMQLKRVVEMAGMIEYCDFFTQPSVIDKNEDNLLRPDLIIKMPSG
KQIIIDAKVPLDSYMDAISQNDLQIQKEKLKNHSLAIKKHINDLGKKEYWNQFENTPELV
VLFLTGEGVFSAALEYEPALIEIGVEKKVIIATPITLIALLRAIAYGWKQEMIAENAKKI
SELGHILYERICTMGENFDNLRRSLKSAVDHYNKTAGSLEARVFPAAREFNKLGIHAKNK
SLSAAKELESLPRSLHTEGLKVD
>ELAGILAN_01117 IS4 family transposase ISWosp9
MEDMYKGYGSSYRDCENNTKSGIKLQLVFDYLNQALDKLNFMEGIRSDQGYRDYLNGLSA
NDLLIFDLGYFVPSSFKQIDEAGAYFVSRYKSDTNIYDIETNQKIELLEYLEGQLSSEKE
VLLGKEVKTKVRIICQKLTEEQSMARRRKANKLAKSHGYTSSQKNQKLLDWSIFITNVPE
SKINAEQILTVYRVRWQIELLFKLYKSHINLDKLKGKTNPFRVLCELYAKLCAILVFHGM
IGCVKLKKNTELSLTKAFIELKRRVRELFLILNNIVNNLKIFLKKLTIIWSKFSLKDRYR
KTRVSTLSSLHSLT
>ELAGILAN_01118 IS4 family transposase ISWpi18
MVLPSGEIEVLATSLMDEQKFQTGGFKELYFLRWGVETFFAKLKGRLSLENFTGKSVESV
KQDFWSAIFISNLESVMTEDVEEALNMDLTDDKLKRSINKSVSFNAIKNLAFDIFATESD
TDCIMDQLSKLFLMNTLAVRKGRKVDRHKVPYLRSFNYQKRVRKHIF
>ELAGILAN_01119 IS4 family transposase ISWpi18
MRKRKLSFIDIFILILRKSVKSLQVILNEFILYRKKDYTVTASAFSQARKKMKHSAFSEI
NEGVVSLYYQDQKFKTCFGFRVLALDASKIILPTSVEIKNEFGSRKIRNQKPKDLGDYAS
ATFAVC
>ELAGILAN_01120 hypothetical protein
MMTSNNSSLLKDSQELTKTKGTIWKPLIAVSLLSVFSFTSGQYLPYVIAAVSGSGAIAAV
PLAIFAVSTVVALISVTYLYPFSGVAE
>ELAGILAN_01121 hypothetical protein
MTLRLILQEVNSSPDLSAENVVEKIKDELQQKLPDIYSEWESNQFDINHTFEVLNCGLLL
IAAKNGCGKVVKHLIKSGANVNVQDVWKKTSLHYSAQYGYMQVVEVLLEEGADVNAQDED
KEIPLHVAAGKRDIEIVQMLLEKVANVNLQDKSGGTALHYATCNANICTPMKDDSAAKIA
GLLLQRGVDVNIKDEDGKTPLHYAIGYELIQTIEMLLKKGADANIKDKDGRAPLYYATLN
YSYRNIRLGGKLLLDCDTTLLGNFYEPYKPSPRMAKLLLNYGANPSCIHRPKAITAGVAV
GILAAIVTPLALVYATALPALAIIGITVASALIVGGISYGAAYKSSEHSLNSKLSEVRCS
VSVQRSGRIR
>ELAGILAN_01122 Transaldolase
MEIFLDSVDLNEIKGLKEFIDGITTNPSLIAKSGRKDKYEDLVREICSIIKGPVSVEVVA
DSHEEMITEGLNLAKIADNVVIKLPLTHEGLISCKKLWTEHKIPVNITLCFSPGQALLAA
KVGACFISPFVGRLDDISYDGLSLIEDICTIYSNYGFDTKVLVASVRSPAHVIEAARLGA
DSITVPAKVLRQLINHPLTDQGLAIFEKDWGVK
>ELAGILAN_01123 hypothetical protein
MTAFVPLIIFLILYLGSGAYFSFIGTDNPLHQVSPVICLLPALFFAVSRGTNKIQHNIDT
VIKGMGDKNTLTMCLIFLFSGAFSAVTQSIGSADTVANLILNFLPARLLLPGVFLASAFI
STAIGTSMGVVALMVPIAVNLAKSGAFGLEIGTATVVGGAVFGDNLSMISDTTIASVSSQ
EASAKDKLKMNSKVALIASIITLIYLAVASNSTKIISISNLDYYSIIKIIPYISLIIMGL
LEVATLVTITINIIIAGVLGITFFDYAIIQFPHDVYDGFKKVNEIVIFALFIGGLSHIMY
KQGQKALHKLIDESNITKTKAEFVIAGIASMFTTLVANNTIAILLSGGIAKRLAQKHSIA
PHRSAYLLDVFACATKGILPYGSQLLLAGSIASVSPISLLTQVYYCFILAAVTIGEIIIN
SRKEKHCAAAT
>ELAGILAN_01124 hypothetical protein
MKNFLLLAVLIFSFAFDANAADAFVDTSDTTSSVICKIIGYTHGIGGPMITIVIIGAALL
AIFGRMPWPALFALGAFTAVFFGAPVVVSKITPGGVICKDGAVADK
>ELAGILAN_01125 hypothetical protein
MKNFLLLVALILFFAFDNAFASSVTDDATSNTICKIVGYTHGIGGPMITIVIIGAALLAI
FGRMPWPALFALGAFTAVFFGAPVVVSKIVPGGVICKNGATACPDGTNWDTSTGACKK
>ELAGILAN_01126 hypothetical protein
MKNFLLVVALILSFAFDAGAPPVPNQSTTFVDTDDTTSSVICKIIGYTHGIGGPMITIVI
IGAALLAIFGRMPWPALFALGAFTAVFFGAPVVVSKITPGGVICQNGAVANKP
>ELAGILAN_01127 Thioredoxin reductase
MKNYKFSTKVLIIGSGAAGYAAAIYAARANLEPIVVTGMQPGGQLTITTDVENYPGFVSI
QGPELMEQMRLHAEKVGAKIIDDEIKSVEQLEDSNEYRFRSSGNTNDYYSDAIIIASGAQ
AKWLGLKSEKEFQGYGVSACATCDGAFFRNKVVAVIGGGNTAVEEAIFLTRFAKEVILIH
RRDKLRAEKVMQDRLFKNDKIKVMWNHTVEQILGEENPKRVAGIAIKSAETQELKVDGVF
IAIGHAPNTGIFKGFVEMDEQGYIITKPGTTLTSRAGVFAAGDVQDKVYRQAVVAAGTGC
MAALDAEKFLES
>ELAGILAN_01128 Alkyl hydroperoxide reductase C
MNLVTKSAIDFTASSVLSDGEIVDDFCLSKRIKNKYAVLFFYPLDFTFVCPTELISLNNR
INEFAKRGVEVIGISVDSKFSHYKWRNTPVNDGGIGEISYTLVSDIKKSISRDYGVLYDD
SIALRATFVIDDKFIVRHQSINDLPLGRNIDEFVRIVDAIKHNEEHGEVCPAGWKKGKPA
MQASDEGVADYLNSYSEEL
>ELAGILAN_01129 hypothetical protein
MSKEYDETKVKPAISTPQGPEGTNGSKAQSVLSNKRKPTINFDDKKYGVKTSKIDQQSLN
KRQESSKLRDFLRSIPIIRRFLARIFTPEKIEIISNPIYDNMEAYKKSQEDYPSKIKDET
SIDDEHTKEVDSKLEKGNVEQVDNKKSRSS
>ELAGILAN_01130 Aspartate-semialdehyde dehydrogenase 2
MGYKIAVIGATGRVGREVLSTLAEFQDEAIDCVIALASKKSEGKKVSFGDKELTVLCLED
YDFVGTNVAIFCAGSHVSEEYVPIATQAGCIVIDNSSHFRMKEGVPLIIPEINKEKIMEY
KNHNIISNPNCTTIQMLLVLHLLHQKAKIKRIVASTYQSTSGAGKAAMDELYDQTKKIFM
NEAKKPKIFSKQIAFNCIPHVGEFMENGSTEEEWKMQEETKKILEEDIKVTATCVRVPVF
IGHAMAVNVEFDQHITEEQAREVLSEAEDSGVLVYNRREDSEYITQIDVVQENAVYVSRI
RRDNTVEHGLNMWIVADNLRKGAALNIVQILEILIREHLSIKCI
>ELAGILAN_01131 hypothetical protein
MNFLKFIELCFQTVVPGCEYNDYQYIKVIADRLEAANVGKMRRIIFNMPPRSMKSLCISV
AWPAWILGNQPTARIIVASYSRLLSEKHSLDTRCIMQSSWYRELFPEVELSKDQNTKYKF
QTVQRGYRIATSVGGTLTGEGGDFIIVDDPLSPAQALSETFRKRATNWFDQTLVARLNNR
KKGVIVLVMHRLHQEDLTGHLLSKPKNIWNHTCLPMISENKEIIYSIKKPAPPFLVPVTR
VTTNEYKSWITASSARMTPPVILYSREEGQLLYPLDGGKEEVEMIKVELGSYAFAAQYQQ
NPLPLSSGIIKREWLKRYRNFSDSLSYVTQSWDTAVSTSSMSNFSVCTTWTKVGNKFYLL
DVYRAKLEYPKLKEQVFSLAARWTPHAILIEAKTSGQQLVQELKTNSDLPIIEIVPHDDK
LTRFYQIVPIIESGKVFLPHQAVWLNDFEYEILMFPETRHDDQVDSTVQYLQWVRDSSSR
VAALRAL
>ELAGILAN_01132 hypothetical protein
MLFSRYKEDLEREIRQLEPGKSLADELSEENTKREIEKLQYQLKEKEGMLTCTQEELASV
KESLEQLQNILQQEKGQATQTEVEYESRGTSMQQQDQGIQAVNNNSSRIASGLRQENKKL
TRDKLTISEQLKQKIREIDELKKNLKQLQEENKQLKQEVTKNAGVDASSSTGQKEAKEAE
VIPQNIMDWPVPIPDDKPEEQKTPLEPIKVNTELSDPKSISAEGPEKSLPLSK
>ELAGILAN_01133 hypothetical protein
MCKELRSFGLPVICVDARHMAAALSARINKNDKNDARGIAQMMRSVSKISCQIKIALGSR
RQLMCSKQQVIGTIRGLLKIHGR
>ELAGILAN_01134 hypothetical protein
MLAPVSLPSIAVTPGSVALEPSTLRTLFASISLPSMAVTPGSVALEPSTLTLPSNLVSAA
VLV
>ELAGILAN_01135 hypothetical protein
MPQKMRVSNHSEYNKFLEKRGNIFHYINEAIEKWYENGPKIPGGNNIYSDKVVILVHIIT
CLFRIGLRQTVGFIAGYLEQIGKNLQVISYSQSSRRFKKLNIKINDCRK
>ELAGILAN_01136 hypothetical protein
MIAENNMEDIEIAIDSTGISIYNNTPGHSKENSEDRKYRSYEQTRKLHVMLNTNSKKAIA
VKYSNG
>ELAGILAN_01137 RNA polymerase-binding transcription factor DksA
MEKLPKIKSPEDYNPSEDEEYMSVKQLEYFSLKLQSILAELEKQELEDNSIDTYYSDEDS
GNEELIKRRKDRKEKIKEALEKIKLGTYGYCDGTGEEIGVERLKANPLAIYCIEEQERVE
KEKNVYNIND
>ELAGILAN_01138 hypothetical protein
MIGSVKKLVIDNKNLTYVVCIFIIMLSLSSFTLENNNKQEVMLTLTWICATFVLQISTNN
LFTSDYHDGILEQIFVQPLSSRLIVAYKIFAHWLLFGLPISVISSIFSFAVLCNSIEHSI
AVGVSLLFNTLIIINISATGNALMIGRNNLASGVSQILVLPMIMPTFVYFKMLTQFENLS
LNIYTLLITILIFVILIVNSTITTHMALKFAVEQD
>ELAGILAN_01139 hypothetical protein
MTFLLTNKTVSFLIVLMAVASTFANFLDQYNIGWVFIIDNMPQDILSSLMPRIREIISGP
PQSLLTLAIVGAVWTASSTIEGLRTILNKAYKVPVSPPYILRRVLSILQFLVITLIITLT
IVFSTLVPMLIDFSYQGLSYTRYLLIEFVLFTVVSWLYFMLPNIKQNLSDVFPGSCVAVI
LWTISASAFKQYLKASFDQLDLIYGSLGGVVVSLLFFYMLSLIFIYGAKFNFQLKYFNGS
R
>ELAGILAN_01140 putative oxidoreductase YciK
MDLAKEKEMGKLEGKVALITGASGGVGSAVAKRFIREGACVILISRSLDNLKPLYNEIEE
LEEFKEGSVKLIQLDLLDFENVKILTNMIESLKLSESGALDILVACAGILGKLNPIHDCE
IEELQNVMNTNFTANWYLLKNLDPMLKKSNAGRAIFMTSEVTLSPSSYPYWMPYAASKVA
LEIMVQIYASETKHTKLCVNAVYTEGPVGSEQAFPGSELVSPDKLTDKFVELASEDCSIS
GKILPLSKSPE
>ELAGILAN_01141 hypothetical protein
MNFLKFIELCFQTVVPGCEYNDYQYIKVIADRLEAASAGEVKRIIFNMPPRSIKSLCASV
AWPAWILGNQPTARIIVASYSQRLSEKHSLDTRGVMQSSWYRALFPEIELSKDQNTKYKF
QTVQRGYRIATSVGGTLTGEGGDFIIVDDPLSSAQALSETLRKRATNWFDQTLVTRLNDR
KKGVIVLVMHRLHQEDLTGHLLSKPKNIWHHICLPMISENKQVIYSIKKPIPPVPIIRVA
QHCATRRLYNKPASPVRILYSREEGQLLYPLDGGKEEVEIIKAELGSYAFAAQYQQNPLP
LSSGIIKPEWLKRYKKFPDNLSHITQSWDTAVSTSNMSNFSVCTTWAKIDNKFYLLDVYR
AKLEYPKLKEQVLSLAARWTPHAILIEAKTSGQQLVQELKTNSDLPIIEIVPHDDKLTRF
HRIAPMIESGKVFLPHQAVWLNDFEYEILMFPETRHDDQVDSTVQYLQWVRNSTSRVAAI
RAL
>ELAGILAN_01142 hypothetical protein
MLTFKNHCGQLHKANTVFVAFTAIYVIGGLAILSTPLWRPSTCKLAAFAATPLGMGVLAF
VAAALTYLAIYAISKNNEISELKALKVIKDGLLVTKDAFREIARNNQVKDEEGKVEKDKY
YIDFSLEGKNYRIIVDINQLTSILGNTLLFKIGSLKEKNDEGKFEAVNETKWNKTLGLDK
DGAKEVNTYLGSPIVEQAAKGKVLD
>ELAGILAN_01143 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MQRSKIKVEIKRLSHGEDLSLPCYATVQSAGMDLYAALNDSAVLNPLERLLVPTGIVIAI
PNGFEGQVRPRSGLAAKHGITVLNSPGTIDSDYRGEVKICLINLSNQPYEIKRGDRIAQI
LISPVSQVIWDDREEFCAEETGRNAGGFGSSGR
>ELAGILAN_01144 hypothetical protein
MAGNPQGMLMDVQVKDNGESECHFVTKWIEFVTLIRVKTSRLPFGPS
>ELAGILAN_01145 hypothetical protein
MFAFINVRALLRSFLILSFEGFIINFLLYLRTLQPRKSNPVVIDVIFVFSSERIRPLS
>ELAGILAN_01146 hypothetical protein
MGKPACCVSKGGSSSNTTSLPNQVAKTKGFEKRAQYYAAKAYSRQADKGDQYHNLKEIIF
IAIADCVLFPNKSEYKSKHTIRDEDTNEHDLKDFYFIFIELPKFPKNKEDQLENIVEKWV
YFFRYADETSEEELEKIIGSDVIIKKAYEELNRFNWSEKEFIAYEQEIKRILDEQAVLAQ
KLDDATEKGREEGKEEGKEEGIQIGHEKGRAEGIQIGAEKGEKQAKITVAKNLLKAGVSI
DIIAQTTGLTVDEVKDLS
>ELAGILAN_01147 hypothetical protein
MNIFVLDENPVIAAQMLCDKHIVKMPLETAQLLSNVFSIALKAPNPFVSTTDQNIAVPYK
LTHSNHPCSLWARQSKGNFCWLIEYGKELCKEYTWRYKRKHKSEEVIDWCDSNKDLLIFR
STDMQAFIQALPDRYKCTNPVKAYREYYLQEKMRFAKWENGREAPGWIVGNPATHFFHIF
S
>ELAGILAN_01148 Iron-sulfur cluster carrier protein
MINEKIVRENLKKVIEQKSGKDVIALGIISSIIIKGQDVGFVLEVAGNTQANEELRRNCE
QAVKAIPGVTKVTVVATCQKQTGQQKAKLHIEGVKNIIVVASGKGGVGKSTVALNLALSL
AKLKHKVALVDADIYGPSIPKMLGAEKLKPEIQDSKAMPIEKYGLHTISIGYFIDKDRAA
IWRGPMITKALYSLLMGTKWSDIEYLIIDTPPGTGDVHLSLMENFNLTGAIIVSTPQELS
LIDARKIYDMFTKLSVPVIGIVENMSYFIQSGSKIYIFGKDGAKKMSEELGIKLLGRVPL
DPQICHASDCGNPLMLSEDLAEIYEDIAQSIVKQ
>ELAGILAN_01149 hypothetical protein
MDLRKEEGILAKKLDEGKIEGKIEVAKNLLKADISIDIISQTTGLPQAEIKRLQEEIT
>ELAGILAN_01150 IS110 family transposase ISWen2
MINNFLGIDVSKERFDVSLSFISKKGKRETRKRKFKNDDTGFQGLLNFLQKHNVEEVKAC
MESTGCYSEALAEFLHNAGYFVSVVNPACIRFYAKSKLTRQKNDQTDAEIIADYCQRQEP
SRWTPPSPEKKKLKHLYRCSNALKDELTLANNHLEKKERLPKEVANAWEDLAMNIEQKIE
TIKNSIRELLKQHKELLEDFQLLLTIPGIGEETAIAILAEIPGIKAFINARQLAAYAGTI
PQNITSGSSVHAKPRLSKTGSRTLRKAMYFPAIAAKKHNPIIMASCERLKEKGKHAMAIV
GAAMRKLLHIVFGVLSSKKAFDPDHIKNYRAKRLTEGLVL
>ELAGILAN_01151 IS66 family transposase ISWen3
MVNLLELCKNLQQKIERLEAKIERLEKENESLKAENKALKIENAELRERLGLSSKNSSIP
SSKELYKIKKNKPKSERNIGGQVGHKGSFRANMDADKVVKIELPNTCECGGEIAICEKPY
IHQKVDLPEIKPYVVEYQLEHGRCRRCGKRRSSKLPEGVTPDTFGPRVKSIIAAFSGFYK
NSKREIASVVNDIFNLNISVGSISNSEHRVASKCKKMYEQIEQEISRSKVLHIDETSHYN
KGKLAWCWMFASNTASFVKFTESRGMKVLQNSKFCNRNSLVITDRYAAYNYFADKNRQIC
WAHLSRDFERLAHSWNIEVKVLGCYLRNVATELFALKKALLKSEIDVLRFVRRARKLRKR
TKYYLKEISRLPEAIGASRVAKNVLRSERMMWKFLDDPENIPLTNNHAERQIRHYVVYRK
NSYFTQSKRGNTFLERIISLYLTWKQRGLNPFQNLLSIVS
>ELAGILAN_01152 hypothetical protein
MNNQNKSKEENKRKKEIEFRILASKGNALLDHEIIETFLSAVHDRAQARAIAKNLVTTCT
GIGRILGREIDELKSVEGVTDSTVSMIFCVKETLTRVFKEGLKKGPILDNLDKLIEYLRV
SIGYSDKENITIMYLNQGCHLIGEEVFAGRRLSIQGK
>ELAGILAN_01153 IS4 family transposase ISWen1
MNKITCLSKKLKEFFNEKAEKISITTRFIKRKRKLKGSSFVKAMVLGNIGVDNCSVETMC
QLLNEDSIDITKQGLDFRFTEEAVEFMKRMYNESVILFKNILQVDCKILQQFNSVKLLDS
SYITLPNSMEEMYKGYGTSYSGYESNTKSGIKLQLVFDYMNQIIDQLNLTEGVRSDQGYR
KHLSNILSNDLLISDLGYFVPSSFKQINEIGAYFISRRYQRI
>ELAGILAN_01154 hypothetical protein
MPLPLILALATLSVLVLALSYKIISNNVELEAKVKGQLEHKEEMLSLEHQELRDENTRLN
ERVDSLMEELCQCKLESEKNKLCLKSEYEDELRLRLEYEDELNLELEHKSREASSLRTQL
TMLRKKVEVEEVKQLKTLESEEQHESSESDIEELEKKLCQSEKEKKELEGKVSDERQKRT
DLESKVDKLCTKEKEYLSKIKELEKESLSLQKEEKESDNTLTTVNDDRDNKVKELNSSLL
KQSSQIEQLQKALLEKKKEEVLFLQRMIEYVTDEVEKLVRENEVIRDDDKKVILQVIQAT
KSVLVEEAAQYLPGETSVPSFMEDPGYTSGCSTPTNSCHTF
>ELAGILAN_01155 hypothetical protein
MRLYYKDITGLIKEPYRSRGRDYFDKRKVQIISVNESQAKSKVVGSNVYRVTLKHDGPLL
SGTCSCPAFVYYGPCKHMAATGFALVALDRKEYRSSARPDEQTLFERFY
>ELAGILAN_01156 hypothetical protein
MALRSKLLDEKVVESAKEMLKKVRNNAYVAKKLNAVIAAKKHSITAVAKICCISRKALTA
>ELAGILAN_01157 IS630 family transposase ISWpi10
MYPEKELFFFDESRFGTHSKIGHGWFKKGIRTQVKVKLGRQNFYLYSAVNPRNGESSSSN
VNTDCMNIFLEQMSQYLGTREAFLIMDCASWHKSKNLKVPKNIDIIYLPPYSPDLNPVER
FWLYIKQNILRNKIYDTIALLESALCKFITSLSHSTIKKLCNAAYLIH
>ELAGILAN_01158 hypothetical protein
MLNNLQLLLPGHYQSGSSVSKRSCICKIGSERIRKALYMPAIVVKNHNNHFQKFCQRLAS
KGKCPKVIVLALMRKLMHVFFGILKKNQPFNCNFVG
>ELAGILAN_01159 hypothetical protein
MQSLKDDKVQQTNRLENKNMHSSCKEAISKVILAIEEQIIVLEKEINEHINNYPHLKNMV
ENLKTIKGIGYLTAVAVVAEMPSVDNFDNAKQFTAFAARTLSIGIVSK
>ELAGILAN_01160 hypothetical protein
MQVNAILGVDISKKKFDVCLLVDSKKRHKVFQNNQDGFAKLVVWCNGHGANLTHLCLEAT
SWYGEDLATFMHDLGHNVSIVNPESFWQK
>ELAGILAN_01161 IS630 family transposase ISWpi10
MDKIKANKRNSKKNLNGAISKYPEKELFFFDESRFGTHSKVGHGWFKKGIRTQVKTKLGR
QNFYLYSAVNPRNGESSSLFAPNVNTDCMNIFLEQMSQYLETREAFLVMDCASWHRSKNL
KVPKNIDIIYLPPYSPELNPVERLWLYIKQNILRNKIYDTIALLEGALCKFITSLASSTI
KQLCNVSYLTGQQ
>ELAGILAN_01162 IS630 family transposase ISWpi10
MALRSKLLDEKVVESAKEMLKKVRNNAYVSKKLNAVIAAKKYSITAVAKIYCISRSALTS
WVKLLKFGREEKLFAPPQRRRKTKLNQVQLQQIEEWIEENPNITIKEMRIRIQEKFRLNI
SKSTVHRYMQKMKFSYITPRPVHNGQDKSKQEEFKKKSQWSY
>ELAGILAN_01163 IS4 family transposase ISWosp8
MNLSWRGYRLIAADGSGMRLPSSGEIVSEFEPNGTTGTIGNLFVDLCTSLICSARLAAWN
IGEQTLAAEQLPEVITQMRLLNQEKLLFIYDRLQ
>ELAGILAN_01164 hypothetical protein
MCNILSLHMCDAQGPWNPDQITEYRLNFSVLFGVMRQKLYQVLIAPKNFQALFKYTR
>ELAGILAN_01165 hypothetical protein
MLHLTGLGNSALDPSSHAAWMTSYGPRMTEKRTQITPYNVIPARDAGIQVFLAIIG
>ELAGILAN_01166 hypothetical protein
MDVLVPALATVGTDDTKKVYTKSVADTAFAKIDASNLTEAANKKAFAEAILPAQDGDKSI
LVDKLGDAIASTDKAEYNVGTEQTAKQFLNSRGLIPSEDAIFNRLTSDDKFKTSVTIDVN
ASNNGFQEAVKNVMSQPKFDIPVGDDVALDWTW
>ELAGILAN_01167 hypothetical protein
MIFFIIKLITKTFQEFQENTTKKILGTHNEGRKEKEYLVGQVVYEKKHGERNNLKTRYKN
QVVKENLSNKVIINNRNRTIHRGNIKF
